{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 25)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nIdentify All ePHI and Relevant Information Systems                    | • Identify where ePHI is generated within the organization, where it enters the organization, where it moves within the organization, where it is stored, and where it leaves the organization. • Identify all systems 30 that house ePHI. Be sure to identify mobile devices, medical equipment, and IoT devices that store, process, or transmit ePHI. • Include all hardware and software that are used to collect, store, process, or transmit ePHI. • Analyze business functions and verify the ownership and control of information system elements as necessary. • Consider the impact of a merger or acquisition on risks to ePHI. During a merger or acquisition, new data pathways may be introduced that lead to ePHI being stored, processed, or transmitted in previously unanticipated places. | • Has all ePHI generated, stored, processed, and transmitted within the organization been identified? • Are all hardware and software for which the organization is responsible periodically inventoried? • Is the hardware and software inventory updated on a regular basis? • Have hardware and software that maintains or transmits ePHI been identified? Does this inventory include removable media and remote access devices? • Is the current configuration of organizational systems documented, including connections to other systems? • Has a BIA been performed? |\n| 2. Conduct Risk Assessment 31 32 Implementation Specification (Required) | • Conduct an accurate and thorough assessment of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of ePHI held by the covered entity or business associate. | • Are there any prior risk assessments, audit comments, security requirements, and/or security test results? • Is there intelligence available from agencies, the Office of the Inspector General (OIG), the United States Computer Emergency Readiness Team (US-CERT), virus alerts, and/or vendors?"}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 24}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 72)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ninformation; restrict access solely to the employees identified and only for the functions performed on behalf of the group health plan; and provide a mechanism for resolving issues of noncompliance.\nAny employee of the plan sponsor who receives protected health information for payment, health care operations or other matters related to the group health plan must be identified in the plan documents either by name or function. We assume that since individuals employed by the plan sponsor may change frequently, the group health plan would likely describe such individuals in a general manner. Any disclosure to employees or classes of employees not identified in the plan documents is not a permissible disclosure. To the extent a group health plan does have its own employees separate from the plan sponsor's employees, as the workforce of a covered entity ( i.e. the group health plan), they also are bound by the permitted uses and disclosures of this rule. The certification that must be given to the group health plan must state that the plan sponsor agrees to: (1) Not use or further disclose protected health information other than as permitted or required by the plan documents or as required by law; (2) ensure that any subcontractors or agents to whom the plan sponsor provides protected health information agree to the same restrictions; (3) not use or disclose the protected health information for employment-related actions; (4) report to the group health plan any use or disclosure that is inconsistent with the plan documents or this regulation; (5) make the protected health information accessible to individuals; (6) allow individuals to amend their information; (7) provide an accounting of its disclosures; (8) make its practices available to the Secretary for determining compliance; (9) return and destroy all protected health information when no longer needed, if feasible; and (10) ensure that the firewalls have been established."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 71}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 334)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nits on subsequent use and disclosure; and requiring return or destruction of the information at the earliest possible time.) Others said the court order should impose a ''minimum necessary'' standard.\nResponse: We have not revised the regulation in response to comments suggesting that we impose additional standards relating to disclosures to comply with court orders. Unlike administrative subpoenas, where there is no independent review of the order, court orders are issued by an independent judicial officer, and we believe that covered entities should be permitted under this rule to comply with them. Court orders are issued in a wide variety of cases, and we do not know what hardships might arise by imposing standards that would require judicial officers to make specific findings related to privacy. Comment: At least one commenter argued that the proposed rule would have placed too much burden on covered entities to evaluate whether to release information in response to a court order. This comment suggested that the regulation allow disclosure to attorneys for assessment of what the covered entity should release in response to a court order. Response: This regulation does not change current requirements on or rights of covered entities with respect to court orders for the release of health information. Where such disclosures are required today, they continue to be required under this rule. Where other law allows a covered entity to challenge a court order today, this rule will not reduce the ability of a covered entity to mount such a challenge. Under §164.514, a covered entity will be permitted to rely on the face of a court order to meet this rule's requirements for verification of the legal authority of the request for information. A covered entity may disclose protected health information to its attorneys as needed, to perform health care operations, including to assess the covered entity's appropriate response to court orders."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 333}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 430)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nor are together a single covered entity. (See § 164.504(b) for the rules requiring such designation.) If only one covered entity is designated for the subsidiaries, only one privacy officer is needed.\nFurther, we do not prohibit the privacy official of one covered entity from serving as the privacy official of another covered entity, so long as all the requirements of this rule are met for each such covered entity. ## Section 164.530(b)-Training\n\nComment: A few commenters felt that the proposed provision was too stringent, and that the content of the training program should be left to the reasonable discretion of the covered entity. Response: We clarify that we do not prescribe the content of the required training; the nature of the training program is left to the discretion of the covered entity. The scenarios in the NPRM preamble of potential approaches to training for different sized covered entities were intended as examples of the flexibility and scalability of this requirement. Comment: Most commenters on this provision asserted that recertification/ retraining every three years is excessive, restrictive, and costly. Commenters felt that retraining intervals should be left to the discretion of the covered entity. Some commenters supported retraining only in the event of a material change. Some commenters supported the training requirement as specified in the NPRM. Response: For the reasons cited by the commenters, we eliminate the triennial recertification requirements in the final rule. We also clarify that retraining is not required every three years. Retraining is only required in the case of material changes to the privacy policies and procedures of the covered entity. Comment: Several commenters objected to the burden imposed by required signatures from employees after they are trained. Many commenters suggested that electronic signatures be accepted for various reasons."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 429}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 402)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nResponse: We acknowledge that widespread restrictions on the use and disclosure of protected health information could result in some difficulties related to payment, research, quality assurance, etc.\nHowever, in our efforts to protect the privacy of health information about individuals, we have sought a balance in determining the appropriate level of individual control and the smooth operation of the health care system. In the final rule, we require certain covered providers and permit all covered entities to obtain consent from individuals for use and disclosure of protected health information for treatment, payment, and health care operations (see § 164.506). In order to give individuals some control over their health information for uses and disclosures of protected health information for treatment, payment, and health care operations, we provide individuals with the opportunity to request restrictions of such uses and disclosures. Because the right to request restrictions encourages discussions about how protected health information may be used and disclosed and about an individual's concerns about such uses and disclosures, it may improve communications between a provider and patient and thereby improve care. According to a 1999 survey on the Confidentiality of Medical Records by the California HealthCare Foundation, one out of every six people engage in behavior to protect themselves from unwanted disclosures of health information, such as lying to providers or avoiding seeking care. This indicates that, without the ability to request restrictions, individuals would have incentives to remain silent about important health information that could have an effect on their health and health care, rather than consulting a health care provider. Further, this policy is not a dramatic change from the status quo."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 401}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 197)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nr<15>2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\n- (B) The designation of an affiliated covered entity must be documented and the documentation maintained as required by paragraph (c) of this section.\n- (ii) Safeguard requirements. An affiliated covered entity must ensure that it complies with the applicable requirements of this part, including, if the affiliated covered entity combines the functions of a health plan, health care provider, or health care clearinghouse, § 164.308(a)(4)(ii)(A) and §164.504(g), as applicable. *\n\n*\n\n*\n\n*\n\n*\n\n- ■ 29. Revise § 164.106 to read as follows:\n\n## §164.106 Relationship to other parts. In complying with the requirements of this part, covered entities and, where provided, business associates, are required to comply with the applicable provisions of parts 160 and 162 of this subchapter. - ■ 30. The authority citation for subpart C of part 164 is revised to read as follows:\n\nAuthority: 42 U.S.C. 1320d-2 and 1320d4; sec. 13401, Pub. L. 111-5, 123 Stat. 260. - ■ 31. Revise § 164.302 to read as follows:\n\n## §164.302 Applicability. A covered entity or business associate must comply with the applicable standards, implementation specifications, and requirements of this subpart with respect to electronic protected health information of a covered entity. - ■ 32. In § 164.304, revise the definitions of ''Administrative safeguards'' and ''Physical safeguards'' to read as follows:\n\n## §164.304 Definitions. *\n\n*\n\n*\n\n*\n\n*\n\nAdministrative safeguards are administrative actions, and policies and procedures, to manage the selection, development, implementation, and maintenance of security measures to protect electronic protected health information and to manage the conduct of the covered entity's or business associate's workforce in relation to the protection of that information."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 196}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 427)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nat it was unreasonable to expect covered entities to track disclosures that are requested by the individual. They believed that consumers should be responsible for keeping track of their own requests.\nOther commenters asked that we specify that entities need not retain and provide copies of the individual's authorization to disclose protected health information. Some commenters were particularly concerned that if they maintain all patient information on a computer system, it would be impossible to link the paper authorization with the patient's electronic records. Another commenter suggested we allow entities to submit copies of authorizations after the 30-day deadline for responding to the individual, as long as the accounting itself is furnished within the 30-day window. Response: In the final rule we do not require disclosures to the individual to be included in the accounting. Other disclosures requested by the individual must be included in the accounting, unless they are otherwise excepted from the requirement. We do not agree that individuals should be required to track these disclosures themselves. In many cases, an authorization may authorize a disclosure by more than one entity, or by a class of entities, such as all physicians who have provided medical treatment to the individual. Absent the accounting, the individual cannot know whether a particular covered entity has acted on the authorization. We agree, however, that it is unnecessarily burdensome to require covered entities to provide the individual with a copy of the authorization. We remove the requirement. Instead, we require the accounting to contain a brief statement describing the purpose for which the protected health information was disclosed. The statement must be sufficient to reasonably inform the individual of the basis for the disclosure."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 426}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 34)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nin order to allow covered entities to use whatever is reasonable and appropriate. ''Digital signatures'' and ''soft tokens'' may be used, as well as many other mechanisms, to implement this standard.\nThe proposed mandatory implementation feature, ''Unique user identification,'' has been moved from this standard and is now a required implementation specification under ''Access control'' at § 164.312(a)(1). 17:54 Feb 19, 2003\n\nPO 00000\n\nFrm 00024\n\n''Automatic logoff'' has also been moved from this standard to the ''Access control'' standard and is now an addressable implementation specification. ## 5. Transmission Security (§ 164.312(e)(1))\n\nUnder ''Technical Security Mechanisms to Guard Against Unauthorized Access to Data that is Transmitted Over a Communications Network,'' we proposed that ''Communications/network controls'' be required to protect the security of health information when being transmitted electronically from one point to another over open networks, along with a combination of mandatory and optional implementation features. We proposed that some form of encryption must be employed on ''open'' networks such as the Internet or dial-up lines. In this final rule, we adopt integrity controls and encryption, as addressable implementation specifications. a. Comment: We received a number of comments asking for overall clarification as well as a definition of terms used in this section. A definition for the term ''open networks'' was the most requested action, but there was a general expression of dislike for the manner in which we approached this section, with some comments suggesting that the entire section be rewritten. A significant number of comments were received on the question of encryption requirements when dial-up lines were to be employed as a means of connectivity."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 33}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 142)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n, however, we modify the definition of designated record set. For a discussion of the significant changes made to the definition of designated record set, see § 164.501 and the corresponding preamble.\nUnder the revised definition, individuals have a right of access to any protected health information that is used, in whole or in part, to make decisions about individuals. This information includes, for example, information used to make health care decisions or information used to determine whether an insurance claim will be paid. Covered entities often incorporate the same protected health information into a variety of different data systems, not all of which will be utilized to make decisions about individuals. For example, information systems that are used for quality control or peer review analyses may not be used to make decisions about individuals. In that case, the information systems would not fall within the definition of designated record set. We do not require entities to grant an individual access to protected health information maintained in these types of information systems. ## Duration of the Right of Access\n\nAs in the proposed rule, covered entities must provide access to individuals for as long as the protected health information is maintained in a designated record set. ## Exceptions to the Right of Access\n\nIn the NPRM, we proposed to establish a right for individuals to\n\nVerDate 11<MAY>2000\n\n19:16 Dec 27, 2000\n\naccess any protected health information maintained in a designated record set. Though we proposed to permit covered entities to deny access in certain situations relating to the particular individual requesting access, we did not specifically exclude any protected health information from the right of access. In the final rule, we specify three types of information to which individuals do not have a right of access, even if the information is maintained in a designated record set."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 141}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.314(a) require?"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n§164.314(a) . 84 Readers may find useful resources in Appendix F, including OCR BAA guidance and/or templates that include applicable language. • Execute new or update existing agreements or arrangements, as appropriate. • Identify roles and responsibilities. • Include security requirements in business associate contracts and agreements to address the confidentiality, integrity, and availability of ePHI. • Specify any training requirements associated with the contract/agreement or arrangement, if reasonable and appropriate. | • Who is responsible for coordinating and preparing the final agreem"}], "metadata": {"source": "nist_sp800-66r2", "cfr_section": "§164.314(a)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 26)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n• What are the current and planned controls? • Have likelihood and impact been determined for relevant threats and vulnerabilities? • Have risk ratings been determined for relevant threats and vulnerabilities? • Is the facility located in a region prone to any natural disasters, such as earthquakes, floods, or fires? • Has responsibility been assigned to check all hardware and software -including hardware and software used for remote access -to determine whether selected security settings are enabled? • Is there an analysis of current safeguards and their effectiveness relative to the identified risks? • Have all processes involving ePHI been considered, including creating, receiving, maintaining, and transmitting |\n| 3. Implement a Risk Management Program 33 Implementation Specification (Required) | • Implement security measures sufficient to reduce risks and vulnerabilities to a reasonable and appropriate level to comply with §164.306(a). • Risk management should be performed with regular frequency to examine past decisions, reevaluate risk likelihood and impact levels, and assess the effectiveness of past remediation efforts • Create a Risk Management policy and program 34 that outlines organizational risk appetite and risk tolerance, personnel duties, responsible parties, the frequency of risk management, and required documentation. • A risk management methodology is included in Sec. 4 of this document. • Risk management resources are also included in Appendix F. | it? • Is executive leadership and/or management involved in risk management decisions? • Has a risk management program been created with related policies? • Does the regulated entity need to engage other resources (e.g., external expertise) to assist in risk management? • Do current safeguards ensure the confidentiality, integrity, and availability of all ePHI? • Do current safeguards protect against reasonably anticipated uses or disclosures of ePHI that are not permitted by the Privacy Rule?"}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 25}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 204)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nication at the end of the leave. The commenter sought clarification as to whether a provider could disclose information to an employer without first obtaining an individual's consent or authorization.\nAnother commenter suggested that the final rule explicitly exclude from the rule disclosures authorized by the FMLA, because, in the commenter's view, it provides more than adequate protection for the confidentiality of medical records in the employment context. Response: We disagree that the FMLA provides adequate privacy protections for individually identifiable health information. As we understand the FMLA, the need for employers to obtain protected health information under the statute is analogous to the employer's need for protected health information under the ADA. In both situations, employers may need protected health information to fulfill their obligations under these statutes, but neither statute requires covered entities to provide the information directly to the employer. Thus, covered entities in these circumstances will need an individual's authorizations before the disclosure is made to the employer. ## Federal Common Law\n\nComment: One commenter did not want the privacy rules to interfere with the federal common law governing collective bargaining agreements permitting employers to insist on the cooperation of employees with medical fitness evaluations. Response: We do not seek to interfere with legal medical fitness evaluations. These rules require a covered entity to have an individual's authorization before the information resulting from such evaluations is disclosed to the employer unless another provision of the rule applies. We do not prohibit employers from conditioning employment, accommodations, or other benefits, when legally permitted to do so, upon the individual/employee providing an authorization that would permit the disclosure of protected health information to employers by covered entities. See § 164.508(b)(4) below."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 203}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 406)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntter policy to allow covered entities to refuse to honor restrictions that they believe are not appropriate and leave the individual with the option of seeking service from a different covered entity.\nIn addition, many covered entities have information systems that would make it difficult or impossible to accommodate certain restrictions. Comment: Some commenters requested that self-pay patients have additional rights to restrict protected health information. Others believed that this policy would result in de facto discrimination against those patients that could not afford to pay out-ofpocket. Response: Under the final rule, the decision whether to tie an agreement to restrict to the way the individual pays for services is left to each covered entity. We have not provided self-pay patients with any special rights under the rule. Comment: Some commenters suggested that we require restrictions to be clearly noted so that insurers and other providers would be aware that they were not being provided with complete information. Response: Under the final rule, we do not require or prohibit a covered entity to note the existence of an omission of information. We encourage covered entities to inform others of the existence of a restriction, in accordance with professional practice and ethics, when appropriate to do so. In deciding whether or not to disclose the existence of a restriction, we encourage the covered entity to carefully consider whether disclosing the existence is tantamount to disclosure of the restricted protected health information so as to not violate the agreed to restriction. Comment: A few commenters said that covered entities should have the right to modify or revoke an agreement to restrict use or disclosure of protected health information. Response: We agree that, as circumstances change, covered entities should be able to revisit restrictions to which they had previously agreed."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 405}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 17)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\nd Assessment\n\nThe FDA recommends that manufacturers characterize and assess identified vulnerabilities because it will provide information that will aid manufacturers to triage remediation activities.\nWhen characterizing the exploitability of a vulnerability, the manufacturer should consider factors such as remote exploitability, attack complexity, threat privileges, actions required by the user, exploit code maturity, and report confidence. Scoring systems such as the 'Common Vulnerability Scoring System' (CVSS) 43 provide a consistent framework for assessing exploitability by quantifying the impact of the factors that influence exploitability. See Section VI for additional guidance on vulnerability risk assessment. ## ii. Risk Analysis and Threat Modeling\n\nThe FDA recommends that manufacturers conduct cybersecurity risk analyses that include threat modeling for each of their devices and to update those analyses over time. Risk analyses and threat modeling should aim to triage vulnerabilities for timely remediation. Threat modeling is a procedure for optimizing Network/Application/Internet Security by identifying objectives and vulnerabilities, and then defining countermeasures to prevent, or mitigate the effects of, threats to the system. Threat modeling provides traditional risk management and failure mode analysis paradigms, and a framework to assess threats from active adversaries/malicious use. For each vulnerability, a summary report should be produced that concisely summarizes the risk analysis and threat modeling information. Due to the cyclical nature of the analyses, the information should be traceable to related documentation. 43 'Common Vulnerability Scoring System,' Version 3.0, Scoring Calculator (https://www.first.org/cvss/calculator/3.0). ## iii. Analysis of Threat Sources 44\n\nThe FDA recommends manufacturers to analyze possible threat sources."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 16}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 373)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nally severe response, the Department's medical staff have access to the employee's medical records for the purpose of making a medical suitability determination under Executive Orders 10450 and 12968.\nTo restrict the Department's access to information at such a crucial time due to a lack of employee authorization leaves the Department no option but to suspend the employee's security clearance. This action automatically would result in an immediate forced departure from post, which negatively would affect both the Department, due to the unexpected loss of personnel, and the individual, due to the fact that a forced departure can have a long-term impact on his or her career in the Foreign Service. For this reason, the rule contains a limited security clearance exemption for the Department of State. The exemption allows the Department's own medical staff to continue to have access to an employee's medical file for the purpose of making a medical suitability determination for security purposes. The medical staff can convey a simple ''yes'' or ''no'' response to those individuals conducting the security investigation within the Department. In this way, the Department is able to make security determinations in exigent circumstances without disclosing any specific medical information to any employees other than the medical personnel who otherwise have routine access to these same medical records in an everyday non-security context. Second, and similarly, the final rule establishes a similar system for disclosures of protected health information necessary to determine worldwide availability or availability for mandatory service abroad under sections 101(a)(4) and 504 of the Foreign Service Act. The Act requires that Foreign Service members be suitable for posting throughout the world and for certain specific assignments. For this reason, we permit a limited exemption to serve the purposes of the statute."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 372}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 515)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n- (ii) Provide that the group health plan will disclose protected health information to the plan sponsor only upon receipt of a certification by the plan sponsor that the plan documents have been amended to incorporate the following provisions and that the plan sponsor agrees to: - (A) Not use or further disclose the information other than as permitted or required by the plan documents or as required by law; - (B) Ensure that any agents, including a subcontractor, to whom it provides protected health information received from the group health plan agree to the same restrictions and conditions that apply to the plan sponsor with respect to such information; - (C) Not use or disclose the information for employment-related actions and decisions or in connection with any other benefit or employee benefit plan of the plan sponsor; - (D) Report to the group health plan any use or disclosure of the information that is inconsistent with the uses or disclosures provided for of which it becomes aware; - (E) Make available protected health information in accordance with §164.524; - (F) Make available protected health information for amendment and incorporate any amendments to protected health information in accordance with §"}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 514}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 177)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nAnalysts (including responsibilities for designing systems and procedures), which is approximately $37.74/hr. See http://www.bls.gov/\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00115\n\nmaking them altogether.\nWe acknowledge the potential for some lost revenue due to these modifications in cases where covered entities are currently receiving financial remuneration from third parties to send health-related communications to individuals. However, as we do not know to what extent covered entities today currently operate in this manner, and commenters did not include specific information in this regard, we do not have data that could inform quantifying such loss. The final rule also requires an individual's authorization before a covered entity may disclose protected health information in exchange for remuneration (i.e., ''sell'' protected health information), even if the disclosure is for an otherwise permitted disclosure under the Privacy Rule. The final rule includes several exceptions to this authorization requirement. In the proposed rule, we stated that on its face, this new prohibition would appear to increase the burden to covered entities by requiring them to obtain authorizations in situations in which no authorization is currently required. However, we believed such a scenario to be unlikely. We believed most individuals would not authorize disclosures of their protected health information when they were informed the covered entity would be remunerated for the disclosure. Thus, we believed covered entities would simply discontinue making such disclosures as it would not be\n\noes/current/oes \\_ nat.htm . To this wage rate we have added 50 percent for benefits, which results in a total cost of $56.61/hr. Fmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with worthwhile for covered entities to continue to attempt to obtain such authorizations. We requested comment on these assumptions."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 176}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.404(d)(1) require?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n§164.404(d)(1). The statute also requires that, if the individual is deceased, notice must be sent to the last known address of the next of kin. The interim final rule adopts this provision at "}], "metadata": {"source": "breach_notification_2009", "cfr_section": "§164.404(d)(1)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 544)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nfication: Personnel designations. A covered entity must document the personnel designations in paragraph (a)(1) of this section as required by paragraph (j) of this section. (b)(1) Standard: Training.\nA covered entity must train all members of its workforce on the policies and procedures with respect to protected health information required by this subpart, as necessary and appropriate for the members of the workforce to\n\nFrm 00366\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ncarry out their function within the covered entity. - (2) Implementation specifications: Training. (i) A covered entity must provide training that meets the requirements of paragraph (b)(1) of this section, as follows:\n2. (A) To each member of the covered entity's workforce by no later than the compliance date for the covered entity;\n3. (B) Thereafter, to each new member of the workforce within a reasonable period of time after the person joins the covered entity's workforce; and\n4. (C) To each member of the covered entity's workforce whose functions are affected by a material change in the policies or procedures required by this subpart, within a reasonable period of time after the material change becomes effective in accordance with paragraph (i) of this section. 5. (ii) A covered entity must document that the training as described in paragraph (b)(2)(i) of this section has been provided, as required by paragraph (j) of this section. 6. (c)(1) Standard: Safeguards. A covered entity must have in place appropriate administrative, technical, and physical safeguards to protect the privacy of protected health information. - (2) Implementation specification: Safeguards. A covered entity must reasonably safeguard protected health information from any intentional or unintentional use or disclosure that is in violation of the standards, implementation specifications or other requirements of this subpart. 8. (d)(1) Standard: Complaints to the covered entity."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 543}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 126)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nexercising reasonable diligence, such as what frequency of monitoring for breaches is expected or what types of systems must covered entities and business associates have in place to detect breaches.\n## Final Rule\n\nWe retain § 164.404(a)(2) in this final rule without modification. We decline to adopt the suggestion that a covered entity be deemed to have discovered a breach only when management is notified of the breach. The HITECH Act itself provides that a breach is to be treated as discovered by a covered entity or business associate if ''any person, other than the individual committing the breach, that is an employee, officer, or other agent of such entity or associate'' knows or should reasonably have known of the breach. This concept is also consistent with the HIPAA Enforcement Rule and the Federal common law of agency. We encourage covered entities and business associates to ensure their workforce members and other agents are adequately trained on the importance of prompt reporting of privacy and security incidents. With respect to those commenters asking for guidance on what it means for a covered entity to be exercising reasonable diligence, we note that the term reasonable diligence, as defined in §160.401, means the business care and prudence expected from a person seeking to satisfy a legal requirement under similar circumstances. The determination of whether a person acted with reasonable diligence is generally a factual one, since what is reasonable depends on the circumstances. Factors to be considered include whether a covered entity or business associate took reasonable steps to learn of breaches and whether there were indications of breaches that a person seeking to satisfy the Rule would have investigated under similar circumstances."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 125}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 494)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nther estimate that it will require each health plan, on average, only 10 seconds to disseminate each notice. The total annual burden associated with this requirement is calculated to be 267,000 hours.\nHealth care providers with direct treatment relationships would provide a copy of the notice to an individual at the time of first service delivery to the individual, make the notice available at the service delivery site for individuals to request and take with them, whenever the content of the notice is revised, make the notice available upon request and post the notice, if required by this section, and post a copy of the notice in a location where it is reasonable to expect individuals seeking services from the provider to be able to read the notice. The annual number of notices disseminated by all providers is 613 million. We further estimate that it will require each health provider, on average, 10 seconds to disseminate each notice. This estimate is based upon the assumption that the required notice will be incorporated into and disseminated with other patient materials. The total annual burden associated with this requirement is calculated to be 1 million hours. In addition, a covered entity must document compliance with the notice requirements by retaining copies of the notices issued by the covered entity. Refer to § 164.530 for discussion. ## Section 164.522-Rights To Request Privacy Proteciton for Protected Health Information\n\nGiven that the burden associated with the following information collection requirements will differ significantly, by the type and size of health plan or health care provider, we are explicitly soliciting comment on the burden associated with the following requirements; as outlined and required by this section, covered entities must provide individuals with the opportunity to request restrictions related to the uses or disclosures of protected health information for treatment, payment, or health care operations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 493}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 271)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nires authorization, many of the activities are meaningless. For example, an employee who fails a drug test is unlikely to give authorization to the provider to share the information with the employer.\nResponse: Health care providers are covered entities under this rule if they conduct standard transactions. A health care provider who is an employee and is administering drug testing on behalf of the employer, but does not conduct standard transactions, is not a covered entity. If the health care provider is a covered entity, then we require authorization for the provider to disclose protected health information to an employer. Nothing in this rule, however, prohibits the employer from conditioning an individual's employment on agreeing to the drug testing and requiring the individual to sign an authorization allowing his or her drug test results to be disclosed to the employer. Comment: One commenter stated its belief that only a health center at an academic institution would be a covered entity under the component approach. This commenter believed it was less clear whether or not other components that may create protected health information ''incidentally'' through conducting research would also become covered entities. Response: While a covered entity must designate as a health care component the functions that make it a health care provider, the covered entity remains responsible for the actions of its workforce. Components that create protected health information through research would be covered entities to the extent they performed one of the required transactions described in §164.500; however, it is possible that the research program would not be part of the health care component, depending on whether the research program performed or supported covered functions."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 270}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 32)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nitical configuration settings such as energy output. ## · Execution Integrity\n\n- Use industry-accepted best practices to maintain and verify integrity of code while it is being executed on the device.\nFor example, Host-based Intrusion Detection/Prevention Systems (HIDS/HIPS) can be used to accomplish this goal; and\n- Carefully design and review all code that handles the parsing of external data using automated (e.g., static and dynamic analyses) and manual (i.e., code review) methods. ## Confidentiality\n\nManufacturers should ensure support for the confidentiality 81 of any/all data whose disclosure could lead to patient harm (e.g., through the unauthorized use of otherwise valid credentials, lack of encryption). Loss of confidentiality of credentials could be used by a threat-actor to effect multi-patient harm. Lack of encryption to protect sensitive information and or data at rest and in transit can expose this information to misuse that can lead to patient harm. For example, confidentiality is required in the handling and storage of cryptographic keys used for authentication because disclosure could lead to unauthorized use/abuse of device functionality. The proper implementation of authorization and authentication schemes as described in Sections A and B of this appendix will generally ensure confidentiality. However, manufacturers should evaluate and assess whether this is the case during their threat modeling and other risk management activities and make any appropriate changes to their medical device systems to ensure appropriate confidentiality controls are in place. ## Event Detection and Logging\n\nEvent detection and logging are critical capabilities that should be present in a device and the larger system in which it operates in order to ensure that suspected and successful attempts to compromise a medical device may be identified and tracked."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 31}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 2)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nindividuals' rights to receive electronic copies of their health information and to restrict disclosures to a health plan concerning treatment for which the individual has paid out of pocket in full.\n- Modify the individual authorization and other requirements to facilitate research and disclosure of child immunization proof to schools, and to enable access to decedent information by family members or others. - Require modifications to, and redistribution of, a covered entity's notice of privacy practices. - Adopt the additional HITECH Act enhancements to the Enforcement Rule not previously adopted in the October 30, 2009, interim final rule (referenced immediately below), such as the provisions addressing enforcement of noncompliance with the HIPAA Rules due to willful neglect. 2. Final rule adopting changes to the HIPAA Enforcement Rule to incorporate the increased and tiered civil money penalty structure provided by the HITECH Act, originally published as an interim final rule on October 30, 2009. 3. Final rule on Breach Notification for Unsecured Protected Health Information under the HITECH Act, which replaces the breach notification rule's ''harm'' threshold with a more objective standard and supplants an interim final rule published on August 24, 2009. 4. Final rule modifying the HIPAA Privacy Rule as required by the Genetic Information Nondiscrimination Act (GINA) to prohibit most health plans from using or disclosing genetic information for underwriting purposes, which was published as a proposed rule on October 7, 2009. Fmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nsroberts on DSK5SPTVN1PROD with\n\n## iii. Costs and Benefits\n\nThis final rule is anticipated to have an annual effect on the economy of $100 million or more, making it an economically significant rule under Executive Order 12866. Accordingly, we have prepared a Regulatory Impact Analysis that presents the estimated costs and benefits of the proposed rule."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 1}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 120)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntion permits a covered entity to make disclosures that are required by other laws, such as state mandatory reporting laws, or are required by legal process such as court orders or grand jury subpoena.\n## Section 164.512(k)-Uses and Disclosures for Specialized Government Functions\n\n## Application to Military Services\n\nIn the NPRM we would have permitted a covered entity providing health care to Armed Forces personnel to use and disclose protected health information for activities deemed necessary by appropriate military command authorities to assure the proper execution of the military mission, where the appropriate military authority had published by notice in the Federal Register (In the NPRM, we proposed that the Department of Defense would publish this Federal Register notice in the future.) The final rule takes a similar approach while making some modifications to the NPRM. One modification concerns the information that will be required in the Federal Register notice. The NPRM would have required a listing of (i) appropriate military command authorities; (ii) the circumstances for which use or disclosure without individual authorization would be required; and (iii) activities for which such use or disclosure would occur in order to assure proper execution of the military mission. In the final rule, we eliminate the third category and also slightly modify language in the second category to read: ''the purposes for\n\nVerDate 11<MAY>2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00079\n\nwhich the protected health information may be used or disclosed.''\n\nAn additional modification concerns the rule's application to foreign military and diplomatic personnel. The NPRM would have excluded foreign diplomatic and military personnel, as well as their dependents, from the proposed definition of ''individual,'' thereby excluding any protected health information created about these personnel from the NPRM's privacy protections."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 119}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 525)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n, from the party seeking the information that reasonable efforts have been made by such party to secure a qualified protective order that meets the requirements of paragraph (e)(1)(v) of this section.\n(iii) For the purposes of paragraph (e)(1)(ii)(A) of this section, a covered entity receives satisfactory assurances from a party seeking protecting health information if the covered entity receives from such party a written statement and accompanying documentation demonstrating that:\n\n- (A) The party requesting such information has made a good faith attempt to provide written notice to the individual (or, if the individual's location is unknown, to mail a notice to the individual's last known address);\n- (B) The notice included sufficient information about the litigation or proceeding in which the protected health information is requested to permit the individual to raise an objection to the court or administrative tribunal; and\n- (C) The time for the individual to raise objections to the court or administrative tribunal has elapsed, and:\n- ( 1 ) No objections were filed; or ( 2 ) All objections filed by the individual have been resolved by the court or the administrative tribunal and the disclosures being sought are consistent with such resolution. - (iv) For the purposes of paragraph (e)(1)(ii)(B) of this section, a covered entity receives satisfactory assurances from a party seeking protected health information, if the covered entity receives from such party a written statement and accompanying documentation demonstrating that:\n- (A) The parties to the dispute giving rise to the request for information have agreed to a qualified protective order and have presented it to the court or administrative tribunal with jurisdiction over the dispute; or\n- (B) The party seeking the protected health information has requested a qualified protective order from such court or administrative tribunal."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 524}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 485)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntion every three years and retraining in the event of material changes in policy. Based on public comment, particularly from small businesses, the Department has lessened the burden in the final rule.\nAs in the proposal, the final rule requires all employees who are likely to have contact with protected health information to be trained. Covered entities will have to train employees by the compliance date specific to the type of covered entity and train new employees within a reasonable time of initial employment. In addition, a covered entity will have to train each member of its workforce whose functions are affected by a material change in the policies or procedures of such entity. However, the final rule leaves to the employer the decisions regarding the nature and method of training to achieve this requirement. The Department expects a\n\nVerDate 11<MAY>2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00323\n\nwide variety of options to be made available by associations, professional groups, and vendors. Methods might include classroom instruction, videos, booklets, or brochures tailored to particular levels of need of workers and employers. Moreover, the recertification requirement of the NPRM has been dropped to ease the burden on small entities. ## Consent\n\nThe NPRM proposed prohibiting covered entities from requiring individuals to provide written consent for the use and disclosure of protected health information for treatment, payment, and health care operations purposes. The final rule requires certain health care providers to obtain written consent before using or disclosing protected health information for treatment, payment, and health care operations, with a few exceptions. This requirement was included in the final rule in response to comments that this reflects current practice of health care providers health care providers with direct treatment relationships."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 484}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 31)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\ndefinition of the term ''facility,'' as used in the proposed ''Media controls'' requirement description. Commenters were unclear whether we were talking about a corporate entity or the physical plant.\nResponse: The term ''facility'' refers to the physical premises and the interior and exterior of a building(s). We have added this definition to § 164.304. d. Comment: Several commenters believe the ''Media controls'' implementation features are too onerous and should be deleted. Response: While the ''Device and media controls'' standard must be met, we believe, based upon further review, that implementation of all specifications would not be necessary in every situation, and might even be counterproductive in some situations. For example, small providers would be unlikely to be involved in large-scale moves of equipment that would require systematic tracking, unlike, for example, large health care providers or health plans. We have, therefore, reclassified the ''Accountability and data backup'' implementation specification as\n\n17:54 Feb 19, 2003\n\nPO 00000\n\nFrm 00022\n\naddressable to provide more flexibility in meeting the standard. e. Comment: One commenter was concerned about the accountability impact of audit trails on system resources and the pace of system services. Response: The proposed audit trail implementation feature appears as the addressable ''Accountability'' implementation specification. The name change better reflects the purpose and intended scope of the implementation specification. This implementation specification does not address audit trails within systems and/or software. Rather it requires a record of the actions of a person relative to the receipt and removal of hardware and/or software into and out of a facility that are traceable to that person. The impact of maintaining accountability on system resources and services will depend upon the complexity of the mechanism to establish accountability."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 30}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 214)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthe Fifth Amendment protections against forced self incrimination. Other commenters stated that covered entities should be given the reason the Secretary needs to have access to its books and records.\nAnother commenter stated that there should be a limit to the frequency or extent of intrusion by the federal government into the business practices of a covered entity and that these provisions violate the Fourth Amendment of the Constitution. Finally, a coalition of church plans suggested that the Secretary provide church plans with additional procedural safeguards to reduce unnecessary intrusion into internal church operations. These suggested safeguards included permitting HHS to obtain records and other documents only if they are relevant and necessary to compliance and enforcement activities related to church plans, requiring a senior official to determine the appropriateness of compliance-related activities for church plans, and providing church plans with a selfcorrecting period similar to that Congress expressly provided in Title I of HIPAA under the tax code. Response: The final rule retains the proposed language in these two provisions with one change. The rule adds a provision indicating that the Secretary's access to information held by the covered entity may be at any time and without notice where exigent circumstances exist, such as where time is of the essence because documents might be hidden or destroyed. Thus, covered entities will generally receive notice before the Secretary seeks to access the entity's books or records. Other than the exigent circumstances language, the language in these two provisions is virtually the same as the language in this Department's regulation implementing Title VI of the Civil Rights Act of 1964. 45 CFR 80.6(b) and (c). The Title VI regulation is incorporated by reference in other Department regulations prohibiting discrimination of the basis of disability. 45 CFR 84.61."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 213}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 91)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ndisclosure of protected health information (other than psychotherapy notes), provided that the covered entity does not condition the provision of treatment on the individual signing the authorization.\nFor example, a covered health care provider that had a treatment relationship with an individual prior to the individual's enrollment in a clinical trial, but that is now providing research-related treatment to the individual, may elect to request a compound authorization from the individual: an authorization under §164.508(d) for the provider to use the protected health information it created prior to the initiation of the research that involves treatment, combined with an authorization under § 164.508(f) regarding use and disclosure of protected health information the covered provider will create for the purpose of the clinical trial. This compound authorization would be valid, provided the covered provider did not condition the research-related treatment on obtaining the authorization required under § 164.508(f), as permitted in § 164.508(b)(4)(i). However, we anticipate that covered entities will almost always, if not always, condition the provision of research-related treatment on the individual signing the authorization under §164.508(f) for the covered\n\nFrm 00060\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nentity's use or disclosure of protected health information created for the research."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 90}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 133)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\neration to the covered entity from a third party, the authorization must state that such remuneration is involved. - (b) Implementation specifications: general requirements. -(1) Valid authorizations.\n(i) A valid authorization is a document that meets the requirements in paragraphs (a)(3)(ii), (c)(1), and (c)(2) of this section, as applicable. - (ii) A valid authorization may contain elements or information in addition to the elements required by this section, provided that such additional elements or information are not inconsistent with the elements required by this section. - (2) Defective authorizations. An authorization is not valid, if the document submitted has any of the following defects:\n- (i) The expiration date has passed or the expiration event is known by the covered entity to have occurred;\n- (ii) The authorization has not been filled out completely, with respect to an element described by paragraph (c) of this section, if applicable;\n- (iii) The authorization is known by the covered entity to have been revoked;\n- (iv) The authorization violates paragraph (b)(3) or (4) of this section, if applicable;\n- (v) Any material information in the authorization is known by the covered entity to be false. - (3) Compound authorizations."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 132}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 403)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntheir medical information will have on treatment of other medical conditions, and therefore, allowing them to restrict use or disclosure of some information is contrary to the patient's best interest.\nResponse: We agree that patients may find it difficult to make such a calculus, and that it is incumbent on health care providers to help them do so. Health care providers may deny requests for or limit the scope of the restriction requested if they believe the restriction is not in the patient's best interest. Comment: One commenter asked whether an individual's restriction to disclosure of information will be a bar to liability for misdiagnosis or failure to diagnose by a covered entity who can trace its error back to the lack of information resulting from such restriction. Response: Decisions regarding liability and professional standards are determined by state and other law. This rule does not establish or limit liability for covered entities under those laws. We expect that the individual's request to restrict the disclosure of their protected health information would be considered in the decision of whether or not a covered entity is liable. Comment: One commenter requested that we allow health plans to deny coverage or reimbursement when a covered health care provider's agreement to restrict use or disclosure prevents the plan from getting the information that is necessary to determine eligibility or coverage. Response: In this rule, we do not modify insurers' rules regarding information necessary for payment. We recognize that restricting the disclosure of information may result in a denial of payment. We expect covered providers to explain this possibility to individuals when considering their requests for restrictions and to make alternative payment arrangements with individuals if necessary."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 402}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 313)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncase, jurisdictions have determined that public policy purposes cannot be achieved absent the use of certain protected health information, and we have chosen in general not to disturb their judgments.\nOn the other hand, where jurisdictions have determined that certain protected health information is not necessary to achieve\n\nFrm 00207\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\na public policy purpose, and only have permitted its use or disclosure, we do not believe that those judgments reflect an interest in use or disclosure strong enough to override the Congressional goal of protecting privacy rights. Moreover, the comments failed to present any compelling circumstance to warrant such a general provision. Despite commenters' concerns to the contrary, most of the beneficial uses and disclosures that the commenters referenced to support a general provision were, in fact, uses or disclosures already permissible under the rule. For example, the general statutory authorities relied on by one state health agency to investigate disease outbreaks or to comply with health data-gathering guidelines for reporting to certain federal agencies are permissible disclosures to public health agencies. Finally, in the final rule, we add new provisions to § 164.512 to address three examples raised by commenters of uses and disclosures that are authorized or permitted by law, but may not be required by law. First, commenters expressed concern for the states that provide for voluntary reporting to law enforcement or state protective services of domestic violence or of abuse, neglect or exploitation of the elderly or other vulnerable adults. As discussed below, a new section, § 164.512(c), has been added to the final rule to specifically address uses and disclosures of protected health information in cases of abuse, neglect, or domestic violence."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 312}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 17)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nealth information'' at §160.103 to provide that the Privacy and Security Rules do not protect the individually identifiable health information of persons who have been deceased for more than 50 years.\n## Overview of Public Comment\n\nThe public comments received on this proposal are discussed and responded to below in the section describing the modifications to § 164.502(f). ## Final Rule\n\nFor the reasons stated in the section regarding § 164.502(f), the final rule adopts the proposed modification to the definition of ''protected health information.''\n\n## d. Definition of ''State''\n\n## Proposed Rule\n\nThe HITECH Act at section 13400 includes a definition of ''State'' to mean ''each of the several States, the District of Columbia, Puerto Rico, the Virgin Islands, Guam, American Samoa, and the Northern Mariana Islands.'' This definition varies from paragraph (2) of the HIPAA definition of ''State'' at §160.103, which does not include reference to American Samoa and the Northern Mariana Islands. Thus, for consistency with the definition applied to the HIPAA Rules by the HITECH Act, we proposed to add reference to American Samoa and the Commonwealth of the Northern Mariana Islands in paragraph (2) of the definition of ''State'' at § 160.103. 18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00012\n\n## Final Rule\n\nThe Department did not receive substantive public comment on this proposal and the final rule adopts the proposed modifications to the definition of ''State.''\n\n## e."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 16}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 47)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrotection Agency as examples of oversight agencies that conduct oversight of government regulatory programs for which health information is necessary for determining compliance with program standards.\nIn the final rule, we include the following as additional examples of health oversight activities: (1) The U.S. Department of Justice's civil rights enforcement activities, and in particular, enforcement of the Civil Rights of Institutionalized Persons Act (42 U.S.C. 1997-1997j) and the Americans with Disabilities Act (42 U.S.C. 12101 et seq. ), as well as the EEOC's civil rights enforcement activities under titles I and V of the ADA; (2) the FDA's oversight of food, drugs, biologics, devices, and other products pursuant to the Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq. ) and the Public Health Service Act (42 U.S.C. 201 et seq. ); and (3) data analysis -performed by a public agency or by a person or entity acting under grant of authority from or under contract with a public agency -to detect health care fraud. ''Overseeing the health care system,'' which is included in the definition of health oversight, encompasses activities such as: oversight of health care plans;\n\noversight of health benefit plans; oversight of health care providers; oversight of health care and health care delivery; oversight activities that involve resolution of consumer complaints; oversight of pharmaceuticals, medical products and devices, and dietary supplements; and a health oversight agency's analysis of trends in health care costs, quality, health care delivery, access to care, and health insurance coverage for health oversight purposes. We recognize that health oversight agencies, such as the U.S. Department of Labor's Pension and Welfare Benefits Administration, may perform more than one type of health oversight. For example, agencies may sometimes perform audits and investigations and at other times conduct general oversight of health benefit plans."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 46}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 320)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ny could compromise the ability of law enforcement and oversight officials to perform their duties appropriately. Therefore, in the final rule, we retain the approach of proposed § 164.515 of the NPRM.\nSection 164.528(a)(2) of the final rule states that an individual's right to receive an accounting of\n\nVerDate 11<MAY>2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ndisclosures to a health oversight agency, law enforcement official, or for national security or intelligence purposes may be temporarily suspended for the time specified by the agency or official. As described in § 164.528(a)(2), for such a suspension to occur, the agency or official must provide the affected covered entity with a written request stating that an accounting to the individual would be reasonably likely to impede the agency's activity. The request must specify the time for which the suspension is required. We believe that providing a permanent exemption to the right to accounting for disclosures for health oversight purposes would fail to ensure that individuals are sufficiently informed about the extent of disclosures of their protected health information. Comment: One commenter recommended making disclosures to health oversight agencies subject to a modified version of the NPRM's proposed three-part test governing disclosure of protected health information to law enforcement pursuant to an administrative request (as described in proposed §164.510(f)(1)). Response: We disagree that it would be appropriate to apply the procedural requirements for law enforcement to health oversight. We apply more extensive procedural requirements to law enforcement disclosures than to disclosures for health oversight because we believe that law enforcement investigations more often involve situations in which the individual is the subject of the investigation (and thus could suffer adverse consequences), and we believe that it is appropriate to provide greater protection to individuals in such cases."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 319}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 460)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd or identifiers removed at the earliest possible time. Another approach has been for states to require researchers to obtain sensitive, identifiable information from a state public health department.\nOne state does not allow automatic release of protected health information for research purposes without notifying the subjects that their health information may be used in research and allowing them an opportunity to object to the use of their information. 43\n\nComparing state statutes to the final rule: The variability of state law regarding privacy of individually identifiable health information and the limitations of the applicability of many\n\n43 ''Medical records and privacy: Empirical effects of legislation; A memorial to Alice Hersh''; McCarthy, Douglas B; Shatin, Deborah; et al. Health Service Research: April 1, 1999; No. 1, Vol. 34; p. 417. The article details the effects of the Minnesota law conditioning disclosure of protected health information on patient authorization. such laws demonstrates the need for uniformity and minimum standards for privacy protection. This regulation is designed to meet these goals while allowing stricter state laws to be enacted and remain effective. A comparison of state privacy laws with the final regulation highlights several of the rule's key implications:\n\n- The rule will affect more entities than are covered or encompassed under many state laws. - No state law requires covered entities to make their privacy and access policies available to patients. Thus, all covered entities that have direct contact with patients will be required by this rule to prepare a statement of their privacy protection and access policies. This necessarily assumes that entities have to develop procedures if they do not already have them in place. - Among the three categories of covered entities, it appears that health plans will be the most significantly affected by the access provisions of the rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 459}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 325)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nisclosure is not accompanied by a court order, the covered entities be prohibited from disclosing protected health information unless the individual has been given notice and an opportunity to object.\nAnother commenter recommended requiring, in most circumstances, notice and an opportunity to object before a court order is issued and requiring the requestor of information to provide a signed document attesting the date of notification and forbid disclosure until ten days after notice is given. Response: We agree that in some cases the provision of notice with an opportunity to object to the disclosure is appropriate. Thus, in the final rule we provide that a covered entity may disclose protected health information in response to a subpoena, discovery request or other lawful process that is not accompanied by a court order if it receives satisfactory assurance from the party seeking the request that the requesting party has made a good faith attempt to provide written notice to the individual that includes sufficient information about the litigation or proceeding to permit the individual to raise an objection to the court or administrative tribunal and that the time for the individual to raise objections has elapsed (and that none were filed or all have been resolved). Covered entities may make reasonable efforts to provide such notice as well. In certain instances, however, the final rule permits covered entities to disclose protected health information for judicial and administrative proceedings without notice to the individual if the party seeking the request has made reasonable efforts to seek a qualified protective order, as described in the rule. A covered entity may also make reasonable efforts to seek a qualified protective order in order to make the disclosure."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 324}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 40)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\number of individuals affected, (d) steps the entity took to notify affected individuals and the degree of success it had in reaching affected individuals, and (e) steps taken to improve data security.\nWe anticipate the time and cost to prepare the report will be the same as that required for issuing a notice to the media. The cost for reporting the 56 breaches affecting 500 or more individuals based on the 2008 data is $4,200. ## Cost of Investigating a Breach\n\nAs a prerequisite to issuing a notice to individuals or to the media and the report to the Secretary when a breach occurs, the covered entity will need to conduct some form of investigation to determine the nature and cause of the breach. We anticipate that most breaches involving fewer than 500 records or individuals will be relatively easy to investigate and may involve a day of investigation to determine the cause and the extent of the breach. An office manager's time at $50 per hour multiplied by 8 hours equals $400 and multiplied by the number of breaches affecting fewer than 500 individuals is $20,000. We note that this estimate includes the time required to produce the documentation required by §164.414(a). For breaches involving 500 or more individuals, the breach investigation may take considerably longer and involve significantly greater costs. The FTC, in its proposed rule (74 FR 17921 and footnote 27) estimated 100 hours at a cost of $4,652. We accept this cost for investigating a breach as an upper bound, but we expect that the average investigation will take half the time and cost approximately $2,300. Based on the Ponemon report cited above, the most frequent cause for data breaches was a lost laptop computer accounting for 35 percent of all data breaches."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 39}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 99)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nheir commonly understood meanings, as well as any specialized meanings, pursuant to the Food, Drug, and Cosmetic Act (21 U.S.C. 321 et seq. ) or the Public Health Service Act (42 U.S.C. 201 et seq. ).\nFor example, ''postmarketing surveillance'' is intended to mean activities related to determining the safety or effectiveness of a product after it has been approved and is in commercial distribution, as well as certain Phase IV (post-approval) commitments by pharmaceutical companies. With respect to devices, ''post-marketing surveillance'' can be construed to refer to requirements of section 522 of the Food, Drug, and Cosmetic Act regarding certain implanted, life-sustaining, or lifesupporting devices. The term ''track'' includes, for example, tracking devices under section 519(e) of the Food, Drug, and Cosmetic Act, units of blood or other blood products, as well as tracebacks of contaminated food. In § 164.512(b)(iii), the term ''required'' refers to requirements in statute, regulation, order, or other\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nlegally binding authority exercised by the FDA. The term ''directed,'' as used in this section, includes other official agency communications such as guidance documents. We note that under this provision, a covered entity may disclose protected health information to a nongovernmental organization without individual authorization for inclusion in a private data base or registry only if the disclosure is otherwise for one of the purposes described in this provision ( e.g., for tracking products pursuant to FDA direction or requirements, for postmarketing surveillance to comply with FDA requirements or direction.)\n\nTo make a disclosure that is not for one of these activities, covered entities must obtain individual authorization or must meet the requirements of another provision of this rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 98}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 78)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nan electronic signature that meets those standards will be sufficient under this rule. We do not require any verification of the individual's identity or authentication of the individual's signature.\nWe expect covered health care providers that are required to obtain consent to employ the same level of scrutiny to these signatures as they do to the signature obtained on a document regarding the individual's consent to undergo treatment by the provider. ## Section 164.506(d)-Defective Consents\n\nUnder §164.506(d), there is no ''consent'' within the meaning of the rule if the completed document lacks a required element or if the individual has revoked the consent in accordance with §164.506(b)(5). ## Section 164.506(e)-Resolving Conflicting Consents and Authorizations\n\nSituations may arise where a covered entity that has obtained the individual's consent for the covered entity to use or disclose protected health information to carry out treatment, payment, or health care operations is asked to disclose protected health information pursuant to another written legal permission from the individual, such as an authorization, that was obtained by another person. Under §164.506(e), when the terms of a covered entity's consent conflict with the terms of another written legal permission from the individual to use or disclose protected health information (such as a consent obtained under state law by another covered entity or an authorization), the covered entity must adhere to the more restrictive document. By conflict, we mean that the consent and authorization contain inconsistencies. In implementing this section, we note that the consent under this section references the notice provided to the individual and the individual's right to request restrictions."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 77}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 7)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nnications about a covered entity's own products and services. As it proposed to do, the Department eliminates the special provisions for marketing health-related products and services at § 164.514(e).\nExcept as provided for at § 164.508(a)(3), a covered entity must have the individual's prior written authorization to use or disclose protected health information for marketing communications and will no longer be able to do so simply by meeting the disclosure and opt-out provisions, previously set forth in § 164.514(e). The Department agrees with commenters that the authorization provides individuals with more control over whether they receive marketing communications and better privacy protections for such uses and disclosures of their health information. In response to commenters who opposed this proposal, the Department does not believe that an opt-out requirement for marketing communications would provide a sufficient level of control for patients regarding their health information. Nor does the Department believe that a blanket authorization provides sufficient privacy protections for individuals. Section 164.508(c) sets forth the core elements of an authorization necessary to give individuals control of their protected health information. Those requirements give individuals sufficient information and notice regarding the type of use or disclosure of their protected health information that they are authorizing. Without such specificity, an authorization would not have meaning. Indeed, blanket marketing authorizations would be considered defective under § 164.508(b)(2). The Department adopts the general definition of ''marketing'' with one clarification."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 6}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 23)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nlents). A conduit transports information but does not access it other than on a random or infrequent basis as may be necessary for the performance of the transportation service, or as required by law.\nSince no disclosure is intended by the covered entity and the probability of exposure of any particular protected health information to a conduit is very small, we do not consider a conduit to be a business associate of the covered entity. We do not consider a financial institution to be acting on behalf of a covered entity, and therefore no business associate contract is required, when it processes consumer-conducted financial transactions by debit, credit or other payment card, clears checks, initiates or processes electronic funds transfers, or conducts any other activity that directly facilitates or effects the transfer of funds for compensation for health care. A typical consumerconducted payment transaction is when a consumer pays for health care or health insurance premiums using a check or credit card. In these cases the identity of the consumer is always included and some health information (e.g., diagnosis or procedure) may be implied through the name of the health care provider or health plan being paid. Covered entities that initiate such payment activities must meet the minimum necessary disclosure requirements described in the preamble to § 164.514. ## Covered Entity\n\nWe provided this definition in the NPRM for convenience of reference and proposed it to mean the entities to which part C of title XI of the Act applies. These are the entities described in section 1172(a)(1): Health plans, health care clearinghouses, and health care providers who transmit any health information in electronic form in connection with a transaction referred\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nto in section 1173(a)(1) of the Act (a ''standard transaction'')."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 22}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "When must a HIPAA breach be reported to HHS?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n<unknown>\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160, 162, and 164 [CMS-0049-F] RIN 0938-AI57\n\n## Health Insurance Reform: Security Standards\n\nAGENCY: Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Final rule. SUMMARY: This final rule adopts standards for the security of electronic protected health information to be implemented by health plans, health care clearinghouses, and certain health care providers. The use of the security standards will improve the Medicare and Medicaid programs, and otherFederal health programs and private health programs, and the effectiveness and efficiency of the health care industry in general by establishing a level of protection for certain electronic health information. This final rule implements some of the requirements of the Administrative Simplification subtitle of the Health Insurance Portability andAccountability Act of 1996 (HIPAA). DATES: Effective Date: These regulations are effective on April 21, 2003. Compliance Date: Covered entities, with the exception of small health plans, must comply with the requirements of this final rule by April 21, 2005. Small health plans must comply with the requirements of this final rule by April 21, 2006. FOR FURTHER INFORMATION CONTACT: William Schooler, (410) 786-0089. SUPPLEMENTARY INFORMATION:\n\n## Availability of Copies and Electronic Access\n\nTo order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 or by faxing to (202) 5122250. The cost for each copy is $10."}], "metadata": {"source": "security_rule_2003", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 62)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ne appropriate. Thus, the covered entity requesting an authorization for its own use of protected health information may provide assurances that the information will remain subject to the Privacy Rule.\nSimilarly, if a third party, such as a researcher, is seeking an authorization for research, the statement may refer to the privacy protections that the researcher will provide for the data. Under §164.508(c)(3), authorizations must be written in plain language so that individuals can understand the information contained in the form, and thus be able to make an informed decision about whether to give the authorization. A few commenters urged the Department to keep the plain language requirement as a core element of a valid authorization. Under the December 2000 Rule, the plain language requirement was not a requisite for a valid authorization. Nevertheless, under both the December 2000 Rule and the final modifications, authorizations must be written in plain language. The fact that the plain language requirement is not a core element does not diminish its importance or effect, and the failure to meet this requirement is a violation of the Rule. Finally, under § 164.508(c)(4), covered entities who seek an authorization are required to provide the individual with a copy of the signed authorization form. ## Response to Other Public Comments\n\nComment: A number of commenters specifically expressed support of the proposed authorization requirement for marketing, and urged the Department to adopt the requirement. However, one commenter claimed that requiring authorizations for marketing would reduce hospitals' ability to market their programs and services effectively in order to compete in the marketplace, and that obtaining, storing, and maintaining marketing authorizations would be too burdensome."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 61}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 480)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrmation is through the notice requirement. Increased use of mental health and services would be expected to be beneficial to the persons receiving the care, to their families, and to society at large.\nThe direct benefit to the individual from treatment would include improved quality of life, reduced disability associated with mental conditions, reduced mortality rate, and increased productivity associated with reduced disability and mortality. The benefit to families would include quality of life improvements and reduced medical costs for other family members associated with abusive behavior by the treated individual. The potential economic benefits associated with improving privacy of individually identifiable health information and thus encouraging some portion of individuals to seek initial mental health treatment or increase service use are difficult to quantify well. Nevertheless, using a methodology similar to the one used above to estimate potential savings in cancer costs, one can lay out a range of possible benefit levels to illustrate the possibility of cost savings associated with an expansion of mental health and treatment to individuals who, due to protections offered by the privacy regulation, might seek treatment that they otherwise would not have. This can be illustrated by drawing upon existing data on the economic costs of mental illness and the treatment effectiveness of interventions. The 1998 Substance Abuse and Mental Health Statistics Source Book from the Substance Abuse and Mental Health Services Administration (SAMHSA) estimates that the economic\n\n68 Standard Medical information; see http:// www.mayohealth.org for examples. VerDate 11<MAY>2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00318\n\nFmt 4701\n\nSfmt 4700\n\ncost to society of mental illness in 1994 was about $204.4 billion."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 479}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement administrative controls?"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\n<unknown>\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRIN 0991-AB14\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY: Office for Civil Rights, HHS. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (''HHS'' or ''Department'') modifies certain standards in the Rule entitled ''Standards for Privacy of Individually Identifiable Health Information'' (''Privacy Rule''). The Privacy Rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996. The purpose of these modifications is to maintain strong protections for the privacy of individually identifiable health information while clarifying certain of the Privacy Rule's provisions, addressing the unintended negative effects of the Privacy Rule on health care quality or access to health care, and relieving unintended administrative burdens created by the Privacy Rule. DATES: This final rule is effective on October 15, 2002. FOR FURTHER INFORMATION CONTACT: Felicia Farmer, 1-866-OCR-PRIV (1866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION:\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 (or toll-free at 1-866-5121800) or by fax to (202) 512-2250. The cost for each copy is $10.00."}], "metadata": {"source": "privacy_mod_2002", "safeguard_type": "administrative", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement administrative controls?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n<unknown>\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\n## Office of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRin: 0991-AB08\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY : Office of the Assistant Secretary for Planning and Evaluation, DHHS. ACTION\n\n: Final rule. SUMMARY : This rule includes standards to protect the privacy of individually identifiable health information. The rules below, which apply to health plans, health care clearinghouses, and certain health care providers, present standards with respect to the rights of individuals who are the subjects of this information, procedures for the exercise of those rights, and the authorized and required uses and disclosures of this information. The use of these standards will improve the efficiency and effectiveness of public and private health programs and health care services by providing enhanced protections for individually identifiable health information. These protections will begin to address growing public concerns that advances in electronic technology and evolution in the health care industry are resulting, or may result, in a substantial erosion of the privacy surrounding individually identifiable health information maintained by health care providers, health plans and their administrative contractors. This rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and\n\nAccountability Act of 1996. DATES : The final rule is effective on February 26, 2001. ## FOR FURTHER INFORMATION CONTACT :\n\nKimberly Coleman, 1-866-OCR-PRIV (1-866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION :\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954."}], "metadata": {"source": "privacy_rule_2000", "safeguard_type": "administrative", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement administrative controls?"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\n## Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on June 27, 2025. A draft select update to this document was issued on March 13, 2024. This document supersedes 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,' issued September 27, 2023. For questions about this document regarding CDRH-regulated devices, contact CyberMed@fda.hhs.gov. For questions about this document regarding CBER-regulated devices, contact the Office of Communication, Outreach, and Development (OCOD) at 1-800-835-4709 or 240-402-8010, or by email at industry.biologics@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Center for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to https://www.regulations.gov. Submit written comments to the Dockets Management Staff, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2021-D-1158. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an email request to CDRH-Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number GUI00001825 and complete title of the guidance in the request."}], "metadata": {"source": "fda_premarket_2023", "safeguard_type": "administrative", "implementation_spec": "required", "entity_type": "covered_entity", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 272)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n'knew or reasonably should have known'' of improper use of protected health information and failed to take reasonable steps to cure a breach of the business partner contract or terminate the contract.\nMany commenters urged that the term ''knew or should have known'' be clearly defined, with examples. Some commenters stated that covered entities should be liable only when they have actual knowledge of the material breach of the privacy rules by the business partner. Others recommended creation of a process by which a business partner could seek advice to determine if a particular disclosure would be appropriate. Some commenters stated that, in order to create an environment that would encourage covered entities to report misuses of protected health information, a covered entity should not be punished if it discovered an inappropriate disclosure. Response: With regard to our authority to require business associate contracts, we clarify that Congress gave the Department explicit authority to regulate what uses and disclosures of protected health information by covered entities are ''authorized.'' If covered entities were able to circumvent the requirements of these rules by the simple expedient of contracting out the performance of various functions, these rules would afford no protection to individually identifiable health information and be rendered meaningless. It is thus reasonable to place restrictions on disclosures to business associates that are designed to ensure that the personal medical information disclosed to them continues to be protected and used and further\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ndisclosed only for appropriate (i.e., permitted or required) purposes. We do not agree that business associate contracts would necessarily have complex terms or result in significant time and resource burdens. The implementation specifications for business associate contracts set forth in §164.504 are straightforward and clear."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 271}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 447)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nin the final small entities analysis (below), reflecting policy changes in the final rule and additional information and data collected by the Department since the issuance of the proposal last fall.\nWe believe that these estimates reasonably reflect the costs that various types of small entities will experience in general, though the actual costs of particular providers might vary considerably based on their current practices and technology. Comment: A respondent expressed the belief that small providers would bear a disproportionate share of the regulation's administrative burden because of the likelihood of larger companies incurring fewer marginal costs due to greater in-house resources to aid in the legal and technical analysis of the proposed rule. Response: As explained below, the Department does not agree with the assertion that small entities will be disproportionately affected. Based on discussions with a number of groups, the Department expects many professional and trade associations to provide their members with analysis of the regulation, including model policies, statements and basic training materials. This will minimize the cost for most small entities. Providers that use protected health information for voluntary practices, such as marketing or research, are more likely to need specific legal and technical assistance, but these are likely to be larger providers. Comment: Several commenters took issue with the ''top-down'' approach that we used to estimate costs for small businesses, believing that this methodology provided only a single point estimate, gave no indication of the variation around the estimate, and was subject to numerous methodological errors since the entities to which the numerator pertained may not have been\n\nFrm 00296\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nthe same as the denominator."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 446}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 128)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nentity or business associate to describe how the breach occurred such that it would create a roadmap for future breaches. ## Final Rule\n\nWe retain § 164.404(c) in this final rule without modification.\nThe content requirements in the Rule generally mirror the content requirements in the statute and each element is an important component of the notice to ensure individuals receive the information they need to protect themselves to the extent possible from the consequences of a breach and to learn what is being done to mitigate the breach and prevent future breaches. At the same time, the content provisions are sufficiently flexible to allow covered entities and business associates to tailor the breach notices based on the circumstances surrounding the breach and of the entity. In our experience in administering the Rule since 2009, the Rule provides sufficient flexibility to describe to the individual the circumstances surrounding the breach in a more general manner that still provides the individual with pertinent information but that does not provide a roadmap to third parties for future breaches. For example, the notice need not explain the exact type of vulnerability in the security of a covered entity's electronic records system that led to unauthorized access and how that vulnerability was exploited. Similarly, a covered entity has flexibility in describing what the covered entity is doing in response to a breach. Where employee sanctions are relevant based on the circumstances of the breach, a covered entity may determine that it wants to describe the sanctions imposed more generally and nothing in the Rule would require that the notice include the names of the employees involved. For example, a covered entity may want to indicate generally that the employees involved have been appropriately disciplined, particularly if multiple employees received varying levels of sanctions based on their degrees of involvement in the breach."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 127}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 22)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n0.410, which pertains only to affirmative defenses, to §160.401, so that they would apply to the entirety of Subpart D of Part 160 and the provisions regarding the imposition of civil money penalties.\nThe IFR did not modify the definitions themselves as the HITECH Act did not amend the definitions. Even though the HITECH Act did not amend the definitions of these terms,\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with the Department in its NPRM proposed certain modifications to the definition of ''reasonable cause'' to clarify the mens rea (state of mind) required for this category of violations, and to avoid the situation where certain violations would not fall within one of the established penalty tiers. This modification is discussed below. The Department did not propose modifications to the definitions of ''reasonable diligence'' and ''willful neglect.''\n\nIn the NPRM, the Department also included examples and guidance as to how the Department planned to apply the definitions of ''reasonable cause,'' ''reasonable diligence,'' and ''willful neglect'' to distinguish among the tiers of culpability. 75 FR 40877-40879. As commenters generally found this guidance helpful, the Department intends to publish the guidance on its web site. Modifications to the Definition of ''Reasonable Cause''\n\n## Proposed Rule\n\nReasonable cause is currently defined at § 160.401 to mean: ''circumstances that would make it unreasonable for the covered entity, despite the exercise of ordinary business care and prudence, to comply with the administrative simplification provision violated.'' This definition is consistent with the Supreme Court's ruling in United States v. Boyle, 469 U.S. 241, 245 (1985), which focused on whether circumstances were beyond the regulated person's control, thereby making compliance unreasonable. See 70 FR 20224, 20238."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 21}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 90)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nct research involving treatment to bind themselves to a more limited scope of uses and disclosures of research information than they would otherwise be permitted to make with non-research information.\nRather than creating a single definition of ''research information,'' we allow covered entities the flexibility to define that subset of protected health information they create during clinical research that is not necessary for treatment, payment, or health care operations and that the covered entity will use or disclose under more limited circumstances than it uses or discloses other protected health information. In designing their authorizations, we expect covered entities to be mindful of the often highly sensitive nature of research information and the impact of individuals' privacy concerns on their willingness to participate in research. Covered entities seeking authorization to use or disclose protected health information they create for the purpose of research that includes treatment of individuals, including clinical trials, must include in the authorization (in addition to the applicable elements required above) a description of the extent to which some or all of the protected health information created for the research will also be used or disclosed for purposes of treatment, payment, and health care operations. For example, if the covered entity intends to seek reimbursement from the individual's health plan for the routine costs of care associated with the research protocol, it must explain in the authorization the types of information that it will provide to the health plan for this purpose. This information, and the circumstances under which disclosures will be made for treatment, payment, and health care operations, may be more limited than the information and circumstances described in the covered entity's general consent and notice of privacy practices."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 89}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 92)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nhe Privacy Rule permits covered entities that participate in an OHCA to satisfy the notice requirements through the use of a joint notice, provided that the relevant conditions of §164.520(d) are met.\nSection 164.520(d)(3) further provides that provision of a joint notice to an individual by any one of the covered entities included in the joint notice satisfies the notice provision requirements at § 164.520(c) with respect to all others covered by the joint\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00061\n\nnotice. Thus, a health care provider with a direct treatment relationship with an individual that is participating in an OHCA only need make a good faith effort to obtain the individual's acknowledgment of the joint notice if that provider is the covered entity within the OHCA that is providing the joint notice to the individual. Where the joint notice is provided to the individual by a participating covered entity other than a provider with a direct treatment relationship with the individual, no acknowledgment need be obtained. However, covered entities that participate in an OHCA are not required to utilize a joint notice and may maintain separate notices. In such case, each covered health care provider with a direct treatment relationship within the OHCA must make a good faith effort to obtain the individual's acknowledgment of the notice he or she provides. Similarly, an affiliated covered entity may have one single notice that covers all of its affiliates. Thus, if the affiliated covered entity's notice is provided to the individual by a health care provider with which the individual has a direct treatment relationship, the health care provider must make a good faith effort to obtain the individual's acknowledgment of receipt of the notice. Alternatively, where the affiliated entity's notice is provided to the individual by a participating entity other than a provider with a direct treatment relationship with the individual, no acknowledgment need be obtained."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 91}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance?"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron Applied Cybersecurity Division Information Technology Laboratory\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\nFebruary 2024\n\n<!-- image -->\n\nU.S. Department of Commerce Gina M. Raimondo, Secretary\n\nNational Institute of Standards and Technology\n\nCertain commercial equipment, instruments, software, or materials, commercial or non-commercial, are identified in this paper in order to specify the experimental procedure adequately. Such identification does not imply recommendation or endorsement of any product or service by NIST, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose. There may be references in this publication to other publications currently under development by NIST in accordance with its assigned statutory responsibilities. The information in this publication, including concepts and methodologies, may be used by federal agencies even before the completion of such companion publications. Thus, until each publication is completed, current requirements, guidelines, and procedures, where they exist, remain operative. For planning and transition purposes, federal agencies may wish to closely follow the development of these new publications by NIST. Organizations are encouraged to review all draft publications during public comment periods and provide feedback to NIST."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 0}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 188)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nlikely to be a major cause of uncertainty. We have deferred to Congressional intent by crafting the permissible releases for public health, abuse, and oversight broadly. See, §§ 164.512(b)-(d) below.\nSince there must first be a conflict between a state law and a federal requirement in order for an issue of preemption to even arise, we think that, as a practical matter, few preemption questions should arise with respect to sections 1178(b) and 1178(c). With respect to preemption of state privacy laws under section 1178(a)(2)(B), however, we agree that the situation may be more difficult to ascertain, because the Secretary does not determine the preemption status of a state law under that section, unlike the situation with respect to section 1178(a)(2)(A). We have tried to define the term ''more stringent'' to identify and particularize the factors to be considered by courts to those relevant to privacy interests. The more specific (than the statute) definition of this term at § 160.202 below should provide some\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00124\n\nguidance in making the determination as to which law prevails. Ambiguity in the state of the law might also be a factor to be taken into account in determining whether a penalty should be applied. Comment: Several comments recommended that exception determinations or advisory opinions encompass a state act or code in its entirety (in lieu of a provision-specific evaluation) if it is considered more stringent as a whole than the regulation. It was argued that since the provisions of a given law are typically interconnected and related, adopting or overriding them on a provision-byprovision basis would result in distortions and/or unintended consequences or loopholes."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 187}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 411)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthey are covered entities or business associates of covered entities, and they must provide access only to protected health information that they maintain (or that their business associates maintain).\nIt would not be efficient to require a covered entity to compare another entity's information with that of the entity to which the request was addressed. (See the discussion regarding covered entities for information about whether a pharmacy benefit manager is a covered entity.)\n\nWe disagree with the fourth point: a billing company will be required by its business associate contract only to provide the requested protected health information to its physician client. This action will not violate any fiduciary responsibility. The physician client would in turn be required by the rule to provide access to the individual. Comment: Some commenters asked for clarification that the clearinghouse function of turning non-standardized data into standardized data does not create non-duplicative data and that ''duplicate'' does not mean ''identical.'' A few commenters suggested that duplicated information in a covered entity's designated record set be supplied only once per request. Response: We consider as duplicative information the same information in different formats, media, or presentations, or which have been standardized. Business associates who have materially altered protected health information are obligated to provide individuals access to it. Summary information and reports, including those of lab results, are not the same as the underlying information on which the summaries or reports were based. A clean document is not a duplicate of the same document with notations. If the same information is kept in more than one location, the covered entity has to produce the information only once per request for access. Comment: A few commenters suggested requiring covered entities to disclose to third parties without exception at the requests of individuals."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 410}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 76)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nty is\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nprohibited under § 164.502(a)(1) from using or disclosing protected health information for the purpose(s) included in the consent.\nA covered entity that seeks a consent must adhere to the individual's decision. In § 164.506(a)(5), we specify that a consent obtained by one covered entity is not effective to permit another covered entity to use or disclose protected health information, unless the consent is a joint consent. See §164.506(f) and the corresponding preamble discussion below regarding joint consents. A consent provides the individual's permission only for the covered entity that obtains the consent to use or disclose protected health information for treatment, payment, and health care operations. A consent under this section does not operate to authorize another covered entity to use or disclose protected health information, except where the other covered entity is operating as a business associate. We note that, where a covered entity is acting as a business associate of another covered entity, the business associate covered entity is acting for or on behalf of the principal covered entity, and its actions for or on behalf of the principal covered entity are authorized by the consent obtained by the principal covered entity. Thus, under this section, a health plan can obtain a consent that permits the health plan and its business associates to use and disclose protected health information that the health plan and its business associates create or receive. That consent cannot, however, permit another covered entity (that is not a business associate) to disclose protected health information to the health plan or to any other person. If a covered entity wants to obtain the individual's permission for another covered entity to disclose protected health information to it for treatment, payment, or health care operations purposes, it must seek an authorization in accordance with § 164.508(e)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 75}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 284)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nsed approach and requires most covered health care providers to obtain a consent from their patients to use or disclose protected health information for treatment, payment, and health care operations.\nProviders who have an indirect treatment relationship with the patient, as defined in § 164.501, cannot\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00188\n\nbe expected to have an opportunity to obtain consent and may continue to rely on regulatory authorization for their uses and disclosures for these purposes. As described in the comments, it is the relationship between the health care provider and the patient that is the basis for many decisions about uses and disclosures of protected health information. Much of the individually identifiable health information that is the subject of this rule is created when a patient interacts with a health care provider. By requiring covered providers to obtain consent for treatment, payment, and health care operations, the individual will have appropriate opportunity to consider the appropriate uses and disclosures of his or her protected health information. We also require that the consent contain a reference to the provider's notice, which contains a more detailed description of the provider's practices relating to uses and disclosures of protected health information. This combination provides the basis for an individual to have an informed conversation with his or her provider and to request restrictions. It is our understanding that it is common practice for providers to obtain consent for this type of informationsharing today. Many providers and provider organizations stated that they are ethically obligated to obtain the patient's consent and that it is their practice to do so. A 1998 study by Merz, et al, published in the Journal of Law, Medicine and Ethics examined hospital consent forms regarding disclosure of medical information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 283}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 191)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nprioritization and management considerations discussed above with respect to advisory opinions are also relevant here and make us reluctant to agree to a deadline for making exception determinations.\nThis is particularly true at the outset, since we have no experience with such requests. We therefore have no basis for determining how long processing such requests will take, how many requests we will need to process, or what resources will be available for such processing. We agree that states and other requesters should receive timely responses and will make every effort to make determinations as expeditiously as possible, but we cannot commit to firm deadlines in this initial rule. Once we have experience in handling exception requests, we will consult with states and others in regard to their experiences and concerns and their suggestions for improving the Secretary's expeditious handling of such requests. VerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00126\n\nWe are not accepting the suggestion that requests for exception be deemed approved if not acted upon in some defined time period. Section 1178(a)(2)(A) requires a specific determination by the Secretary. The suggested policy would not be consistent with this statutory requirement. It is also inadvisable from a policy standpoint, in that it would tend to maximize exceptions. This would be contrary to the underlying statutory policy in favor of uniform federal standards. Comment: One commenter took exception to the requirement for states to seek a determination from the Department that a provision of state law is necessary to prevent fraud and abuse or to ensure appropriate state regulation of insurance plans, contending that this mandate could interfere with the Insurance Commissioners' ability to do their jobs."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 190}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 329)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nations. A few commenters argued that effective law enforcement requires early access to as much information as possible, to rule out suspects, assess severity of criminal acts, and for other purposes.\nA few commenters noted the difficulties criminal investigators and prosecutors face when fighting complex criminal schemes. In general, these commenters argued that all disclosures of protected health information to law enforcement should be allowed, or for elimination of the process requirements proposed in §164.510(f)(1). Response: The importance and legitimacy of law enforcement activities are beyond question, and they are not at issue in this regulation. We permit disclosure of protected health information to law enforcement officials without authorization in some situations precisely because of the importance of these activities to public safety. At the same time, individuals' privacy interests also are important and legitimate. As with all the other disclosures of protected health information permitted under this regulation, the rules we impose attempt to balance competing and legitimate interests. Comment: Law enforcement representatives stated that law enforcement agencies had a good track record of protecting patient privacy and that additional restrictions on their access and use of information were not warranted. Some commenters argued that no new limitations on law enforcement access to protected health information were necessary, because sufficient safeguards exist in state and federal laws to prevent inappropriate disclosure of protected health information by law enforcement. Response: Disclosure of protected health information by law enforcement is not at issue in this regulation. Law enforcement access to protected health information in the first instance, absent any re-disclosure by law enforcement, impinges on individuals' privacy interests and must therefore be justified by a public purpose that outweighs individuals' privacy interests."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 328}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 456)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncorrecting the market failure also have practical implications. Where patients are concerned about lack of privacy protections, they might fail to get medical treatment that they would otherwise seek.\nThis failure to get treatment may be especially likely for certain conditions, including mental health, and HIV. Similarly, patients who are concerned about lack of privacy protections may report health information inaccurately to their providers when they do seek treatment. For instance, they might decide not to mention that they are taking prescription drugs that indicate that they have an embarrassing condition. These inaccurate reports may lead to mis-diagnosis and less-than-optimal treatment, including inappropriate additional medications. In short, the lack of privacy safeguards can lead to efficiency losses in the form of forgone or inappropriate treatment. In summarizing the economic arguments supporting the need for this regulation, the discussion here has emphasized the market failures that will be addressed by this regulation. These arguments become considerably stronger with the shift from predominantly paper to predominantly electronic records. As discussed in the benefits section below, the proposed privacy protections may prevent or reduce the risk of unfair treatment or discrimination against vulnerable categories of persons, such as those who are HIV positive, and thereby, foster better health. The proposed regulation may also help educate providers, health plans, and the general public about how protected health information is used. This education, in turn, may lead to\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00302\n\nbetter information practices in the future. ## D. Baseline Privacy Protections\n\nAn analysis of the costs and benefits of the regulation requires a baseline from which to measure the regulation's effects. For some regulations, the baseline is relatively straightforward."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 455}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 7)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\na medical device as a vector to compromise a connected device or system. ## F. Patient Harm\n\nHarm 15 is the physical injury or damage to the health of people, or damage to property or the environment.\nPatient harm is defined as physical injury or damage to the health of patients, including death. Risks to health posed by the device may result in patient harm. This guidance outlines the assessment of whether the risk 16 of patient harm is sufficiently controlled or uncontrolled. This assessment is based on an evaluation of the likelihood of exploit, the impact of exploitation on the device's safety and essential performance, and the severity of patient harm if exploited (see section VI). Other harms, such as loss of confidential information, including compromise of protected health information (PHI), are not considered 'patient harms' for the purposes of this guidance. 13 ICS-CERT - Industrial Control Systems Cyber Emergency Response Team\n\n14 See Department of Homeland Security, 'Frequently Asked Questions about Information Sharing and Analysis Organizations (ISAOs).'\n\n15 ANSI/AAMI/ISO 14971: 2007/(R)2010: Medical Devices - Application of Risk Management to Medical Devices, section 2.2 - definition of harm. 16 ANSI/AAMI/ISO 14971: 2007/(R)2010: Medical Devices - Application of Risk Management to Medical Devices, section 2.16 - definition of risk. ## Contains Nonbinding Recommendations\n\nNevertheless, the FDA recommends that manufacturers consider protecting the confidentiality of such information as part of their overall comprehensive risk management program."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 6}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 9)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nlations at 42 CFR part 2. These provisions require the confidentiality of substance abuse patient records. VerDate Nov&lt;24&gt;2008\n\nharm-especially in light of fears about employment discrimination.\nWe also address impermissible uses and disclosures involving limited data sets (as the term is used at 45 CFR 164.514(e) of the Privacy Rule), in paragraph (1) of the definition of ''breach'' at § 164.402 of the interim final rule. In the RFI discussed above, we asked for public comment on whether limited data sets should be considered unusable, unreadable, or indecipherable and included as a methodology in the guidance. A limited data set is created by removing the 16 direct identifiers listed in §164.514(e)(2) from the protected health information. 9 These direct identifiers include the name, address, social security number, and account number of an individual or the individual's relative, employer, or household member. When these 16 direct identifiers are removed from the protected health information, the information is not completely deidentified pursuant to 45 CFR 164.514(b). In particular, the elements of dates, such as dates of birth, and zip codes, are allowed to remain within the limited data set, which increase the potential for re-identification of the information. Because there is a risk of re-identification of the information within a limited data set, the Privacy Rule treats this information as protected health information that may only be used or disclosed as permitted by the Privacy Rule. Several commenters suggested that the limited data set should not be included in the guidance as a method to render protected health information unusable, unreadable, or indecipherable to unauthorized individuals such that breach notification is not required."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 8}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 154)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nies workforce will also be covered by the policies and procedures for ''minimum necessary'' use of protected health information, pursuant to § 164.514(d). We expect these provisions to work in tandem.\nWe do not prescribe the particular measures that covered entities must take to meet this standard, because the nature of the required policies and procedures will vary with the size of the covered entity and the type of activities that the covered entity undertakes. (That is, as with other provisions of this rule, this requirement is ''scalable.'') Examples of appropriate safeguards include requiring that documents containing protected health information be shredded prior to disposal, and requiring that doors to medical records departments (or to file cabinets housing such records) remain locked and limiting which personnel are authorized to have the key or pass-code. We intend this to be a common sense, scalable, standard. We do not require covered entities to guarantee the safety of protected health information against all assaults. Theft of protected health information may or may not signal a violation of this rule, depending on the circumstances and whether the covered entity had reasonable policies to protect against theft. Organizations such as the Association for Testing and Materials (ASTM) and the American Health Information Management Association (AHIMA) have developed a body of recommended practices for handling of protected health information that covered entities may find useful. We note that the proposed HIPAA Security Standards would require covered entities to safeguard the privacy and integrity of health information. For electronic information, compliance with both regulations will be required. In § 164.518(c)(2) of the NPRM we proposed requirements for verification procedures to establish identity and authority for permitted disclosures of protected health information. In the final rule, this material has been moved to § 164.514(h)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 153}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does 45cfr160 say about HIPAA compliance?"}, {"role": "assistant", "content": "According to 45cfr160:\n\n[Skip to main content](#main-content)\n\nMenu\n\n[![GovInfo logo](/media/GovInfo_logo_gray.png)](/)\n[Search](#searchHolder)\n\n* Browse\n  + [A to Z](/browse-a-z)\n  + [Category](/app/browse/category)\n  + [Date](/app/browse/date)\n  + [Committee](/browse/committee)\n  + [Author](/app/browse/author)\n* About\n  + [About](/about)\n  + [Policies](/about/policies)\n  + [Authentication](/about/authentication)\n  + [Digital Preservation](/about/digital-preservation)\n  + [History](/about/history)\n  + [Agency Submission](/about/agency-submission)\n  + [U.S. Government Information](/about/us-gov-info)\n  + [FDsys Retirement](/about#fdsys-transition)\n* Developers\n  + [Developer Hub](/developers)\n  + [API](https://api.govinfo.gov/docs)\n  + [Bulk Data Repository](%20/bulkdata)\n  + [Link Service](/link-docs)\n  + [Feeds](/feeds)\n  + [Sitemaps](/sitemaps)\n  + [System Design](/developers/system-design)\n* Features\n  + [All Features](/features)\n  + [Featured Content](/features/featured-content)\n  + [News](/features/news)\n  + [Release Notes](/features/release-notes)\n  + [Finding Publications](/features/finding-publications)\n* Help\n  + [Help](/help)\n  + [Finding Information](%20/help/finding-info)\n  + [What's Available](/help/whats-available)\n  + [Tutorials and Handouts](/help/tutorials-handouts)\n  + [Other Resources](%20/help/other-resources)\n* Feedback\n  + [Submit Feedback](https://www.surveymonkey.com/r/govinfo-feedback-survey)\n  + [Contact Us](/contact)\n\n* [Toggle the Search Widget\n  Search](#searchHolder)\n\n# Page Not Found\n\n![Icon: Share using Facebook](/sites/default/files/fb-icon-white.png)\n![Icon: Share using Email](/sites/default/files/email-icon-white.png)\n![Icon: Copy Link URL](/sites/default/files/link-icon-white.png)\n\n[Help](/help/other)\n\n---\n\n**Error occurred."}], "metadata": {"source": "45cfr160", "safeguard_types": ["unknown"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 0}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 55)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncourtordered warrants, and subpoenas issued by a court. We note that disclosures ''required by law'' include disclosures of protected health information required by this regulation in § 164.502(a)(2).\nIt does not include contracts between private parties or similar voluntary arrangements. This list is illustrative only and is not intended in any way to limit the scope of this paragraph or other paragraphs in § 164.512 that permit uses or disclosures to the extent required by other laws. We note that nothing in this rule compels a covered entity to make a use or disclosure required by the legal demands or prescriptions listed in this clarification or by any other law or legal process, and a covered entity remains free to challenge the validity of such laws and processes. ## Research\n\nWe proposed to define ''research'' as it is defined in the Federal Policy for the Protection of Human Subjects, at 45 CFR part 46, subpart A (referred to elsewhere in this rule as ''Common Rule''), and in addition, elaborated on the meaning of the term ''generalizable knowledge.'' In §164.504 of the proposed rule we defined research as ''* * * a systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge. 'Generalizable knowledge' is knowledge related to health that can be applied to populations outside of the population served by the covered entity.''\n\nThe final rule eliminates the further elaboration of ''generalizable knowledge.'' Therefore, the rule defines ''research'' as the term is defined in the Common Rule: a systematic investigation, including research\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ndevelopment, testing and evaluation, designed to develop or contribute to generalizable knowledge. ## Research Information Unrelated to Treatment\n\nWe delete this definition and the associated requirements from the final rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 54}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 3)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n...........38                         |\n| 5.1.5. Security Awareness and Training (§ 164.308(a)(5)) ...................................................................41                      |\n| 5.1.6.\nSecurity Incident Procedures (§ 164.308(a)(6)) .........................................................................44                   |\n| 5.1.7. Contingency Plan (§ 164.308(a)(7))............................................................................................47             |\n| 5.1.8. Evaluation (§ 164.308(a)(8)).......................................................................................................51        |\n| 5.2.1. Facility Access Controls (§ 164.310(a)).......................................................................................56             |\n| 5.1.9. Business Associate Contracts and Other Arrangements (§ 164.308(b)(1))................................54                                      |\n| 5.2.2. Workstation Use (§ 164.310(b)).................................................................................................59            |\n| 5.2.3. Workstation Security (§ 164.310(c)) ..........................................................................................61             |\n\n| 5.2.4. Device and Media Controls (§ 164.310(d)).................................................................................63                                                                                                                        |\n|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|\n| 5.3.1."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 2}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 168)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nactually subject to the regulation. Response: We reject the commenter's suggestion. We believe it is clear in the final rule that the entities subject to the regulation are those listed at § 160.102.\nHowever, we acknowledge that how the rule applies to integrated or other complex health systems needs to be addressed; we have done so in § 164.504 and in other provisions, such as those addressing organized health care arrangements. Comment: The preamble should clarify that self-insured group health and workmen's compensation plans are not covered entities or business partners. Response: In the preamble to the proposed rule we stated that certain types of insurance entities, such as workers' compensation, would not be covered entities under the rule. We do not change this position in this final rule. The statutory definition of health plan does not include workers' compensation products, and the regulatory definition of the term specifically excludes them. However, HIPAA specifically includes most group health plans within the definition of ''health plan.''\n\nComment: A health insurance issuer asserted that health insurers and third party administrators are usually required by employers to submit reports describing the volume, amount, payee, basis for services rendered, types of claims paid and services for which payment was requested on behalf of it covered employees. They recommended that the rule permit the disclosure of protected health information for such purposes. Response: We agree that health plans should be able to disclose protected health information to employers sponsoring health plans under certain circumstances. Section 164.504(f) explains the conditions under which protected health information may be disclosed to plan sponsors. We believe that this provision gives sponsors access to the information they need, but protects individual's information to the extent possible under our legislative authority."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 167}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 56)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nt specifications in the HIPAA, the purpose of the law, and principles that support the regulatory philosophy set forth in the E.O. 12866 of September 30, 1993, and the Paperwork Reduction Act of 1995.\nIn order to be designated as such, a standard should do the following:\n\n- Meet the needs of the health data standards user community, particularly health care providers, health plans, and health care clearinghouses. This principle supports the regulatory goal of cost-effectiveness. - Improve the efficiency and effectiveness of the health care system by leading to cost reductions for or improvements in benefits from electronic health care transactions. This principle supports the regulatory goals of cost-effectiveness and avoidance of burden. - Be consistent and uniform with the other HIPAA standards (that is, their data element definitions and codes, and their privacy and security requirements) and, secondarily, with other private and public sector health data standards. This principle supports the regulatory goals of consistency and avoidance of incompatibility, and it establishes a performance objective for the standard. - Be supported by an ANSIaccredited standards developing organization or other private or public organization that would ensure continuity and efficient updating of the standard over time. This principle supports the regulatory goal of predictability. - Have timely development, testing, implementation, and updating procedures to achieve administrative simplification benefits faster. This\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\n- Have low additional development and implementation costs relative to the benefits of using the standard. This principle supports the regulatory goals of cost-effectiveness and avoidance of burden. Jkt 200001\n\nprinciple establishes a performance objective for the standard. - Be precise and unambiguous but as simple as possible. This principle supports the regulatory goals of predictability and simplicity."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 55}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 306)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nappeared that an unconscious patient had been abused and disclosing that the individual is in the facility could give the attacker sufficient information to seek out the person and repeat the abuse).\nUnder the final rule, when the opportunity to object to uses and disclosures for a facility's directory cannot practicably be provided due to an individual's incapacity or an emergency treatment circumstance, covered health care providers may use or disclose some or all of the protected health information that the rule allows to be included in the directory, if the disclosure is: (1) consistent with the individual's prior expressed preference, if known to the covered health care provider; and (2) in the individual's best interest, as determined by the covered health care provider in the exercise of professional judgement. The rule allows covered health care providers making decisions about incapacitated patients to include some portions of the patient's information (such as name) but not other information (such as location in the facility) to protect patient interests. Section 164.510(b)-Uses and Disclosures for Involvement in the Individual's Care and Notification Purposes\n\nComment: A number of comments supported the NPRM's proposed approach, which would have allowed covered entities to disclose protected health information to the individual's next of kin, family members, or other close personal friends when the individual verbally agreed to the disclosure. These commenters agreed that the presumption should favor disclosures to the next of kin, and they believed that health care providers should encourage individuals to share genetic information and information about transmittable diseases with family members at risk. Others agreed with the general approach but suggested the individual's agreement be noted in the medical record."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 305}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 119)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrly, in situations involving a serious and imminent threat to public health or safety, law enforcement officials may be seeking protected health information from covered entities to locate a fugitive.\nIn the final rule, we clarify that if a situation fits one section of the rule (for example, § 164.512(j) on serious and imminent threats to health or safety), covered entities may disclose protected health information pursuant to that section, regardless of whether the disclosure also could be made pursuant to another section ( e.g., §164.512(f)), regarding disclosure to law enforcement officials). The proposed rule did not address situations in which covered entities could make disclosures to law enforcement officials about oral statements admitting participation in violent conduct or about escapees. In the final rule we permit, but do not require, covered entities to use or disclose protected health information, consistent with applicable law and standards of ethical conduct, in specific situations in which the covered entity, in good faith, believes the use or disclosure is necessary to permit law enforcement authorities to identify or apprehend an individual. Under paragraph (j)(1)(ii)(A) of this section, a covered entity may take such action because of a statement by an individual admitting participation in a violent crime that the covered entity reasonably believes may have resulted in serious physical harm to the victim. The\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nprotected health information that is disclosed in this case is limited to the statement and to the protected health information included under the limited identifying and location information in §164.512(f)(2), such as name, address, and type of injury. Under paragraph (j)(1)(ii)(B) of this section, a covered entity may take such action where it appears from all the circumstances that the individual has escaped from a correctional institution or from lawful custody."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 118}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 7)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nds or implementation specifications (as the terms are defined at § 160.103). Such provisions are in effect and apply at the time the final rule becomes effective or as otherwise specifically provided.\nIn addition, as explained above, our general rule for a 180-day compliance period for new or modified standards would not apply where we expressly provide a different compliance period in\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with the regulation for one or more provisions. For purposes of this rule, the 180-day compliance period would not govern the time period required to modify those business associate agreements that qualify for the longer transition period in § 164.532, as we discuss further below. Finally, the provisions of section 13402(j) of the HITECH Act apply to breaches of unsecured protected health information discovered on or after September 23, 2009, the date of the publication of the interim final rule. Thus, during the 180 day period before compliance with this final rule is required, covered entities and business associates are still required to comply with the breach notification requirements under the HITECH Act and must continue to comply with the requirements of the interim final rule. We believe that this transition period provides covered entities and business associates with adequate time to come into compliance with the revisions in this final rule and at the same time to continue to fulfill their breach notification obligations under the HITECH Act. ## IV. Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under the HITECH Act; Other Modifications to the HIPAA Rules\n\nThe discussion below provides a section-by-section description of the final rule, as well as responds to public comments where substantive comments were received regarding particular provisions. ## A."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 6}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 23)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nconsistent with the HIPAA Enforcement Rule (45 CFR part 160, subparts C through E), which provides that the federal common law of agency applies in determining agency liability under the HIPAA Rules.\nAlso, as with § 164.404(a)(2), we have modified the statutory language slightly to better conform to existing language in the HIPAA Enforcement Rule at 45 CFR 160.410, by incorporating the term ''reasonable diligence.'' We have made\n\nVerDate Nov&lt;24&gt;2008\n\nthese clarifications for consistency and uniformity across the regulations. Section 164.410(b) implements section 13402(d)(1) of the Act and provides that, with the exception provided in § 164.412, a business associate must provide notice of a breach of unsecured protected health information to a covered entity without unreasonable delay and in no case later than 60 days following the discovery of a breach. With respect to breaches at the business associate, the covered entity must provide the required notifications to affected individuals under §164.404(a) without unreasonable delay, but no later than 60 days. If a business associate is acting as an agent of a covered entity, then, pursuant to § 164.404(a)(2), the business associate's discovery of the breach will be imputed to the covered entity. Accordingly, in such circumstances, the covered entity must provide notifications under § 164.404(a) based on the time the business associate discovers the breach, not from the time the business associate notifies the covered entity. In contrast, if the business associate is an independent contractor of the covered entity (i.e., not an agent), then the covered entity must provide notification based on the time the business associate notifies the covered entity of the breach. As reflected in the comments we received in response to the timing of business associate notification to a covered entity following a breach, covered entities may wish to address the timing of the notification in their business associate contracts."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 22}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 332)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nommenters expressed concern that people will 8be less likely to provide protected health information for public health purposes if they fear the information could be used for law enforcement purposes.\nResponse: This regulation does not affect law enforcement access to records held by public health authorities, nor does it expand current law enforcement access to records held by covered entities. These agencies are for the most part not covered entities under HIPAA. Therefore, this regulation should not reduce current cooperation with public health efforts. Relationship to Other Provisions of This Regulation\n\nComment: Several commenters pointed out an unintended interaction between proposed §§164.510(f) and 164.510(n). Because proposed §164.510(n), allowing disclosures mandated by other laws, applied only if the disclosure would not fall into one of the categories of disclosures provided for in § 164.510 (b)-(m), disclosures of protected health information mandated for law enforcement purposes by other law would have been preempted. Response: We agree, and in the final rule we address this unintended interaction. It is not our intent to preempt these laws. To clarify the interaction between these provisions, in the final rule we have specifically added language to the paragraph addressing disclosures for law enforcement that permits covered entities to comply with legal mandates, and have included a specific cross reference in the provision of the final rule that permits covered entities to make other disclosures required by law. See § 164.512(a). Comment: Several commenters argued that, when a victim of abuse or of a crime has requested restrictions on disclosure, the restrictions should be communicated to any law enforcement officials who receive that protected health information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 331}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 90)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ndetails such as the form that the acknowledgment must take or the process for obtaining the acknowledgment. For example, the final Rule does not require an individual's signature to be on the notice.\nInstead, a covered health provider is permitted, for example, to have the individual sign a separate sheet or list, or to simply initial a cover sheet of the notice to be retained by the provider. Alternatively, a\n\nVerDate Aug&lt;2,&gt;2002\n\npharmacist is permitted to have the individual sign or initial an acknowledgment within the log book that patients already sign when they pick up prescriptions, so long as the individual is clearly informed on the log book of what they are acknowledging and the acknowledgment is not also used as a waiver or permission for something else (such as a waiver to consult with the pharmacist). For notice that is delivered electronically as part of first service delivery, the Department believes the provider's system should be capable of capturing the individual's acknowledgment of receipt electronically. In addition, those covered health care providers that choose to obtain consent from an individual may design one form that includes both a consent and the acknowledgment of receipt of the notice. Covered health care providers are provided discretion to design the acknowledgment process best suited to their practices. While the Department believes that the notice acknowledgment process must remain flexible, the Department does not consider oral acknowledgment by the individual to be either a meaningful or appropriate manner by which a covered health care provider may implement these provisions. The notice acknowledgment process is intended to provide a formal opportunity for the individual to engage in a discussion with a health care provider about privacy. At the very least, the process is intended to draw the individual's attention to the importance of the notice."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 89}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 15)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\none commenter stated, ''By avoiding prescription of the specific technologies health care entities should use to meet the law's requirements, you are opening the door for industry to apply innovation.\nTechnologies that don't currently exist or are impractical today could, in the near future, enhance health information security while minimizing the overall cost.'' Several other commenters stated that the requirements should be general enough to withstand changes to technology without becoming obsolete. One commenter anticipates no problems with meeting the standards. In contrast, one commenter suggested that whenever possible, specific technology recommendations should provide sufficient detail to promote systems interoperability and decrease the tendency toward adoption of multiple divergent standards. Several commenters stated that by letting each organization determine its own rules, the rules impose procedural burdens without any substantive benefit to security. Response: The overwhelming majority of comments supported our position. We do not believe it is appropriate to make the standards technology-specific because technology is simply moving too fast, for example, the increased use and sophistication of internet-enabled hand held devices. We believe that the implementation of these rules will promote the security of electronic protected health information by (1) providing integrity and confidentiality; (2) allowing only authorized individuals\n\n17:54 Feb 19, 2003\n\nPO 00000\n\nFrm 00011\n\naccess to that information; and (3) ensuring its availability to those authorized to access the information. The standards do not allow organizations to make their own rules, only their own technology choices. ## 3. Miscellaneous Comments\n\na."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 14}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 116)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ndentification of the IRB or privacy board. The NPRM did not propose that the documentation of waiver include a statement identifying the IRB or privacy board that approved the waiver of authorization.\nIn the final rule we require that such a statement be included in the documentation of alteration or waiver of individual authorization. By this requirement we mean that the name of the IRB or privacy board must be included in such documentation, not the names of individual members of the board. 2. Description of protected health information approved for use or disclosure. The NPRM did not propose that the documentation of waiver include a description of the protected health information that the IRB or privacy board had approved for use or disclosure without individual authorization. In considering waiver of authorization criterion\n\n§164.512(i)(2)(ii)(D), we expect the IRB or privacy board to consider the amount of information that is minimally needed for the study. The final rule requires that the documentation of IRB or\n\nFrm 00076\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nprivacy board approval of the alteration or waiver of authorization describe the protected health information for which use or access has been determined to be necessary for the research by the IRB or privacy board. For example, if the IRB or privacy board approves only the use or disclosure of certain information from patients' medical records, and not patients' entire medical record, this must be stated on the document certifying IRB or privacy board approval. 3. Review and approval procedures. The NPRM would not have required documentation of IRBs' or privacy boards' review and approval procedures."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 115}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 52)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nd Regulatory Affairs, Office of Management and Budget, Room 10235, New Executive Office Building, Washington, DC 20503, Attn: Brenda Aguilar, CMS Desk Officer. ## IV. Regulatory Impact Analysis\n\n## A.\nOverall Impact\n\nWe have examined the impacts of this rule as required by Executive Order 12866 (September 1993, Regulatory Planning and Review), the Regulatory Flexibility Act (RFA) (September 16, 1980, Pub. L. 96-354), section 1102(b) of the Social Security Act, the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4), and Executive Order 13132. Executive Order 12866 (as amended by Executive Order 13258, which merely reassigns responsibility of duties) directs agencies to assess all costs and benefits of available regulatory alternatives and, if regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis (RIA) must be prepared for major rules with economically significant effects ($100 million or more in any 1 year). Although we cannot determine the specific economic impact of the standards in this final rule (and individually each standard may not have a significant impact), the overall impact analysis makes clear that, collectively, all the standards will have a significant impact of over $100 million on the economy. Because this rule affects over 2 million entities, a requirement as low as $50 per entity would render this rule economically significant. This rule requires each of these entities to engage in, for example, at least some risk assessment activity; thus, this rule is almost certainly economically significant even though we do not have an estimate of the marginal impact of the additional security standards. However, the standards adopted in this rule are considerably more flexible than those anticipated in the overall impact analysis."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 51}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 283)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n(270 days) and avoid paying penalty taxes as allowed in the Internal Revenue Code. Response: We do not believe there is sufficient reason to treat church plans differently than other covered entities.\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nThe intent of the compliance reviews is to determine whether or not the plan is abiding by the regulation, not to gather information on the general operations of the church. As required by § 160.310(c), the covered entity must provide access only to information that is pertinent to ascertaining compliance with part 160 or subpart E of 164. Comment: Several commenters stated that employers often advocate on behalf of their employees in benefit disputes and appeals, answer questions with regard to the health plan, and generally help them navigate their health benefits. These commenters questioned whether this type of assistance would be allowed under the regulation, whether individual consent was required, and whether this intervention would make them a covered entity. Response: The final rule does nothing to hinder or prohibit plan sponsors from advocating on behalf of group health plan participants or providing assistance in understanding their health plan. Under the privacy rule, however, the plan sponsor could not obtain any information from the group health plan or a covered provider unless authorization was given. We do not believe obtaining authorization when advocating or providing assistance will be impractical or burdensome since the individual is requesting assistance and therefore should be willing to provide authorization. Advocating on behalf of participants or providing other assistance does not make the plan sponsor a covered entity. ## Section 164.506-Consent for Treatment, Payment, and Health Care Operations\n\nComment: Many commenters supported regulatory authorization for treatment, payment, and health care operations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 282}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 321)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\narticipate in criminal investigations. To clarify the boundary between law enforcement and oversight for purposes of complying with this rule, we add new language in the final rule, at §164.512(d)(2).\nThis section indicates that health oversight activities do not include an investigation or activity in which the individual is the subject of the investigation or activity and the investigation or activity does not arise out of and is not directly related to health care fraud. In this rule, we describe investigations involving suspected health care fraud as investigations related to: (1) The receipt of health care; (2) a claim for public benefits related to health; or (3) qualification for, or receipt of public benefits or services where a patient's health is integral to the claim for public benefits or services. In such cases, where the individual is the subject of the investigation and the investigation does not relate to health care fraud, identified as investigations regarding issues (a) through (c), the rules regarding disclosure for law enforcement purposes (see § 164.512(f)) apply. Where the individual is not the subject of the activity or investigation, or where the investigation or activity relates to health care fraud, a covered entity may make a disclosure pursuant to § 164.512(d)(1), allowing uses and disclosures for health oversight activities. For example, when the U.S. Department of Labor's Pension and Welfare Benefits Administration (PWBA) needs to analyze protected health information about health plan enrollees in order to conduct an audit or investigation of the health plan ( i.e., the enrollees are not subjects of the investigation) to investigate potential fraud by the health plan, the health plan may disclose protected health information to the PWBA under the health oversight rules."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 320}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 18)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nand privacy concerns with a covered entity being required to obtain contact information for next of kin of a deceased patient, if the individual did not otherwise provide the information while alive.\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\24AUR2.SGM\n\n24AUR2\n\nJkt 217001\n\nerowe on DSK5CLS3C1PROD with RULES\\_2\n\nIf a covered entity does not have sufficient contact information for some or all of the affected individuals, or if some notices are returned as undeliverable, the covered entity must provide substitute notice for the unreachable individuals in accordance with § 164.404(d)(2) of the interim final rule. Substitute notice should be provided as soon as reasonably possible after the covered entity is aware that it has insufficient or out-of-date contact information for one or more affected individuals. Whatever form of substitute notice is provided, the notice must contain all the elements that §164.404(c) requires be included in the direct written notice to individuals. With respect to decedents, however, the rule provides that a covered entity is not required to provide substitute notice for the next of kin or personal representative in cases where the covered entity either does not have contact information or has out-of-date contact information for the next of kin or personal representative. Section 164.404(d)(2) requires that the substitute form of notice be reasonably calculated to reach the individuals for whom it is being provided. If there are fewer than 10 individuals for whom the covered entity has insufficient or out-ofdate contact information to provide the written notice, § 164.404(d)(2)(i) permits the covered entity to provide substitute notice to such individuals through an alternative form of written notice, by telephone, or other means."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 17}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 30)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nduces a more homogeneous distribution of affected individuals and improves the reliability of the analysis. Removing the outlier reduced the number of affected individuals from 5,087,032 to 2,887,032.\nAlthough the type of data breach that occurred in 2008 was not unusual, the number of persons affected was six times greater than the next highest breach and the number of individuals affected is far from the average number for the year. In 2007, a State mental health agency reported the loss of records affecting 2.9 million individuals resulting from the agency's data processor's negligence. The next largest breach in 2007 involved 375,000 individuals and represents one eighth the number of individuals in the mental health agency breach. Without doubt, breaches of the magnitude we see in the university hospital and State mental health breaches are a serious concern to the Department. Excluding such disproportionately large breaches from the cost analysis should not be construed as a lack of interest or concern in the security of protected health information at these institutions. We could have included the university hospital breach in our 2008 analysis, but it is clear that the incident does not represent the average or typical case. Since our purpose is to present and illustrate the costs of an average breach, we believe that the inclusion of the one unusually large breach in 2008 would skew the results and present a distorted picture of the level of costs that a typical covered entity could expect. In reviewing the following analysis, one must keep in mind that we are able to capture only breaches that are either reported to the DataLoss database or are reported in the media. We suspect that some percent of breaches in the healthcare sector as well as in other sectors of the economy go unreported either because they are not detected or because, in the opinion of the entity, no harm was done."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 29}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 91)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nDSK5SPTVN1PROD with of information to be provided in the actual breach notification to the individual. However, covered entities that wish to include additional or more detailed information may do so.\nThese changes represent material changes to the NPP of covered entities. We disagree with the few commenters who argued that such modifications to §164.520 do not constitute material changes of privacy practices requiring the distribution of new NPPs. The modifications to § 164.520 are significant and are important to ensure that individuals are aware of the HITECH Act changes that affect privacy protections and individual rights regarding protected health information. Section 164.520(c)(1) of the final rule requires a health plan that currently posts its NPP on its Web site in accordance with § 164.520(c)(3)(i) to: (1) Prominently post the material change or its revised notice on its web site by the effective date of the material change to the notice (e.g., the compliance date of this final rule) and (2) provide the revised notice, or information about the material change and how to obtain the revised notice, in its next annual mailing to individuals then covered by the plan, such as at the beginning of the plan year or during the open enrollment period. Health plans that do not have customer service web sites are required to provide the revised NPP, or information about the material change and how to obtain the revised notice, to individuals covered by the plan within 60 days of the material revision to the notice. These requirements apply to all material changes including, where applicable, the rule change adopted pursuant to GINA to prohibit most health plans from using or disclosing genetic information for underwriting purposes. We believe these distribution requirements best balance the right of individuals to be informed of their privacy rights with the burden on health plans to provide the revised NPP."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 90}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 362)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nion in a specific and meaningful way, an expiration date, and where, use of disclosure of the requested information will result in financial gain to the entity, a statement that such gain will result.\nWe believe that the authorization requirements provide individuals with information necessary to determine whether to authorize a specific use or disclosure of protected health information about themselves, that are not required by the Common Rule. Therefore, in the final rule, we retain the requirement for authorization for all uses and disclosures of protected health information not otherwise permitted without authorization by the rule. Some of the proposed requirements for authorization were modified in the final rule as discussed in the preamble on §164.508. The comments received on specific proposed elements of authorization as they would have pertained to research are addressed below. Comment: A number of commenters, including several from industry and consumer groups, recommended that the final rule require patients' informed consent as stipulated in the Common Rule. These commenters asserted that the proposed authorization document was inadequate for research uses and disclosures of protected health information since it included fewer elements than required for informed consent under the Common Rule, including for example, the Common Rule's requirement that the informed consent document include: (1) A description of any reasonably foreseeable risks or discomforts to the subject; (2) a description of any benefits to the subject or to others which may reasonably be expected from the research (Common Rule, § \\_\\_ .116(a)). Response: While we agree that the ethical conduct of research requires the voluntary informed consent of research subjects, as stipulated in the Common Rule, as we have stated elsewhere, the privacy rule is limited to protecting the confidentiality of individually identifiable health information, and not protecting human subjects more broadly."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 361}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 52)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ntes that are subcontractors. Rather, a business associate would be required to obtain such assurances from a subcontractor. Thus, the proposed provisions would not change the parties to the contracts.\nFor example, a covered entity may choose to contract with a business associate (contractor) to use or disclose protected health information on its behalf, the business associate may choose to obtain the services of (and exchange protected health information with) a subcontractor (subcontractor 1), and that subcontractor may, in turn, contract with another subcontractor (subcontractor 2) for services involving protected health information. The contractor and subcontractors 1 and 2 would now be business associates with direct liability under the HIPAA Rules, and would be required to obtain business associate agreements with the parties with whom they contract for services that involve access to protected health information. (Note, however, as discussed above with respect to the definition of ''business associate,'' direct liability under the HIPAA Rules would attach regardless of whether the contractor and subcontractors have entered into the required business associate agreements.)\n\nWe also proposed to remove §164.502(e)(1)(iii), which provides that a covered entity that violates the satisfactory assurances it provided as a business associate of another covered entity will be in noncompliance with the Privacy Rule's business associate agreement provisions, given that proposed changes to § 164.502 would now restrict directly the uses and disclosures of protected health information by a business associate, including a covered entity acting as a business associate, to those uses and disclosures permitted by its business associate agreement."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 51}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 230)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nreveal the type of\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ninformation (such as the diagnosis) that is detrimental to an individual's privacy interest in the work environment.\nResponse: References to personal information such as those suggested by the commenters could be individually identifiable health information if the references were created or received by a health care provider, health plan, employer, or health care clearinghouse and they related to the past, present, or future physical or mental health or condition, the provision of health care to an individual, or the past, present, or future payment for the provision of health care to an individual. Although these fitness for duty statements may not reveal a diagnosis, they do relate to a present physical or mental condition of an individual because they describe the individual's capacity to perform the physical and mental requirements of a particular job at the time the statement is made (even though there may be other non-health-based qualifications for the job). If these statements were created or received by one of more of the entities described above, they would be individually identifiable health information. ## Law Enforcement Official\n\nComment: Some commenters, particularly those representing health care providers, expressed concern that the proposed definition of ''law enforcement official'' could have allowed many government officials without health care oversight duties to obtain access to protected health information without patient consent. Response: We do not intend for the definition of ''law enforcement official'' to be limited to officials with responsibilities directly related to health care. Law enforcement officials may need protected health information for investigations or prosecutions unrelated to health care, such as investigations of violent crime, criminal fraud, or crimes committed on the premises of health care providers."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 229}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 504)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nion. - 164.526 Amendment of protected health information. - 164.528 Accounting of disclosures of protected health information. - 164.530 Administrative requirements. - 164.532 Transition requirements.\n- 164.534 Compliance dates for initial implementation of the privacy standards. Authority: 42 U.S.C. 1320d-2 and 1320d4, sec. 264 of Pub. L. 104-191, 110 Stat. 2033-2034 (42 U.S.C. 1320(d-2(note)). ## Subpart A-General Provisions\n\n## §164.102 Statutory basis. The provisions of this part are adopted pursuant to the Secretary's authority to prescribe standards, requirements, and implementation standards under part C of title XI of the Act and section 264 of Public Law 104191. ## §164.104 Applicability. Except as otherwise provided, the provisions of this part apply to covered entities: health plans, health care clearinghouses, and health care providers who transmit health information in electronic form in connection with any transaction referred to in section 1173(a)(1) of the Act. ## §164.106 Relationship to other parts. In complying with the requirements of this part, covered entities are required to comply with the applicable provisions of parts 160 and 162 of this subchapter. ## Subpart B-D-[Reserved]\n\n## Subpart E-Privacy of Individually Identifiable Health Information\n\n## §164.500 Applicability. (a) Except as otherwise provided herein, the standards, requirements, and\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nimplementation specifications of this subpart apply to covered entities with respect to protected health information. (b) Health care clearinghouses must comply with the standards, requirements, and implementation specifications as follows:\n\n- (1) When a health care clearinghouse creates or receives protected health information as a business associate of another covered entity, the clearinghouse must comply with:\n2. (i) Section 164.500 relating to applicability;\n3. (ii) Section 164.501 relating to definitions;\n4."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 503}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 186)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nvocated allowing all covered entities (including individuals, providers and insurers), or private sector organizations, to request determinations and opinions with respect to preemption of state laws.\nSeveral commenters argued that limiting requests to states would deny third party stakeholders, such as life and disability income insurers, any means of resolving complex questions as to what rule they are subject to. One commenter noted that because it is an insurer who will be liable if it incorrectly analyzes the interplay between laws and reaches an incorrect conclusion, there would be little incentive for the states to request clarification. It would also cause large administrative burdens which, it was stated, would be costly and confusing. It was also suggested that the request for the exception be made to the applicable state's attorney general or chief legal officer, as well as the Secretary. Various changes to the language were suggested, such as adding that ''a covered entity, or any other entity impacted by this rule'' be allowed to submit the written request. Response: We agree, and have changed §164.204(a) below accordingly. The decision to eliminate advisory opinions makes this issue moot with respect to those opinions. Comment: Several commenters noted that it was unclear under the proposed rule which state officials would be authorized to request a determination. Response: We agree that the proposed rule was unclear in this respect. The final rule clarifies who may make the request for a state, with respect to exception determinations. See, §160.204(a). The language adopted should ensure that the Secretary receives an authoritative statement from the state. At the same time, this language provides states with flexibility, in that the governor or other chief elected official may choose to designate other state officials to make such requests."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 185}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 202)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nlation conflicts with the DOT guidelines regarding positive alcohol and drug tests that require the employer be notified in writing of the results. This document contains protected health information.\nIn addition, the treatment center records must be provided to the Substance Abuse Professional (''SAP'') and the employer must receive a report from SAP with random drug testing recommendations. Response: It is our understanding that DOT requires drug testing of all applicants for employment in safetysensitive positions or individuals being transferred to such positions. Fmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nEmployers, pursuant to DOT regulations, may condition an employee's employment or position upon first obtaining an authorization for the disclosure of results of these tests to the employer. Therefore, we do not believe the final rules conflict with the DOT requirements, which do not prohibit obtaining authorizations before such information is disclosed to employers. ## Developmental Disabilities Act\n\nComment: One commenter urged HHS to ensure that the regulation would not impede access to individually identifiable health information to entities that are part of the Protection and Advocacy System to investigate abuse and neglect as authorized by the Developmental Disabilities Bill of Rights Act. Response: The Developmental Disabilities Assistance and Bill of Rights Act of 2000 (''DD Act'') mandates specific disclosures of individually identifiable health information to Protection and Advocacy systems designated by the chief elected official of the states and Territories. Therefore, covered entities may make these disclosures under § 164.512(a) without first obtaining an individual's authorization, except in those circumstances in which the DD Act requires the individual's authorization. Therefore, the rules below will not impede the functioning of the existing Protection and Advocacy System."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 201}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 108)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nion'' as (i) name; (ii) address; (iii) Social Security number; (iv) date of birth; (v) place of birth; (vi) type of injury or other distinguishing characteristic; and (vii) date and time of treatment.\nThe final rules generally adopts this provision of the NPRM with a few modifications. In the final rule, we expand the circumstances under which limited information about suspects, fugitives, material witnesses, and missing persons may be disclosed, to include not only cases in which law enforcement officials are seeking to identify such individuals, but also cases in which law enforcement officials are seeking to locate such individuals. In addition, the final rule modifies the list of data elements that may be disclosed under this provision, in several ways. We expand the list of elements that may be disclosed under these circumstances, to include ABO blood type and Rh factor, as well as date and time of death, if applicable. We remove ''other distinguishing characteristic'' from the list of items that may be disclosed for the location and identification purposes described in this paragraph, and instead allow covered entities to disclose only a description of distinguishing physical characteristics, such as scars and tattoos, height, weight, gender, race, hair and eye color, and the presence or absence of facial hair such as a beard or moustache. In addition, in the final rule, protected health information associated with the following cannot be disclosed pursuant to § 164.512(f)(2): DNA data and analyses; dental records; or typing, samples or analyses of tissues or bodily fluids other than blood ( e.g., saliva). If a covered entity discloses additional information under this provision, the covered entity will be out of compliance and subject to sanction."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 107}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 198)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nto evaluate the existing laws with which they must comply in light of the requirements of the final regulation, we are unable to respond substantially to comments that do not pose specific questions.\nWe offer, however, the following guidance: if an covered entity is required to disclose protected health information pursuant to a specific statutory or regulatory scheme, the covered entity generally will be permitted under § 164.512(a) to make these disclosures without a consent or authorization; if, however, a statute or regulation merely suggests a disclosure, the covered entity will need to determine if the disclosure comes within another category of permissible disclosure under §§ 164.510 or 164.512 or, alternatively, if the disclosure would otherwise come within § 164.502. If not, the entity will need to obtain a consent or authorization for the disclosure. Comment: One commenter sought clarification as to when a disclosure is considered to be ''required'' by another law versus ''permitted'' by that law. Responses: We use these terms according to their common usage. By ''required by law,'' we mean that a covered entity has a legal obligation to disclose the information. For example, if a statute states that a covered entity must report the names of all individuals presenting with gun shot wounds to the emergency room or else be fined $500 for each violation, a covered entity would be required by law to disclose the protected health information necessary to comply with this mandate. The privacy regulation permits this type of disclosure, but does not require it. Therefore, if a covered entity chose not to comply with the reporting statute it would violate only the reporting statute and not the privacy regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 197}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 409)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nm and not to a policyholder or subscriber, if the\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nindividual states that he or she may be in danger from disclosure of such information.\nWe did not generally require health plans to send information to the patient and not the policyholder or subscriber because we believed it would be administratively burdensome and because the named insured may have a valid need for such information to manage payment and benefits. ## Sensitive Subjects\n\nComment: Many commenters requested that additional protections be placed on sensitive information, including information regarding HIV/ AIDS, sexually transmitted diseases, mental health, substance abuse, reproductive health, and genetics. Many requested that we ensure the regulation adequately protects victims of domestic violence. They asserted that the concern for discrimination or stigma resulting from disclosure of sensitive health information could dissuade a person from seeking needed treatment. Some commenters noted that many state laws provide additional protections for various types of information. They requested that we develop federal standards to have consistent rules regarding the protection of sensitive information to achieve the goals of cost savings and patient protection. Others requested that we require patient consent or special authorization before certain types of sensitive information was disclosed, even for treatment, payment, and health care operations, and some thought we should require a separate request for each disclosure. Some commenters requested that the right to request restrictions be replaced with a requirement for an authorization for specific types of sensitive information. There were recommendations that we require covered entities to develop internal policies to address sensitive information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 408}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 262)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\npersonal representative of a deceased individual if they have the authority to act on behalf of such individual or such individual's estate for any decision, not only decisions related to health care.\nWe create a broader scope for a person who is a personal representative of a deceased individual because the deceased individual can not request that information be disclosed pursuant to an authorization, whereas a living individual can do so. Comment: Some commenters asked that the NPRM provision allowing informal decision-makers access to the protected health information of an incapacitated individual should be maintained in the final rule. Response: We agree with the commenters, and retain permission for covered entities to share protected health information with informal decision-makers, under conditions specified in § 164.510(b). A person need not be a personal representative for such disclosure of protected health information to be made to an informal decision-maker. Comment: Commenters urged that individuals with mental retardation, who can provide verbal agreement or authorization, should have control over dissemination of their protected health information, in order to increase the privacy rights of such individuals. Response: Individuals with mental retardation have control over dissemination of their protected health information under this rule to the extent that state law provides such individuals with the capacity to act on their own behalf. We note that a covered entity need not disclose information pursuant to a consent or authorization. Therefore, even if state law determines that an individual with mental retardation is not competent to act and a personal representative provides authorization for a disclosure, a covered entity may choose not to disclose such information if the individual who lacks capacity to act expresses his or her desire that such information not be disclosed."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 261}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 263)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne is required by law, or when the minor may lawfully obtain a health care service without the consent of a parent, and the minor, a court, or another person authorized by law consents to such service.\nThe third exception is based on guidelines of the American Pediatric Association, current practice, and agreement by parents. If a parent assents to an agreement of confidentiality between a covered provider and a minor with respect to a health care service, the parent is not the personal representative of the minor with respect to the protected health information created or received subject to that confidentiality agreement. In such circumstances, the minor would have the authority to act as an individual, with respect to such protected health information. Comment: Some commenters requested that we permit minors to exercise the rights of an individual when applicable law requires parental notification as opposed to parental consent. Response: We adopt this policy in the final rule. If the minor consents to a health care service, and no other consent to such health care service is required by law, regardless of whether the consent of another person has also been obtained or notification to another person has been given, only the minor may be treated as the individual with respect to the protected health information relating to such health care service. The rule does not affect state law that authorizes or requires notification to a parent of a minor's decision to obtain a health care service to the extent authorized or required by such law. In addition, state parental notification laws do not affect the rights of minors under this regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 262}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 52)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nose of obtaining payment under a contract for reinsurance (including stop-loss and excess of loss insurance). Utilization review activities now include concurrent and retrospective review of services.\nIn addition, we modify this definition to clarify that the activities described in section 1179 of the Act are included in the definition of ''payment.'' We add new subclause (vi) allowing covered entities to disclose to consumer reporting agencies an individual's name, address, date of birth, social security number and payment history, account number, as well as the name and address of the individual's health care provider and/or health plan, as appropriate. Covered entities may make disclosure of this protected health information to consumer reporting agencies for purposes related to collection of premiums or reimbursement. This allows reporting not just of missed payments and overdue debt but also of subsequent positive payment experience ( e.g., to expunge the debt). We consider such positive payment experience to be ''related to'' collection of premiums or reimbursement. The remaining activities described in section 1179 are included in other language in this definition. For example, ''authorizing, processing, clearing, settling, billing, transferring, reconciling or collecting, a payment for, or related to, health plan premiums or health care'' are covered by paragraph (2)(iii) of the definition, which allows use and disclosure of protected health\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00035\n\ninformation for ''billing, claims management, collection activities and related health care data processing.'' ''Claims management'' also includes auditing payments, investigating and resolving payment disputes and responding to customer inquiries regarding payments. Disclosure of protected health information for compliance with civil or criminal subpoenas, or with other applicable laws, are covered under § 164.512 of this regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 51}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 509)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nst make reasonable efforts to limit protected health information to the minimum necessary to accomplish the intended purpose of the use, disclosure, or request. - (2) Minimum necessary does not apply.\nThis requirement does not apply to:\n- (i) Disclosures to or requests by a health care provider for treatment;\n- (ii) Uses or disclosures made to the individual, as permitted under paragraph (a)(1)(i) of this section, as required by paragraph (a)(2)(i) of this section, or pursuant to an authorization under §164.508, except for authorizations requested by the covered entity under § 164.508(d), (e), or (f);\n- (iii) Disclosures made to the Secretary in accordance with subpart C of part 160 of this subchapter;\n\nFrm 00345\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\n(iv) Uses or disclosures that are required by law, as described by §164.512(a); and\n\n- (v) Uses or disclosures that are required for compliance with applicable requirements of this subchapter. - (c) Standard: Uses and disclosures of protected health information subject to an agreed upon restriction. A covered entity that has agreed to a restriction pursuant to § 164.522(a)(1) may not use or disclose the protected health information covered by the restriction in violation of such restriction, except as otherwise provided in § 164.522(a). - (d) Standard: Uses and disclosures of de-identified protected health information. - (1) Uses and disclosures to create deidentified information. A covered entity may use protected health information to create information that is not individually identifiable health information or disclose protected health information only to a business associate for such purpose, whether or not the deidentified information is to be used by the covered entity. - (2) Uses and disclosures of deidentified information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 508}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 36)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nlanguage in the proposal could potentially be construed as allowing a hybrid entity to designate only the business associate-like functions as the health care component, and exclude covered functions.\nThe commenter urged the Department to clarify that a hybrid entity must, at a minimum, designate a component that performs covered functions as a health care component, and that a health care provider cannot avoid having its treatment component considered a health care component by relying on a billing department to conduct its standard electronic transactions. These commenters urged the Department to retain the existing policy by requiring those organizations whose primary functions are not health care to be hybrid entities and to institute firewall protections between their health care and other components. Final Modifications. After consideration of the comments, the Department adopts in the final Rule the proposed approach to provide covered entities that otherwise qualify the discretion to decide whether to be a hybrid entity. To do so, the Department eliminates the term ''primary'' from the definition of ''hybrid entity'' at §164.504(a). Any covered entity that otherwise qualifies ( i.e., is a single legal entity that performs both covered and non-covered functions) and that designates health care component(s) in accordance with § 164.504(c)(3)(iii) is a hybrid entity. A hybrid entity is required to create adequate separation, in the form of firewalls, between the health care component(s) and other components of the entity. Transfer of protected health information held by the health care component to other components of the hybrid entity continues to be a disclosure under the Privacy Rule, and, thus, allowed only to the same extent such a disclosure is permitted to a separate entity. Most of the requirements of the Privacy Rule continue to apply only to the health care component(s) of a hybrid entity."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 35}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 197)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne consent of the individual. Response: These comments did not provide specific facts or legal basis for the claims. We are, thus, unable to provide a substantive response to these particular comments.\nHowever, we note\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nthat the rule requires disclosures only to the individual or to the Secretary to determine compliance with this rule. Other uses or disclosures under this rule are permissive, not required. Therefore, if a particular use or disclosure under this rule is viewed as interfering with a right that prohibited the use or disclosure, the rule itself is not what requires the use or disclosure. ## Void for Vagueness\n\nComment: One comment suggested that the Secretary's use of a ''reasonableness'' standard is unconstitutionally vague. Specifically, this comment objected to the requirement that covered entities use ''reasonable'' efforts to use or disclose the minimum amount of protected health information, to ensure that business partners comply with the privacy provisions of their contracts, to notify business partners of any amendments or corrections to protected health information, and to verify the identity of individuals requesting information, as well as charge only a ''reasonable'' fee for inspecting and copying health information. This comment asserted that the Secretary provided ''inadequate guidance'' as to what qualifies as ''reasonable.''\n\nResponse: We disagree with the comment's suggestion that by applying a ''reasonableness'' standard, the regulation has failed to provide for ''fair warning'' or ''fair enforcement.'' The ''reasonableness'' standard is wellestablished in law; for example, it is the foundation of the common law of torts. Courts also have consistently held as constitutional statutes that rely upon a ''reasonableness'' standard. Our reliance upon a ''reasonableness'' standard, thus, provides covered entities with constitutionally sufficient guidance."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 196}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 279)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntory authority to cover employers or other entities that sponsor group health plans. In contrast, many commenters stated that without covering employers, meaningful privacy protection is unattainable.\nResponse: We agree that group health plans are separate legal entities from their plan sponsors and that the group health plan itself may be operated by employees of the plan sponsor. We make significant modification to the proposed rule to better reflect this reality. We design the requirements in the final regulation to use the existing regulatory tools provided by ERISA, such as the plan documents required by that law and the constellation of plan administration functions defined by that law that established and maintain the group health plan. We recognize plan sponsors' legitimate need for health information in certain situations while, at the same time, protecting health information from being used for employment-related functions or for other functions related to other employee benefit plans or other benefits provided by the plan sponsor. We do not attempt to directly regulate plan sponsors, but pursuant to our authority to regulate health plans, we place restrictions on the flow of information from covered entities to non-covered entities. The final rule permits group health plans to disclose protected health information to plan sponsors, and allows them to authorize health insurance issuers or HMOs to disclose protected health information to plan sponsors, if the plan sponsors agree to use and disclose the information only as permitted or required by the regulation. The information may be used only for plan administration functions performed on behalf of the group health plan and specified in the plan documents."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 278}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 61)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ndefinition of sale should more clearly capture those disclosures where remuneration is provided in exchange for protected health information, rather than all disclosures that may involve remuneration.\nA number of commenters were concerned that fees paid for services or programs that involve the disclosure of protected health information but that are not fees to purchase the data themselves nonetheless would turn such disclosure into a sale of protected health information. For example, some commenters were concerned that the disclosure of research results to a research sponsor would be a sale of protected health information because the sponsor paid the covered entity for its services in conducting the research\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00041\n\nstudy or project. Other commenters expressed concern about the authorization requirements for the sale of protected health information applying to programs for which a covered entity receives funding and, as a condition of that funding, is required to report data, such as under the Medicare and Medicaid incentive payment programs for meaningful users of certified electronic health record technology and certain State grant programs. A few commenters were concerned that the exchange of protected health information through a health information exchange (HIE) that is paid for through fees assessed on HIE participants could be considered sale of protected health information. Commenters also asked for clarification on the meaning and scope of the term ''direct and indirect remuneration,'' and some were particularly concerned that ''indirect remuneration'' meant nonfinancial benefits provided in exchange for protected health information could turn a disclosure into a sale of protected health information."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 60}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 21)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nder 21 CFR 820.30(f), a manufacturer must establish and maintain procedures for verifying the device design. Such verification shall confirm that the design output meets the design input requirements.\nUnder 21 CFR 820.30(g), a manufacturer must establish and maintain procedures for validating its device design. Such design validation shall include software validation and risk analysis, where appropriate. FDA recommends verification and validation include sufficient testing performed by the manufacturer on the cybersecurity of the medical device system through which the manufacturer verifies and validates their inputs and outputs, as appropriate. Security testing documentation and any associated reports or assessments should be submitted in the premarket submission. FDA recommends that the following types of testing, among others, be considered for inclusion in the submission:\n\n- Security requirements;\n- Manufacturers should provide evidence that each design input requirement was implemented successfully. - Manufacturers should provide evidence of their boundary analysis and rationale for their boundary assumptions. - Threat mitigation;\n- Manufacturers should provide details and evidence of testing that demonstrates effective risk control measures according to the threat models provided in the\n\n## Contains Nonbinding Recommendations\n\nglobal system, multi-patient harm, updatability and patchability, and security use case views. - Manufacturers should ensure the adequacy of each cybersecurity risk control (e.g., security effectiveness in enforcing the specified security policy, performance for maximum traffic conditions, stability, and reliability, as appropriate). - Vulnerability Testing (such as section 9.4 of ANSI/ISA 62443-4-1); and\n- Manufacturers should provide details and evidence 46 of the following testing and analyses:\n- Abuse or misuse cases, malformed and unexpected inputs;\n- Robustness. - Fuzz testing."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 20}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 80)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nnt organizations with the appearance of legitimate suppliers in the critical life cycle path that then inject corrupted or malicious information system components into the organizational supply chain.\n|\n| Deliver, insert, or install malicious capabilities. | Deliver, insert, or install malicious capabilities. |\n| Deliver known malware to internal organizational information systems (e.g., virus via email). | Adversary uses common delivery mechanisms (e.g., email) to install or insert known malware (e.g., malware whose existence is known) into organizational information systems. |\n| Deliver modified malware to internal organizational information systems. | Adversary uses more sophisticated delivery mechanisms than email (e.g., web traffic, instant messaging) to deliver malware and possibly modifications of known malware to gain access to internal organizational information systems. |\n| Deliver targeted malware for control of internal systems and the exfiltration of data. | Adversary installs malware that is specifically designed to take control of internal organizational information systems, identify sensitive information, exfiltrate the information back to the adversary, and conceal these actions. |\n| Deliver malware by providing removable media. | Adversary places removable media (e.g., flash drives) containing malware in locations external to organizational physical perimeters but where employees are likely to find the media (e.g., facilities parking lots, exhibits at conferences attended by employees) and use it on organizational information systems. |\n| Insert untargeted malware into downloadable software and/or into commercial information technology products. | Adversary corrupts or inserts malware into common freeware, shareware, or commercial information technology products. Adversary is not targeting specific organizations but simply looking for entry points into internal organizational information systems."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 79}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 9)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nealth information but do not access the information other than on a random or infrequent basis are not business associates. See http://www.hhs.gov/ocr/ privacy/hipaa/faq/providers/business/ 245.html .\nIn contrast, entities that manage the exchange of protected\n\n2 Department of Health and Human Services Office of the National Coordinator for Health Information Technology, The National Alliance for Health Information Technology Report to the Office of the National Coordinator for Health Information Technology: Defining Key Health Information Terms, Pg. 24 (2008). 3 Id. at 25. VerDate Mar&lt;15&gt;2010\n\nhealth information through a network, including providing record locator services and performing various oversight and governance functions for electronic health information exchange, have more than ''random'' access to protected health information and thus, would fall within the definition of ''business associate.''\n\n## Overview of Public Comments\n\nCommenters generally supported the inclusion of Health Information Organizations, personal health record vendors, and similar entities in the definition of ''business associate.'' However, commenters sought various clarifications as discussed below. Commenters generally supported use of the term Health Information Organization in lieu of more restrictive terms, such as Regional Health Information Organization. Some commenters suggested that the term Health Information Organization be defined, so as to avoid confusion as the industry develops, and suggested various alternatives for doing so. Several commenters recommended that the Office for Civil Rights (OCR) maintain a Web site link that lists current terms for entities that OCR considers to be Health Information Organizations. Other commenters requested clarification on what it means to have ''access on a routine basis'' to protected health information for purposes of the definition and determining whether certain entities are excluded as mere conduits."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 8}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the administrative safeguards under HIPAA?"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n## Postmarket Management of Cybersecurity in Medical Devices\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on December 28, 2016. The draft of this document was issued on January 22, 2016. For questions regarding this document, contact Suzanne Schwartz, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5434, Silver Spring, MD 20993-0002, 301-796-6937. For questions regarding this document as applied to devices regulated by CBER, contact the Office of Communication, Outreach and Development in CBER at 1-800-835-4709 or 240-402-8010 or ocod@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of the Center Director\n\nCenter for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to http://www.regulations.gov . Submit written comments to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2015-D-5105. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an e-mail request to CDRH-Guidance@fda.hhs.gov to receive an electronic copy of the guidance. Please use the document number 1400044 to identify the guidance you are requesting. ## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), by written request, Office of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., Bldg."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_type": "administrative", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 490)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nfor provisions like the notice requirement, we used SIC code revenue data in a two-step process. First, we apportioned the cost of each provision among sectors of the health care industry by SIC code.\nFor example, because hospital revenue accounts for 27 percent of all health care revenue, we multiplied the total cost of each such provision by 27 percent to determine the cost for the hospital sector in total. Then to determine the cost for small hospitals specifically, we calculated the proportion by the overall cost. For example, 45.1 percent of all hospital revenue is generated by small hospital, therefore, the cost to small hospitals was assumed to account for 45.1 percent of all hospital costs. Estimates, by nature\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nare inexact. However, we feel this is a reasonable way to determine the small business costs attributable to this regulation given the limited data from which to work. Total Costs and Costs Per Establishment for Small Business\n\nBased on the methodology described above, the total cost of complying with the final rule in the initial year of 2003 is $1.9 billion. The ongoing costs to small business from 2004 to 2012 is $9.3 billion. Table C presents the initial and ongoing costs to small business by each SIC code. According to this table, small doctors offices, small dentists offices and small hospitals will face the highest cost of complying with the final rule. VerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00327\n\nFmt 4701\n\nSfmt 4700\n\nHowever, much of the reason for the higher costs faced by these three groups of small health care providers is explained by the fact that there are a significant number of health care providers in these categories."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 489}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement administrative controls?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\nRIN 0991-AB56\n\n## Breach Notification for Unsecured Protected Health Information\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Interim final rule with request for comments. SUMMARY: The Department of Health and Human Services (HHS) is issuing this interim final rule with a request for comments to require notification of breaches of unsecured protected health information. Section 13402 of the Health Information Technology for Economic and Clinical Health (HITECH) Act, part of the American Recovery and Reinvestment Act of 2009 (ARRA) that was enacted on February 17, 2009, requires HHS to issue interim final regulations within 180 days to require covered entities under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and their business associates to provide notification in the case of breaches of unsecured protected health information. For purposes of determining what information is ''unsecured protected health information,'' in this document HHS is also issuing an update to its guidance specifying the technologies and methodologies that render protected health information unusable, unreadable, or indecipherable to unauthorized individuals. DATES: Effective Date: This interim final rule is effective September 23, 2009. Comment Date: Comments on the provisions of this interim final rule are due on or before October 23, 2009. Comments on the information collection requirements associated with this rule are due on or before September 8, 2009. ADDRESSES: You may submit comments, identified by RIN 0991-AB56, by any of the following methods (please do not submit duplicate comments):\n\n- Regular, Express, or Overnight Mail: U.S. Department of Health and Human Services, Office for Civil Rights, Attention: HITECH Breach Notification, Hubert H."}], "metadata": {"source": "breach_notification_2009", "safeguard_type": "administrative", "implementation_spec": "required", "entity_type": "covered_entity", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the administrative safeguards under HIPAA?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\nRIN 0991-AB56\n\n## Breach Notification for Unsecured Protected Health Information\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Interim final rule with request for comments. SUMMARY: The Department of Health and Human Services (HHS) is issuing this interim final rule with a request for comments to require notification of breaches of unsecured protected health information. Section 13402 of the Health Information Technology for Economic and Clinical Health (HITECH) Act, part of the American Recovery and Reinvestment Act of 2009 (ARRA) that was enacted on February 17, 2009, requires HHS to issue interim final regulations within 180 days to require covered entities under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and their business associates to provide notification in the case of breaches of unsecured protected health information. For purposes of determining what information is ''unsecured protected health information,'' in this document HHS is also issuing an update to its guidance specifying the technologies and methodologies that render protected health information unusable, unreadable, or indecipherable to unauthorized individuals. DATES: Effective Date: This interim final rule is effective September 23, 2009. Comment Date: Comments on the provisions of this interim final rule are due on or before October 23, 2009. Comments on the information collection requirements associated with this rule are due on or before September 8, 2009. ADDRESSES: You may submit comments, identified by RIN 0991-AB56, by any of the following methods (please do not submit duplicate comments):\n\n- Regular, Express, or Overnight Mail: U.S. Department of Health and Human Services, Office for Civil Rights, Attention: HITECH Breach Notification, Hubert H."}], "metadata": {"source": "breach_notification_2009", "safeguard_type": "administrative", "implementation_spec": "required", "entity_type": "covered_entity", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 256)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ns asked that the rule be revised to authorize disclosures to clergy, for directory purposes, to organ and tissue procurement organizations, and to the American Red Cross without patient authorization.\nResponse: We agree and revise the final rule accordingly. The new policies and the rationale for these policies are found in §§ 164.510 and 164.512, and the corresponding preamble. Comment: One commenter recommended that the rule apply only to the ''disclosure'' of protected health information by covered entities, rather than to both ''use'' and ''disclosure.'' The commenter stated that the application of the regulation to a covered entity's use of individually identifiable health information offers little benefit in terms of protecting protected health information, yet imposes costs and may hamper many legitimate activities, that fall outside the definition of treatment, payment or health care operations. Another commenter similarly urged that the final regulation draw substantive distinctions between restrictions on the ''use'' of individually identifiable health information and on the ''disclosure'' of such information, with broader latitude for ''uses'' of such information. The commenter believed that internal ''uses'' of such information generally do not raise the same issues and concerns that a disclosure of that information might raise. It was argued that any concerns about the potential breadth of use of this information could be addressed through application of the ''minimum necessary'' standard. The commenter also argued that Congressional intent was that a ''disclosure'' of individually identifiable health information is potentially much more significant than a ''use'' of that information. Response: We do not accept the commenter's broad recommendation to apply the regulation only to the ''disclosure'' of protected health information and not to ''use'' of such information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 255}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 102)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nted health information, and reflect greater public accountability ( e.g., through the required public comment process or because enacted by elected representatives). For example, a Wisconsin law (Wis.\nStat § 46.90(4)) states that any person may report to a county agency or state official that he or she believes that abuse or neglect has occurred. Pursuant to §164.512(c)(1)(iii), a covered entity may make a report only if the specific type or subject matter of the report ( e.g., abuse or neglect of the elderly) is included in the law authorizing the report, and such a disclosure may only be made to a public authority specifically identified in the law authorizing the report. Furthermore, we note that disclosures under this part of the paragraph are further limited to two circumstances. In the first case, a covered entity, in the exercise of professional judgment, must believe that the disclosure is necessary to prevent serious harm to the individual or to other potential victims. The second case addresses situations in which an individual who is a victim of abuse, neglect or domestic violence is unable to agree due to incapacity and a law enforcement or other public official authorized to receive the report represents that the protected health information for which disclosure is sought is not intended to be used against the individual and that an immediate law enforcement activity that depends on the disclosure would be materially and adversely affected by waiting until the individual if able to agree to the disclosure. We note that, in this second case, a covered entity may exercise discretion, consistent with professional judgment as to the patient's\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nbest interest, in deciding whether to make the requested disclosure."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 101}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 76)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nhers involved in the care or payment for care of the decedent prior to death, unless doing so is inconsistent with any prior expressed preference of the individual that is known to the covered entity.\nThese commenters felt that such permissive disclosures would help facilitate important and appropriate communications with family members and others who had been involved in the individual's care or payment for health care prior to the individual's death but who may not rise to the level of personal representative. Some commenters stated that the provision recognizes the legitimate interest that family members may have in a decedent's health information as it affects their own health care. A few commenters opposed the proposal to expressly permit communications with family members and other persons who had been involved with the individual's care or payment for care prior to death. Two commenters felt it would be a large burden on covered entities to determine the legitimacy of a requestor as a family member or individual involved in the care or payment for care. One commenter questioned the need for family members to have access to decedent health information and the likelihood of anyone other than the\n\nVerDate Mar&lt;15&gt;2010\n\npersonal representative to have been meaningfully involved in the care or payment for care of the decedent. ## Final Rule\n\nThe final rule adopts the proposal to amend §164.510(b) to permit covered entities to disclose a decedent's protected health information to family members and others who were involved in the care or payment for care of the decedent prior to death, unless doing so is inconsistent with any prior expressed preference of the individual that is known to the covered entity."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 75}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 175)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nether insured or self-insured) that integrate traditional employee health benefits coverage and workers' compensation coverage for the treatment of on-the-job injuries and illnesses under one program.\nIt was stated that this clarification was essential if the Secretary persisted in excluding workers' compensation from the final rule. Response: We understand concerns that such plans may use and disclose individually identifiable health information. We therefore clarify that to the extent that 24-hour coverage plans have a health care component that meets the definition of ''health plan'' in the final rule, such components must abide by the provisions of the final rule. In the final rule, we have added a new provision to § 164.512 that permits covered entities to disclose information under workers' compensation and similar laws. A health plan that is a 24hour plan is permitted to make disclosures as necessary to comply with such laws. Comment: A number of commenters urged that certain types of insurance entities, such as workers' compensation and automobile insurance carriers, property and casualty insurance health plans, and certain forms of limited benefits coverage, be included in the definition of ''health plan.'' It was argued that consumers deserve the same protection with respect to their health information, regardless of the entity using it, and that it would be inequitable to subject health insurance carriers to more stringent standards than other types of insurers that use individually identifiable health information. Response: The Congress did not include these programs in the definition of a ''health plan'' under section 1171 of the Act. Further, HIPAA's legislative history shows that the House Report's (H. Rep. 104-496) definition of ''health plan'' originally included certain benefit programs, such as workers' compensation and liability insurance, but was later amended to clarify the definition and remove these programs."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 174}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 217)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n2, and the HHS implementing regulation, 45 CFR part 5, provide substantial protection for records about individuals where disclosure would constitute an unwarranted invasion of their personal privacy.\nIn implementing the privacy regulation, OCR plans to continue its current practice of protecting its complaint files from disclosure. OCR treats these files as investigatory records compiled for law enforcement purposes. Moreover, OCR maintains that disclosing protected health information in these files generally constitutes an unwarranted invasion of personal privacy. It is not clear in regarding the use of mental health professionals, whether the commenter believes that such professionals should be involved because they would be best able to keep psychotherapy notes confidential or because such professionals can best understand the meaning or relevance of such notes. OCR anticipates that it will not have to obtain a copy or review psychotherapy notes in investigating most complaints regarding noncompliance in regard to such notes. There may be some cases where a review of the notes may be needed such as where we need to identify that the information a covered entity disclosed was in fact psychotherapy notes. If we need to obtain a copy of psychotherapy notes, we will keep these notes confidential and secure. OCR investigative staff will be trained to ensure that they fully respect the confidentiality of personal information. In addition, while the specific contents of these notes is generally not relevant to violations under this rule, if such notes are relevant, we will secure the expertise of mental health professionals if needed in reviewing psychotherapy notes. Comment: A member of Congress and a number of privacy and consumer groups expressed concern with whether OCR has adequate funding to carry out the major responsibility of enforcing the complaint process established by this rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 216}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 428)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nper year, except in ''emergency situations.'' Others recommended that we enable entities to recoup some of the costs associated with implementation by allowing the entity to charge for an accounting.\nResponse: We agree that covered entities should be able to defray costs of excessive requests. The final rule provides individuals with the right to receive one accounting without charge in a twelve-month period. For additional requests by an individual within a twelve-month period, the covered entity may charge a reasonable, cost-based fee. If it imposes such a fee, the covered entity must inform the individual of the fee in advance and provide the individual with an opportunity to withdraw or modify the request to avoid or reduce the fee. Comment: In the NPRM, we solicited comments on the appropriate duration of the individual's right to an accounting. Some commenters supported the NPRM's requirement that the right exist for as long as the covered entities maintains the protected health information. One commenter, however, noted that most audit control systems do not retain data on activity for indefinite periods of time. Other commenters noted that laws governing the length of retention of clinical records vary by state and by provider type and suggested that entities be allowed to adhere to state laws or policies established by professional organizations or accrediting bodies. Some commenters suggested that the\n\nFrm 00283\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nlanguage be clarified to state that whatever minimum requirements are in place for the record should also guide covered entities in retaining their capacity to account for disclosures over that same time, but no longer. Several commenters asked us to consider specific time limits. It was pointed out that proposed §164.520(f)(6) of the NPRM set a sixyear time limit for retaining certain information including authorization forms and contracts with business partners."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 427}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 155)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nsection 105 of GINA, the Department proposed a new prohibition on health plans using or disclosing protected health information that is genetic information for underwriting purposes at §164.502(a)(3).\nWe made clear that such a provision would operate notwithstanding the other provisions in the Privacy Rule permitting uses and disclosures, and proposed a conforming change to § 164.502(a)(1)(iv) to clarify further that an authorization could not be used to permit a use or disclosure of genetic information for underwriting purposes. ## Overview of Public Comments\n\nSome commenters expressly supported the proposed modification to the Privacy Rule to include the prohibition, and the proposed clarification that an authorization cannot be used to otherwise permit a prohibited use or disclosure of genetic information. One commenter suggested adding the examples from the preamble to the regulatory text, as well as language to the regulatory text to clarify that the prohibition applies to genetic information obtained by a health plan prior to the passage of GINA. ## Final Rule\n\nThe final rule adopts the proposed prohibition on a health plan's use or disclosure of genetic information for underwriting purposes, except with regard to health plans that are issuers of long term care policies, as explained above in section VI.C.1 regarding to which plans the final rule applies. This prohibition, located in this final rule at §164.502(a)(5), applies to all genetic information from the compliance date of these modifications forward, regardless of when or where the genetic information originated. We do not believe a clarification of this fact in the regulatory text is necessary. Consistent with Sec."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 154}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 107)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nopy or electronic media (i.e., physical media such as a compact disc (CD) or universal serial bus (USB) flash drive), if the individual requests that the electronic copy be provided on portable media.\nThis reorganization and the addition of the phrase ''electronic media'' reflected our understanding that since section 13405(e)(2) of the HITECH Act permits only the inclusion of labor costs in the charge for electronic copies, it by implication excludes charging for the supplies that are used to create an electronic copy of the individual's protected health information, such as the hardware (computers, scanners, etc.) or software that is used to generate an electronic copy of an individual's protected health information in response to an access request. We noted that this limitation is in contrast to a covered entity's ability to charge for supplies for hard copies of protected health information (e.g., the cost of paper, the prorated cost of toner and wear and tear on the printer). See 65 FR 82462, 82735, Dec. 28, 2000 (responding to a comment seeking clarification on ''capital cost for copying'' and other supply costs by indicating that a covered entity was free to recoup all of their reasonable costs for copying). We asserted that this interpretation was consistent with the fact that, unlike a hard copy, which generally exists on paper, an electronic copy exists independent of media, and can be transmitted securely via multiple methods (e.g., email, a secure web-based portal, or an individual's own electronic media) without accruing any ancillary supply costs. We also noted, however, that our interpretation of the statute would permit a covered entity to charge a reasonable and cost-based fee for any\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00071\n\nelectronic media it provided, as requested or agreed to by an individual. While we proposed to renumber the remaining factors at § 164.524(c)(4), we did not propose to amend their substance."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 106}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 29)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nto notify an affected individual or the decision would be subject to significantly varying State laws (which are generally focused on breaches of financial information rather than health information).\nBecause notification requires expenditures and exposes the covered entity to loss of business and possible legal action, there is little incentive for the entity to take such action. While individuals whose protected health information was improperly accessed would be forewarned and as a result of being notified, could take action to mitigate financial or personal harm, they may not continue to patronize the entity which notifies them. If alternative providers in the individual's community offer similar services, the individual may take their business to one of the alternative entities. Moreover, if other individuals, not directly affected by the breach, learn of the event, they too may seek services from other providers out of fear that their protected health information may be improperly accessed. The Ponenmon Institute, LLC report of February 2009, ''2008 Annual Study: Cost of a Data Breach'' estimates that 69 percent of the cost of a data breach is the result of lost business (see page 4). The study identifies the health care industry as experiencing the highest customer turnover rate directly attributable to data breaches of protected health information. Moreover, since a health care provider is unlikely to suffer financially from the direct loss of protected health information, there is little incentive for the covered entity to notify affected individuals. In such situations, the covered entity may perceive that it is more beneficial to not disclose breaches. The possibility of lawsuits arising out of a lack of response to the breach represents a risk but one which is uncertain and lies in the future. This compares to the more imminent and certain risk of loss of business if the entity discloses the breach."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 28}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 247)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nve the broad definition of ''public health authority'' is appropriate to achieve that end. Comment: Some commenters said that they performed public health activities in analyzing data and information.\nThese comments suggested that activities conducted by provider and health plan organizations that compile and compare data for benchmarking performance, monitoring, utilization, and determining the health needs of a given market should be included as part of the public health exemption. One commenter recommended amending the regulation to permit covered entities to disclose protected health information to private organizations for public health reasons. Response: We disagree that such a change should be made. In the absence of some nexus to a government public health authority or other underlying legal authority, covered entities would have no basis for determining which data collections are ''legitimate'' and how the confidentiality of the information will be protected. In addition, the public health functions carved out for special protection by Congress are explicitly limited to those established by law. Comment: Two commenters asked for additional clarification as to whether the Occupational Safety and Health Administration (OSHA) and the Mine Safety and Health Administration (MSHA) would be considered public health authorities as indicated in the preamble. They suggested specific language for the final rule. Commenters also suggested that we specify that states operating OSHA-approved programs also are considered public health authorities. One comment applauded the Secretary's recognition of OSHA as both a health oversight agency and public health authority. It suggested adding OSHA-approved programs that operate in states to the list of entities included in these categories. In addition, the comment requested the final regulation specifically mention these entities in the text of the regulation as well."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 246}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 105)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nentities requested clarification that they are permitted to send individuals unencrypted emails if they have advised the individual of the risk, and the individual still prefers the unencrypted email.\nSome felt that the ''duty to warn'' individuals of risks associated with unencrypted email would be unduly burdensome on covered entities. Covered entities also requested clarification that they would not be responsible for breach notification in the event that unauthorized access of protected health information occurred as a result of sending an unencrypted email based on an individual's request. Finally, one commenter emphasized the importance that individuals are allowed to decide if they want to receive unencrypted emails. Response: We clarify that covered entities are permitted to send individuals unencrypted emails if they have advised the individual of the risk, and the individual still prefers the unencrypted email. We disagree that the ''duty to warn'' individuals of risks associated with unencrypted email would be unduly burdensome on covered entities and believe this is a necessary step in protecting the protected health information. We do not expect covered entities to educate individuals about encryption technology and the information\n\nVerDate Mar&lt;15&gt;2010\n\nsecurity. Rather, we merely expect the covered entity to notify the individual that there may be some level of risk that the information in the email could be read by a third party. If individuals are notified of the risks and still prefer unencrypted email, the individual has the right to receive protected health information in that way, and covered entities are not responsible for unauthorized access of protected health information while in transmission to the individual based on the individual's request. Further, covered entities are not responsible for safeguarding information once delivered to the individual. ## b."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 104}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 44)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nd that there may be circumstances in which a covered entity provides a population-based communication to further the treatment of the health care status or condition of an entire group of individuals.\nOther commenters suggested that the distinction between communications for treatment and those for health care operations purposes should be made based on the entity providing the communication: If a health care provider is providing the communication, it should be deemed for treatment purposes; however, if the communication is made by a covered entity other than a health care provider, the determination should be based on whether the communication is individual (treatment) or population based (health care operations). With respect to the subsidized treatment communications, commenters opposed to the opt out notification generally took one of three positions: All such communications should require authorizations to best protect patient privacy; an opt in method would better permit individuals to make more informed choices about whether to receive such communications; or a covered entity should be permitted to make these communications without an opportunity to opt out, because of unintended effects that may adversely affect the quality of care provided. Some commenters asked, if the opt out requirement is retained, that OCR ensure that covered entities are given significant flexibility in determining how best to implement the opt out requirement. Additionally, the vast majority of commenters did not believe there should be an opportunity to opt out of receiving subsidized treatment communications prior to receipt of the first such communication. The commenters believed that requiring an\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00030\n\nopportunity to opt out prior to the first communication would be too costly and burdensome for most covered entities."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 43}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 299)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nans and other covered entities may seek the individual's consent for the covered entity's use and disclosure of protected health information to carry out treatment, payment, or health care operations.\nIf the consent is sought in conjunction with enrollment, the health plan may condition enrollment in the plan on obtaining the individual's consent. Under §164.506(a)(5), we specify that a consent obtained by one covered entity is not effective to permit another covered entity to use or disclose protected health information for payment purposes. If state law requires a Medicaid agency to obtain the individual's authorization for providers to disclose protected health information to the Medicaid agency for payment purposes, the agency may do so under §164.508(e). This authorization must not be a condition of enrollment or eligibility, but may be a condition of payment of a claim for specified benefits if the disclosure is necessary to determine payment of the claim. ## Revocation of Authorizations\n\nComment: Many commenters supported the right to revoke an authorization. Some comments, however, suggested that we require authorizations to remain valid for a minimum period of time, such as one year or the duration of the individual's enrollment in a health plan. Response: We retain the right for individuals to revoke an authorization at any time, with certain exceptions. We believe this right is essential to ensuring that the authorization is voluntary. If an individual determines that an authorized use or disclosure is no longer in her best interest, she should be able to withdraw the authorization and prevent any further uses or disclosures. Comment: Several commenters suggested that we not permit individuals to revoke an authorization if the revocation would prevent an investigation of material misrepresentation or fraud."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 298}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 185)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nAn advocacy group in Vermont argued that the Vermont legislature was poised to enact stronger and more comprehensive privacy laws and stated that the group would resent a federal prohibition on that.\nResponse: The premise of these comments appears to be that the provision-by-provision approach of Subpart B, which is expressed in the definition of the term ''contrary'', is wrong. As we explained in the preamble to the proposed rules (at 64 FR 59995),\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00122\n\nhowever, the statute dictates a provision-by-provision comparison of state and federal requirements, not the overall comparison suggested by these comments. We also note that the approach suggested would be practically and analytically problematic, in that it would be extremely difficult, if not impossible, to determine what is a legitimate stopping point for the provisions to be weighed on either the state side or the federal side of the scale in determining which set of laws was the ''more stringent.'' We accordingly do not accept the approach suggested by these comments. With respect to the comment of the Vermont group, nothing in the rules below prohibits or places any limits on states enacting stronger or more comprehensive privacy laws. To the extent that states enact privacy laws that are stronger or more comprehensive than contrary federal requirements, they will presumably not be preempted under section 1178(a)(2)(B). To the extent that such state laws are not contrary to the federal requirements, they will act as an overlay on the federal requirements and will have effect. Comment: One comment raised the issue of whether a private right of action is a greater penalty, since the proposed federal rule has no comparable remedy. Response: We have reconsidered the proposed ''penalty'' provision of the proposed definition of ''more stringent'' and have eliminated it."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 184}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 491)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne effective date. As discussed in section E, state and local government costs will be in the order of $460 million in 2003 and $2.4 billion over ten years. Estimates for later years are not practical.\nThe changes in technology are likely to alter the nature of medical record-keeping, and the uses of medical data are likely to vary dramatically over this period. Therefore, any estimates for years beyond 2012 are not feasible. ## B. Particular Regions, Communities, or Industrial Sectors\n\nThe rule applies to the health care industry and would, therefore, affect that industry disproportionately. Any long-run increase in the costs of health care services would largely be passed on to the entire population of consumers. However, as discussed in the administrative implication regulation, the Transactions Rule is estimated to save the health care industry nearly $30 billion over essentially the same time period. This more than offsets the costs of the Privacy Rule; indeed, as discussed above, the establishment of consistent, national standards for the protection of medical information is essential to fully realize the savings from electronic transactions standards and other advances that may be realized through ''e-health'' over the next decade. Without strong privacy rules, patients and providers may be very reluctant to fully participate in electronic and e-health opportunities. ## C. National Productivity and Economic Growth\n\nThe rule is not expected to substantially affect productivity or economic growth. It is possible that\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nproductivity and growth in certain sectors of the health care industry could be slightly lower than otherwise because of the need to divert research and development resources to compliance activities. The diversion of resources to compliance activities would be temporary."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 490}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 9)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ntness club without obtaining authorizations, but could not pass along to its members discounts to a health fitness club that the members would be able to obtain directly from the health/fitness clubs.\nIn further response to comments, the Department has added new language to the definition of ''marketing'' to close what commenters perceived as a loophole that a covered entity could sell protected health information to another company for the marketing of that\n\nVerDate Aug&lt;2,&gt;2002\n\ncompany's products or services. For example, many were concerned that a pharmaceutical company could pay a provider for a list of patients with a particular condition or taking a particular medication and then use that list to market its own drug products directly to those patients. The commenters believed the proposal would permit this to happen under the guise of the pharmaceutical company acting as a business associate of the covered entity for the purpose of recommending an alternative treatment or therapy to the individual. The Department agrees with commenters that the potential for manipulating the business associate relationship in this fashion should be expressly prohibited. Therefore, the Department is adding language that would make clear that business associate transactions of this nature are marketing. Marketing is defined expressly to include ''an arrangement between a covered entity and any other entity whereby the covered entity discloses protected health information to the other entity, in exchange for direct or indirect remuneration, for the other entity or its affiliate to make a communication about its own product or service that encourages recipients of the communication to purchase or use that product or service.'' These communications are marketing and can only occur if the covered entity obtains the individual's authorization pursuant to § 164.508."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 8}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 524)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ndiate enforcement activity that depends upon the disclosure would be materially and adversely affected by waiting until the individual is able to agree to the disclosure. (2) Informing the individual.\nA covered entity that makes a disclosure permitted by paragraph (c)(1) of this section must promptly inform the individual that such a report has been or will be made, except if:\n\n(i) The covered entity, in the exercise of professional judgment, believes informing the individual would place the individual at risk of serious harm; or\n\n(ii) The covered entity would be informing a personal representative, and the covered entity reasonably believes the personal representative is responsible for the abuse, neglect, or other injury, and that informing such person would not be in the best interests of the individual as determined by the covered entity, in the exercise of professional judgment. (d) Standard: Uses and disclosures for health oversight activities. (1) Permitted disclosures. A covered entity may disclose protected health information to a health oversight agency for oversight activities authorized by law, including audits; civil, administrative, or criminal investigations; inspections; licensure or disciplinary actions; civil, administrative, or criminal proceedings\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00354\n\nor actions; or other activities necessary for appropriate oversight of:\n\n- (i) The health care system;\n\n(ii) Government benefit programs for which health information is relevant to beneficiary eligibility;\n\n(iii) Entities subject to government regulatory programs for which health information is necessary for determining compliance with program standards; or\n\n(iv) Entities subject to civil rights laws for which health information is necessary for determining compliance. (2) Exception to health oversight activities."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 523}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 104)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nion period\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00069\n\navailable to contracts existing as of the compliance date of the Privacy Rule, rather than as of the effective date of the transition modification.\nOthers requested that the Department apply the transition period to all business associate arrangements, even those arrangements for which there was no existing written contract. Some commenters urged the Department to modify the end date of the transition period. A few of these commenters requested that the transition period apply to existing business associate contracts until they expired or were renewed, with no specified end date in the regulation. It was also suggested that the Department simply provide one extra year, until April 14, 2004, for compliance with the business associate contract provisions, without the provision that a renewal or modification of the contract would trigger an earlier transition period end date. A few commenters requested further guidance as to the types of actions the Department would or would not consider to be a ''renewal or modification'' of the contract. Additionally, numerous commenters requested that the Department further clarify a covered entity's responsibilities with regard to their business associates during the transition period. Commenters expressed concerns with the proposal's requirement that the transition provisions would not have relieved a covered entity of its responsibilities with respect to an individual's rights to access or amend his or her protected health information held by business associates, or receive an accounting of disclosures by a business associate. Similarly, commenters raised concerns that the transition provisions would not have relieved a covered entity of its responsibilities to make information available to the Secretary, including information held by a business associate, as necessary for the Secretary to determine compliance."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 103}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 25)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nWe note here several circumstances that are important. The type of service and skill level required to perform the service are relevant factors in determining whether a business associate is an agent.\nFor example, a business associate that is hired to perform de-identification of protected health information for a small provider would likely not be an agent because the small provider likely would not have the expertise to provide interim instructions regarding this activity to the business associate. Also, an agency relationship would not likely exist when a covered entity is legally or\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with otherwise prevented from performing the service or activity performed by its business associate. For example, the accreditation functions performed by a business associate cannot be performed by a covered entity seeking accreditation because a covered entity cannot perform an accreditation survey or award accreditation. We also note that a business associate can be an agent of a covered entity: (1) Despite the fact that a covered entity does not retain the right or authority to control every aspect of its business associate's activities; (2) even if a covered entity does not exercise the right of control but evidence exists that it holds the authority to exercise that right; and (3) even if a covered entity and its business associate are separated by physical distance (e.g., if a covered entity and business associate are located in different countries). ## Response to Other Public Comments\n\nComment: One commenter asked whether the Department intends to eliminate the exceptions afforded by the Federal common law of agency. This commenter also argued that if a business associate were an agent of a covered entity, and a HIPAA compliant business associate agreement was in place, any deviation from the terms in the agreement would be by definition outside the scope of agency."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 24}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 4)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nth the federal government and by states as health information systems continue to evolve. ## Need for a National Health Privacy Framework\n\n## The Importance of Privacy\n\nPrivacy is a fundamental right.\nAs such, it must be viewed differently than any ordinary economic good. The costs and benefits of a regulation must, of course, be considered as a means of identifying and weighing options. At the same time, it is important not to lose sight of the inherent meaning of privacy: it speaks to our individual and collective freedom. A right to privacy in personal information has historically found expression in American law. All fifty states today recognize in tort law a common law or statutory right to privacy. Many states specifically provide a remedy for public revelation of private facts. Some states, such as California and Tennessee, have a right to privacy as a matter of state constitutional law. The multiple historical sources for legal rights to privacy are traced in many places, including Chapter 13 of Alan Westin's Privacy and Freedom and in Ellen Alderman &amp; Caroline Kennedy, The Right to Privacy (1995). Throughout our nation's history, we have placed the rights of the individual at the forefront of our democracy. In the Declaration of Independence, we asserted the ''unalienable right'' to ''life, liberty and the pursuit of happiness.'' Many of the most basic protections in the Constitution of the United States are imbued with an attempt to protect individual privacy while balancing it against the larger social purposes of the nation. To take but one example, the Fourth Amendment to the United States Constitution guarantees that ''the right of the people to be secure in their persons, houses, papers and effects, against unreasonable searches and seizures, shall not be violated.'' By referring to the need for security of ''persons'' as well as ''papers and effects'' the Fourth Amendment suggests enduring values in American law that relate to privacy."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 3}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 88)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\ning the CIS Critical Security Controls could use the 'CIS CRITICAL SECURITY CONTROLS (1.0.0)' (shown in the first column) informative reference in conjunction with the mappings provided in Appendix D.\nThe regulated entity could begin by consulting the mapping in Appendix D to identify the applicable Cybersecurity Framework Subcategories for a standard or implementation specification. Then the regulated entity could use the 'CIS CRITICAL SECURITY CONTROLS (1.0.0)' informative reference to locate the applicable CIS critical security controls for each identified Cybersecurity Framework Subcategory. This process would help the regulated entity determine the CIS critical security controls that align with the standards and implementation specifications of the Security Rule. Another helpful component of the OLIR Program is the Derived Relationship Mapping (DRM) Analysis Tool. A DRM is the result of using the relationships between Reference Documents and a Focal Document to make inferences about relationships between the Reference Documents. For example, the OLIR catalog contains an informative reference that maps Subcategories of the Cybersecurity Framework to security controls in SP 800-53r5. Another informative reference maps elements of the Cybersecurity Framework to elements in multiple versions of the HITRUST CSF. A DRM can be created that depicts the relationships between the two Reference Documents: SP 800-53r5 and the HITRUST CSF. This DRM can help a regulated entity understand the SP 800-53 security controls that align with the various elements of the HITRUST CSF. These DRMs can be dynamically generated on the OLIR website. With much of the relationship data already defined by the SME, a user can simply generate a full report between two Reference Documents and export it to a comma-separated values format."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 87}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 452)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhe requirements of the Transactions Rule, which included an estimate of a net savings to the health care system of $29.9 billion over ten years (2002 dollars) and a net present value of $19.1 billion.\nThe Department expects that the savings and costs generated by all administrative simplification standards should result in a net savings to the health care system. ## B. Summary of Costs and Benefits\n\nMeasuring both the economic costs and benefits of health information privacy is difficult. Traditionally, privacy has been addressed by state laws, contracts, and professional practices and guidelines. Moreover, these practices have been evolving as computers have dramatically increased the potential use of medical data; the scope and form of health information is likely to be very different ten years from now than it is today. This final regulation is both altering current health information privacy practice and shaping its evolution as electronic uses expand. To estimate costs, the Department used information from published studies, trade groups and associations, public comments to the proposed regulation, and fact-finding by staff. The analysis focused on the major policy areas in the regulation that would result in significant costs. Given the vast array of institutions affected by this regulation and the considerable variation in practices, the Department sought to identify the ''typical'' current practice for each of the major policy areas and estimate the cost of change resulting from the regulation. Because of the paucity of data and incomplete information on current practices, the Department has consistently made conservative assumptions (that is, given uncertainty, we have made assumptions that, if incorrect, are more likely to overstate rather than understate the true cost). Benefits are difficult to measure because people conceive of privacy primarily as a right, not as a commodity."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 451}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 5)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncommon-sense right to privacy in one's personal information. Examples include Alan Westin, Privacy and Freedom (1967) and Janna Malamud Smith, Private Matters: In Defense of the Personal Life (1997).\nThese writings emphasize the link between privacy and freedom and privacy and the ''personal life,'' or the ability to develop one's own personality and self-expression. Smith, for instance, states:\n\nThe bottom line is clear. If we continually, gratuitously, reveal other people's privacies, we harm them and ourselves, we undermine the richness of the personal life, and we fuel a social atmosphere of mutual exploitation. Let me put it another way: Little in life is as precious as the freedom to say and do things with people you love that you would not say or do if someone else were present. And few experiences are as fundamental to liberty and autonomy as maintaining control over when, how, to whom, and where you disclose personal material. Id. at 240-241. In 1890, Louis D. Brandeis and Samuel D. Warren defined the right to privacy as ''the right to be let alone.'' See L. Brandeis, S. Warren, ''The Right\n\nFrm 00004\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nTo Privacy,'' 4 Harv.L.Rev. 193. More than a century later, privacy continues to play an important role in Americans' lives. In their book, The Right to Privacy, (Alfred A. Knopf, New York, 1995) Ellen Alderman and Caroline Kennedy describe the importance of privacy in this way:\n\nPrivacy covers many things. It protects the solitude necessary for creative thought. It allows us the independence that is part of raising a family. It protects our right to be secure in our own homes and possessions, assured that the government cannot come barging in. Privacy also encompasses our right to self-determination and to define who we are. Although we live in a world of noisy self-confession, privacy allows us to keep certain facts to ourselves if we so choose."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 4}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 539)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\naccess requested would be reasonably likely to reveal the source of the information. VerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00363\n\n(3) Reviewable grounds for denial .\nA covered entity may deny an individual access, provided that the individual is given a right to have such denials reviewed, as required by paragraph (a)(4) of this section, in the following circumstances:\n\n(i) A licensed health care professional has determined, in the exercise of professional judgment, that the access requested is reasonably likely to endanger the life or physical safety of the individual or another person;\n\n(ii) The protected health information makes reference to another person (unless such other person is a health care provider) and a licensed health care professional has determined, in the exercise of professional judgment, that the access requested is reasonably likely to cause substantial harm to such other person; or\n\n(iii) The request for access is made by the individual's personal representative and a licensed health care professional has determined, in the exercise of professional judgment, that the provision of access to such personal representative is reasonably likely to cause substantial harm to the individual or another person. (4) Review of a denial of access . If access is denied on a ground permitted under paragraph (a)(3) of this section, the individual has the right to have the denial reviewed by a licensed health care professional who is designated by the covered entity to act as a reviewing official and who did not participate in the original decision to deny. The covered entity must provide or deny access in accordance with the determination of the reviewing official under paragraph (d)(4) of this section. (b) Implementation specifications: requests for access and timely action . (1) Individual's request for access ."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 538}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 67)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nefits on the provision of an authorization. This limitation is intended to ensure that authorization from an individual for a use or disclosure of protected health information is voluntarily provided.\nHowever, there are exceptions to this general rule for certain circumstances, including in the research context, where a covered entity may condition the provision of research-related treatment, such as in a clinical trial, on obtaining the individual's authorization for the use or disclosure of protected health information for such research. Permitting the use of protected health information is part of the decision to receive care through a clinical trial, and health care providers conducting such trials are able to condition researchrelated treatment on the individual's willingness to authorize the use or disclosure of protected health information for research associated with the trial. Section 164.508(b)(3) generally prohibits what are termed ''compound authorizations,'' i.e., where an authorization for the use and disclosure of protected health information is combined with any other legal permission. However, § 164.508(b)(3)(i) carves out an exception to this general prohibition, permitting the combining of an authorization for a research study with any other written permission for the same study, including another authorization or informed consent to participate in the research. Nonetheless, §164.508(b)(3)(iii) prohibits combining an authorization that conditions treatment, payment, enrollment in a health plan, or eligibility for benefits (conditioned authorization) with an authorization for another purpose for which treatment, payment, enrollment, or eligibility may not be conditioned (unconditioned authorization)."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 66}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 391)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ner suggested that some kind of PKI credentialing certificate should be required. Response: This regulation does not address specific technical protocols utilized to meet the verification requirements.\nIf the requirements of the rule are otherwise met, the mechanism for meeting them can be determined by the covered entity. Comment: A few commenters wanted more clarification on the verification procedures. One commenter wanted to know if contract number is enough for verification. A few commenters wanted to know if a callback or authorization on a letterhead is acceptable. A few commenters wanted to know if plans are considered to ''routinely do business'' with all of their members. Response: In the final rule, we modify the proposed provision and require covered entities to have policies and procedures reasonably designed to verify the identify and authority of persons requesting protected health information. Whether knowledge of a contract number is reasonable evidence of authority and identity will depend on the circumstances. Call-backs and letterhead are typically used today for verification, and are acceptable under this rule if reasonable under the circumstances. For communications with health plan members, the covered entity will already have information about each individual, collected during enrollment, that can be used to establish identity, especially for verbal or electronic inquiries. For example, today many health plans ask for the social security or policy number of individuals seeking information or assistance by telephone. How this verification is done is left up to the covered entity. Comment: One commenter expressed the need for consistency on verification requirements between this rule and the Security regulation. Response: We will make every effort to ensure consistency prior to publishing the final Security Rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 390}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 47)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nd)(1), the first sentence of paragraph (e)(1), (g)(1), (h), the first sentence of paragraph (i)(1), (i)(2)(i) and add paragraph (j)(1)(iv) to read as follows:\n\n## §164.530 Administrative requirements.\n*\n\n*\n\n*\n\n*\n\n*\n\n(b)(1) Standard: Training. A covered entity must train all members of its workforce on the policies and\n\n15:01 Aug 21, 2009\n\nPO 00000\n\nFrm 00031\n\nFmt 4701\n\nSfmt 4700\n\nprocedures with respect to protected health information required by this subpart and subpart D of this part, as necessary and appropriate for the members of the workforce to carry out their functions within the covered entity. <!-- formula-not-decoded -->\n\n- (C) To each member of the covered entity's workforce whose functions are affected by a material change in the policies or procedures required by this subpart or subpart D of this part, within a reasonable period of time after the material change becomes effective in accordance with paragraph (i) of this section. *\n\n*\n\n*\n\n*\n\n*\n\n(d)(1) Standard: Complaints to the covered entity. A covered entity must provide a process for individuals to make complaints concerning the covered entity's policies and procedures required by this subpart and subpart D of this part or its compliance with such policies and procedures or the requirements of this subpart or subpart D of this part. *\n\n*\n\n*\n\n*\n\n*\n\n(e)(1) Standard: Sanctions. A covered entity must have and apply appropriate sanctions against members of its workforce who fail to comply with the privacy policies and procedures of the covered entity or the requirements of this subpart or subpart D of this part.* * *\n\n*\n\n*\n\n*\n\n*\n\n*\n\n- (g) Standard: Refraining from intimidating or retaliatory acts."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 46}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 48)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\ndix F, including OCR BAA guidance and/or templates that include applicable language. • Execute new or update existing agreements or arrangements, as appropriate. • Identify roles and responsibilities.\n• Include security requirements in business associate contracts and agreements to address the confidentiality, integrity, and availability of ePHI. • Specify any training requirements associated with the contract/agreement or arrangement, if reasonable and appropriate. | • Who is responsible for coordinating and preparing the final agreement or arrangement? • Does the agreement or arrangement specify how information is to be transmitted to and from the business associate? • Have security controls been specified for the business associate? • Are clear responsibilities identified and established regarding potentially overlapping HIPAA obligations (e.g., if hosting ePHI in the cloud, will the covered entity, business associate, or both address encryption)? • Have appropriate organizational personnel been trained in the process of initiating and maintaining a business associate agreement (BAA)? |\n\n83  See Sec. 5.4.1, HIPAA Standard: Business Associate Contracts or Other Arrangements. 84  See Sec. 5.4.1, HIPAA Standard: Business Associate Contracts or Other Arrangements. ## 5.2. Physical Safeguards\n\n## 5.2.1. Facility Access Controls (§ 164.310(a)) 85\n\nHIPAA Standard: Implement policies and procedures to limit physical access to its electronic information systems and the facility or facilities in which they are housed, while ensuring that properly authorized access is allowed. Table 17."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 47}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.530(e) require?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n§164.530(e)(1) but modify the proposed provision on sanctions to clarify that the sanctions required under this rule do not apply to workforce members of a covered entity for whistleblower disclosures.\n\n## Disclosures by Workforce Members Who Are Crime Victims\n\nThe proposed rule did not address disclosures by workforce members who are victims of a crime. In the final rule, we clarify that a covered entity is not in violation of the rule when a workforce member of a covered entity who is the victim of a crime discloses protected health information to law enforcement officials about the suspecte"}], "metadata": {"source": "privacy_rule_2000", "cfr_section": "§164.530(e)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "When must a HIPAA breach be reported to HHS?"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRIN 0991-AB14\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY: Office for Civil Rights, HHS. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (''HHS'' or ''Department'') modifies certain standards in the Rule entitled ''Standards for Privacy of Individually Identifiable Health Information'' (''Privacy Rule''). The Privacy Rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996. The purpose of these modifications is to maintain strong protections for the privacy of individually identifiable health information while clarifying certain of the Privacy Rule's provisions, addressing the unintended negative effects of the Privacy Rule on health care quality or access to health care, and relieving unintended administrative burdens created by the Privacy Rule. DATES: This final rule is effective on October 15, 2002. FOR FURTHER INFORMATION CONTACT: Felicia Farmer, 1-866-OCR-PRIV (1866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION:\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 (or toll-free at 1-866-5121800) or by fax to (202) 512-2250. The cost for each copy is $10.00."}], "metadata": {"source": "privacy_mod_2002", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 69)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nKey activities, descriptions, and sample questions for the Requirements for Group Health Plans standard | | Key Activities | Description | Sample Questions | |----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 1 | Amend Plan Documents of the Group Health Plan to Address the Plan Sponsor's Security of ePHI Implementation Specification (Required) | • Amend the plan documents to incorporate provisions to require the plan sponsor to implement administrative, technical, and physical safeguards that will reasonably and appropriately protect the confidentiality, integrity, and availability of ePHI that it creates, receives, maintains, or transmits on behalf of the group health plan."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 68}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 231)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nr law enforcement purposes to be limited to those in which a law enforcement official knows that\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00153\n\nlaw has been violated.\nAccordingly, we revise the definition of ''law enforcement official'' to include investigations of ''potential'' violations of law. ## Marketing\n\nComments related to ''marketing'' are addressed in the responses to comments regarding § 164.514(e). ## Payment\n\nComment: One commenter urged that the Department not permit protected health information to be disclosed to a collection agency for collecting payment on a balance due on patient accounts. The commenter noted that, at best, such a disclosure would only require the patient's and/or insured's address and phone number. Response: We disagree. A collection agency may require additional protected health information to investigate and assess payment disputes for the covered entity. For example, the collection agency may need to know what services the covered entity rendered in order to resolve disputes about amounts due. The information necessary may vary, depending on the nature of the dispute. Therefore we do not specify the information that may be used or disclosed for collection activities. The commenter's concern may be addressed by the minimum necessary requirements in § 164.514. Under those provisions, when a covered entity determines that a collection agency only requires limited information for its activities, it must make reasonable efforts to limit disclosure to that information. Comment: A number of commenters supported retaining the expansive definition in the proposed rule so that current methods of administering the claims payment process would not be hindered by blocking access to protected health information. Response: We agree and retain the proposed overall approach to the definition."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 230}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 73)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\non an adverse event. In addition, to the extent an adverse event is required to be reported by law, the disclosure of protected health information for this purpose is also permitted under §164.512(a).\nFor example, a Federally funded researcher who is a covered health care provider under the Privacy Rule may disclose protected health information related to an adverse event to the National Institutes of Health\n\nVerDate Aug&lt;2,&gt;2002\n\n(NIH) if required to do so by NIH regulations. Even if not required to do so, the researcher may also disclose adverse events directly to NIH as a public health authority. To the extent that NIH has public health matters as part of its official mandate it qualifies as a public health authority under the Privacy Rule, and to the extent it is authorized by law to collect or receive reports about injury and other adverse events such collection would qualify as a public health activity. 2. Institutional Review Board (IRB) or Privacy Board Approval of a Waiver of Authorization\n\nDecember 2000 Privacy Rule. The Privacy Rule builds upon existing Federal regulations governing the conduct of human subjects research. In particular, the Rule at § 164.512(i) establishes conditions under which covered entities can use and disclose protected health information for research purposes without individual authorization if the covered entity first obtains either of the following:\n\n- Where a review of protected health information is conducted preparatory to research or where research is conducted solely on decedents' information, certain representations from the researcher, including that the use or disclosure is sought solely for such a purpose and that the protected health information is necessary for the purpose. - Documentation of approval of a waiver of authorization from an Institutional Review Board (IRB) or a Privacy Board."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 72}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 85)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\niting. When an individual revokes an authorization, a covered entity that knows of such revocation must stop making uses and disclosures pursuant to the authorization to the greatest extent practical.\nA covered entity may continue to use and disclose protected health information in accordance with the authorization only to the extent the covered entity has taken action in reliance on the authorization. For example, a covered entity is not required to retrieve information that it has already disclosed in accordance with the authorization. (See above for discussion of how written revocation of an authorization and knowledge of that revocation may differ.)\n\nWe also include an additional exception. Under § 164.508(b)(5), individuals do not have the right to revoke an authorization if the authorization was obtained as a condition of obtaining insurance coverage and other applicable law provides the insurer that obtained the authorization with the right to contest a claim under the policy. We intend this exception to permit insurers to obtain necessary protected health information during contestability periods under state law. For example, an individual may not revoke an authorization for the disclosure of protected health information to a life insurer for the purpose of investigating material misrepresentation if the individual's policy is still subject to the contestability period. ## Documentation\n\nIn the final rule, we clarify that a covered entity must document and retain any signed authorization as required by § 164.530(j) (see below)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 84}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 96)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nenters wanted some or all of the\n\nVerDate Aug&lt;2,&gt;2002\n\ndisclosures which are permitted at §164.512 without individual consent or authorization to also be exempt from the accounting requirements.\nOthers proposed alternative means of accounting for disclosures for research, particularly when such disclosures involve large numbers of records. These commenters argued that accounting for each individual record disclosed for a large research project would be burdensome and may deter covered entities from participating in such research. Rather than an individual accounting, the commenters suggested that the covered entity be required only to disclose a listing of all relevant protocols under which an individual's information may have been released during the accounting period, the timeframes during which disclosures were made under a protocol, and the name of the institution and researcher or investigator responsible for the protocol, together with contact information for the researcher. The National Committee on Vital Health Statistics, while not endorsing a protocol listing directly, recommended the Department consider alternatives to minimize the burden of the accounting requirements on research. Finally, several commenters objected to the elimination of the accounting requirement for authorized disclosures. Some of these commenters expressed concern that the proposal would eliminate the requirement to account for the authorized disclosure of psychotherapy notes. Others were primarily concerned that the proposal would weaken the accounting rights of individuals. According to these commenters, informing the individual of disclosures was only part of the purpose of an accounting. Even with regard to authorized disclosures, an accounting could be important to verify that disclosures were in accord with the scope and purpose as stated in the authorization and to detect potentially fraudulent, altered, or otherwise improperly accepted authorizations."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 95}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.404(d)(1) require?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n§164.404(d)(1)(ii) provided that notice\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00085\n\nof a breach be sent to either the individual's next of kin or personal representative, as such term is used for purposes of the Privacy Rule, recognizing that in some cases, a covered entity may have contact information for a personal representative of a deceased individual rather than the next of kin. To address administrative and privacy concerns with a covered entity being required to obtain contact information for the next of kin of a deceased patient in cases where the individual did not otherwise provide th"}], "metadata": {"source": "hitech_omnibus_2013", "cfr_section": "§164.404(d)(1)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 129)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nused for purposes of the Privacy Rule, recognizing that in some cases, a covered entity may have contact information for a personal representative of a deceased individual rather than the next of kin.\nTo address administrative and privacy concerns with a covered entity being required to obtain contact information for the next of kin of a deceased patient in cases where the individual did not otherwise provide the information while alive, the interim final rule also clarified that a covered entity is only required to provide notice to the next of kin or personal representative if the covered entity both knows the individual is deceased and has the address of the next of kin or personal representative of the decedent. If a covered entity does not have sufficient contact information for some or all of the affected individuals, or if some notices are returned as undeliverable, the interim final rule required a covered entity to provide substitute notice for the unreachable individuals in accordance with §164.404(d)(2). The interim final rule required that substitute notice be provided as soon as reasonably possible after the covered entity is aware that it has insufficient or out-of-date contact information for one or more affected individuals and that the notice contain all the elements that § 164.404(c) requires be included in the direct written notice to individuals. With respect to decedents, however, the interim final rule provided that a covered entity is not required to provide substitute notice for the next of kin or personal representative in cases where the covered entity either does not have contact information or has out-of-date contact information for the next of kin or personal representative. Section 164.404(d)(2) of the interim final rule required that, whatever method used, the substitute form of notice be reasonably calculated to reach the individuals for whom it is being provided."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 128}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the physical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\n## Office of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRin: 0991-AB08\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY : Office of the Assistant Secretary for Planning and Evaluation, DHHS. ACTION\n\n: Final rule. SUMMARY : This rule includes standards to protect the privacy of individually identifiable health information. The rules below, which apply to health plans, health care clearinghouses, and certain health care providers, present standards with respect to the rights of individuals who are the subjects of this information, procedures for the exercise of those rights, and the authorized and required uses and disclosures of this information. The use of these standards will improve the efficiency and effectiveness of public and private health programs and health care services by providing enhanced protections for individually identifiable health information. These protections will begin to address growing public concerns that advances in electronic technology and evolution in the health care industry are resulting, or may result, in a substantial erosion of the privacy surrounding individually identifiable health information maintained by health care providers, health plans and their administrative contractors. This rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and\n\nAccountability Act of 1996. DATES : The final rule is effective on February 26, 2001. ## FOR FURTHER INFORMATION CONTACT :\n\nKimberly Coleman, 1-866-OCR-PRIV (1-866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION :\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954."}], "metadata": {"source": "privacy_rule_2000", "safeguard_type": "physical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 474)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nes for each amendment request at a cost of $47.28 per hour (2000 CPS). The first-year cost for the amendment policy is estimated to be $5 million. The ten-year cost of this provision is $78.8 million.\n## Law Enforcement and Judicial and Administrative Proceedings\n\nThe law enforcement provisions of the final rule allow disclosure of protected health information without patient authorization under four circumstances: (1) Pursuant to legal process or as otherwise required by law; (2) to locate or identify a suspect, fugitive, material witness, or missing person; (3) under specified conditions regarding a victim of crime; and (4) and when a covered entity believes the protected health information constitutes evidence of a crime committed on its premises. As under current law and practice, a covered entity may disclose protected health information to a law enforcement official if such official. Based on our fact finding, we are not able to estimate any additional costs from the final rule regarding disclosures to law enforcement officials. The final rule makes clear that current court orders and grand jury subpoenas will continue to provide a basis for covered entities to disclose protected health information to law enforcement officials. The three-part test, which covered entities must use to decide whether to disclose information in response to an administrative request such as an administrative subpoena, represents a change from current practice. There will be only minimal costs to draft the standard language for such subpoenas. We are unable to estimate other costs attributable to the use of administrative subpoenas."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 473}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 268)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhe final rule, we remove the example of use and disclosure to non-health related divisions of the covered entity from the list of examples of uses and disclosures requiring authorization in § 164.508.\nWe determined that the example could lead covered entities to the mistaken conclusion that some uses or disclosures that would otherwise be permitted under the rule without authorization would require authorization when made to a nonhealth related division of the covered entity. In the final rule, we clarify that disclosure to a non-health related division does not require authorization if the use or disclosure is otherwise permitted or required under the rule. For example, in § 164.501 we define health care operations to include conducting or arranging for legal and auditing services. A covered entity that is the health care component of a larger entity is permitted under the final rule to include the legal department of the larger entity as part of the health care component. The covered entity may not, however, generally permit the disclosure of protected health information from the health care component to non-health related divisions unless they support the functions of the health care component and there are policies and procedures in place to restrict the further use to the support of the health related functions. Comment: Many commenters, especially those who employed providers, supported our position in the proposed rule to consider only the health care component of an entity to be the covered entity. They stated that this was a balanced approach that would allow them to continue conducting business. Some commenters felt that there was ambiguity in the regulation text of the proposed rule and requested that the final rule explicitly clarify that only the health care component is considered the covered entity, not the entity itself."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 267}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 84)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nlosure of psychotherapy notes for both treatment and research purposes; and an authorization for the disclosure of the individual's demographic information for both marketing and fundraising purposes.\nExamples of invalid compound authorizations include: an authorization for the disclosure of protected health information for treatment, for research, and for determining payment of a claim for benefits, when the covered entity will refuse to pay the claim if the individual does not sign the authorization; or an authorization for the disclosure of psychotherapy notes combined with an authorization to disclose any other protected health information. ## Prohibition on Conditioning Treatment, Payment, Eligibility, or Enrollment\n\nWe proposed to prohibit covered entities from conditioning treatment or payment on the provision by the individual of an authorization, except when the authorization was requested in connection with a clinical trial. In the case of authorization for use or disclosure of psychotherapy notes or research information unrelated to treatment, we proposed to prohibit covered entities from conditioning treatment, payment, or enrollment in a health plan on obtaining such an authorization. We retain this basic approach but refine its application in the final rule. In addition to the general prohibition on conditioning treatment and payment, covered entities are also prohibited (with certain exceptions described below) from conditioning eligibility for benefits or enrollment in a health plan on obtaining an authorization. This prohibition extends to all authorizations, not just authorizations for use or disclosure of psychotherapy notes. This prohibition is intended to prevent covered entities from coercing individuals into signing an authorization for a use or disclosure that is not necessary to carry out the primary services that the covered entity provides to the individual."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 83}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 93)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nonditions when they need to be transferred by ambulance, at which time it may not be effective or appropriate to provide the notice and obtain the individual's acknowledgment of receipt of the notice.\nResponse: During emergency treatment situations, the final Rule at §164.520(c)(2)(i)(B) delays the\n\nVerDate Aug&lt;2,&gt;2002\n\n19:04 Aug 13, 2002\n\nJkt 197001\n\nrequirement for provision of the notice until reasonably practicable after the emergency situation, and exempts health care providers from having to make a good faith effort to obtain an individual's acknowledgment. As the provisions are not intended to apply only to ambulance providers, the Department does not believe that defining emergency with respect to such providers is appropriate or necessary. Nor does the Department believe that expanding these provisions to cover non-emergency trips of ambulance providers is appropriate. The provisions are intended to provide exceptions for those situations where providing the notice and obtaining an individual's acknowledgment may not be feasible or practicable. Where such extenuating circumstances do not exist, the Department expects that covered health care providers are able to provide individuals with a notice and make a good faith effort to obtain their acknowledgment of receipt. Where an individual does not provide an acknowledgment, the Rule requires only that the provider document his good faith effort to obtain the acknowledgment. Comment: A number of commenters requested clarification on how to implement the ''good faith'' standard and urged the Department to provide more specific guidance and examples. Some commenters expressed concern over the perceived liability that would arise from such a discretionary standard. Response: Covered entities are provided much discretion to implement the notice acknowledgment process as best suited to their specific business practices."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 92}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 180)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nealth Plan\n\nComment: One commenter recommended that we delete the reference to $5 million in the definition and instead define a ''small health plan'' as a health plan with fewer than 50 participants.\nIt was stated that using a dollar limitation to define a ''small health plan'' is not meaningful for selfinsured plans and some other types of health plan coverage arrangements. A commenter pointed out that the general definition of a health plan refers to ''50 or more participants,'' and that using a dollar factor to define a ''small health plan'' would be inconsistent with this definition. Response: We disagree. The Small Business Administration (SBA) promulgates size standards that indicate the maximum number of employees or annual receipts allowed for a concern (13 CFR 121.105) and its affiliates to be considered ''small.'' The size standards themselves are expressed either in number of employees or annual receipts (13 CFR 121.201). The size standards for compliance with programs of other agencies are those for SBA programs which are most comparable to the programs of such other agencies, unless otherwise agreed by the agency and the SBA (13 CFR 121.902). With respect to the insurance industry, the SBA has specified that annual receipts of $5 million is the maximum allowed for a concern and its affiliates to be considered small (13 CFR 121.201). Consequently, we retain the proposal's definition in the final rule to be consistent with SBA requirements. We understand there may be some confusion as to the meaning of ''annual receipts'' when applied to a health plan. For our purposes, therefore, we consider ''pure premiums'' to be equivalent to ''annual receipts.''\n\n## Workforce\n\nComment: Some commenters requested that we exclude ''volunteers'' from the definition of workforce. They stated that volunteers are important contributors within many covered entities, and in particular hospitals."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 179}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 68)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nthe authorization clearly differentiates between the conditioned and unconditioned research components and clearly allows the individual the option to opt in to the unconditioned research activities.\nThese provisions would allow covered entities to combine authorizations for the use and disclosure of protected health information for clinical trials and related biospecimen banking activities, as well as other scenarios that often occur in research studies. While we did not propose to alter the core elements or required statements integral to a valid authorization, we stated that covered entities would have some flexibility with respect to how they met the authorization requirements. For example, covered entities could facilitate an individual's understanding of a compound authorization by describing the unconditioned research activity on a separate page of a compound authorization and could also crossreference relevant sections of a compound authorization to minimize the potential for redundant language. In addition, a covered entity could use a separate check-box for the unconditioned research activity to signify whether an individual has opted-in to the unconditioned research activity, while maintaining one signature line for the authorization, or alternatively provide a distinct signature line for the unconditioned authorization to signal that the individual is authorizing optional research that will not affect research-related treatment. We requested comment on additional methods that would clearly differentiate to the individual the conditioned and unconditioned research activities on the compound authorization. ## Overview of Public Comments\n\nAlmost all commenters on this topic strongly supported the proposal to allow combined authorizations for conditioned and unconditioned research activities."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 67}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 511)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nand disclosures consistent with notice. A covered entity that is required by § 164.520 to have a notice may not use or disclose protected health information in a manner inconsistent with such notice.\nA covered entity that is required by §164.520(b)(1)(iii) to include a specific statement in its notice if it intends to engage in an activity listed in §164.520(b)(1)(iii)(A)-(C), may not use or disclose protected health information for such activities, unless the required statement is included in the notice. (j) Standard: Disclosures by whistleblowers and workforce member crime victims. (1) Disclosures by whistleblowers. A covered entity is not considered to have violated the requirements of this subpart if a member of its workforce or a business associate discloses protected health information, provided that:\n\n(i) The workforce member or business associate believes in good faith that the covered entity has engaged in conduct that is unlawful or otherwise violates professional or clinical standards, or that the care, services, or conditions provided by the covered entity potentially endangers one or more patients, workers, or the public; and\n\n(ii) The disclosure is to:\n\n- (A) A health oversight agency or public health authority authorized by law to investigate or otherwise oversee the relevant conduct or conditions of the covered entity or to an appropriate health care accreditation organization for the purpose of reporting the allegation of failure to meet professional standards or misconduct by the covered entity; or\n\n(B) An attorney retained by or on behalf of the workforce member or business associate for the purpose of determining the legal options of the workforce member or business associate with regard to the conduct described in paragraph (j)(1)(i) of this section. (2) Disclosures by workforce members who are victims of a crime."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 510}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 119)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\notected health information has been compromised since the recipient of the information is obligated to protect the privacy and security of the information in a similar manner as the disclosing entity.\nWe also emphasize that this factor should be considered in combination with the factor discussed above regarding the risk of reidentification. If the information impermissibly used or disclosed is not immediately identifiable, entities should determine whether the unauthorized person who received the protected health information has the ability to re-identify the information. For example, if information containing dates of health care service and diagnoses of certain employees was impermissibly disclosed to their employer, the employer may be able to determine that the information pertains to specific employees based on other information available to the employer, such as dates of absence from work. In this case, there may be more than a low probability that the protected health information has been compromised. Several commenters suggested that a risk assessment need be completed following only impermissible\n\nVerDate Mar&lt;15&gt;2010\n\ndisclosures of protected health information, since information impermissibly ''used'' remains within the covered entity or business associate. We disagree. The final rule requires a risk assessment to be performed following both impermissible uses and disclosures (that do not otherwise fall within the other enumerated exceptions to breach). However, the fact that information only is impermissibly used within a covered entity or business associate and the impermissible use does not result in further impermissible disclosure outside the entity, is something that may be taken into account in conducting the risk assessment and may reduce the probability that the protected health information has been compromised."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 118}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 441)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nwhat would be the effect of the rule on research on records compiled before the effective date of the rule. Response: These comments are addressed in connection with the discussion of § 164.532 above.\nJkt 194001\n\nPO 00000\n\nFrm 00292\n\nFmt 4701\n\nSfmt 4700\n\n## Impact Analyses\n\n## Cost/Benefit Analysis\n\nComment: Many commenters made general statements to the effect that the cost estimates for implementing the provisions of the proposed regulation were incomplete or greatly understated. Response: The proposal, including the cost analysis, is, in effect, a first draft. The purpose of the proposal was to solicit public comment and to use those comments to refine the final regulation. As a result of the public comment, the Department has significantly refined our initial cost estimates for implementing this regulation. The cost analysis below reflects a much more complete analysis of the major components of the regulation than was presented in the proposal. Comment: Numerous commenters noted that significant areas of potential cost had not been estimated and that if they were estimated, they would greatly increase the total cost of the regulation. Potential cost areas identified by various respondents as omitted from the analyses include the minimum disclosure requirements; the requisite monitoring by covered entities of business partners with whom they share private health information; creation of de-identified information; internal complaint processes; sanctions and enforcement; the designation of a privacy official and creation of a privacy board; new requirements for research/ optional disclosures; and future litigation costs. Response: We noted in the proposed rule that we did not have data from which to estimate the costs of many provisions, and solicited comments providing such data. The final analysis below reflects the best estimate possible for these areas, based on the information available."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 440}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 336)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nminimum purpose rule.''\n\nResponse: A rule requiring only that the request for information be in writing and signed fails to impose appropriate substantive standards for release of health information.\nA rule requiring only sufficient information for the covered entity to make a ''minimum necessary'' determination would leave these decisions entirely to covered entities' discretion. We believe that protection of individuals' privacy interests must start with a minimum floor of protections applicable to all. We believe that while covered entities may be free to provide additional protections (within the limits of the law), they should not have the ability to allow unjustified access to health information. Comment: Some commenters argued that the requirement for an unspecified ''finding'' for a court order should be removed from the proposed rule, because it would have been confusing and would have provided no guidance to a court as to what finding would be sufficient. Response: We agree that the requirement would have been confusing, and we delete this language from the final regulation. Comment: A few commenters argued that the proposed three-part test should not be applied where existing federal or state law established a standard for issuing administrative process. Response: It is the content of such a standard, not its mere existence, that determines whether the standard strikes an appropriate balance between individuals' privacy interests and the public interest in effective law enforcement activities. We assume that current authorities to issue administrative subpoena are all subject to some standards. When an existing standard provides at least as much protection as the three-part test imposed by this regulation, the existing standard\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00223\n\nis not disturbed by this rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 335}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 282)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nor ''high cost'' employees. This same commenter requested guidance in what types of information can be released to employers to help them determine the organization's responsibilities and liabilities.\nResponse: In the final regulation we recognize the diversity in plan sponsors' need for protected health information. Many plan sponsors need access to protected health information to perform plan administration functions, including eligibility and enrollment functions, quality assurance, claims processing, auditing, monitoring, trend analysis, and management of carve-out plans (such as vision and dental plans). In the final regulation we allow group health plans to disclose protected health information to plan sponsors if the plan sponsor voluntarily agrees to use the information only in accordance with the purposes stated in the plan documents and as permitted by the regulation. We clarify, however, that plan administration does not include any employment-related decisions, including fitness for duty determinations, or duties related to other employee benefits or plans. Plan documents may only permit health insurance issuers to disclose protected health information to a plan sponsor as is otherwise permitted under this rule and consistent with the minimum necessary standard. Some plan sponsors, including those with a fully insured group health plan, do not perform plan administration functions on behalf of group health plans, but still may require health information for other purposes, such as modifying, amending or terminating the plan or soliciting bids from prospective issuers or HMOs. In the ERISA context actions undertaken to modify, amend or terminate a group health plan may be known as ''settlor'' functions (see Lockheed Corp. v. Spink, 517 U.S. 882 (1996)). For example, a plan sponsor may require access to information to evaluate whether to adopt a three-tiered drug formulary."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 281}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance?"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\n## Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on June 27, 2025. A draft select update to this document was issued on March 13, 2024. This document supersedes 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,' issued September 27, 2023. For questions about this document regarding CDRH-regulated devices, contact CyberMed@fda.hhs.gov. For questions about this document regarding CBER-regulated devices, contact the Office of Communication, Outreach, and Development (OCOD) at 1-800-835-4709 or 240-402-8010, or by email at industry.biologics@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Center for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to https://www.regulations.gov. Submit written comments to the Dockets Management Staff, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2021-D-1158. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an email request to CDRH-Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number GUI00001825 and complete title of the guidance in the request."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 0}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 65)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ned for in the contract. - Require the business associate to provide access to non-duplicative protected health information to the subject of that information, in accordance with proposed § 164.514(a).\n- Require the business associate to ensure that any subcontractors or agents to whom it provides protected health information received from the covered entity will agree to the same restrictions and conditions that apply to the business associate with respect to such information. - Require the business associate to make available its internal practices, books and records relating to the use and disclosure of protected health information received from the covered entity to the Secretary for the purposes of enforcing the provisions of this rule. - Require the business associate to incorporate any amendments or corrections to protected health information when notified by the covered entity that the information is inaccurate or incomplete. - Require the business associate, at termination of the contract, to return or destroy all protected health information received from the covered entity that the business associate still maintains in any form to the covered entity and prohibit the business associate from retaining such protected health information in any form. - State that individuals who are the subject of the protected health information disclosed are intended to be third party beneficiaries of the contract. - Authorize the covered entity to terminate the contract, if the covered entity determines that the business associate has violated a material term of the contract. We also stated in the preamble to the NPRM that the contract could have included any additional arrangements that did not violate the provisions of this regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 64}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 158)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nanges to the NPP resulting from changes pursuant to the HITECH Act. ## 10. Other Comments\n\nComment: One commenter requested clarification on preemption with regard to the new underwriting prohibition.\nResponse: Pursuant to subpart B of Part 160 of the HIPAA Administrative Simplification Rules, to the extent that a provision of State law requires a use or disclosure of genetic information for an activity that would otherwise constitute ''underwriting purposes,'' such State law would be preempted by the Privacy Rule unless an exception at §160.203 applies. In contrast, State laws that provide greater privacy protection for genetic information than the Privacy Rule continue to remain in place. Comment: One commenter asked how a health care provider should ensure that releasing an individual's information to a health plan will not result in an inappropriate disclosure to the health plan for underwriting\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00104\n\npurposes. This commenter also asked what the rules are for access to protected health information about an individual by the individual's extended family members seeking to determine if they are affected by a genetic trait. Response: With respect to the first question, these rules do not apply to health care providers. A covered health provider may continue to disclose protected health information, including genetic information, where doing so meets the minimum necessary standard, to health plans for payment purposes. Under this Rule, the onus is on the health plan to not use or disclose protected health information it receives for such purposes for prohibited underwriting purposes. Further, health plans continue to be required by the Privacy Rule to limit requests of protected health information to the minimum necessary when requesting such information from other covered entities. The regulations implementing sections 101-103 of GINA also restrict the ability of health plans covered by those rules to request genetic information."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 157}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 46)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ndo not intend the term to apply to persons with whom the covered entity has no other business; this provision is intended to permit covered entities to provide service to their existing customer base.\nWe note that this definition, either alone or in conjunction with the definition of ''organized health care arrangement,'' allows an entity such as an integrated staff model HMO, whether legally integrated or whether a group of\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00031\n\nassociated entities, that hold themselves out as an organized arrangement to share protected health information under §164.506. In these cases, the sharing of protected health information will be either for the operations of the disclosing entity or for the organized health care arrangement in which the entity is participating. Whether a disclosure is allowable for health care operations under this provision is determined separately from whether a business associate contract is required. These provisions of the rule operate independently. Disclosures for health care operations may be made to an entity that is neither a covered entity nor a business associate of the covered entity. For example, a covered academic medical center may disclose certain protected health information to community health care providers who participate in one of its continuing medical education programs, whether or not such providers are covered health care providers under this rule. A provider attending a continuing education program is not thereby performing services for the covered entity sponsoring the program and, thus, is not a business associate for that purpose. Similarly, health plans may disclose for due diligence purposes to another entity that may or may not be a covered entity or a business associate."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 45}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.105 require?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n§164.105(a)). Researchers who are not part of the covered entity's workforce and are not themselves covered entities are not subject to the standards.\n\n4. Comment: Several commenters stated that internal networks and external networks should be treated differently. One commenter asked for further clarification of the difference\n\nVerDate Jan&lt;31&gt;2003\n\nbetween what needs to be secured external to a corporation versus the security of data movement within an organization. Another stated that complying with the security standards for internal communications may prove difficult and costly to mo"}], "metadata": {"source": "security_rule_2003", "cfr_section": "§164.105", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 6)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nis applicable to breaches occurring on or after 30 days from the date of publication of this interim final rule. See Section IV.K. Effective/Compliance Date of this rule for further discussion. ## B.\nDefinitions-Section 164.402\n\nSection 164.402 of the interim final rule adopts definitions for the terms ''breach'' and ''unsecured protected health information.''\n\n## 1. Breach\n\nSection 13402 of the Act and this interim final rule require covered entities and business associates to provide notification following a breach of unsecured protected health information. Section 13400(1)(A) of the Act defines ''breach'' as the ''unauthorized acquisition, access, use, or disclosure of protected health information which compromises the security or privacy of the protected health information, except where an unauthorized person to whom such information is disclosed would not reasonably have been able to retain such information.'' Section 13400(1)(B) of the Act provides several exceptions to the definition of ''breach.'' Based on section 13400(1)(A), we have defined ''breach'' at § 164.402 of the interim final rule as ''the acquisition, access, use, or disclosure of protected health information in a manner not permitted under subpart E of this part which compromises the security or privacy of the protected health information.'' We have added paragraph (1) to the definition to clarify when the security or privacy of information is considered to be compromised. Paragraph (2) of the definition then includes the statutory exceptions, including the exception within section 13400(1)(A) that refers to whether the recipient would reasonably have been able to retain the information. PO 00000\n\nFrm 00005\n\nProtected Health Information\n\nWe note that the definition of ''breach'' is limited to protected health information."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 5}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 311)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nn cases involving domestic violence. These circumstances are unique and are best decided by a covered entity, in the exercise of professional judgment, in each situation rather than by a blanket rule.\n## Section 164.512-Uses and Disclosures for Which Consent, Authorization, or Opportunity to Agree or Object Is Not Required\n\n## Section 164.512(a)-Uses and Disclosures Required by Law\n\nComment: Numerous commenters addressed directly or by implication the question of whether the provision permitting uses and disclosures of protected health information if required by other law was necessary. Other commenters generally endorsed the need for such a provision. One such\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ncommenter approved of the provision as a needed fail-safe mechanism should the enumeration of permissible uses and disclosures of protected health information in the NPRM prove to be incomplete. Other commenters cited specific statutes which required access to protected health information, arguing that such a provision was necessary to ensure that these legally mandated disclosures would continue to be permitted. For example, some commenters argued for continued access to protected health information to investigate and remedy abuse and neglect as currently required by the Developmental Disabilities Assistance and Bill of Rights, 42 U.S.C. 6042, and the Protection and Advocacy for Mentally Ill Individuals Act, 42 U.S.C. 10801. Some comments urged deletion of the provision for uses and disclosures required by other law. This concern appeared to be based on a generalized concern that the provision fostered government intrusion into individual medical information. Finally, a number of commenters also urged that the required by law provision be deleted. These commenters argued that the proposed provision would have undermined the intent of the statute to preempt state laws which were less protective of individual privacy."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 310}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 15)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nish and maintain custodial control of device source code (the original 'copy' of the software) throughout\n\n33 The use of 'component' in this guidance is consistent with the definition in 21 CFR 820.3.\n## Contains Nonbinding Recommendations\n\nthe lifecycle of a device as part of configuration management. 34 This may be accomplished through different methods, such as source code escrow or source code backups, among others. 35\n\nManufacturers may not have control of source code due to licensing restrictions, terms of supplier agreements, or other challenges. While source code is not required to be provided in premarket submissions, manufacturers should include plans for how third-party software components could be updated or replaced if support ends or other software issues arise in premarket submissions. The device manufacturer should also provide users with whatever information they may need in the device labeling to allow them to manage risks associated with the software components, including known vulnerabilities, configuration specifications, and other relevant security and risk management considerations. One tool to help manage supply chain risk as well as clearly identify and track the software incorporated into a device is an SBOM, as described below. ## (a) Software Bill of Materials (SBOM)\n\nAn SBOM can aid in the management of cybersecurity risks that exist throughout the software stack. A robust SBOM includes both the device manufacturer-developed components and thirdparty components, including purchased/licensed software and open-source software, and the upstream software dependencies that are required/depended upon by proprietary, purchased/licensed, and open-source software."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 14}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 20)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nons of noncompliance through voluntary corrective action, there may be circumstances (such as circumstances indicating willful neglect), where the Secretary may proceed directly to formal enforcement.\n## Overview of Public Comments\n\nOne commenter supported maintaining the current language at §§160.306 and 160.308 of the Enforcement Rule, providing the Secretary with discretion to conduct complaint investigations and compliance reviews, regardless of indications of willful neglect. One commenter suggested that OCR look to whether facts indicate a ''probable,''\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00014\n\nrather than ''possible,'' violation due to willful neglect to limit the likelihood of unnecessary formal investigations or compliance reviews. While one commenter supported the proposal to require a compliance review in circumstances indicating a possible violation due to willful neglect, others argued that requiring compliance reviews in such circumstances is not required by the statute, will detract from resources to investigate complaints, and will be duplicative if a formal complaint investigation is also underway. Several commenters expressed concern over the proposal at §160.312(a) to give the Secretary discretion, rather than to require the Secretary, to attempt to resolve investigations or compliance reviews indicating noncompliance by informal means, even in cases of noncompliance that did not involve willful neglect (e.g., cases involving reasonable cause or lack of knowledge of a violation). Commenters indicated support for the Department's seeking compliance through voluntary corrective action as opposed to formal enforcement proceedings and argued that the Department should retain the requirement for the Secretary to attempt informal resolution in all circumstances except those involving willful neglect. One commenter recommended that the Secretary be able to assess penalties regardless of whether corrective action was obtained."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 19}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 267)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nate or dangerous conduct. Permitting potential whistleblowers to consult an attorney provides them with a better understanding of their legal options. We rephrase the provision to improve its clarity.\nComment: One commenter suggested that a notice of information practices that omits disclosure for voluntary reporting of fraud will chill internal whistleblowers who will be led to believe-falsely-that they would violate federal privacy law, and be lawfully subject to sanction by their employer, if they reported fraud to health oversight agencies. Response: The notice of information practices describes a covered entity's information practices. A covered entity does not make whistleblower disclosures of protected health information, nor can it be expected to anticipate any such disclosures by its workforce. Comment: One commenter suggested that the whistleblower provisions could allow covered entities to make illegal disclosures to police through the back door by having an employee who believes there is a violation of law do the disclosing. Any law could have been violated and the violator could be anyone (a patient, a member of the patient's family, etc.)\n\nResponse: We have eliminated whistleblower disclosures for law enforcement purposes from the list of circumstances in which the covered entity will be protected under this rule. This provision is intended to protect the covered entity when a member of its workforce or a business associate discloses protected health information to whistleblow on the covered entity (or its business associates); it is not intended for disclosures of conduct by the individual who is the subject of the information or third parties."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 266}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 475)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nr programs operated by the federal government are subject to requirements placed on covered entities under this rule, including, but not limited to, those outlined in Section D of the impact analysis.\nWhile many of these federal programs already afford privacy protections for individual health information through the Privacy Act and standards set by the Departments and implemented through their contracts with providers, this rule is nonetheless expected to create additional requirements. Further, we anticipate that most federal health programs will, to some extent, need to modify their existing practices to comply fully with this rule. The cost to federal programs that function as health plans will be generally the same as those for the private sector. A unique cost to the federal government will be in the area of enforcement. The Office for Civil Rights (OCR), located at the Department of Health and Human Services, has the primary responsibility to monitor and audit covered entities. OCR will monitor and audit covered entities in both the private and government sectors, will ensure compliance with requirements of this rule, and will investigate complaints from individuals alleging violations of their privacy rights. In addition, OCR will be required to recommend penalties and other remedies as part of their enforcement activities. These responsibilities represent an expanded role for OCR. Beyond OCR, the enforcement provisions of this rule may have additional costs to the federal government through increased litigation, appeals, and inspector general oversight. Examples of other unique costs to the federal government may include such activities as public health surveillance at the Centers for Disease Control and\n\nPrevention, health research projects at the Agency for Healthcare Research and Quality, clinical trials at the National Institutes of Health, and law enforcement investigations and prosecutions by the Federal Bureau of Investigations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 474}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 335)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nduals receive notice and opportunity to contest the validity of legal process under which their protected health information will be disclosed, prior to disclosure of their records to law enforcement.\nSome of these commenters recommended adding this requirement to provisions proposed in the NPRM, while others recommended establishing this requirement as part of a new requirement for a judicial warrant prior to all disclosures of protected health information to law enforcement. At least one of these commenters proposed an exception to such a notice requirement where notice might lead to destruction of the records. Response: Above we discuss the reasons why we believe it is inappropriate to require consent or a judicial order prior to any release of protected health information to law enforcement. Many of those reasons apply here, and they lead us not to impose such a notice requirement. Comment: A few commenters believed that the proposed requirements in § 164.510(f)(1) would hinder investigations under the Civil Rights for Institutionalized Persons Act (CRIPA). Response: We did not intend that provision to apply to investigations under CRIPA, and we clarify in the final rule that covered entities may disclose protected health information for such investigations under the health oversight provisions of this regulation (see § 164.512(d) for further detail). ## Comments Suggesting Changes to the Proposed Three-Part Test\n\nComment: Many commenters argued for changes to the proposed three-part test that would make the test more difficult to meet. Many of these urged greater, but unspecified, restrictions. Others argued that the proposed test was too stringent, and that it would have hampered criminal investigations and prosecutions. Some argued that it\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nwas too difficult for law enforcement to be specific at the beginning of an investigation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 334}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 10)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nevice cybersecurity design and documentation are expected to scale with the cybersecurity risk of that device. Manufacturers should take into account the larger system in which the device may be used.\nFor example, a cybersecurity risk assessment performed on a simple, non-connected thermometer may conclude that the risks are limited, and therefore such a device needs only a limited security architecture (i.e., addressing only device hardware and software) and few security controls based on the technical characteristics and design of the device. However, if a thermometer is used in a safety-critical control loop, or is connected to networks or other devices, then the cybersecurity risks for the device are considered to be greater and more substantial design controls should result. Submitters should consider including in premarket submissions to FDA documentation generated from those design controls used during the development of a device with cybersecurity risks as a way to demonstrate reasonable assurance of safety and effectiveness. This guidance identifies the cybersecurity information FDA recommends to help support a premarket submission for devices within the scope of this guidance, including but not limited to cyber devices. 20\n\nAs cybersecurity is part of device safety and effectiveness, cybersecurity controls established during premarket development should also take into consideration the intended and actual use environment (see Section IV.B). Cybersecurity risks evolve over time and as a result, the effectiveness of cybersecurity controls may degrade as new risks, threats, and attack methods emerge. In the 510(k) context, FDA evaluates the cybersecurity information submitted and the\n\n20 As previously discussed, section 524B of the FD&amp;C Act requires the submission of certain documentation for cyber devices. See Section VII of this guidance for more information on cyber devices."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 9}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the differences between covered entity and business associate obligations under HIPAA?"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n## Postmarket Management of Cybersecurity in Medical Devices\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on December 28, 2016. The draft of this document was issued on January 22, 2016. For questions regarding this document, contact Suzanne Schwartz, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5434, Silver Spring, MD 20993-0002, 301-796-6937. For questions regarding this document as applied to devices regulated by CBER, contact the Office of Communication, Outreach and Development in CBER at 1-800-835-4709 or 240-402-8010 or ocod@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of the Center Director\n\nCenter for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to http://www.regulations.gov . Submit written comments to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2015-D-5105. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an e-mail request to CDRH-Guidance@fda.hhs.gov to receive an electronic copy of the guidance. Please use the document number 1400044 to identify the guidance you are requesting. ## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), by written request, Office of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., Bldg."}], "metadata": {"source": "fda_postmarket_2016", "entity_type": "both", "safeguard_types": ["physical", "technical", "administrative"], "type": "entity_obligations"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.406 require?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n§164.406(a) that, for purposes of this provision, ''State'' also includes American Samoa and the Northern Mariana Islands. With respect to jurisdiction, we clarify that, for purposes of this provision, jurisdiction is a geographic area smaller than a state, such as a county, city, or town.\n\nTo illustrate how these provisions apply, we provide the following example. If laptops containing the unsecured protected health information of more than 500 residents of a particular city were stolen from a covered entity, notification under this section should be provided to prominent media outlets servin"}], "metadata": {"source": "breach_notification_2009", "cfr_section": "§164.406", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 221)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nmaintain information by name or other patient identifier. Response: We have modified the proposed definition of the designated record set to focus on how information is used, not how it is retrieved.\nInformation may be retrieved or retrievable by name, but if it is never used to make decisions about any\n\nFrm 00146\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nindividuals, the burdens of requiring a covered entity to find it and to redact information about other individuals outweigh any benefits to the individual of having access to the information. When the information might be used to affect the individual's interests, however, that balance changes and the benefits outweigh the burdens. We confirm that this regulation does not require covered entities to maintain any particular record set by name or identifier. Comment: A few commenters recommended denial of access for information relating to investigations of claims, fraud, and misrepresentations. Many commenters suggested that sensitive, proprietary, and legal documents that are ''typical state law privileges'' be excluded from the right to access. Specific suggestions for exclusion, either from the right of access or from the definition of designated record set, include quality assurance activities, information related to medical appeals, peer review and credentialing, attorney-client information, and compliance committee activities. Some commenters suggested excluding information already supplied to individuals on previous requests and information related to health care operations. However, some commenters felt that such information was already excluded from the definition of designated record set. Other commenters requested clarification that this provision will not prevent patients from getting information related to medical malpractice. Response: We do not agree that records in these categories are never used to affect the interests of individuals."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 220}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 109)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nions, activities, or services do not involve the use or disclosure of protected health information, and where any access to protected health information by such persons would be de minimus, if at all.\nFor example, a health care provider is not required to enter into a business associate contract with its janitorial service because the performance of such service does not involve the use or disclosure of protected health information. In this case, where a janitor has contact with\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\nprotected health information incidentally, such disclosure is permissible under § 164.502(a)(1)(iii) provided reasonable safeguards are in place. The Department is aware that similar questions still remain with respect to the business associate provisions of the Privacy Rule and intends to provide technical assistance and further clarifications as necessary to address these questions. Comment: A few commenters urged that the Department modify the Privacy Rule's requirement for a covered entity to take reasonable steps to cure a breach or end a violation of its business associate contract by a business associate. One commenter recommended that the requirement be modified instead to require a covered entity who has knowledge of a breach to ask its business associate to cure the breach or end the violation. Another commenter argued that a covered entity only should be required to take reasonable steps to cure a breach or end a violation if the business associate or a patient reports to the privacy officer or other responsible employee of the covered entity that a misuse of protected health information has occurred. Response: It is expected that a covered entity with evidence of a violation will ask its business associate, where appropriate, to cure the breach or end the violation."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 108}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 50)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\npressed specific confusion regarding the liability of business associates for the provision of e-access under the rule. ## Final Rule\n\nThe final rule adopts the proposed modifications to § 164.502(a).\nThe provisions specifying a business associate's permitted and required uses and disclosures of protected health information are renumbered from §164.502(a)(4) and (a)(5), as proposed, to § 164.502(a)(3) and (a)(4), as §164.502(a)(5) of the final rule now includes provisions to address prohibited uses and disclosures. Section 164.502(a)(5) is discussed below in the sections describing the prohibitions on the sale of protected health information and the use or disclosure of genetic information for underwriting purposes. In response to specific comments asking for clarification regarding when business associate liability would attach, we provide the following. As we discussed above, the final rule provides that a business associate is a person who performs functions or activities on behalf of, or certain services for, a covered entity or another business associate that involve the use or disclosure of protected health information. The final rule establishes that a person becomes a business associate by definition, not by the act of contracting with a covered entity or otherwise. Therefore, liability for impermissible uses and disclosures attaches immediately when a person creates, receives, maintains, or transmits protected health information on behalf of a covered entity or business associate and otherwise meets the definition of a business associate."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 49}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What is considered a breach under HIPAA?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 or by faxing to (202) 5122250. The cost for each copy is $10.\nAs an alternative, you can view and photocopy the Federal Register document at most libraries designated as Federal Depository Libraries and at\n\nVerDate Jan&lt;31&gt;2003\n\nmany other public and academic libraries throughout the country that receive the Federal Register . This Federal Register document is also available from the Federal Register online database through GPO access, a service of the U.S. Government Printing Office. The Web site address is http:// www.access.gpo.gov/nara/index.html . ## I. Background\n\nThe Department of Health and Human Services (HHS) Medicare Program, other Federal agencies operating health plans or providing health care, State Medicaid agencies, private health plans, health care providers, and health care clearinghouses must assure their customers (for example, patients, insured individuals, providers, and health plans) that the integrity, confidentiality, and availability of electronic protected health information they collect, maintain, use, or transmit is protected. The confidentiality of health information is threatened not only by"}], "metadata": {"source": "security_rule_2003", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 49)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nication. - Moved proposed §142.308(b)(3)(ii), ''Emergency mode operations,'' implementation feature to §164.310(a)(2)(i). It is now part of the ''Contingency operations'' implementation specification.\n- Removed proposed §142.308(b)(3)(iii), ''Equipment control (into and out of site),'' as this information is now covered under §164.310(d)(1), ''Device and media controls.''\n- Moved proposed §142.308(b)(3)(iv), ''A facility security plan,'' to §164.310(a)(2)(ii). - Moved proposed §142.308(b)(3)(v), ''Procedure for verifying access authorizations,'' to § 164.310(a)(2)(iii) and renamed as ''Access control and validation procedures.'' Removed the word ''formal'' from text. - Moved proposed §142.308(b)(3)(vi), ''Maintenance records,'' to §164.310(a)(2)(iv). - Moved proposed\n- §142.308(b)(3)(vii), ''Need to know procedures for personnel access,'' to sect; 164.310(a)(2)(iii) and renamed as ''Access control and validation procedures.''\n- Moved proposed §142.308(b)(3)(viii), ''Procedures to sign in visitors and provide escort, if appropriate,'' to § 164.310(a)(2)(iii) and renamed as ''Access control and validation procedures.''\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\nJkt 200001\n\n- Moved proposed §142.308(b)(3)(ix), ''Testing and revision,'' to §164.310(a)(2)(iii) and renamed as ''Access control and validation procedures.''\n- Moved proposed §142.308(b)(5), ''Secure work station location,'' to §164.310(c) and renamed as ''Workstation security.''\n- Moved proposed §142.308(b)(4), ''Policy and guidelines on workstation use,'' to § 164.310(b) and renamed as ''Workstation use.''\n- Removed proposed §142.308(b)(6), ''Security awareness training,'' as a separate requirement."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 48}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 110)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nthan is necessary, but cautioned against mandates that would unreasonably divert provider resources (e.g., five days would be unreasonable when a provider must take time to include explanatory notes).\n## Final Rule\n\nThe final rule modifies the timeliness requirements for right to access and to obtain a copy of protected health information at § 164.524(b). We remove the provision at § 164.524(b)(2)(ii) that permits 60 days for timely action when protected health information for access is not maintained or accessible to the covered entity on-site. We retain and renumber as necessary the provision at §164.524(b)(2)(iii) that permits a covered entity a one-time extension of 30 days to respond to the individual's request (with written notice to the individual of the reasons for delay and the expected date by which the entity will complete action on the request). We believe the 30 day timeframe for access is appropriate and achievable by covered entities given the increasing expectation and capacity to provide individuals with almost instantaneous electronic access to the protected health information in those records through personal health records or similar electronic means. While a covered entity is permitted 30 days to provide access (with a 30-day extension when necessary), we encourage covered entities to provide individuals with access to their information sooner, and to take advantage of technologies that provide individuals with immediate access to their health information. Nevertheless, for covered entities that continue to make use of off-site storage or have additional time constraints to providing access, the 30 day extension remains available for a covered entity to\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00073\n\nexercise."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 109}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 42)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nhat only the receipt of financial remuneration in exchange for making a communication, as opposed to in-kind or any other type of remuneration, is relevant for purposes of the definition of marketing.\nWe also proposed a conforming change to the required authorization provisions for marketing communications at § 164.508(a)(3) to add the term ''financial'' before ''remuneration'' and to refer to the new definition of ''financial remuneration.''\n\nThe proposed rule emphasized that financial remuneration for purposes of the definition of ''marketing'' must be in exchange for making the communication itself and be from or on behalf of the entity whose product or service is being described. Thus, under these proposed provisions, an authorization would be required prior to a covered entity making a communication to its patients regarding the acquisition of, for example, new state of the art medical equipment if the equipment manufacturer paid the covered entity to send the communication to its patients; but not if a local charitable organization, such as a breast cancer foundation, funded the covered entity's mailing to patients about new state of the art mammography screening equipment. Furthermore, it would not constitute marketing and no authorization would be required if a hospital sent flyers to its\n\nVerDate Mar&lt;15&gt;2010\n\npatients announcing the opening of a new wing where the funds for the new wing were donated by a third party, since the financial remuneration to the hospital from the third party was not in exchange for the mailing of the flyers. Second, we proposed to include the statutory exception to marketing at section 13406(a)(2)(A) for communications regarding refill reminders or otherwise about a drug or biologic that is currently being prescribed for the individual, provided any financial remuneration received by the covered entity for making the communication is reasonably related to the covered entity's cost of making the communication."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 41}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 29)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nKey activities, descriptions, and sample questions for the Assigned Security Responsibility standard | Key Activities | Description | Sample Questions | |--------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 1."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 28}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.522(d)(4) require?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n§164.522(d)(4). The commenters indicated that, as proposed, the rule would make it difficult to enforce compliance within the workforce. One commenter stated that the proposed 164.522(d)(4) ''is extremely broad and may allow an employee to reveal protected health information to fellow employees, the media and others (e.g., an employee may show a medical record to a friend or relative before filing a complaint with the Department). This commenter further stated that covered entities will ''absolutely be prevented from prohibiting such conduct.'' One commenter suggested adding that a covered ent"}], "metadata": {"source": "privacy_rule_2000", "cfr_section": "§164.522(d)(4)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 8)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nment,'' or ''health care operations.'' The purpose of the exclusions from the definition of marketing is to facilitate those communications that enhance the individual's access to quality health care.\nBeyond these important communications, the public strongly objected to any commercial use of protected health information to attempt to sell products or services, even when\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00006\n\nthe product or service is arguably health related. In light of these strong public objections, ease of administration is an insufficient justification to categorically exempt all communications about payment and health care operations from the definition of ''marketing.''\n\nHowever, in response to comments, the Department is clarifying the language that excludes from the definition of ''marketing'' those communications that describe network participants and the services or benefits of the covered entity. Several commenters, particularly insurers, were concerned that the reference to a ''plan of benefits'' was too limiting and would prevent them from sending information to their enrollees regarding enhancements or upgrades to their health insurance coverage. They inquired whether the following types of communications would be permissible: enhancements to existing products; changes in deductibles/copays and types of coverage (e.g., prescription drug); continuation products for students reaching the age of majority on parental policies; special programs such as guaranteed issue products and other conversion policies; and prescription drug card programs. Some health plans also inquired if they could communicate with beneficiaries about ''one-stop shopping'' with their companies to obtain long-term care, property, casualty, and life insurance products. The Department understands the need for covered health care providers and health plans to be able to communicate freely to their patients or enrollees about their own products, services, or benefits."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 7}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 503)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\neview of the pertinent policies, procedures, or practices of the covered entity and of the circumstances regarding any alleged acts or omissions concerning compliance. ## § 160.308 Compliance reviews.\nThe Secretary may conduct compliance reviews to determine whether covered entities are complying with the applicable requirements of this part 160 and the applicable standards, requirements, and implementation specifications of subpart E of part 164 of this subchapter. ## § 160.310 Responsibilities of covered entities. - (a) Provide records and compliance reports. A covered entity must keep such records and submit such compliance reports, in such time and manner and containing such information, as the Secretary may determine to be necessary to enable the Secretary to ascertain whether the covered entity has complied or is complying with the applicable requirements of this part 160 and the applicable standards, requirements, and implementation specifications of subpart E of part 164 of this subchapter. - (b) Cooperate with complaint investigations and compliance reviews. A covered entity must cooperate with the Secretary, if the Secretary undertakes an investigation or compliance review of the policies, procedures, or practices of a covered entity to determine whether it is complying with the applicable requirements of this part 160 and the standards, requirements, and implementation specifications of subpart E of part 164 of this subchapter. - (c) Permit access to information. (1) A covered entity must permit access by the Secretary during normal business hours to its facilities, books, records, accounts, and other sources of information, including protected health information, that are pertinent to ascertaining compliance with the applicable requirements of this part 160 and the applicable standards, requirements, and implementation specifications of subpart E of part 164 of this subchapter."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 502}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 65)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\novision. Another commenter argued that the original authorization form should indicate whether the recipient of the protected health information will further exchange the information for remuneration.\nResponse: It is expected to be the usual case that if a covered entity or business associate that receives protected health information in exchange for remuneration wishes to further disclose that information in exchange for remuneration, then an additional authorization in accordance with § 164.508 must be obtained because such disclosures will not be encompassed by the original authorization. However, it may be possible that redisclosures of information for remuneration by a recipient covered entity or business associate do not require an additional authorization, provided it is sufficiently clear to the individual in the original authorization that the recipient covered entity or business associate will further disclose the individual's protected health information in exchange for remuneration. In response to the commenter that argued that the original authorization form should indicate whether the recipient of the protected health information will further exchange the information for remuneration, as explained above we believe the language included in Section 13405 of the HITECH Act was to alert the individual as to whether the disclosures he or she was authorizing at the time involved remuneration. Where the recipient of protected health information pursuant to an authorization is a third party that is not a covered entity or business associate, we do not have authority to require that entity to disclose to the disclosing covered entity or business associate whether it plans to further exchange the protected health information for remuneration for purposes of including such information on the authorization\n\nVerDate Mar&lt;15&gt;2010\n\nform. However, covered entities that are informed of such information may include it on the authorization form if they wish to."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 64}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 54)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nlying with the requirements of part C of title XI, the Secretary established interdepartmental implementation teams who consulted with appropriate State and Federal agencies and private organizations.\nThese external groups consisted of the National Committee on Vital and Health Statistics (NCVHS) Subcommittee on Standards and Security, the Workgroup for Electronic Data Interchange (WEDI), the National Uniform Claim Committee (NUCC), the National Uniform Billing Committee (NUBC), and the American Dental Association (ADA). The teams also received comments on the proposed regulation from a variety of organizations, including State Medicaid agencies and other Federal agencies. ## B. Anticipated Effects\n\nThe analysis in the August 2000, Transaction Rule included the expected costs and benefits of the administrative simplification regulations related to electronic systems for 10 years. Although only the electronic transaction standards were promulgated in the transaction rule, HHS expected affected parties to make systems compliance investments collectively because the regulations are so integrated. Moreover, the data available to us were also based on the collective requirements of this regulation. It is not feasible to identify the incremental technological and computer costs for each regulation. Although HHS is issuing rules under HIPAA sequentially, affected entities and vendors are bundling services, that is, they have been anticipating the various needs and are designing relatively comprehensive systems as they develop hardware and software. For example, a vendor developing a system for electronic billing would also anticipate and include security features, even in the absence of any regulation. Moreover, a draft of the security rule was first published in 1998. Even though the final is different (and less burdensome), vendors had a reasonable indication of the direction policy would go."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 53}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 191)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nained for the purpose of offering or providing health benefits to the employees of two or more employers. - (x) The health care program for uniformed services under title 10 of the United States Code.\n- (xi) The veterans health care program under 38 U.S.C. chapter 17. *\n\n*\n\n*\n\n*\n\n*\n\nVerDate Mar&lt;15&gt;2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\n(xv) The Medicare Advantage program under Part C of title XVIII of the Act, 42 U.S.C. 1395w-21 through 1395w-28. *\n\n*\n\n*\n\n*\n\n*\n\nManifestation or manifested means, with respect to a disease, disorder, or pathological condition, that an individual has been or could reasonably be diagnosed with the disease, disorder, or pathological condition by a health care professional with appropriate training and expertise in the field of medicine involved. For purposes of this subchapter, a disease, disorder, or pathological condition is not manifested if the diagnosis is based principally on genetic information. *\n\n*\n\n*\n\n*\n\n*\n\nProtected health information * * * (2) Protected health information excludes individually identifiable\n\n- health information:\n- (i) In education records covered by the Family Educational Rights and Privacy Act, as amended, 20 U.S.C. 1232g;\n- (ii) In records described at 20 U.S.C. 1232g(a)(4)(B)(iv);\n- (iii) In employment records held by a covered entity in its role as employer; and\n- (iv) Regarding a person who has been deceased for more than 50 years. *\n\n*\n\n*\n\n*\n\n*\n\nRespondent means a covered entity or business associate upon which the Secretary has imposed, or proposes to impose, a civil money penalty. *\n\n*\n\n*\n\n*\n\n*\n\nStandard means a rule, condition, or requirement:\n\n- (1) Describing the following information for products, systems, services, or practices:\n2. (i) Classification of components;\n3. (ii) Specification of materials, performance, or operations; or\n4. (iii) Delineation of procedures; or\n- (2) With respect to the privacy of protected health information."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 190}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 206)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n2. (i) An authorization for the use or disclosure of protected health information for a research study may be combined with any other type of written permission for the same or another research study.\nThis exception includes combining an authorization for the use or disclosure of protected health information for a research study with another authorization for the same research study, with an authorization for the creation or maintenance of a research database or repository, or with\n\nVerDate Mar&lt;15&gt;2010\n\n- a consent to participate in research. Where a covered health care provider has conditioned the provision of research-related treatment on the provision of one of the authorizations, as permitted under paragraph (b)(4)(i) of this section, any compound authorization created under this paragraph must clearly differentiate between the conditioned and unconditioned components and provide the individual with an opportunity to opt in to the research activities described in the unconditioned authorization. - (ii) An authorization for a use or disclosure of psychotherapy notes may only be combined with another authorization for a use or disclosure of psychotherapy notes. - (iii) An authorization under this section, other than an authorization for a use or disclosure of psychotherapy notes, may be combined with any other such authorization under this section, except when a covered entity has conditioned the provision of treatment, payment, enrollment in the health plan, or eligibility for benefits under paragraph (b)(4) of this section on the provision of one of the authorizations. The prohibition in this paragraph on combining authorizations where one authorization conditions the provision of treatment, payment, enrollment in a health plan, or eligibility for benefits under paragraph (b)(4) of this section does not apply to a compound authorization created in accordance with paragraph (b)(3)(i) of this section. *\n\n*\n\n*\n\n*\n\n*\n\n- ■ 50. Amend §164.510 as follows:\n- ■ a."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 205}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 258)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\na statement unacceptable. Appropriate protection for these disclosures requires law or regulation directly applicable to the recipient of the information, not further burden on the disclosing entity.\nWhere, however, the recipient of protected health information is providing a service to or on behalf of the covered entity this balance changes. It is consistent with long-standing legal principles to hold the covered entity to a higher degree of responsibility for the actions of its agents and contractors. See §164.504 for a discussion of the responsibilities of covered entities for the actions of their business associates with respect to protected health information. ## Section 164.502(b)-Minimum Necessary\n\nComments on the minimum necessary standard are addressed in the preamble to § 164.514(d). Section 164.502(c)-Uses or Disclosures of Protected Health Information Subject to an Agreed Upon Restriction\n\nComments on the agreed upon restriction standard are addressed in the preamble to § 164.522(a). ## Section 164.502(d)-Uses and Disclosures of De-Identified Protected Health Information\n\nComments on the requirements for deidentifying information are addressed in the preamble to § 164.514(a)-(c). ## Section 164.502(e)-Business Associates\n\nComments on business associates are addressed in the preamble to §164.504(e). ## Section 164.502(f)-Deceased Individuals\n\nComment: Most commenters on this topic generally did not approve of the Secretary's proposal with regard to protected health information about deceased individuals. The majority of these commenters argued that our proposal was not sufficiently protective of such information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 257}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 290)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nwho advocated for no special protections based their opposition on the difficulty in drawing a distinction between physical and mental health and that special protections should be left to the states.\nMany health plans and employers did not support additional protections for psychotherapy notes because they stated they need access to this information to assess the adequacy of treatment, the severity of a patient's condition, the extent of a disability, or the ability to\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00192\n\nmonitor the effectiveness of an individual's mental health care and eligibility for benefits. Other commenters, many from insurance companies, cited the need to have psychotherapy notes to detect fraud. A few commenters said that it was not necessary to provide additional protections to psychotherapy notes because the ''minimum necessary'' provisions of the NPRM provide sufficient protections. Response: In the final rule, a covered entity generally must obtain an authorization for disclosure of psychotherapy notes, or for use by a person other than the person who created the psychotherapy notes. This authorization is specific to psychotherapy notes and is in addition to the consent an individual may have given for the use or disclosure of other protected health information to carry out treatment, payment, and health care operations. This additional level of individual control provides greater protection than a general application of the ''minimum necessary'' rule. Nothing in this regulation weakens existing rules applicable to mental health information that provide more stringent protections. We do not intend to alter the holding in Jaffee v. Redmond. Generally, we have not treated sensitive information differently from other protected health information; however, we have provided additional protections for psychotherapy notes because of Jaffee v. Redmond and the unique role of this type of information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 289}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 349)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ng secondary reviews. We do not believe that it is appropriate to restrict the deliberations or judgments of privacy boards, nor do we have the authority under this rule to instruct IRBs on this issue.\nInstead, we reiterate that all disclosures for research purposes under § 164.512(i) are voluntary, and that institutions may choose to impose more stringent requirements for any use and disclosure permitted under § 164.512. Frm 00231\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nComment: Some commenters were concerned about the implications of proposed §164.510(j) on multi-center research. These commenters argued that for multi-center research, researchers may require protected health information from multiple covered entities, each of whom may have different requirements for the documentation of IRB or privacy board review. Therefore, there was concern that documentation that may suffice for one covered entity, may not for another, thereby hindering multi-center research. Response: Since § 164.512(i) establishes minimum documentation standards for covered health care providers and health plans using or disclosing protected health information for research purposes, we understand that some covered providers and health plans may choose to require additional documentation requirements for researchers. We note, however, that nothing in the final rule would preclude a covered health care provider or health plan from developing the consistent documentation requirements provided they meet the requirements of §164.512(i)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 348}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 14)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nevice lifecycle. If a penetration tester, for example, was able to exploit a vulnerability, the ability of a threat actor to exploit that vulnerability is likely to increase over the device lifecycle.\nFurthermore, vulnerabilities identified in CISA's Known Exploited Vulnerabilities Catalog should be designed out of the device, as they are already being exploited and expose the medical device system and users to the risk. FDA recommends that the cybersecurity risk assessment provided in premarket submissions capture the risks and controls identified from the threat model. The methods used for scoring the risk pre- and post-mitigation and the associated acceptance criteria as well as the method for transferring security risks into the safety risk assessment process should also be provided as part of the premarket submission. ## 3. Interoperability Considerations\n\nInteroperability is an important consideration when assessing the cybersecurity of the end-to-end medical device system. As identified in FDA's guidance 'Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices,' hereafter referred to as the 'Interoperability Guidance,' interoperable medical devices have the ability to exchange and use information through an electronic interface with another medical or nonmedical product, system, or device. As part of a medical device system, a device may have cybersecurity considerations from interoperable functionality, including but not limited to interfaces with:\n\n- Other medical devices and accessories;\n- 'Other functions' as identified in FDA's guidance 'Multiple Function Device Products: Policy and Considerations;'\n- Healthcare infrastructure (e.g., network, Electronic Medical Records, medical imaging systems); and\n- General-purpose computing platforms."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 13}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 138)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nug&lt;2,&gt;2002\n\nentity that sponsored the research and the researcher. *\n\n*\n\n*\n\n*\n\n*\n\n15. Amend §164.530 as follows: a. Redesignate paragraph (c)(2) as (c)(2)(i). - b. Add paragraph (c)(2)(ii). - c.\nRemove the words ''the requirements'' from paragraph (i)(4)(ii)(A) and add in their place the word ''specifications.''\n\nThe addition reads as follows:\n\n## §164.530 Administrative requirements. *\n\n*\n\n*\n\n*\n\n*\n\n- (c) Standard: Safeguards. * * * (2) Implementation specifications: Safeguards. (i) * * *\n- (ii) A covered entity must reasonably safeguard protected health information to limit incidental uses or disclosures made pursuant to an otherwise permitted or required use or disclosure. *\n\n*\n\n*\n\n*\n\n*\n\n16. Revise § 164.532 to read as follows:\n\n## §164.532 Transition provisions. - (a) Standard: Effect of prior authorizations. Notwithstanding §§164.508 and 164.512(i), a covered entity may use or disclose protected health information, consistent with paragraphs (b) and (c) of this section, pursuant to an authorization or other express legal permission obtained from an individual permitting the use or disclosure of protected health information, informed consent of the individual to participate in research, or a waiver of informed consent by an IRB. (b) Implementation specification: Effect of prior authorization for purposes other than research. Notwithstanding any provisions in §164.508, a covered entity may use or disclose protected health information that it created or received prior to the applicable compliance date of this subpart pursuant to an authorization or other express legal permission obtained from an individual prior to the applicable compliance date of this subpart, provided that the authorization or other express legal permission specifically permits such use or disclosure and there is no agreed-to restriction in accordance with §164.522(a). - (c) Implementation specification: Effect of prior permission for research."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 137}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 37)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nRecommended Premarket Submission Documentation | Type of Premarket Submission Documentation | Guidance Section(s) | IDE Submission* | |----------------------------------------------|-----------------------|--------------------------------------------------------------| | Cybersecurity Risk Management Report | Sections V, VI.B | Could be helpful to submit, but not specifically recommended | ## Contains Nonbinding Recommendations | Type of Premarket Submission Documentation | Guidance Section(s) | IDE Submission* | |--------------------------------------------------------|---------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------| | - Threat Model (may include Architecture Views) | Sections V.A.1, V.A.3, V.A.4, V.A.5, V.B.2, Appendix 1, Appendix 2 | Could be helpful to submit, but not specifically recommended (see Architecture View recommendations) | | - Cybersecurity Risk Assessment | Sections V.A.2, V.A.3, V.A.4, V.A.5, V.A.6 | Could be helpful to submit, but not specifically recommended | | - SBOM | Sections V.A.4, VI.A | Recommended | | - Vulnerability Assessment and Software Support | Section V.A.4 | Could be helpful to submit, but not specifically recommended | | - Unresolved Anomalies Assessment | Section V.A.5 | Could be helpful to submit, but not specifically recommended | | - Traceability | Sections V.A, V.A.1, V.A.2, V.A.3, V.A.4."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 36}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 89)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nAppendix E of Revision 1 to be a separate Section 3 that focuses on Risk Assessment. Updated the Risk Assessment section to align with content from SP 800-30 and the NIST IR 8286 series of documents.\n| Section 3         |\n| NIST SP 800-66r2 | February 2024 | Substantive    | Moved the Risk Management section to Section 4 and updated the content to align with the NIST IR 8286 series of documents. | Section 4         |\n| NIST SP 800-66r2 | February 2024 | Editorial      | Updated the section 'Considerations When Applying the HIPAA Security Rule' and added Descriptions and Sample Questions. | Section 5         |\n| NIST SP 800-66r2 | February 2024 | Editorial      | Moved References from Appendix C to the end of the body to match the updated template. Updated references as needed. | References        |\n| NIST SP 800-66r2 | February 2024 | Editorial      | Moved Acronyms from Appendix B to Appendix A and updated as needed. | Appendix A        |\n| NIST SP 800-66r2 | February 2024 | Editorial      | Moved Glossary from Appendix A to Appendix B to match the updated template. | Appendix B        |\n| NIST SP 800-66r2 | February 2024 | Substantive    | Created Appendix C, including the risk assessment tables that appear in SP 800-30. These are references from Section 3, Risk Assessment. | Appendix C        |\n| NIST SP 800-66r2 | February 2024 | Substantive    | Extracted the crosswalk table from Appendix D and moved it online to the NIST Cybersecurity and Privacy Reference Tool for easier reference by readers. Also combined this online table to include the key activities, descriptions, and sample questions from Section 5 to provide more information in one place."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 88}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 5)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\ntient records, will not need to establish policies and procedures for granting access to that electronic protected health information because the access rights are equal for all of the individuals. a.\nComment: A large number of commenters indicated that mandating 69 implementation features would result in a regulation that is too burdensome, intrusive, and difficult to implement. These commenters requested that the implementation features be made optional to meet the requirements. A number of other commenters requested that all implementation features be removed from the regulation. Response: Deleting the implementation specifications would result in the standards being too general to understand, apply effectively, and enforce consistently. Moreover, a number of implementation specifications are so basic that no covered entity could effectively protect electronic protected health information without implementing them. We selected 13 of these mandatory implementation specifications based on (1) the expertise of Federal security experts and generally accepted industry practices and, (2) the recommendation for immediate implementation of certain technical and organizational practices and procedures described in Chapter 6 of For The Record: Protecting Electronic Health Information, a 1997 report by the National Research Council (NRC). These mandatory implementation specifications are referred to as required implementation specifications and are reflected in the NRC report's recommendations. Risk Analysis and Risk management are found in the NRC recommendation title System Assessment; Sanction Policy is required in the Sanctions recommendation; Information system Activity Review is discussed in Audit Trails; Response and Reporting circumstances."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 4}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 99)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ndividual's protected health information may have already been disclosed to the health plan. With respect to restrictions and follow-up care, we continue to maintain the approach discussed in the NPRM.\nIf an individual has a restriction in place with respect to a health care service but does not pay out of pocket and request a restriction with regard to follow-up treatment, and the provider needs to include information that was previously restricted in the bill to the health plan in order to have the service deemed medically necessary or appropriate, then the provider is permitted to disclose such information so long as doing so is consistent with the provider's minimum necessary policies and procedures. We also clarify that such a disclosure would continue to be permitted for payment purposes and thus, would not require the individual's written authorization. However, as we did in the NPRM, we highly encourage covered entities to engage in open dialogue with individuals to ensure that they are aware that previously restricted protected health information may be disclosed to the health plan unless they request an additional restriction and pay out of pocket for the follow-up care. ## Response to Other Public Comments\n\nComment: Several commenters asked that the provision be limited to just providers and not to covered entities in general. Commenters also asked for clarification on whether the restriction prohibits providers from giving protected health information to health plans solely for payment or health care\n\nVerDate Mar&lt;15&gt;2010\n\noperations purposes in such cases or all entities that may receive protected health information for payment or health care operations. Response: We clarify that this provision, in effect, will apply only to covered health care providers. However, the provisions of § 164.522(a) apply to covered entities generally and thus, we decline to alter the regulatory text."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 98}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 237)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\no describe their usage. This is particularly relevant to the NCPDP standards for retail pharmacy transactions referenced by these commenters, in which the current standard leaves most fields optional.\nFor this reason, we do not accept this suggestion. VerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00157\n\nThe term 'payment card' was intended to apply to a debit or credit card used to initiate payment transactions with a financial institution. We clarify that pharmacy benefit cards, as well as other health benefit cards, are used for identification of individual, plan, and benefits and do not qualify as ''other payment cards.''\n\nComment: Two commenters asked the following questions regarding the banking provisions of the proposed rule: (1) Does the proposed regulation stipulate that disclosures to banks and financial institutions can occur only once a patient has presented a check or credit card to the provider, or pursuant to a standing authorization?; and (2) Does the proposed rule ban disclosure of diagnostic or other related detailed payment information to financial institutions? Response: We do not ban disclosure of diagnostic information to financial institutions, because some such information may be evident simply from the name of the payee (e.g., when payment is made to a substance abuse clinic). This type of disclosure, however, is permitted only when reasonably necessary for the transaction (see requirements for minimum necessary disclosure of protected health information, in § 164.502 and §164.514). Similarly, we do not stipulate that such disclosure may be made only once a patient has presented a check or credit card, because some covered entities hire financial institutions to perform services such as management of accounts receivables and other back office functions. In providing such services to covered entities, the financial institution will need access to protected health information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 236}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 128)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nride, professional judgment and standards. For example, we expect that covered entities will implement policies that allow persons involved in treatment to have access to the entire record, as needed.\n## Disclosures of Protected Health Information\n\nFor any type of disclosure that is made on a routine, recurring basis, a covered entity must implement policies and procedures (which may be standard protocols) that permit only the disclosure of the minimum protected health information reasonably necessary to achieve the purpose of the disclosure. Individual review of each disclosure is not required. Instead, under §164.514(d)(3), these policies and procedures must identify the types of protected health information to be disclosed, the types of persons who would receive the protected health information, and the conditions that would apply for such access. We recognize that specific disclosures within a type may vary, and require that the policies address what is the norm for the type of disclosure involved. For example, a covered entity may decide to participate in research studies and therefore establish a protocol to minimize the information released for such purposes, e.g., by requiring researchers requesting disclosure of data contained in paper-based records to review the paper records on-site and to\n\nFrm 00084\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nabstract only the information relevant to the research. Covered entities must develop policies and procedures (which may be standard protocols) to apply to disclosures to routinely hired types of business associates. For instance, a standard protocol could describe the subset of information that may be disclosed to medical transcription services. For non-routine disclosures, a covered entity must develop reasonable criteria for determining, and limiting disclosure to, only the minimum amount of protected health information necessary to accomplish the purpose of the disclosure."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 127}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 42)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nwe have submitted a request to OMB for review of these information collection requirements on an emergency basis, pursuant to 5 CFR 1320.13. We are providing an abbreviated comment period of 14 days.\nInterested persons are invited to send comments by September 8, 2009 regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency's functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. To comment on this collection of information or to obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, e-mail your comment or request, including your address and phone number to Sherette.funncoleman@hhs.gov, or call the Reports Clearance Office on (202) 690-6162."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 41}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 34)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nI logged and retained, including decisions that arise from review activities?\n• Are decisions related to the establishment and modification of workforce member authorization to access ePHI documented?\n|\n\n| Key Activities                                                       | Description                                                                                                                                                                                                                                                                                                                                                                                                                                            | Sample Questions                                                                                                                                                                                                                                                                                                                                                                                                                                          |\n|----------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|\n| 4."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 33}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 130)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nto be able to discuss their own health-related products and services, or those of third parties, as part of their everyday business and as part of promoting the health of their patients and enrollees.\nThe provision is restricted to uses by covered entities or disclosures to their business associates pursuant to a contract that requires confidentiality, ensuring that protected health information is not distributed to third parties. To provide individuals with a better understanding of how their protected health information is being used for marketing, the provision requires that the communication identify that the covered entity is the source of the communication; a covered entity may not send out information about the product of a third party without disclosing to the individual where the communication originated. We also require covered entities to disclose any direct or indirect remuneration from third parties. This requirement permits individuals to better understand why they are receiving a communication, and to weigh the extent to which their information is being used to promote their health or to enrich the covered entity. Covered entities also are required to include in their communication (unless it is a general newsletter or similar device) how the individual may prevent further communications about health-related products and services. This provision enhances individuals' control over how their information is being used. Finally, where a covered entity targets communications to individuals on the basis of their health status or condition, we require that the entity make a determination that the product or service being communicated may be beneficial to the health of the type of individuals targeted, and that the communication to the targeted individuals explain why they have been targeted and how the product or service relates to their health."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 129}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 4)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\nhese efforts reduce vulnerabilities, minimize consequences, and identify and disrupt threats. PPD-21 encourages all public and private stakeholders to share responsibility in achieving these outcomes.\nIn recognition of the shared responsibility for cybersecurity, the security industry has established resources including standards, guidelines, best practices and frameworks for stakeholders to adopt a culture of cybersecurity risk management. Best practices include collaboratively assessing cybersecurity intelligence information for risks to device functionality and clinical risk. FDA believes that, in alignment with EO 13636 and PPD-21, public and private stakeholders should collaborate to leverage available resources and tools to establish a common understanding that assesses risks for identified vulnerabilities in medical devices among the information technology community, healthcare delivery organizations (HDOs), the clinical user community, and the medical device community. These collaborations can lead to the consistent assessment and mitigation of cybersecurity threats and vulnerabilities, and their impact on medical devices, ultimately reducing potential risk of patient harm. Cybersecurity risk management is a shared responsibility among stakeholders including the medical device manufacturer, the user, the Information Technology (IT) system integrator, Health IT developers, and an array of IT vendors that provide products that are not regulated by the FDA. FDA seeks to encourage collaboration among stakeholders by clarifying, for those stakeholders it regulates, recommendations associated with mitigating cybersecurity threats to device functionality and device users."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 3}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the technical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron Applied Cybersecurity Division Information Technology Laboratory\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\nFebruary 2024\n\n<!-- image -->\n\nU.S. Department of Commerce Gina M. Raimondo, Secretary\n\nNational Institute of Standards and Technology\n\nCertain commercial equipment, instruments, software, or materials, commercial or non-commercial, are identified in this paper in order to specify the experimental procedure adequately. Such identification does not imply recommendation or endorsement of any product or service by NIST, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose. There may be references in this publication to other publications currently under development by NIST in accordance with its assigned statutory responsibilities. The information in this publication, including concepts and methodologies, may be used by federal agencies even before the completion of such companion publications. Thus, until each publication is completed, current requirements, guidelines, and procedures, where they exist, remain operative. For planning and transition purposes, federal agencies may wish to closely follow the development of these new publications by NIST. Organizations are encouraged to review all draft publications during public comment periods and provide feedback to NIST."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_type": "technical", "implementation_spec": "both", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 32)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nection 1176(b) of the Social Security Act to eliminate the affirmative defense for such violations, absent corrective action during a 30-day period, it did not revise the Secretary's waiver authority.\nAs a result, the Enforcement IFR amended §160.412 to reflect the revisions made to § 160.410 to provide that ''[r]egardless of whether\n\nVerDate Mar&lt;15&gt;2010\n\nviolations occur before, on, or after February 18, 2009, the Secretary had the authority to provide a waiver for violations due to reasonable cause and not willful neglect that are not timely corrected (pursuant to the correction period in revised § 160.410(a)(3)(ii) or (b)(2)(ii), as applicable).'' See 74 FR 56129. The proposed rule included conforming changes to § 160.412 to align the provision with the revisions to §160.410. See 75 FR 40881. The proposed revision would effectively provide the Secretary with the authority to waive a civil money penalty, in whole or in part, for violations described in § 160.410(b)(2) (occurring prior to February 18, 2009, and due to circumstances that would make it unreasonable for the covered entity, despite the exercise of ordinary business care and prudence, to comply with the administrative simplification provision violated) or § 160.410(c) (occurring on or after February 18, 2009, and involving an establishment to the satisfaction of the Secretary that the violation is not due to willful neglect) and that are not corrected within the period specified under such paragraphs."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 31}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 177)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ned by smaller companies to provide their associates with special employee discounts or other membership incentives so that they can obtain health care, including prescription drugs, at reduced prices.\nThe commenter asserted that if these discount and membership incentive programs were covered by the regulation, many smaller employers might discontinue offering them to their employees, rather than deal with the administrative burdens and costs of complying with the rule. Response: Only those special employee discounts or membership incentives that are ''employee welfare benefit plans'' as defined in section 3(1) of the Employee Retirement Income Security Act of 1974, 29 U.S.C. 1002(1), and provide ''medical care'' (as defined in section 2791(a)(2) of the Public Health Service Act, 42 U.S.C. 300gg91(a)(2)), are health plans for the purposes of this rule. Discount or membership incentive programs that are not group health plans are not covered by the rule. Comment: Several commenters agreed with the proposal to exclude ''excepted benefits'' such as disability income insurance policies, fixed indemnity critical illness policies, and per diem long-term care policies from the definition of ''health plan,'' but were concerned that the language of the proposed rule did not fully reflect this intent. They asserted that clarification was necessary in order to avoid confusion and costs to both consumers and insurers. One commenter stated that, while HHS did not intend for the rule to apply to every type of insurance coverage that paid for medical care, the language of the proposed rule did not bear this out."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 176}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 546)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthe documentation required by paragraph (j)(1) of this section for six years from the date of its creation or the date when it last was in effect, whichever is later. (k) Standard: Group health plans.\n(1) A group health plan is not subject to the standards or implementation specifications in paragraphs (a) through (f) and (i) of this section, to the extent that:\n\n(i) The group health plan provides health benefits solely through an insurance contract with a health insurance issuer or an HMO; and\n\n(ii) The group health plan does not create or receive protected health information, except for:\n\n(A) Summary health information as defined in § 164.504(a); or\n\n(B) Information on whether the individual is participating in the group health plan, or is enrolled in or has disenrolled from a health insurance issuer or HMO offered by the plan. (2) A group health plan described in paragraph (k)(1) of this section is subject to the standard and implementation specification in paragraph (j) of this section only with respect to plan documents amended in accordance with §164.504(f). ## §164.532 Transition provisions. (a) Standard: Effect of prior consents and authorizations. Notwithstanding other sections of this subpart, a covered entity may continue to use or disclose protected health information pursuant to a consent, authorization, or other express legal permission obtained from an individual permitting the use or disclosure of protected health information that does not comply with §§164.506 or 164.508 of this subpart consistent with paragraph (b) of this section. (b) Implementation specification: Requirements for retaining effectiveness of prior consents and authorizations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 545}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the physical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\nRIN 0991-AB56\n\n## Breach Notification for Unsecured Protected Health Information\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Interim final rule with request for comments. SUMMARY: The Department of Health and Human Services (HHS) is issuing this interim final rule with a request for comments to require notification of breaches of unsecured protected health information. Section 13402 of the Health Information Technology for Economic and Clinical Health (HITECH) Act, part of the American Recovery and Reinvestment Act of 2009 (ARRA) that was enacted on February 17, 2009, requires HHS to issue interim final regulations within 180 days to require covered entities under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and their business associates to provide notification in the case of breaches of unsecured protected health information. For purposes of determining what information is ''unsecured protected health information,'' in this document HHS is also issuing an update to its guidance specifying the technologies and methodologies that render protected health information unusable, unreadable, or indecipherable to unauthorized individuals. DATES: Effective Date: This interim final rule is effective September 23, 2009. Comment Date: Comments on the provisions of this interim final rule are due on or before October 23, 2009. Comments on the information collection requirements associated with this rule are due on or before September 8, 2009. ADDRESSES: You may submit comments, identified by RIN 0991-AB56, by any of the following methods (please do not submit duplicate comments):\n\n- Regular, Express, or Overnight Mail: U.S. Department of Health and Human Services, Office for Civil Rights, Attention: HITECH Breach Notification, Hubert H."}], "metadata": {"source": "breach_notification_2009", "safeguard_type": "physical", "implementation_spec": "required", "entity_type": "covered_entity", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 8)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nin place breach notification policies for personally identifiable information that take into account the likely risk of harm caused by a breach in determining whether breach notification is required.\nThus, to determine if an impermissible use or disclosure of protected health information constitutes a breach, covered entities and business associates will need to perform a risk assessment to determine if there is a significant risk of harm to the individual as a result of the impermissible use or disclosure. In performing the risk assessment, covered entities and business associates may need to consider a number or combination of factors, some of which are described below. 7\n\nCovered entities and business associates should consider who impermissibly used or to whom the information was impermissibly disclosed when evaluating the risk of harm to individuals. If, for example, protected health information is impermissibly disclosed to another entity governed by the HIPAA Privacy and Security Rules or to a Federal agency that is obligated to comply with the Privacy Act of 1974 (5 U.S.C. 552a) and the Federal Information Security Management Act of 2002 (44 U.S.C. 3541 et seq. ), there may be less risk of harm to the individual, since the recipient entity is obligated to protect the privacy and security of the information it received in the same or similar manner as the entity that disclosed the information. In contrast, if protected health information is impermissibly disclosed to any entity or person that does not have similar obligations to maintain the privacy and security of the information, the risk of harm to the individual is much greater. We expect that there may be circumstances where a covered entity takes immediate steps to mitigate an impermissible use or disclosure, such as by obtaining the recipient's satisfactory assurances that the information will not be further used or disclosed (through a confidentiality agreement or similar means) or will be destroyed."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 7}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 400)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nutomatically and contemporaneously providing the notice electronically in response to the individual's first request for service, provided the individual agrees to receiving the notice electronically.\nEven though we require all covered entity web sites to post the entity's notice prominently, we note that such posting is not sufficient to meet the distribution requirements. A covered internet-based provider must send the notice electronically at the individual's first request for service, just as other covered providers with direct treatment relationships must give individuals a copy of the notice as of the first service delivery after the compliance date. We do not intend to create competitive advantages among covered providers. A web-based and a non-webbased covered provider each have the same alternatives available for distribution of the notice. Both types of covered providers may provide either a paper copy or an electronic copy of the notice. Comment: We received several comments suggesting that some covered entities should be exempted from the notice requirement or permitted to combine notices with other covered entities. Many comments argued that the notice requirement would be burdensome for hospital-based physicians and result in numerous, duplicative notices that would be meaningless or confusing to patients. Other comments suggested that multiple health plans offered through the same employer should be permitted to produce a single notice. Response: We retain the requirement for all covered health care providers and health plans to produce a notice of information practices. Health care clearinghouses are required to produce a notice of information practices only to the extent the clearinghouse creates or receives protected health information other than as a business associate of a covered entity. See § 164.500(b)(2)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 399}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 417)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\noners' Health Information Privacy Model Act establishes the right of an individual who is the subject of protected health information to amend protected health information to correct any inaccuracies.\nThe National Conference of Commissioners on Uniform State Laws' Uniform Health Care Information Act states, ''Because accurate health-care information is not only important to the delivery of health care, but for patient applications for life, disability and health insurance, employment, and a great many other issues that might be involved in civil litigation, this Act allows a patient to request an amendment in his record.''\n\nSome states also establish a right for individuals to amend health information about them. For example, Hawaii law (HRS section 323C-12) states, ''An individual or the individual's authorized representative may request in writing that a health care provider that generated certain health care information append additional information to the record in order to improve the accuracy or completeness of the information; provided that appending this information does not erase or obliterate any of the original information.'' Montana law (MCA section 50-16-543) states, ''For purposes of accuracy or completeness, a patient may request in writing that a health care provider correct or amend its record of the patient's health care information to which he has access.'' Connecticut, Georgia, and Maine provide individuals a right to request correction, amendment, or deletion of recorded personal information about them maintained by an insurance institution. Many other states have similar provisions. Industry and standard-setting organizations have also developed\n\n28 Privacy Protection Study Commission, ''Personal Privacy in an Information Society,'' July 1977, p. 300-303. 29 Health Privacy Working Group, ''Best Principles for Health Privacy,'' Health Privacy Project, Institute for Health Care Research and Policy, Georgetown University, July 1999."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 416}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.524(c)(2)(ii) require?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n§164.524(c)(2)(ii) to require that if an individual requests an electronic copy of protected health information that is maintained electronically in one or more designated record sets, the covered\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00067\n\nentity must provide the individual with access to the electronic information in the electronic form and format requested by the individual, if it is readily producible, or, if not, in a readable electronic form and format as agreed to by the covered entity and the individual. In such cases, to the extent possible, we expect covered entities to provide the ind"}], "metadata": {"source": "hitech_omnibus_2013", "cfr_section": "§164.524(c)(2)(ii)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 22)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nrger breaches above, the interim final rule provides that information about breaches involving less than 500 individuals is to be provided to the Secretary in the manner specified on the HHS Web site.\nHHS will specify on its Web site the information to be\n\n15:01 Aug 21, 2009\n\nPO 00000\n\nFrm 00015\n\nsubmitted and how to submit such information. For calendar year 2009, the covered entity is only required to submit information to the Secretary for breaches occurring after the effective date of this regulation, i.e., on or after September 23, 2009. Information about breaches occurring prior to that date need not be submitted. This is because, pursuant to § 164.400, this subpart only applies to breaches occurring on or after that date. We emphasize that although covered entities need only provide notification to the Secretary of breaches involving less than 500 individuals annually, they must still provide notification of such breaches to affected individuals without unreasonable delay and not later than 60 days after discovery of the breach pursuant to § 164.404. In addition, we note that pursuant to § 164.414(a), a covered entity must follow the documentation requirements that otherwise apply to the HIPAA Privacy Rule under § 164.530 with respect to the requirements of this rule. Thus, pursuant to § 164.530(j)(2), covered entities must maintain the internal log or other documentation for six years. Further, as with other required documentation, a covered entity must make such information available to the Secretary upon request in accordance with § 160.310. ## F. Notification by a Business Associate-164.410\n\nSection 13402(b) of the Act requires a business associate of a covered entity that accesses, maintains, retains, modifies, records, destroys, or otherwise holds, uses, or discloses unsecured protected health information to notify the covered entity when it discovers a breach of such information."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 21}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 527)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nized by law. A covered entity that also performs the duties of a coroner or medical examiner may use protected health information for the purposes described in this paragraph. - (2) Funeral directors.\nA covered entity may disclose protected health information to funeral directors,\n\nconsistent with applicable law, as necessary to carry out their duties with respect to the decedent. If necessary for funeral directors carry out their duties, the covered entity may disclose the protected health information prior to, and in reasonable anticipation of, the individual's death. (h) Standard: Uses and disclosures for cadaveric organ, eye or tissue donation purposes. A covered entity may use or disclose protected health information to organ procurement organizations or other entities engaged in the procurement, banking, or transplantation of cadaveric organs, eyes, or tissue for the purpose of facilitating organ, eye or tissue donation and transplantation. - (i) Standard: Uses and disclosures for research purposes. (1) Permitted uses and disclosures. A covered entity may use or disclose protected health information for research, regardless of the source of funding of the research, provided that:\n- (i) Board approval of a waiver of authorization."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 526}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 6)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n|\n| Fig. 1.\nExcerpt of informative references in the OLIR catalog ...........................................................107                                                                                                                                     |\n\n## Acknowledgments\n\nThe author wishes to thank Nick Heesters from the Department of Health and Human Services (HHS) Office for Civil Rights (OCR), who greatly contributed to the document's development. The author also gratefully acknowledges the many contributions from the public and private sectors during the public review process whose thoughtful and constructive comments improved the quality and usefulness of this publication. ## Executive Summary\n\nThis publication aims to help educate readers about the security standards included in the Health Insurance Portability and Accountability Act (HIPAA) Security Rule [Sec. Rule], as amended by the Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act [HITECH] and the Genetic Information Nondiscrimination Act and Other Modifications to the HIPAA Rules [OMNIBUS], 1 as well as assist regulated entities 2 in their implementation of the Security Rule. It includes a brief overview of the HIPAA Security Rule, provides guidance for regulated entities on assessing and managing risks to electronic protected health information (ePHI), identifies typical activities that a regulated entity might consider implementing as part of an information security program, and lists additional resources that regulated entities may find useful when implementing the Security Rule. The Security Rule is flexible, scalable, and technology-neutral."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 5}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement technical controls?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160, 162, and 164 [CMS-0049-F] RIN 0938-AI57\n\n## Health Insurance Reform: Security Standards\n\nAGENCY: Centers for Medicare &amp; Medicaid Services (CMS), HHS. ACTION: Final rule. SUMMARY: This final rule adopts standards for the security of electronic protected health information to be implemented by health plans, health care clearinghouses, and certain health care providers. The use of the security standards will improve the Medicare and Medicaid programs, and otherFederal health programs and private health programs, and the effectiveness and efficiency of the health care industry in general by establishing a level of protection for certain electronic health information. This final rule implements some of the requirements of the Administrative Simplification subtitle of the Health Insurance Portability andAccountability Act of 1996 (HIPAA). DATES: Effective Date: These regulations are effective on April 21, 2003. Compliance Date: Covered entities, with the exception of small health plans, must comply with the requirements of this final rule by April 21, 2005. Small health plans must comply with the requirements of this final rule by April 21, 2006. FOR FURTHER INFORMATION CONTACT: William Schooler, (410) 786-0089. SUPPLEMENTARY INFORMATION:\n\n## Availability of Copies and Electronic Access\n\nTo order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 or by faxing to (202) 5122250. The cost for each copy is $10."}], "metadata": {"source": "security_rule_2003", "safeguard_type": "technical", "implementation_spec": "both", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 40)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nKey activities, descriptions, and sample questions for the Contingency Plan standard | Key Activities | Description | Sample Questions | |--------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 1."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 39}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 36)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nwas zero. There is evidence, on the other hand, that the ''Total Affected'' in this group is less than 500 based on information we were able to obtain from the California Department of Public Health.\nFor the first six months of this year (the first year that California's law requiring notification of data breaches involving protected health information went into effect), of the 196 cases that have been examined to date, none of the cases has involved more than 499 affected individuals. We interpret this fact as pointing to the likelihood that the number of individuals or records affected where the number is unknown is likely to be less than 500 and a majority of cases may fall into the under\n\nVerDate Nov&lt;24&gt;2008\n\nten category. Because of the gap in the data for breaches involving fewer than ten individuals, our estimate for this group may be understated. We invite public comment on this point. The third limitation is the way information finds its way into the database. Since the database is privately maintained and operated and is not responsible to either a state or federal agency for regulating its content, the completeness and accuracy of information posted on the Web site is unknown. Generally, the information posted on the Web site is gleaned from published sources or individuals with knowledge of the breaches submitting information. Nevertheless, we cannot be completely confident in the reliability of the information obtained from this source. Therefore, as is evident from the lack of affected records or individuals in the ''under ten'' grouping, it is highly likely that a certain number of breaches never reach the database, thus resulting in an undercount of the total number of breaches and the total number of individuals or records affected. We invite public comment on this point. ## (3) Estimating the Costs\n\n## (a) Baseline\n\nApproximately 45 States have laws that to varying degrees contain breach notification provisions similar to the Act."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 35}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 392)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nion requirements will provide great uncertainty to providers who receive authorizations from life, disability income and long-term care insurers in the course of underwriting and claims investigation.\nThey are unaware of any breaches of confidentiality associated with these circumstances and believe the rule creates a solution to a non-existent problem. Another commenter stated that it is too burdensome for health care providers to verify requests that are normally received verbally or via fax. Response: This rule requires covered health care providers to adhere to current best practices for verification. That is, when the requester is not known to the covered provider, the provider makes a reasonable effort to determine that the protected health information is being sent to the entity authorized to receive it. Our fact finding reveals that this is often done by sending the information to a recognizable organizational address or if being transmitted by fax or phone by calling the requester back through the main organization switchboard rather than through a direct phone number. We agree that these procedures seem to work reasonably well in current practice and are sufficient to meet the relevant requirements in the final rule. Comments: One comment suggested requiring a form of photo identification such as a driver's license or certain personal information such as date of birth to verify the identity of the individual. Response: These are exactly the types of standard procedures for verifying the identity of individuals that are envisioned by the final rule. Most health care entities already conduct such procedures successfully. However, it is unwise to prescribe specific means of verification for all situations. Instead, we require policies and procedures reasonably designed for purposes of verification."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 391}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 477)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthan societal aggregates. We have estimated the value an insured individual would need to place on increased privacy to make the privacy regulation a net benefit to those who receive health insurance.\nOur estimates are derived from data produced by the 1998 Current Population Survey from the Census Bureau (the most recent available at the time of the analysis), which show that 220 million persons are covered by either private or public health insurance. Joining the Census Bureau data with the costs calculated in Section E, we have estimated the cost of the regulation to be approximately $6.25 per year (or approximately $0.52 per month) for each insured individual (including people in government programs). If we assume that individuals who use the health care system will be willing to pay more than this per year to improve health information privacy, the benefits of the proposed regulation will outweigh the cost. This is a conservative estimate of the number of people who will benefit from the regulation because it assumes that only those individuals who have health insurance or are in government programs will use medical services or benefit from the provisions of the proposed regulation. Currently, there are 42 million Americans who do not have any form of health care coverage. The estimates do not include those who pay for medical care directly, without any insurance or government support. By lowering the number of users in the system, we have inflated our estimate of the per-person cost of the regulation; therefore, we assume that our estimate\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nrepresents the highest possible cost for an individual. An alternative approach to determining how people would have to value increased privacy for this regulation to be beneficial is to look at the costs divided by the number of encounters with health care professionals annually."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 476}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 438)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nation, or permission, consistent with any limitations it expressed, to use or disclose the protected health information it created or received prior to or after the compliance date of this regulation.\nIf a covered entity wishes to use or disclose protected health information but no such consent, authorization, or permission exists, it must obtain an authorization pursuant\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nto § 164.508 or obtain a waiver of authorization under § 164.512(i). To the extent such a project is ongoing and the researchers are unable to locate the individuals whose protected health information they are using or disclosing, we believe the IRB or privacy board under the criteria set forth in §164.512(i) will be able to take that circumstance into account when conducting its review. In most instances, we believe this type of research will be able to obtain a waiver of authorization and be able to continue uninterrupted. Comment: Several comments raised questions about the application of the rule to individually identifiable information created prior to (1) the effective date of the rule, and (2) the compliance dates of the rule. One commenter suggested that the rule should apply only to information gathered after the effective date of the final rule. A drug manufacturer asked what would be the effect of the rule on research on records compiled before the effective date of the rule. Response: We disagree with the commenter's suggestion. The requirements of this regulation apply to all protected health information held by a covered entity, regardless of when or how the covered entity obtained the information. Congress required us to adopted privacy standards that apply to individually identifiable health information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 437}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 64)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nes, such as a fingerprint • MFA utilizes two or more authentication approaches to enforce stronger authentication. • Consider implementing MFA solutions 140 when the risk to ePHI is sufficiently high.\n| • What are the strengths and weaknesses of each available option? • Which can be best supported with assigned resources (e.g., budget/staffing)? • What level of authentication is appropriate for each access to ePHI based on the assessment of risk? • Has the organization identified all instances of access to ePHI (including by services, vendors, or application programming interfaces [APIs]) and considered appropriate authentication requirements based on the risk assessment? |\n\n139 See Sec. 5.3.1, HIPAA Standard: Access Control ; Sec. 5.3.2, HIPAA Standard: Audit Controls ; and [SP 800-63B], Digital Identity Guidelines: Authentication and Lifecycle Management . 140  Some MFA implementations may offer greater protection than others. Consider the pros and cons of each MFA option in light of the risk to ePHI."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 63}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 366)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nlth information by covered entities. Comment: In contrast, a few commenters recommended that there be fewer requirements on covered entities for internal research uses of protected health information.\nResponse: For the reasons discussed above in § 164.501 on the definition of ''research,'' we disagree that an individual's privacy interest is of less concern when covered entities use protected health information for research purposes than when covered entities disclose protected health information for research purposes. Therefore, in the final rule, the researchrelated requirements of § 164.512(i) apply to both uses and disclosures of protected health information for research purposes without authorization. ## Additional Resources for IRBs\n\nComment: A few commenters recommended that HHS work to provide additional resources to IRBs to assist them in meeting their new responsibilities. Response: This recommendation is beyond our statutory authority under HIPAA, and therefore, cannot be addressed by the final rule. However, we fully agree that steps should be taken to moderate the workload of IRBs and to ensure adequate resources for their activities. Through the Office for Human Research Protections, the Department is committed to working with institutions and IRBs to identify efficient ways to optimize utilization of resources, and is committed to developing guidelines for appropriate staffing and workload levels for IRBs."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 365}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 112)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nion 164.512(g) allows covered entities to disclose protected health information to funeral directors, consistent with applicable law, as necessary to carry out their duties with respect to a decedent.\nFor example, the rule allows hospitals to disclose to funeral directors the fact that an individual has donated an organ or tissue, because this information has implications for funeral home staff duties associated with embalming. When necessary for funeral directors to carry out their duties, covered entities may disclose protected health information prior to and in reasonable anticipation of the individual's death. Whereas the NPRM did not address the issue of disclosure of psychotherapy notes without individual authorization to coroners and medical examiners, the final rule allows such disclosures. The NPRM did not include in proposed §164.510(e) language stating that where a covered entity was itself a coroner or medical examiner, it could use protected health information for the purposes of engaging in a coroner's or a medical examiner's activities. The final rule includes such language to address situations such as where a public hospital performs medical examiner functions. In such cases, the hospital's on-staff coroners can use protected health information while conducting post-mortem investigations, and other hospital staff can analyze any information associated with these investigations, for example, as part of the process of determining the cause of the individual's death. ## Section 164.512(h)-Uses and Disclosures for Cadaveric Donation of Organs, Eyes, or Tissues\n\nIn the NPRM we proposed to include the procurement or banking of blood, sperm, organs, or any other tissue for administration to patients in the definition of ''health care'' (described in proposed §160.103)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 111}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 119)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nns are accurate that the costs for the consent provisions are much higher than estimated, the cost savings associated with the retraction of these provisions would, therefore, be significantly higher.\nThe Department does not believe the Federal government engages in significant marketing as defined in the Privacy Rule. The Federal government will have business associates under the Privacy Rule, and, therefore, the sample language proposed in this rulemaking will be of benefit to Federal departments and agencies. The Department has not estimated the Federal government's portion of the $35 million savings it estimated for this change. Similarly, the Federal government, which conducts and sponsors a significant amount of research that is subject to IRBs, will realize some savings as a result of the research modifications in this rulemaking. The Department does not\n\nVerDate Aug&lt;2,&gt;2002\n\nhave sufficient information, however, to estimate the Federal government's portion of the total $146 million savings with respect to research modifications. ## D. Costs to State and Local Government\n\nThe modifications also may affect the costs to State and local governments. However, these effects likely will be small. As with the Federal government, State and local governments will have any costs of the additional notice requirement offset by the savings realized by the elimination of the consent requirement. As discussed above, to the extent concerns are accurate that the costs for the consent provisions are much higher than estimated, the cost savings associated with the retraction of these provisions would, therefore, be significantly higher. State and local governments could realize savings from the sample language for business associates and the changes in research, but the savings are likely to be small. The Department does not have sufficient information to estimate the State and local government's share of the net savings from the modifications. ## E."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 118}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 60)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd by law consents to such health care service; or (3) a parent assents to an agreement of confidentiality between a covered health care provider and the minor with respect to such health care service.\nWe note that the definition of health care includes services, but we use ''health care service'' in this provision to clarify that the scope of the rights of minors under this rule is limited to the protected health information related to a particular service. Under this provision, we do not provide a minor with the authority to act under the rule unless the state has given them the ability to obtain health care without consent of a parent, or the parent has assented. In addition, we defer to state law where the state authorizes or prohibits disclosure of protected health information to a parent. See part 160, subpart B, Preemption of State Law. This rule does not affect parental notification laws that permit or require disclosure of protected health information to a parent. However, the rights of a minor under this rule are not otherwise affected by such notification. In the final rule, the provision regarding personal representatives of deceased individuals has been changed to clarify the provision. The policy has not changed substantively from the NPRM. Finally, we added a provision in the final rule to permit covered entities to elect not to treat a person as a personal representative in abusive situations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 59}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 206)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhas adopted this privilege. Comment: A few comments discussed whether one remedy for violating the privacy regulation should be to exclude or suppress evidence obtained in violation of the regulation.\nOne comment supported using this penalty, while another opposed it. Response: We do not have the authority to mandate that courts apply or not apply the exclusionary rule to evidence obtained in violation of the regulation. This issue is in the purview of the courts. ## Federal Tort Claims Act\n\nComment: One comment contended that the proposed regulation's requirement mandating covered entities to name the subjects of protected health information disclosed under a business partner contract as third party intended beneficiaries under the contract would have created an impermissible right of action against the government under the Federal Tort Claims Act (''FTCA''). Response: Because we have deleted the third party beneficiary provisions from the final rules, this comment is moot. Comment: Another comment suggested the regulation would hamper the ability of federal agencies to disclose protected health information to their attorneys, the Department of Justice, during the initial stages of the claims brought under the FTCA. Response: We disagree. The regulation applies only to federal agencies that are covered entities. To the extent an agency is not a covered entity, it is not subject to the regulation; to the extent an agency is a covered entity, it must comply with the regulation. A covered entity that is a federal agency may disclose relevant information to its attorneys, who are business associates, for purposes of health care operations, which includes uses or disclosures for legal functions. See § 164.501 (definitions of ''business associate'' and ''health care operations'')."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 205}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 19)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\ntate law to keep information confidential. While revisions to a practice's or plan's current activities may be necessary, the development of entirely new systems or procedures may not be necessary. s.\nComment: One commenter stated that there is no system for which risk has been eliminated and expressed concern over phrases such as covered entities must ''assure that electronic health information pertaining to an individual remains secure.''\n\nResponse: We agree with the commenter that there is no such thing as a totally secure system that carries no risks to security. Furthermore, we believe the Congress' intent in the use of the word ''ensure'' in section 1173(d) of the Act was to set an exceptionally high goal for the security of electronic protected health information. However, we note that the Congress also recognized that some trade-offs would be necessary, and that ''ensuring'' protection did not mean providing protection, no matter how expensive. See section 1173(d)(1)(A)(ii) of the Act. Therefore, when we state that a covered entity must ensure the safety of the information in its keeping, we intend\n\nVerDate Jan&lt;31&gt;2003\n\nthat a covered entity take steps, to the best of its ability, to protect that information. This will involve establishing a balance between the information's identifiable risks and vulnerabilities, and the cost of various protective measures, and will also be dependent upon the size, complexity, and capabilities of the covered entity, as provided in § 164.306(b). ## E. Administrative Safeguards (§ 164.308)\n\nWe proposed that measures taken to comply with the rule be appropriate to protect the health information in a covered entity's care. Most importantly, we proposed to require that both the measures taken and documentation of those measures be kept current, that is, reviewed and updated periodically to continue appropriately to protect the health information in the care of covered entities."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 18}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 157)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nto the protected health information they maintain about the enrollees in such group health plans. The group health plans subject to this provision will have only limited protected health information.\nTherefore, imposing these requirements on the group health plan would impose burdens not outweighed by a corresponding enhancement in privacy protections. ## Section 164.532-Transition Provisions\n\nIn the NPRM, we did not address the effect of the regulation on consents and authorizations covered entities obtained prior to the compliance date of the regulation. In the final rule, we clarify that, in certain circumstances, a covered entity may continue to rely upon consents, authorizations, or other express legal permissions obtained prior to the compliance date of this regulation to use or disclose protected health information even if these consents, authorizations, or permissions do not meet the requirements set forth in §§ 164.506 or 164.508. We realize that a covered entity may wish to rely upon a consent, authorization, or other express legal permission obtained from an individual prior to the compliance date of this regulation which permits the use or disclosure of individually identifiable health information for activities that come within treatment, payment, or health care operations (as defined in §164.501), but that do not meet the requirements for consents set forth in §164.506. In the final rule, we permit a covered entity to rely upon such consent, authorization, or permission to use or disclose protected health information that it created or received before the applicable compliance date of the regulation to carry out the treatment, payment, or health care operations as long as it meets two requirements. First, the covered entity may not make any use or disclosure that is expressly excluded from the consent, authorization, or permission. Second, the covered entity must comply with all limitations expressed in the consent, authorization, or permission."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 156}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement technical controls?"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron Applied Cybersecurity Division Information Technology Laboratory\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\nFebruary 2024\n\n<!-- image -->\n\nU.S. Department of Commerce Gina M. Raimondo, Secretary\n\nNational Institute of Standards and Technology\n\nCertain commercial equipment, instruments, software, or materials, commercial or non-commercial, are identified in this paper in order to specify the experimental procedure adequately. Such identification does not imply recommendation or endorsement of any product or service by NIST, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose. There may be references in this publication to other publications currently under development by NIST in accordance with its assigned statutory responsibilities. The information in this publication, including concepts and methodologies, may be used by federal agencies even before the completion of such companion publications. Thus, until each publication is completed, current requirements, guidelines, and procedures, where they exist, remain operative. For planning and transition purposes, federal agencies may wish to closely follow the development of these new publications by NIST. Organizations are encouraged to review all draft publications during public comment periods and provide feedback to NIST."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_type": "technical", "implementation_spec": "both", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 102)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\na covered entity's obligation to provide individuals with electronic access to their records will be governed by the business associate agreement between the covered entity and the business associate.\nFor example, the business associate agreement may provide for the business associate to give copies of the requested information directly to the individual, or to the covered entity for the covered entity to provide the copies to the individual. There is no separate requirement on business associates to provide individuals with direct access to their health records, if that is not what has been agreed to between the covered entity and the business associate in the business associate agreement. ## a. Form and Format\n\n## Proposed Rule\n\nSection 164.524(c)(2) of the Privacy Rule currently requires a covered entity to provide the individual with access to the protected health information in the form or format requested by the individual, if it is readily producible in such form or format, or, if not, in a readable hard copy form or such other\n\nVerDate Mar&lt;15&gt;2010\n\nform or format as agreed to by the covered entity and the individual. Section 13405(e) of the HITECH Act expands this requirement by explicitly requiring a covered entity that uses or maintains an EHR with respect to protected health information to provide the individual with a copy of such information in an electronic format. We proposed to implement this statutory provision, in conjunction with our broader authority under section 264(c) of HIPAA, by requiring, in proposed §164.524(c)(2)(ii), that if the protected health information requested is maintained electronically in one or more designated record sets, the covered entity must provide the individual with access to the electronic information in the electronic form and format requested by the individual, if it is readily producible, or, if not, in a readable electronic form and format as agreed to by the covered entity and the individual."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 101}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 481)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n112.6 billion divided by 43.4 million people with mental illness). 73 The treatment cost of mental illness per person with mental illness is $2,110 ($91.7 billion divided by 43.4 million individuals).\nIf we assume that indirect economic costs saved by encouraging more individuals with mental illness to enter treatment are offset by the additional treatment costs, the net savings is about $480 per person. As stated above, appropriate treatment of mental health disorders can result in 50-80 percent of individuals experiencing improvements in these types of conditions. Therefore, we multiply the number of individuals with mental disorders who would seek treatment with greater privacy protections (2.07 million) by the treatment effectiveness rate by the net savings per effective treatment ($480). Assuming a 50 percent success rate, this equation yields annual savings of $497 million. Assuming an 80 percent success rate, this yields annual savings of $795 million. Given the existing data on the annual economic costs of mental illness and the rates of treatment effectiveness for these disorders, coupled with assumptions regarding the percentage of individuals who would seek mental health treatment with greater privacy protections, the potential net economic benefits could range from approximately $497 million to $795 million annually. ## V. Final Regulatory Flexibility Analysis\n\n## A. Introduction\n\nPursuant to the Regulatory Flexibility Act 5 U.S.C. 601 et seq., the Department must prepare a regulatory flexibility analysis if the Secretary certifies that a final rule would have a significant economic impact on a substantial number of small entities. 74\n\nThus, we assume that 15 percent of the population have an untreated mental disorder (three-quarters of 20 percent) and 5 percent have an untreated addictive disorder (one-quarter of 20 percent). 72 According to the Population Estimates Program, Population Division, U.S. Census Bureau, the U.S."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 480}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 118)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nse, the NPRM offered modifications, such as more closely aligning the Privacy and Common Rule criteria, to ease the burden and, correspondingly, estimated cost savings of these proposed modifications.\nThe specific comments appear to dispute the research cost estimates in the final Rule, as their delineated issues are not reflective of the modifications and cost savings specified in the NPRM. In any event, no reliable empirical, direct information on the estimates of financial impact that either supported or contradicted the Department's calculations was provided. Therefore, our estimates remain unchanged."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 117}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 25)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nies and procedures based on their own assessment of what protected health information is reasonably necessary for a particular purpose, given the characteristics of their business and their workforce.\nHowever, the Department does not believe a regulatory modification is necessary because the Department has made its policy clear not only in the preamble to the proposed modifications but also in previous guidance and in this preamble. Comment: A commenter argued that the Department should exempt disclosures for any of the standard transactions as required by the Transactions Rule, when information is requested by a health plan or its business associate. Response: The Department disagrees. The Privacy Rule already exempts from the minimum necessary standard data elements that are required or situationally required in any of the standard transactions (§ 164.502(b)(2)(v)). If, however, a standard transaction permits the use of optional data elements, the minimum necessary standard applies. For example, the standard transactions adopted for the outpatient pharmacy sector use optional data elements. The payer currently specifies which of the optional data elements are needed for payment of its particular pharmacy claims. The minimum necessary standard applies to the payer's request for such information. A pharmacist is permitted to rely on the payer's request for information, if reasonable to do so, as the minimum necessary for the intended disclosure. Comment: A few commenters expressed concerns with respect to a covered entity's disclosures for research purposes. Specifically, one commenter was concerned that a covered entity will not accept documentation of an external IRB's waiver of authorization for purposes of reasonably relying on the request as the minimum necessary. It was suggested that the Department deem that a disclosure to a researcher based on appropriate documentation from an IRB or Privacy Board meets the minimum necessary standard."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 24}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 181)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nere made. Some of these comments recognized that the Secretary's authority under section 1178 of the Act is limited and acknowledged that the Secretary's proposals were within her statutory authority.\nOne commenter suggested that the exception determination process would result in a very costly and laborious and sometimes inconsistent analysis of the occasions in which state law would\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nsurvive federal preemption, and thus suggested the final privacy regulations preempt state law with only limited exceptions, such as reporting child abuse. Many other comments, however, recommended changing the proposed preemption provisions to preempt state privacy laws on as blanket a basis as possible. One comment argued that the assumption that more stringent privacy laws are better is not necessarily true, citing a 1999 GAO report finding evidence that the stringent state confidentiality laws of Minnesota halted the collection of comparative information on health care quality. Several comments in this vein were also received in the Transactions rulemaking. The majority of these comments took the position that exceptions to the federal standards should either be prohibited or discouraged. It was argued that granting exceptions to the standards, particularly the transactions standards, would be inconsistent with the statute's objective of promoting administrative simplification through the use of uniform transactions. Many other commenters, however, endorsed the ''federal floor'' approach of the proposed rules. (These comments were made in the context of the proposed privacy regulations.) These comments argued that this approach was preferable because it would not impair the effectiveness of state privacy laws that are more protective of privacy, while raising the protection afforded medical information in states that do not enact laws that are as protective as the rules below."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 180}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 94)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nare provider learns of an incapacitated patient's prior expression of preference not to be included in a facility's directory, the facility must not include the patient's information in the directory.\nFor cases involving patients admitted to a health care facility in an\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00062\n\nincapacitated or emergency treatment circumstance who during the course of their stay become capable of decisionmaking, the final rule takes an approach similar to that described in the NPRM. The final rule states that when an individual who was incapacitated or in an emergency treatment circumstance upon admission to an inpatient facility and whose condition stabilizes such that he or she is capable of decisionmaking, a covered health care provider must, when it becomes practicable, inform the individual about its policies regarding the facility's directory and provide the opportunity to object to the use or disclosure of protected health information about themselves for the directory. ## Section 164.510(b)-Uses and Disclosures for Involvement in the Individual's Care and Notification Purposes\n\nIn cases involving an individual with the capacity to make health care decisions, the NPRM would have allowed covered entities to disclose protected health information about the individual to a next-of-kin, to other family members, or to close personal friends of the individual if the individual had agreed orally to such disclosure. If such agreement could not practicably or reasonably be obtained ( e.g., when the individual was incapacitated), the NPRM would have allowed disclosure of protected health information that was directly relevant to the person's involvement in the individual's health care, consistent with good health professional practices and ethics. The NPRM defined next-of-kin as defined under state law."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 93}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 31)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n| 56                       | 2,887,032                        | 2,211         | 0.043                       | 123,800    |\n| Annual Report to the Secretary ...........................................\n| 106                      | 2,888,804                        | 30            | 0.001                       | 3,180      |\n| TOTAL COST ............................................................... | ........................ | ........................ | 160,616       | 5.89                        | 17,025,306 |\n\n* Source: http://www.datalossdb.org. Our cost impact for HIPAA covered entities of approximately $17 million is approximately 350 percent of the FTC cost estimate for non-HIPAA covered entities. The FTC estimate was based on requiring toll-free lines for six months. Their final rule requires toll-free lines for only three months, as does this rule. This should reduce the FTC estimated costs by approximately half to about $5 million; about 30 percent of our cost estimate for HIPAA covered entities of $17 million. Benefits: Notifying individuals of a breach of their personal health information as close in time to the breach can benefit the individuals directly affected, as well as other entities such as credit card companies and credit agencies. We found little information showing the monetary benefits of medical data notification, but one study 14 presents evidence to show that the sooner affected individuals learn of their personal financial information being compromised, the lower the risk of financial loss to the individual. We did not find any information regarding the benefits of notification of breached medical information. However, early notification of the breach of sensitive medical information may help an affected individual mitigate the embarrassment that exposure of sensitive medical information may cause."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 30}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 57)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nentities must, as under the proposed rule, obtain the individual's ''authorization'' in order to use or disclose psychotherapy notes for most purposes: see §164.508(a)(2) for exceptions to this rule.\nWe delete the proposed special treatment of ''research information unrelated to treatment.''\n\nWe revise the application of the general standard to require all covered entities to obtain the individual's verbal ''agreement'' before using or disclosing protected health information for facility directories, to persons assisting in the individual's care, and for other purposes described in § 164.510. Unlike ''consent'' and ''authorization,'' verbal agreement may be informal and implied from the circumstances (for details on who must obtain such agreements and the requirements they must meet, see §164.510). Verbal agreements are intended to accommodate situations where it is neither appropriate to remove from the individual the ability to control the protected health information nor appropriate to require formal, written permission to share such information. For the most part, these provisions reflect current practices. As under the proposed rule, we permit covered entities to use or disclose protected health information without the individual's consent, authorization or agreement for specified\n\nFrm 00038\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\npublic policy purposes, in compliance with the requirements in § 164.512. We permit covered entities to disclose protected health information to the individual who is the subject of that information without any condition. We note that this may include disclosures to ''personal representatives'' of individuals as provided by § 164.502(g). We permit a covered entity to use or disclose protected health information for other lawful purposes if the entity obtains a written ''authorization'' from the individual, consistent with the provisions of § 164.508."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 56}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 89)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nat would be required by this proposed rule. The Department requested comment on these options, as well as any other options for informing individuals in a timely manner of material changes to the NPP.\nSection 164.520(c)(2)(iv) requires that when a health care provider with a direct treatment relationship with an individual revises the NPP, the health care provider must make the NPP available upon request on or after the effective date of the revision and must comply with the requirements of §164.520(c)(2)(iii) to have the NPP available at the delivery site and to post the notice in a clear and prominent location. We did not propose changes to these provisions because we did not believe these requirements to be overly burdensome but we requested comment on the issue. ## Overview of Public Comments\n\nWe received several comments expressing support for the proposed requirement that the NPP include a statement about the uses and disclosures that require authorization. However, other commenters opposed this requirement, arguing that because not all uses and disclosures will apply to every individual, the statement will cause confusion and unnecessary concern. Additionally, these commenters argued that the cost of listing all of the situations requiring authorization would be significant. We received several comments in support of the proposed requirement that the NPP include a specific statement about authorization for uses and disclosures of psychotherapy notes. Some of these commenters requested that the final rule require covered providers to describe in their NPPs their recordkeeping practices with regard to psychotherapy notes and how those practices affect what information can be used and disclosed. Several commenters argued that only covered entities that record psychotherapy notes should be required to include a statement about the authorization requirement for psychotherapy notes in their NPPs."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 88}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 71)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nrposes of complying with the Rule's requirement at § 164.508(c)(1)(iv) that an authorization must include a description of each purpose of the requested use or disclosure. See 67 FR 53182, 53226, Aug.\n14, 2002. In part, the Department's interpretation was based on a concern that patients could lack necessary information in the authorization to make an informed decision about the future research. In addition, it was recognized that not all uses and disclosures of protected health information for a future research purpose would require a covered entity to re-contact the individual to obtain another authorization (e.g., uses or disclosures with a waiver of\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with authorization from an Institutional Review Board or Privacy Board as provided under § 164.512(i) or of a limited data set pursuant to a data use agreement under § 164.514(e) for the future research purpose). Subsequent to issuing this interpretation, the Department heard concerns from covered entities and researchers that the Department's interpretation encumbers secondary research, and limits an individual's ability to agree to the use or disclosure of their protected health information for future research. In addition, many commenters noted that the Department's interpretation limiting the scope of a HIPAA authorization for research appeared to diverge from the current practice under the Common Rule with respect to the ability of a researcher to seek subjects' informed consent to future research so long as the future research uses are described in sufficient detail to allow an informed consent."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 70}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 259)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne final rule we revise our policy to extend protections on the protected health information about a deceased individual to remain in effect for as long as the covered entity maintains the information.\nFor purposes of this regulation, this means that, except for uses and disclosures for research purposes (see §164.512(i)), covered entities must under this rule protect the protected health information about a deceased individual in the same manner and to the same extent as required for the protected health information of living individuals. This policy alleviates the burden on the covered entity from having to determine whether or not the person has died and if so, how long ago, when determining whether or not the information can be released. Comment: One commenter asked us to delete our standard for deceased individuals, asserting that the deceased have no constitutional right to privacy and state laws are sufficient to maintain protections for protected health information about deceased individuals. Response: We understand that traditional privacy law has historically stripped privacy protection on information at the time the subject of the information dies. However, as we pointed out in the preamble to the proposed rule, the dramatic proliferation of electronic-based interchanges and maintenance of information has enabled easier and more ready access to information that once may have been de facto protected for most people because of the difficulty of its collection and aggregation. It is also our understanding that current state laws vary widely with regard to the privacy protection of a deceased individual's individually identifiable health information. Some are less protective than others and may not take into account the implications of disclosure of genetic and hereditary information on living individuals. For these reasons, a regulatory standard is needed here in order to adequately protect the privacy interests of those who are living."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 258}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 42)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nt 197001\n\naccess to quality health care or the efficient payment for such health care, the Department's goal is, and has always been, to permit these activities to occur with little or no restriction.\nConsistent with this goal, the Privacy Rule published in December 2000 generally provided covered entities with permission to use and disclose protected health information as necessary for treatment, payment, and health care operations. For certain health care providers that have direct treatment relationships with individuals, such as many physicians, hospitals, and pharmacies, the December 2000 Privacy Rule required such providers to obtain an individual's written consent prior to using or disclosing protected health information for these purposes. The Department designed consent as a one-time, general permission from the individual, which the individual would have had the right to revoke. A health care provider could have conditioned treatment on the receipt of consent. Other covered entities also could have chosen to obtain consent but would have been required to follow the consent standards if they opted to do so. The consent requirement for health care providers with direct treatment relationships was a significant change from the Department's initial proposal published in November 1999. At that time, the Department proposed to permit all covered entities to use and disclose protected health information to carry out treatment, payment, and health care operations without any requirement that the covered entities obtain an individual's consent for such uses and disclosures, subject to a few limited exceptions. Further, the Department proposed to prohibit covered entities from obtaining an individual's consent for uses and disclosures of protected health information for these purposes, unless required by other applicable law."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 41}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 45)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nmates should be publicized for comparison purposes. Still another commenter stated that HHS must provide accurate public sector implementation cost figures and provide funds to offset the cost burden.\nOne commenter asked for cost benefit evaluations to understand the relationship between competing technologies, levels of security and potential threats to be guarded against. These would demonstrate the costs and the benefits to be gained for both large and small organizations and would provide an understanding of how the levels of security vary by organization size and what the inducements and support available to facilitate adoption are. One commenter suggested that we establish a workgroup to more fully assess the costs and provide Federal funds to offset implementation costs. One commenter noted a seeming disconnect between two statements in the preamble. Section A, Security standards, states, ''no individual small entity is expected to experience direct costs that exceed benefits as a result of this rule.'' In contrast, section E, Factors in establishing the security standards reads, ''We cannot estimate the perentity cost of implementation because there is no information available regarding the extent to which providers', plans', and clearinghouses' current security practices are deficient.''\n\nResponse: We are unable to estimate, of the nation's 2 million-plus health plans and 1 million-plus providers that conduct electronic transactions, the number of entities that would require new or modified security safeguards and procedures beyond what they currently have in place. Nor are we able to estimate the number of entities that neither conduct electronic transactions nor maintain individually identifiable electronic health information but may become covered entities at some future time."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 44}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 364)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhould eliminate the possibility that research requiring access to protected health information could be determined to be ''exempt'' from IRB review, as provided by the Common Rule (§ \\_\\_ .101(b)(4)).\nResponse: The rule did not propose nor intend to modify any aspect of the Common Rule, including the provision that exempts from coverage, ''research involving the collection or study of existing data, documents, records, pathological specimens, or diagnostic specimens, if these sources are publically available, or if the information is recorded by the investigator in such a manner that subjects cannot be identified, directly or indirectly through identifiers linked to the subjects' (§ \\_\\_ .101(b)(4)). For the reasons discussed above, we have included a provision in the final rule for reviews preparatory to research that was modeled on this exemption to the Common Rule. ## Deceased Persons Exception for Research\n\nComment: A few commenters expressed support for the proposal to allow use and disclosure of protected health information about decedents for research purposes without the protections afforded to the protected health information of living individuals. One commenter, for example, explained that it extensively uses such information in its research, and any restrictions were likely to impede its efforts. Alternately, a number of commenters provided arguments for eliminating the research exception for deceased persons. They commented that the same concerns regarding use and disclosure of genetic and hereditary information for other purposes apply in the research context. VerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00241\n\nThey believed that in many cases the risk of identification was greater in the research context because researchers may attempt to identify genetic and hereditary conditions of the deceased."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 363}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 209)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrmation to certain entities pursuant to various federal statutes. For example, federal agencies must not withhold information from a Congressional oversight committee or the General Accounting Office.\nSimilarly, some federal agencies must provide the Bureau of the Census and the National Archives and Records Administration with certain information. This comment expressed concern that the privacy regulation would conflict with these requirements. Additionally, the commenter asked whether the privacy notice would need to contain these uses and disclosures and recommended that a general statement that these federal agencies would disclose protected health information when required by law be considered sufficient to meet the privacy notice requirements. Response: To the extent a federal agency acting as a covered entity is required by federal statute to disclose protected health information, the regulation permits the disclosure as required by law under § 164.512(a). The notice provisions at §164.520(b)(1)(ii)(B) require covered entities to provide a brief description of the purposes for which the covered\n\nFrm 00138\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nentity is permitted or required by the rules to use or disclose protected health information without an individual's written authorization. If these statutes require the disclosures, covered entities subject to the requirement may make the disclosure pursuant to § 164.512(a). Thus, their notice must include a description of the category of these disclosures. For example, a general statement such as the covered entity ''will disclose your protected health information to comply with legal requirements'' should suffice. Comment: One comment stressed that the final rule should not inadvertently preempt mandatory reporting laws duly enacted by federal, state, or local legislative bodies."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 208}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 61)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|\n| 4.\nDevelop Appropriate Standard Operating Procedures 124  | • Determine the types of audit trail data and monitoring procedures that will be needed to derive exception reports. • Determine the frequency of audit log reviews based on the risk assessment and risk management processes. | • How will exception reports or logs be reviewed? • Has the organization considered the use of automation to assist in the monitoring and review of system activity? • Are the organization's monitoring system activity and logs reviewed frequently enough to sufficiently protect ePHI? • Where will monitoring reports be filed and maintained? • Is there a formal process in place to address system misuse, abuse, and fraudulent activity? 125 • How will managers and employees be notified, when appropriate, regarding suspect activity? |\n| 5. Implement the Audit/System Activity Review Process 126 | • Activate the necessary audit system. • Begin logging and auditing procedures. | • What mechanisms (e.g., metrics) will be implemented to assess the effectiveness of the audit process? • What is the plan to revise the audit process when needed? |\n\n124  See Sec. 5.1.1, HIPAA Standard: Security Management Process, and Key Activity 5.1.1.7, Develop and Deploy the Information System Activity Review Process. 125  See Sec. 5.1.1, HIPAA Standard: Security Management Process, and Key Activity 5.1.1.6, Develop and Implement a Sanction Policy. 126  See Sec. 5.1.1, HIPAA Standard: Security Management Process, and Key Activity 5.1.1.9, Implement the Information System Activity Review and Audit Process. ## 5.3.3. Integrity (§ 164.312(c))\n\nHIPAA Standard: Implement policies and procedures to protect electronic protected health information from improper alteration or destruction . Table 23."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 60}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 84)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nffected workforce members sign an\n\nVerDate Aug&lt;2,&gt;2002\n\nagreement with the covered entity, comparable to confidentiality agreements that employees handling sensitive information frequently sign.\nA few commenters questioned the enforceability of the data use agreements. The Department clarifies that, if the recipient breaches a data use agreement, HHS cannot take enforcement action directly against that recipient unless the recipient is a covered entity. Where the recipient is a covered entity, the final modifications provide that such covered entity is in noncompliance with the Rule if it violates a data use agreement. See §164.514(e)(4)(iii)(B). Additionally, the Department clarifies that the disclosing covered entity is not liable for breaches of the data use agreement by the recipient of the limited data set. However, similar to business associate agreements, if a covered entity knows of a pattern of activity or practice of the data recipient that constitutes a material breach or violation of the data recipient's obligation under the data use agreement, then it must take reasonable steps to cure the breach or end the violation, as applicable, and, if unsuccessful, discontinue disclosure of protected health information to the recipient and report the problem to the Secretary. And the recipient is required to report to the covered entity any improper uses or disclosures of limited data set information of which it becomes aware. We also clarify that the data use agreement requirements apply to disclosures of the limited data set to agents and subcontractors of the original limited data set recipient. In sum, we have created the limited data set option because we believe that this mechanism provides a way to allow important research, public health and health care operations activities to continue in a manner consistent with the privacy protections of the Rule."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 83}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 172)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nthe NPPs within 60 days of the material changes. Table 5 below presents our analysis of costs to the providers, insurers, and third party administrators that are required to issue NPPs under the rule.\n38\n\n## TABLE 5-SUMMARY OF COMPLIANCE COST FOR NOTICES OF PRIVACY PRACTICES\n\n| Cost elements                                                                                                                                                                                                                                                                                                                                                                                                                                                             | Providers                                                                                                   | Health insurers & third party adminis- trators                                                            | Total (approx.)                                           |\n|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|-----------------------------------------------------------|\n| Drafting NPPs ..................................................................................................... Printing NPPs ....................................................................................................."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 171}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 70)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nby law to defend tort suits brought against certain covered entities; in such circumstances, however, the United States, and not the individual covered entity, is the client and is potentially liable.\nIn such situations, covered entities must be able to disclose protected health information needed to carry out the representation, but the particular requirements that would otherwise apply to a business associate relationship may not be possible to obtain. Subsection (iii) makes clear that, where the relationship is required by law, the covered entity complies with the rule if it attempts, in good faith, to obtain satisfactory assurances as are required by this paragraph and, if such attempt fails, documents the attempts and the reasons that such assurances cannot be obtained. The operation of the final rule maintains the construction discussed in the preamble to the NPRM that a business associate (including a business associate that is a covered entity) that has business associate contracts with more than one covered entity generally may not use or disclose the protected health information that it creates or receives in its capacity as a business associate of one covered entity for the purposes of carrying out its responsibilities as a business associate of another covered entity, unless doing so would be a lawful use or disclosure for each of the covered entities and the business associate's contract with each of the covered entities permits the business associate to undertake the activity. For example, a business associate performing a function under health care operations on behalf of an organized health care arrangement would be permitted to combine or aggregate the protected health information obtained from covered entities participating in the arrangement to the extent necessary to carry out the authorized activity and in conformance with its business associate contracts."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 69}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 29)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ninformation about his or her minor child under § 164.524, in the rare circumstance in which the parent is technically not the personal representative of his or her minor child under the Privacy Rule.\nThis policy would apply particularly where State or other law is silent or unclear. Overview of Public Comments. The following discussion provides an overview of the public comment received on this proposal. Additional comments received on this issue are discussed below in the section entitled, ''Response to Other Public Comments.''\n\nThe Department received a number of comments on the proposed changes to the parents and minors provisions of the Privacy Rule. Many commenters, particularly health care providers involved in provision of health care to minors, requested that the Department return to the approach under the Privacy Rule published in December 2000, because they believed that the proposed approach would discourage minors from seeking necessary health care. At a minimum, these commenters suggested that the Department clarify that discretion to grant a parent access under the proposal is limited to the covered health care provider that is providing treatment to the minor. Supporters of the proposal asserted that the Department was moving in the right direction, but many also advocated for more parental rights. They asserted that parents have protected rights to act for their children and that the Privacy Rule interferes with these rights. There were also some commenters that were confused by the new proposal and others that requested a Federal standard that would preempt all State laws. Final Modifications. The Department will continue to defer to State or other applicable law and to remain neutral to the extent possible. However, the Department is adopting changes to the standards in the December 2000 Privacy Rule, where they do not operate as\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00020\n\nintended and are inconsistent with the Department's underlying goals."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 28}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 49)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nrees with this position. Our research indicates that a signed consent form is most typically treated as a waiver of rights by a patient and not as a binding agreement between a provider and a patient.\nFurther, many States have laws assigning the ownership of records, apart from any consent requirements. The Privacy Rule does not address, and is not intended to affect, existing laws governing the ownership of health records. 19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00033\n\nComment: A few commenters claimed that the signed notice of a provider's privacy policy is meaningless if the individual has no right to withhold consent and the NPRM approach would reinforce the fact that individuals have no say in how their health information is used or disclosed. Response: The Department disagrees. The individual's options under the consent requirement established by the Privacy Rule published in December 2000 and the voluntary consent and strengthened notice provisions adopted by this Rule are the same. Under the previous Rule, a patient who disagreed with the covered entity's information practices as stated in the notice could withhold consent and not receive treatment, or could sign the consent form and obtain treatment despite concerns about the information practices. The patient could request that the provider restrict the use and/or disclosure of the information. Under the Rule as modified, a patient who disagrees with the covered entity's information practices as stated in the notice, can choose not to receive treatment from that provider, or can obtain treatment despite concerns about the information practices. The patient can request that the provider restrict the use and/or disclosure of the information. The result, for the patient, is the same. Comment: One commenter requested clarification with respect to the effect of a revocation of voluntary consent and whether agreed-to restrictions must be honored."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 48}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 86)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ncommon data use agreement. Furthermore, that data use agreement can be combined with a business associate agreement into a single agreement that meets the requirements of both Privacy Rule provisions.\nComment: A few commenters argued that a data use agreement should not be required for data users getting a limited data set and performing data analysis as part of the Medicaid rebate validation process under which third-party data vendors, working for pharmaceutical companies, collect prescription claims data from State agencies and analyze the\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00057\n\nresults for errors and discrepancies. They argued that State agencies often find entering into such contracts difficult and time consuming. Consequently, if States have to establish data use or similar agreements, then the Medicaid rebate validation process could be adversely impacted. Response: We are not persuaded that there is a compelling reason to exempt this category of limited data set use from the requirements for a data use agreement, as compared to other important uses. The data use agreement is key to ensuring the integrity of the limited data set process and avoiding inappropriate further uses and disclosures. Comment: One commenter stated that allowing disclosure of the limited data set without IRB or Privacy Board review would create a loophole in the Privacy Rule, with Federally funded research continuing to undergo IRB review while private research would not. Response: The Rule continues to make no distinction between disclosure of protected health information to Federally and privately funded researchers. To obtain a limited data set from a covered entity, both Federallyfunded and privately-funded researchers must enter into a data use agreement with the covered entity."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 85}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 85)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nand the information system, device, or network is unavailable while the spill is investigated and mitigated. |\n| Obtain information by the externally located interception of wireless network traffic.\n| Adversary intercepts organizational communications over wireless networks (e.g., targets public wireless access or hotel networking connections, drive-by subversion of home or organizational wireless routers). |\n| Obtain unauthorized access. | Adversary with authorized access to organizational information systems gains access to resources that exceed authorization. |\n| Obtain sensitive data or information from publicly accessible information systems. | Adversary scans or mines information on publicly accessible servers and web pages of organizations with the intent of finding sensitive information. |\n| Obtain information by opportunistically stealing or scavenging information systems or components. | Adversary steals information systems or components (e. g., laptop computers or data storage media) that are left unattended outside of the physical perimeters of organizations or scavenges discarded components. |\n| Maintain a presence or set of capabilities. | Maintain a presence or set of capabilities. |\n| Obfuscate adversary actions. | Adversary takes actions to inhibit the effectiveness of the intrusion detection systems or auditing capabilities within organizations. |\n| Adapt cyber attacks based on detailed surveillance. | Adversary adapts their behavior in response to surveillance and organizational security measures. |\n| Coordinate a campaign. | Coordinate a campaign. |\n| Coordinate a campaign of multi-staged attacks (e.g., hopping). | Adversary moves the source of malicious commands or actions from one compromised information system to another, making analysis difficult. |\n| Coordinate a campaign that combines internal and external attacks across multiple information systems and information technologies."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 84}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 54)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhe severability of this provision. As discussed below, we believe we have ample legal authority to cover all individually identifiable health information transmitted or maintained by covered entities.\nWe have structured the definition this way so that, if a court were to disagree with our view of our authority in this area, the rule would still be operational, albeit with respect to a more limited universe of information. Other provisions of the rules below may also be severable, depending on their scope and operation. For example, if the rule itself provides a fallback, as it does with respect to the various discretionary uses and disclosures permitted under § 164.512, the provisions would be severable under case law. The definition in the final rule retains the exception relating to individually identifiable health information in ''education records'' governed by FERPA. We also exclude the records described in 20 U.S.C. 1232g(a)(4)(B)(iv). These are records of students held by post-secondary educational institutions or of students 18 years of age or older, used exclusively for health care treatment and which have not been disclosed to anyone other than a health care provider at the student's request. (See discussion of FERPA above.)\n\nWe have removed the exception for individually identifiable health information of inmates of correctional facilities and detainees in detention facilities. Individually identifiable health information about inmates is protected health information under the final rule, and special rules for use and disclosure of the protected health\n\nFrm 00036\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ninformation about inmates and their ability to exercise the rights granted in this rule are described below."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 53}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 16)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nvulnerabilities and predisposing conditions. For any of the various threats identified above to result in an impactful risk, each needs a vulnerability or predisposing condition that can be exploited.\nA vulnerability is a weakness in an information system, system security procedures, internal controls, or implementation that could be exploited by a threat source. A predisposing condition 23 is a condition that exists within an organization, a mission/business process, or information system that\n\n21  Regulated entities may benefit from [IR 8286A], specifically Section 2.2.2, when identifying threats to ePHI. 22  See also the OCR Quarter 1 2022 Cybersecurity Newsletter. 23  Predisposing conditions include, for example, the location of a facility in a hurricane- or flood-prone region (increasing the likelihood of exposure to hurricanes or floods) or a stand-alone information system with no external network connectivity (decreasing the likelihood of exposure to a network-based cyber attack). These types of vulnerabilities create a predisposition to threat events having adverse impacts on organizations. contributes to (i.e., increases or decreases) the likelihood that a threat event will result in adverse impacts once initiated. The identification of vulnerabilities or predisposing conditions that a threat could exploit to cause an impact is an important component of risk assessment. While it is necessary to review threats and vulnerabilities as unique elements, they are often considered at the same time. Many organizations will consider a given loss scenario and evaluate both, such as what threat sources might initiate which threat events or what vulnerabilities or predisposing conditions those threat sources might exploit to cause an adverse impact. The regulated entity develops a list of vulnerabilities (i.e., flaws or weaknesses) that could be exploited by potential threat sources."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 15}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 144)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ntion of ''health plan.''\n\nThe 60-day public comment period for the proposed rule closed on December 7, 2009, and the Department received approximately twenty-five comments in response to its proposal.\n16 After considering the public comments, the Department is issuing this final rule to strengthen the privacy protections for genetic information in accordance with GINA and the Department's general authority under sections 262 and 264 of HIPAA. In developing this rule, the Department consulted with the Departments of Labor and Treasury, as required by section 105(b)(1) of GINA, to ensure, to the extent practicable, consistency across the regulations. In addition, the Department coordinated with the EEOC in the development of these regulations. The provisions of the proposed rule and the public comments received that were within the scope of the proposed rule are described in more detail below in the section-by-section description of the final rule. C. Section-by-Section Description of Final Rule and Response to Public Comments\n\n1. Scope: Extension of Required Protections to All Health Plans Subject to the HIPAA Privacy Rule\n\n## Proposed Rule\n\nSection 105 of GINA requires HHS to modify the Privacy Rule to prohibit ''a covered entity that is a group health plan, health insurance issuer that issues health insurance coverage, or issuer of a medicare [sic] supplemental policy'' from using or disclosing genetic information for underwriting purposes. Section 105 of GINA provides that the terms ''group health plan'' and ''health insurance coverage'' have the meanings given such terms under section 2791 of the Public Health Service Act (PHSA) (42 U.S.C. 300gg-91), and that the term ''medicare [sic] supplemental policy'' has the meaning given such term in section 1882(g) of the Social Security\n\n16 The public comments are available at http:// www.regulations.gov . 18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00095\n\nAct."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 143}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 128)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\niness Associate may use Protected Health Information to report violations of law to appropriate Federal\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00085\n\nand State authorities, consistent with §164.502(j)(1).\n## Obligations of Covered Entity\n\nProvisions for Covered Entity To Inform Business Associate of Privacy Practices and Restrictions [provisions dependent on business arrangement]\n\n(a) Covered Entity shall notify Business Associate of any limitation(s) in its notice of privacy practices of Covered Entity in accordance with 45 CFR 164.520, to the extent that such limitation may affect Business Associate's use or disclosure of Protected Health Information. (b) Covered Entity shall notify Business Associate of any changes in, or revocation of, permission by Individual to use or disclose Protected Health Information, to the extent that such changes may affect Business Associate's use or disclosure of Protected Health Information. (c) Covered Entity shall notify Business Associate of any restriction to the use or disclosure of Protected Health Information that Covered Entity has agreed to in accordance with 45 CFR 164.522, to the extent that such restriction may affect Business Associate's use or disclosure of Protected Health Information. ## Permissible Requests by Covered Entity\n\nCovered Entity shall not request Business Associate to use or disclose Protected Health Information in any manner that would not be permissible under the Privacy Rule if done by Covered Entity. [Include an exception if the Business Associate will use or disclose protected health information for, and the contract includes provisions for, data aggregation or management and administrative activities of Business Associate]. ## Term and Termination\n\n(a) Term."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 127}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 41)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nnformation could be substantial and could have financial and economic consequences. We lack data on the frequency and extent of damages from the inappropriate release of sensitive medical information.\nNotifying a person of unauthorized access can, however, enable a person to take measures to reduce the damage. Notification can enable them to prepare psychologically and take actions to prepare for the consequences. The individual also may take steps to prepare others for the possible consequences. Benefits to the HIPAA covered entity will rest with the actions it takes to prevent data breaches. As our analysis demonstrates, the costs of notification for an entity may be significant, although in the aggregate in terms of overall health care costs, they are extremely small. Nevertheless, we believe that the costs of the interim final rule are avoidable if either before a covered entity experiences a breach or following one, the entity adopts measures to strengthen its data security. As pointed out, the most frequent form of data loss is the result of lost or stolen laptops and data bearing media such as hard drives. If the data on these devices is encrypted, then under the interim final rule definition of a breach, the event would not require the covered entity or the business associate to notify affected individuals. Because much of the harm resulting from breaches of protected health information may come from the pain and suffering individuals' may sustain to their reputations and standing in their communities, the benefits that reductions in the number of breaches and number of individuals affected is hard to quantify while the costs of the rule are identifiable and specific. For these reasons, we are unable to estimate the net benefits of the rule."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 40}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 52)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ncare operations activities. The proposed provision was intended to allow information to flow from one covered entity to another for activities important to providing quality and effective health care.\nThe proposal would have applied only to disclosures of protected health information to other covered entities. By limiting such disclosures to those entities that are required to comply with the Privacy Rule, the Department intended to ensure that the protected health information remained protected. The Department believed that this\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00035\n\nwould create the appropriate balance between meeting an individual's privacy expectations and meeting a covered entity's need for information for quality-related health care operations. Further, such disclosures would be permitted only to the extent that each entity has, or had, a relationship with the individual who is the subject of the information being disclosed. Where the relationship between the individual and the covered entity has ended, a disclosure of protected health information about the individual would be allowed only if related to the past relationship. The Department believed that this limitation would be necessary in order to further protect the privacy expectations of the individual. The proposal made clear that these provisions would not eliminate a covered entity's responsibility to apply the Privacy Rule's minimum necessary provisions to both the disclosure of and request for protected health information for payment and health care operations purposes. In addition, the proposal strongly encouraged the use of deidentified information, wherever feasible."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 51}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 328)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\naddition, one commenter urged the Secretary to be sensitive to these concerns about delay and other negative impacts on the timely determination of disability by SSA for mentally impaired individuals.\nResponse: Under the final rule, covered entities may disclose protected health information pursuant to an administrative order so the flow of protected health information from covered entities to SSA and the states should not be disrupted. Although some commenters urged that special rules should be included for state and federal agencies that need protected health information, the Secretary rejects that suggestion because, wherever possible, the public and the private sectors should operate under the same rules regarding the disclosure of health information. To the extent the activities of SSA constitute an actual administrative tribunal, covered entities must follow the requirements of §164.512(e), if they wish to disclose protected health information to SSA in those circumstances. Not all administrative inquiries are administrative tribunals, however. If SSA's request for protected health information comes within another category of permissible exemptions, a covered entity, following the requirements of the applicable section, may disclose the information to SSA. For example, if SSA seeks information for purposes of health oversight, a covered entity that wishes to disclose the information to SSA may do so under §164.512(d) and not § 164.512(e). If the disclosure does not come within one of the other permissible disclosures would a covered entity need to meet the requirements of § 164.512(e). If the SSA request does not come within another permissible disclosure, the agency will be treated like anyone else under the rules. The Secretary recognizes that even under current circumstances, professional medical records personnel do not always respond unquestioningly to an agency's request for health information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 327}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 492)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nled cost assumptions associated with these PRA requirements. We explicitly seek, and will consider, public comment on our assumptions as they relate to the PRA requirements summarized in this section.\n## Section 160.204-Process for Requesting Exception Determinations\n\nSection 160.204 would require persons requesting to except a provision of state law from preemption under §160.203(a) to submit a written request, that meets the requirements of this section, to the Secretary to except a provision of state law from preemption under §160.203. The burden associated with these requirements is the time and effort necessary for a state to prepare and submit the written request for an exception determination to the Secretary for approval. On an annual basis it is estimated that it will take 40 states 16 hours each to prepare and submit a request. The total annual burden associated with this requirement is 640 hours. The Department solicits public comment on the number of requests and hours for others likely to submit requests. ## Section 160.306-Complaints to the Secretary\n\nA person who believes that a covered entity is not complying with the applicable requirements of part 160 or the applicable standards, requirements,\n\nFrm 00334\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nand implementation specifications of Subpart E of part 164 of this subchapter may file a complaint with the Secretary. This requirement is exempt from the PRA as stipulated under 5 CFR 1320.4(a)(2), an audit/administrative action exemption. ## Section 160.310-Responsibilities of Covered Entities\n\nA covered entity must keep such records and submit such compliance reports, in such time and manner and containing such information, necessary to enable the Secretary to ascertain whether the covered entity has complied or is complying with the applicable requirements of part 160 and the applicable standards, requirements, and implementation specifications of subpart E of part 164."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 491}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 133)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nendents under the plan who are affected by a breach, so long as they all reside at a single address and the covered entity clearly identifies on the notice the individuals to which the notice applies.\nFurther, a covered entity may send a notice regarding the breach of a dependent child's protected health information addressed to the plan participant and/or participant's spouse living with the dependent child, so long as the participant and/or participant's spouse are the personal representatives of the dependent child and the notice clearly identifies to whom it applies. Such notices by first-class mail would meet the written notice requirements of §164.404(d)(1)(i). However, one breach notice covering both the plan participant and the dependents under the plan mailed to the plan participant's address would not suffice if the address\n\nVerDate Mar&lt;15&gt;2010\n\nof one or more dependents affected by the breach was different than the participant's address. Further, where a plan participant (and/or spouse) is not the personal representative of a dependent under the plan, a covered entity must address a breach notice to the dependent himself or herself. Comment: Several commenters expressed support for the acknowledgment in the preamble to the interim final rule that some covered entities may have obligations under Civil Rights laws to ensure that breach notifications are provided to individuals in alternative languages, and in alternative formats, such as Braille, large print, or audio, where appropriate. Some commenters requested additional guidance regarding how to ensure compliance with these laws with respect to breach notifications. Response: Additional guidance on how to comply with Title VI of the Civil Rights Act of 1964, Section 504 of the Rehabilitation Act of 1973, and the Americans with Disabilities Act of 1990, is available on the OCR Web site at http://www.hhs.gov/ocr/civilrights/ ."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 132}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 4)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\npment of the Privacy Rule and many of these comments were addressed in the preamble of the Privacy Rule. Therefore, we are referring the reader to that document for a discussion of those issues. ## 2.\nLevel of Detail\n\nWe solicited comments as to the level of detail expressed in the required implementation features; that is, we specifically wanted to know whether commenters believe the level of detail of any proposed requirement went beyond what is necessary or appropriate. We received numerous comments expressing the view that the security standards should not be overly prescriptive because the speed with which technology is evolving could make specific requirements obsolete and might in fact deter technological progress. We have accordingly written the final rule to frame the standards in terms that are as generic as possible and which, generally speaking, may be met through various approaches or technologies. ## 3. Implementation Specifications\n\nIn addition to adopting standards, this rule adopts implementation specifications that provide instructions for implementing those standards. However, in some cases, the standard itself includes all the necessary instructions for implementation. In these instances, there may be no corresponding implementation specification for the standard specifically set forth in the regulations text. In those instances, the standards themselves also serve as the implementation specification. In other words, in those instances, we are adopting one set of instructions as both the standard and the implementation specification. The implementation specification would, accordingly, in those instances be required. In this final rule, we adopt both ''required'' and ''addressable'' implementation specifications. We introduce the concept of ''addressable implementation specifications'' to provide covered entities additional flexibility with respect to compliance with the security standards."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 3}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 15)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nice for a covered entity that does fall within the definition of business associate, such as the health care operations function of creating a de-identified or limited data set for the covered entity.\nSee paragraph (6)(v) of the definition of ''health care operations.'' Where the researcher is also the intended recipient of the de-identified data or limited data set, the researcher must return or destroy the identifiers at the time the business associate relationship to create the data set terminates and the researcher now wishes to use the deidentified data or limited data set (subject to a data use agreement) for a research purpose. Comment: A few commenters asked for clarification as to whether the business associate provisions applied to banking and financial institutions. Commenters sought clarification as to whether the exemption at § 1179 of the HIPAA statute for financial institutions was applicable to subcontractors. Response: This final rule is not intended to affect the status of financial institutions with respect to whether they are business associates. The HIPAA Rules, including the business associate provisions, do not apply to banking and\n\nVerDate Mar&lt;15&gt;2010\n\nfinancial institutions with respect to the payment processing activities identified in § 1179 of the HIPAA statute, for example, the activity of cashing a check or conducting a funds transfer. Section 1179 of HIPAA exempts certain activities of financial institutions from the HIPAA Rules, to the extent that these activities constitute authorizing, processing, clearing, settling, billing, transferring, reconciling, or collecting payments for health care or health plan premiums. However, a banking or financial institution may be a business associate where the institution performs functions above and beyond the payment processing activities identified above on behalf of a covered entity, such as performing accounts receivable functions on behalf of a health care provider."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 14}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 522)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nt on behalf of the individual to pick up filled prescriptions, medical supplies, X-rays, or other similar forms of protected health information. - (4) Use and disclosures for disaster relief purposes.\nA covered entity may use or disclose protected health information to a public or private entity authorized by law or by its charter to assist in disaster relief efforts, for the purpose of coordinating with such entities the uses or disclosures permitted by paragraph (b)(1)(ii) of this section. The requirements in paragraphs (b)(2) and (3) of this section apply to such uses and disclosure to the extent that the covered entity, in the exercise of professional judgment, determines that the requirements do not interfere with the ability to respond to the emergency circumstances. §164.512 Uses and disclosures for which consent, an authorization, or opportunity to agree or object is not required. A covered entity may use or disclose protected health information without the written consent or authorization of\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nthe individual as described in §§164.506 and 164.508, respectively, or the opportunity for the individual to agree or object as described in § 164.510, in the situations covered by this section, subject to the applicable requirements of this section. When the covered entity is required by this section to inform the individual of, or when the individual may agree to, a use or disclosure permitted by this section, the covered entity's information and the individual's agreement may be given orally. - (a) Standard: Uses and disclosures required by law. (1) A covered entity may use or disclose protected health information to the extent that such use or disclosure is required by law and the use or disclosure complies with and is limited to the relevant requirements of such law."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 521}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 2)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\ncation provides practical guidance and resources that can be used by regulated entities of all sizes to safeguard ePHI and better understand the security concepts discussed in the HIPAA Security Rule.\n## Keywords\n\nadministrative safeguards; Health Insurance Portability and Accountability Act; implementation specification; physical safeguards; risk assessment; risk management; Security Rule; standards; technical safeguards. ## Reports on Computer Systems Technology\n\nThe Information Technology Laboratory (ITL) at the National Institute of Standards and Technology (NIST) promotes the U.S. economy and public welfare by providing technical leadership for the Nation's measurement and standards infrastructure. ITL develops tests, test methods, reference data, proof of concept implementations, and technical analyses to advance the development and productive use of information technology. ITL's responsibilities include the development of management, administrative, technical, and physical standards and guidelines for the cost-effective security and privacy of other than national security-related information in federal information systems. The Special Publication 800-series reports on ITL's research, guidelines, and outreach efforts in information system security, and its collaborative activities with industry, government, and academic organizations. ## Document Conventions\n\nThe terms 'should' and 'should not' indicate that, among several possibilities, one is recommended as particularly suitable without mentioning or excluding others, that a certain course of action is preferred but not necessarily required, or that (in the negative form) a certain possibility or course of action is discouraged but not prohibited. The terms 'may' and 'need not' indicate a course of action permissible within the limits of the publication. The terms 'can' and 'cannot' indicate a possibility and capability, whether material, physical, or causal."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 1}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 376)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nidentified information. One commenter suggested that we mandate an assessment to see if de-identified information could be used before the use or disclosure of identified information would be allowed.\nResponse: We believe that this final rule establishes a reasonable mechanism for the creation of de-identified information and the fact that this deidentified information can be used without having to follow the policies, procedures, and documentation required to use individually identifiable health information should provide an incentive to encourage its use where appropriate. We disagree with the comment suggesting that we require an assessment of whether de-identified information could be used for each use or disclosure. We believe that such a requirement would be too burdensome on covered entities, particularly with respect to internal uses, where entire records are often used by medical and other personnel. For disclosures, we believe that such an assessment would add little to the protection provided by the minimum necessary requirements in this final rule. Comments: One commenter asked if de-identification was equivalent to destruction of the protected health information (as required under several of the provisions of this final rule). Response: The process of deidentification creates a new dataset in addition to the source dataset containing the protected health information. This process does not substitute for actual destruction of the source data. Modifications to the Proposed Standard for De-Identification\n\nComments: Several commenters called for clarification of proposed language in the NPRM that would have permitted a covered entity to treat information as de-identified, even if specified identifiers were retained, as long as the probability of identifying subject individuals would be very low. Commenters expressed concern that the ''very low'' standard was vague."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 375}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What is considered a breach under HIPAA?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nelectronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954.\nSpecify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nplaced by calling the order desk at (202) 512-1800 or by fax to (202) 512-2250. The cost for each copy is $8.00. As an alternative, you can view and photocopy the Federal Register document at most libraries designated as Federal Depository Libraries and at many other public and academic libraries throughout the country that receive the Federal Register . Electronic Access: This document is available electronically at http:// aspe.hhs.gov/admnsimp/ as well as at the web site of the Government Printing Office at http://www.access.gpo.gov/ su \\_ docs/aces/aces140.html. ## I. Background\n\n## Table of Contents\n\n## Sec. - 160.101 Statutory basis and purpose. 160.102 Applicability. 160.103 Definitions. - 160.104 Modifications. 160.201 Applicability\n\n160.202\n\nDefinitions. 160.203 General rul"}], "metadata": {"source": "privacy_rule_2000", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 97)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n0 of the NPRM. In the final rule we also eliminate proposed §164.510(g) on government health data systems and proposed § 164.510(i) on banking and payment processes. These changes are discussed below.\n## Approach to Use of Protected Health Information\n\nProposed §164.510 of the NPRM included specific subparagraphs addressing uses of protected health\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00064\n\nFmt 4701\n\nSfmt 4700\n\ninformation by covered entities that were also public health agencies, health oversight agencies, government entities conducting judicial or administrative proceedings, or government heath data systems. Such covered entities could use protected health information in all instances for which they could disclose the information for these purposes. In the final rule, as discussed below, we retain this language in the paragraphs on public health activities and health oversight. However, we eliminate this clause with respect to uses of protected health information for judicial and administrative proceedings, because we no longer believe that there would be any situations in which a covered entity would also be a judicial or administrative tribunal. Proposed §164.510(e) of the NPRM, regarding disclosure of protected health information to coroners, did not include such a provision. In the final rule we have added it because we believe there are situations in which a covered entity, for example, a public hospital conducting post-mortem investigations, may need to use protected health information for the same purposes for which it would have disclosed the information to a coroner. While the right to request restrictions under §164.522 and the consents required under § 164.506 do not apply to the use and disclosure of protected health information under § 164.512, we do not intend to preempt any state or other restrictions, or any right to enforce such agreements or consents under other law."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 96}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 93)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nof the HITECH Act, we proposed a number of changes to the Privacy Rule's provisions regarding an individual's right to\n\nVerDate Mar&lt;15&gt;2010\n\nrequest restrictions of certain uses and disclosures.\nFirst, we proposed at §164.522(a)(1)(vi) to require a covered entity to agree to a request by an individual to restrict the disclosure of protected health information about the individual to a health plan if: (A) the disclosure is for the purposes of carrying out payment or health care operations and is not otherwise required by law; and (B) the protected health information pertains solely to a health care item or service for which the individual, or person on behalf of the individual other than the health plan, has paid the covered entity in full. In recognition that there are many situations in which family members or other persons may pay for the individual's treatment, we proposed to include language to the provision to ensure that this requirement not be limited to solely the individual paying for the health care item or service but would also include payment made by another person, other than the health plan, on behalf of the individual. We proposed to modify §164.522(a)(1)(ii), which states that a covered entity is not required to agree to a restriction, to refer to this exception to that general rule. We noted in the NPRM that in cases where an individual has exercised his or her right to restrict disclosure to a health plan under the above circumstances, the covered entity is also prohibited from making such disclosures to a business associate of the health plan, because a covered entity may only disclose protected health information to a business associate of another covered entity if the disclosure would be permitted directly to the other covered entity."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 92}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 67)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\n(i) permits the continued use and disclosure of protected health information already obtained pursuant to a valid authorization to the extent necessary to preserve the integrity of the research study.\nFor example, the reliance exception would permit the\n\nVerDate Aug&lt;2,&gt;2002\n\ncontinued use and disclosure of protected health information to account for a subject's withdrawal from the research study, as necessary to incorporate the information as part of a marketing application submitted to the FDA, to conduct investigations of scientific misconduct, or to report adverse events. However, the reliance exception would not permit a covered entity to continue disclosing additional protected health information to a researcher or to use for its own research purposes information not already gathered at the time an individual withdraws his or her authorization. The Department believes that this clarification of the Rule will minimize the negative effects on research caused by participant withdrawal and will allow for important continued uses and disclosures to occur, while maintaining privacy protections for research subjects. ## Response to Other Public Comments\n\nComment: In opposition to the March 2002 NPRM, one commenter suggested prohibiting the combining of authorization forms with an informed consent when the covered entity disclosing the protected health information is not otherwise participating in research. The commenter argued that the NPRM would allow covered entities to receive more information than necessary to fulfill a patient's authorization request, such as information about the particular type or purpose of the study itself, and could, thereby, violate the patient's privacy. Response: The Department acknowledges the concern raised by these commenters; however, prohibiting the combination of authorization forms with an informed consent reduces the flexibility proposed in the March 2002 NPRM."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 66}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 33)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n|\n| 524292 .............. | Third Party Administrators ....................................................................................................................................\n| 3,522                |\n\n- 1 Office of Advocacy, Small Business Administration http://www.sba.gov/advo/research/data.html. - 2 Centers for Medicare and Medicaid Services. - 3 The Chain Pharmacy Industry http://www.nacds.org/wmspage.cfm?parm1=507. Healthcare clearinghouses are also considered covered entities. In the final rule implementing the 5010 standard published in the Federal Register on January 16, 2009 (74 FR 3318), we estimated that 162 clearinghouses will be affected by the interim final rule. b. How Many Breaches Will Require Notification? (1) What Is a Breach of Protected Health Information? The interim final rule at § 164.402 defines a breach as an event that ''compromises the security or privacy of the protected health information,'' which means that it poses a significant risk of financial, reputational, or other harm to the individual. Events such as hacking into a database to steal protected health information would clearly constitute a breach of protected health information. Other events, however, such as a hospital inadvertently posting protected health\n\nVerDate Nov&lt;24&gt;2008\n\n15:01 Aug 21, 2009\n\nJkt 217001\n\ninformation on a Web site, or the office staff mailing a medical report to the wrong patient, may constitute a breach. In the case of posting information on a facility's Web site or mailing the wrong report, the entity responsible for the inappropriate release of protected health information may not have to notify the affected person if the entity has determined (e.g., by performing a risk assessment) that the release of the protected health information will not result in financial, reputational, or other harm to the individual."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 32}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 422)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\npreamble discussion regarding our decision to use this language. Comments: A few commenters called for a record of all disclosures, including a right of access to a full audit trail where one exists.\nSome commenters stated while audit trails for paper records are too expensive to require, the privacy rule should not discourage audit trails, at least for computer-based records. They speculated that an important reason for maintaining a full audit trail is that most abuses are the result of activity by insiders. On the other hand, other commenters pointed out that an enormous volume of records would be created if the rule requires recording all accesses in the manner of a full audit trail. One commenter supported the NPRM's reference to the proposed HIPAA Security Rule, agreeing that access control and disclosure requirements under this rule should be coordinated with the final HIPAA Security Rule. The commenter recommended that HHS add a reference to the final HIPAA Security Rule in this section and keep specific audit log and reporting requirements generic in the privacy rule. Response: Audit trails and the accounting of disclosures serve different functions. In the security field, an audit trail is typically a record of each time a sensitive record is altered, how it was altered and by whom, but does not usually record each time a record is used or viewed. The accounting required by this rule provides individuals with information about to whom a disclosure is made. An accounting, as described in this rule, would not capture uses. To the extent that an audit trail would capture uses, consumers reviewing an audit trail may not be able to distinguish between\n\nFrm 00279\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\naccesses of the protected health information for use and accesses for disclosure. Further, it is not clear the degree to which the field is technologically poised to provide audit trails."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 421}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 65)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ned special authorization requirements at § 164.508(f). The December 2000 Privacy Rule, at §164.508(b)(5), also permitted individuals to revoke their authorization at any time, with limited exceptions.\nFurther, the December 2000 Privacy Rule prohibited the combining of the authorization for the use or disclosure of existing protected health information with any other legal permission related to the research study. March 2002 NPRM. Several of those who commented on the December 2000 Privacy Rule argued that certain authorization requirements in § 164.508 were unduly complex and burdensome as applied to research uses and disclosures. In particular, several commenters favored eliminating the Rule's specific provisions at § 164.508(f) for authorizations for uses and disclosures of protected health information for research that includes treatment of the individual. The Department also heard from several provider groups who argued in favor of permitting covered entities to combine all of the research authorizations required by the Privacy Rule with the informed consent to participate in the research. Commenters also noted that the Rule's requirement for an ''expiration date or event that relates to the individual or the purpose of the use or disclosure'' runs counter to the needs of research databases and repositories that are often retained indefinitely. In response to these concerns, the Department proposed to a number of modifications to simplify the authorization requirements both generally, and in certain circumstances, as they specifically applied to uses and disclosures of protected health information for research. In particular, the Department proposed a single set of authorization requirements for all uses and disclosures, including those for research purposes."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 64}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 24)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\natment,'' as the term is defined in § 164.501, and ''health care.'' Other key revisions include adding the term ''assessment'' in subparagraph (1) and deleting proposed subparagraph (3) from the rule.\nTherefore the procurement or banking of organs, blood (including autologous blood), sperm, eyes or any other tissue or human product is not considered to be health care under this rule and the organizations that perform such activities would not be considered health care providers when conducting these functions. As described in §164.512(h), covered entities are permitted to disclose protected health information without individual authorization, consent, or agreement (see below for explanation of authorizations, consents, and agreements) as necessary to facilitate cadaveric donation. ## Health Care Clearinghouse\n\nIn the NPRM, we defined ''health care clearinghouse'' as a public or private entity that processes or facilitates the processing of nonstandard data elements of health information into standard data elements. The entity receives health care transactions from health care providers or other entities, translates the data from a given format into one acceptable to the intended payor or payors, and forwards the processed transaction to appropriate payors and clearinghouses. Billing services, repricing companies, community health management information systems, community health information systems, and ''value-added'' networks and switches would have been considered to be health care clearinghouses for purposes of this part, if they perform the functions of health care clearinghouses as described in the preceding sentences. In the final regulation, we modify the definition of health care clearinghouse to reflect changes in the definition published in the Transactions Rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 23}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 141)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\npersons to whom they disclose protected health information of the existence of any restriction on that information. A restriction is only binding on the covered entity that agreed to the restriction.\nWe encourage covered entities to inform others of the existence of a restriction when it is appropriate to do so. We note, however, that disclosure of the existence of a restriction often amounts to a de facto disclosure of the restricted information itself. If a restriction does not permit a covered entity to disclose protected health information to a particular person, the covered entity must carefully consider whether disclosing the existence of the restriction to that person would also violate the restriction. ## Section 164.522(b)-Confidential Communications Requirements\n\nIn the NPRM, we did not directly address the issue of whether an individual could request that a covered entity restrict the manner in which it communicated with the individual. As described above, the NPRM would have provided individuals with the right to request that health care providers restrict uses and disclosures of protected health information for treatment, payment and health care operations, but would not have required providers to agree to such a restriction. In the final rule, we require covered entities to permit individuals to request that the covered entity provide confidential communications of protected health information about the individual. The requirement applies to\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ncommunications from the covered entity to the individual, and also communications from the covered entity that would otherwise be sent to the named insured of an insurance policy that covers the individual as a dependent of the named insured. Individuals may request that the covered entity send such communications by alternative means or at alternative locations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 140}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 176)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\null compliance by business associates with the Security Rule requirements. Table 6 below presents the range of our estimates of the costs to business associates of achieving compliance with the rules.\n## TABLE 6-BUSINESS ASSOCIATE COST ESTIMATES IN 2011 DOLLARS\n\n| Data element                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | Security rule compliance documentation                                                                                              | BAA between business as- sociates and subcontractors                 |\n|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------|\n| Estimated number of affected entities ........................................................................... Hours needed to complete compliance activities .......................................................... Cost per hour ................................................................................................................."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 175}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement physical controls?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\nRIN 0991-AB56\n\n## Breach Notification for Unsecured Protected Health Information\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Interim final rule with request for comments. SUMMARY: The Department of Health and Human Services (HHS) is issuing this interim final rule with a request for comments to require notification of breaches of unsecured protected health information. Section 13402 of the Health Information Technology for Economic and Clinical Health (HITECH) Act, part of the American Recovery and Reinvestment Act of 2009 (ARRA) that was enacted on February 17, 2009, requires HHS to issue interim final regulations within 180 days to require covered entities under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and their business associates to provide notification in the case of breaches of unsecured protected health information. For purposes of determining what information is ''unsecured protected health information,'' in this document HHS is also issuing an update to its guidance specifying the technologies and methodologies that render protected health information unusable, unreadable, or indecipherable to unauthorized individuals. DATES: Effective Date: This interim final rule is effective September 23, 2009. Comment Date: Comments on the provisions of this interim final rule are due on or before October 23, 2009. Comments on the information collection requirements associated with this rule are due on or before September 8, 2009. ADDRESSES: You may submit comments, identified by RIN 0991-AB56, by any of the following methods (please do not submit duplicate comments):\n\n- Regular, Express, or Overnight Mail: U.S. Department of Health and Human Services, Office for Civil Rights, Attention: HITECH Breach Notification, Hubert H."}], "metadata": {"source": "breach_notification_2009", "safeguard_type": "physical", "implementation_spec": "required", "entity_type": "covered_entity", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 8)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nnter (CSRC 5 ). ## 1.2. Applicability\n\nThe guidance provided in this publication is applicable to all covered entities and their business associates of all sizes that store, process, or transmit ePHI.\nWhile the Security Rule requires regulated entities to safeguard ePHI, covered entities are required by the Privacy Rule 6 to safeguard all forms of protected health information (PHI). The HIPAA Privacy Rule at 164.530(c)(1) states, 'A covered entity must have in place appropriate administrative, technical, and physical safeguards to protect the privacy of protected health information.' Essentially, this covers all oral, written, and electronic PHI (to the extent not covered by the Security Rule). Business associates maintain their own direct liability under the HIPAA Privacy, Security, and\n\n4  See https://www.hhs.gov/hipaa/index.html and https://www.hhs.gov/hipaa/for-professionals/security/index.html. 5 See http://csrc.nist.gov. 6  See https://www.hhs.gov/hipaa/for-professionals/privacy/index.html. Breach Notification Rules (collectively, the 'HIPAA Rules') with respect to their role as business associates. For example, business associates are required to comply with the Security Rule in its entirety; business associate breach notification obligations differ from that of a covered entity; and business associates are subject to liability for only certain provisions of the Privacy Rule. A summary of a business associate's direct HIPAA liability 7 is available. Federal, state, local, and tribal governments and private-sector organizations that compose the critical health infrastructure of the United States are encouraged to consider using the guidance in this publication, as appropriate. NIST publications may be useful to any entity seeking to understand the security issues raised by the HIPAA Security Rule, regardless of that entity's size, structure, or distribution of security responsibilities."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 7}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 30)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nplements section 1178. Second, the definition of ''more stringent'' has been changed by eliminating the criterion relating to penalties and by framing the criterion under paragraph (1) more generally.\nAlso, we have clarified that the term ''individual'' means the person who is the subject of the individually identifiable health information, since the term ''individual'' is defined this way only in subpart E of part 164, not in part 160. Third, the definition of ''state law'' has been changed by substituting the words ''statute, constitutional provision'' for the word ''law,'' the words ''common law'' for the word ''decision,'' and adding the words ''force and'' before the word ''effect'' in the proposed definition. Fourth, in §160.203, several criteria relating to the statutory grounds for exception determinations have been further spelled out: (1) The words '' related to the provision of or payment for health care'' have been added to the exception for fraud and abuse; (2) the words ''to the extent expressly authorized by statute or regulation'' have been added to the exception for state regulation of health plans; (3) the words ''of serving a compelling need related to public health, safety, or welfare, and, where a standard, requirement, or implementation specification under part 164 of this subchapter is at issue, where the Secretary determines that the intrusion into privacy is warranted when balanced against the need to be served'' have been added to the general exception ''for other purposes''; and (4) the statutory provision regarding controlled substances has been elaborated on as follows: ''Has as its principal purpose the regulation of the manufacture, registration, distribution, dispensing, or other control of any controlled substance, as defined at 21 U.S.C. 802, or which is deemed a controlled substance by state law.''\n\nThe most extensive changes have been made to proposed § 160.204. The provision for advisory opinions has been eliminated."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 29}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 85)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nd, a covered entity who believes that another covered entity's request to include date of birth in the limited data set is not warranted is free to negotiate with the recipient about that requirement.\nIf the entity requesting a limited data set including date of birth is not one on whose request a covered entity may reasonably rely under §164.514(d)(3)(iii), and the covered entity believes inclusion of date of birth is not warranted, the covered entity must either negotiate a reasonably\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\nnecessary limited data set or not make a disclosure. The Department amends §164.514(e)(3)(ii) to make clear that a covered entity may engage a business associate to create a limited data set, in the same way it can use a business associate to create de-identified data. As with de-identified data, a business associate relationship arises even if the limited data set is not being created for the covered entity's own use. For instance, if a researcher needs county data, but the covered entity's data contains only the postal address of the individual, a business associate may be used to convert the covered entity's geographical information into that needed by the researcher. The covered entity may hire the intended recipient of the limited data set as a business associate for this purpose. That is, the covered entity may provide protected health information, including direct identifiers, to a business associate who is also the intended data recipient, to create a limited data set of the information responsive to the business associate's request. Finally, the Department amends §164.528 to make clear that the covered entity does not need to include disclosures of protected health information in limited data sets in any accounting of disclosures provided to the individual."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 84}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 40)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nidual's designee, as necessary to satisfy a covered entity's obligations with respect to an individual's request for an electronic copy of protected health information. See § 164.502(a)(3) and (a)(4).\nFurther, a business associate is directly liable for failing to make reasonable efforts to limit protected health information to the minimum necessary to accomplish the intended purpose of the use, disclosure, or request. See § 164.502(b). Finally, business associates are directly liable for failing to enter into business associate agreements with subcontractors that create or receive protected health information on their behalf. See §164.502(e)(1)(ii). As was the case under the Privacy Rule before the HITECH Act, business associates remain contractually liable for all other Privacy Rule obligations that are included in\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with their contracts or other arrangements with covered entities. 2. Section 164.501-Definitions a. Definition of ''Health Care Operations''\n\n## Proposed Rule\n\nPSQIA provides, among other things, that Patient Safety Organizations (PSOs) are to be treated as business associates of covered health care providers. Further, PSQIA provides that the patient safety activities of PSOs are deemed to be health care operations of covered health care providers under the Privacy Rule. See 42 U.S.C. 299b-22(i). To conform to these statutory provisions, we proposed to amend paragraph (1) of the definition of ''health care operations'' to include an express reference to patient safety activities, as defined in the PSQIA implementing regulation at 42 CFR 3.20. Many health care providers participating in the voluntary patient safety program authorized by PSQIA are HIPAA covered entities. PSQIA acknowledges that such providers must also comply with the Privacy Rule and deems patient safety activities to be health care operations under the Privacy Rule."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 39}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the differences between covered entity and business associate obligations under HIPAA?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\n## RIN 0945-AA03\n\nModifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (HHS or ''the Department'') is issuing this final rule to: Modify the Health Insurance Portability and Accountability Act (HIPAA) Privacy, Security, and Enforcement Rules to implement statutory amendments under the Health Information Technology for Economic and Clinical Health Act (''the HITECH Act'' or ''the Act'') to strengthen the privacy and security protection for individuals' health information; modify the rule for Breach Notification for Unsecured Protected Health Information (Breach Notification Rule) under the HITECH Act to address public comment received on the interim final rule; modify the HIPAA Privacy Rule to strengthen the privacy protections for genetic information by implementing section 105 of Title I of the Genetic Information Nondiscrimination Act of 2008 (GINA); and make certain other modifications to the HIPAA Privacy, Security, Breach Notification, and Enforcement Rules (the HIPAA Rules) to improve their workability and effectiveness and to increase flexibility for and decrease burden on the regulated entities. DATES: Effective date: This final rule is effective on March 26, 2013. Compliance date: Covered entities and business associates must comply with the applicable requirements of this final rule by September 23, 2013. FOR FURTHER INFORMATION CONTACT: Andra Wicks 202-205-2292. SUPPLEMENTARY INFORMATION:\n\nVerDate Mar&lt;15&gt;2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n## I."}], "metadata": {"source": "hitech_omnibus_2013", "entity_type": "both", "safeguard_types": ["physical", "technical", "administrative"], "type": "entity_obligations"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 3)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nnd enhance the rights of consumers by providing them access to their health information and controlling the inappropriate use of that information; (2) to improve the quality of health care in the U.S.\nby restoring trust in the health care system among consumers, health care professionals, and the multitude of organizations and individuals committed to the delivery of care; and (3) to improve the efficiency and effectiveness of health care delivery by creating a national framework for health privacy protection that builds on efforts by states, health systems, and individual organizations and individuals. This regulation is the second final regulation to be issued in the package of rules mandated under title II subtitle F section 261-264 of the Health Insurance Portability and Accountability Act of 1996 (HIPAA), Public Law 104-191, titled ''Administrative Simplification.'' Congress called for steps to improve ''the efficiency and effectiveness of the health care system by encouraging the development of a health information system through the establishment of standards and requirements for the electronic transmission of certain health information.'' To achieve that end, Congress required the Department to promulgate a set of interlocking regulations establishing standards and protections for health information systems. The first regulation in this set,\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00003\n\nStandards for Electronic Transactions 65 FR 50312, was published on August 17, 2000 (the ''Transactions Rule''). This regulation establishing Standards for Privacy of Individually Identifiable Health Information is the second final rule in the package. A rule establishing a unique identifier for employers to use in electronic health care transactions, a rule establishing a unique identifier for providers for such transactions, and a rule establishing standards for the security of electronic information systems have been proposed."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 2}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 91)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nts such acknowledgment be mailed back to the provider. The Department would not consider the health care provider in violation of the Rule if the individual chooses not to mail back an acknowledgment.\nThe Department clarifies, however, that where a health care provider's initial contact with the patient is simply to schedule an appointment, the notice provision and acknowledgment requirements may be satisfied at the time the individual arrives at the provider's facility for his or her\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\nappointment. For service provided electronically, the Department believes that, just as a notice may be delivered electronically, a provider should be capable of capturing the individual's acknowledgment of receipt electronically in response to that transmission. Finally, the Department does not agree with those commenters who argued that the proposed notice acknowledgment requirements are not an adequate alternative to the prior consent requirements, nor with those who argued that the proposed acknowledgment process should be strengthened if an individual's consent is no longer required. The Department believes that the notice acknowledgment process retains the important aspects of the consent process, such as creating an opportunity for a discussion between the individual and the provider of privacy issues, including the opportunity for the individual to request restrictions on how her information may be used and disclosed as permitted by § 164.522. Additionally, the Department believes that requiring certain health care providers to obtain the individual's acknowledgment of receipt of the notice, rather than make a good faith effort to do so, would remove the flexibility of the standard and increase the burden substantially on covered entities. Such a modification, therefore, would have the potential to cause workability and operational problems similar to those caused by the prior consent requirements."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 90}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 370)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nestablished based on recommendations by Congress, veterans groups, and veterans; that it has existed for many years; and that there has been no objection to, or problems associated with, the program.\nWe also note that the\n\nDepartment of Transportation (DoT) and the Department of Veterans Affairs operate an analogous transfer program with respect to United States Coast Guard personnel, who comprise part of the U.S. Armed Forces. The protected health information involved the DoD/ DVA transfer program is being disclosed and used for a limited purpose that directly benefits the individual. This information is covered by, and thus subject to the protections of, the Privacy Act. For these reasons, the final rule retains the DoD/DVA transfer program proposed in the NPRM. In addition, we expand the NPRM's proposed provisions regarding the Department of Veterans Affairs to include the DoT/ DVA program, to authorize the continued transfer of these records. Comment: The Department of Veterans Affairs supported the NPRM's proposal to allow it to use and disclose protected health information among components of the Department so that it could make determinations on whether an individual was entitled to benefits under laws administered by the Department. Some commenters said that the permissible disclosure pursuant to this section appeared to be sufficiently narrow in scope, to respond to an apparent need. Some commenters also said that the DVA's ability to make benefit determinations would be hampered if an individual declined to authorize release of his or her protected health information. A few commenters, however, questioned whether such an exchange of information currently occurs between the components. A few commenters also believed the proposed rule should be expanded to permit sharing of information with other agencies that administer benefit programs."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 369}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What is considered a breach under HIPAA?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nember 23, 2013. FOR FURTHER INFORMATION CONTACT: Andra Wicks 202-205-2292. SUPPLEMENTARY INFORMATION:\n\nVerDate Mar&lt;15&gt;2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n## I.\nExecutive Summary and Background\n\n- A. Executive Summary\n- i. Purpose of the Regulatory Action Need for the Regulatory Action\n\nThis final rule is needed to strengthen the privacy and security protections established under the Health Insurance Portability and Accountability of 1996 Act (HIPAA) for individual's health information maintained in electronic health records and other formats. This final rule also makes changes to the HIPAA rules that are designed to increase flexibility for and decrease burden on the regulated entities, as well as to harmonize certain requirements with those under the Department's Human Subjects Protections regulations. These changes are consistent with, and arise in part from, the Department's obligations under Executive Order 13563 to conduct a retrospective review of our existing regulations for the purpose of identifying ways to reduce costs and increase flexibilities under the HIPAA Rules. We discuss our specific burden reduction efforts more fully in the Regulat"}], "metadata": {"source": "hitech_omnibus_2013", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 186)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ne rule may produce savings that may offset some or all of the added costs. We must also separately identify costs to be incurred by the private sector and those incurred by State and Federal entities.\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00121\n\nSome of the costs of the regulation will fall on covered entities, which are primarily health care providers and health plans. 46 For the purpose of these calculations, we included all provider costs as private sector costs. While we recognize that some providers are State or Federal entities, we do not have adequate information to estimate the number of public providers, but we believe the number to be significantly less than 10 percent of all providers shown in Table 1. Therefore, as we did for the RFA analysis and for ease of calculation, we assumed that all provider costs are private sector costs. We did not receive any comments on this assumption. With respect to health plans, based on the data discussed in section C, we estimate that 60 percent of policy holders are served by private sector health plans and 40 percent of policy holders are served by public sector plans. Therefore, we attribute 60 percent of health plan costs to the private sector and 40 percent of plan costs to the public sector. The remaining costs of complying with the regulation will be borne by business associates of covered entities. We do not have data with which to estimate the numbers of private versus public entity business associates. However, we believe that the vast majority of, if not all, business associates, are private entities. Therefore, we assumed all business associate costs are private sector costs. Of the specific costs we can identify, we estimate that approximately 91 percent of all costs, or between $103.7 and $205 million, will fall on private sector health care providers, health plans, and business associates. The remaining costs, approximately $10.320.4 million, will fall on public sector health plans."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 185}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 103)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nty reasonably believes that such person is responsible for the abuse, neglect, or other injury that has already occurred and that informing that person would not be in the individual's best interests.\n## Section 164.512(d)-Uses and Disclosures for Health Oversight Activities\n\nUnder §164.510(c) of the NPRM, we proposed to permit covered entities to disclose protected health information to health oversight agencies for oversight activities authorized by law, including audit, investigation, inspection, civil, criminal, or administrative proceeding or action, or other activity necessary for appropriate oversight of: (i) the health care system; (ii) government benefit programs for which health information is relevant to beneficiary eligibility; or (iii) government regulatory programs for which health information is necessary for determining compliance with program standards. In § 164.512(d) of the final rule, we modify the proposed language to include civil and criminal investigations. In describing ''other activities necessary for oversight'' of particular entities, we add the phrase ''entities subject to civil rights laws for which health information is necessary for determining compliance.'' In addition, in the final rule, we add ''licensure or disciplinary actions'' to the list of oversight activities authorized by law for which covered entities may disclose protected health information to health oversight agencies. The NPRM's definition of ''health oversight agency'' (in proposed § 164.504) included this phrase, but it was inadvertently excluded from the regulation text at proposed §164.510(c). We make this change in the regulation text of the final rule to conform to the NPRM's definition of health oversight agency and to reflect the full range of activities for which we intend to allow covered entities to disclose protected health information to health oversight agencies."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 102}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 300)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nessed concern as to whether the proposed rule's standard to protect the protected health information about a deceased individual for two years would interfere with the payment of death benefit claims.\nThe commenter asked that the regulation permit the beneficiary or payee under a life insurance policy to authorize disclosure of protected health information pertaining to the cause of death of a decedent or policyholder. Specifically, the commenter explained that when substantiating a claim a beneficiary, such as a fiancee or friend, may be unable to obtain the authorization required to release information to the insurer, particularly if, for example, the decedent's estate does not require probate or if the beneficiary is not on good terms with the decedent's next of kin. Further, the commenter stated that particularly in cases where the policyholder dies within two years of the policy's issuance (within the policy's contestable period) and the cause of death is uncertain, the insurer's inability to access relevant protected health information would significantly interfere with claim payments and increase administrative costs. Response: We do not believe this will be a problem under the final regulation, because we create an exception to the right to revoke an authorization if the authorization was obtained as a condition of obtaining insurance coverage and other applicable law provides the insurer that obtained the authorization with the right to contest a claim under the policy. Thus, if a policyholder dies within the two year contestability period, the authorization the insurer obtained from the policyholder prior to death could not be revoked during the contestability period. ## Core Elements and Requirements\n\nComment: Many commenters raised concerns about the required elements for a valid authorization."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 299}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 201)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nto make a communication about a product or service that encourages recipients of the communication to purchase or use the product or service. - (2) Marketing does not include a communication made:\n2.\n(i) To provide refill reminders or otherwise communicate about a drug or biologic that is currently being prescribed for the individual, only if any financial remuneration received by the covered entity in exchange for making the communication is reasonably related to the covered entity's cost of making the communication. 3. (ii) For the following treatment and health care operations purposes, except where the covered entity receives financial remuneration in exchange for making the communication:\n4. (A) For treatment of an individual by a health care provider, including case management or care coordination for the individual, or to direct or recommend alternative treatments, therapies, health care providers, or settings of care to the individual;\n5. (B) To describe a health-related product or service (or payment for such product or service) that is provided by, or included in a plan of benefits of, the covered entity making the communication, including communications about: the entities participating in a health care provider network or health plan network; replacement of, or enhancements to, a health plan; and health-related products or services available only to a health plan enrollee that add value to, but are not part of, a plan of benefits; or\n6. (C) For case management or care coordination, contacting of individuals with information about treatment alternatives, and related functions to the extent these activities do not fall within the definition of treatment. - (3) Financial remuneration means direct or indirect payment from or on behalf of a third party whose product or service is being described. Direct or indirect payment does not include any payment for treatment of an individual."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 200}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 7)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nare reminded of the Security Rule's flexibility of approach. The HHS Office for Civil Rights (OCR) does not prescribe any particular risk assessment or risk management methodology. Section 3 and Sec.\n4 provide background information about risk assessment and risk management processes, respectively, as well as approaches that regulated entities may choose to use in assessing and managing risk to ePHI. Many regulated entities may benefit from more specific guidance concerning how to comply with the standards and implementation specifications of the Security Rule. To that end, Sec. 5 highlights considerations for a regulated entity when implementing the Security Rule. Key activities, descriptions, and sample questions are provided for each standard. The key activities suggest actions that are often associated with the security functions suggested by that standard. Many of these key activities are often included in a robust security program and may be useful to regulated entities. The descriptions provide expanded explanations about each of the key activities and the types of activities that a regulated entity may pursue when implementing the standard. The sample questions are a non-exhaustive list of questions that a regulated entity may ask itself to determine whether the standard has been adequately implemented. Regulated entities may implement the Security Rule more effectively if they are shown controls catalogs and cybersecurity activities that align with each standard. To assist regulated entities, this publication includes mappings of the Security Rule's standards and implementation specifications to Cybersecurity Framework [NIST CSF] Subcategories and applicable security controls detailed in NIST Special Publication (SP) 800-53r5 (Revision 5), Security and Privacy Controls for Information Systems and Organization s [SP 800-53]. The mapping also lists additional NIST publications relevant to each Security Rule standard."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 6}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 131)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\neiving such information for these purposes may not use or disclose it for any other purpose, except as may be required by law, if the insurance or benefits contract is not placed with the health plan.\n## Section 164.514(h)-Verification of Identity and Authority of Persons Requesting Protected Health Information\n\n## Disclosure of Protected Health Information\n\nWe reorganize the provision regarding verification of identity of individuals requesting protected health information to improve clarity, but we retain the substance of requirements proposed in the NPRM in §164.518(c), as follows. The covered entity must establish and use written policies and procedures (which may be standard protocols) that are reasonably designed to verify the identity and authority of the requestor where the covered entity does not know the person requesting the protected health information. The knowledge of the person may take the form of a known place of business, address, phone or fax number, as well a known human being. Where documentation, statements or representations, whether oral or written, from the person requesting the protected health information is a condition of disclosure under this rule or other law, this verification must involve obtaining such documentation statement, or representation. In such a case, additional verification is only required where this regulation (or other law)\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nrequires additional proof of authority and identity. The NPRM proposed that covered entities would be permitted to rely on the required documentation of IRB or privacy board approval to constitute sufficient verification that the person making the request was a researcher and that the research is authorized. The final rule retains this provision. For most disclosures, verifying the authority for the request means taking reasonable steps to verify that the request is lawful under this regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 130}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 9)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\nstored, accessed, or transferred from a medical device to an external recipient, and may result in patient harm. Manufacturers should respond in a timely fashion to address identified vulnerabilities.\nCritical components of such a program include:\n\n- Monitoring cybersecurity information sources for identification and detection of cybersecurity vulnerabilities and risk;\n- Maintaining robust software lifecycle processes that include mechanisms for:\n- o monitoring third party software components for new vulnerabilities throughout the device's total product lifecycle;\n- o design verification and validation for software updates and patches that are used to remediate vulnerabilities, including those related to Off-the-shelf software;\n- Understanding, assessing and detecting presence and impact of a vulnerability;\n- Establishing and communicating processes for vulnerability intake and handling\n- Note: The FDA has recognized ISO/IEC 30111:2013: Information Technology - Security Techniques - Vulnerability Handling Processes;\n- Using threat modeling to clearly define how to maintain safety and essential performance of a device by developing mitigations that protect, respond and recover from the cybersecurity risk;\n\n## Contains Nonbinding Recommendations\n\n- Adopting a coordinated vulnerability disclosure policy and practice. The FDA has recognized ISO/IEC 29147:2014: Information Technology - Security Techniques Vulnerability Disclosure which may be a useful resource for manufacturers; and\n- Deploying mitigations that address cybersecurity risk early and prior to exploitation. Postmarket cybersecurity information may originate from an array of sources including independent security researchers, in-house testing, suppliers of software or hardware technology, health care facilities, and information sharing and analysis organizations. It is strongly recommended that manufacturers participate in an ISAO that shares vulnerabilities and threats that impact medical devices."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 8}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 53)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nler work forces, and therefore, would assume less risk. The smaller amount of risk involved means that the response to that risk can be developed on a smaller scale than that for larger organizations.\nIndividuals and States are not included in the definition of a small entity. However, the security standards will affect small entities, such as providers and health plans, and vendors in much the same way as they affect any larger entities. Small providers who conduct electronic transactions and small health plans must meet the provisions of this regulation and implement the security standards. A more detailed analysis of the impact on small entities is part of the impact analysis published on August 17, 2000 (65 FR 50312), which provided the impact for all of the HIPAA standards, except privacy. As we discussed above, the scalability factor of the standards means that the requirements placed upon small providers and plans would be consistent with the complexity of their operations. Therefore, small providers and plans with appropriate security processes in place would need to do relatively little in order to comply with the standards. Moreover, small plans will have an additional year to come into compliance. In addition, section 1102(b) of the Act requires us to prepare a regulatory impact analysis if a rule may have a significant impact on the operations of a substantial number of small rural hospitals. This analysis must conform to the provisions of section 604 of the RFA. For purposes of section 1102(b) of the Act, we define a small rural hospital as a hospital that is located outside of a Metropolitan Statistical Area and has fewer than 100 beds. While this rule may have a significant impact on small rural hospitals, the impact should be minimized by the scalability factors of the standards, as discussed above in the impact on all small entities."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 52}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 41)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nt a covered entity may change its policies and procedures at any time, provided that it documents\n\nVerDate Jan&lt;31&gt;2003\n\nand implements the changes in accordance with the applicable requirements.\nCovered entities must also document designations, for example, of affiliation between covered entities (see § 164.105(b)), and other actions, as required by other provisions of the subpart. 1. Comment: One commenter wanted development of written policies regarding such things as confidentiality and privacy rights for access to medical records, and approval of research by a review board when appropriate. Response: These issues are covered in the Privacy Rule (65 FR 82462) (see, in particular, § 164.512(i), § 164.524, and §164.530(i)). 2. Comment: One commenter asked if standards will override agreements that require others to maintain hardcopy documentation (for example, signature on file) and no longer require submitters to maintain hardcopy documentation. Response: The security standards will require a minimum level of documentation of security practices. Any agreements between trading partners for the exchange of electronic protected health information that impose additional documentation requirements will not be overridden by this final rule. 3. Comment: One commenter stated that there should be a requirement to document only applications deemed necessary by an applications and data criticality assessment. Response: Electronic protected health information must be afforded security protection under this rule regardless of what application it resides in. The measures taken to protect that information must be documented. 4. Comment: One commenter asked how detailed the documentation must be. Another commenter asked what ''kept current'' meant. Response: Documentation must be detailed enough to communicate the security measures taken and to facilitate periodic evaluations pursuant to §164.308(a)(8)."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 40}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 386)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\na professional hired to provide\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00255\n\nprofessional services as to what information is the minimum necessary for that purpose.\nComment: Commenters from the law enforcement community expressed concern that providers may attempt to misuse the minimum necessary standard as a means to restrict access to information, particularly with regard to disclosures for health oversight or to law enforcement officials. Response: The minimum necessary standard does not apply to disclosures required by law. Since the disclosures to law enforcement officials to which this standard applies are all voluntary, there would be no need for a covered entity to ''manipulate'' the standard; it could decline to make the disclosure. Comment: Some commenters argued that the only exception to the application of the standard should be when an individual requests access to his or her own information. Many of these commenters expressed specific concerns about victims of domestic violence and other forms of abuse. Response: We do not agree with the general assertion that disclosure to the individual is the only appropriate exception to the minimum necessary standard. There are other, limited, circumstances in which application of the minimum necessary standard could cause significant harm. For reasons described above, disclosures of protected health information for treatment purposes are not subject to this standard. Similarly, as described in detail in the preamble to § 164.512(a), where another public body has mandated the disclosure of health information, upsetting that judgment in this regulation would not be appropriate."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 385}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 86)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nill is investigated and mitigated. |\n| Mishandling of critical and/or sensitive information by authorized users | An authorized privileged user inadvertently exposes critical or sensitive information.\n|\n| Incorrect privilege settings                                             | An authorized privileged user or administrator erroneously assigns a user excessive privileges or sets privilege requirements on a resource too low. |\n| Communications contention                                                | Communications performance is degraded due to contention. |\n| Unreadable display                                                       | The display is unreadable due to aging equipment. |\n| Earthquake at primary facility                                           | An earthquake of an organization-defined magnitude at the primary facility makes that facility inoperable. |\n| Fire at primary facility                                                 | A fire (not due to adversarial activity) at the primary facility makes that facility inoperable. |\n| Fire at backup facility                                                  | A fire (not due to adversarial activity) at a backup facility makes that facility inoperable or destroys backups of software, configurations, data, and/or logs. |\n| Flood at primary facility                                                | A flood (not due to adversarial activity) at the primary facility makes that facility inoperable. |\n| Flood at backup facility                                                 | A flood (not due to adversarial activity) at a backup facility makes that facility inoperable or destroys backups of software, configurations, data, and/or logs. |\n| Hurricane at primary facility                                            | A hurricane of organization-defined strength at the primary facility makes that facility inoperable."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 85}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 6)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\nor more medical purposes that perform these purposes without being part of a hardware medical device (http://www.imdrf.org/docs/imdrf/final/technical/imdrf-tech131209-samd-key-definitions-140901.pdf).\n9\n\nSee FDA Guidance:  'Mobile Medical Applications'\n\n(http://www.fda.gov/downloads/MedicalDevices/.../UCM263366.pdf). 10 See FDA Guidance 'Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices'\n\n(http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM482649). ## Contains Nonbinding Recommendations\n\n(http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm0 77812.htm). This guidance does not apply to investigational devices. 11\n\n## IV. Definitions\n\nFor the purposes of this guidance, the following definitions are used:\n\n## A. Compensating Controls\n\nA cybersecurity compensating control is a safeguard or countermeasure deployed, in lieu of, or in the absence of controls designed in by a device manufacturer. These controls are external to the device design, configurable in the field, employed by a user, and provide supplementary or comparable cyber protection for a medical device 12 . For example, a manufacturer's assessment of a cybersecurity vulnerability determines that unauthorized access to a networked medical device will most likely impact the device's safety or essential performance. However, the manufacturer determines that the device can safely and effectively operate without access to the host network, in this case the hospital network. The manufacturer instructs users to configure the network to remove the ability of unauthorized/unintended access to the device from the hospital network. This type of counter measure is an example of a compensating control. ## B. Controlled Risk\n\nControlled risk is present when there is sufficiently low (acceptable) residual risk of patient harm due to a device's particular cybersecurity vulnerability. ## C."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 5}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 96)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrcise of professional judgment in determining the scope of the person's involvement in the individual's care and the time period for which the individual is agreeing to the other person's involvement.\nFor example, if a friend simply picks up a patient from the hospital but has played no other role\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nin the individual's care, hospital staff should not call the friend to disclose lab test results a month after the initial encounter with the friend. However, if a patient routinely brings a spouse into the doctor's office when treatment is discussed, a physician can infer that the spouse is playing a long-term role in the patient's care, and the rule allows disclosure of protected health information to the spouse consistent with his or her role in the patient's care, for example, discussion of treatment options. The NPRM did not specifically address situations in which disaster relief organizations may seek to obtain protected health information from covered entities to help coordinate the individual's care, or to notify family or friends of an individual's location or general condition in a disaster situation. In the final rule, we account for disaster situations in this paragraph. Specifically, we allow covered entities to use or disclose protected health information without individual agreement to federal, state, or local government agencies engaged in disaster relief activities, as well as to private disaster relief or disaster assistance organizations (such as the Red Cross) authorized by law or by their charters to assist in disaster relief efforts, to allow these organizations to carry out their responsibilities in a specific disaster situation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 95}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 136)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nements of paragraphs (e)(2) and (e)(3) of this section, if the covered entity enters into a data use agreement with the limited data set recipient, in accordance with paragraph (e)(4) of this section.\n- (2) Implementation specification: Limited data set: A limited data set is protected health information that excludes the following direct identifiers of the individual or of relatives, employers, or household members of the individual:\n- (i) Names;\n- (ii) Postal address information, other than town or city, State, and zip code;\n- (iii) Telephone numbers;\n- (iv) Fax numbers;\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\n- (v) Electronic mail addresses;\n- (vi) Social security numbers;\n- (vii) Medical record numbers;\n- (viii) Health plan beneficiary\n- numbers;\n- (ix) Account numbers;\n- (x) Certificate/license numbers;\n- (xi) Vehicle identifiers and serial numbers, including license plate numbers;\n- (xii) Device identifiers and serial numbers;\n- (xiii) Web Universal Resource Locators (URLs);\n- (xiv) Internet Protocol (IP) address numbers;\n\n(xv) Biometric identifiers, including finger and voice prints; and\n\n(xvi) Full face photographic images and any comparable images. - (3) Implementation specification: Permitted purposes for uses and disclosures. (i) A covered entity may use or disclose a limited data set under paragraph (e)(1) of this section only for the purposes of research, public health, or health care operations. 2. (ii) A covered entity may use protected health information to create a limited data set that meets the requirements of paragraph (e)(2) of this section, or disclose protected health information only to a business associate for such purpose, whether or not the limited data set is to be used by the covered entity. - (4) Implementation specifications: Data use agreement. -(i) Agreement required."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 135}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 289)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nre a covered entity to use or disclose protected health information without the individual's authorization, the covered entity must obtain the individual's authorization to make the use or disclosure.\nMultiple covered entities working together as an integrated delivery system or otherwise may satisfy this requirement in at least three ways. First, each covered entity may separately obtain an authorization directly from the individual who is the subject of the protected health information to be used or disclosed. Second, one covered entity may obtain\n\nFrm 00191\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\na compound authorization in accordance with § 164.508(b)(3) that authorizes multiple covered entities to use and disclose protected health information. In accordance with §164.508(c)(1)(ii), each covered entity, or class of covered entities, that is authorized to make the use or disclosure must be clearly identified. Third, if the requirements in § 164.504(d) are met, the integrated delivery system may elect to designate itself as a single affiliated covered entity. A valid authorization obtained by that single affiliated covered entity would satisfy the authorization requirements for each covered entity within the affiliated covered entity. Whichever option is used, because these authorizations are being requested by a covered entity for its own use or disclosure, the authorization must contain both the core elements in § 164.508(c) and the additional elements in § 164.508(d). ## Sale, Rental, or Barter\n\nComment: Proposed §164.508 listed examples of activities that would have required authorization, which included disclosure by sale, rental, or barter. Some commenters requested clarification that this provision is not intended to affect mergers, sale, or similar transactions dealing with entire companies or their individual divisions."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 288}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.414 require?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n§164.414, discussed below, gives covered entities and business associates the burden of demonstrating that no breach has occurred because the impermissible use or disclosure did not pose a significant risk of harm to the individual. Covered entities and business associates must document their risk assessments, so that they can demonstrate, if necessary, that no breach notification was required following an impermissible use or disclosure of protected health information. For impermissible uses or disclosures of protected health information that fall under the narrow exception at paragraph (1)(i"}], "metadata": {"source": "breach_notification_2009", "cfr_section": "§164.414", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 130)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ntute Web notice, must be conspicuous and thus, covered entities should consider the location and duration of the notice to ensure the notice is reasonably calculated to reach the affected individuals.\nFinally, we clarified that covered entities with out-of-date or insufficient\n\nVerDate Mar&lt;15&gt;2010\n\ncontact information for some individuals can attempt to update the contact information so that they can provide direct written notification, in order to limit the number of individuals for whom substitute notice is required and, thus, potentially avoid the obligation to provide substitute notice through a Web site or major print or broadcast media under §164.404(d)(2)(ii). In accordance with the statute, §164.404(d)(3) makes clear that notice to the individual by telephone or other means may be provided, in addition to the direct written notice required by §164.404(d)(1), in cases deemed by the covered entity to require urgency because of possible imminent misuse of unsecured protected health information. ## Overview of Public Comments\n\nSeveral commenters questioned which entity has the responsibility for providing notifications to individuals when a breach occurs at or by a business associate and whether a covered entity could delegate its breach notification obligations to a business associate. Some commenters asked about the notification obligations in cases where a covered entity's business associate that experiences a breach is also a covered entity itself. Others requested clarification regarding the obligations for providing breach notification where multiple covered entities and business associates are involved in health information exchange and it may be unclear where a breach occurred and/or which entity has responsibility for the breach."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 129}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 124)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nn the hope that the computer will be recovered. Comment: Some commenters asked that we create an exception to breach to cover certain routine impermissible disclosures of protected health information.\nFor example, commenters asked that we except from notification disclosures made as a result of the covered entity mailing information to a patient's old address, faxing information to the wrong number, disclosures made as a result of leaving a voice message at the wrong number reminding a patient of an upcoming appointment, or, in situations where patients have identical or similar names, contacting the wrong patient to inform him or her that lab results were ready. Response: We decline to create such an exception. The ability of a covered entity or business associate to demonstrate that a particular situation poses a low probability that the protected health information was compromised is very fact specific and will depend on an assessment of all of the factors discussed above, such as to whom the information was disclosed, what information was disclosed, and what mitigation has taken place. We also note that, in some cases, some of the situations contemplated by the commenters may fall within an existing exception. For example, if a covered entity mails protected health information about an individual to a wrong address, the impermissible disclosure may fall into the exception at paragraph (1)(iii) of the definition of breach if the information is returned, undelivered and unopened, to the covered entity, such that an unauthorized recipient could not reasonably have retained the\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00082\n\ninformation."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 123}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 459)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ny a few states allow individuals access to health information held by all their health care providers and health plans. In 33 states, individuals may access their hospital and health facility records.\nOnly 13 states guarantee individuals access to their HMO records, and 16 states provide individuals access to their medical information when it is held by insurers. Seven states have no statutory right of patient access; three states and the District of Columbia have laws that only assure individuals' right to access their mental health records. Only one state permits individuals access to records about them held by health care providers, but it excludes pharmacists from the definition of provider. Thirteen states grant individuals statutory right of access to pharmacy records. The amount that entities are allowed to charge for copying of individuals' records varies widely from state to state. A study conducted by the American Health Information Management Association 40 found considerable variation in the amounts, structure, and\n\n40 ''Practice Briefs,'' Journal of AHIMA; Harry Rhodes, Joan C. Larson, Association of Health Information Outsourcing Service; January 1999. Jkt 194001\n\nPO 00000\n\ncombination of fees for search and retrieval, and the copying of the record. In 35 states, there are laws or regulations that set a basis for charging individuals inspecting and copying fees. Charges vary not only by state, but also by the purpose of the request and the facility holding the health information. Also, charges vary by the number of pages and whether the request is for Xrays or for standard medical information. Of the 35 states with laws regulating inspection and copying charges, seven states either do not allow charges for retrieval of records or require that the entity provide the first copy free of charge. Some states may prohibit hospitals from charging patients a retrieval and copying fee, but allow clinics to do so."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 458}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 20)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\ngraph (c) of this section, we require that notification to the media under this provision include the same information required to be included in the notification to the individual under § 164.404(c).\nWe expect that most covered entities will provide notification to the media under this section in the form of a press release. Commenters asked that we define what constitutes a ''prominent media outlet.'' We do not define ''prominent media outlet'' in this regulation because what constitutes a prominent media outlet will differ depending upon the State or jurisdiction affected. For\n\nVerDate Nov&lt;24&gt;2008\n\nexample, for a breach affecting 500 or more individuals across a particular state, a prominent media outlet may be a major, general-interest newspaper with a daily circulation throughout the entire state. In contrast, a newspaper serving only one town and distributed on a monthly basis, or a daily newspaper of specialized interest (such as sport, politics) would not be viewed as a prominent media outlet. If a breach affects 500 or more individuals in a limited jurisdiction, such as a city, then a prominent media outlet may be a major, general-interest newspaper with daily circulation throughout the city, even though the newspaper does not serve the whole State. Commenters also asked HHS to clarify what is meant by ''State or jurisdiction'' for purposes of notice to the media under this provision. We note that ''State'' is already defined at § 160.103 of the HIPAA Rules to mean ''any of the several States, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, and Guam.'' That definition applies to this new provision. We also note that the Act includes a definition of ''State'' which applies for purposes of this provision and defines ''State'' to include, in addition to what is included at § 160.103, American Samoa and the Northern Mariana Islands."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 19}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 43)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nrs asked that it be incorporated into the definitions section of the final rule. One\n\n17:54 Feb 19, 2003\n\nPO 00000\n\nFrm 00030\n\ncommenter stated that the glossary should not be part of this final rule.\nResponse: The terms defined in the glossary in Addendum 2 of the proposed rule are found throughout this final rule, either as part of the text of §164.306 through § 164.312 or under §164.304, as appropriate. We included only terms relevant to the particular standards and implementation specifications being adopted. 3. Comment: Several commenters requested that the mapped matrix located in Addendum 3 of the proposed rule be included in this final rule, either as part of the rule or as an addendum, while others stated that it should not be part of this final rule. Several commenters cited items to be added to the mapped matrix. Response: The mapped matrix was merely a snapshot of current standards and guidelines that the implementation team was able to obtain for review during the development of the security and electronic signature requirements and was provided in the proposed rule as background material. Since this matrix has not been fully populated or kept up-to-date, it is not being published as part of this final rule. Where relevant, we do reference various standards and guidelines indicated in the matrix in this preamble. ## L. Miscellaneous Issues\n\n## 1. Preemption\n\nThe statute requires generally that the security standards supersede contrary provisions of State law including State law requiring medical or health plan records to be maintained or transmitted in written rather than electronic formats. The statute provides certain exceptions to the general rule; section 1178(a)(2) of the Act identifies conditions under which an exception applies. The proposed rule did not provide for a process for making exception determinations; rather, a process was proposed in the privacy rulemaking and was adopted with the Privacy Rule (see part 160, subpart B)."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 42}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 30)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nstringent'' ( see §160.202) that addresses the disclosure of protected health information about a minor to a parent has been moved to the standards regarding parents and minors ( see §164.502(g)(3)).\nThe addition of paragraphs (g)(3)(ii)(A) and (B) of §164.502, clarify that State and other applicable law governs when such law explicitly requires, permits, or prohibits disclosure of protected health information to a parent. In connection with moving the language, the language is changed from the December 2000 Privacy Rule in order to adapt it to the new section. Section 164.502(g)(3)(ii)(A) states that a covered entity may disclose protected health information about a minor to a parent if an applicable provision of State or other law permits or requires such disclosure. By adopting this provision, the Department makes clear that nothing in the regulation prohibits disclosure of health information to a parent if, and to the extent that, State or other law permits or requires such disclosure. The Privacy Rule defers to such State or other law and permits covered entities to act in accordance to such law. Section 164.502(g)(3)(ii)(B) states that a covered entity may not disclose protected health information about a minor to a parent if an applicable provision of State or other law prohibits such disclosure. Again, regardless of how the Privacy Rule would operate in the absence of explicit State or other law, if such law prohibits the disclosure of protected health information about a minor to a parent, so does the Privacy Rule. The revision also clarifies that deference to State or other applicable law includes deference to established case law as well as explicit provisions in statutes or regulations that permit, require, or prohibit particular disclosures. The second change, regarding access to protected health information, also reflects the same policy as proposed in the NPRM."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 29}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 404)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nicted protected health information is needed to provide emergency treatment to the individual who requested the restriction, the covered entity may use or disclose such information for such treatment.\nComment: Commenters asked that we require covered entities to keep an accounting of the requests for restrictions and to report this information to the Department in order for the Department to determine whether covered entities are showing ''good faith'' in dealing with these requests. Response: We require that covered entities that agree to restrictions with individuals document such restrictions. A covered entity must retain such documentation for six years from the date of its creation or the date when it last was in effect, whichever is later. We do not require covered entities to keep a record of all requests made, including those not agreed to, nor that they report such requests to the Department. The decision to agree to restrictions is that of the covered entity. Because there is no requirement to agree to a restriction, there is no reason to impose the burden to document requests that are denied. Any reporting requirement could undermine the purpose of this provision by causing the sharing, or appearance of sharing, of information for which individuals are seeking extra protection. Comment: One commenter asserted that providers that currently allow such restrictions will choose not to do so under the rule based on the guidance of legal counsel and loss prevention managers, and suggested that the Secretary promote competition among providers with respect to privacy by developing a third-party ranking mechanism. Response: We believe that providers will do what is best for their patients, in accordance with their ethics codes, and will continue to find ways to accommodate requested restrictions when they believe that it is in the patients' best interests."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 403}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 51)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nr determine the business associate's compliance with the HIPAA Rules, 7 for a failure to provide an accounting of disclosures, 8 and for a failure to comply with the requirements of the Security Rule.\n9 Business associates remain contractually liable for other requirements of the business associate agreement (see below for a discussion of the business associate agreement provisions). With respect to a business associate's direct liability for a failure to provide access to a copy of electronic protected health information, business associates are liable for providing electronic access in accordance with their business associate agreements. Therefore, business associates may provide electronic access directly to individuals or their designees, or may provide the electronic protected health information to the covered entity (which then provides the electronic access to individuals or their designees). As with many other provisions in the HIPAA Rules, the Department leaves the details to the contracting parties, and is concerned only that access is provided to the individual, not with which party provides the access. ## ii. Minimum Necessary\n\n## Proposed Rule\n\nWe proposed to modify the minimum necessary standard at § 164.502(b) to require that when business associates use, disclose, or request protected health information from another covered entity, they limit protected health information to the minimum necessary to accomplish the intended purpose of the use, disclosure, or request. Applying the minimum necessary standard is a condition of the permissibility of many uses and disclosures of protected health information. Thus, a business associate is not making a permitted use or disclosure under the Privacy Rule if it does not apply the minimum necessary standard, where appropriate. Additionally, the HITECH Act at section 13405(b) addresses the application of minimum necessary and, in accordance with 13404(a), also applies such requirements to business associates."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 50}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 348)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nwe believe that the federal system of human subjects protections continues to be a good model to protect the privacy of individually identifiable health information that is used for research purposes.\nThis model of privacy protection is also consistent with the recent recommendations of both the Institute of Medicine in their report entitled, ''Protecting Data Privacy in\n\nHealth Services Research,'' and the Joint Commission on Accreditation of Healthcare Organizations and the National Committee for Quality Assurance in their report entitled, ''Protecting Personal Health Information: A Framework for Meeting the Challenges in a Managed Care Environment.'' Both of these reports similarly concluded that health services research that involves the use of individually identifiable health information should undergo IRB review or review by another board with sufficient expertise in privacy and confidentiality protection. Furthermore, it is important to recognize that the Common Rule applies not only to interventional research, but also to research that uses individually identifiable health information, including archival research and health services research. The National Bioethics Advisory Commission (NBAC) is currently developing a report on the federal oversight of human subjects research, which is expected to address the unique issues raised by noninterventional human subjects research. The Department looks forward to receiving NBAC's report, and carefully considering the Commission's recommendations. This final rule is the first step in enhancing patients' privacy and we will propose modifications to the rule if changes are warranted by the Commission's findings and recommendations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 347}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 407)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ning an explanation as to the reason for the request as a condition of accommodating the request. The individual does not need to be in an abusive situation to make such requests of a covered provider.\nThe only conditions that a covered provider may place on an individual is that the request be reasonable with respect to the administrative burden on the provider, the request to be in writing, the request specify an alternative address or other method of contact, and that (where relevant) the individual provide information about how payment will be handled. What is reasonable may vary by the size or type of covered entity; however, additional modest cost to the provider would not be unreasonable. An individual also has a right to restrict communications from a health plan. The right is the same as with covered providers except it is limited to cases where the disclosure of information could endanger the individual. A health plan may require an individual to state this fact as a condition of accommodating the individual's request for confidential communications. This would provide victims of domestic violence the right to control such disclosures. Comment: Commenters opposed the provision of the NPRM (§ 164.506(c)(1)(ii)(B)) stating that an individual's right to request restrictions on use or disclosure of protected health information would not apply in emergency situations as set forth in proposed §164.510(k). Commenters asserted that victims who have been harmed by violence may first turn to emergency services for help and that, in such situations, the victim should be able to request that the perpetrator not be told of his or her condition or whereabouts. Response: We agree with some of the commenters' concerns. In the final rule, the right to request restrictions is available to all individuals regardless of the circumstance or the setting in which the individual is obtaining care."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 406}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement technical controls?"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRIN 0991-AB14\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY: Office for Civil Rights, HHS. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (''HHS'' or ''Department'') modifies certain standards in the Rule entitled ''Standards for Privacy of Individually Identifiable Health Information'' (''Privacy Rule''). The Privacy Rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996. The purpose of these modifications is to maintain strong protections for the privacy of individually identifiable health information while clarifying certain of the Privacy Rule's provisions, addressing the unintended negative effects of the Privacy Rule on health care quality or access to health care, and relieving unintended administrative burdens created by the Privacy Rule. DATES: This final rule is effective on October 15, 2002. FOR FURTHER INFORMATION CONTACT: Felicia Farmer, 1-866-OCR-PRIV (1866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION:\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 (or toll-free at 1-866-5121800) or by fax to (202) 512-2250. The cost for each copy is $10.00."}], "metadata": {"source": "privacy_mod_2002", "safeguard_type": "technical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 395)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\non to understand how information about them can be used and disclosed and to prompt them to ask for additional information to obtain a clearer understanding, while minimizing covered entities' burden.\nA notice that stated only that the covered entity would make all disclosures required by law, as suggested by some of these commenters, would fail to inform individuals of the uses and disclosures of information about them that are permitted, but not required, by law. We clarify that each and every disclosure required by law need not be listed on the notice. Rather, the covered entity can include a general statement that disclosures required by law will be made. Comment: Some comments argued that the covered entity should not have to provide notice about uses and disclosures that are permitted under the rule without authorization. Other comments suggested that the notice should inform individuals about all of the uses and disclosures that may be made, with or without the individual's authorization. Response: When the individual's permission is not required for uses and disclosures of information, we believe providing the required notice is the most effective means of ensuring that individuals are aware of how information about them may be shared. The notice need not describe uses and disclosures for which the individual's permission is required, because the individual will be informed of these at the time permission to use or disclose the information is requested. We additionally require covered entities, even those required to obtain the individual's consent for use and disclosure of protected health information for treatment, payment, and health care operations, to describe those uses and disclosures in their notice."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 394}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 357)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne, and social stigma. Fmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nComment: A number of commenters were concerned about the interaction between the proposed rule and the Common Rule.\nOne commenter opposed the four proposed waiver criteria which differed from the Common Rule's criteria for the waiver of informed consent (§ /�������������������������\u000f����/�������������������������\u000f���� .116(d)) on the grounds that the four criteria proposed in addition to the Common Rule's waiver criteria would apply only to the research use and disclosure of protected health information by covered entities. This commenter argued that this would lead to different standards for the protection of other kinds of individually identifiable health information used in research that will fall outside of the scope of the final rule. This commenter concluded that this inconsistency would be difficult for IRBs to administer, difficult for IRB members to distinguish, and would be ethically questionable. For these reasons, many commenters recommended that the final rule should permit the waiver criteria of the Common Rule, to be used in lieu of the waiver criteria identified in the proposed rule. Response: We disagree with the comments recommending that the waiver criteria of the Common Rule should be permitted to be used in lieu of the waiver criteria identified in the proposed rule. The Common Rule's waiver criteria were designed to protect research subjects from all harms associated with research, not specifically to protect individuals' privacy interests."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 356}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 347)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrotected health information by covered entities, not the protection of human research subjects more generally. Therefore, the rule cannot standardize human subjects protections throughout the country.\nGiven the limited scope of the final rule with regard to research, the Department believes that the option to obtain documentation of privacy board approval for an alteration or waiver of authorization in lieu of IRB approval provides covered entities with needed flexibility. Therefore, in the final rule we have retained the option for covered entities to rely on documentation of privacy board approval that specified criteria have been met. We disagree with the rationale suggested by commenters who argued that the option for privacy board review must be maintained because requiring IRB review to include all aspects of patient privacy could diffuse focus and significantly compromise an IRB's ability to execute its primary patient protection role. For research that involves the use of individually identifiable health information, assessing the risk to the privacy of research subjects is currently one of the key risks that must be assessed and addressed by IRBs. In fact, we expect that it will be appropriate for many research organizations that have existing IRBs to rely on these IRBs to meet the documentation requirements of §164.512(i). Comment: One health care provider organization recommended that the IRB or privacy board mechanism of review should be applied to non-research uses and disclosures. Response: We disagree. Imposing documentation of privacy board approval for other public policy uses and disclosures permitted by § 164.512 would result in undue delays in the use or disclosure of protected health information that could harm individuals and the public."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 346}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 86)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\npported allowing a process for individuals who have opted out of receiving further fundraising communications to opt back in and the final rule at § 164.514(f)(2)(v) permits covered entities have one.\nLike the discretion given to covered entities regarding the methods through which an individual can opt out, the final rule gives covered entities the discretion to determine how individuals should be able to opt back in. For example, a covered entity could include as a part of a routine newsletter sent to all patients a phone number individuals can call to be put on a fundraising list. While some commenters suggested that opt outs should be time limited such that an individual automatically opts back in after a certain period of time, we do not believe that an individual's election not to receive further fundraising communications is something that should automatically lapse. Because the individual has actively chosen to opt out, only a similar active decision by the individual to opt back in will suffice. Additionally, where an individual who has opted out of fundraising communications makes a donation to a covered entity, it does not serve, absent a separate election to opt back in, to automatically add the individual back onto the mailing list for fundraising communications. The Privacy Rule currently permits covered entities to use or disclose only demographic information relating to the individual and dates of health care provided to the individual for fundraising communications. In response to several commenters who asked for clarification regarding the scope of demographic information, the final rule, at § 164.514(f)(1)(i), clarifies that demographic information relating to an individual includes names, addresses, other contact information, age, gender, and dates of birth."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 85}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 28)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nwere remediated in the device since the last authorization. If so, manufacturers should describe how remediation was performed following the recommendations in FDA's Postmarket Cybersecurity Guidance.\n## · 524B(b)(3)\n\n- Section 524B(b)(3) of the FD&amp;C Act requires manufacturers of cyber devices to provide an SBOM, including commercial, open-source, and off-the-shelf software components. To assist with complying with this requirement, we recommend that a manufacturer of a cyber device provide an SBOM that contains the information recommended in Section V.A.4.b above. In general, in its cybersecurity review, FDA intends to focus substantive review on modifications to cybersecurity controls or modifications that are likely to affect cybersecurity. However, regardless of the type of change being proposed to the device in the premarket submission, FDA intends to take into account known cybersecurity concerns that are applicable to such device when conducting its premarket reviews and in determining whether the device has a reasonable assurance of cybersecurity. ## E. Reasonable Assurance of Cybersecurity of Cyber Devices\n\nSection 3305(c) of FDORA provides that nothing in section 524B of the FD&amp;C Act 'shall be construed to affect the Secretary's authority related to ensuring that there is a reasonable assurance of the safety and effectiveness of devices, which may include ensuring that there is a reasonable assurance of the cybersecurity of certain cyber devices . . .' FDA interprets this provision to mean that a 'reasonable assurance of cybersecurity' can be part of FDA's determination of a device's safety and effectiveness."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 27}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 10)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nished in the Transactions and Privacy Rules. a. Comment: A number of commenters asked that the definition of ''health information'' be expanded to include information collected by additional entities.\nSeveral commenters wanted the definition to include health information collected, maintained, or transmitted by any entity, and one commenter suggested the inclusion of aggregated information not identifiable to an individual. Several commenters asked that eligibility information be excluded from the definition of information. Several commenters wanted the definition broadened to include demographics. Response: Our definition of health information is taken from the definition in section 1171(4) of the Act, which provides that health information relates to the health or condition of an individual, the provision of health care to an individual, or payment for the provision of health care to an individual. The statutory definition also specifies the entities by which health information is created or received. We note that, because ''individually identifiable health information'' is a subset of ''health information'' and by statute includes demographic information, ''health information'' necessarily includes demographic information. We think this is clear as a matter of statutory construction and does not require further regulatory change. b. Comment: Several commenters asked that we clarify the difference between ''health information'' and ''individually identifiable'' and ''health information pertaining to an individual'' as used in the August 12, 1998 proposed rule (63 FR 43242)."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 9}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "When must a HIPAA breach be reported to HHS?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\n## Office of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRin: 0991-AB08\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY : Office of the Assistant Secretary for Planning and Evaluation, DHHS. ACTION\n\n: Final rule. SUMMARY : This rule includes standards to protect the privacy of individually identifiable health information. The rules below, which apply to health plans, health care clearinghouses, and certain health care providers, present standards with respect to the rights of individuals who are the subjects of this information, procedures for the exercise of those rights, and the authorized and required uses and disclosures of this information. The use of these standards will improve the efficiency and effectiveness of public and private health programs and health care services by providing enhanced protections for individually identifiable health information. These protections will begin to address growing public concerns that advances in electronic technology and evolution in the health care industry are resulting, or may result, in a substantial erosion of the privacy surrounding individually identifiable health information maintained by health care providers, health plans and their administrative contractors. This rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and\n\nAccountability Act of 1996. DATES : The final rule is effective on February 26, 2001. ## FOR FURTHER INFORMATION CONTACT :\n\nKimberly Coleman, 1-866-OCR-PRIV (1-866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION :\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954."}], "metadata": {"source": "privacy_rule_2000", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 69)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nion regarding authorizations for future research). Also, this provision continues to allow for a covered entity to combine such authorizations with informed consent documents for the research studies.\nThe final rule provides covered entities, institutions, and Institutional Review Boards with flexibility to determine the best approach for clearly differentiating the conditioned and unconditioned research activities and giving research participants the option to opt in to the unconditioned research activities. We decline to permit a combined authorization that only allows the individual the option to opt out of the unconditioned research activities (e.g., ''check here if you do NOT want your data provided to the biospecimen bank'') because an opt out option does not provide individuals with a clear ability to authorize the optional research activity, and may be viewed as coercive by individuals. The final rule does not remove the requirement that an individual affirmatively authorize the unconditioned research activities; it merely provides flexibility to streamline the authorization process by combining the forms. With respect to the commenters that believed there is insufficient evidence that combining conditioned and unconditioned research activities into a compound authorization would be beneficial, and that such compound authorizations may be confusing for patients, as indicated above, there have been anecdotal reports to the Department that the use of multiple authorization forms has caused confusion among research subjects. Further, we note that these modifications do not remove the required elements of an authorization that are necessary to inform the individual about the study (e.g., description of the information to be used or disclosed, description of the purpose, etc.); they merely introduce flexibility to avoid redundant language that would otherwise be necessary to include in the authorizations for the multiple research activities."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 68}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.530(e)(1) require?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n§164.530(e)(1) but modify the proposed provision on sanctions to clarify that the sanctions required under this rule do not apply to workforce members of a covered entity for whistleblower disclosures.\n\n## Disclosures by Workforce Members Who Are Crime Victims\n\nThe proposed rule did not address disclosures by workforce members who are victims of a crime. In the final rule, we clarify that a covered entity is not in violation of the rule when a workforce member of a covered entity who is the victim of a crime discloses protected health information to law enforcement officials about the suspecte"}], "metadata": {"source": "privacy_rule_2000", "cfr_section": "§164.530(e)(1)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 129)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nto time as is necessary for Covered Entity to comply with the requirements of the Privacy Rule and the Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191. - (c) Survival.\nThe respective rights and obligations of Business Associate under\n\nVerDate Aug&lt;2,&gt;2002\n\nSection [Insert Section Number Related to ''Effect of Termination''] of this Agreement shall survive the termination of this Agreement. (d) Interpretation. Any ambiguity in this Agreement shall be resolved to permit Covered Entity to comply with the Privacy Rule. ## List of Subjects\n\n## 45 CFR Part 160\n\nElectronic transactions, Employer benefit plan, Health, Health care, Health facilities, Health insurance, Health records, Medicaid, Medical research, Medicare, Privacy, Reporting and record keeping requirements. ## 45 CFR Part 164\n\nElectronic transactions, Employer benefit plan, Health, Health care, Health facilities, Health insurance, Health records, Medicaid, Medical research, Medicare, Privacy, Reporting and record keeping requirements. Dated: August 6, 2002. ## Tommy G. Thompson,\n\nSecretary. For the reasons set forth in the preamble, the Department amends 45 CFR subtitle A, subchapter C, as follows:\n\n## PART 160-GENERAL ADMINISTRATIVE REQUIREMENTS\n\n1. The authority citation for part 160 continues to read as follows:\n\nAuthority: Sec. 1171 through 1179 of the Social Security Act (42 U.S.C. 1320d-1329d8), as added by sec. 262 of Pub. L. No. 104191, 110 Stat. 2021-2031 and sec. 264 of Pub. L. No. 104-191 (42 U.S.C. 1320d-2(note)). 2. Amend §160.102(b), by removing the phrase ''section 201(a)(5) of the Health Insurance Portability Act of 1996, (Pub. L. No. 104-191)'' and adding in its place the phrase ''the Social Security Act, 42 U.S.C. 1320a7c(a)(5)''. 3. In § 160.103 add the definition of ''individually identifiable health information'' in alphabetical order to read as follows:\n\n## §160.103 Definitions."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 128}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 17)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nf information are never protected health information, and will put the focus incorrectly on the nature of the information rather than the reasons for which the covered entity obtained the information.\nFor example, drug screening test results will be protected health information when the provider administers the test to the employee, but will not be protected health information when, pursuant to the employee's authorization, the test results are provided to the provider acting as employer and placed in the employee's employment record. Similarly, the results of a fitness for duty exam will be protected health information when the provider administers the test to one of its employees, but will not be protected health information when the results of the fitness for duty exam are turned over to the provider as employer pursuant to the employee's authorization. Furthermore, while the examples provided by commenters represent typical files or records that may be maintained by employers, the Department does not believe that it has sufficient information to provide a complete definition of employment record. Therefore, the Department does\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00012\n\nnot adopt as part of this rulemaking a definition of employment record, but does clarify that medical information needed for an employer to carry out its obligations under FMLA, ADA, and similar laws, as well as files or records related to occupational injury, disability insurance eligibility, sick leave requests and justifications, drug screening results, workplace medical surveillance, and fitness-for-duty tests of employees, may be part of the employment records maintained by the covered entity in its role as an employer."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 16}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 204)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nrovided in paragraph (e)(4) of this section; and\n- (B) The contract may permit the business associate to provide data aggregation services relating to the health care operations of the covered entity.\n- (ii) Provide that the business associate will:\n- (A) Not use or further disclose the information other than as permitted or required by the contract or as required by law;\n- (B) Use appropriate safeguards and comply, where applicable, with subpart C of this part with respect to electronic protected health information, to prevent use or disclosure of the information other than as provided for by its contract;\n- (C) Report to the covered entity any use or disclosure of the information not provided for by its contract of which it becomes aware, including breaches of unsecured protected health information as required by § 164.410;\n- (D) In accordance with §164.502(e)(1)(ii), ensure that any\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n- subcontractors that create, receive, maintain, or transmit protected health information on behalf of the business associate agree to the same restrictions and conditions that apply to the business associate with respect to such information;\n- (E) Make available protected health information in accordance with §164.524;\n- (F) Make available protected health information for amendment and incorporate any amendments to protected health information in accordance with § 164.526;\n- (G) Make available the information required to provide an accounting of disclosures in accordance with §164.528;\n- (H) To the extent the business associate is to carry out a covered entity's obligation under this subpart, comply with the requirements of this subpart that apply to the covered entity in the performance of such obligation."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 203}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 448)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nments. Moreover, although an establishment may have only a few employees, the firm may have a large number of workers (the total of all its various establishments) and therefore not be a small entity.\nAs discussed below, there is some discrepancy between the aggregate numbers we use for the regulatory impact analysis (RIA) and the regulatory flexibility analysis (RFA). We concluded that for purposes of the RFA, which is intended to measure the effects on small entities, we would use Small Business Administration data, which defines entities based on revenues rather than physical establishments to count the number of small entities in various SIC. This provides a more accurate estimate of small entities affected. For the RIA, which is measuring total effects, we believe the establishment based surveys provide a more reliable count. Comment: Because small businesses must notify patients of their privacy policies on patients' first visit after the effective date of the regulation, several commenters argued that staff would have to search records either manually or by computer on a daily basis to determine if patients had been seen since the regulation was implemented. Response: Under the final regulation, all covered entities will have to provide patients copies of their privacy policy at the first visit after the effective date of the regulation. The Department does not view this as burdensome. We expect that providers will simply place a note or marker at the beginning of a file (electronic or paper) when a patient is given the notice. This is neither timeconsuming nor expensive, and it will not require constant searches of records. Comment: A commenter stated that the definitions of small business, small entity, and a small health plan are\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ninconsistent because the NPRM includes firms with annual receipts of $5 million or less and non-profits."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 447}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.502(e)(2) require?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n§164.502(e)(2)'' and for compliance with the other privacy provisions in the HITECH Act. Section 13404 does not create direct liability for business associates with regard to compliance with all requirements under the Privacy Rule (i.e., does not treat them as covered entities). Therefore, under the final rule, a business associate is directly liable under the Privacy Rule for uses and disclosures of protected health information that are not in accord with its business associate agreement or the Privacy Rule. In addition, a business associate is directly liable for failing to disclose protecte"}], "metadata": {"source": "hitech_omnibus_2013", "cfr_section": "§164.502(e)(2)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance?"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n## Postmarket Management of Cybersecurity in Medical Devices\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on December 28, 2016. The draft of this document was issued on January 22, 2016. For questions regarding this document, contact Suzanne Schwartz, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5434, Silver Spring, MD 20993-0002, 301-796-6937. For questions regarding this document as applied to devices regulated by CBER, contact the Office of Communication, Outreach and Development in CBER at 1-800-835-4709 or 240-402-8010 or ocod@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of the Center Director\n\nCenter for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to http://www.regulations.gov . Submit written comments to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2015-D-5105. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an e-mail request to CDRH-Guidance@fda.hhs.gov to receive an electronic copy of the guidance. Please use the document number 1400044 to identify the guidance you are requesting. ## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), by written request, Office of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., Bldg."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 0}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 129)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n, covered entities making disclosures to public officials that are permitted under §164.512 may rely on the representation of a public official that the information requested is the minimum necessary.\n## Uses and Disclosures for Research\n\nIn making a minimum necessary determination regarding the use or disclosure of protected health information for research purposes, a covered entity may reasonably rely on documentation from an IRB or privacy board describing the protected health information needed for research and consistent with the requirements of §164.512(i), ''Uses and Disclosures for Research Purposes.'' A covered entity may also reasonably rely on a representation made by the requestor that the information is necessary to prepare a research protocol or for research on decedents. The covered entity must ensure that the representation or documentation of IRB or privacy board approval it obtains from a researcher describes with sufficient specificity the protected health information necessary for the research. Covered entities must use or disclose such protected health information in a manner that minimizes the scope of the use or disclosure. ## Standards for Electronic Transactions\n\nWe clarify that under\n\n- §164.502(b)(2)(v), covered entities are\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nnot required to apply the minimum necessary standard to the required or situational data elements specified in the implementation guides for HIPAA administrative simplification standard transactions in the Transactions Rule. The standard does apply for uses or disclosures in standard transactions that are made at the option of the covered entity. ## Section 164.514(e)-Marketing\n\nIn the proposed rule, we would have required covered entities to obtain the individual's authorization in order to use or disclose protected health information to market health and nonhealth items and services."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 128}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 100)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nned from six years to two years or three years. Response: The Department selected six years as the time period for an accounting to be consistent with documentation retention requirements in the Rule.\nWe note that the Rule exempts from the accounting disclosures made prior to the compliance date for Rule, or April 14, 2003. Therefore, it will not be until April 2009 that a full six year accounting period will occur. Also, the Rule permits individuals to request and the covered entity to provide for an accounting for less than full six year period. For example, an individual may be interested only in disclosures that occurred in the prior year or in a particular month. The Department will monitor the use of the accounting requirements after the compliance date and will evaluate the need for changes in the future if the six year period for the accounting proves to be unduly burdensome. Comment: Commenters requested clarification of the need to account for disclosures to business associates, noting that while the regulation states that disclosures to and by a business associate are subject to an accounting, most such disclosures are for health care operations for which no accounting is required. Response: The Department clarifies that the implementation specification in §164.528(b)(1), that expressly includes in the content of an accounting disclosures to or by a business associate, must be read in conjunction with the basic standard for an accounting for disclosures in § 164.528(a). Indeed, the implementation specification expressly references the standard. Read together, the Rule does not require an accounting of any disclosure to or by a business associate that is for any exempt purpose, including disclosures for treatment, payment, and health care operations. Comment: One commenter wanted health care providers to be able to charge reasonable fees to cover the retrieval and preparation costs of an accounting for disclosures."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 99}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 46)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nquired by paragraph (a) of this section without unreasonable delay and in no case later than 60 calendar days after discovery of a breach. - (c) Implementation specifications: Content of notification.\nThe notification required by paragraph (a) of this section shall meet the requirements of §164.404(c). ## §164.408 Notification to the Secretary. (a) Standard. A covered entity shall, following the discovery of a breach of unsecured protected health information\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\24AUR2.SGM\n\n24AUR2\n\nJkt 217001\n\nerowe on DSK5CLS3C1PROD with RULES\\_2\n\nas provided in § 164.404(a)(2), notify the Secretary. - (b) Implementation specifications: Breaches involving 500 or more individuals. For breaches of unsecured protected health information involving 500 or more individuals, a covered entity shall, except as provided in §164.412, provide the notification required by paragraph (a) of this section contemporaneously with the notice required by § 164.404(a) and in the manner specified on the HHS Web site. - (c) Implementation specifications: Breaches involving less than 500 individuals. For breaches of unsecured protected health information involving less than 500 individuals, a covered entity shall maintain a log or other documentation of such breaches and, not later than 60 days after the end of each calendar year, provide the notification required by paragraph (a) of this section for breaches occurring during the preceding calendar year, in the manner specified on the HHS Web site. ## §164.410 Notification by a business associate. - (a) Standard. (1) A business associate shall, following the discovery of a breach of unsecured protected health information, notify the covered entity of such breach. - (2) Breaches treated as discovered."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 45}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 36)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nAlthough some of these reports are required by the Food, Drug, and Cosmetic Act or its accompanying regulations, other types of reporting are voluntary.\nWe believe that these reports, while not mandated, play a critical role in ensuring that individuals receive safe and effective drugs and devices. Therefore, in § 164.512(b)(1)(iii), we have provided that covered entities may disclose protected health information to a person subject to the jurisdiction of the Food and Drug Administration for specified purposes, such as reporting adverse events, tracking medical devices, or engaging in other post marketing surveillance. We describe the scope and conditions of such disclosures in more detail in §164.512(b). ## Clinical Laboratory Improvement Amendments\n\nCLIA, 42 U.S.C. 263a, and the accompanying regulations, 42 CFR part 493, require clinical laboratories to comply with standards regarding the testing of human specimens. This law requires clinical laboratories to disclose test results or reports only to authorized persons, as defined by state law. If a state does not define the term, the federal law defines it as the person who orders the test. We realize that the person ordering the test is most likely a health care provider and not the individual who is the subject of the protected health information included within the result or report. Under this requirement, therefore, a clinical laboratory may be prohibited by law from providing the individual who is the subject of the test result or report with access to this information. Although we believe individuals should be able to have access to their individually identifiable health information, we recognize that in the specific area of clinical laboratory testing and reporting, the Health Care Financing Administration, through regulation, has provided that access may be more limited."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 35}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 388)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nComment: We received a wide variety of suggestions with respect to authorization for uses and disclosures of protected health information for marketing purposes.\nSome commenters supported requiring authorization for all such uses and disclosures. Other commenters suggested permitting all such uses and disclosures without authorization. Some commenters suggested we distinguish between marketing to benefit the covered entity and marketing to benefit a third party. For example, a few commenters suggested we should prohibit covered entities from seeking authorization for any use or disclosure for marketing purposes that benefit a third party. These commenters argued that the third parties should be required to obtain the individual's authorization directly from the individual, not through a covered entity, due to the potential for conflicts of interest. While a few commenters suggested that we require covered entities to obtain authorization to use or disclose protected health information for the purpose of marketing its own products and services, the majority argued these types of marketing activities are vital to covered entities and their customers and should therefore be permitted to occur without authorization. For example, commenters suggested covered entities should be able to use and disclose protected health information without authorization in order to provide appointment reminders, newsletters, information about new initiatives, and program bulletins. Finally, many commenters argued we should not require authorization for the use or disclosure of protected health information to market any health-related goods and services, even if those goods and services are offered by a third party. Some of these commenters suggested that individuals should have an opportunity to opt out of these types of marketing activities rather than requiring authorization."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 387}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 161)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n| 88,396                                  |\n| 524114 ............................................................................. | Health Insurance Carriers 28 .............................\n| 730                  | 276                                     |\n| 524292 ............................................................................. | Third Party Administrators Working on Behalf of Covered Health Plans 29 . | 750                  | 750                                     |\n| Total Entities ............................................................. | ........................................................................... | 698,238              | 697,784                                 |\n\n## B. Why is this rule needed? This final rule is needed to strengthen and expand the privacy and security protections for individuals' health information and privacy rights established under the HIPAA, as mandated by the HITECH Act and GINA. These enhancements are necessary to ensure continued adequate protections for health information, as well as trust in the health care system, particularly as the adoption and use of electronic health records increases. Importantly, among other changes, the rule makes business associates of covered entities directly liable for Federal penalties for failures to comply with certain provisions of the rule. This expansion in liability closes a large gap in protection that existed prior to these\n\n23 Although we do not have data on the numbers of business associates, our enforcement experience leads us to believe that each covered entity has, on average, two to three business associates, for a total of 1-2 million business associates. This number likely overestimates the number of business associates, as some entities may be business associates to multiple covered entities."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 160}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.306 require?"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n§164.306(a). • Risk management should be performed with regular frequency to examine past decisions, reevaluate risk likelihood and impact levels, and assess the effectiveness of past remediation efforts • Create a Risk Management policy and program 34 that outlines organizational risk appetite and risk tolerance, personnel duties, responsible parties, the frequency of risk management, and required documentation. • A risk management methodology is included in Sec. 4 of this document. • Risk management resources are also included in Appendix F. | it? • Is executive leadership and/or management "}], "metadata": {"source": "nist_sp800-66r2", "cfr_section": "§164.306", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 7)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ner Attitudes about Health Web Sites, California Health Care Foundation, at 3 (January, 2000). Unless public fears are allayed, we will be unable to obtain the full benefits of electronic technologies.\nThe absence of national standards for the confidentiality of health information has made the health care industry and the population in general uncomfortable about this primarily financially-driven expansion in the use of electronic data. Many plans, providers, and clearinghouses have taken steps to safeguard the privacy of individually identifiable health information. Yet they must currently rely on a patchwork of State laws and regulations that are incomplete and, at times, inconsistent. States have, to varying degrees, attempted to enhance confidentiality by establishing laws governing at least some aspects of medical record privacy. This approach, though a step in the right direction, is inadequate. These laws fail to provide a consistent or comprehensive legal foundation of health information privacy. For example, there is considerable variation among the states in the type of information protected and the scope of the protections provided. See Georgetown Study, at Executive Summary; Lawrence O. Gostin, Zita Lazzarrini, Kathleen M. Flaherty,\n\nLegislative Survey of State Confidentiality Laws, with Specific Emphasis on HIV and Immunization, Report to Centers for Disease Control, Council of State and Territorial Epidemiologists, and Task Force for Child Survival and Development, Carter Presidential Center (1996) (Gostin Study). Moreover, electronic health data is becoming increasingly ''national''; as more information becomes available in electronic form, it can have value far beyond the immediate community where the patient resides."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 6}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 10)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nity Framework constitute 'recognized security practices' under the statute and can help organizations meet Congressional intent by implementing the guidance contained in this NIST Special Publication.\n10  These may include the Medicare Promoting Interoperability Program, which requires an annual risk assessment to avoid Medicare financial penalties, and forthcoming cyber incident reporting mandates from the Cybersecurity &amp; Infrastructure Security Agency (CISA) as required by the Cyber Incident Reporting for Critical Infrastructure Act of 2022 (CIRCIA). incident resulted in harms to patients. Implementing and improving cybersecurity practices can help regulated entities ensure the safety of patients. ## 2. HIPAA Security Rule\n\nThe HIPAA Security Rule [Sec. Rule] specifically focuses on safeguarding the confidentiality, integrity, and availability of ePHI. The ePHI that a regulated entity creates, receives, maintains, or transmits must be protected against reasonably anticipated threats, hazards, and impermissible uses and/or disclosures. In general, the requirements, standards, and implementation specifications of the Security Rule apply to the following regulated entities:\n\n- Covered Healthcare Providers -Any provider of medical or other health services or supplies who transmits any health information in electronic form in connection with a transaction for which HHS has adopted a standard. - Health Plans -Any individual or group plan that provides or pays the cost of medical care (e.g., a health insurance issuer and the Medicare and Medicaid programs). - Healthcare Clearinghouses -A public or private entity that processes another entity's healthcare transactions from a standard format to a non-standard format or vice versa. - Business Associate -A person or entity 11 that performs certain functions or activities that involve the use or disclosure of protected health information on behalf of or provides services to a covered entity."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 9}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 499)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncare provider means a provider of services (as defined in section 1861(u) of the Act, 42 U.S.C. 1395x(u)), a provider of medical or health services (as defined in section 1861(s) of the Act, 42 U.S.C.\n1395x(s)), and any other person or organization who furnishes, bills, or is paid for health care in the normal course of business. Health information means any information, whether oral or recorded in any form or medium, that:\n\n- (1) Is created or received by a health care provider, health plan, public health authority, employer, life insurer, school or university, or health care clearinghouse; and\n- (2) Relates to the past, present, or future physical or mental health or condition of an individual; the provision of health care to an individual; or the past, present, or future payment for the provision of health care to an individual. Health insurance issuer (as defined in section 2791(b)(2) of the PHS Act, 42 U.S.C. 300gg-91(b)(2) and used in the definition of health plan in this section) means an insurance company, insurance service, or insurance organization (including an HMO) that is licensed to engage in the business of insurance in a State and is subject to State law that regulates insurance. Such term does not include a group health plan. Health maintenance organization (HMO) (as defined in section 2791(b)(3) of the PHS Act, 42 U.S.C. 300gg-91(b)(3) and used in the definition of health plan in this section) means a federally qualified HMO, an organization recognized as an HMO under State law, or a similar organization regulated for solvency under State law in the same manner and to the same extent as such an HMO. Health plan means an individual or group plan that provides, or pays the cost of, medical care (as defined in section 2791(a)(2) of the PHS Act, 42 U.S.C. 300gg-91(a)(2)). - (1) Health plan includes the following, singly or in combination:\n2. (i) A group health plan, as defined in this section."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 498}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 18)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\na specified time frame. 47,48 The FDA has recognized ISO/IEC 29147:2014: Information Technology - Security Techniques - Vulnerability Disclosure that may be a useful resource for manufacturers. ## D.\nRisk Mitigation of Safety and Essential Performance\n\nOnce the preceding information has been assessed and characterized, manufacturers should determine if the risk of patient harm presented by the vulnerability are adequately controlled by existing device features and/or manufacturer defined compensating controls (i.e., residual risk levels are acceptable). Actions taken should reflect the magnitude of the problem and align with the risks encountered. Manufacturers should also include an evaluation of residual risk, benefit/risk, and risk introduced by the remediation. Manufacturers should design their devices to ensure that risks inherent in remediation are properly mitigated including ensuring that the remediation is adequate and validated, that the device designs incorporate mechanisms for secure and timely updates. Changes made for vulnerabilities of controlled risk are generally considered device enhancements, not recalls. Cybersecurity routine updates and patches are generally considered a type of device enhancement. 47 The FDA has recognized ISO/IEC 29147:2014: Information Technology - Security Techniques - Vulnerability Disclosure\n\n48 ISO/IEC 30111:2013: Information Technology - Security Techniques - Vulnerability Handling Processes"}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 17}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 497)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd rule, the Department consulted with representatives of the National Congress of American Indians and the National Indian Health Board, as well as with a representative of the self-governance Tribes.\nDuring the consultation, we discussed issues regarding the application of Title II of HIPAA to the Tribes, and potential variations based on the relationship of each Tribe with the IHS for the purpose of providing health services. Participants raised questions about the status of Tribal laws regarding the privacy of health information. ## List of Subjects\n\n## 45 CFR Part 160\n\nElectronic transactions, Employer benefit plan, Health, Health care, Health facilities, Health insurance, Health records, Medicaid, Medical research, Medicare, Privacy, Reporting and record keeping requirements. ## 45 CFR Part 164\n\nElectronic transactions, Employer benefit plan, Health, Health care, Health facilities, Health insurance, Health records, Medicaid, Medical research, Medicare, Privacy, Reporting and record keeping requirements. Note: to reader: This final rule is one of several proposed and final rules that are being published to implement the Administrative Simplification provisions of the Health Insurance Portability and Accountability Act of 1996. 45 CFR subchapter C consisting of Parts 160 and 162 was added at 65 FR 50365, Aug. 17, 2000. Part 160 consists of general provisions, Part 162 consists of the various administrative simplification regulations relating to transactions and identifiers, and new Part 164 consists of the regulations implementing the security and privacy requirements of the legislation. Dated: December 19, 2000. ## Donna Shalala,\n\nSecretary,\n\nFor the reasons set forth in the preamble, 45 CFR Subtitle A, Subchapter C, is amended as follows:\n\n1. Part 160 is revised to read as follows:\n\n## PART 160-GENERAL ADMINISTRATIVE REQUIREMENTS\n\n## Subpart A-General Provisions\n\n- 160.101 Statutory basis and purpose. - 160.102 Applicability. - 160.103 Definitions."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 496}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 8)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nation is de-identified (as truly anonymous information would be), it is not covered by this rule because it is no longer electronic protected health information (see 45 CFR 164.502(d) and 164.514(a)).\nElectronic protected health information received, created, or maintained by a covered entity, or that is transmitted by covered entities, is covered by the security standards and must be protected. To the extent a researcher is a covered entity, the researcher must comply with these standards with respect to electronic protected health information. Otherwise, the conditions for release of such information to researchers is governed by the Privacy Rule. See, for example, 45 CFR 164.512(i), 164.514(e) and 164.502(d). These standards would not apply to the researchers as such in the latter circumstances. 7. Comment: One commenter asked to what extent individual patients are subject to the standards. For example, some telemedicine practices support the use of diagnostic systems in the patient's home, which can be used to conduct tests and send results to a remote physician. In other cases, patients may be responsible for the filing of insurance claims directly and will need the ability to verify facts, confirm receipt of claims, and so on. The commenter asked if it is the intent of the rule to include electronic transmission to or from the patient. Response: Patients are not covered entities and, thus, are not subject to these standards. With respect to transmissions from covered entities, covered entities must protect electronic protected health information when they transmit that information. See also the discussion of encryption in section III.G. Fmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\nJkt 200001\n\n## C. Transition to the Final Rule\n\nThe proposed rule included definitions for a number of terms that have now already been promulgated as part of the Transactions Rule or the Privacy Rule."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 7}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 3)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ns. Through the hearings, the NCVHS specifically solicited public input on issues related to certain key standards in the Privacy Rule: consent, minimum necessary, marketing, fundraising, and research.\nThe resultant public testimony and subsequent recommendations submitted to the Department by the NCVHS also served to inform the development of these proposed modifications. ## II. Overview of the March 2002 Notice of Proposed Rulemaking (NPRM)\n\nAs described above, through public comments, testimony at public hearings, meetings at the request of industry and other stakeholders, as well as other communications, the Department learned of a number of concerns about the potential unintended effects certain provisions would have on health care quality and access. On March 27, 2002, in response to these concerns, and pursuant to HIPAA's provisions for modifications to the standards, the Department proposed modifications to the Privacy Rule (67 FR 14776). The Department proposed to modify the following areas or provisions of the Privacy Rule: consent; uses and disclosures for treatment, payment, and health care operations; notice of privacy practices; minimum necessary uses and disclosures, and oral communications; business associates; uses and disclosures for marketing; parents as the personal representatives of unemancipated minors; uses and disclosures for research purposes; uses and disclosures for which authorizations are required; and deidentification. In addition to these key areas, the proposal included changes to other provisions where necessary to clarify the Privacy Rule. The Department also included in the proposed Rule a list of technical corrections intended as editorial or typographical corrections to the Privacy Rule."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 2}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 226)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\non that is being combined is from separate insurers or from one entity that has a health component and also provides excepted benefits. See the discussion relating to health care components, §164.504.\nWe note that under the arrangements described above, the final rule provides substantial flexibility to covered entities to provide general data and statistical analyses, resulting in the disclosure of de-identified information, to employers and other customers. An employer also may receive protected health information from a covered entity for any purpose, including those described in comment above, with the authorization of the individual. See §164.508. Comment: A number of commenters asserted that the proposed definition appeared to limit training and educational activities to that of health care professionals, students, and trainees. They asked that we expand the definition to include other educationrelated activities, such as continuing education for providers and training of non-health care professionals as needed for supporting treatment or payment. Response: We agree with the commenters that the definition of health care operations was unnecessarily limiting with respect to educational activities and expand the definition of health care operations to include ''conducting training programs in which students, trainees, or practitioners in areas of health care learn under supervision to practice or improve their skills as health care providers.'' We clarify that medical rounds are considered treatment, not health care operations. Comment: A few commenters outlined the need to include the training of non-health care professionals, such as health data analysts, administrators, and computer programmers within the definition of health care operations. It was argued that, in many cases, these professionals perform functions which support treatment and payment and will need access to protected health information in order to carry out their responsibilities."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 225}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 378)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nentity not relying on the safe harbor may determine that information from which sufficient other identifiers have been removed but which retains birth date or zip code is not reasonably identifiable.\nAs discussed above, such a determination must be made by a person with appropriate knowledge and expertise applying generally accepted statistical and scientific methods for rendering information not identifiable. Although we have determined that all of the specified identifiers must be removed before a covered entity meets the safe harbor requirements, we made modifications in the final rule to the specified identifiers on the list to permit some information about age and geographic area to be retained in deidentified information. For age, we specify that, in most cases, year of birth may be retained, which can be combined with the age of the subject to provide sufficient information about age for most uses. After considering current and evolving practices and consulting with federal experts on this topic, including members of the Confidentiality and Data Access Committee of the Federal\n\n17 Sweeney, L. Guaranteeing Anonymity when Sharing Medical Data, the Datafly System. Masys, D., Ed. Proceedings, American Medical Informatics Association, Nashville, TN: Hanley &amp; Belfus, Inc., 1997:51-55. VerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nCommittee on Statistical Methodology, Office of Management and Budget, we concluded that in general, age is sufficiently broad to be allowed in deidentified information, although all dates that might be directly related to the subject of the information must be removed or aggregated to the level of year to prevent deduction of birth dates. Extreme ages-90 and over-must be aggregated further (to a category of 90+, for example) to avoid identification of very old individuals (because they are relatively rare). This reflects the minimum requirement of the current recommendations of the Bureau of the Census."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 377}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 240)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nred. This limitation would be particularly harmful for information used and disclosed by health care providers, who are likely to maintain a great deal of information never contained in a transaction.\nWe disagree with the arguments that the Secretary lacks legal authority to cover all individually identifiable health information transmitted or maintained by covered entities. The arguments raised by these comments have two component parts: (1) That the Secretary's authority is limited by form, to individually identifiable health information in electronic form only; and (2) that the Secretary's authority is limited by content, to individually identifiable health information that is contained in what commenters generally termed the ''HIPAA transactions,'' i.e., information contained in a transaction for which a standard has been adopted under section 1173(a) of the Act. VerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00159\n\nWith respect to the issue of form, the statutory definition of ''health information'' at section 1171(4) of the Act defines such information as ''any information, whether oral or recorded in any form or medium '' (emphasis added) which is created or received by certain entities and relates to the health condition of an individual or the provision of health care to an individual (emphasis added). ''Individually identifiable health information'', as defined at section 1171(6) of the Act, is information that is created or received by a subset of the entities listed in the definition of ''health information'', relates to the same subjects as ''health information,'' and is, in addition, individually identifiable."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 239}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 70)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nKey activities, descriptions, and sample questions for the Policies and Procedures standard | Key Activities | Description | Sample Questions | |----------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 1."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 69}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 45)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\ntion testing. • Conduct penetration testing (where testers attempt to compromise system security for the sole purpose of testing the effectiveness of security controls), if reasonable and appropriate.\n• Evaluation may include reviewing organizational policies and procedures, assessing the implementation of security | • If available, have staff members with knowledge of IT security been consulted and included in the evaluation team? • Are appropriate personnel notified of planned environmental or operational changes that could affect the security of ePHI? • Is a change management process in place that includes identification and communication of environmental and operational changes that could affect the security of ePHI? • If penetration testing has been determined to be reasonable and appropriate, has specifically worded, written approval from senior management been received for any planned penetration testing? • Has the process been formally communicated to those who have been assigned roles and responsibilities in the evaluation process? • Has the organization explored the use of automated tools to support the evaluation process?"}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 44}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 36)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nces and assets. ## Appendix 3. Submission Documentation for Investigational Device Exemptions\n\nFDA understands the need to balance innovation and security in designs especially during clinical trials.\nIn order to ensure security is addressed early in the device design, FDA has identified a subset of the documentation recommended throughout this guidance to submit with IDE applications. Under 21 CFR 812.25, manufacturers must provide an investigational plan as a part of their IDE application. For investigational devices within the scope of this guidance, FDA recommends that this investigational plan include information on the cybersecurity of the subject device. Specifically, FDA recommends the following documentation be included as part of IDE applications:\n\n- Inclusion of cybersecurity risks as part of informed consent form (21 CFR 50.25(a)(2) and 21 CFR 812.25(g));\n- Global, multi-patient and updateability/patchability views (21 CFR 812.25(c), (d));\n- Security use case views for functionality with safety risks (e.g., implant programming) (21 CFR 812.25(c), (d));\n- Software Bill of Materials (21 CFR 812.25(c), (d)); and\n- General labeling - connectivity and associated general cybersecurity risks, updateability/process (21 CFR 812.25(f)). FDA intends to review this information in the context of the overall benefit-risk assessment of investigational devices as outlined in FDA's guidance 'Factors to Consider When Making Benefit-Risk Determinations for Medical Device Investigational Device Exemptions.' Therefore, approval of an IDE based on the documentation recommended above does not preclude the possibility of future cybersecurity questions or concerns being raised during review of a subsequent marketing application. This is, in part, due to the understanding that design changes may be needed and the temporal nature of cybersecurity."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 35}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 397)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nisclosure of health information, we believe this should be a matter left to each individual and that requiring covered entities to initiate discussions with each individual would be overly burdensome.\nComment: Some commenters suggested that covered entities, particularly health plans, should be permitted to distribute their notice in a newsletter or other communication with individuals. Response: We agree, so long as the notice is sufficiently separate from other important documents. We therefore prohibit covered entities from combining the notice in a single document with either a consent (§ 164.506) or an authorization (§ 164.508), but do not otherwise prohibit covered entities from including the notice in or with other documents the covered entity shares with individuals. Comment: Some comments suggested that covered entities should not be required to respond to requests for the notice from the general public. These comments indicated that the requirement would place an undue burden on covered entities without benefitting individuals. Response: We proposed that the notice be publicly available so that individuals may use the notice to compare covered entities' privacy practices and to select a health plan or health care provider accordingly. We therefore retain the proposed requirement for covered entities to provide the notice to any person who requests a copy, including members of the general public. Comment: Many commenters argued that the distribution requirements for health plans should be less burdensome. Some suggested requiring distribution upon material revision, but not every three years. Some suggested that health plans should only be required to distribute their notice annually or upon re-enrollment. Some suggested that health plans should only have to distribute their notice upon initial enrollment, not re-enrollment. Other commenters supported the proposed approach."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 396}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.404(d)(1)(ii) require?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n§164.404(d)(1)(ii), but provides that such notice be sent to either the individual's next of kin or personal representative, as such term is used for purposes of the Privacy Rule, recognizing that in some cases, a covered entity may have contact information for a personal representative of a deceased individual rather than the next of kin. We believe this conforms to the intent of the statute and improves consistency between this subpart and the Privacy Rule. Under 45 CFR 164.502(g), a ''personal representative'' of a deceased individual is a person who has authority to act on behalf of the de"}], "metadata": {"source": "breach_notification_2009", "cfr_section": "§164.404(d)(1)(ii)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 208)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ning in this subchapter should be construed to diminish the authority of any Inspector General, including the authority provided in the Inspector General Act of 1978. See discussion of § 160.102 above.\n## Medicare and Medicaid\n\nComment: One comment suggested possible inconsistencies between the regulation and Medicare/Medicaid requirements, such as those under the Quality Improvement System for Managed Care. This commenter asked that HHS expand the definition of health care operations to include health promotion activities and avoid potential conflicts. Response: We disagree that the privacy regulation would prohibit managed care plans operating in the Medicare or Medicaid programs from fulfilling their statutory obligations. To the extent a covered entity is required by law to use or disclose protected health information in a particular manner, the covered entity may make such a use or disclosure under §164.512(a). Additionally, quality assessment and improvement activities come within the definition of ''health care operations.'' Therefore, the specific example provided by the commenter would seem to be a permissible use or disclosure under § 164.502, even if it were not a use or disclosure ''required by law.''\n\nComment: One commenter stated that Medicare should not be able to require the disclosure of psychotherapy notes because it would destroy a practitioner's ability to treat patients effectively. Response: If the Title XVIII of the Social Security Act requires the disclosure of psychotherapy notes, the final rule permits, but does not require, a covered entity to make such a disclosure under § 164.512(a). If, however, the Social Security Act does not require such disclosures, Medicare does not have the discretion to require the disclosure of psychotherapy notes as a public policy matter because the final rule provides that covered entities, with limited exceptions, must obtain an individual's authorization before disclosing psychotherapy notes."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 207}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 215)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\no suggested that the Secretary undertake an assessment of ''best practices'' of covered entities and document and promote the findings to serve as a convenient ''road map'' for other covered entities.\nAnother commenter suggested that we work with providers to create implementation guidelines modeled after the interpretative\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nguidelines that HCFA creates for surveyors on the conditions of participation for Medicare and Medicaid contractors. Response: While we have not in the final rule committed the Secretary to any specific model of providing guidance or assistance, we do state our intent, subject to budget and staffing constraints, to develop a technical assistance program that will include the provision of written material when appropriate to assist covered entities in achieving compliance. We will consider other models including HCFA's Medicare and Medicaid interpretative guidelines. Further information regarding the Secretary's technical assistance program may be provided in the Federal Register and on the HHS Office for Civil Rights (OCR) Web Site. While OCR plans to have fully trained staff available to respond to questions, its ability to provide individualized advice in regard to such matters as the appropriateness of a particular disclosure or the sufficiency of compliance activities will be based on staff resources and demands. The idea of looking at ''best practices'' and sharing information with all covered entities is a good one and we will explore how best to do this. We note that a covered entity is not excused from compliance with the regulation because of any failure to receive technical assistance or guidance. ## Basis for Violation Findings and Enforcement\n\nComment: A number of commenters asked that covered entities not be liable for violations of the rule if they have acted in good faith."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 214}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 134)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nif the unsecured protected health information of more than 500 residents of such State or jurisdiction is, or is reasonably believed to have been, accessed, acquired, or disclosed during such breach.\nThis media notice is in addition to, not a substitute for, individual notice. In accordance with the Act, §164.406(b) of the interim final rule required covered entities to notify prominent media outlets without unreasonable delay and in no case later than 60 calendar days after discovery of the breach. Section 164.406(c) of the interim final rule required that the\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with notification to the media include the same information required to be included in the notification to the individual under § 164.404(c). The interim final rule did not define ''prominent media outlet'' because what constitutes a prominent media outlet will differ depending upon the State or jurisdiction affected. For a breach affecting more than 500 individuals across a particular state, a prominent media outlet may be a major, general interest newspaper with a daily circulation throughout the entire state. In contrast, a newspaper serving only one town and distributed on a monthly basis, or a daily newspaper of specialized interest (such as sports or politics) would not be viewed as a prominent media outlet. Where a breach affects more than 500 individuals in a limited jurisdiction, such as a city, then a prominent media outlet may be a major, general-interest newspaper with daily circulation throughout the city, even though the newspaper does not serve the whole State. With regard to the term ''State,'' the existing definition of ''State'' at §160.103 of the HIPAA Rules applies."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 133}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 182)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nese modifications will make the rule easier for covered entities and business associates to implement and will result in consistency of notification across entities which will benefit consumers. ## 3.\nCompound Authorizations for Research Uses and Disclosures\n\nWe proposed to permit compound authorizations for the use or disclosure of protected health information for conditioned and unconditioned research activities provided that the authorization clearly differentiates between the conditioned and unconditioned research components and clearly allows the individual the option to opt in to the unconditioned research activities. We believed that the proposed provision would reduce burden and costs on the research community by eliminating the need for multiple forms for research studies involving both a clinical trial and a related biospecimen banking activity or study and by harmonizing the Privacy Rule's authorization requirements with the informed consent requirements under the Common Rule. This change to the Rule had long been sought by the research community. While we expected burden reduction and cost savings due to these modifications, we had no data which to quantify an estimate of such savings. We requested comment on the anticipated savings that this change would bring to the research community. As explained above, the final rule adopts the proposal to permit compound research authorizations. While almost all commenters on this topic were supportive and agreed that the change would result in reduced burdens and costs due to a reduction in forms and harmonization with the Common Rule, we did not receive significant comment that could inform our quantifying the anticipated costsavings associated with this modification. ## 4."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 181}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 60)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nDetermine the Activities That Will Be Tracked or Audited                        | • Determine the appropriate scope of audit controls that will be necessary in information systems that contain or use ePHI based on the regulated entity's risk assessment and other organizational factors. 120 • Determine what activities need to be captured using the results of the risk assessment and risk management processes. | • Where is ePHI at risk in the organization? 121 • What systems, applications, or processes make ePHI vulnerable to unauthorized or inappropriate tampering, uses, or disclosures? 122 • What activities will be audited (e.g., creating ePHI, accessing ePHI, modifying ePHI, transmitting ePHI, and/or deleting files or records that contain ePHI)? • What should the audit record include (e.g., user responsible for the activity; event type, date, or time)? • Are audit records generated for all systems/devices that create, store, process, or transmit ePHI? |\n| 2. Select the Tools That Will Be Deployed for Auditing and System Activity Reviews | • Evaluate existing system capabilities and determine whether any changes or upgrades are necessary. | • What tools are in place? • What are the most appropriate monitoring tools for the organization (e.g., third-party, freeware, or operating system-provided)? • Are changes/upgrades to information systems reasonable and appropriate? |\n| 3. Develop and Deploy the Information System Activity Review/Audit Policy          | • Document and communicate to the workforce the organization's decisions on audits and reviews. | • Who is responsible for the overall audit process and results? • How often will audits take place? • How often will audit results be analyzed? • What is the organization's sanction policy for employee violations? 123 • Where will audit information reside (e.g., separate server)? |\n\n120  See Sec."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 59}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 343)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd, funeral directors increasingly receive bodies after organ and tissue donation, which has implications for funeral home staff duties associated with embalming. Response: We agree with the commenter.\nIn the final rule, we permit covered entities to disclose protected health information to funeral directors, consistent with applicable law, as necessary to carry out their duties with respect to a decedent. When necessary for funeral directors to carry out their duties, covered entities may disclose protected health information prior to and in reasonable anticipation of the individual's death. Comment: One commenter recommended clarifying in the final rule that it does not restrict law enforcement agencies' release of medical information that many state records laws require to be reported, for example, as part of autopsy reports. The commenter recommended stating that law enforcement officials may independently gather medical information, that such information would not be covered by these rules, and that it would continue to be covered under applicable state and federal access laws. Response: HIPAA does not give HHS statutory authority to regulate law enforcement officials' use or disclosure of protected health information. As stated elsewhere, we continue to support enactment of comprehensive privacy legislation to cover disclosure and use of all individually identifiable health information. Comment: One commenter recommended prohibiting health plans and covered health care providers from disclosing psychotherapy notes to coroners or medical examiners. Response: We disagree with the commenter who asserted that psychotherapy notes should only be used by or disclosed to coroners and medical examiners with authorization. Psychotherapy notes are sometimes needed by coroners and medical examiners to determine cause of death, such as in cases where suicide is suspected as the cause of death."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 342}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 138)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nplan for research purposes without authorization (subject to the requirements of this rule) and one contract specifies that the issuer must always obtain authorizations for these uses and disclosures.\nThe issuer accordingly develops two notices reflecting these different practices and satisfies its distribution requirements by providing the relevant notice to the relevant group health plan participants. We proposed to require covered health care providers with face-to-face contact with individuals to provide the notice to all such individuals at the first service delivery to the individual during the one year period after the compliance date. After this one year period, covered providers with face-to-face contact with individuals would have been required to distribute the notice to all new patients at the first service delivery. Covered providers without face-to-face contact with individuals would have been required to provide the notice in a reasonable period of time following first service delivery. We proposed to require all covered providers to post the notice in a clear and prominent location where it would be reasonable to expect individuals seeking services from the covered provider to be able to read the notice. We would have required revisions to be posted promptly. In the final rule, we vary the distribution requirements according to whether the covered health care provider has a direct treatment\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nrelationship with an individual, rather than whether the covered health care provider has face-to-face contact with an individual. See § 164.501 and the corresponding discussion in this preamble regarding the definition of indirect treatment relationship. Covered health care providers that have direct treatment relationships with individuals must provide the notice to such individuals as of the first service delivery after the compliance date."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 137}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 512)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nher than the requirements of this section, apply only to the health care component(s) of the entity, as specified in this section. (c)(1) Implementation specification: Application of other provisions.\nIn applying a provision of this subpart, other than this section, to a hybrid entity:\n\nJkt 194001\n\nPO 00000\n\n- (i) A reference in such provision to a ''covered entity'' refers to a health care component of the covered entity;\n- (ii) A reference in such provision to a ''health plan,'' ''covered health care provider,'' or ''health care clearinghouse'' refers to a health care component of the covered entity if such health care component performs the functions of a health plan, covered health care provider, or health care clearinghouse, as applicable; and\n\n(iii) A reference in such provision to ''protected health information'' refers to protected health information that is created or received by or on behalf of the health care component of the covered entity. - (2) Implementation specifications: Safeguard requirements. The covered entity that is a hybrid entity must ensure that a health care component of the entity complies with the applicable requirements of this subpart."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 511}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 12)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nss associate, if the acquisition, access, or use was made in good faith, within the course and scope of employment or other professional relationship, and does not result in further use or disclosure.\nWe modified the statutory language to use ''workforce members'' instead of employees. Workforce member is a defined term in 45 CFR 160.103 and means ''employees, volunteers, trainees, and other persons whose conduct, in the performance of work for a covered entity, is under the direct control of such entity, whether or not they are paid by the covered entity.''\n\nA person is acting under the authority of a covered entity or business associate if he or she is acting on its behalf. This may include a workforce member of a covered entity, an employee of a business associate, or even a business associate of a covered entity. Similarly, to determine whether the access, acquisition, or use was made ''within the scope of authority,'' the covered entity or business associate should consider whether the person was acting on its behalf at the time of the inadvertent acquisition, access, or use. Additionally, while the statutory language provides that this exception applies where the recipient does not further use or disclose the information, we have interpreted this exception as encompassing circumstances where the recipient does not further use or disclose the information in a manner not permitted under the Privacy Rule. In circumstances where any further use or disclosure of the information is permissible under the Privacy Rule, we interpret that there is no breach because\n\nVerDate Nov&lt;24&gt;2008\n\nthe security and privacy of the information has not been compromised by any such permissible use or disclosure. To illustrate this exception, we offer the following example. A billing employee receives and opens an e-mail containing protected health information about a patient which a nurse mistakenly sent to the billing employee."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 11}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 112)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nt an\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00074\n\nOHCA may include only professional staff members. ## Final Rule\n\nThe final rule implements the technical, conforming, and clarifying changes as proposed.\nIn response to the comments regarding which entities may participate in an OHCA, we clarify that a covered entity participating in an OHCA or the OHCA itself may contract with a business associate to provide certain functions, activities, or services on its behalf that involve access to protected health information, provided the applicable requirements of §§164.502(e), 164.504(e), 164.308(b) and 164.314(a) are met. Further, the definition of an organized health care arrangement (OHCA) at § 160.103 includes a clinically integrated care setting in which individuals typically receive health care from more than one health care provider. We modified §164.506(c)(5) as discussed above in recognition of the fact that not all participants in a clinically integrated care setting may be covered entities (e.g., hospital with physicians with staff privileges that are not workforce members). Such change does not permit employers and pharmaceutical representatives to receive access to protected health information from or through an OHCA in a manner they would otherwise be prohibited from now. ## V. Modifications to the Breach Notification Rule Under the HITECH Act\n\n## A. Background\n\nSection 13402 of the HITECH Act requires HIPAA covered entities to provide notification to affected individuals and to the Secretary of HHS following the discovery of a breach of unsecured protected health information. In some cases, the Act requires covered entities also to provide notification to the media of breaches."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 111}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 77)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nentity that is creating protected health information for the research may elect to combine the consent required under this section with the research-related authorization required under § 164.508(f).\nFor example, a covered health care provider that provides health care to an individual for research purposes and for non-research purposes must obtain a consent under this section for all of the protected health information it maintains. In addition, it must obtain an authorization in accordance with §164.508(f) which describes how it will use and disclose the protected health information it creates for the research for purposes of treatment, payment, and health care operations. Section 164.506(b)(4) permits the covered entity to satisfy these two requirements with a single document. See § 164.508(f) and the corresponding preamble discussion for a more detailed description of research authorization requirements. Under §164.506(b)(5), individuals may revoke a consent in writing at any time, except to the extent that the covered entity has taken action in reliance on the consent. Upon receipt of the written revocation, the covered entity must stop processing the information for use or disclosure, except to the extent that it has taken action in reliance on the consent. A covered health care provider may refuse, under this rule, to continue to treat an individual that revokes his or her consent. A health plan may disenroll an individual that revokes a consent that was sought in conjunction with the individual's enrollment in the health plan. Covered entities must document and retain any signed consent as required by §164.530(j). ## Section 164.506(c)-Consent Content Requirements\n\nUnder §164.506(c), the consent must be written in plain language. See the preamble discussion regarding notice of privacy practices for a description of plain language requirements. We do not provide a model consent in this rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 76}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 361)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthe National Bioethics Advisory Commission's report, and will modify the provisions for expedited review in the privacy rule if changes are warranted by the Commission's findings and recommendations.\n## Required Signature\n\nComment: A few commenters asserted that the proposed requirement that the written documentation of IRB or privacy board approval be signed by the chair of the IRB or the privacy board was too restrictive. Some commenters recommended that the final rule permit the documentation of IRB or privacy board approval to be signed by persons other than the IRB or privacy board chair, including: (1) Any person authorized to exercise executive authority under IRB's or privacy board's written procedures; (2) the IRB's or privacy board's acting chair or vice chair in the absence of the chair, if permitted by IRB procedures; and (3) the covered entity's privacy official. Response: We agree with the commenters who argued that the final rule should permit the documentation of IRB or privacy board approval to be signed by someone other than the chair of the board. In the final rule, we permit the documentation of alteration or waiver of authorization to be signed by the chair or other member, as designated by the chair of the IRB or privacy board, as applicable. ## Research Use and Disclosure With Authorization\n\nComment: Some commenters, including several industry and\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00239\n\nFmt 4701\n\nSfmt 4700\n\nconsumer groups, argued that the proposed rule would establish a twotiered system for public and private research. Privately funded research conducted with an authorization for the use or disclosure of protected health information would not require IRB or privacy board review, while publically funded research conducted with authorization would require IRB review as required by the Common Rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 360}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the required HIPAA security measures?"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n## Postmarket Management of Cybersecurity in Medical Devices\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on December 28, 2016.\n\nThe draft of this document was issued on January 22, 2016.\n\nFor questions regarding this document, contact Suzanne Schwartz, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5434, Silver Spring, MD 20993-0002, 301-796-6937. For questions regarding this document as applied to devices regulated by CBER, contact the Office of Communication, Outreach and Development in CBER at 1-800-835-4709 or 240-402-8010 or ocod@fda.hhs.gov.\n\n<!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of the Center Director\n\nCenter for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to http://www.regulations.gov . Submit written comments to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2015-D-5105. Comments may not be acted upon by the Agency until the document is next revised or updated.\n\n## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet.  You may also send an e-mail request to CDRH-Guidance@fda.hhs.gov to receive an electronic copy of the guidance.  Please use the document number 1400044 to identify the guidance you are requesting.\n\n## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), by written request, Office of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., Bldg. 71, Room 3128, Silver Spring, MD 209930002, or by calling 1-800-835-4709 or 240-402-8010, by email, ocod@fda.hhs.gov or from the Internet at http://www.fda.gov/BiologicsBloodVaccines/Gui"}], "metadata": {"source": "fda_postmarket_2016", "implementation_spec": "required", "safeguard_types": ["physical", "technical", "administrative"], "type": "implementation"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 101)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrule, disclosures of protected health information related to child abuse continues to be addressed in the paragraph allowing disclosure for public health activities (§ 164.512(b)), as described above.\nBecause HIPAA addresses child abuse specifically in connection with a state's public health activities, we believe it would not be appropriate to include child abuserelated disclosures in this separate paragraph on abuse. State laws continue to apply with respect to child abuse, and the final rule does not in any way interfere with a covered entity's ability to comply with these laws. In the final rule, we address disclosures about other victims of abuse, neglect and domestic violence in §164.512(c) rather than in the law enforcement paragraph. Section 164.512(c) establishes conditions for disclosure of protected health information in cases involving domestic violence other than child abuse ( e.g., spousal abuse), as well as those involving abuse or neglect ( e.g., abuse of nursing home residents or residents of facilities for the mentally retarded). This paragraph addresses reports to law enforcement as well as to other authorized public officials. The provisions of this paragraph supersede the provisions of § 164.512(a) and §164.512(f)(1)(i) to the extent that those provisions address the subject matter of this paragraph. Under the circumstances described below, the final rule allows covered entities to disclose protected health information about an individual whom the covered entity reasonably believes to be a victim of abuse, neglect, or domestic violence. In this paragraph, references to ''individual'' should be construed to mean the individual believed to be the victim. The rule allows such disclosure to any governmental authority authorized by law to receive reports of such abuse, neglect, or domestic violence."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 100}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the technical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\n## Office of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRin: 0991-AB08\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY : Office of the Assistant Secretary for Planning and Evaluation, DHHS. ACTION\n\n: Final rule. SUMMARY : This rule includes standards to protect the privacy of individually identifiable health information. The rules below, which apply to health plans, health care clearinghouses, and certain health care providers, present standards with respect to the rights of individuals who are the subjects of this information, procedures for the exercise of those rights, and the authorized and required uses and disclosures of this information. The use of these standards will improve the efficiency and effectiveness of public and private health programs and health care services by providing enhanced protections for individually identifiable health information. These protections will begin to address growing public concerns that advances in electronic technology and evolution in the health care industry are resulting, or may result, in a substantial erosion of the privacy surrounding individually identifiable health information maintained by health care providers, health plans and their administrative contractors. This rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and\n\nAccountability Act of 1996. DATES : The final rule is effective on February 26, 2001. ## FOR FURTHER INFORMATION CONTACT :\n\nKimberly Coleman, 1-866-OCR-PRIV (1-866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION :\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954."}], "metadata": {"source": "privacy_rule_2000", "safeguard_type": "technical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 316)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd to'' the FDA. The regulation text and preamble list the FDA-related activities for which we believe disclosure of protected health information to private entities without authorization is warranted.\nWe believe it is appropriate to allow disclosure of protected health information without authorization to private entities only: For purposes that the FDA has, in effect, identified as national priorities by issuing regulations or express directions requiring such disclosure; or if such disclosure is necessary for a product recall. For example, we believe it is appropriate to allow covered health care providers to disclose to a medical device manufacturer recalling defective heart valves the names and last known addresses of patients in whom the provider implanted the valves. Thus, in the final rule, we allow covered entities to disclose protected health information to entities subject to FDA jurisdiction for the following activities: To report adverse events (or similar reports with\n\nFrm 00209\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nrespect to food or dietary supplements), product defects or problems (including problems with the use or labeling of a product), or biological product deviations, if the disclosure is made to the person required or directed to report such information to the FDA; to track products if the disclosure is made to a person required or directed by the FDA to track the product; to enable product recalls, repairs, or replacement (including locating and notifying individuals who have received products of product recalls, withdrawals, or other problems); or to conduct post-marketing surveillance to comply with requirements or at the direction of the FDA. The preamble above provides further detail on the meaning of some of the terms in this list."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 315}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 467)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\negulation's requirements appropriate for various types of health care providers; checklists of steps entities will have to take to comply; training materials; and recommended procedures or guidelines.\nThe Department spoke with a number of professional associations, and they confirmed that they would expect to provide such materials for their members at either the federal or state level. Using Faulkner and Gray's Health Data Directory 2000 , we identified 216 associations that would be likely to provide guidance to members. In addition, we assume three organizations (i.e., one for hospitals, health plans, and other health care providers) in each state would also provide some additional services to help covered entities coordinate the requirements of this rule with state laws and requirements. The Department assumed that these associations would each provide 320 hours of legal analysis at $150 per hour, and 640 hours of senior analysts time at $50 per hour. This equals $17.3 million. Hourly rates for legal council are the average billing rate for a staff attorney. 51 The senior analysts rates are based on a salary of $75,000 per year, plus benefits, which was provided by a major professional association. For larger health care entities such as hospitals and health plans, the Department assumed that the complexity of their operations would require them to seek more customized assistance from outside council or consultants. Therefore, the Department assumes that each hospital and health plan (including self-administered, selfinsured health plans) will, on average, require 40 hours of outside assistance. The resulting cost for external policy development is estimated to be $112 million. All covered entities are expected to require some time for internal policy development beyond what is provided by associations or outside consultants. For most non-hospital providers, the external assistance will provide most of the necessary information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 466}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 150)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nof ''family member'' was consistent with GINA's legislative history, which suggests that the term ''family member'' is to be broadly construed to provide the maximum protection against discrimination.\n18 In addition, the Department proposed to include in the definition of ''family member'' nonexhaustive lists of persons who are first-, second-, third-, or fourth-degree relatives. Finally, within the definition of ''family member,'' the Department proposed to refer to the definition of ''dependent'' contained in the implementing regulations at 45 CFR 144.103 rather to the PHSA directly. ## Overview of Public Comments\n\nOne commenter expressed support for including relatives by affinity and by less than full consanguinity, agreeing that this interpretation is consistent with Congressional intent and provides the most privacy protection for individuals. This commenter also was supportive of including non-exhaustive lists of persons who are first-, second-, third-, and fourth-degree relatives to add clarity to the definition. ## Final Rule\n\nAs we received only support with regard to the definition of ''family member,'' the final rule adopts without modification the definition of ''family member'' proposed in the NPRM. This definition also is consistent with the definition found in the implementing regulations for sections 101-103 of GINA and with which compliance is already required by most health plans. ## f. Definition of ''Manifestation or Manifested''\n\n## Proposed Rule\n\nAlthough not separately defined by GINA, the terms ''manifestation'' or ''manifested'' are used in GINA in three important contexts. First, GINA uses the term ''manifestation'' to incorporate ''family medical history'' into the definition of ''genetic information'' by stating that ''genetic information'' includes, with respect to an individual, the manifestation of a disease or disorder in family members of such individual."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 149}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 291)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n12(d); when needed by a coroner or medical examiner, in accordance with §164.512(g)(1); or when needed to avert a serious and imminent threat to health or safety, in accordance with §164.512(j)(1)(i).\nComment: A commenter suggested that we follow the federal regulations governing confidentiality of alcohol and substance abuse records as a model for limited disclosure of psychotherapy notes for audits or evaluations. Under these regulations, a third party payor or a party providing financial assistance may access confidential records for auditing purposes if the party agrees in writing to keep the records secure and destroy any identifying information upon completion of the audit. (42 CFR part 2)\n\nResponse: We agree that the federal regulations concerning alcohol and drug abuse provide a good model for protection of information. However, according to our fact-finding discussions, audit or evaluation should not require access to psychotherapy notes. Protected health information kept in the medical record about an individual should be sufficient for these purposes. The final rule does not require authorization for use or disclosure of psychotherapy notes when needed for oversight of the covered health care provider who created the psychotherapy notes. Comment: A provider organization urged that the disclosure of psychotherapy notes be strictly prohibited except to the extent needed in litigation brought by the client against the mental health professional on the grounds of professional malpractice or disclosure in violation of this section. Response: We agree that psychotherapy notes should be available for the defense of the provider who created the notes when the individual who is the subject of the notes puts the contents of the notes at issue in a legal case. In the final rule, we allow the provider to disclose the notes to his or her lawyer for the purpose of preparing a defense."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 290}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 24)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nese issues in their business associate contracts, we emphasize that we do not intend for this section to interfere with the current relationship between covered entities and their business associates.\nBusiness associates and covered entities will continue to have the flexibility to set forth specific obligations for each party, such as who will provide notice to individuals and when the notification from the business associate to the\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\24AUR2.SGM\n\n24AUR2\n\nJkt 217001\n\nerowe on DSK5CLS3C1PROD with RULES\\_2\n\ncovered entity will be required, following a breach of unsecured protected health information, so long as all required notifications are provided and the other requirements of the interim final rule are met. We encourage the parties to consider which entity is in the best position to provide notice to the individual, which may depend on circumstances, such as the functions the business associate performs on behalf of the covered entity and which entity has the relationship with the individual. We also encourage the parties to ensure the individual does not receive notifications from both the covered entity and the business associate about the same breach, which may be confusing to the individual. Finally, we note that where an entity provides PHRs to customers of a HIPAA covered entity through a business associate arrangement but also provides PHRs directly to the public and a breach of its records occurs, in certain cases, as described in its rule, the FTC will deem compliance with certain provisions of HHS' rule as compliance with FTC's rule. In particular, in such situations, it may be appropriate for the vendor to provide the same breach notice to all its PHR customers since it has a direct relationship with all the affected individuals."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 23}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 183)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nin shorthand in the tests set out at §160.202. Response: We believe that the definition proposed represents a policy that is as clear as is feasible and which can be applied nationally and uniformly.\nAs was noted in the preamble to the proposed rules (at 64 FR 59997), the tests in the proposed definition of ''contrary'' are adopted from the jurisprudence of ''conflict preemption.'' Since preemption is a judicially developed doctrine, it is reasonable to interpret this term as indicating that the statutory analysis should tie in to the analytical formulations employed by the courts. Also, while the court-developed tests may not be as clear as commenters would like, they represent a long-term, thoughtful consideration of the problem of defining when a state/federal conflict exists. They will also, we assume, generally be employed by the courts when conflict issues arise under the rules below. We thus see no practical alternative to the proposed definition and have retained it unchanged. With respect to various suggestions for shorthand versions of the proposed tests, such as the arguably broader term ''inconsistent with,'' we see no operational advantages to such terms. Comment: One comment asked that the Department clarify that if state law is not preempted, then the federal law would not also apply. Response: This comment raises two issues, both of which deserve discussion. First, a state law may not be preempted because there is no conflict with the analogous federal requirement; in such a situation, both laws can, and must, be complied with. We thus do not accept this suggestion, to the extent that it suggests that the federal law would give way in this situation. Second, a state law may also not be preempted because it comes within section 1178(a)(2)(B), section 1178(b), or section 1178(c); in this situation, a contrary federal law would give way."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 182}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 401)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nt for uses and disclosures of protected health information to carry out treatment, payment, and health care operations. See § 164.506 and the corresponding preamble discussion of consent requirements.\nWe note that this rule does not preempt other applicable laws that require a signed notice and does not prohibit a covered entity from requesting an individual to sign the notice. Comment: Some commenters supported requiring covered entities to adhere to their privacy practices, as described in their notice. They argued that the notice is meaningless if a covered entity does not actually have to follow the practices contained in its notice. Other commenters were concerned that the rule would prevent a covered entity from using or disclosing protected health information in otherwise lawful and legitimate ways because of an intentional or inadvertent omission from its published notice. Some of these commenters suggested requiring the notice to include a description of some or all disclosures that are required or permitted by law. Some commenters stated that the adherence requirement should be eliminated because it would generally inhibit covered entities' ability to innovate and would be burdensome. Response: We agree that the value of the notice would be significantly diminished absent a requirement that covered entities adhere to the statements they make in their notices. We therefore retain the requirement for covered entities to adhere to the terms of the notice. See § 164.502(i). Many of these commenters' concerns regarding a covered entity's inability to use or disclose protected health information due to an intentional or inadvertent omission from the notice are addressed in our revisions to the proposed content requirements for the notice."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 400}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 69)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd make without giving rise to a business associate relationship, the business associate is not required to ensure that the restrictions or conditions of the business associate contract are maintained.\nFor example, if a business associate acts as the billing agent of a health care provider, and discloses protected health information on behalf of the hospital to health plans, the business associate has no responsibility with respect to further uses or disclosures by the health plan. In the example above, where a covered entity has a business associate contract with a lawyer, and the lawyer discloses protected health information to an expert witness in preparation for litigation, the lawyer again would have no responsibility under this subpart with respect to uses or disclosures by the expert witness, because such witness is not undertaking the functions, activities or services that the business associate lawyer has agreed to perform. However, if a covered entity contracts with a third party administrator to provide claims management, and the administrator delegates management of the pharmacy benefits to a third party, the business associate third party administrator must ensure that the pharmacy manager abides by the restrictions and conditions in the business associate contract between the covered entity and the third party administrator. We provide in § 164.504(c)(3) several methods other than a business associate\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ncontract that will satisfy the requirement for satisfactory assurances under this section. First, when a government agency is a business associate of another government agency that is a covered entity, we permit memorandum of understanding between the agencies to constitute satisfactory assurance for the purposes of this rule, if the memorandum accomplishes each of the objectives of the business associate contract."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 68}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 308)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\na few comments that misunderstood the provision as addressing disclosures related to deceased individuals. Response: We understand that use of the term next of kin in this section may cause confusion.\nTo promote clarity in the final rule, we eliminate the term ''next of kin,'' as well as the term's proposed definition. In the final rule, we address comments on next of kin and the deceased in the section on\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ndisclosure of protected health information about deceased individuals in § 164.512(g). Comments: A number of commenters expressed concern for the interaction of the proposed section with state laws. Some of these comments interpreted the NPRM's use of the term next of kin as referring to individuals with health care power of attorney and thus they believed that the proposed rule's approach to next of kin was inappropriately informal and in conflict with state law. Others noted that some state laws did not allow health care information to be disclosed to family or friends without consent or other authorization. One commenter said that case law may be evolving toward imposing a more affirmative duty on health care practitioners to inform next of kin in a variety of circumstances. One commenter noted that state laws may not define clearly who is considered to be the next of kin. Response: The intent of this provision was not to interfere with or change current practice regarding health care powers of attorney or the designation of other personal representatives. Such designations are formal, legal actions which give others the ability to exercise the rights of or make treatment decisions related to individuals."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 307}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 68)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|\n| 2.\nContract Must Provide That the Business Associates Enter Into Contracts With Subcontractors to Ensure the Protection of ePHI Implementation Specification (Required) | • In accordance with § 164.308(b)(2), ensure that any subcontractors that create, receive, maintain, or transmit ePHI on behalf of the business associate agree to comply with the applicable requirements of this subpart by entering into a contract or other arrangement that complies with this section. | • Has the business associate identified all of its subcontractors that will create, receive, maintain, or transmit ePHI? • Has the business associate ensured that contracts in accordance with § 164.314 are in place with its subcontractors identified in the previous question? |\n| 3. Contract Must Provide That Business Associates Will Report Security Incidents Implementation Specification (Required)                                                | • Report to the covered entity any security incident of which it becomes aware, including breaches of unsecured PHI as required by § 164.410. • Maintain clear lines of communication between covered entities and business associates regarding the protection of ePHI as per the BAA or contract. • Establish a reporting mechanism and a process for the business associate to use in the event of a security incident or breach. | • Is there a procedure in place for reporting security incidents, including breaches of unsecured PHI by business associates? • Have key business associate staff been identified as points of contact in the event of a security incident or breach? • Does the contract include clear time frames and responsibilities regarding the investigation and reporting of security incidents and breaches? |\n| 4."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 67}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the required HIPAA security measures?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\n## Office of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRin: 0991-AB08\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY : Office of the Assistant Secretary for Planning and Evaluation, DHHS.\n\nACTION\n\n: Final rule.\n\nSUMMARY : This rule includes standards to protect the privacy of individually identifiable health information. The rules below, which apply to health plans, health care clearinghouses, and certain health care providers, present standards with respect to the rights of individuals who are the subjects of this information, procedures for the exercise of those rights, and the authorized and required uses and disclosures of this information.\n\nThe use of these standards will improve the efficiency and effectiveness of public and private health programs and health care services by providing enhanced protections for individually identifiable health information. These protections will begin to address growing public concerns that advances in electronic technology and evolution in the health care industry are resulting, or may result, in a substantial erosion of the privacy surrounding individually identifiable health information maintained by health care providers, health plans and their administrative contractors. This rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and\n\nAccountability Act of 1996.\n\nDATES : The final rule is effective on February 26, 2001.\n\n## FOR FURTHER INFORMATION CONTACT :\n\nKimberly Coleman, 1-866-OCR-PRIV (1-866-627-7748) or TTY 1-866-7884989.\n\n## SUPPLEMENTARY INFORMATION :\n\nAvailability of copies, and electronic access.\n\nCopies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order "}], "metadata": {"source": "privacy_rule_2000", "implementation_spec": "required", "safeguard_types": ["physical", "technical", "administrative"], "type": "implementation"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 298)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nses, but the individual only agrees to the fundraising disclosure, the\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ncovered entity is not permitted to make the marketing disclosure.\n## Prohibition on Conditioning Treatment, Payment, Eligibility, or Enrollment\n\nComment: Many commenters supported the NPRM's prohibition of covered entities from conditioning treatment or payment on the individual's authorization of uses and disclosures. Some commenters requested clarification that employment can be conditioned on an authorization. Some commenters recommended that we eliminate the requirement for covered entities to state on the authorization form that the authorization is not a condition of treatment or payment. Some commenters suggested that we prohibit the provision of anything of value, including employment, from being conditioned on receipt of an authorization. In addition, many commenters argued that patients should not be coerced into signing authorizations for a wide variety of purposes as a condition of obtaining insurance coverage. Some health plans, however, requested clarification that health plan enrollment and eligibility can be conditioned on an authorization. Response: We proposed to prohibit covered entities from conditioning treatment, payment, or enrollment in a health plan on an authorization for the use or disclosure of psychotherapy notes (see proposed § 164.508(a)(3)(iii)). We proposed to prohibit covered entities from conditioning treatment or payment on authorization for the use or disclosure of any other protected health information (see proposed §164.508(a)(2)(iii)). We resolve this inconsistency by clarifying in § 164.508(b)(4) that, with certain exceptions, a covered entity may not condition the provision of treatment, payment, enrollment in a health plan, or eligibility for benefits on an authorization for the use or disclosure of any protected health information, including psychotherapy notes."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 297}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 242)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ned to investigate possible violations of the rule. Some government programs, such as Medicare, are authorized under other law to gain access to certain beneficiary records for administrative purposes.\nHowever, these programs are covered by the rule and its privacy protections apply. Comment: Some commenters asked us to clarify how schools would be treated by the rule. Some of these commenters worried that privacy would be compromised if schools were exempted from the provisions of the final rule. Other commenters thought that school medical records were included in the provisions of the NPRM. Response: We agree with the request for clarification and provide guidance regarding the treatment of medical records in schools in the ''Relationship to Other Federal Laws'' preamble discussion of FERPA, which governs the privacy of education records. Comment: One commenter was concerned that only some information from a medical chart would be included as covered information. The commenter was especially concerned that transcribed material might not be considered covered information. Frm 00160\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nResponse: As stated above, all individually identifiable health information in any form, including transcribed or oral information, maintained or transmitted by a covered entity is covered under the provisions of the final rule. Comment: In response to our solicitation of comments on the scope of the definition of protected health information, many commenters asked us to narrow the scope of the proposed definition to include only information in electronic form. Others asked us to include only information from the HIPAA standard transactions. Response: For the reasons stated by the commenters who asked us to expand the proposed definition, we reject these comments. We reject these approaches for additional reasons, as well."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 241}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 56)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nnd disclose protected health information as necessary for its own management and administration if the business associate agreement permits such activities, or to carry out its legal responsibilities.\nOther than the exceptions for the business associate's management and\n\nVerDate Mar&lt;15&gt;2010\n\nadministration and for data aggregation services relating to the health care operations of the covered entity, the business associate may not use or disclose protected health information in a manner that would not be permissible if done by the covered entity (even if such a use or disclosure is permitted by the business associate agreement). Comment: One commenter suggested requiring subcontractors to return or destroy all protected health information received from or created for a business associate when the contract with the business associate is terminated. Response: The final rule at §164.504(e)(5) does apply the requirements at § 164.504(e)(2) through (4) (which set forth the requirements for agreements between covered entities and their business associates) to agreements between business associates and their subcontractors. This includes §164.504(e)(2)(ii)(J), which requires the business associate to return or destroy all protected health information received from, or created or received on behalf of, the covered entity at the termination of the contract, if feasible. When this requirement is applied to the agreement between the business associate and its business associate subcontractor, the effect is a contractual obligation for the business associate subcontractor to similarly return or destroy protected health information at the termination of the contract, if feasible. Comment: One commenter suggested requiring a business associate to disclose all subcontractors of the business associate to a covered entity within thirty days of the covered entity's request."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 55}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 249)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nh, if the Common Rule's definition of ''research'' is modified in the future, the Department of Health and Human Services will consider whether the definition should also be modified for this subpart.\nComment: Some commenters urged the Department to establish precise definitions for ''health care operations'' and ''research'' to provide clear guidance to covered entities and adequate privacy protections for the subjects of the information whose information is disclosed for these purposes. One commenter supported the definition of ''research'' proposed in the NPRM, but was concerned about the ''crossover'' from data analyses that begin as health care operations but later become ''research'' because the analytical results are of such importance that they should be shared through publication, thereby contributing to generalizable knowledge. To distinguish between the definitions of ''health care operations'' and ''research,'' a few commenters recommended that the rule make this distinction based upon whether the activity is a ''use'' or a ''disclosure.'' These commenters recommend that the ''use'' of protected health information for research without patient authorization should be exempt from the proposed research provisions provided that protected health information was not disclosed in the final analysis, report, or publication. Response: We agree with commenters that at times it may be difficult to distinguish projects that are health operations and projects that are research. We note that this ambiguity exists today, and disagree that we can address this issue with more precise definitions of research and health care operations. Today, the issue is largely one of intent. Under the Common Rule, the ethical and regulatory obligations of the researcher stem from the intent of the activity. We follow that approach\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nhere."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 248}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 143)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthis privacy rule. Therefore, to alleviate this additional regulatory burden, we have exempted these laboratories, or the relevant components of them, from the access requirements of this regulation.\n## Grounds for Denial of Access\n\nIn the NPRM we proposed to permit covered health care providers and health plans to deny an individual access to inspect and copy protected health information about them for five reasons: (1) a licensed health care professional determined the inspection and copying was reasonably likely to endanger the life or physical safety of the individual or another person; (2) the information was about another person (other than a health care provider) and a licensed health care professional determined the inspection and copying was reasonably likely to cause substantial harm to that other person; (3) the information was obtained under a promise of confidentiality from someone other than a health care provider and the inspection and copying was likely to reveal the source of the information; (4) the information was obtained by a covered provider in the course of a clinical trial, the individual agreed to the denial of access in consenting to participate in the trial, and the trial was in progress; and (5) the information was compiled in reasonable anticipation of, or for use in, a legal\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nproceeding. In the NPRM, covered entities would not have been permitted to use these grounds to deny individuals access to protected health information that was also subject to the Privacy Act. In the final rule, we retain all of these grounds for denial, with some modifications. One of the proposed grounds for denial (regarding legal proceedings) is retained as an exception to the right of access. (See discussion above.) We also include additional grounds for denial and create a right for individuals to request review of certain denials."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 142}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 229)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nefore, included in subpart E of part 164 only. We clarify that the requirements in the proposed Security Standards are distinct and separate from the privacy safeguards promulgated in this final rule.\nComment: Several commenters expressed confusion and requested clarification as to what is considered health information or individually identifiable health information for purposes of the rule. For example, one commenter was concerned that information exists in collection agencies, credit bureaus, etc., which could be included under the proposed regulation but may or may not have been originally obtained by a covered entity. The commenter noted that generally this information is not clinical, but it could be inferred from the data that a health care provider provided a person or member of person's family with health care services. The commenter urged the Secretary to define more clearly what and when information is covered. One commenter queried how a nonmedical record keeper could tell when personal information is health information within the meaning of rule, e.g., when a worker asks for a low salt meal in a company cafeteria, when a travel voucher of an employee indicates that the traveler returned from an area that had an outbreak of fever, or when an airline passenger requests a wheel chair. It was suggested that the rule cover health information in the hands of schools, employers, and life insurers only when they receive individually identifiable health information from a covered entity or when they create it while providing treatment or making payment. Response: This rule applies only to individually identifiable health information that is held by a covered entity. Credit bureaus, airlines, schools, and life insurers are not covered entities, so the information described in the above comments is not protected health information. Similarly, employers are not covered entities under the rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 228}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 4)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\n|\n| B. | B. | Devices Subject to Section 524B of the FD&C Act ......................................................\n| 31                                                                                                                                                                                                                        |\n| C. | C. | Documentation Recommendations to Comply with Section 524B of the FD&C Act... | 32                                                                                                                                                                                                                        |\n| 1. | 1. | Plans and Procedures (Section 524B(b)(1)) ............................................................... | 32                                                                                                                                                                                                                        |\n| 2. Design, Develop, and Maintain Processes and Procedures to Provide a Reasonable Assurance of Cybersecurity (Section 524B(b)(2)) ............................................................... | 2. Design, Develop, and Maintain Processes and Procedures to Provide a Reasonable Assurance of Cybersecurity (Section 524B(b)(2)) ............................................................... | 2. Design, Develop, and Maintain Processes and Procedures to Provide a Reasonable Assurance of Cybersecurity (Section 524B(b)(2)) ............................................................... | 34                                                                                                                                                                                                                        |\n\n## Contains Nonbinding Recommendations\n\n| 3."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 3}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 117)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nducted in such a manner that only de-identified protected health information is recorded by the researchers and the protected health information is not removed from the premises of the covered entity.\nFor such uses and disclosures of protected health information, the final rule requires that the covered entity obtain from the researcher representations that use or disclosure is sought solely to review protected health information as necessary to prepare a research protocol or for similar purposes preparatory to research, no protected health information is to be removed from the covered entity by the researcher in the course of the review, and the protected health information for which use or access is sought is necessary for the research purposes. The intent of this provision is to permit covered entities to use and disclose protected health information to assist in the development of a research hypothesis and aid in the recruitment of research participants. We understand that researchers sometimes require access to protected health information to develop a research protocol, and to determine whether a specific covered entity has protected health information of prospective research participants that would meet the eligibility criteria for enrollment into a research study. Therefore, this provision permits covered entities to use and disclose protected health information for these preliminary research activities without individual authorization and without documentation that an IRB or privacy\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00077\n\nboard has altered or waived individual authorization. ## Research on Protected Health Information of the Deceased\n\nThe NPRM would have permitted the use and disclosure of protected health information of deceased persons for research without the authorization of a legal representative, and without the requirement for written documentation of IRB or privacy board approval in proposed §164.510(j)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 116}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 6)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nd rule. Commenters stated that they could not, or did not wish to, adopt various security measures suggested in examples. Other commenters asked that we include additional options within the examples.\nSome commenters referred specifically to the example provided in the proposed rule demonstrating how a small or rural provider might comply with the standards. One commenter asked for clarification that the examples are not mandatory measures that are required to demonstrate compliance, but are merely meant as a guide when implementing the security standards. Another commenter expressed support for the use of examples to clarify the intent of text descriptions. Response: We wish to clarify that examples are used only as illustrations of possible approaches, and are included to serve as a springboard for ideas. The steps that a covered entity will actually need to take to comply with these regulations will be dependent upon its own particular environment and circumstances and risk assessment. The examples do not describe mandatory measures, nor do they represent the only, or even the best, way of achieving compliance. The most appropriate means of compliance for any covered entity can only be determined by that entity assessing its own risks and deciding upon the measures that would best mitigate those risks. ## B. Applicability (§ 164.302)\n\nWe proposed that the security standards would apply to health plans, health care clearinghouses, and to health care providers that maintain or transmit health information electronically. The proposed security standards would apply to all electronic health information maintained or transmitted, regardless of format (standard transaction or a proprietary format). No distinction would be made between internal corporate entity communication or communication\n\n17:54 Feb 19, 2003\n\nPO 00000\n\nFrm 00005\n\nexternal to the corporate entity."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 5}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 140)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nout whether an impermissible use or disclosure is a breach that requires notification. These commenters asked if both parties must be in agreement before breach notification obligations are triggered.\nResponse: The covered entity is ultimately responsible for providing individuals with notification of breaches and, as indicated above, the clock for notifying individuals of breaches begins upon knowledge of the incident, even if it is not yet clear whether the incident qualifies as a breach for purposes of this rule. Further, this final rule clarifies that the default presumption is that an impermissible use or disclosure is a breach unless it can be determined through a risk assessment that there is a low probability that the data may be compromised. This standard should allow for more uniform application of the risk assessment approach across covered entities and business associates. Comment: One commenter stated that the requirement that a business\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with associate notify a covered entity of a breach of unsecured protected health information is duplicative of a business associate's other obligations to notify the covered entity of privacy violations and security incidents. Response: Business associates are required to report to covered entities any security incidents or uses or disclosures of protected health information not provided for by their business associate agreements, which include but are broader than breaches of unsecured protected health information under this Rule. For example, a security incident need not lead to unauthorized access to protected health information (and thus, is not a breach) but is still an event that should be reported to the covered entity."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 139}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 43)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nprovider, we proposed to continue to allow subsidized treatment communications, but conditioned on providing the individual with notice and an opportunity to opt out of receiving such communications.\nSpecifically, to ensure the individual is aware that he or she may receive subsidized treatment communications from his or her provider and has the opportunity to elect not to receive them, the proposed rule would have required at § 164.514(f)(2) that: (1) The covered health care provider's notice of privacy practices include a statement informing individuals that the provider may send treatment communications to the individual concerning treatment alternatives or other health-related products or services where the provider receives financial remuneration from a third party in exchange for making the communication, and the individual has a right to opt out of receiving such communications; and (2) the treatment communication itself disclose the fact of remuneration and provide the individual with a clear and conspicuous opportunity to elect not to receive any further such communications. We requested comment on how the opt out should apply to future subsidized treatment communications (i.e., should the opt out prevent all future subsidized treatment communications by the provider or just those dealing with the particular product or service described in the current communication?). We also requested comment on the workability of requiring health care providers that intend to send subsidized treatment communications to individuals to provide an individual with the opportunity to opt out of receiving such communications prior to the individual receiving the first communication and what mechanisms\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with could be put into place to implement such a requirement."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 42}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 31)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ne made by a health care professional, who is accustomed to exercising professional judgment. A health plan may also exercise such discretion if the decision is made by a licensed health care provider.\nThe Department takes no position on the ability of a minor to consent to treatment and no position on how State or other law affects privacy between the minor and parent. Where State or other law is unclear, covered entities should continue to conduct the same analysis of such law as they do now to determine if access is permissible or not. Because the Privacy Rule defers to State and other law in the area of parents and minors, the Department assumes that the current practices of health care providers with respect to access by parents and confidentiality of minor's records are consistent with State and other applicable law, and, therefore, can continue under the Privacy Rule. Parental access under this section would continue to be subject to any limitations on activities of a personal representative in § 164.502(g)(5) and §164.524(a)(2) and (3). In cases in which the parent is not the personal representative of the minor and State or other law does not require parental access, this provision does not provide a parent a right to demand access and does not require a covered entity to provide access to a parent. Furthermore, nothing in these modifications shall affect whether or not a minor would have a right to access his or her records. That is, a covered entity's exercise of discretion to not grant a parent access does not affect the right of access the minor may have under the Privacy Rule. A covered entity may deny a parent access in accordance with State or other law and may be required to provide access to the minor under the Privacy Rule."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 30}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 34)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nhave read or otherwise retained the information, then providing the patient report to the wrong patient does not constitute a breach. (2) How Many Breaches Occur and How Many Individuals Are Affected?\nThe sources for identifying the number of HIPAA covered entity breaches and the number of individuals are limited to State health agencies and one database maintained by a nonprofit organization. There is no national registry of data breaches that captures all data breaches. Thus, we have to rely on the few sources available to us and accept that each source has specific limitations. Essentially, we examined three sources and methods for estimating the number of breaches and then attempted to apply them to the universe of HIPAA covered entities and their business associates. On April 20, 2009, the FTC published a proposed rule that would implement section 13407 of ARRA (74 FR 17914) and that applies to entities that are not HIPAA covered entities but which may retain, accept, and process personal health information in the form of personal health records. Examples of the kind of entities to which the FTC rule applies are web-based organizations that will receive, store, and maintain an individual's health information for that individual. The FTC estimated there are 900 such entities. To arrive at an estimate of the number of breaches per year that would occur to personal health records that these entities retain, the FTC examined a general database of breaches from 2002 to 2007. They identified 246 breaches occurring within the 5-year period for businesses. Averaging the number of breaches over the 5-year period equals 50 breaches per year. FTC next identified 418,713 retail businesses with revenues of $1 million or more per year."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 33}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 23)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nstating that it may not be applicable or even appropriate in all circumstances and should be so qualified or posed as guidelines. A number of commenters stated that the requirement should be deleted.\nOne commenter stated that much of the material covered under the ''Termination procedures'' requirement is already covered in ''Information access control.'' A number of commenters stated that this requirement\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\nJkt 200001\n\nwas too detailed and some of the requirements excessive. Response: Based upon the comments received, we agree that termination procedures should not be a separate standard; however, consideration of termination procedures remains relevant for any covered entity with employees, because of the risks associated with the potential for unauthorized acts by former employees, such as acts of retribution or use of proprietary information for personal gain. We further agree with the reasoning of the commenters who asked that these procedures be made optional; therefore, ''Termination procedures'' is now reflected in this final rule as an addressable implementation specification. We also removed reference to all specific termination activities, for example, changing locks, because, although the activities may be considered appropriate for some covered entities, they may not be reasonable for others. f. Comment: One commenter asked whether human resource employee termination policies and procedures must be documented to show the types of security breaches that would result in termination. Response: Policies and procedures implemented to adhere to this standard must be documented (see § 164.316 below). The purpose of termination procedure documentation under this implementation specification is not to detail when or under which circumstances an employee should be terminated. This information would more appropriately be part of the entity's sanction policy."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 22}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 269)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nth plan, adheres to the health plan requirements) and uses or discloses protected health information of individuals who receive limited functions from the component only for the appropriate functions.\nSee §§164.504(c)(2) and 164.504(g). For example, a covered entity that includes both a hospital and a health plan may not use protected health information obtained from an individual's hospitalization for the health plan, unless the individual is also enrolled in the health plan. We note that covered entities are permitted to make a disclosure to a health care provider for treatment of an individual without restrictions. Comment: One commenter stated that multiple health care components of a single organization should be able to be treated as a single component entity for the purposes of this rule. Under this approach, they argued, one set of policies and procedures would govern the entire component and protected health information could be shared among components without authorization. Similarly, other commenters stated that corporate subsidiaries and affiliated entities should not be treated as separate covered entities. Response: We agree that some efficiencies may result from designating multiple component entities as a single covered entity. In the final rule we allow legally distinct covered entities that share common ownership or control to designate themselves or their health care components as a single covered entity. See § 164.504(d). Common ownership is defined as an ownership or equity interest of five percent or more. Common control exists if an entity has the power-directly or indirectly-to significantly influence or direct the actions or policies of another entity. If the affiliated entity contains health care components, it must implement safeguards to prevent the\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nlarger entity from using protected health information maintained by the component entity."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 268}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.508(a)(3)(i) require?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n§164.508(a)(3)(i). However, a covered entity must obtain prior written authorization from an individual to send communications to the individual about non-health related products or services or to give or sell the individual's protected health information to a third party for marketing. Still, concerns have remained about the ability under these provisions for a third party to pay a covered entity to send health-related communications to an individual about the third party's products or services.\n\nSection 13406(a) of the HITECH Act limits the health-related communications that may be considere"}], "metadata": {"source": "hitech_omnibus_2013", "cfr_section": "§164.508(a)(3)(i)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 280)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nwe have taken in the final rule recognizes the special relationship between plan sponsors and group health plans, including group health plans that provide benefits through a self-insured arrangement.\nThe final rule allows plan sponsors and employees of plan sponsors access to protected health information for purposes of plan administration. The group health plan is bound by the permitted uses and disclosures of the regulation, but may disclose protected health information to plan sponsors under certain circumstances. To the extent that group health plans do not provide health benefits through an insurance contract, they are required to establish a privacy officer and provide training to employees who have access to protected health information, as well as meet the other applicable requirements of the regulation. Comment: Some commenters supported our position not to require individual consent for employers to have access to protected health information for purposes of treatment, payment, and health care operations. For employer sponsored insurance to continue to exist as it does today, the commenters stressed, this policy is essential. Other commenters encouraged the Department to amend the regulation to require authorization for disclosure of information to employers. These commenters stressed that because the employer was not a covered entity, individual consent is the only way to prohibit potential abuses of information. Response: In the final regulation, we maintain the position in the proposed rule that a health plan, including a group health plan, need not obtain individual consent for use and disclosure of protected health information for treatment, payment and or health care operations purposes. However, we impose conditions (described above) for making such disclosures to the plan sponsor. Because employees of the plan sponsor often perform health care operations and payment (e.g."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 279}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the technical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n## Postmarket Management of Cybersecurity in Medical Devices\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on December 28, 2016. The draft of this document was issued on January 22, 2016. For questions regarding this document, contact Suzanne Schwartz, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5434, Silver Spring, MD 20993-0002, 301-796-6937. For questions regarding this document as applied to devices regulated by CBER, contact the Office of Communication, Outreach and Development in CBER at 1-800-835-4709 or 240-402-8010 or ocod@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of the Center Director\n\nCenter for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to http://www.regulations.gov . Submit written comments to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2015-D-5105. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an e-mail request to CDRH-Guidance@fda.hhs.gov to receive an electronic copy of the guidance. Please use the document number 1400044 to identify the guidance you are requesting. ## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), by written request, Office of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., Bldg."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_type": "technical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 241)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nered covered information, i.e., faxes, voice mail messages, etc. A subset of these commenters took issue particularly with the inclusion of oral communications within the scope of covered information.\nThe commenters argued that covering information when it takes oral form (e.g., verbal discussions of a submitted claim) makes the regulation extremely costly and burdensome, and even impossible to administer. Another commenter also offered that it would make it nearly impossible to discuss health information over the phone, as the covered entity cannot verify that the person on the other end is in fact who he or she claims to be. Response: We disagree. Covering oral communications is an important part of keeping individually identifiable health information private. If the final rule were not to cover oral communication, a conversation about a person's protected health information could be shared with anyone. Therefore, the same protections afforded to paper and electronically based information must apply to verbal communication as well. Moreover, the Congress explicitly included ''oral'' information in the statutory definition of health information. Comment: A few commenters supported, without any change, the approach proposed in the NPRM to limit the scope of covered information to individually identifiable health information in any form once the information is transmitted or maintained electronically. These commenters asserted that our statutory authority limited us accordingly. Therefore, they believed we had proposed protections to the extent possible within the bounds of our statutory authority and could not expand the scope of such protections without new legislative authority. Response: We disagree with these commenters regarding the limitations under our statutory authority. As explained above, we have the authority to extend the scope of the regulation as we have done in the final rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 240}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 412)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n: 28DER2\n\nSfmt 4700\n\nResponse: While we agree that in the vast majority of instances individuals should have access to information about them, we cannot agree that a blanket rule would be appropriate.\nFor example, where a professional familiar with the particular circumstances believes that providing such access is likely to endanger a person's life or physical safety, or where granting such access would violate the privacy of other individuals, the benefits of allowing access may not outweigh the harm. Similarly, we allow denial of access where disclosure would reveal the source of confidential information because we do not want to interfere with a covered entity's ability to maintain implicit or explicit promises of confidence. We create narrow exceptions to the rule of open access, and we expect covered entities to employ these exceptions rarely, if at all. Moreover, we require covered entities to provide access to any protected health information requested after excluding only the information that is subject to a denial. The categories of permissible denials are not mandatory, but are a means of preserving the flexibility and judgment of covered entities under appropriate circumstances. Comment: Many commenters supported our proposal to allow covered entities to deny an individual access to protected health information if a professional determines either that such access is likely to endanger the life or physical safety of a person or, if the information is about another person, access is reasonably likely to cause substantial harm to such person. Some commenters requested that the rule also permit covered entities to deny a request if access might be reasonably likely to cause psychological or mental harm, or emotional distress. Other commenters, however, were particularly concerned about access to mental health information, stating that the lack of access creates resentment and distrust in patients."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 411}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 276)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nay choose to treat the employee of the vendor as a member of the covered entity's workforce, rather than as a business associate. See the preamble discussion to the definition of workforce, § 160.103.\nWith regard to medical device manufacturers, we clarify that a device manufacturer that provides ''health care'' consistent with the rule's definition, including being a ''supplier'' under the Medicare program, is a health care provider under the final rule. We do not require a business associate contract when protected health information is shared among health care providers for treatment purposes. However, a device manufacturer that does not provide ''health care'' must be a business associate of a covered entity if that manufacturer receives or creates protected health information in the performance of functions or activities on behalf of, or the provision of specified services to, a covered entity. As to financial institutions, they are business associates under this rule when they conduct activities that cause them to meet the definition of business associate. See the preamble discussion of the definition of ''payment'' in §164.501, for an explanation of activities of a financial institution that do not require it to have a business associated contract. Disease managers may be health care providers or health plans, if they otherwise meet the respective definitions and perform disease management activities on their own behalf. However, such persons may also be business associates if they perform disease management functions or services for a covered entity."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 275}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 372)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n164.510(f)), would have allowed covered entities to disclose protected health information for national security, intelligence, and Presidential protective activities only to law enforcement officials.\nWe recognize that many officials authorized by law to carry out intelligence, national security, and\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00246\n\nPresidential protective functions are not law enforcement officials. Therefore, the final rule allows covered entities to disclose protected health information pursuant to this provision not only to law enforcement officials, but to all federal officials authorized by law to carry out the relevant activities. In addition, we remove this provision from the law enforcement section and include it in § 164.512(k) on uses and disclosures for specialized government functions\n\n## Medical Suitability Determinations\n\nComment: A few comments opposed the NPRM's provision allowing the Department of State to use protected health information for medical clearance determinations. These commenters believed that the scope of permissible disclosures under the proposed provision was too broad. While acknowledging that the Department may have legitimate needs for access to protected health data, the commenters believed that implementation of the proposed provision would not have provided adequate procedural safeguards for the affected State Department employees. A few comments said that the State Department should be able to obtain protected health information for medical clearance determinations only with authorization. A few comments also said that the Department should be able to disclose such information only when required for national security purposes. Some commenters believed that the State Department should be subject to the Federal Register notice requirement that the NPRM would have applied to the Department of Defense."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 371}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 125)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nuidelines, renders protected health information unusable, unreadable, or indecipherable to unauthorized individuals such that notification is not required in the event of a breach of such information.\n## Overview of Public Comments\n\nWhile we received a number of technical and other comments on the guidance, we did not receive any comments on the language of the above definition itself. We intend to address the comments on the guidance in our next update to the guidance. ## Final Rule\n\nThe final rule modifies the interim final rule's definition of ''unsecured protected health information'' to replace the term ''unauthorized individuals'' in the definition with ''unauthorized persons.'' The term ''individual'' is defined in § 160.103 to mean the person who is the subject of the protected health information, which is not what is intended with the reference to ''individual'' in the definition of ''unsecured protected health information.'' Accordingly, the final rule uses more appropriately the term ''unauthorized persons.'' The final rule also modifies the definition to remove the term ''on the HHS Web site'' as unnecessary language. While we remove the reference to the HHS Web site from the regulatory text, we do plan to continue to post updates to the guidance on the Web site as they are issued. ## 2. Section 164.404-Notification to Individuals\n\n## Interim Final Rule\n\nSection 13402(a) of the Act provides that a covered entity that accesses, maintains, retains, modifies, records, stores, destroys, or otherwise holds, uses, or discloses unsecured protected health information shall, in the case of a breach of such information that is discovered by the covered entity, notify\n\nVerDate Mar&lt;15&gt;2010\n\neach affected individual whose unsecured protected health information has been, or is reasonably believed by the covered entity to have been, accessed, acquired, or disclosed as a result of such breach."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 124}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 11)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n. Uses and disclosures of limited data sets that include this information continue to be permissible under the Privacy Rule if the applicable requirements, such as a data use agreement, are satisfied.\nFurther, we note that a covered entity or business associate is not responsible for a breach by a third party to whom it permissibly disclosed protected health information, including limited data sets, unless the third party received the information in its role as an agent of the covered entity or business associate. To the extent that a third party recipient of the information is itself a covered entity, and the information is breached while at the third party (i.e., used or disclosed in an impermissible manner and in a manner determined to compromise the privacy or security of the information), then the third party will be responsible for complying with the provisions of\n\n15:01 Aug 21, 2009\n\nPO 00000\n\nFrm 00008\n\nthis interim final rule. In cases where a covered entity is the recipient of a limited data set pursuant to § 164.514(e) of the Privacy Rule and it is unable to re-identify the individuals after a breach occurs, it may satisfy the requirements of § 164.404 without re-identifying the information, by providing substitute notice to the individuals as required by paragraph (d)(2) of that section. We note that the discussion above regarding ''limited data sets'' applies to any protected health information that excludes the 16 direct identifiers listed at § 164.514(e)(2), regardless of whether the information is used for health care operations, public health, or research purposes (see § 164.514(e)(3)(i)), and is subject to a data use agreement under §164.514(e) of the Privacy Rule."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 10}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 75)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nuired to obtain the patient's consent to use protected health information about the patient for the consultation. These covered providers are, however, permitted to obtain consent, as described below.\nSecond, covered health care providers that create or receive protected health information in the course of providing health care to inmates of a correctional institution are not required to obtain the inmate's consent prior to using or disclosing protected health information about the inmate to carry out treatment, payment, and health care operations. See § 164.501 and the corresponding preamble discussion regarding the definitions of ''correctional institution'' and ''inmate.'' These providers may use and disclose protected health information as otherwise permitted under the rule. These providers are permitted, however, to obtain consent, as described below. In addition, we permit covered health care providers to use and disclose protected health information, without consent, to carry out treatment, payment, and health care operations, if the protected health information was created or received in certain treatment situations. In the treatment situations described in § 164.506(a)(3) and immediately below, the covered health care provider must attempt to obtain the individual's consent. If the covered provider is unable to obtain consent, but documents the attempt and the reason consent was not obtained, the covered provider may, without consent, use and disclose the protected health information resulting from the treatment as otherwise permitted under the rule. All other protected health information about that individual that the covered health care provider creates or receives, however, is subject to the consent requirements. This exception to the consent requirement applies to protected health information created or received in any of three treatment situations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 74}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 35)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nof the organization, such a modification is not necessary. Additionally, several commenters stated that requiring a hybrid entity to include business associate departments is excessive and burdensome.\nSome of these commenters further stated that business associate departments of a hybrid entity will likely commit limited time, personnel, and staff hours to Privacy and Security Rule compliance and suggested that the hybrid entity should implement applicable entitywide policies and procedures and separately ensure that business associate departments implement specific practices scaled to the business associate's use or disclosure of protected health information. In contrast, several commenters supported the proposed change. Several of these commenters suggested that the modification would better facilitate compliance, because requiring the covered entity to include the business associate department in the health care component would better protect the protected health information held by the business associate and would ensure consistent standards within the health care component of the covered entity. ## Final Rule\n\nMany covered entities perform both covered and non-covered functions as part of their business operations. For such covered entities, the entire entity is generally required to comply with the Privacy Rule. However, the hybrid entity provisions of the HIPAA Rules permit the entity to limit the application of the Rules to the entity's components that perform functions that would make the component a ''covered entity'' if the component were a separate legal entity. Specifically, this provision allows an entity to designate a health care component by documenting the components of its organization that perform covered entity functions."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 34}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 7)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nubpart, although such a violation may lead to a use or disclosure of protected health information that is not permitted under the Privacy Rule and thus, may potentially be a breach under this subpart.\nThe Act does not define the terms ''acquisition'' and ''access.'' Several commenters asked that we define or identify the differences between acquisition, access, use, and disclosure of protected health information, for purposes of the definition of ''breach.'' We interpret ''acquisition'' and ''access'' to information based on their plain meanings and believe that both terms are encompassed within the current definitions of ''use'' and ''disclosure'' in the HIPAA Rules. Accordingly, we have not added separate definitions for these terms. We have retained the statutory terms in the regulation in order to maintain consistency with the statute. In addition, we note that while the HIPAA Security Rule at § 164.304 includes a definition of the term ''access,'' such definition is limited to the ability to use ''system resources'' and not to access to information more generally and thus, we have revised that definition to make clear that it does not apply for purposes of these breach notification rules. For an acquisition, access, use, or disclosure of protected health information to constitute a breach, it must constitute a violation of the Privacy Rule. Therefore, one of the first steps in determining whether notification is necessary under this subpart is to determine whether a use or disclosure violates the Privacy Rule. We note that uses or disclosures that impermissibly involve more than the minimum necessary information, in violation of §§ 164.502(b) and 164.514(d), may qualify as breaches under this subpart."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 6}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 32)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nencryption technology out paces health IT adoption, we can predict fewer\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\24AUR2.SGM\n\n24AUR2\n\nerowe on DSK5CLS3C1PROD with RULES\\_2\n\nreportable breaches under this rule.\nGiven the state of flux, however, we believe the most prudent analysis is to simply rely on the historical data at hand. ## a. Affected Entities\n\nSection 13402 of the Act applies to HIPAA covered entities that are health care providers, health plans, or clearinghouses and their business associates that access, maintain, retain, modify, record, store, destroy, or otherwise hold, use, or disclose unsecured protected health information. Based on 2006 data from the Office of Advocacy, Small Business Administration there are 605,845 health care entities, 4,567 health insurance plans and third party administrators. The Centers for Medicare &amp; Medicaid Services report 107,567 durable medical equipment and prosthetic suppliers, and the National Association of Chain Drug Stores reports 88,396 pharmacies. In addition, we estimate that each covered entity has contractual arrangements with three business associates as defined under our regulations at 45 CFR 160.103. It should be noted, however, that many of the same business associates contract or have arrangements with many different HIPAA covered entities. To the extent that this occurs, the total number of business associates will be overstated. Since we do not know the extent of duplication among business associates, we cannot estimate\n\nthe number of business associates affected by this rule. However, we can estimate that approximately 0.9 million HIPAA covered entities will be subject to the interim final rule. Table 2 presents the number of HIPAA covered entities. However, as noted, only the number of HIPAA covered entities is well established. It is possible the number of affected business associates could be small if a few firms contracted with many HIPAA entities."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 31}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 323)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthe rule runs afoul of state judicial procedures for enforcement of subpoenas that require judicial involvement only when a party seeks to enforce a subpoena. Response: We disagree with this comment.\nThe final rule permits covered entities to disclose protected health information for any judicial or administrative procedure in response to a subpoena, discovery request, or other lawful process if the covered entity has received satisfactory assurances that the party seeking the disclosure has made reasonable efforts to ensure that the individual has been given notice of the request or has made reasonable efforts to secure a qualified protective order from a court or administrative tribunal. A covered entity may disclose protected health information in response to a subpoena, discovery request, or other lawful process without a satisfactory assurance if it has made reasonable efforts to provide the individual with such notice or to seek a qualified protected order itself. These rules do not require covered entities or parties seeking the disclosure of protected health information to involve the judiciary; they may choose the notification option rather than seeking a qualified protective order. Many states have already enacted laws that incorporate these concepts. In California, for instance, an individual must be given ten days notice that his or her medical records are being subpoenaed from a health care provider and state law requires that the party seeking the records furnishes the health care provider with proof that the notice was given to the individual. In Montana, a party seeking discovery or compulsory process of medical records must give notice to the individual at least ten days in advance of serving the request on a health care provider, Service of the request must be accompanied by written certification that the procedure has been followed."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 322}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 80)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nhe data use agreement whenever the HMAC is used. Comment: One commenter requested that HHS update the safe harbor deidentification standard with prohibited 3-digit zip codes based on 2000 Census data.\nResponse: The Department stated in the preamble to the December 2000 Privacy Rule that it would monitor such data and the associated re-identification risks and adjust the safe harbor as necessary. Accordingly, the Department provides such updated information in response to the above comment. The Department notes that these three-digit zip codes are based on the five-digit zip Code Tabulation Areas created by the Census Bureau for the 2000 Census. This new methodology also is briefly described below, as it will likely be of interest to all users of data tabulated by zip code. The Census Bureau will not be producing data files containing U.S. Postal Service zip codes either as part of the Census 2000 product series or as a post Census 2000 product. However, due to the public's interest in having statistics tabulated by zip code, the Census Bureau has created a new statistical area called the Zip Code Tabulation Area (ZCTA) for Census 2000. The ZCTAs were designed to overcome the operational difficulties of creating a well-defined zip code area by using Census blocks (and the addresses found in them) as the basis for the ZCTAs. In the past, there has been no correlation between zip codes and Census Bureau geography. Zip codes can cross State, place, county, census tract, block group and census block boundaries. The geographic entities the Census Bureau uses to tabulate data are relatively stable over time. For instance, census tracts are only defined every ten years. In contrast, zip codes can change more frequently."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 79}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 68)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n|\n| Assigned Security Responsibility .............. Workforce Security ....................................\n| 164.308(a)(2) 164.308(a)(3)         | Information System Activity Review (R) (R) Authorization and/or Supervision (A) Workforce Clearance Procedure                                                           |\n| Information Access Management ............. | 164.308(a)(4)                       | Termination Procedures (A) Isolating Health care Clearinghouse Function (R) Access Authorization (A)                                                                    |\n| Security Awareness and Training ............. | 164.308(a)(5)                       | Security Reminders (A) Protection from Malicious Software (A) Log-in Monitoring (A)                                                                                     |\n| Security Incident Procedures .................... Contingency Plan ...................................... | 164.308(a)(6) 164.308(a)(7)         | Password Management (A) Response and Reporting (R) Data Backup Plan (R) Disaster Recovery Plan (R) Emergency Mode Operation Plan (R) Testing and Revision Procedure (A) |\n| Evaluation ................................................. Business Associate Contracts and Other Arrangement. | 164.308(a)(8) 164.308(b)(1)         | Applications and Data Criticality Analysis (A) (R) Written Contract or Other Arrangement (R)                                                                            |\n| Physical Safeguards                                                                                                                                              | Physical Safeguards                 | Physical Safeguards                                                                                                                                                     |\n| Facility Access Controls ............................"}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 67}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 454)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n| 8.2                                     |\n| Requirements on Research ....................................................................................................... ..............\n|                                         | 40 2                                                 | 60.5                                    |\n| Training ....................................................................................................................... ............................. |                                         | 287.1                                                | 50.0                                    |\n| De-Identification of Information ............................................................................................... |                                         | 124.2                                                | 117.0                                   |\n| Employers with Insured Group Health Plans ...................................................................................... .... | 52                                      | 4                                                    | 0                                       |\n| Internal Complaints ............................................................................................................ ...................... |                                         | 6.6                                                  | 10.7                                    |\n| Total * ............................................................................................................................... ................. |                                         | 3,242.0                                              | 1,556 9                                 |\n| Net Present Value .............................................................................................................. ....................."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 453}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 4)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nthen privacy protections for genetic information. This final rule implements the modifications required by GINA, as well as most of the privacy, security, and enforcement provisions of the HITECH Act.\nThis final rule also includes certain other modifications to the HIPAA Rules to improve their workability and effectiveness. ## ii. The Health Information Technology for Economic and Clinical Health Act\n\nThe HITECH Act is designed to promote the widespread adoption and interoperability of health information technology. Subtitle D of title XIII, entitled ''Privacy,'' supports this goal by adopting amendments designed to strengthen the privacy and security protections for health information established by HIPAA. These provisions include extending the applicability of certain of the Privacy and Security Rules' requirements to the business associates of covered entities; requiring that Health Information Exchange Organizations and similar organizations, as well as personal health record vendors that provide services to covered entities, shall be treated as business associates; requiring HIPAA covered entities and business associates to provide for notification of breaches of ''unsecured protected health information''; establishing new limitations on the use and disclosure of protected health information for marketing and fundraising purposes; prohibiting the sale of protected health information; and expanding individuals' rights to access their protected health information, and to obtain restrictions on certain disclosures of protected health information to health plans. In addition, subtitle D adopts provisions designed to strengthen and expand HIPAA's enforcement provisions. We discuss these statutory provisions in more detail below where we describe section-by-section how this final rule implements the provisions."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 3}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 315)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\now, we agree with the commenters who suggested that the proposed provision that would have permitted disclosures to government health data bases was overly broad, and we remove it from the final rule.\nWe reviewed the important purposes for which some commenters said government agencies needed protected health information, and we believe that most of those needs can be met through the other categories of permitted uses and disclosures without authorization allowed under the final rule, including provisions permitting covered entities to disclose information (subject to certain limitations) to government agencies for public health, health oversight, law enforcement, and otherwise as required by law. For example, the final rule continues to allow collection of protected health information without authorization to monitor trends in the spread of infectious disease, morbidity and mortality. Comment: Several commenters recommended expanding the scope of disclosures permissible under proposed §164.510(b)(1)(iii), which would have allowed covered entities to disclose protected health information to private entities that could demonstrate that they were acting to comply with requirements, or at the direction, of a public health authority. These commenters said that they needed to collect individually identifiable health information in the process of drug and device development, approval, and post-market surveillance-activities that are related to, and necessary for, the FDA regulatory process. However, they noted that the specific data collections involved were not required by FDA regulations. Some commenters said that they often devised their own data collection methods, and that health care providers disclosed information to companies voluntarily for activities such as post-marketing surveillance and efficacy surveys. Commenters said they used this information to comply with FDA requirements such as reporting adverse events, filing other reports, or recordkeeping."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 314}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 75)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\notection to be long enough so as not to provide an incentive for covered entities to change their record retention policies in order to profit from the data about a decedent once 50 years has elapsed.\nWith respect to commenters' concerns regarding protected health information about decedents that is sensitive, such as HIV/AIDS, substance abuse, or mental health information, or that involves psychotherapy notes, we emphasize that the 50-year period of protection for decedent health information under the Privacy Rule does not override or interfere with State or other laws that provide greater protection for such information, or the professional responsibilities of mental health or other providers. Covered entities may continue to provide privacy protections to decedent information beyond the 50-year period, and may be required to do so under other applicable laws or as part of their professional responsibility. Alternatively, covered entities may choose to destroy decedent information although other applicable law may prescribe or limit such destruction. We also decline to limit protections under the Privacy Rule to a certain period beyond the last date in the\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00050\n\nmedical record. While we appreciate the challenges that may be present in determining the date of death of an individual in cases in which it is not sufficiently clear from the age of the record whether the individual is deceased, we believe that this determination is necessary in closer cases to protect the individual, as well as living relatives and others, who may be affected by disclosure of the information. Further, as we stated in the NPRM, this modification has no impact on a covered entity's disclosures permitted under other provisions of the Privacy Rule."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 74}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 8)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nAssociation (AHIMA), an average of 150 people ''from nursing staff to x-ray technicians, to billing clerks'' have access to a patient's medical records during the course of a typical hospitalization.\nWhile many of these individuals have a legitimate need to see all or part of a patient's records, no laws govern who those people are, what information they are able to see, and what they are and are not allowed to do with that information once they have access to it. According to the National Research Council, individually identifiable health information frequently is shared with:\n\n- Managed care organizations;\n- Consulting physicians;\n- Health insurance companies\n- Self-insured employers;\n- Life insurance companies;\n- Pharmacies;\n- Clinical laboratories;\n- Pharmacy benefit managers;\n- Accrediting organizations;\n- State and Federal statistical\n\nagencies; and\n\n- Medical information bureaus. Much of this sharing of information is done without the knowledge of the patient involved. While many of these functions are important for smooth functioning of the health care system, there are no rules governing how that\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ninformation is used by secondary and tertiary users. For example, a pharmacy benefit manager could receive information to determine whether an insurance plan or HMO should cover a prescription, but then use the information to market other products to the same patient. Similarly, many of us obtain health insurance coverage though our employer and, in some instances, the employer itself acts as the insurer. In these cases, the employer will obtain identifiable health information about its employees as part of the legitimate health insurance functions such as claims processing, quality improvement, and fraud detection activities. At the same time, there is no comprehensive protection prohibiting the employer from using that information to make decisions about promotions or job retention."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 7}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 440)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\no broadly and generally invalidate any state law that comes within their ambit. We do not agree that this is the effect of section\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\n1178.\nRather, what section 1178 doeswhere it acts to preempt-is to preempt the state law in question with respect to the actions of covered entities to which the state law applies. Thus, if a provision of state law is preempted by section 1178, covered entities within that state to which the state law applies do not have to comply with it, and must instead comply with the contrary federal standard, requirement, or implementation specification. However, as compliance with the contrary federal standard, requirement, or implementation specification is not required until the applicable compliance date, we do not view the state law in question as meeting the test of being ''contrary.'' That is, since compliance with the federal standard, requirement, or implementation standard is not required prior to the applicable compliance date, it is possible for covered entities to comply with the state law in question. See §160.202 (definition of ''contrary''). Thus, since the state law is not ''contrary'' to an applicable federal standard, requirement, or implementation specification in the period before which compliance is required, it is not preempted. Several implications of this analysis should be spelled out. First, one conclusion that flows from this analysis is that preemption is specific to covered entities and does not represent a general invalidation of state law, as suggested by many commenters. Second, because preemption is covered entity-specific, preemption will occur at different times for small health plans than it will occur for all other covered entities."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 439}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 95)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhome from the hospital extensive information about the patient's surgery or past medical history when the friend or relative had no need for this information. The final rule takes a similar approach.\nUnder the final rule, when an individual is not present (for example, when a friend of a patient seeks to pick up the patient's prescription at a pharmacy) or when the opportunity to agree or object to the use or disclosure cannot practicably be provided due to the individual's incapacity or an emergency circumstance, covered entities may, in the exercise of professional judgment, determine whether the disclosure is in the individual's best interests and if so, disclose only the protected health information that is directly relevant to the person's involvement with the individual's health care. For example, this provision allows covered entities to inform relatives or others involved in a patient's care, such as the person who accompanied the individual to the emergency room, that a patient has suffered a heart attack and to provide updates on the patient's progress and prognosis when the patient is incapacitated and unable to make decisions about such disclosures. In addition, this section allows covered entities to disclose functional information to individuals assisting in a patient's care; for example, it allows hospital staff to give information about a person's mobility limitations to a friend driving the patient home from the hospital. It also allows covered entities to use professional judgment and experience with common practice to make reasonable inferences of the individual's best interest in allowing a person to act on an individual's behalf to pick up filled prescriptions, medical supplies, X-rays, or other similar forms of protected health information. Thus, under this provision, pharmacists may release a prescription to a patient's friend who is picking up the prescription for him or her."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 94}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 74)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nsign authorizations for uses and disclosures of protected health information for treatment, payment, and health care operations, unless required by other applicable law. See proposed §164.508(a)(iv).\nWe instead proposed requiring covered entities to produce a notice describing their information practices, including practices with respect to uses and disclosures to carry out treatment, payment, and health care operations. In the final rule, we retain the requirement for covered entities to obtain the individual's written permission (an ''authorization'') for uses and disclosures of protected health information that are not otherwise permitted or required under the rule. However, under the final rule, we add a second type of written permission for use or disclosure of protected health information: a ''consent'' for uses and disclosures to carry out treatment, payment, and health care operations. In the final rule, we permit, and in some cases require, covered entities to obtain the individual's written permission for the covered entity to use or disclose protected health information other than psychotherapy notes to carry out treatment, payment, and health care operations. We refer to this written permission as a ''consent.''\n\nThe ''consent'' and the ''authorization'' do not overlap. The requirement to obtain a ''consent'' applies in different circumstances than the requirement to obtain an authorization. In content, a consent and an authorization differ substantially from one another. As described in detail below, a ''consent'' allows use and disclosure of protected health information only for treatment, payment, and health care operations. It is written in general terms and refers the individual to the covered entity's notice for further information about the covered entity's privacy practices. It allows use and disclosure of protected health information by the covered entity seeking the consent, not by other persons."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 73}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 266)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne. We address uses and disclosures of protected health information by covered entities, and when a covered entity will violate this rule due to the actions of a workforce member or business associate.\nIn the final rule, we provide that a covered entity is not in violation of the rule when a workforce member or business associate has a good faith belief that the conduct being reported is unlawful or otherwise violates professional or clinical standards, or potentially endangers patients, employees or the public. We concur that the NPRM language requiring only a ''belief'' was insufficient. Consequently, we have strengthened the standard to require a good faith belief that an inappropriate behavior has occurred. Comment: A number of commenters believe that employees should be encouraged to report violations of professional or clinical standards, or report situations where patients, employees, or the public would be put at risk. Their contention is that employees, especially health care employees, may not know whether the problem they have encountered meets a legal threshold of wrongdoing, putting them at jeopardy of sanction if they are incorrect, even if the behavior did reflect violation of professional and clinical standards or put patients, employees, or the public at risk. Response: We agree that covered entities should be protected when their employees and others engage in the conduct described by these commenters. We therefore modify the proposal to protect covered entities when the whistleblowing relates to violations of professional or clinical standards, or situations where the public may be at risk, and eliminate the reference to ''evidence.''\n\nComments: A significant number of those commenting on the whistleblower provision felt that this provision was contrary to the rest of the rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 265}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 216)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nyear, but not less than six months to bring any acquisition up to standard. The commenter stated that the Secretary should encourage, not discourage, compliant companies to acquire noncompliant ones.\nAnother commenter\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nexpressed a general concern about resolution of enforcement if an entity faced with a HIPAA complaint acquires or merges with an entity not covered by HIPAA. Response: As discussed above, the Secretary will encourage voluntary efforts to cure violations of the rule, and will consider that fact in determining whether to bring a compliance action. We do not agree, however, that we should limit our authority to pursue violations of the rule if the situation warrants it. Comment: One commenter was concerned about the ''undue risk'' of liability on originators of information, stemming from the fact that ''the number of covered entities is limited and they are unable to restrict how a recipient of information may use or redisclose information * * *''\n\nResponse: Under this rule, we do not hold covered entities responsible for the actions of recipients of protected health information, unless the recipient is a business associate of the covered entity. We agree that it is not fair to hold covered entities responsible for the actions of persons with whom they have no on-going relationship, but believe it is fair to expect covered entities to hold their business associates to appropriate standards of behavior with respect to health information. ## Other Compliance and Enforcement Comments\n\nComment: A number of comments raised questions regarding the Secretary's priorities for enforcement. A few commenters stated that they supported deferring enforcement until there is experience using the proposed standards."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 215}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement physical controls?"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron Applied Cybersecurity Division Information Technology Laboratory\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\nFebruary 2024\n\n<!-- image -->\n\nU.S. Department of Commerce Gina M. Raimondo, Secretary\n\nNational Institute of Standards and Technology\n\nCertain commercial equipment, instruments, software, or materials, commercial or non-commercial, are identified in this paper in order to specify the experimental procedure adequately. Such identification does not imply recommendation or endorsement of any product or service by NIST, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose. There may be references in this publication to other publications currently under development by NIST in accordance with its assigned statutory responsibilities. The information in this publication, including concepts and methodologies, may be used by federal agencies even before the completion of such companion publications. Thus, until each publication is completed, current requirements, guidelines, and procedures, where they exist, remain operative. For planning and transition purposes, federal agencies may wish to closely follow the development of these new publications by NIST. Organizations are encouraged to review all draft publications during public comment periods and provide feedback to NIST."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_type": "physical", "implementation_spec": "both", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 42)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nacted legislation governing standards with respect to the privacy of individually identifiable health information, or the Secretary of HHS has promulgated final regulations containing these standards.\nOne commenter stated, ''we find\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\nJkt 200001\n\nourselves in the difficult position of reacting to proposed rules setting the standards for how information should be physically and electronically protected, without having reached agreement on the larger issues of consent for and disclosure of individual medical information.''\n\nResponse: The effective date of the final rule is 60 days after this final rule is published in the Federal Register . The statute sets forth the compliance dates for the standards. Covered entities must comply with this final rule no later than 24 months (36 months for small plans) after the effective date. The final Privacy Rule has already been published. We note that numerous comments concerning the timing of the adoption of privacy and security standards were also received in the privacy rulemaking and are discussed in the Privacy Rule at 65 FR 82752. 2. Comment: One commenter asked that proposed § 142.312 be rewritten to separate the effective dates for the Security Rule and the Transactions Rule. Response: The proposed rule incorporated general language applicable to all the proposed Administrative Simplification standards. Language concerning standards other than Security is not included in § 164.318. Because this final rule is adopted after the Transactions Rule was adopted, the compliance dates for the security standards differ from those for the transactions standards. Comments concerning general effective dates were addressed in the Transactions Rule. Comments specific to the security standards are addressed here. 3. Comment: Several commenters suggested that we not allow early implementation of the Security Rules."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 41}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 33)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n| Key Activities | Description | Sample Questions | |---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | • Ensure that there is a list of personnel with authority to approve user requests to access ePHI and systems with ePHI."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 32}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 431)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nn workforce members to implement the covered entity's privacy policies and procedures, and do such things as pass evidence of potential problems to those responsible, is in line with these principles.\nFor example, the comments and our fact finding indicate that, today, many hospitals require their workforce members to sign a confidentiality agreement, and include confidentiality matters in their employee handbooks. ## Section 164.530(c)-Safeguards\n\nComments: A few comments assert that the rule requires some institutions that do not have adequate resources to develop costly physical and technical safeguards without providing a funding mechanism to do so. Another comment said that the vague definitions of adequate and appropriate safeguards could be interpreted by HHS to require the purchase of new computer systems and reprogram many old ones. A few other comments suggested that the safeguards language was vague and asked for more specifics. Response: We require covered entities to maintain safeguards adequate for their operations, but do not require that\n\nFrm 00285\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nspecific technologies be used to do so. Safeguards need not be expensive or high-tech to be effective. Sometimes, it is an adequate safeguard to put a lock on a door and only give the keys to those who need access. As described in more detail in the preamble discussion of § 164.530, we do not require covered entities to guarantee the safety of protected health information against all assaults. This requirement is flexible and scalable to allow implementation of required safeguards at a reasonable cost. Comments: A few commenters noted that once protected health information becomes non-electronic, by being printed for example, it escapes the protection of the safeguards in the proposed Security Rule. They asked if this safeguards requirement is intended to install similar security protections for non-electronic information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 430}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 38)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nIf a device-specific guidance contains additional or different recommendations to those in this table, the device-specific recommendations should be followed. If a manufacturer is unsure, they should utilize the FDA Q-submission process. ## Appendix 5. Terminology\n\nThe terminology listed here are for the purposes of this guidance and are intended for use in the context of assessing medical device cybersecurity. These terms are not intended to be applied in any context beyond this guidance. Anomaly - any condition that deviates from the expected behavior based on user needs, requirements, specifications, design documents, or standards. Asset - anything that has value to an individual or an organization. 87\n\nAttack Surface Analysis -evaluation of attack surface to determine all avenues of ingress and egress to and from a system including common vulnerabilities and exposed ports and services. 88\n\nAuthentication - the act of verifying the identity of a user, process, or device as a prerequisite to allowing access to the device, its data, information, or systems, or provision of assurance that a claimed characteristic of an entity is correct. 89\n\nAuthenticity - information, hardware, or software having the property of being genuine and being able to be verified and trusted; confidence that the contents of a message originate from the expected party and has not been modified during transmission or storage. 90\n\nAuthorization - the right or a permission that is granted to a system entity to access a system resource. 91\n\nAvailability - the property of data, information, and information systems to be accessible and usable on a timely basis in the expected manner (i.e., the assurance that information will be available when needed). 92\n\nBoundary Analysis - the process of uniquely assigning information resources to an information system, which defines the security boundary for that system."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 37}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 79)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nNote: Natural and human-made disasters can also be characterized in terms of their severity and/or duration. However, because the threat source and the threat event are strongly identified, severity and duration can be included in the description of the threat event (e.g., Category 5 hurricane causes extensive damage to the facilities that house mission-critical systems, making those systems unavailable for three weeks). | Range of effects  |\n\nTable 31. Representative examples of adversarial threat events\n\n| Threat Events (Characterized by Tactics, Techniques, and Procedures [TTPs])   | Description                                                                                                                                                                                                                                                                                                                                               |\n|-------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|\n| Perform reconnaissance and gather information. | Perform reconnaissance and gather information. |\n| Perform perimeter network reconnaissance and scanning. | Adversary uses commercial or free software to scan organizational perimeters to obtain a better understanding of the information technology infrastructure and improve the ability to launch successful attacks. |\n| Perform network sniffing of exposed networks. | Adversary with access to exposed wired or wireless data channels used to transmit information uses network sniffing to identify components, resources, and protections."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 78}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 355)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nre than one unaffiliated member to address concerns about conflict of interest among members. Response: We disagree that privacy boards should be required to include more than one unaffiliated member.\nWe believe that the revised membership criterion for the unaffiliated member of the privacy board, and the criterion that requires that the board have no member participating in a review of any project in which the member has a conflict of interest, are sufficient to ensure that no member of the board has a conflict of interest in a research proposal under their review. Comment: Many commenters also recommended that the membership of privacy boards be required to be more similar to that of IRBs. These commenters were concerned that privacy boards, as described in the proposed rule, would not have the needed expertise to adequately review and oversee research involving the use of protected health information. A few of these commenters also recommended that IRBs be required to have at least one member trained in privacy or security matters. Response: We disagree with the comments asserting that the membership of privacy boards should be required be more similar to IRBs. Unlike IRBs, privacy boards only have responsibility for reviewing research proposals that involve the use or disclosure of protected health information without authorization. We agree, however, that the proposed rule may not have ensured that the privacy board had the necessary expertise to protect adequately individuals' privacy rights and interests. Therefore, in the final rule, we have modified one of the membership criteria for privacy board to require that the board has members with varying backgrounds and appropriate professional competency as necessary to review the effect of the research protocol on the individual's privacy rights and related interests."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 354}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 510)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nis section through a written contract or other written agreement or arrangement with the business associate that meets the applicable requirements of §164.504(e). - (f) Standard: Deceased individuals.\nA covered entity must comply with the requirements of this subpart with respect to the protected health information of a deceased individual. - (g)(1) Standard: Personal representatives. As specified in this paragraph, a covered entity must, except as provided in paragraphs (g)(3) and (g)(5) of this section, treat a personal representative as the individual for purposes of this subchapter. - (2) Implementation specification: adults and emancipated minors. If under applicable law a person has authority to act on behalf of an individual who is an adult or an emancipated minor in making decisions related to health care, a covered entity must treat such person as a personal representative under this subchapter, with respect to protected health information relevant to such personal representation. (3) Implementation specification: unemancipated minors."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 509}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 29)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\no prove that information originated at a known and trusted source, and that the information has not been altered in transit between the original source and the point at which authenticity is verified.\nIt is important to note that while authenticity implies that data is accurate and has been safeguarded from unauthorized user modification (i.e., integrity), integrity alone does not provide assurance that the data is real and came from a trusted source. Therefore, for the purposes of this guidance, authentication is discussed as a larger security objective over integrity. Authentication of entities exists where a device and the system in which it operates is able to prove the identity of an endpoint (whether hardware and/or software) from which it is sending and/or receiving information, or authorized user/operator at that endpoint. As part of normal operations within a secure system, devices should verify the authenticity of information from external entities, as well as prove the authenticity of information that they generate. A medical device system that appropriately accounts for authenticity can evaluate and ensure authenticity for:\n\n- Information at rest (stored);\n- Information in transit (transmitted);\n- Entity authentication of communication endpoints, whether those endpoints consist of software or hardware;\n- Software binaries;\n- Integrity of the execution state of currently running software; and\n- Any other appropriate parts of the medical device system where a manufacturer's threat model and/or risk analyses reveal the need for it. On a technical level, the strength of a device's authentication scheme is defined by the amount of effort, including time, that an unauthorized party would need to expend to identify the decomposition of the authentication scheme."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 28}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 442)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ned and intangible but real. Medical privacy is not a good people buy or sell in a market; therefore, it is very difficult to quantify. The benefits discussion in the proposal reflects this difficulty.\nThe examples presented in the proposal were meant to be illustrative of the benefits based on a few areas of medicine where some relevant data was available. Unfortunately, no commenters provided either a better methodological approach or better data for assessing the overall benefits of privacy. Therefore, we believe the analysis in the proposal represents a valid illustration of the benefits of privacy, and we do not believe it is feasible to provide an overall dollar estimate of the benefits of privacy in the aggregate. Comment: One commenter criticized the benefit analysis as being incomplete because it did not consider the potential cost of new treatments that might be engendered by increased confidence in medical privacy resulting from the regulation. Response: There is no data or model to reliably assess such long-term behavioral and scientific changes, nor to determine what portion of the increasingly rapid evolution of new improved treatments might stem from improved privacy protections. Moreover, to be complete, such analysis would have to include the savings that might be realized from earlier detection and treatment. It is not possible at this time to project the magnitude or even the direction of the net effects of the response to privacy that the commenter suggests. ## Scope of the Regulation\n\nComment: Numerous commenters noted the potential cost and burden of keeping track in medical records of information which had been transmitted electronically, which would be subject to the rule, as opposed to information that had only been maintained in paper form."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 441}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 196)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nWe disagree. These requirements are consistent with U.S. Supreme Court cases holding that warrantless administrative searches of commercial property are not per se violations of the Fourth Amendment.\nThe provisions requiring that covered entities provide access to certain material to determine compliance with the regulation come within the wellsettled exception regarding closely regulated businesses and industries to the warrant requirement. From state and local licensure laws to the federal fraud and abuse statutes and regulations, the health care industry is one of the most\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ntightly regulated businesses in the country. Because the industry has such an extensive history of government oversight and involvement, those operating within it have no reasonable expectation of privacy from the government such that a warrant would be required to determine compliance with the rules. In addition, the cases cited by the commenters concern unannounced searches of the premises and facilities of particular entities. Because our enforcement provisions only provide for the review of books, records, and other information and only during normal business hours with notice, except for exceptional situations, this case law does not apply. As for business associates, they voluntarily enter into their agreements with covered entities. This agreement, therefore, functions as knowing and voluntary consents to the search (even assuming it could be understood to be a search) and obviates the need for a warrant. ## Fifth Amendment\n\nComment: Several comments asserted that the proposed rules violated the Fifth Amendment because in the commenters' views they authorized the taking of privacy property without just compensation or due process of law. Response: We disagree. The rules set forth below do not address the issue of who owns an individual's medical record."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 195}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 220)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nn Society,'' July 1977, p. 298-299. report ''Best Principles for Health Privacy,'' the Health Privacy Working Group recommended that individuals should have the right to access information about them.\n3 The National Association of Insurance Commissioners' Health Information Privacy Model Act establishes the right of an individual to examine or receive a copy of protected health information in the possession of the carrier or a person acting on behalf of the carrier. Many states also establish a right for individuals to access health information about them. For example, Alaska law (AK Code 18.23.005) entitles patients ''to inspect and copy any records developed or maintained by a health care provider or other person pertaining to the health care rendered to the patient.'' Hawaii law (HRS section 323C-11) requires health care providers and health plans, among others, to permit individuals to inspect and copy protected health information about them. Many other states have similar provisions. Industry and standard-setting organizations also have developed policies to enable individual access to health information. The National Committee for Quality Assurance and the Joint Commission on Accreditation of Healthcare Organizations issued recommendations stating, ''Patients' confidence in the protection of their information requires that they have the means to know what is contained in their records. The opportunity for patients to review their records will enable them to correct any errors and may provide them with a better Society for Testing and Materials state, understanding of their health status and treatment.'' 4 Standards of the American ''The patient or his or her designated\n\npersonal representative has access rights to the data and information in his or her health record and other health information databases except as restricted by law."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 219}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the differences between covered entity and business associate obligations under HIPAA?"}, {"role": "assistant", "content": "According to 45cfr164:\n\n[Skip to main content](#main-content)\n\nMenu\n\n[![GovInfo logo](/media/GovInfo_logo_gray.png)](/)\n[Search](#searchHolder)\n\n* Browse\n  + [A to Z](/browse-a-z)\n  + [Category](/app/browse/category)\n  + [Date](/app/browse/date)\n  + [Committee](/browse/committee)\n  + [Author](/app/browse/author)\n* About\n  + [About](/about)\n  + [Policies](/about/policies)\n  + [Authentication](/about/authentication)\n  + [Digital Preservation](/about/digital-preservation)\n  + [History](/about/history)\n  + [Agency Submission](/about/agency-submission)\n  + [U.S. Government Information](/about/us-gov-info)\n  + [FDsys Retirement](/about#fdsys-transition)\n* Developers\n  + [Developer Hub](/developers)\n  + [API](https://api.govinfo.gov/docs)\n  + [Bulk Data Repository](%20/bulkdata)\n  + [Link Service](/link-docs)\n  + [Feeds](/feeds)\n  + [Sitemaps](/sitemaps)\n  + [System Design](/developers/system-design)\n* Features\n  + [All Features](/features)\n  + [Featured Content](/features/featured-content)\n  + [News](/features/news)\n  + [Release Notes](/features/release-notes)\n  + [Finding Publications](/features/finding-publications)\n* Help\n  + [Help](/help)\n  + [Finding Information](%20/help/finding-info)\n  + [What's Available](/help/whats-available)\n  + [Tutorials and Handouts](/help/tutorials-handouts)\n  + [Other Resources](%20/help/other-resources)\n* Feedback\n  + [Submit Feedback](https://www.surveymonkey.com/r/govinfo-feedback-survey)\n  + [Contact Us](/contact)\n\n* [Toggle the Search Widget\n  Search](#searchHolder)\n\n# Page Not Found\n\n![Icon: Share using Facebook](/sites/default/files/fb-icon-white.png)\n![Icon: Share using Email](/sites/default/files/email-icon-white.png)\n![Icon: Copy Link URL](/sites/default/files/link-icon-white.png)\n\n[Help](/help/other)\n\n---\n\n**Error occurred."}], "metadata": {"source": "45cfr164", "entity_type": "both", "safeguard_types": ["unknown"], "type": "entity_obligations"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\n## Office of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRin: 0991-AB08\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY : Office of the Assistant Secretary for Planning and Evaluation, DHHS. ACTION\n\n: Final rule. SUMMARY : This rule includes standards to protect the privacy of individually identifiable health information. The rules below, which apply to health plans, health care clearinghouses, and certain health care providers, present standards with respect to the rights of individuals who are the subjects of this information, procedures for the exercise of those rights, and the authorized and required uses and disclosures of this information. The use of these standards will improve the efficiency and effectiveness of public and private health programs and health care services by providing enhanced protections for individually identifiable health information. These protections will begin to address growing public concerns that advances in electronic technology and evolution in the health care industry are resulting, or may result, in a substantial erosion of the privacy surrounding individually identifiable health information maintained by health care providers, health plans and their administrative contractors. This rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and\n\nAccountability Act of 1996. DATES : The final rule is effective on February 26, 2001. ## FOR FURTHER INFORMATION CONTACT :\n\nKimberly Coleman, 1-866-OCR-PRIV (1-866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION :\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 0}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 8)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n00-53; SP 800-53A; SP 800-27; SP 800-60; SP 800-37; CNSSI-4009. Note:  Adapted from NIST definition (SP 800-53). ## Contains Nonbinding Recommendations\n\nmitigate the effects of, threats to the system.\n19 For medical devices, threat modeling can be used to strengthen security by identifying vulnerabilities and threats to a particular product, products in a product line, or from the organization's supply chain that can cause patient harm. ## J. Uncontrolled Risk\n\nUncontrolled risk is present when there is unacceptable residual risk of patient harm due to inadequate compensating controls and risk mitigations. ## K. Vulnerability\n\nA vulnerability is a weakness in an information system, system security procedures, internal controls, human behavior, or implementation that could be exploited by a threat. ## V. General Principles\n\nFDA recognizes that medical device cybersecurity is a shared responsibility among stakeholders including health care facilities, patients, providers, and manufacturers of medical devices. Failure to maintain cybersecurity can result in compromised device functionality, loss of data (medical or personal) availability or integrity, or exposure of other connected devices or networks to security threats. This in turn may have the potential to result in patient illness, injury or death. Effective cybersecurity risk management is intended to reduce the risk to patients by decreasing the likelihood that device functionality is intentionally or unintentionally compromised by inadequate cybersecurity."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 7}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 14)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nm the definition of business associate as a conduit also applies in the context of subcontractors as well. We refer readers to the above discussion regarding transmission services and conduits. ## iv.\nExceptions to Business Associate Proposed Rule\n\nSections 164.308(b)(2) and 164.502(e)(1)(ii) of the HIPAA Rules currently describe certain circumstances, such as when a covered entity discloses protected health information to a health care provider concerning the treatment of an individual, in which a covered entity is not required to enter into a business associate contract or other arrangement with the recipient of the protected health information. We proposed to move these provisions to the definition of ''business associate'' itself as exceptions to make clear that the Department does not consider the recipients of the protected health information in these circumstances to be business associates. The movement of these exceptions also was intended to help clarify that a person or an entity is a business associate if the person or\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00010\n\nentity meets the definition of ''business associate,'' even if a covered entity, or business associate with respect to a subcontractor, fails to enter into the required business associate contract with the person or entity. ## Final Rule\n\nThe Department did not receive substantive public comment on this proposal. The final rule includes the exceptions within the definition of ''business associate.''\n\n## v. Technical Changes to the Definition Proposed Rule\n\nFor clarity and consistency, we also proposed to change the term ''individually identifiable health information'' in the current definition of ''business associate'' to ''protected health information,'' since a business associate has no obligation under the HIPAA Rules with respect to individually identifiable health information that is not protected health information."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 13}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 498)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n# §160.103 Definitions. Except as otherwise provided, the following definitions apply to this subchapter:\n\nAct means the Social Security Act. ANSI stands for the American National Standards Institute.\nBusiness associate: (1) Except as provided in paragraph (2) of this definition, business associate means, with respect to a covered entity, a person who:\n\n- (i) On behalf of such covered entity or of an organized health care arrangement (as defined in § 164.501 of this subchapter) in which the covered entity participates, but other than in the capacity of a member of the workforce of such covered entity or arrangement, performs, or assists in the performance of:\n- (A) A function or activity involving the use or disclosure of individually identifiable health information, including claims processing or administration, data analysis, processing or administration, utilization review, quality assurance, billing, benefit management, practice management, and repricing; or\n- (B) Any other function or activity regulated by this subchapter; or\n- (ii) Provides, other than in the capacity of a member of the workforce of such covered entity, legal, actuarial, accounting, consulting, data aggregation (as defined in § 164.501 of this subchapter), management,\n- administrative, accreditation, or financial services to or for such covered entity, or to or for an organized health care arrangement in which the covered entity participates, where the provision of the service involves the disclosure of individually identifiable health information from such covered entity or arrangement, or from another business associate of such covered entity or arrangement, to the person."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 497}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 30)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nalso appropriate, however, because ''Physical safeguards'' defines the physical operations (processes) that provide access to the facility to implement the associated plans, developed under §164.308.\nWe agree, however, that the term ''contingency operations'' better describes, and would include, disaster recovery and emergency mode operations, and have modified the regulation text accordingly (see § 164.310(a)(1)). e. Comment: Commenters were concerned about having to address in their facility security plan the exterior/ interior security of a building when they are one of many occupants rather than the sole occupant. Additional commenters were concerned that the responsibility for physical security of the building could not be delegated to a third party when the covered entity shares the building with other offices. Response: The facility security plan is an addressable implementation specification. However, the covered entity retains responsibility for considering facility security even where it shares space within a building with other organizations. Facility security measures taken by a third party must be considered and documented in the covered entity's facility security plan, when appropriate. Fmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\nJkt 200001\n\n## 3. Workstation Use (§ 164.310(b))\n\nWe proposed policy and guidelines on workstation use that included documented instructions/procedures delineating the proper functions to be performed and the manner in which those functions are to be performed (for example, logging off before leaving a workstation unattended) to maximize the security of health information. In this final rule, we adopt this standard. Comment: One commenter was concerned most people may be misled by the use of ''terminal'' as an example in the definition of workstation. The concern was that the standard only addresses ''fixed location devices,'' while in many instances the workstation has become a laptop computer."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 29}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 16)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\nby proactively addressing cybersecurity vulnerabilities and minimizing exploits through the timely deployment of risk control measures including communication and coordination with patients and users.\n41 See the web page titled 'Unique Device Identification - UDI'\n\nhttp://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/UniqueDeviceIdentification/ for more information\n\n42 See 21 CFR 814.39. ## Contains Nonbinding Recommendations\n\nFDA intends to consider the following in determining whether a manufacturer is an active participant in an ISAO:\n\n1. The manufacturer is a member of an ISAO that shares vulnerabilities and threats that impact medical devices;\n2. The ISAO has documented policies pertaining to participant agreements, business processes, operating procedures, and privacy protections;\n3. The manufacturer shares vulnerability information with the ISAO, including any customer communications pertaining to cybersecurity vulnerabilities; and\n4. The manufacturer has documented processes for assessing and responding to vulnerability and threat intelligence information received from the ISAO. This information should be traceable to medical device risk assessments, countermeasure solutions, and mitigations. Manufacturers that wish to be considered by FDA to be active participants in an ISAO are recommended to maintain objective evidence documenting that they meet the four criteria above. ## X. Appendix: Elements of an Effective Postmarket Cybersecurity Program\n\nIt is recommended that the following elements, consistent with the NIST Framework for Improving Critical Infrastructure Cybersecurity (i.e., Identify, Protect, Detect, Respond, and Recover;\n\nhttps://www.nist.gov/sites/default/files/documents/cyberframework/cybersecurityframework-021214.pdf ), be included as part of a manufacturer's cybersecurity risk management program. ## A. Identify\n\n## i."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 15}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 32)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nKey activities, descriptions, and sample questions for the Information Access Management standard | Key Activities | Description | Sample Questions | |--------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 1."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 31}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 107)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nements entirely. Several commenters urged that the Department exempt covered entities from having to enter into contracts with business associates who are also covered entities under the Privacy Rule.\nAlternatively, one commenter suggested that the Department simplify the requirements by requiring a covered entity that is a business associate to specify in writing the uses and disclosures the covered entity is permitted to make as a business associate. 19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00071\n\nOther commenters requested that the Department allow business associates to self-certify or be certified by a third party or HHS as compliant with the Privacy Rule, as an alternative to the business associate contract requirement. Certain commenters urged the Department to modify the Rule to eliminate the need for a contract with accreditation organizations. Some commenters suggested that the Department do so by reclassifying private accreditation organizations acting under authority from a government agency as health oversight organizations, rather than as business associates. Response: The proposed modifications regarding business associates were intended to address the concerns of commenters with respect to having insufficient time to reopen and renegotiate what could be thousands of contracts for some covered entities by the compliance date of the Privacy Rule. The proposed modifications did not address changes to the definition of, or requirements for, business associates generally. The Department has, in previous guidance, as well as in the preamble to the December 2000 Privacy Rule, explained its position with respect to most of the above concerns. However, the Department summarizes its position in response to such comments briefly below. The Department recognizes that most covered entities acquire the services of a variety of other persons or entities to assist in carrying covered entities' health care activities."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 106}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 33)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\n-malware may be recommended based on the environment and associated risks of the device. Different operating systems will likely follow a case-by-case determination based on network exposure and risk.\n- For devices that leverage Embedded Operating Systems (e.g., Real-Time Operating Systems, Windows embedded):\n- Antivirus/malware detection/protection software is generally not needed unless a particular risk or threat is identified that would not be addressed by other expected security controls. - Design devices to enable software configuration management and permit tracking and control of software changes to be electronically obtainable (i.e., machine readable) by authorized users. - Design devices to facilitate the performance of variant analyses such that the same vulnerabilities can be identified across device models and product lines. 82 Forensic evidence capture is a necessary part of digital forensics. NIST SP 800-86 defines digital forensics as 'The application of science to the identification, collection, examination, and analysis, of data while preserving the integrity of the information and maintaining a strict chain of custody for the data.' https://doi.org/10.6028/NIST.SP.800-86\n\n## Contains Nonbinding Recommendations\n\n- Design devices to notify users when malfunctions or anomalous device behavior, including those potentially related to a cybersecurity breach, are detected. - Consider designing devices such that they are able to produce an SBOM in a machine readable format. ## Resiliency and Recovery\n\nDevices should be designed to be resilient to possible cyber incident scenarios (also known as 'cyber-resiliency') and maintain availability. Cyber-resiliency capabilities are important for medical devices because they provide a safety margin against unknown future vulnerabilities."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 32}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 415)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthese comments, and confirm that neither failure to pay a bill nor burden are lawful reasons to deny access under this rule. Covered entities may deny access only for the reasons provided in the rule.\nComment: Some commenters requested that the final rule not include detailed procedural requirements about how to respond to requests for access. Others made specific recommendations on the procedures for providing access, including requiring written requests, requiring specific requests instead of blanket requests, and limiting the frequency of requests. Commenters generally argued against requiring covered entities to acknowledge requests, except under certain circumstances, because of the potential burden on entities. Response: We intend to provide sufficient procedural guidelines to ensure that individuals have access to their protected health information, while maintaining the flexibility for covered entities to implement policies and procedures that are appropriate to their needs and capabilities. We believe that a limit on the frequency of requests individuals may make would arbitrarily infringe on the individual's right of access and have, therefore, not included such a limitation. To limit covered entities' burden, we do not require covered entities to acknowledge receipt of the individuals' requests, other than to notify the individual once a decision on the request has been made. We also permit a covered entity to require an individual to make a request for access in writing and to discuss a request with an individual to clarify which information the individual is actually requesting. If individuals agree, covered entities may provide access to a subset of information rather than all protected health information in a designated record set. We believe these changes provide covered entities with greater flexibility without compromising individuals' access rights."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 414}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 254)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nfacility) is a treatment activity that does not require authorization. Response: We agree that the described activity is ''treatment,'' because it constitutes referral and coordination of health care.\nComment: Comments called for the removal of ''other services'' from the definition. Response: We disagree with the concept that only health care services are appropriately included in the treatment definition. We have modified this definition to instead include ''the provision, coordination, or management of health care and related services.'' This definition allows health care providers to offer or coordinate social, rehabilitative, or other services that are associated with the provision of health care. Our use of the term ''related'' prevents ''treatment'' from applying to the provision of services unrelated to health care. Comment: Several commenters stated that the definition of treatment should include organ and tissue recovery activities. They asserted that the information exchanged and collected to request consent, evaluate medical information about a potential donor and perform organ recoveries relates to treatment and are not administrative activities. When hospitals place a patient on the UNOS list it is transferring individually identifiable health information. Also, when an organ procurement organization registers a donor with UNOS it could be disclosing protected health information. Commenters questioned whether these activities would be administrative or constitute treatment. Response: In the proposed rule we included in the definition of ''health care'' activities related to the procurement or organs, blood, eyes and other tissues."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 253}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 324)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ndisclosure of protected health information for judicial and administrative proceedings should require a court order and/or judicial review unless the subject of the information consents to disclosure.\nThese commenters believed that an attorney's certification should not be considered sufficient authority to override an individual's privacy, and that the proposed rule made it too easy for a party to litigation to obtain information about the other party. Response: As a general matter, we agree with these comments. As noted, the final rule deletes the provision that would permit a covered entity to disclose protected health information pursuant to an attorney's certification that the individual is a party to the litigation and has put his or her medical condition at issue. Under the final rule, covered entities may disclose protected health information in response to a court or administrative order, provided that only the protected health information expressly authorized by the order is disclosed. Covered entities may also disclose protected health information in response to a subpoena, discovery request, or other lawful process without a court order, but only if the covered entity receives satisfactory assurances that the party seeking disclosure has made reasonable efforts to ensure that the individual has been notified of the request or that reasonable efforts have been made by the party seeking the information to secure a qualified protective order. Additionally, a covered entity may disclose protected health information in response to a subpoena, discovery request, or other lawful process without a satisfactory assurance if it makes reasonable efforts to provide the individual with such notice or to seek a qualified protected order itself. We also note that the final rule specifically provides that nothing in Subchapter C should be construed to diminish the authority of any Inspector General, including authority provided in the Inspector General Act of 1978."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 323}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 131)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nor to another of its business associates. This is the case even if the breach of the covered entity's protected health information occurred at or by a business associate that is also a covered entity.\nFor example, if a covered provider (Provider A) hires another covered provider's practice (Provider B) as a business associate to perform his billing and other back office functions, and a breach of Provider A's protected health information occurs at Provider B while performing these functions for Provider A, it remains Provider A's responsibility to provide breach notification to the affected individuals, although Provider A may delegate this\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with responsibility to Provider B as its business associate. Covered entities and business associates should consider which entity is in the best position to provide notice to the individual, which may depend on various circumstances, such as the functions the business associate performs on behalf of the covered entity and which entity has the relationship with the individual. Similarly, when multiple covered entities participate in electronic health information exchange and there is a breach of unsecured protected health information at a Health Information Organization (HIO), the obligation to notify individuals of the breach falls to the covered entities. We recognize that it may be difficult to determine what breached information is attributable to which covered entity's individuals. For example, an HIO may store centralized electronic health records (EHRs) for a community, with each EHR including information generated by multiple covered entities. In such circumstances, it may be necessary for the HIO to notify all potentially affected covered entities and for those covered entities to delegate to the HIO the responsibility of sending the required notifications to the affected individuals."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 130}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 45)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nkt 197001\n\nThe Department adopts the approach that was proposed in the NPRM, because it is the only one that resolves the operational problems that have been identified in a simple and uniform manner.\nFirst, this Rule strengthens the notice requirements to preserve the opportunity for individuals to discuss privacy practices and concerns with providers. (See section III.H. of the preamble for the related discussion of modifications to strengthen the notice requirements.) Second, the final Rule makes the obtaining of consent to use and disclose protected health information for treatment, payment, or health care operations optional on the part of all covered entities, including providers with direct treatment relationships. A health care provider that has a direct treatment relationship with an individual is not required by the Privacy Rule to obtain an individual's consent prior to using and disclosing information about him or her for treatment, payment, and health care operations. They, like other covered entities, have regulatory permission for such uses and disclosures. The fact that there is a State law that has been using a similar model for years provides us confidence that this is a workable approach. Other rights provided by the Rule are not affected by this modification. Although covered entities will not be required to obtain an individual's consent, any uses or disclosures of protected health information for treatment, payment, or health care operations must still be consistent with the covered entity's notice of privacy practices. Also, the removal of the consent requirement applies only to consent for treatment, payment, and health care operations; it does not alter the requirement to obtain an authorization under § 164.508 for uses and disclosures of protected health information not otherwise permitted by the Privacy Rule or any other requirements for the use or disclosure of protected health information."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 44}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 118)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nfor the use or disclosure of information for research to comply with the requirements applicable to individual authorization for the release of protected health information (proposed § 164.508(a)(2)).\nIf an individual had initiated the use or disclosure of his/her protected health information for research, or any other purpose, the covered entity would have been required to obtain a completed authorization for the use or disclosure of protected health information as proposed in § 164.508(c). The final rule retains these requirements for research conducted with authorization, as required by §164.508. In addition, for the use and disclosure of protected health information created by a covered entity for the purpose, in whole or in part, of research that includes treatment of the individual, the covered entity must meet the requirements of § 164.508(f). ## Interaction with the Common Rule\n\nThe NPRM stated that the proposed rule would not override the Common Rule. Where both the NPRM and the Common Rule would have applied to research conducted by the covered entity-either with or without individuals' authorization-both sets of regulations would have needed to be followed. This statement remains true in the final rule. In addition, we clarify that FDA's human subjects regulations must also be followed if applicable. ## Section 164.512(j)-Uses and Disclosures to Avert a Serious Threat to Health or Safety\n\nIn the NPRM we proposed to allow covered entities to use or disclose protected health information without individual authorization-consistent with applicable law and ethics standards-based on a reasonable belief that use or disclosure of the protected health information was necessary to prevent or lessen a serious and imminent threat to health or safety of an individual or of the public."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 117}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 455)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n1&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00301\n\nnational rules, patients may face significant costs in trying to learn and understand the nature of a company's privacy policies.\nThe costs of learning about companies' policies are magnified by the difficulty patients face in detecting whether companies, in fact, are complying with those policies. Patients might try to adopt strategies for monitoring whether companies have complied with their announced policies. These sorts of strategies, however, are both costly (in time and effort) and likely to be ineffective. In addition, modern health care often requires protected health information to flow legitimately among multiple entities for purposes of treatment, payment, health care operations, and other necessary uses. Even if the patient could identify the provider whose data ultimately leaked, the patient could not easily tell which of those multiple entities had impermissibly transferred her information. Therefore, the cost and ineffectiveness of monitoring leads to less than optimal protection of individually identifiable health information. The incentives facing a company that acquires individually identifiable health information also discourage privacy protection. A company gains the full benefit of using such information, including its own marketing efforts or its ability to sell the information to third parties. The company, however, does not suffer the losses from disclosure of protected health information; the patient does. Because of imperfect monitoring, customers often will not\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\n597.7\n\n5,756.7\n\n5,905. 1,125.1\n\n800.3\n\n391.0\n\n227\n\n16.8\n\n78.8\n\n584.8\n\n737\n\n1,177.4\n\n52.4\n\n103.2\n\n17,554.7\n\n11,801.8\n\nlearn of, and thus not be able to take efficient action to prevent uses or disclosures of sensitive information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 454}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 238)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ns, such as persons with disabilities, who may be concerned about potential discrimination, embarrassment or stigmatization, or domestic violence victims, who may hide the real cause of their injuries.\nIn addition, commenters felt that a more uniform standard that covered all records would reduce the complexity, burden, cost, and enforcement problems that would result from the NPRM's proposal to treat electronic and nonelectronic records differently. Specifically, they suggested that such a standard would eliminate any confusion regarding how to treat mixed records (paper records that include information that has been stored or transmitted electronically) and would eliminate the need for health care providers to keep track of which portions of a paper record have been (or will be) stored or transmitted electronically, and which are not. Many of these commenters argued that limiting the definition to information that is or has at one time been electronic would result in different protections for electronic and paper records, which they believe would be unwarranted and give consumers a false sense of security. Other comments argued that the proposed definition would cause confusion for providers and patients and would likely cause difficulties in claims processing. Many others complained about the difficulty of determining whether information has been maintained or transmitted electronically. Some asked us to explicitly list the electronic functions that are intended to be excluded, such as voice mail, fax, etc. It was also recommended that the definitions of ''electronic transmission'' and ''electronic maintenance'' be deleted. It was stated that the rule may apply to many medical devices that are regulated by the FDA. A commenter also asserted that the proposal's definition was technically flawed in that computers are also involved in analog electronic transmissions such as faxes, telephone, etc., which is not the intent of the language."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 237}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 250)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nvariety of other discussions that help them maintain and improve the quality of care they provide. Quality of care improves when providers exchange information about treatment successes and failures.\nThese activities require sharing of protected health information. We do not intend this rule to interfere with these important activities. We therefore define treatment broadly and allow use and disclosure of protected health information about one individual for the treatment of another individual. Under this definition, only health care providers or a health care provider working with a third party can perform treatment activities. In this way, we temper the breadth of the definition by limiting the scope of information sharing. The various codes of professional ethics also help assure that information sharing among providers for treatment purposes will be appropriate. We note that poison control centers are health care providers for purposes of this rule. We consider the counseling and follow-up consultations provided by poison control centers with individual providers regarding patient outcomes to be treatment. Therefore, poison control centers and other health care providers can share protected health information about the treatment of an individual without a business associate contract. Comment: Many commenters suggested that ''treatment'' activities should include services provided to both a specific individual and larger patient populations and therefore urged that the definition of treatment specifically allow for such activities, sometimes referred to as ''disease management'' activities. Some argued that an analysis of an overall population is integral to determining which individuals would benefit from disease management services. Thus, an analysis of health care claims for enrolled populations enables proactive contact with those identified individuals to notify them of the availability of services."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 249}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 66)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nment hardware, software, and/or procedural mechanisms that record and examine activity in information systems that contain or use electronic protected health information. - (c)(1) Standard: Integrity.\nImplement policies and procedures to protect\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\nJkt 200001\n\nelectronic protected health information from improper alteration or destruction. - (2) Implementation specification: Mechanism to authenticate electronic protected health information (Addressable). Implement electronic mechanisms to corroborate that electronic protected health information has not been altered or destroyed in an unauthorized manner. 2. (d) Standard: Person or entity authentication. Implement procedures to verify that a person or entity seeking access to electronic protected health information is the one claimed. 3. (e)(1) Standard: Transmission security. Implement technical security measures to guard against unauthorized access to electronic protected health information that is being transmitted over an electronic communications network. - (2) Implementation specifications:\n5. (i) Integrity controls (Addressable). Implement security measures to ensure that electronically transmitted electronic protected health information is not improperly modified without detection until disposed of. 6. (ii) Encryption (Addressable). Implement a mechanism to encrypt electronic protected health information whenever deemed appropriate. ## §164.314 Organizational requirements. - (a)(1) Standard: Business associate contracts or other arrangements. - (i) The contract or other arrangement between the covered entity and its business associate required by §164.308(b) must meet the requirements of paragraph (a)(2)(i) or (a)(2)(ii) of this section, as applicable."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 65}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 46)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nnificant issues regarding the\n\nPO 00000\n\nFrm 00032\n\nfunding and implementation of HIPAA by Medicaid State agencies, and intends to address them through normal channels of communication with States. d.\nComment: One commenter stated that the proposed rule does not establish how the security standards will contribute to reduced cost for providers. One commenter expected the unintended result of this regulation will be impediment of EDI growth and perhaps even a decline in EDI use by providers. Another stated that the proposed rule actively discourages physician EDI participation by suggesting a fallback to paper processing for those unable to meet the cost of highly complex security compliance. Response: Ensuring the integrity of an electronic message, its delivery to the correct person, and its confidentiality must be an integral part of conducting electronic commerce. We believe that the consistent application of the measures provided in this rule will actually encourage use of EDI because it will provide increased confidence in the reliability and confidentiality of health information to all parties involved. Also, the implementation of these security requirements will reduce the potential overall cost of risk to a greater extent than additional security controls will increase costs. Put another way, the potential cost of not reasonably addressing security risks could substantially exceed the cost of compliance. e. Comment: One commenter stated that the implementation impact of the technical safeguards is clearly understated for physicians who use digitally-based equipment that has been in place for some time. The commenter believes that the rule will likely have greatest impact on the installed base of digital systems, including imaging modalities and other medical devices that store or transmit patient information because software for legacy systems will likely require retrofitting or replacement to come into compliance."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 45}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the required HIPAA security measures?"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRIN 0991-AB14\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY: Office for Civil Rights, HHS. ACTION: Final rule.\n\nSUMMARY: The Department of Health and Human Services (''HHS'' or ''Department'') modifies certain standards in the Rule entitled ''Standards for Privacy of Individually Identifiable Health Information'' (''Privacy Rule''). The Privacy Rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996.\n\nThe purpose of these modifications is to maintain strong protections for the privacy of individually identifiable health information while clarifying certain of the Privacy Rule's provisions, addressing the unintended negative effects of the Privacy Rule on health care quality or access to health care, and relieving unintended administrative burdens created by the Privacy Rule. DATES: This final rule is effective on October 15, 2002.\n\nFOR FURTHER INFORMATION CONTACT: Felicia Farmer, 1-866-OCR-PRIV (1866-627-7748) or TTY 1-866-7884989.\n\n## SUPPLEMENTARY INFORMATION:\n\nAvailability of copies, and electronic access.\n\nCopies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 (or toll-free at 1-866-5121800) or by fax to (202) 512-2250. The cost for each copy is $10.00. Alternatively, you may view and photocopy the Federal Register document at most libraries designated as Federal Depository Libraries and at many other public and academic libraries thr"}], "metadata": {"source": "privacy_mod_2002", "implementation_spec": "required", "safeguard_types": ["physical", "technical", "administrative"], "type": "implementation"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What's the difference between required and addressable implementation specifications?"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron Applied Cybersecurity Division Information Technology Laboratory\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\nFebruary 2024\n\n<!-- image -->\n\nU.S. Department of Commerce Gina M. Raimondo, Secretary\n\nNational Institute of Standards and Technology\n\nCertain commercial equipment, instruments, software, or materials, commercial or non-commercial, are identified in this paper in order to specify the experimental procedure adequately. Such identification does not imply recommendation or endorsement of any product or service by NIST, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose.\n\nThere may be references in this publication to other publications currently under development by NIST in accordance with its assigned statutory responsibilities. The information in this publication, including concepts and methodologies, may be used by federal agencies even before the completion of such companion publications. Thus, until each publication is completed, current requirements, guidelines, and procedures, where they exist, remain operative. For planning and transition purposes, federal agencies may wish to closely follow the development of these new publications by NIST.\n\nOrganizations are encouraged to review all draft publications during public comment periods and provide feedback to NIST. Many NIST cybersecurity publications, other than the ones noted above, are av"}], "metadata": {"source": "nist_sp800-66r2", "implementation_spec": "both", "safeguard_types": ["physical", "technical", "administrative"], "type": "implementation"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 43)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd which are held by a business associate of the covered entity are part of the\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00029\n\ncovered entity's designated record sets.\nAlthough we do not specify particular types of records that are always included in the designated record sets of clearinghouses when they are not acting as business associates, this definition includes a group of records that such a clearinghouse uses, in whole or in part, to make decisions about individuals. For the most part we retain, with slight modifications, the definition of ''record,'' defining it as any item, collection, or grouping of information that includes protected health information and is maintained, collected, used, or disseminated. ## Direct Treatment Relationship\n\nThis term was not included in the proposed rule. Direct treatment relationship means a relationship between a health care provider and an individual that is not an indirect treatment relationship (see definition of indirect treatment relationship, below). For example, outpatient pharmacists and Web-based providers generally have direct treatment relationships with patients. Outpatient pharmacists fill prescriptions written by other providers, but they furnish the prescription and advice about the prescription directly to the patient, not through another treating provider. Web-based providers generally deliver health care independently, without the orders of another provider. A provider may have direct treatment relationships with some patients and indirect treatment relationships with others. In some provisions of the final rule, providers with indirect treatment relationships are excepted from requirements that apply to other providers. See § 164.506 regarding consent for uses and disclosures of protected health information for treatment, payment, and health care operations, and § 164.520 regarding notice of information practices."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 42}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 369)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\npermissible in the civilian world may be impermissible in the military. We also note that individuals entering military service are aware that they will not have, and enjoy, the same rights as others.\nThe proposed rule would have authorized covered entities to use and disclose protected health information about armed forces personnel only for\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nactivities considered necessary by appropriate military command authorities to assure the proper execution of the military mission. In order for the military mission to be achieved and maintained, military command authorities need protected health information to make determinations regarding individuals' medical fitness to perform assigned military duties. The proposed rule required the Department of Defense (DoD) to publish a notice in the Federal Register identifying its intended uses and disclosures of protected health information, and we have retained this approach in the final rule. This notice will serve to limit command authorities' access to protected health information to circumstances in which disclosure of protected health information is necessary to assure proper execution of the military mission. With respect to comments regarding the lack of procedural safeguards for individuals, including those who are victims of domestic violence and abuse, we note that the rule does not provide new authority for covered entities providing health care to individuals who are Armed Forces personnel to use and disclose protected health information. Rather, the rule allows the Armed Forces to use and disclose such information only for those military mission purposes which will be published separately in the Federal Register . In addition, we note that the Privacy Act of 1974, as implemented by the DoD, provides numerous protections to individuals. We modify the proposal to publish privacy rules for the military in the Federal Register ."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 368}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 65)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nKey activities, descriptions, and sample questions for the Transmission Security standard | Key Activities | Description | Sample Questions | |-----------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 1."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 64}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 307)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nying or locating) a family member, a personal representative of the individual, or another person responsible for the care of the individual, of the individual's location, general condition, or death.\nThe final rule includes separate provisions for situations in which the individual is present and for when the individual is not present at the time of disclosure. When the individual is present and can make his or her own decisions, a covered entity may disclose protected health information only if the covered entity: (1) Obtains the\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nindividual's agreement to disclose to the third parties involved in the individual's care; (2) provides the individual with the opportunity to object to the disclosure, and the individual does not express an objection; or (3) reasonably infers from the circumstances, based on the exercise of professional judgement, that the individual does not object to the disclosure. The final rule continues to permit disclosures in circumstances when the individual is not present or when the opportunity to agree or object to the use or disclosure cannot practicably be provided due to the individual's incapacity or an emergency circumstance. In such instances, covered entities may, in the exercise of professional judgement, determine whether the disclosure is in the individual's best interests and if so, disclose only the protected health information that is directly relevant to the person's involvement with the individual's health care. As discussed in the preamble for this section, we do not intend to disrupt most covered entities' current practices with respect to informing family members and others with whom a patient has a close personal relationship about a patient's specific health condition when a patient is incapacitated due to a medical emergency and the family member or close personal friend comes to the covered entity to ask about the patient's condition."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 306}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 15)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\ng., implantable defibrillator, pacemaker, etc.) can be reprogrammed by an unauthorized user. If exploited, this vulnerability could result in permanent impairment, a life-threatening injury, or death.\nThe manufacturer is not aware that the vulnerability has been exploited and determines that the vulnerability is related to a hardcoded password. The risk assessment concludes that the exploitability of the vulnerability is moderate and the risk of patient harm is uncontrolled. The manufacturer notifies appropriate stakeholders, and distributes a validated emergency patch within 60 days. The manufacturer does not actively participate as a member of an ISAO and therefore reports this action to the FDA under 21 CFR 806.10. - A vulnerability known to the security community, yet unknown to a medical device manufacturer, is incorporated into a class II device during development. Following clearance, the manufacturer becomes aware of the vulnerability and determines that the device continues to meet its specifications, and that no device malfunctions or patient injuries have been reported. There is no evidence that the identified vulnerability has been exploited. However, it was determined that the vulnerability introduced a new failure mode to the device that impacts its essential performance, and the device's design controls do not mitigate the risk. The manufacturer conducts a risk assessment and determines that without additional mitigations, the risk of patient harm is uncontrolled. Since the manufacturer does not currently have a software update to mitigate the impact of this vulnerability on the device's essential performance, within 30 days of learning of the vulnerability the manufacturer notifies its customers, the ISAO, and user community of the cybersecurity risk and instructs them to disconnect the device from the hospital network to prevent unauthorized access to the device."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 14}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 199)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nnd\n- (C) Report to the covered entity any security incident of which it becomes aware, including breaches of unsecured protected health information as required by § 164.410. - (ii) Other arrangements.\nThe covered entity is in compliance with paragraph (a)(1) of this section if it has another arrangement in place that meets the requirements of § 164.504(e)(3). - (iii) Business associate contracts with subcontractors. The requirements of paragraphs (a)(2)(i) and (a)(2)(ii) of this section apply to the contract or other arrangement between a business associate and a subcontractor required by § 164.308(b)(4) in the same manner as such requirements apply to contracts or other arrangements between a covered entity and business associate. - (b) * * *\n\n(2) *\n\n*\n\n*\n\n- (iii) Ensure that any agent to whom it provides this information agrees to implement reasonable and appropriate security measures to protect the information; and\n\n*\n\n*\n\n*\n\nE:\\FR\\FM\\25JAR2.SGM\n\n*\n\n*\n\n25JAR2\n\n*\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n- ■ 38. Revise the introductory text of §164.316 and the third sentence of paragraph (a) to read as follows:\n\n## §164.316 Policies and procedures and documentation requirements. A covered entity or business associate must, in accordance with § 164.306: (a) * * * A covered entity or business associate may change its policies and procedures at any time, provided that the changes are documented and are implemented in accordance with this subpart. *\n\n*\n\n*\n\n*\n\n*\n\n- ■ 39. Revise § 164.402 to read as follows:\n\n## §164.402 Definitions. As used in this subpart, the following terms have the following meanings:\n\nBreach means the acquisition, access, use, or disclosure of protected health information in a manner not permitted under subpart E of this part which compromises the security or privacy of the protected health information. - (1) Breach excludes:\n2."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 198}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 58)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nsecurity standards we adopt in this rule were developed with considerable input from the health care industry, including providers, health plans, clearinghouses, vendors, and standards organizations.\nIndustry members strongly advocated the flexible approach we adopt in this rule, which permits each affected entity to develop cost-effective security measures appropriate to their particular needs. We believe that this approach will yield the lowest implementation cost to industry while ensuring that electronic protected health information is safeguarded. All of the nation's health plans (over 2 million) and providers (over 600,000) will need to conduct some level of gap analysis to assess current procedures against the standards. However, we cannot estimate the number of covered entities that would have to implement additional security systems and procedures to meet the adopted standards. Also, we are not able to estimate the number of providers that do not conduct electronic transactions\n\nVerDate Jan&lt;31&gt;2003\n\ntoday but may choose to do so at some future time (these would be entities that send and receive paper transactions and maintain paper records and thus would not be affected). We believe that the security standards represent the minimum necessary for adequate protection of health information in an electronic format and as such should be implemented by all covered entities. As discussed earlier in this preamble, the security requirements are both scalable and technically flexible; and while the law requires each health plan that is not a small plan to comply with the security and electronic signature requirements no later than 24 months after the effective date of the final rule, small plans will be allowed an additional 12 months to comply. Since we are unable to estimate the number of entities that may need to make changes to meet the security standards, we are also unable to estimate the cost for those entities."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 57}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 146)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne information is maintained or accessible on-site. Covered entities must act on a request for access within 60 days of receiving the request if the information is not maintained or accessible on-site.\nIf the covered entity is unable to act on a request within the applicable deadline, it may extend the deadline by no more than 30 days by providing the individual with a written statement of the reasons for the delay and the date by which the covered entity will complete its action on the request. This written statement describing the extension must be provided within the standard deadline. A covered entity may only extend the deadline once per request for access. This provision permits a covered entity to take a total of up to 60 days to act on a request for access to information maintained on-site and up to 90 days to act on a request for access to information maintained off-site. The requirements for a covered entity to comply with or deny a request for access, in whole or in part, are described below. ## Section 164.524(c)-Provision of Access\n\nIn the NPRM, we proposed to require covered health care providers and health plans, upon accepting a request for access, to notify the individual of the decision and of any steps necessary to fulfill the request; to provide the information requested in the form or format requested, if readily producible in such form or format; and to facilitate the process of inspection and copying. We generally retain the proposed approach in the final rule. If a covered entity accepts a request, in whole or in part, it must notify the individual of the decision and provide the access requested. Individuals have the right both to inspect and to copy protected health information in a designated record set. The individual may choose whether to inspect the information, to copy the information, or to do both."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 145}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 17)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\ner's processes, FDA recommends that a manufacturer track and record the measures and metrics below, 38 and provide them in premarket submissions and PMA annual reports (21 CFR 814.84), when available.\n39 Selecting appropriate measures and metrics for the processes that define an SPDF is important to ensure that device design appropriately addresses cybersecurity in compliance with the QS regulation. At a minimum, FDA recommends tracking the following measures and metrics, or those that provide equivalent information:\n\n- Percentage of identified vulnerabilities that are updated or patched (defect density);\n- Duration from vulnerability identification to when it is updated or patched; and\n- Duration from when an update or patch is available to complete implementation in devices deployed in the field, to the extent known. Averages of the above measures should be provided if multiple vulnerabilities are identified and addressed. These averages may be provided over multiple time frames based on volume or in response to process or procedure changes to increase efficiencies of these measures over time. ## B. Security Architecture\n\nManufacturers are responsible for identifying cybersecurity risks in their devices and the systems in which they expect those devices to operate, and implementing the appropriate controls to mitigate those risks. These risks may include those introduced by device reliance on hospital networks, cloud infrastructure, or 'other functions' (as defined in FDA's guidance 'Multiple Function Device Products: Policy and Considerations'), for example. A security architecture, like a system architecture, defines the system and all end-to-end connections into and/or out of the system. A security architecture definition process 40 includes both high-level definitions of the devices and/or systems that interact, and detailed information on the implementations for how those interactions occur and are secured."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 16}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 120)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nthese modifications make sure that vast research resources continue to be usable for important research that result in development of new medical technology and increased quality of health care. ## 3.\nSharing Information for Quality Activities and Public Health\n\nHealth plans and health care providers play a valuable role in assessing the quality of health care and improving health care outcomes. The modifications ensure access to health information needed by covered entities and others involved in quality activities. The increased sharing of information will help to limit medical error rates and to determine appropriate, high quality treatment for specific conditions by encouraging these issues to be studied and allowing benchmarking against similar entities. The modifications, in creating a limited data set, also encourages private entities to continue studies and research in\n\nVerDate Aug&lt;2,&gt;2002\n\nsupport of public health activities. These activities help reduce the spread and occurrence of diseases. ## 4. Availability of Information About Treatment Alternatives\n\nUnderstanding treatment alternatives is an important factor in increasing an individual's involvement in his or her own treatment and making informed health care decisions. By streamlining the marketing requirements, the modifications make it easier for a covered entity to understand that they may share valuable information about treatment alternatives with their patients or enrollees, and the conditions for doing so. These modifications make sure that covered entities will be permitted to continue to share important treatment alternative information that gives patients knowledge about newer, less expensive, and/or more appropriate health care options. ## F. Alternatives\n\nIn July 2001, the Department clarified the Privacy Rule in guidance, where feasible, to resolve some of the issues raised by commenters."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 119}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 110)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nate contract that the business associate will provide the accounting to individuals, as may be appropriate given the protected health information held by, and the functions of, the business associate.\nComment: One commenter asked whether a business associate agreement in electronic form, with an electronic signature, would satisfy the Privacy Rule's business associate requirements. Response: The Privacy Rule generally allows for electronic documents to\n\nPO 00000\n\nFrm 00073\n\nqualify as written documents for purposes of meeting the Rule's requirements. This also applies with respect to business associate agreements. However, currently, no standards exist under HIPAA for electronic signatures. Thus, in the absence of specific standards, covered entities should ensure any electronic signature used will result in a legally binding contract under applicable State or other law. Comment: Certain commenters raised concerns with the Rule's classification of attorneys as business associates. A few of these commenters urged the Department to clarify that the Rule's requirement at § 164.504(e)(2)(ii)(H), which requires a contract to state the business associate must make information relating to the use or disclosure of protected health information available to the Secretary for purposes of determining the covered entity's compliance with the Rule, not apply to protected health information in possession of a covered entity's lawyer. Commenters argued that such a requirement threatens to impact attorney-client privilege. Others expressed concern over the requirement that the attorney, as a business associate, must return or destroy protected health information at termination of the contract. It was argued that such a requirement is inconsistent with many current obligations of legal counsel and is neither warranted nor useful. Response: The Department does not modify the Rule in this regard. The Privacy Rule is not intended to interfere with attorney-client privilege."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 109}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 62)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nthat a covered entity should be permitted to disclose protected health information without individual authorization as required by law, even if remuneration is received in exchange for the disclosure.\nCommenters also submitted a number of comments and questions regarding the ability of business associates to receive fees under both the proposed exception specifically for fees paid by a covered entity to a business associate and the general exception that would allow a covered entity to receive a reasonable, cost-based fee to cover the costs to prepare and transmit the data or a fee otherwise expressly permitted by other law for any disclosure permitted by the Privacy Rule. While commenters generally supported these exceptions, commenters were concerned that these exceptions appeared not to cover the common situation where a business associate, rather than the covered entity, receives remuneration from a third party for making a permitted disclosure under the Privacy Rule. For example, a number of commenters stated that covered entities often outsource to release of information (ROI) vendors the processing of requests for copies of medical records from third parties and\n\nVerDate Mar&lt;15&gt;2010\n\nthat these vendors and not the covered entities bill for the reasonable costs of providing the records to the requestors. Commenters asked that the final rule clarify that business associates can continue to receive payment of costs from third parties for providing this service on behalf of covered entities. Another commenter requested that the final rule clarify that the exception for remuneration to a business associate for activities performed on behalf of a covered entity also applies to remuneration received by subcontractors performing services on behalf of business associates."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 61}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 13)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nd, therefore, require prior authorization and those that are not marketing. The Department intends to update its guidance on this topic and address specific examples raised by commenters at that time.\nComment: A number of commenters wanted the Department to amend the face-to-face authorization exception. Some urged that it be broadened to include telephone, mail and other common carriers, fax machines, or the Internet so that the exception would cover communications between providers and patients that are not in person. For example, it was pointed out that some providers, such as home\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\ndelivery pharmacies, may have a direct treatment relationship, but communicate with patients through other channels. Some raised specific concerns about communicating with ''shut-ins'' and ''persons living in rural areas.'' Other commenters asked the Department to make the exception more narrow to cover only those marketing communications made by a health care provider, as opposed to by a business associate, or to cover only those marketing communications of a provider that arise from a treatment or other essential health care communication. Response: The Department believes that expanding the face-to-face authorization exception to include telephone, mail, and other common carriers, fax machines or the Internet would create an exception essentially for all types of marketing communications. All providers potentially use a variety of means to communicate with their patients. The authorization exclusion, however, is narrowly crafted to permit only face-toface encounters between the covered entity and the individual. The Department believes that further narrowing the exception to place conditions on such communications, other than that it be face-to-face, would neither be practical nor better serve the privacy interests of the individual."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 12}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 41)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nVerDate Aug&lt;2,&gt;2002\n\nadopted in this rulemaking does not affect this policy. The Privacy Rule does not define the information that may be transmitted for enrollment and disenrollment purposes.\nRather, the Department in the Transactions Rule has adopted a standard transaction for enrollment and disenrollment in a health plan. That standard (ASC X12N 834, Benefit Enrollment and Maintenance, Version 4010, May 2000, Washington Publishing Company) specifies the required and situationally required data elements to be transmitted as part of such a transaction. While the standard enrollment and disenrollment transaction does not include any substantial clinical information, the information provided as part of the transaction may indicate whether or not tobacco use, substance abuse, or short, long-term, permanent, or total disability is relevant, when such information is available. However, the Department clarifies that, in disclosing or maintaining information about an individual's enrollment in, or disenrollment from, a health insurer or HMO offered by the group health plan, the group health plan may not include medical information about the individual above and beyond that which is required or situationally required by the standard transaction and still qualify for the exceptions for enrollment and disenrollment information allowed under the Rule. Comment: Several commenters recommended that enrollment and disenrollment information specifically be excluded from the definition of ''protected health information.'' They argued that this change would be warranted because enrollment and disenrollment information do not include health information. They further argued that such a change would help alleviate confusion surrounding the application of the Privacy Rule to employers."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 40}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 121)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nblic, including automated collection techniques. Section A below summarizes the proposed information collection requirements on which we explicitly seek, and will consider, public comment for 30 days.\nDue to the complexity of this regulation, and to avoid redundancy of effort, we are referring readers to Section V (Final Regulatory Impact Analysis published in the Federal Register on December 28, 2000), to review the detailed cost assumptions associated with these PRA requirements. Section B below references the HIPAA Privacy Rule regulation sections published for 60-day public comment on November 3, 1999, and for 30-day public comment on December 28, 2000,\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\nin compliance with the PRA public comment process. These earlier publications contained the information collection requirements for these sections as required by the PRA. The portions of the Privacy Rule, included by reference only in Section B, have not changed subsequent to the two public comment periods. Thus, the Department has fulfilled its statutory obligation to solicit public comment on the information collection requirements for these provisions. The information in Section B is pending OMB PRA approval, but is not reopened for comment. However, for clarity purposes, we will upon this publication submit to OMB for PRA review and approval the entire set of information collection requirements required referenced in §§ 160.204, 160.306, 160.310, 164.502, 164.504, 164.506, 164.508, 164.510, 164.512, 164.514, 164.520, 164.522, 164.524, 164.526, 164.528, and 164.530. ## Section A\n\n1."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 120}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 12)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nCongress to enact a medical privacy statute and asked the Secretary of Health and Human Services to provide Congress with recommendations for protecting the confidentiality of health care information.\nThe Congress further recognized the importance of such standards by providing the Secretary with authority to promulgate regulations on health care privacy in the event that lawmakers were unable to act within the allotted three years. Finally, it also is important for the U.S. to join the rest of the developed world in establishing basic medical privacy protections. In 1995, the European Union (EU) adopted a Data Privacy Directive requiring its 15 member states to adopt consistent privacy laws by October 1998. The EU urged all other nations to do the same or face the potential loss of access to information from EU countries. ## Statutory Background\n\nHistory of the Privacy Component of the Administrative Simplification Provisions\n\nThe Congress addressed the opportunities and challenges presented by the rapid evolution of health information systems in the Health Insurance Portability and Accountability Act of 1996 (HIPAA), Public Law 104-191, which was enacted on August 21, 1996. Sections 261 through 264 of HIPAA are known as the Administrative Simplification provisions. The major part of these Administrative Simplification\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00009\n\nprovisions are found at section 262 of HIPAA, which enacted a new part C of title XI of the Social Security Act (hereinafter we refer to the Social Security Act as the ''Act'' and we refer to all other laws cited in this document by their names). In section 262, Congress primarily sought to facilitate the efficiencies and cost savings for the health care industry that the increasing use of electronic technology affords."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 11}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 211)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n.504(e) that were in effect on such date; and\n- (ii) The contract or other arrangement is not renewed or modified from March 26, 2013, until September 23, 2013. - (2) Limited deemed compliance period.\nA prior contract or other arrangement that meets the qualification requirements in paragraph (e) of this section shall be deemed compliant until the earlier of:\n- (i) The date such contract or other arrangement is renewed or modified on or after September 23, 2013; or\n- (ii) September 22, 2014. *\n\n*\n\n*\n\n*\n\n*\n\n- (f) Effect of prior data use agreements. If, prior to [January 25, 2013, a covered entity has entered into and is operating pursuant to a data use agreement with a recipient of a limited data set that complies with § 164.514(e), notwithstanding § 164.502(a)(5)(ii), the covered entity may continue to disclose a limited data set pursuant to such agreement in exchange for remuneration from or on behalf of the recipient of the protected health information until the earlier of:\n- (1) The date such agreement is renewed or modified on or after September 23, 2013; or\n\n(2) September 22, 2014. *\n\n*\n\n*\n\n*\n\n*\n\nDated: January 15, 2013. ## Kathleen Sebelius,\n\nSecretary. [FR Doc. 2013-01073 Filed 1-17-13; 4:15 pm]\n\nBILLING CODE 4153-01-P\n\nFmt 4701\n\nSfmt 9990\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\n18:57 Jan 24, 2013\n\nJkt 229001"}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 210}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 20)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nhe individual pursuant to § 164.528. The Department does not believe such a requirement would be practicable; in many instances, the covered entity may not know that an incidental disclosure occurred.\nTo make this policy clear, the Department includes an explicit exception for such disclosures to the accounting standard at § 164.528(a)(1). ## Response to Other Public Comments\n\nComment: One commenter expressed concern that the requirement reasonably to safeguard protected health information would be problematic because any unintended use or disclosure could arguably demonstrate a failure to ''reasonably safeguard.'' This commenter requested that the Department either delete the language in §164.530(c)(2)(ii) or modify the language to make clear that the fact that an incidental use or disclosure occurs does not imply that safeguards were not reasonable. Response: The Department clarifies that the fact that an incidental use or disclosure occurs does not by itself imply that safeguards were not reasonable. However, the Department does not believe that a modification to the proposed language is necessary to express this intent. The language proposed and now adopted at §164.530(c)(2)(ii) requires only that the covered entity reasonably safeguard protected health information to limit incidental uses or disclosures, not that the covered entity prevent all incidental uses and disclosures. Thus, the Department expects that incidental uses and disclosures will occur and permits such uses and disclosures to the extent the covered entity has in place reasonable safeguards and has applied the minimum necessary standard, where applicable. Comment: Another commenter requested that the Department clarify its proposal to assure that unintended disclosures will not result in civil penalties. Response: The Department's authority to impose civil monetary penalties on\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00014\n\nviolations of the Privacy Rule is defined in HIPAA."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 19}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 6)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n5&gt;2010\n\nmodifications to the HIPAA Rules, and we proposed to add a provision at §160.105 to address the compliance date generally for implementation of new or modified standards in the HIPAA Rules.\nWe proposed that §160.105 would provide that with respect to new standards or implementation specifications or modifications to standards or implementation specifications in the HIPAA Rules, except as otherwise provided, covered entities and business associates would be required to comply with the applicable new or modified standards or implementation specifications no later than 180 days from the effective date of any such change. For future modifications to the HIPAA Rules necessitating a longer compliance period, we would specify a longer period in the regulatory text. Finally, we proposed to retain the compliance date provisions at §§164.534 and 164.318, which provide the compliance dates of April 14, 2003, and April 20, 2005, for initial implementation of the HIPAA Privacy and Security Rules, respectively, for historical purposes only. ## Overview of Public Comments\n\nMost of the comments addressing the proposed compliance periods as outlined above fell into three categories. First, several commenters supported the proposed compliance timelines and agreed that 180 days is sufficient time for covered entities, business associates, and subcontractors of all sizes to come into compliance with the final rule. Second, a few commenters supported the proposed 180-day compliance period, but expressed concern that the Department may wish to extend the 180day compliance period in the future, if it issues modifications or new provisions that require a longer compliance period."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 5}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 158)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nafter to the applicable compliance date of this rule for purposes of the project provided that the covered entity complies with all limitations expressed in the consent, authorization, or permission.\nIf, pursuant to this section, a covered entity relies upon a previously obtained consent, authorization, or other express legal permission and agrees to a request for a restriction by an individual under §164.522(a), any subsequent use or disclosure under that consent, authorization, or permission must comply with the agreed upon restriction as well. We believe it is necessary to grandfather in previously obtained consents, authorizations, or other express legal permissions in these circumstances to ensure that important functions of the health care system are not impeded. We link the effectiveness of such consents, authorizations, or permissions in these circumstances to the applicable compliance date to give covered entities sufficient notice of the requirements set forth in §§ 164.506 and 164.508. The rule does not change the past effectiveness of consents, authorizations, or other express legal permissions that do not come within this section. This means that uses or disclosures of individually identifiable health information made prior to the compliance date of this regulation are not subject to sanctions, even if they were made pursuant to documents or permissions that do not meet the requirements of this rule or were made without permission. This rule alters only the future effectiveness of the previously obtained consents, authorizations, or permissions. Covered entities are not required to rely upon these consents, authorizations, or permissions and may obtain new consents or authorizations that meet the applicable requirements of §§ 164.506 and 164.508."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 157}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 26)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\ninstance of access to or use of information. Fmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\nJkt 200001\n\nd. Comment: One commenter stated that this requirement should address suspected misuse also.\nResponse: We agree that security incidents include misuse of data; therefore, this requirement is addressed. e. Comment: Several commenters asked that this requirement be deleted. One commenter asked that we delete the implementation features. Response: As indicated above, we have adopted the proposed standard and combined the implementation specifications. ## 7. Contingency Plan (§ 164.308(a)(7)(i))\n\nWe proposed that a contingency plan must be in effect for responding to system emergencies. The plan would include an applications and data criticality analysis, a data backup plan, a disaster recovery plan, an emergency mode operation plan, and testing and revision procedures. In this final rule, we make the implementation specifications for testing and revision procedures and an applications and data criticality analysis addressable, but otherwise require that the contingency features proposed be met. a. Comment: Several commenters suggested the contingency plan requirement be deleted. Several thought that this aspect of the proposed regulation went beyond its intended scope. Another believed that more discussion and development is needed before developing regulatory guidance on contingency plans. Others wanted this to be an optional requirement. In contrast, one commenter requested more guidance concerning contingency planning. Still others wanted to require that a contingency plan be in place but stated that we should not regulate its contents. One comment stated that data backup, disaster recovery, and emergency mode operation should not be part of this requirement. Response: A contingency plan is the only way to protect the availability, integrity, and security of data during unexpected negative events."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 25}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 424)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne public policy reasons for limiting the extent to which a criminal investigation is made known publicly, including the possibility that suspects may destroy or falsify evidence, hide assets, or flee.\nThe commenter also pointed out that disclosure of an investigation may unfairly stigmatize a person or entity who is eventually found to be innocent of any wrongdoing. On the other hand, many commenters disagreed with the exemption for recording disclosures related to oversight activities and law enforcement. Many of these commenters stated that the exclusion would permit broad exceptions for government purposes while holding disclosures for private purposes to a more burdensome standard. Some commenters felt that the NPRM made it too easy for law enforcement to obtain an exception. They suggested that law enforcement should not be excepted from the accounting provision unless there is a court order. One commenter recommended that a written request for exclusion be dated, signed by a supervisory official, and contain a certification that the official is personally familiar with the purpose of the request and the justification for exclusion from accounting. Response: We do not agree with comments suggesting that we permanently exclude disclosures for oversight or law enforcement from the accounting. We believe generally that individuals have a right to know who is obtaining their health information and for what purposes. At the same time, we agree with commenters that were concerned that an accounting could tip off subjects of investigations. We have retained a timelimed exclusion period similar to that proposed in the NPRM."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 423}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 18)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nwith the lack of uniform Federal and State privacy laws, we note that the preemption provisions of the HIPAA Rules are based on section 1178 of the Social Security Act and section 264(c)(2) of HIPAA.\nThrough these statutory provisions, Congress made clear that the HIPAA privacy requirements are to supersede only contrary provisions of State law, and not even in all such cases, such as where the provision of State law provides more stringent privacy protections than the HIPAA Privacy Rule. Accordingly, the HIPAA Privacy Rule provides a Federal floor of privacy protections, with States free to impose more stringent privacy protections should they deem appropriate. ## b. Section 160.202-Definitions i. Definition of ''Contrary'' Proposed Rule\n\nThe term ''contrary'' is defined in §160.202 to make clear when the preemption provisions of HIPAA apply to State law. For the reasons set forth on page 40875 of the July 2010 NPRM, we proposed to amend the definition of ''contrary'' by inserting references to business associates in paragraph (1) of the definition. We also expanded the reference to the HITECH statutory provisions in paragraph (2) of the definition to encompass all of the sections of subtitle D of the HITECH Act, rather than merely to section 13402, which was added by the breach notifications interim final rule. These\n\nVerDate Mar&lt;15&gt;2010\n\nchanges would give effect to section 13421(a). ## Final Rule\n\nThe Department did not receive substantive public comment on this proposal. The final rule adopts the proposed modifications. ## ii. Definition of ''More Stringent'' Proposed Rule\n\nThe term ''more stringent'' is part of the statutory preemption language under HIPAA. HIPAA preempts State law that is contrary to a HIPAA privacy standard unless, among other exceptions, the State law is more stringent than the contrary HIPAA privacy standard. We proposed to amend the definition to add a reference to business associates."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 17}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 127)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nmeframe, such determinations are fact specific and there are many factors that may be relevant, including the nature of the breach, number of individuals affected, and resources of the covered entity.\n## Content of the Notification\n\nSection 13402(f) of the HITECH Act set forth the content requirements for the breach notice to the individual. Section 164.404(c) of the interim final rule incorporated the statutory elements, requiring the following information be included in the notices, to the extent possible: (1) A brief description of what happened, including the date of the breach and the date of the discovery of the breach, if known; (2) a description of the types of unsecured protected health information that were involved in the breach (such as whether full name, social security number, date of birth, home address, account number, diagnosis, disability code, or other types of information were involved); (3) any steps individuals should take to protect themselves from potential harm resulting from the breach; (4) a brief description of what the covered entity involved is doing to investigate the breach, mitigate the harm to individuals, and to protect against any further breaches; and (5) contact procedures for individuals to ask questions or learn additional information, which shall include a tollfree telephone number, an email address, Web site, or postal address. The interim final rule added the term ''diagnosis,'' to the parenthetical listing of examples of types of protected health information, which was not in the statute, to make clear that, where appropriate, a covered entity may need to indicate in the notification to the individual whether and what types of treatment information were involved in a breach."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 126}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 164)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nvices, is a health care provider because the manufacturer is providing ''health care'' as defined in the rule. However, that manufacturer is a covered entity only if it conducts standard transactions.\nWe do not intend that a manufacturer of supplies that are generic and not customized or otherwise specifically designed for particular individuals, e.g., ace bandages for a hospital, is a health care provider. Such a manufacturer is not providing ''health care'' as defined in the rule and is therefore not a covered entity. We note that, even if such a manufacturer is a covered entity, it may be an ''indirect treatment provider'' under this rule, and thus not subject to all of the rule's requirements. With regard to a ''supplier component,'' the final rule addresses the status of the unit or unit(s) of a larger entity that constitute a ''health care component.'' See further discussion under §164.504 of this preamble. Finally, we clarify that drug, biologics, and device manufacturers are not health care providers simply by virtue of their manufacturing activities. The manufacturer must be providing health care consistent with the final\n\nFrm 00108\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nrule's definition in order to be considered a health care provider. Comment: A few commenters asked that the Department clarify that pharmaceutical manufacturers are not covered entities. It was explained that pharmaceutical manufacturers provide support and guidance to doctors and patients with respect to the proper use of their products, provide free products for doctors to distribute to patients, and operate charitable programs that provide pharmaceutical drugs to patients who cannot afford to buy the drugs they need. Response: A pharmaceutical manufacturer is only a covered entity if the manufacturer provides ''health care'' according to the rule's definition and conducts standard transactions."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 163}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 531)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nes or illness without regard to fault. ## §164.514 Other requirements relating to uses and disclosures of protected health information. (a) Standard: de-identification of protected health information.\nHealth information that does not identify an individual and with respect to which there is no reasonable basis to believe that the information can be used to identify an individual is not individually identifiable health information. (b) Implementation specifications: requirements for de-identification of protected health information. A covered entity may determine that health information is not individually identifiable health information only if:\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00358\n\n(1) A person with appropriate knowledge of and experience with generally accepted statistical and scientific principles and methods for rendering information not individually identifiable:\n\n(i) Applying such principles and methods, determines that the risk is very small that the information could be used, alone or in combination with other reasonably available information, by an anticipated recipient to identify an individual who is a subject of the information; and\n\n(ii) Documents the methods and results of the analysis that justify such determination; or\n\n(2)(i) The following identifiers of the individual or of relatives, employers, or household members of the individual, are removed:\n\n(A) Names;\n\n(B) All geographic subdivisions smaller than a State, including street address, city, county, precinct, zip code, and their equivalent geocodes, except for the initial three digits of a zip code if, according to the current publicly available data from the Bureau of the Census:\n\n( 1 ) The geographic unit formed by combining all zip codes with the same three initial digits contains more than 20,000 people; and\n\n( 2 ) The initial three digits of a zip code for all such geographic units containing 20,000 or fewer people is changed to 000."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 530}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 451)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ndually identifiable health information. The third objective is to protect the privacy of all individually identifiable health information held by covered entities, including their business associates.\nHealth information is currently stored and transmitted in multiple forms, including electronic, paper, and oral forms. To provide consistent protection to information, and to avoid requiring covered entities from distinguishing between health information that has been transmitted or maintained electronically and that which has not, this rule covers all individually identifiable health information in any form maintained or transmitted by a covered entity. For purposes of this cost analysis, the Department has assumed all health care providers will be affected by the rule. This results in an overestimation of costs because there are providers that do not engage in any HIPAA standard transactions, and therefore, are not affected. The Department could not obtain any reliable data on the number of such providers, but the available data suggest that there are very few such entities, and given the expected increase in all forms of electronic health care in the coming decade, the number of paper-only providers is likely to decrease. A. Relationship of This Analysis to Analyses in Other HIPAA Regulations\n\nCongress has recognized that privacy standards, implementation specifications and requirements must accompany the electronic data interchange standards, implementation specifications and requirements because the increased ease of transmitting and sharing individually identifiable health\n\nJkt 194001\n\nPO 00000\n\nFrm 00299\n\ninformation will result in an increase in concern regarding privacy and confidentiality of such information. The bulk of the first Administrative Simplification section that was debated on the floor of the Senate in 1994 (as part of the Health Security Act) was made up of privacy provisions."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 450}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 184)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ncarried out. While we acknowledge the overall savings associated with this change, as with other provisions in this rule providing increased flexibility for compliance, we are unable to quantify them.\nFor example, we do not have data on how many family doctors and other providers generally make these types of disclosures and how many requests such providers generally receive for proof of immunization, and we did not receive data from commenters that could inform our estimating savings in this area. ## E. Additional Regulatory Analyses\n\n## 1. Regulatory Flexibility Act\n\nThe Regulatory Flexibility Act requires agencies to analyze and consider options for reducing regulatory burden if the regulation will impose a significant burden on a substantial number of small entities. The Act requires the head of the agency to either certify that the rule would not impose such a burden or perform a regulatory flexibility analysis and consider alternatives to lessen the burden. For the reasons stated below, it is not expected that the cost of compliance will be significant for small entities. Nor is it expected that the cost of compliance will fall disproportionately on small entities. Although many of the covered entities and business associates affected by the rule are small entities, they do not bear a disproportionate cost burden compared to the other entities subject to the rule. Further, with respect to small business associates, only the fraction of these entities that has not made a good faith effort to comply with existing requirements will experience additional costs under the rule. The Department did not receive any comments on its certification in the proposed rules. Therefore, the Secretary certifies that this rule will not have a significant economic impact on a substantial number of small entities."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 183}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 37)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nic security measures, and the operational impact. Thus, the costs of implementing the Security Rule for large, mid-sized, or small business associates will be proportional to their size and resources.\nNotwithstanding the above, based on the comments, we acknowledge that some business associates, particularly the smaller or less sophisticated business associates that may have access to electronic protected health information for limited purposes, may not have engaged in the formal administrative safeguards such as having performed a risk analysis, established a risk management program, or designated a security official, and may not have written policies and procedures, conducted employee training, or documented compliance as the statute and these regulations would now require. For these business associates, we include an estimate for compliance costs below in the regulatory impact analysis. We also refer these business associates to our educational papers and other guidance on compliance with the HIPAA Security Rule found at: http://www.hhs.gov/ocr/ privacy/hipaa/administrative/ securityrule . These materials provide guidance on conducting risk analyses and implementing the other administrative safeguards required by the Security Rule, which may prove helpful to these business associates and facilitate their compliance efforts. b. Section 164.306-Security Standards: General Rules\n\n## Proposed Rule\n\nSection 164.306 sets out the general rules that apply to all of the security\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with standards and implementation specifications that follow in the Security Rule."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 36}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 2)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\n.............................................................. | Background.............................................................................................................................\n| 3                                                                                                                                                                                                                         |\n| IV. | General Principles................................................................................................................... | General Principles................................................................................................................... | 5                                                                                                                                                                                                                         |\n| A. | Cybersecurity is Part of Device Safety and the Quality System Regulation ................... | Cybersecurity is Part of Device Safety and the Quality System Regulation ................... | 5                                                                                                                                                                                                                         |\n| 1. A Secure Product Development Framework (SPDF) may be one way to satisfy the QS regulation .......................................................................................................................... 6 | 1. A Secure Product Development Framework (SPDF) may be one way to satisfy the QS regulation .......................................................................................................................... 6 | 1. A Secure Product Development Framework (SPDF) may be one way to satisfy the QS regulation .........................................................................................................................."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 1}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 345)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncy make reimbursement and related decisions; and to (2) third-party payors that must provide data collected by device manufacturers to HCFA to help the agency make reimbursement and related decisions.\nResponse: The decision to eliminate the general provision permitting disclosures to government health data systems makes this issue moot with respect to such disclosures. We note that the information used by manufacturers to support coverage determinations often is gathered pursuant to patient authorization (as part of informed consent for research) or as an approved research project. There also are many cases in which information can be de-identified before it is disclosed. Where HCFA hires a contractor to collect such protected health information, the contractor may do so under HCFA's authority, subject to the business associate provisions of this rule. Comment: One commenter recommended stating in the final rule that de-identified information from government health data systems can be disclosed to other entities. Response: HHS does not have the authority to regulate re-use or redisclosure of information by agencies or institutions that are not covered entities under the rule. However, we support the policies and procedures that public agencies already have implemented to de-identify any information that they redisclose, and we encourage the continuation of these activities. ## Disclosures for Payment Processes\n\nProposed §164.510(j) of the NPRM would have allowed disclosure of protected health information without authorization for banking and payment processes. In the final rule, we eliminate this provision."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 344}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 193)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nementation specification, including how the state law meets the criteria at §160.203(b).''\n\nResponse: The decision not to have a formal process for issuing advisory opinions renders these issues moot.\n## Sections 160.203(c) and 160.203(d)Statutory Carve-Outs\n\nComment: Several commenters asked that the Department provide more specific examples itemizing activities traditionally regulated by the state that could constitute ''carve-out'' exceptions. These commenters also requested that the Department include language in the regulation stating that if a state law falls within several different exceptions, the state chooses which determination exception shall apply. Frm 00127\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nResponse: We are concerned that itemizing examples in this way could leave out important state laws or create inadvertent negative implications that laws not listed are not included. However, as explained above, we have designed the types of activities that are permissive disclosures for public health under §164.512(b) below in part to come within the carve-out effected by section 1178(b); while the state regulatory activities covered by section 1178(c) will generally come within §164.512(d) below. With respect to the comments asking that a state get to ''choose'' which exception it comes under, we have in effect provided for this with respect to exceptions under section 1178(a)(2)(A), by giving the state the right to request an exception under that section. With respect to exceptions under section 1178(a)(2)(B), those exceptions occur by operation of law, and it is not within the Secretary's power to ''let'' the state choose whether an exception occurs under that section. Comment: Several commenters took the position that the Secretary should not limit the procedural requirements in proposed §160.204(a) to only those applications under proposed §160.203(a)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 192}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 330)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nverifying the identity and authority of the person requesting the disclosures. For example, in some cases law enforcement officials may seek limited but focused information needed to obtain a warrant.\nA witness to a shooting may know the time of the incident and the fact that the perpetrator was shot in the left arm, but not the identity of the perpetrator. Law enforcement would then have a legitimate need to ask local emergency rooms whether anyone had presented with a bullet wound to the left arm near the time of the incident. Law enforcement may not have sufficient information to obtain a warrant, but instead would be seeking such information. In such cases, when only limited identifying information is disclosed and the purpose is solely to ascertain the identity of a person, the invasion of privacy would be outweighed by the public interest. For such circumstances, we allow disclosure of protected health information in response to a law enforcement inquiry where law enforcement is seeking to identify a suspect, fugitive, material witness, or missing person, but allow only disclosure of a limited list of information. Similarly, it is in the public interest to allow covered entities to take appropriate steps to protect the integrity and safety of their operations. Therefore, we permit covered entities on their own initiative to disclose to law enforcement officials protected health information for this purpose. However, we limit such disclosures to protected health information that the covered entity believes in good faith constitutes evidence of criminal conduct that occurred on the premises of the covered entity. We shape the rule's provisions with respect to law enforcement according to the limited scope of our regulatory authority under HIPAA, which applies only to the covered entities and not to law enforcement officials."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 329}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 337)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nan alternative, this commenter suggested explaining what we meant by ''material.''\n\nResponse: Like the term ''relevant,'' the term ''material'' is commonly used in legal standards and well understood.\nComment: At least one commenter suggested deleting the phrase ''reasonably practical'' from the second prong of the test, because, the commenter believed, it was not clear who would decide what is ''reasonably practical'' if the law enforcement agency and covered entity disagreed. Response: We allow covered entities to rely on a representation on the face of the subpoena that the three-part test, including the ''reasonably practical'' criteria, is met. If a covered entity believes that a subpoena is not valid, it may challenge that subpoena in court just as it may challenge any subpoena that today it believes is not lawfully issued. This is true regardless of the specific test that a subpoena must meet, and is not a function of the ''reasonably practical'' criteria. Comment: Some commenters requested elimination of the third prong of the test. One of these commenters suggested that the regulation should specify when de-identified information could not be used. Another recommended deleting the phrase ''could not reasonably be used'' from the third prong of the test, because the commenter believed it was not clear who would determine whether deidentified information ''could reasonably be used'' if the law enforcement agency and covered entity disagreed. Response: We cannot anticipate in regulation all the facts and circumstances surrounding every law enforcement activity today, or in the future as technologies change. Such a rigid approach could not account for the variety of situations faced by covered entities and law enforcement officials, and would become obsolete over time. Thus, we believe it would not be appropriate to specify when deidentified information can or cannot be used to meet legitimate law enforcement needs."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 336}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 493)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nprotected health information for these purposes, covered entities must inform individuals in advance and must provide a meaningful opportunity for the individual to prevent or restrict the disclosure.\nIn certain circumstances, such as in an emergency, when this informal discussion cannot practicably occur, covered entities can make decisions about disclosure or use, in accordance with the requirements of this section based on their professional judgment of what is in the patient's best interest. While these provisions are subject to the PRA, we believe that the burden associated with this requirement is exempt from the PRA as stipulated under 5 CFR 1320.3(b)(2). ## Section 164.512-Uses and Disclosures for Which Consent, Individual Authorization, or Opportunity To Agree or Object Is Not Required\n\nSection 164.1512 includes provisions that allow, but that do not require, covered entities to disclose protected\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nhealth information without individual authorization for a variety of purposes which represent important national priorities. Pursuant to § 164.512, covered entities may disclose protected health information for specified purposes as follows: as required by law; for public health activities; to public officials regarding victims of abuse, neglect, or domestic violence; for health oversight; for judicial and administrative proceedings; for law enforcement; for specified purposes regarding decedents; for organ donation and transplantation; for research; to avert an imminent threat to health or safety; for specialized government functions (such as for intelligence and national security activities); and to comply with workers' compensation laws. While these provisions are subject to the PRA, we believe that the burden associated with this requirement is exempt from the PRA as stipulated under 5 CFR 1320.3(b)(2)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 492}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 33)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nconsent for the treatment in accordance with State law or the treating physician suspects abuse or neglect or reasonably believes that releasing the information to the parent will endanger the child.\nComment: A couple of commenters were concerned that the provisions regarding confidential communications conflict with the Fair Debt Collection Practices Act (FDCPA), which allows collection agencies to contact the party responsible for payment of the debt, be it the spouse or parent (of a minor) of the individual that incurred the debt, and share information that supports the incurrence and amount of the debt. They feared that the Privacy Rule would no longer allow collection agencies to continue this practice. Response: Our analysis of the relevant provisions of the Privacy Rule and the FDCPA does not indicate any conflicts between the two laws. An entity that is subject to the FDCPA and the Privacy Rule (or that must act consistent with the Privacy Rule as a business associate of the covered entity) should be able to comply with both laws, because the FDCPA permits an entity to exercise discretion to disclose information about one individual to another. The FDCPA allows debt collectors to communicate with the debtor's spouse or parent if the debtor is a minor. The provisions of the FDCPA are permissive rather than required. Generally, the Privacy Rule permits covered entities to use the services of debt collectors as the use of such services to obtain payment for the provision of health care comes within the definition of ''payment.'' The Privacy Rule generally does not identify to whom information can be disclosed when a covered entity is engaged in its own payment activities. Therefore, if a covered entity or a debt collector, as a business associate of a covered entity, needs to disclose protected health information to a spouse or a parent, the Privacy Rule generally would not prevent such disclosure."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 32}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 194)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nithin the scope of the agency. - ■ 18. In § 160.404, revise the introductory text of paragraphs (b)(2)(i), (b)(2)(iii), and (b)(2)(iv) to read as follows:\n\n## §160.404 Amount of a civil money penalty.\n*\n\n*\n\n*\n\n(b) *\n\n(2) *\n\n*\n\n*\n\n*\n\n*\n\n*\n\n- (i) For a violation in which it is established that the covered entity or business associate did not know and, by exercising reasonable diligence, would not have known that the covered entity or business associate violated such provision,\n\n*\n\n*\n\n*\n\n*\n\n*\n\n(iii) For a violation in which it is established that the violation was due to willful neglect and was corrected during the 30-day period beginning on the first date the covered entity or business associate liable for the penalty knew, or, by exercising reasonable diligence, would have known that the violation occurred,\n\n*\n\n*\n\n*\n\n*\n\n*\n\n(iv) For a violation in which it is established that the violation was due to willful neglect and was not corrected during the 30-day period beginning on the first date the covered entity or business associate liable for the penalty knew, or, by exercising reasonable diligence, would have known that the violation occurred,\n\n*\n\n*\n\n*\n\n*\n\n*\n\n- ■ 19. Revise § 160.406 to read as follows:\n\n## §160.406 Violations of an identical requirement or prohibition. The Secretary will determine the number of violations of an administrative simplification provision based on the nature of the covered entity's or business associate's obligation to act or not act under the provision that is violated, such as its obligation to act in a certain manner, or within a certain time, or to act or not act with respect to certain persons. In the case of continuing violation of a provision, a separate violation occurs each day the covered entity or business associate is in violation of the provision. 18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00127\n\n- ■ 20. Revise § 160.408 to read as follows:\n\n## §160.408 Factors considered in determining the amount of a civil money penalty."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 193}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 34)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nn the health care component(s) any other components of the entity that support the covered functions in the same way such support may be provided by a business associate (e.g., an auditing component).\nThe health care component was to include such ''business associate'' functions for two reasons: (1) It is impracticable for the entity to contract with itself; and (2) having to obtain an authorization for disclosures to such support components would limit the ability of the hybrid entity to engage in necessary health care operations functions. In order to limit the burden on hybrid entities, most of the requirements of the Privacy Rule only applied to the health care component(s) of the entity and not to the parts of the entity that do not engage in covered functions. The hybrid entity was required to create adequate separation, in the form of firewalls, between the health care component(s) and other components of the entity. Transfer of protected health information held by the health care component to other components of the hybrid entity was a disclosure under the Privacy Rule and was allowed only to the same extent such a disclosure was permitted to a separate entity. In the preamble to the December 2000 Privacy Rule, the Department explained that the use of the term ''primary'' in the definition of a ''hybrid entity'' was not intended to operate with mathematical precision. The Department further explained that it intended a common sense evaluation of whether the covered entity mostly operates as a health plan, health care provider, or health care clearinghouse. If an entity's primary activity was a covered function, then the whole entity would have been a covered entity and the hybrid entity provisions would not have applied. However, if the covered entity primarily conducted nonhealth activities, it would have qualified as a hybrid entity and would have been required to comply with the Privacy Rule with respect to its health care component(s). See 65 FR 82502."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 33}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 73)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nation to be used or disclosed for future research as well as to whom the covered entity may make the requested use or disclosure as there may be some uncertainty of the identity of future researchers.\nThe Secretary's Advisory Committee on Human Research Protections also suggested that the description of information to be collected be allowed to reference information beyond the time of the original study, for example ''your future medical records [at Hospital]'' or ''your future medical records [relating to diseases/ conditions].''\n\nResponse: Covered entities and researchers have flexibility to describe the information to be used or disclosed for the future research, so long as it is reasonable from such description to believe that the individual would expect the information to be used or disclosed for the future research. We also clarify that a description of the protected health information to be used for the future research may include information collected beyond the time of the original study. Further, the Privacy Rule authorization requirements allow a ''class of persons'' to be described for purposes of identifying in the authorization the recipients of the protected health information. Thus, covered entities and researchers have flexibility in the manner in which they describe the recipients of the protected health information for the future\n\nVerDate Mar&lt;15&gt;2010\n\nresearch, so long as it is reasonable from such description to believe that the individual would expect his or her protected health information to be shared with such persons for the future research. Comment: The Secretary's Advisory Committee on Human Research Protections requested that the Department allow for grandfathering of existing, ongoing studies that involve the possibility of future/secondary research, if an Institutional Review Board-approved consent reasonably informed the individuals of the future research."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 72}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 153)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhe covered entity(ies) under §164.504(b). If a subsidiary is defined as a covered entity under this regulation, then a separate privacy official and contact person is required for that covered entity.\nIf several subsidiaries are designated as a single covered entity, pursuant to § 164.504(b), then together they need have only a single privacy officer and contact person. If several covered entities share a notice for services provided on the same premises, pursuant to § 164.520(d), that notice need designate only one privacy official and contact person for the information collected under that notice. These requirements are consistent with the approach recommended by the Joint Commission on Accreditation of Healthcare Organizations, and the National Committee for Quality Assurance, in its paper ''Protecting Personal Health Information; A framework for Meeting the Challenges in a Managed Care Environment.'' This paper notes that ''accountability is enhanced by having focal points who are responsible for assessing compliance with policies and procedures * * * '' (p. 29)\n\n## Training\n\nIn § 164.518(b) of the NPRM we proposed to require that covered entities provide training on the entities' policies and procedures to all members of the workforce likely to have access to protected health information. Each entity would be required to provide initial training by the date on which this rule became applicable. After that date, each covered entity would have to provide training to new members of the workforce within a reasonable time after joining the entity. In addition, we proposed that when a covered entity made material changes in its privacy policies or procedures, it would be required to retrain those members of the workforce whose duties were related to the change within a reasonable time of making the change."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 152}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 27)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nas an insurance company, insurance service, or insurance organization that is licensed to engage in the business of insurance in a state and is subject to state or other law that regulates insurance.\n- (3) A health maintenance organization, defined as a federally qualified health maintenance organization, an organization recognized as a health maintenance organization under state law, or a similar organization regulated for solvency under state law in the same manner and to the same extent as such a health maintenance organization. - (4) Part A or Part B of the Medicare program under title XVIII of the Act. - (5) The Medicaid program under title XIX of the Act. Frm 00018\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\n- (6) A Medicare supplemental policy (as defined in section 1882(g)(1) of the Act, 42 U.S.C. 1395ss). - (7) A long-term care policy, including a nursing home fixed-indemnity policy. - (8) An employee welfare benefit plan or any other arrangement that is established or maintained for the purpose of offering or providing health benefits to the employees of two or more employers. - (9) The health care program for active military personnel under title 10 of the United States Code. - (10) The veterans health care program under 38 U.S.C. chapter 17. - (11) The Civilian Health and Medical Program of the Uniformed Services (CHAMPUS), as defined in 10 U.S.C. 1072(4). - (12) The Indian Health Service program under the Indian Health Care Improvement Act (25 U.S.C. 1601, et seq. ). - (13) The Federal Employees Health Benefits Program under 5 U.S.C. chapter 89. - (14) An approved state child health plan for child health assistance that meets the requirements of section 2103 of the Act. - (15) A Medicare Plus Choice organization as defined in 42 CFR 422.2, with a contract under 42 CFR part 422, subpart K."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 26}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 27)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nrequires a health care provider, upon the request of the injured employee or insurance carrier, to furnish records relating to the treatment or hospitalization for which compensation is being sought.\nSince such disclosure is required by law, it also is permissible under the Privacy Rule at § 164.512(a) and exempt from the minimum necessary standard. The Texas law further provides that a health care provider is permitted to disclose to the insurance carrier records relating to the diagnosis or treatment of the injured employee without the authorization of the injured employee to determine the amount of payment or the entitlement to payment. Since the disclosure only is permitted and not required by Texas law, the provisions at § 164.512(l) would govern to permit such disclosure. In this case, the minimum necessary standard would apply to the disclosure but would allow for information to be disclosed as authorized by the statute, that is, as necessary to ''determine the amount of payment or the entitlement to payment.''\n\nAs another example, under Louisiana workers' compensation law, a health care provider who has treated an employee related to a workers' compensation claim is required to release any requested medical information and records relative to the employee's injury to the employer or the workers' compensation insurer. Again, since such disclosure is required by law, it is permissible under the Privacy Rule at § 164.512(a) and exempt from the minimum necessary standard. The Louisiana law further provides that any information relative to any other treatment or condition shall be available to the employer or workers' compensation insurer through a written release by the claimant. Such disclosure also would be permissible and exempt from the minimum necessary standard under the Privacy Rule if the individual's written authorization is obtained consistent with the requirements of § 164.508."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 26}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 534)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nency, such as a contract for services, memorandum of understanding, or purchase order, that establishes that the person is acting on behalf of the public official. (iii) Authority of public officials.\nA covered entity may rely, if such reliance is reasonable under the circumstances, on any of the following to verify authority when the disclosure of protected health information is to a\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\npublic official or a person acting on behalf of the public official:\n\n(A) A written statement of the legal authority under which the information is requested, or, if a written statement would be impracticable, an oral statement of such legal authority;\n\n(B) If a request is made pursuant to legal process, warrant, subpoena, order, or other legal process issued by a grand jury or a judicial or administrative tribunal is presumed to constitute legal authority. (iv) Exercise of professional judgment. The verification requirements of this paragraph are met if the covered entity relies on the exercise of professional judgment in making a use or disclosure in accordance with § 164.510 or acts on a good faith belief in making a disclosure in accordance with §164.512(j). ## §164.520 Notice of privacy practices for protected health information. - (a) Standard: notice of privacy practices. (1) Right to notice. Except as provided by paragraph (a)(2) or (3) of this section, an individual has a right to adequate notice of the uses and disclosures of protected health information that may be made by the covered entity, and of the individual's rights and the covered entity's legal duties with respect to protected health information. - (2) Exception for group health plans."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 533}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 63)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nnot otherwise be permitted by these rules. Thus, we require that the covered entity erect firewalls to protect against the improper use or disclosure within or by the organization. See §164.504(c)(2).\nThe term ''primary functions'' in the definition of ''hybrid entity'' is not meant to operate with mathematical precision. Rather, we intend that a more common sense evaluation take place: Is most of what the covered entity does related to its health care functions? If so, then the whole entity should be covered. Entities with different insurance lines, if not separately incorporated, present a particular issue with respect to this analysis. Because the definition of ''health plan'' excludes many types of insurance products (in the exclusion under paragraph (2)(i) of the definition), we would consider an entity that has one or more of these lines of insurance in addition to its health insurance lines to come within the definition of ''hybrid entity,'' because the other lines of business constitute substantial parts of the total business operation and are required to be separate from the health plan(s) part of the business. An issue that arises in the hybrid entity situation is what records are covered in the case of an office of the hybrid entity that performs support functions for both the health care component of the entity and for the rest of the entity. For example, this situation could arise in the context of a company with an onsite clinic (which we will assume is a covered health care provider), where the company's business office maintains both clinic records and the company's personnel records. Under the definition of the term ''health care component,'' the business office is part of the health care component (in this hypothetical, the clinic) ''to the extent that'' it is performing covered functions on behalf of the clinic involving the use or disclosure of protected health information that it receives from, creates or maintains for the clinic."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 62}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 501)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntary in connection with determining whether a covered entity is in compliance with this subchapter; or\n3. (ii) To the individual who is the subject of the individually identifiable health information.\n- (2) With respect to the rights of an individual who is the subject of the individually identifiable health information of access to or amendment of individually identifiable health information, permits greater rights of access or amendment, as applicable; provided that, nothing in this subchapter may be construed to preempt any State law to the extent that it authorizes or prohibits disclosure of protected health information about a minor to a parent, guardian, or person acting in loco parentis of such minor. - (3) With respect to information to be provided to an individual who is the subject of the individually identifiable health information about a use, a disclosure, rights, and remedies, provides the greater amount of information. - (4) With respect to the form or substance of an authorization or consent for use or disclosure of individually identifiable health information, provides requirements that narrow the scope or duration, increase the privacy protections afforded (such as by expanding the criteria for), or reduce the coercive effect of the circumstances surrounding the authorization or consent, as applicable. - (5) With respect to recordkeeping or requirements relating to accounting of disclosures, provides for the retention or reporting of more detailed information or for a longer duration. Frm 00340\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\n- (6) With respect to any other matter, provides greater privacy protection for the individual who is the subject of the individually identifiable health information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 500}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 198)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n), paragraph (a)(3)(ii)(C), paragraph (a)(4)(ii)(C), paragraph (a)(6)(ii), and paragraph (a)(8); and\n- ■ b. Revise paragraph (b). The revisions read as follows:\n\n## §164.308 Administrative safeguards.\n(a) A covered entity or business associate must, in accordance with §164.306:\n\n- (1) * * *\n2. (ii) * * *\n3. (A) Risk analysis (Required). Conduct an accurate and thorough assessment of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of electronic protected health information held by the covered entity or business associate. *\n\n*\n\n*\n\n*\n\n*\n\n- (C) Sanction policy (Required). Apply appropriate sanctions against workforce members who fail to comply with the security policies and procedures of the covered entity or business associate. *\n\n*\n\n*\n\n*\n\n*\n\n- (2) Standard: Assigned security responsibility. Identify the security official who is responsible for the development and implementation of the policies and procedures required by this subpart for the covered entity or business associate. - (3) * * *\n3. (ii) * * *\n4. (C) Termination procedures (Addressable). Implement procedures for terminating access to electronic protected health information when the employment of, or other arrangement with, a workforce member ends or as required by determinations made as specified in paragraph (a)(3)(ii)(B) of this section. - (4) * * *\n6. (ii) * * *\n\nVerDate Mar&lt;15&gt;2010\n\n- (C) Access establishment and modification (Addressable). Implement policies and procedures that, based upon the covered entity's or the business associate's access authorization policies, establish, document, review, and modify a user's right of access to a workstation, transaction, program, or process. *\n\n*\n\n*\n\n(6) *\n\n*\n\n*\n\n*\n\n- (ii) Implementation specification: Response and reporting (Required)."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 197}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 59)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nexception to the revocation provision at §164.508(b)(5)(ii) for authorizations obtained as a condition of obtaining insurance coverage when other law gives the insurer the right to contest the policy.\nAdditionally, the Department proposed that the exception to permit conditioning payment of a claim on obtaining an authorization be deleted, since the proposed provision to permit the sharing of protected health information for the payment activities of another covered entity or a health care provider would eliminate the need for an authorization in such situations. Finally, the Department proposed modifications at § 164.508(a)(2)(i)(A), (B), and (C), to clarify its intent that the proposed provisions for sharing protected health information for the treatment, payment, or health care operations of another entity would not apply to psychotherapy notes. There were a number of proposed modifications concerning authorizations for research purposes. Those modifications are discussed in section III.E.2. of the preamble. Overview of Public Comments. The following discussion provides an overview of the public comment received on this proposal. Additional comments received on this issue are discussed below in the section entitled, ''Response to Other Public Comments.''\n\nThere was overwhelming support for the proposed modifications. Overall, supporters were of the opinion that the consolidation and simplification would promote efficiency, simplify compliance, and reduce confusion. Many commenters claimed the changes would eliminate barriers to quality health care. Some commenters claimed the proposed modifications would make the authorization process easier for both providers and individuals, and one commenter said they would make authorizations easier to read and understand."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 58}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 463)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nre broadly or accurately. The inability to quantify benefits, however, does not lessen the importance or value that is ultimately realized by having a national standard for health information privacy.\nThe largest initial costs resulting from the final Privacy Rule stem primarily from the requirement that covered entities use and disclose only the minimum necessary protected health information, that covered entities develop policies and codify their privacy procedures, and that covered entities designate a privacy official and train all personnel with access to individually identifiable health information. The largest ongoing costs will result from the minimum necessary provisions pertaining internal uses of individually identifiable health information, and the cost of a privacy official. In addition, covered entities will have recurring costs for training, disclosure tracking and notice requirements. A smaller number of large entities may have significant costs for de-identification of protected health information and additional requirements for research. The privacy costs are in addition to the Transactions Rule estimates. The cost of complying with the regulation represents approximately 0.23 percent of projected national health expenditures the first year the regulation is enacted. The costs for the first eight years of the final regulation represents 0.07 percent of the increase in national health care costs experienced over the same period."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 462}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 14)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\nety and essential performance than the original vulnerability. The manufacturer must document 37 the timeline rationale for its remediation plan. 38 The customer communication should, at minimum:\n- a.\nDescribe the vulnerability including an impact assessment based on the manufacturer's current understanding,\n- b. State that manufacturer's efforts are underway to address the risk of patient harm as expeditiously as possible,\n- c. Describe compensating controls, if any, and\n- d. State that the manufacturer is working to fix the vulnerability, or provide a defense-in-depth strategy to reduce the probability of exploit and/or severity of harm, and will communicate regarding the availability of a fix in the future. - 3) As soon as possible but no later than 60 days after learning of the vulnerability, the manufacturer fixes the vulnerability, validates the change, and distributes the deployable fix to its customers and user community such that the residual risk is brought down to an acceptable level. In some circumstances, a compensating control could produce a long-term solution provided the risk of patient harm is brought to an acceptable level. Controls should not introduce more risk to the device's safety and essential performance than the original vulnerability. Additionally, the manufacturer should follow-up with end-users as needed beyond the initial 60 day period; 39\n\n36 See 21 CFR 806.10(f). 37 See 21 CFR 820.100 Corrective action and preventive action. 38 See 21 CFR 7.42 Recall strategy for elements of a remediation plan\n\n39 See 21 CFR 7 (b)(3) - Effectiveness checks."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 13}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.532(e)(2) require?"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\n§164.532(e)(2) provides that, during the transition period, covered entities are not relieved of their responsibilities to make information available to the Secretary, including information held by a business associate, as necessary for the Secretary to determine compliance by the covered entity. Similarly, the transition period does not relieve a covered entity of its responsibilities with respect to an individual's rights to access or amend his or her protected health information held by a business associate, or receive an accounting of disclosures by a business associate, as provided for by"}], "metadata": {"source": "privacy_mod_2002", "cfr_section": "§164.532(e)(2)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 18)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nered entity has the medical information, not its record keeping practices, that determines whether the health information is part of an employment record or whether it is protected health information.\nComment: One commenter suggested that the health records of professional athletes should qualify as ''employment records.'' As such, the records would not be subject to the protections of the Privacy Rule. Response: Professional sports teams are unlikely to be covered entities. Even if a sports team were to be a covered entity, employment records of a covered entity are not covered by this Rule. If this comment is suggesting that the records of professional athletes should be deemed ''employment records'' even when created or maintained by health care providers and health plans, the Department disagrees. No class of individuals should be singled out for reduced privacy protections. As noted in the preamble to the December 2000 Rule, nothing in this Rule prevents an employer, such as a professional sports team, from making an employee's agreement to disclose health records a condition of employment. A covered entity, therefore, could disclose this information to an employer pursuant to an authorization. B. Section 164.502-Uses and Disclosures of Protected Health Information: General Rules\n\n## 1. Incidental Uses and Disclosures\n\nDecember 2000 Privacy Rule. The December 2000 Rule did not explicitly address incidental uses and disclosures of protected health information. Rather, the Privacy Rule generally requires covered entities to make reasonable efforts to limit the use or disclosure of, and requests for, protected health information to the minimum necessary to accomplish the intended purpose. VerDate Aug&lt;2,&gt;2002\n\nSee §164.502(b)."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 17}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 48)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd health information relating to such care. (3) With respect to deceased persons, an executor, administrator, or other person authorized under applicable law to act on behalf of the decedent's estate.\nIn addition, we proposed to exclude from the definition:\n\n(1) Foreign military and diplomatic personnel and their dependents who receive health care provided by or paid for by the Department of Defense or other federal agency or by an entity acting on its behalf, pursuant to a country-to-country agreement or federal statute. (2) Overseas foreign national beneficiaries of health care provided by the Department of Defense or other federal agency or by a non-governmental organization acting on its behalf. In the final rule, we eliminate from the definition of ''individual'' the provisions designating a legal representative as the ''individual'' for purposes of exercising certain rights with regard to protected health information. Instead, we include in the final rule a separate standard for ''personal representatives.'' A covered entity must treat a personal representative of an individual as the individual except under specified circumstances. See discussion in\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\n§164.502(g) regarding personal representatives. In addition, we eliminate from the definition of ''individual'' the above exclusions for foreign military and diplomatic personnel and overseas foreign national beneficiaries. We address the special circumstances for use and disclosure of protected health information about individuals who are foreign military personnel in §164.512(k). We address overseas foreign national beneficiaries in §164.500, ''Applicability.'' The protected health information of individuals who are foreign diplomatic personnel and their dependents are not subject to special treatment under the final rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 47}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 194)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n2 below. ## Constitutional Comments and Responses\n\nComment: Several commenters suggested that as a general matter the rule is unconstitutional. Response: We disagree that the rule is unconstitutional.\nThe particular grounds for this conclusion are set out with respect to particular constitutional issues in the responses below. With respect to the comments that simply made this general assertion, the lack of detail of the comments makes a substantive response impossible. VerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\n## Article II\n\nComment: One commenter contended that the Secretary improperly delegated authority to private entities by requiring covered entities to enter into contracts with, monitor, and take action for violations of the contract against their business partners. These comments assert that the selection of these entities to ''enforce'' the regulations violates the Executive Powers Clause and the Appointments and Take Care Clauses. Response: We reject the assertion that the business associate provisions constitute an improper delegation of executive power to private entities. HIPAA provides HHS with authority to enforce the regulation against covered entities. The rules below regulate only the conduct of the covered entity; to the extent a covered entity chooses to conduct its funding through a business associate, those functions are still functions of the covered entity. Thus, no improper delegation has occurred because what is being regulated are the actions of the covered entity, not the actions of the business associate in its independent capacity. We also reject the suggestion that the business associates provisions constitute an improper appointment of covered entities to enforce the regulation and violate the Take Care Clause. Because the Secretary has not delegated authority to covered entities, the inference that she has appointed covered entities to exercise such authority misses the mark."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 193}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 169)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nnsequently, such procurement or banking activities are not considered health care and the organizations that perform such activities are not considered health care providers for purposes of this rule.\nWith respect to disclosure of protected health information by covered entities to facilitate cadaveric organ and tissue donation, the final rule explicitly permits a covered entity to disclose protected health information without authorization, consent, or agreement to organ procurement organizations or other entities engaged in the procurement, banking, or transplantation of cadaveric organs, eyes, or tissue for the purpose of facilitating donation and transplantation. See § 164.512(h). We do not include blood or sperm banking in this provision because, for those activities, there is direct contact with the donor, and thus opportunity to obtain the individual's authorization. Comment: A large number of commenters urged that the term ''assessment'' be included in the list of services in the definition, as ''assessment'' is used to determine the baseline health status of an individual. It was explained that assessments are conducted in the initial step of diagnosis and treatment of a patient. If assessment is not included in the list of services, they pointed out that the services provided by occupational health nurses and employee health information may not be covered. Response: We agree and have added the term ''assessment'' to the definition to clarify that this activity is considered ''health care'' for the purposes of the rule. Comment: One commenter asked that we revise the definition to explicitly exclude plasmapheresis from paragraph (3) of the definition. It was explained that plasmapheresis centers do not have direct access to health care recipients or their health information, and that the limited health information collected about plasma donors is not used to provide health care services as indicated by the definition of health care."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 168}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 15)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nroprietary information, will include ensuring that, in the event that the proposed transaction is not consummated, the information is either returned to its original owner or destroyed as appropriate.\nThey may include protected health information in any such agreement, as they determine appropriate to the circumstances and applicable law. ## 3. Protected Health Information: Exclusion for Employment Records\n\nDecember 2000 Privacy Rule. The Privacy Rule broadly defines ''protected health information'' as individually identifiable health information maintained or transmitted by a covered entity in any form or medium. The\n\nVerDate Aug&lt;2,&gt;2002\n\nDecember 2000 Privacy Rule expressly excluded from the definition of ''protected health information'' only educational and other records that are covered by the Family Education Rights and Privacy Act of 1974, as amended, 20 U.S.C. 1232g. In addition, throughout the December 2000 preamble to the Privacy Rule, the Department repeatedly stated that the Privacy Rule does not apply to employers, nor does it apply to the employment functions of covered entities, that is, when they are acting in their role as employers. For example, the Department stated:\n\nCovered entities must comply with this regulation in their health care capacity, not in their capacity as employers. For example, information in hospital personnel files about a nurses' (sic) sick leave is not protected health information under this rule. 65 FR 82612. However, the definition of protected health information did not expressly exclude personnel or employment records of covered entities. March 2002 NPRM. The Department understands that covered entities are also employers, and that this creates two potential sources of confusion about the status of health information."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 14}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 418)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\no authority to determine the final outcome of the request and may not make actual changes to the medical record. The covered entity must review the individual's request and make appropriate decisions.\nWe have clarified this intent in § 164.526(a)(1) by stating that individuals have a right to have a covered entity amend protected health information and in §164.526(b)(2) by stating that covered entities must act on an individual's request for amendment. Comment: Some comments argued that there is no free-text field in some current transaction formats that would accommodate the extra text required to comply with the amendment provisions ( e.g., sending statements of disagreement along with all future disclosures of the information at issue). Commenters argued that this provision will burden the efficient transmission of information, contrary to HIPAA requirements. Response: We believe that most amendments can be incorporated into the standard transactions as corrections of erroneous data. We agree that some of the standard transactions cannot currently accommodate additional material such as statements of disagreement and rebuttals to such statements. To accommodate these rare situations, we modify the requirements in § 164.526(d)(iii). The provision now states that if a standard transaction does not permit the inclusion of the additional material required by this section, the covered entity may separately transmit the additional material to the recipient of the standard transaction. Commenters interested in modifying the standard transactions to allow the incorporation of additional materials may also bring the issue up for resolution through the process established by the Transactions Rule and described in its preamble. Comment: The NPRM proposed to allow amendment of protected health information in designated record sets."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 417}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 137)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nrivacy practices for protected health information. *\n\n*\n\n*\n\n*\n\n*\n\n- (c) Implementation specifications: provision of notice. * * *\n- (2) Specific requirements for certain covered health care providers.\n* * *\n- (i) Provide the notice:\n- (A) No later than the date of the first service delivery, including service delivered electronically, to such\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00091\n\nFmt 4701\n\nSfmt 4700\n\n- individual after the compliance date for the covered health care provider; or\n- (B) In an emergency treatment situation, as soon as reasonably practicable after the emergency treatment situation. - (ii) Except in an emergency treatment situation, make a good faith effort to obtain a written acknowledgment of receipt of the notice provided in accordance with paragraph (c)(2)(i) of this section, and if not obtained, document its good faith efforts to obtain such acknowledgment and the reason why the acknowledgment was not obtained;\n\n*\n\n*\n\n*\n\n*\n\n*\n\n- (3) Specific requirements for electronic notice. * * *\n2. (iii) * * * The requirements in paragraph (c)(2)(ii) of this section apply to electronic notice. *\n\n*\n\n*\n\n*\n\n*\n\n- (e) Implementation specifications: Documentation. A covered entity must document compliance with the notice requirements, as required by §164.530(j), by retaining copies of the notices issued by the covered entity and, if applicable, any written acknowledgments of receipt of the notice or documentation of good faith efforts to obtain such written acknowledgment, in accordance with paragraph (c)(2)(ii) of this section. 13. Amend §164.522 by removing the reference to ''164.502(a)(2)(i)'' in paragraph (a)(1)(v), and adding in its place ''164.502(a)(2)(ii)''. 14. Amend §164.528 as follows: a. In paragraph (a)(1)(i), remove\n- ''§ 164.502'' and add in its place ''§ 164.506''. - b. Remove the word ''or'' from paragraph (a)(1)(v). - c. Redesignate paragraph (a)(1)(vi) as (a)(1)(ix) and redesignate paragraphs (a)(1)(iii) through (v) as (a)(1)(v) through (vii)."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 136}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 11)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nn individual's right to privacy may conflict with the collective rights of the public * * *. We do not suggest that privacy is an absolute right that reigns supreme over all other rights. It does not.\nHowever, the case for privacy will depend on a number of factors that can influence the balancethe level of harm to the individual involved versus the needs of the public.''\n\n## The Federal Response\n\nThere have been numerous federal initiatives aimed at protecting the privacy of especially sensitive personal information over the past several years-and several decades. While the rules below are likely the largest single federal initiative to protect privacy, they are by no means alone in the field. Rather, the rules arrive in the context of recent legislative activity to grapple with advances in technology, in addition to an already established body of law granting federal protections for personal privacy. In 1965, the House of Representatives created a Special Subcommittee on Invasion of Privacy. In 1973, this Department's predecessor agency, the Department of Health, Education and Welfare issued The Code of Fair Information Practice Principles establishing an important baseline for\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ninformation privacy in the U.S. These principles formed the basis for the federal Privacy Act of 1974, which regulates the government's use of personal information by limiting the disclosure of personally-identifiable information, allows consumers access to information about them, requires federal agencies to specify the purposes for collecting personal information, and provides civil and criminal penalties for misuse of information. In the last several years, with the rapid expansion in electronic technology-and accompanying concerns about individual privacylaws, regulations, and legislative proposals have been developed in areas ranging from financial privacy to genetic privacy to the safeguarding of children on-line."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 10}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 116)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nng covered entity's business associate or is another covered entity, whether the recipient took appropriate mitigating action. Some commenters stated that the default function of the rule was unclear.\nIn particular, these commenters questioned whether the rule required notification of a breach unless it is\n\nVerDate Mar&lt;15&gt;2010\n\ndetermined that a significant risk of harm does not exist, or alternatively, required notification only in cases where significant risk of harm can be demonstrated. Other commenters suggested that we include in the definition an express presumption of a breach unless an entity can show otherwise. Additionally, many commenters responded to the treatment of limited data sets in the interim final rule. Although many commenters expressed support for the assertion that limited data sets that do not contain dates of birth and zip codes do not compromise the security or privacy of protected health information, most of these commenters expressed concern that the interim final rule did not go far enough and should exempt even those limited data sets that contain dates of birth and/ or zip codes from the breach notification requirements. These commenters argued that no impermissible use or disclosure of a limited data set should trigger breach notification obligations because without the 16 direct identifiers that the Privacy Rule requires to be stripped from the information, there is minimal risk of harm to the individual. Additionally, commenters indicated it would be costly and burdensome for entities to have to re-identify the information in a limited data set to provide notification and that reidentifying the information could also pose an additional risk of harm to the affected individuals."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 115}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 178)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ned entity, particularly since the prohibition encompasses both direct and indirect (i.e., non-financial) remuneration. We expect to issue future guidance on this topic to assist entities in complying.\nWith respect to the amounts currently paid to covered entities by researchers, some commenters indicated as a general concern that limiting remuneration received by covered entities from researchers may provide a disincentive for covered entities to continue assisting researchers in their efforts. However, commenters did not quantify what they are paying covered entities above the costs to prepare and transmit the data, nor did they provide information that would give the Department an idea of the extent to which covered entities receive such payments. Therefore, while we acknowledge the potential for some lost revenue to covered entities due to these modifications or some additional costs to researchers to obtain authorizations, we do not have data that could inform quantifying such costs. At the same time, we note that we have made some clarifications in the above preamble discussion regarding these provisions that we believe would lessen any such impact. Specifically, the preamble explains that we do not consider a sale of protected health information to encompass payments a covered entity may receive in the form of grants, or contracts or other arrangements to perform programs or activities, such as a research study, where any provision of protected health information to the payer is a byproduct of the service being provided. Thus, the payment by a research sponsor to a covered entity to conduct a research study is not considered a sale of protected health information even if the\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00116\n\nstudy involves disclosing research results that include protected health information to the sponsor."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 177}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 94)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nual an opportunity to submit payment and requesting comment on the extent to which covered entities must make reasonable efforts to secure payment from the individual prior to billing the health plan.\nWe requested comment on the scope of a restriction and in what circumstances it should apply to a subsequent, but related, treatment\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with encounter, such as follow-up care for treatment of a particular condition. ## Overview of Public Comments\n\nWe received many comments on these proposed provisions and our questions as to how they should apply. A number of commenters generally supported the provisions as being an important right for health care consumers. However, many commenters expressed concerns with these new requirements. Many commenters raised concerns with, and requested guidance on, how to operationalize a restriction. Several commenters were concerned with having to create separate records to ensure that restricted data is not inadvertently sent to or accessible by the health plan or to manually redact information from the medical record prior to disclosure to a health plan. Commenters argued that having to segregate restricted and unrestricted information or redact restricted information prior to disclosure would be burdensome as such a process would generally have to occur manually, and may result in difficulties with ensuring that treating providers continue to have access to the entire medical record. Some commenters were concerned specifically with having to manually redact or create separate records prior to a health plan audit, or otherwise with withholding information from a plan during an audit, to ensure a health plan would not see restricted information."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 93}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 193)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nept if necessary for ascertaining or enforcing compliance with the applicable administrative simplification provisions, if otherwise required by law, or if permitted under 5 U.S.C. 552a(b)(7). - ■ 14.\nRevise § 160.312 to read as follows:\n\n## §160.312 Secretarial action regarding complaints and compliance reviews. - (a) Resolution when noncompliance is indicated. (1) If an investigation of a complaint pursuant to § 160.306 or a compliance review pursuant to §160.308 indicates noncompliance, the Secretary may attempt to reach a resolution of the matter satisfactory to the Secretary by informal means. Informal means may include demonstrated compliance or a completed corrective action plan or other agreement. - (2) If the matter is resolved by informal means, the Secretary will so inform the covered entity or business associate and, if the matter arose from a complaint, the complainant, in writing. - (3) If the matter is not resolved by informal means, the Secretary will-\n- (i) So inform the covered entity or business associate and provide the covered entity or business associate an opportunity to submit written evidence of any mitigating factors or affirmative defenses for consideration under §§160.408 and 160.410 of this part. The covered entity or business associate must submit any such evidence to the Secretary within 30 days (computed in the same manner as prescribed under §160.526 of this part) of receipt of such notification; and\n- (ii) If, following action pursuant to paragraph (a)(3)(i) of this section, the Secretary finds that a civil money penalty should be imposed, inform the covered entity or business associate of such finding in a notice of proposed determination in accordance with §160.420 of this part. - (b) Resolution when no violation is found."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 192}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 533)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\neiving future such communications. 6. (ii) If the covered entity uses or discloses protected health information to target the communication to individuals based on their health status or condition:\n7.\n(A) The covered entity must make a determination prior to making the communication that the product or service being marketed may be beneficial to the health of the type or class of individual targeted; and\n8. (B) The communication must explain why the individual has been targeted\n\nFrm 00359\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nand how the product or service relates to the health of the individual. (iii) The covered entity must make reasonable efforts to ensure that individuals who decide to opt out of receiving future marketing communications, under paragraph (e)(3)(i)(C) of this section, are not sent such communications. (f)(1) Standard: Uses and disclosures for fundraising. A covered entity may use, or disclose to a business associate or to an institutionally related foundation, the following protected health information for the purpose of raising funds for its own benefit, without an authorization meeting the requirements of § 164.508:\n\n(i) Demographic information relating to an individual; and\n\n- (ii) Dates of health care provided to an individual. - (2) Implementation specifications: Fundraising requirements. (i) The covered entity may not use or disclose protected health information for fundraising purposes as otherwise permitted by paragraph (f)(1) of this section unless a statement required by §164.520(b)(1)(iii)(B) is included in the covered entity's notice;\n\n(ii) The covered entity must include in any fundraising materials it sends to an individual under this paragraph a description of how the individual may opt out of receiving any further fundraising communications."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 532}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 61)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncate with them by alternative means, and the health plan must accommodate such a request if it is reasonable and the individual states that disclosure of the information could endanger the individual.\nThe specific provisions relating to confidential communications are in § 164.522. ## Section 164.502(i)-Uses and Disclosures Consistent with Notice\n\nWe proposed to prohibit covered entities from using or disclosing protected health information in a manner inconsistent with their notice of information practices. We retain this provision in the final rule. See § 164.520 regarding notice content and distribution requirements. ## Section 164.502(j)-Disclosures by Whistleblowers and Workforce Member Crime Victims\n\n## Disclosures by Whistleblowers\n\nIn § 164.518(c)(4) of the NPRM we addressed the issue of whistleblowers by proposing that a covered entity not be held in violation of this rule because a member of its workforce or a person associated with a business associate of the covered entity used or disclosed protected health information that such person believed was evidence of a civil or criminal violation, and any disclosure was: (1) Made to relevant oversight agencies or law enforcement or (2) made to an attorney to allow the attorney to determine whether a violation of criminal or civil law had occurred or to assess the remedies or actions at law that may be available to the person disclosing the information. We included an extensive discussion on how whistleblower actions can further the public interest, including reference to the need in some circumstances to utilize protected health information for this purpose as well as reference to the qui tam provisions of the Federal False Claims Act."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 60}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 108)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nhat a covered entity is not responsible for or required to monitor the actions of its business associates. It also was suggested that such language expressly be included in the Rule's regulatory text.\nOne commenter recommended that the Rule provide that business associates are directly liable for their own failure to comply with the Privacy Rule. Another commenter urged that the Department\n\nVerDate Aug&lt;2,&gt;2002\n\neliminate a covered entity's obligation to mitigate any harmful effects caused by a business associate's improper use or disclosure of protected health information. Response: The Privacy Rule does not require a covered entity to actively monitor the actions of its business associates nor is the covered entity responsible or liable for the actions of its business associates. Rather, the Rule only requires that, where a covered entity knows of a pattern of activity or practice that constitutes a material breach or violation of the business associate's obligations under the contract, the covered entity take steps to cure the breach or end the violation. See §164.504(e)(1). The Department does not believe a regulatory modification is necessary in this area. The Department does not have the statutory authority to hold business associates, that are not also covered entities, liable under the Privacy Rule. With respect to mitigation, the Department does not accept the commenter's suggestion. When protected health information is used or disclosed inappropriately, the harm to the individual is the same, regardless of whether the violation was caused by the covered entity or a by business associate. Further, this provision is not an absolute standard intended to require active monitoring of the business associate or mitigation of all harm caused by the business associate. Rather, the provision applies only if the covered entity has actual knowledge of the harm, and requires mitigation only ''to the extent practicable'' by the covered entity. See §164.530(f)."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 107}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 162)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nght we were underestimating the number of breaches that would occur each year. Based upon this information, we have revised the projected annual cost to implement these breach notification provisions.\nWe acknowledge that there may still be some underreporting of breaches as the obligations of the regulation may not yet have penetrated down to all covered entities and business associates. At the same time, we expect that some types of incidents being reported today may not in the future as covered entities and business associates become more familiar with the definition of breach and more adept at performing risk assessments and determining whether a breach has occurred. We have received breach notifications from covered entities in several situations in which notification was not necessary, such as where there was no underlying impermissible use or disclosure under the Privacy Rule or where one of the exceptions to breach clearly applied to the situation. This is the type of overreporting that we expect to diminish in the future. Additionally, covered entities and business associates are beginning to recognize areas of potential weakness and to take systemic actions to prevent breaches from occurring in the future, such as encrypting portable devices to avoid having to provide breach notifications in the event the device is lost or stolen. Table 2 shows the costs of the provisions of the final rule based on the breach notifications we have received from covered entities during calendar years 2010 and 2011. We also present the costs required for investigating breaches and the amount of time we anticipate individuals will spend calling the toll-free number for substitute notice. We estimate the total cost for the breach notification rule to be approximately $14.5 million. Discounting at 3 percent and 7 percent and annualizing over 10 years results in costs of $17 million and $20.6 million, respectively."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 161}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 458)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nable health information from disclosure without patient authorization and emphasized that encrypting information should be a principal means of protecting individually identifiable health information.\nThe statements of a leading managed care association, while endorsing the general principles of privacy protection, were vague on the release of information for purposes other than treatment. The association suggested allowing the use of protected health information without the patient's authorization for what they term ''health promotion.'' It is possible that the use of protected health information for ''health promotion'' may be construed under the rule as part of marketing activities. Based on the review of the leading association standards, we believe that the final rule embodies most or all of the major principles expressed in the standards. However, there are some major areas of difference between the rule and the professional standards reviewed. The final rule generally provides stronger, more consistent, and more comprehensive guarantees of privacy for individually identifiable health information than the professional standards. The differences between the rule and the professional codes include the individual's right of access to health information in the covered entity's possession, relationships between contractors and covered entities, and the requirement that covered entities make their privacy policies and practices available to patients through a notice\n\nFrm 00303\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nand the ability to respond to questions related to the notice. Because the regulation requires that (with a few exceptions) patients have access to their protected health information that a covered entity possesses, large numbers of health care providers may have to modify their current practices in order to allow patient access, and to establish a review process if they deny a patient access."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 457}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 148)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nER2\n\nSfmt 4700\n\n## Section 164.524(e)-Policies, Procedures, and Documentation\n\nAs in the proposed rule, we establish documentation requirements for covered entities that are subject to this provision.\nIn accordance with §164.530(j), the covered entity must retain documentation of the designated record sets that are subject to access by individuals and the titles of the persons or offices responsible for receiving and processing requests for access by individuals. ## Section 164.526-Amendment of Protected Health Information\n\n## Section 164.526(a)-Right to Amend\n\nIn proposed § 164.516, we proposed to establish the individual's right to request a covered health care provider or health plan to amend or correct protected health information about the individual for as long as the covered entity maintains the information. In § 164.526 of the final rule, we retain the general proposed approach, but establish an individual's right to have the covered entity amend, rather than amend or correct, protected health information. This right applies to protected health information and records in a designated record set for as long as the information is maintained in the designated record set. In the final rule, covered health care providers, health plans, and health care clearinghouses that create or receive protected health information other than as a business associate must comply with these requirements. ## Denial of Amendment\n\nWe proposed to permit a covered health care provider or health plan to deny a request for amendment if it determined that the protected health information that was the subject of the request was not created by the covered provider or health plan, would not be available for inspection and copying under proposed §164.514, or was accurate and complete. A covered entity would have been permitted, but not required, to deny a request if any of these conditions were met."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 147}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 123)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nnsome alternatives, consistent with achieving the Rule's goals. The Department does not believe that the amendments to the Privacy Rule would qualify as an unfunded mandate under the statute. ## VIII.\nEnvironmental Impact\n\nThe Department has determined under 21 CFR 25.30(k) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment\n\nVerDate Aug&lt;2,&gt;2002\n\nnor an environmental impact statement is required. ## IX. Executive Order 13132: Federalism\n\nExecutive Order 13132 establishes certain requirements that an agency must meet when it promulgates a rule that imposes substantial direct requirement costs on State and local governments, preempts State law, or otherwise has Federalism implications. The Federalism implications of the Privacy Rule were assessed as required by Executive Order 13132 and published in the Privacy Rule of December 28, 2000 (65 FR 82462, 82797). The amendments with the most direct effect on Federalism principles concerns the clarifications regarding the rights of parents and minors under State law. The amendments make clear the intent of the Department to defer to State law with respect to such rights. Therefore, the Department believes that the amended Privacy Rule would not significantly affect the rights, roles and responsibilities of States. ## X. Sample Business Associate Contract Provisions-Appendix\n\nMarch 2002 NPRM. In response to requests for guidance, the Department provided sample language for business associate contracts. The provisions were provided as an appendix to the preamble and were intended to serve as guidance for covered entities to assist in compliance with the business associate provisions of the Privacy Rule. The proposal was not a model contract, but rather was sample language that could be included in a contract. Overview of Public Comment."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 122}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 159)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhealth information. One comment advocated Congressional efforts to provide a comprehensive federal health privacy law that would integrate the substance abuse regulations with the privacy regulation.\nResponse: We agree that comprehensive privacy legislation is urgently needed. This administration has urged the Congress to pass such legislation. While this regulation will improve the privacy of individuals' health information, only legislation can provide the full array of privacy protection that individuals need and deserve. Comment: Many commenters noted that they do not go to a physician, or do not completely share health information with their physician, because they are concerned about who will have access to that information. Many physicians commented on their patients' reluctance to share information because of fear that their information will later be used against them. Response: We agree that strong federal privacy protections are necessary to enhance patients' trust in the health care system. Comment: Many commenters expressed concerns that this regulation will allow access to health information by those who today do not have such access, or would allow their physician to disclose information which may not lawfully be disclosed today. Many of these commenters stated that today, they consent to every disclosure of health information about them, and that absent their consent the privacy of their health information is ''absolute.'' Others stated that, today, health information is disclosed only pursuant to a judicial order. Several commenters were concerned that this regulation would override stronger state privacy protection. VerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00105\n\nResponse: This regulation does not, and cannot, reduce current privacy protections. The statutory language of the HIPAA specifically mandates that this regulation does not preempt state laws that are more protective of privacy."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 158}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 36)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nole-based access and user-based access. It can be argued that the process of managing access involves allowing and restricting access to those individuals that have been authorized to access the data.\nThe intent of the proposed authorization control implementation feature is now\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\nJkt 200001\n\nincorporated in the access authorization implementation specification under the information access management standard in § 164.308(a)(4). Under the information access management standard, a covered entity must implement, if appropriate and reasonable to its situation, policies and procedures first to authorize a person to access electronic protected health information and then to actually establish such access. These policies and procedures will enable entities to follow the Privacy Rule minimum necessary requirements, which provide when persons should have access to information. ## H. Organizational Requirements (§ 164.314)\n\nWe proposed that each health care clearinghouse must comply with the security standards to ensure all health information and activities are protected from unauthorized access. If the clearinghouse is part of a larger organization, then unauthorized access by the larger organization must be prevented. We also proposed that parties processing data through a third party would be required to enter into a chain of trust partner agreement, a contract in which the parties agree to electronically exchange data and to protect the transmitted data in accordance with the security standards. In this final rule, we have adopted the concepts of hybrid and affiliated entities, as previously defined in §164.504, and now defined in §164.103, and business associates as defined in § 160.103, to be consistent with the Privacy Rule. General organizational requirements related to affiliated covered entities and hybrid entities are now contained in a new §164.105."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 35}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 51)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthe definition, but only with respect to the protected health information of the issuer or HMO that relates to individuals who are or have been participants or beneficiaries in the group health plan.\nWe recognize that many group health plans are funded partially or fully through insurance, and that in some cases the group health plan and issuer or HMO need to coordinate operations to properly serve the enrollees. Second, we include a group health plan and one or more other group health plans each of which are maintained by the same plan sponsor. We recognize that in some instances plan sponsors provide health benefits through a combination of group health plans, and that they may need to coordinate the operations of such plans to better serve the participants and beneficiaries of the plans. Third, we include a combination of group health plans maintained by the same plan sponsor and the health insurance issuers and HMOs with respect to such plans, but again only with respect to the protected health information of such issuers and HMOs that relates to\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nindividuals who are or have been enrolled in such group health plans. We recognize that is some instances a plan sponsor may provide benefits through more than one group health plan, and that such plans may fund the benefits through one or more issuers or HMOs. Again, coordinating health care operations among these entities may be necessary to serve the participants and beneficiaries in the group health plans. We note that the necessary coordination may necessarily involve the business associates of the covered entities and may involve the participation of the plan sponsor to the extent that it is providing plan administration functions and subject to the limits in § 164.504. ## Payment\n\nWe proposed the term payment to mean:\n\n- (1) The activities undertaken by or on behalf of a covered entity that is:\n2."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 50}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 67)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nKey activities, descriptions, and sample questions for the Business Associate Contracts or Other Arrangements standard | | Description | Sample Questions | |-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Key Activities Contract Must Provide That Business Associates Will Comply With the Applicable Requirements of the Security Rule 144 Implementation Specification (Required) | • Contracts between covered entities and business associates must provide that business associates will implement administrative, physical, and technical safeguards that reasonably and appropriately protect the confidentiality, integrity, and availability of the ePHI that the business associate creates, receives, maintains, or transmits on behalf of the covered entity."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 66}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 171)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nlearinghouse may be a covered entity and a business associate of a covered entity under the regulation. As business associates, they would be bound by their contracts with covered plans and providers.\n## Health Care Provider\n\nComment: One commenter pointed out that the preamble referred to the obligations of providers and did not use the term, ''covered entity,'' and thus created ambiguity about the obligations of health care providers who may be employed by persons other than covered entities, e.g., pharmaceutical companies. It was suggested that a better reading of the statute and rule is that where neither the provider nor the company is a covered entity, the rule does not impose an obligation on either the provideremployee or the employer. Response: We agree. We use the term ''covered entity'' whenever possible in the final rule, except for the instances where the final rule treats the entities differently, or where use of the term ''health care provider'' is necessary for purposes of illustrating an example. Comment: Several commenters stated that the proposal's definition was broad, unclear, and/or confusing. Further, we received many comments requesting clarification as to whether specific entities or persons were ''health care providers'' for the purposes of our rule. One commenter questioned whether affiliated members of a health care group (even though separate legal entities) would be considered as one primary health care provider. Response: We permit legally distinct covered entities that share common ownership or control to designate themselves together to be a single covered entity. Such organizations may promulgate a single shared notice of information practices and a consent\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nform. For more detailed information, see the preamble discussion of § 164.504(d)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 170}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 27)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\ng and immediately after a crisis situation. ## 8. Evaluation (§ 164.308(a)(8))\n\nWe proposed that certification would be required and could be performed internally or by an external accrediting agency.\nWe solicited input on appropriate mechanisms to permit an independent assessment of compliance. We were particularly interested in input from those engaging in health care electronic data interchange (EDI), as well as independent certification and auditing organizations addressing issues of documentary evidence of steps taken for compliance; need for, or desirability of, independent verification, validation, and testing of system changes; and certifications required for off-the-shelf products used to meet the requirements of this regulation. We also solicited comments on the extent to which obtaining external certification would create an undue burden on small or rural providers. In this final rule, we require covered entities to periodically conduct an evaluation of their security safeguards to demonstrate and document their compliance with the entity's security policy and the requirements of this subpart. Covered entities must assess the need for a new evaluation based on changes to their security environment since their last evaluation, for example, new technology adopted or responses to newly recognized risks to the security of their information. a. Comment: We received several comments that certification should be performed externally. A larger group of commenters preferred self-certification. The majority of the comments, however, were to the effect that external certification should be encouraged but not mandated. A number of commenters thought that mandating external certification would create an undue financial burden, regardless of the size of the entity being certified. One commenter stated that external certification would not place an undue burden on a small or rural provider."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 26}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 81)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nd by a public official is the minimum necessary information for the stated purpose, if the public official represents that the information requested is the minimum necessary for the stated purpose(s).\nUnder this provision, a covered entity may rely on State law or a State official's determination of the minimum necessary information required for proof of immunization, unless such determination is unreasonable. Comment: Commenters requested guidance on when and how often to obtain agreement for immunization disclosures. Response: We anticipate that covered entities will obtain agreement for the disclosure of immunization records on a case-by-case basis as needed. For example, a parent may call and request that a covered entity provide his or her child's immunization records before the child begins elementary school, if required by State school entry laws. If that child moves to a different school and is unable to transfer their immunization records to the new school, the parent may need to request that the covered entity provide his or her child's immunization records to the new school, if required by State school entry laws. A parent might also generally indicate to a covered entity that he or she affirmatively agrees to the immediate or future disclosure of his or her child's immunization records to the child's school as necessary, or the continued disclosure of such information if, for example, updates are required by the school when a series of vaccinations have been completed. Comment: Commenters requested clarification on the length of time an agreement may be relied upon. 18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00054\n\nResponse: An agreement to permit the disclosure of immunization records is considered effective until revoked by the parent, guardian or other person acting in loco parentis for the individual, or by the individual himself or herself, if the individual is an adult or emancipated minor."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 80}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 489)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nss associates of covered entities. For purposes of the regulatory analyses, we have assumed that TPAs would bear many of the same costs of the health plans to assure compliance for the covered entity.\nTo make this adjustment, we assumed the selfinsured/self administered health plans and TPAs have the average revenue of the health plans contained in the SIC code, and then added those assumed revenues to the SIC code and to the total of all health care expenditures. Moreover, we needed to account for the cost to non-profit institutions that might receive more than $5 million in revenue, because all non-profit institutions are small businesses regardless of revenue. To make this adjustment for hospitals, nursing homes, and home health agencies, we used data on the number of non-profit institutions from industry sources and from data reported to HCFA. With this data, we assumed the current count of establishments in the SIC codes includes these non-profit entities and that non-profits have the same distribution of revenues as all establishments reported in the applicable SIC codes. The proportions discussed below, which determine the cost for small business, therefore include these non-profit establishments in SIC codes 8030, 8060, and 8080. The SIC code tables provided in this RFA do not include several categories of businesses that are included in the total cost to small businesses. Claims clearinghouses are not included in the table because claims clearinghouses report their revenues under the SIC 7374 ''Computer Processing and Data Preparation,'' and the vast majority of businesses in this SIC code are involved in non-medical claims data processing."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 488}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 104)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nat § 164.524(b)(1), which states that the covered entity may require individuals to make requests for access in writing, provided that it informs individuals of such a requirement, remains unchanged.\nTherefore, covered entities may at their option require individuals to make requests for electronic copies of their protected health information in writing. We note that the Privacy Rule allows for electronic documents to qualify as written documents, as well as electronic signatures to satisfy any requirements for a signature, to the extent the signature is valid under applicable law. If the covered entity chooses to require a written request, it has flexibility in determining what information to put into the request form. However, the request form may not be in any way designed to discourage an individual from exercising his or her right. A covered entity may also choose to accept an individual's oral request for an electronic copy of their protected health information without written signature or documentation. Comment: We received several comments on the content that covered entities are required to provide in response to an electronic access request. Some commenters felt that there should be a defined minimum set of data elements to satisfy this requirement, particularly for non-EHR data. Covered entities also requested clarification on\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00069\n\nhow to handle links to images or other data. Response: We clarify that just as is currently required for hard copy protected health information access requests, covered entities must provide an electronic copy of all protected health information about the individual in an electronically maintained designated record set, except as otherwise provided at § 164.524(a). If the designated record set includes electronic links to images or other data, the images or other data that is linked to the designated record set must also be included in the electronic copy provided to the individual."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 103}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 127)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nd or received by Business Associate on behalf of Covered Entity agrees to the same restrictions and conditions that apply through this Agreement to Business Associate with respect to such information.\n(f) Business Associate agrees to provide access, at the request of Covered Entity, and in the time and manner [Insert negotiated terms], to Protected Health Information in a Designated Record Set, to Covered Entity or, as directed by Covered Entity, to an Individual in order to meet the requirements under 45 CFR 164.524. [Not necessary if business associate does not have protected health information in a designated record set.]\n\n(g) Business Associate agrees to make any amendment(s) to Protected Health Information in a Designated Record Set that the Covered Entity directs or agrees to pursuant to 45 CFR 164.526 at the request of Covered Entity or an Individual, and in the time and manner [Insert negotiated terms]. [Not necessary if business associate does not have protected health information in a designated record set.]\n\n(h) Business Associate agrees to make internal practices, books, and records, including policies and procedures and Protected Health Information, relating to the use and disclosure of Protected Health Information received from, or created or received by Business Associate on behalf of, Covered Entity available [to the Covered Entity, or] to the Secretary, in a time and manner [Insert negotiated terms] or designated by the Secretary, for purposes of the Secretary determining Covered Entity's compliance with the Privacy Rule. (i) Business Associate agrees to document such disclosures of Protected Health Information and information related to such disclosures as would be required for Covered Entity to respond to a request by an Individual for an accounting of disclosures of Protected Health Information in accordance with 45 CFR 164.528."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 126}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 76)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ndecided not to adopt this suggestion because such a blanket authorization would not provide individuals with sufficient information to make an informed choice about whether to sign the authorization.\nIn addition, adopting this change also would be inconsistent with Department's decision to eliminate the distinction in the Rule between research that includes treatment and research that does not. Comment: It was suggested that the Department exempt from the Privacy Rule research that is already covered by the Common Rule and/or FDA's human subject protection regulations. Commenters stated that this would reduce the burden of complying with the Rule for covered entities and researchers already governed by human subject protection regulations, while requiring those not previously subject to compliance with human subject protection regulations to protect individuals' privacy. Response: Many who commented on the December 2000 Privacy Rule argued for this option as well. The Department had previously considered, but chose not to adopt, this approach. Since the Common Rule and the FDA's human subject protection regulations contain only two requirements that specifically address confidentiality protections, the Privacy Rule will strengthen existing human subject privacy protections for research. More importantly, the Privacy Rule creates equal standards of privacy protection for research governed by the\n\nVerDate Aug&lt;2,&gt;2002\n\nexisting regulations and research that is not. Comment: It was argued that the waiver provision should be eliminated. The commenter argued that IRBs or Privacy Boards should not have the right to waive a person's privacy rights, and that individuals should have the right to authorize all uses and disclosures of protected health information about themselves."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 75}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What is considered a breach under HIPAA?"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ner and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 (or toll-free at 1-866-5121800) or by fax to (202) 512-2250. The cost for each copy is $10.00.\nAlternatively, you may view and photocopy the Federal Register document at most libraries designated as Federal Depository Libraries and at many other public and academic libraries throughout the country that receive the Federal Register . Electronic Access: This document is available electronically at the HHS\n\nVerDate Aug&lt;2,&gt;2002\n\nOffice for Civil Rights (OCR) Privacy Web site at http://www.hhs.gov/ocr/ hipaa/, as well as at the web site of the Government Printing Office at http:// www.access.gpo.gov/su \\_ docs/aces/ aces140.html. ## I. Background\n\n## A. Statutory Background\n\nCongress recognized the importance of protecting the privacy of health information given the rapid evolution of health information systems in the Health Insurance Portability and Accountability Act of 1996 (HIPAA), Public Law 104-191, which became law on August 21, 1996. HIPAA's Administrative Simplification provisions, sections 261 through 264 of the statute, were designed to improve the efficiency and effectiveness of the health care system by facilitating the electronic exchange of information with respect to certain financial and administrative transactions carried out by health pl"}], "metadata": {"source": "privacy_mod_2002", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 106)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nentities sought clarification on whether or not an authorization is required prior to transmitting the requested electronic protected health information to a third party designated by the individual.\nSome commenters supported the ability to provide electronic protected health information access to third parties without individual authorization, while others felt that authorization should be required. Covered entities requested clarification that they are not liable when making reasonable efforts to verify the identity of a third party recipient identified by the individual. ## Final Rule\n\nThe final rule adopts the proposed amendment §164.524(c)(3) to expressly provide that, if requested by an individual, a covered entity must transmit the copy of protected health information directly to another person designated by the individual. In contrast to other requests under § 164.524, when an individual directs the covered entity to send the copy of protected health information to another designated person, the request must be made in writing, signed by the individual, and clearly identify the designated person and where to send the copy of the protected health information. If a covered entity has decided to require all access requests in writing, the third party recipient information and signature by the individual can be included in the same written request; no additional or separate written request is\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with required. This written request for protected health information to be sent to a designated person is distinct from an authorization form, which contains many additional required statements and elements (see § 164.508(c))."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 105}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 39)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nhave its health care component enter into a MOU with its business associate division, provided that such agreement is legally binding and meets the relevant requirements of § 164.504(e)(3) and (e)(4).\nSuch agreement would eliminate the need for the health care component to include the business associate division or for obtaining the\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\nindividual's authorization to disclose to such division. Additionally, the Department encourages covered entities to develop a notice of privacy practices that is as specific as possible, which may include, for a government hybrid entity, a statement that information may be shared with other divisions within the government entity as permitted by the Rule. However, the notice of privacy practices is not an adequate substitute for, as appropriate, a memorandum of understanding; designation of business associate functions as part of a health care component; or alternatively, conditioning disclosures to such business associate functions on individuals' authorizations. Comment: One commenter requested a clarification that a pharmacyconvenience store, where the pharmacy itself is a separate enclosure under supervision of a licensed pharmacist, is not a hybrid entity. Response: The Department clarifies that a pharmacy-convenience store, if a single legal entity, is permitted, but not required, to be a hybrid entity and designate the pharmacy as the health care component. Alternatively, such an entity may choose to be a covered entity in its entirety. However, if the pharmacy and the convenience store are separate legal entities, the convenience store is not a covered entity simply by virtue of sharing retail space with the covered pharmacy."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 38}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 224)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n4700\n\nResponse: We agree and have modified the regulation text to incorporate quality assessment and improvement activities, including the development of clinical guidelines and protocol development.\nComment: Several commenters stated that the proposal did not provide sufficient guidance regarding compiling and analyzing information in anticipation of or for use in legal proceedings. In particular, they raised concerns about the lack of specificity as to when ''anticipation'' would be triggered. Response: We agree that this provision was confusing and have replaced it with a broader reference to conducting or arranging for legal services generally. Comment: Hospital representatives pointed out the pressure on health care facilities to improve cost efficiencies, make cost-effectiveness studies, and benchmark essential health care operations. They emphasized that such activities often use identifiable patient information, although the products of the analyses usually do not contain identifiable health information. Commenters representing state hospital associations pointed out that they routinely receive protected health information from hospitals for analyses that are used by member hospitals for such things as quality of care benchmark comparisons, market share analysis, determining physician utilization of hospital resources, and charge comparisons. Response: We have expanded the definition of health care operations to include use and disclosure of protected health information for the important functions noted by these commenters. We also allow a covered entity to engage a business associate to provide data aggregation services. See § 164.504(e). Comment: Several commenters argued that many activities that are integral to the day-to-day operations of a health plan have not been included in the definition."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 223}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 379)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nt occur. For a small number of demographic variables (6), this point was quite low (about 20,000 population), but it rose quickly to about 50,000 for 10 variables and to about 80,000 for 15 variables.\nThe Bureau of the Census releases sets of data to the public that it considers safe from reidentification because it limits geographical areas to those containing at least 100,000 people and limits the number and detail of the demographic variables in the data. At the point of approximately 100,000 population, 7.3% of records were unique (and therefore potentially identifiable) on 6 demographic variables from the 1990 Census Short Form: Age in years (90 categories), race (up to 180 categories), sex (2 categories), relationship to householder (14 categories), Hispanic (2 categories), and tenure (owner vs. renter in 5 categories). Using 6 variables derived from the Long Form data, age (10 categories), race (6 categories), sex (2 categories), marital status (5 categories), occupation (54 categories), and personal income (10 categories), raised the percentage to 9.8%. We also examined the results of an NCHS simulation study using national survey data 22 to see if some scientific\n\n20 Statistical Policy Working Paper 22-Report on Statistical Disclosure Limitation Methodology ( http://www.fcsm.gov/working-papers/wp22.html ) (prepared by the Subcommittee on Disclosure Limitation Methodology, Federal Committee on Statistical Methodology, Office of Management and Budget). 21 The Geographic Component of Disclosure Risk for Microdata. Brian Greenberg and Laura Voshell. Bureau of the Census Statistical Research Division Report: Census/SRD/RR-90-13, October, 1990. 22 A Simulation Study of the Identifiability of Survey Respondents when their Community of\n\nsupport could be found for a compromise."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 378}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 239)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ny are not at all limited to electronic communications. We note that medical devices in and of themselves, for example, pacemakers, are not protected health information for purposes of this regulation.\nHowever, information in or from the device may\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nbe protected health information to the extent that it otherwise meets the definition. Comment: Numerous commenters argued that the proposed coverage of any information other than that which is transmitted electronically and/or in a HIPAA transaction exceeds the Secretary's authority under section 264(c)(1) of HIPAA. The principal argument was that the initial language in section 264(c)(1) (''If language governing standards with respect to the privacy of individually identifiable health information transmitted in connection with the transactions described in section 1173(a) of the Social Security Act * * * is not enacted by [August 21, 1999], the Secretary * * * shall promulgate final regulations containing such standards* * *'') limits the privacy standards to ''information transmitted in connection with the [HIPAA] transactions.'' The precise argument made by some commenters was that the grant of authority is contained in the words ''such standards,'' and that the referent of that phrase was ''standards with respect to the privacy of individually identifiable health information transmitted in connection with the transactions described in section 1173(a)* * *''."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 238}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 76)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nhealthcare arrangement, or that provides a service as described in paragraph (1)(ii) of this definition to or for such organized healthcare arrangement by virtue of such activities or services. [Sec.\nRule, §160.103]\n\n## confidentiality\n\nThe property that data or information is not made available or disclosed to unauthorized persons or processes. [Sec. Rule, §164.304]\n\n## covered entities\n\nCovered entity means: (1) A health plan. (2) A healthcare clearinghouse. (3) A healthcare provider who transmits any health information in electronic form in connection with a transaction covered by this subchapter. [Sec. Rule, §160.103]\n\n## electronic protected health information (electronic PHI, or ePHI)\n\nInformation that comes within paragraphs (1)(i) or (1)(ii) of the definition of protected health information as specified in this section (see 'protected health information'). [Sec. Rule, §160.103]\n\n## healthcare clearinghouse\n\nA public or private entity, including a billing service, repricing company, community health management information system or community health information system, and 'value-added' networks and switches, that does either of the following functions:\n\n- (1) Processes or facilitates the processing of health information received from another entity in a nonstandard format or containing nonstandard data content into standard data elements or a standard transaction. - (2) Receives a standard transaction from another entity and processes or facilitates the processing of health information into nonstandard format or nonstandard data content for the receiving entity. [Sec. Rule, §160.103]\n\n## healthcare provider\n\nA provider of services (as defined in section 1861(u) of the Social Security Act, 42 U.S.C. 1395x(u)), a provider of medical or health services (as defined in section 1861(s) of the Social Security Act, 42 U.S.C. 1395x(s)), and any other person or organization who furnishes, bills, or is paid for healthcare in the normal course of business. [Sec."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 75}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 200)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n4.404(a)(2), notify prominent media outlets serving the State or jurisdiction. *\n\n*\n\n*\n\n*\n\n*\n\n- ■ 41. In § 164.408, revise paragraph (c) to read as follows:\n\n## §164.408 Notification to the Secretary.\n*\n\n*\n\n*\n\n*\n\n*\n\n- (c) Implementation specifications: Breaches involving less than 500 individuals. For breaches of unsecured protected health information involving less than 500 individuals, a covered entity shall maintain a log or other documentation of such breaches and, not later than 60 days after the end of each calendar year, provide the notification required by paragraph (a) of this section for breaches discovered during the preceding calendar year, in the manner specified on the HHS web site. - ■ 42. In § 164.410, revise paragraph (a) to read as follows:\n\n## §164.410 Notification by a business associate. - (a) Standard -(1) General rule. A business associate shall, following the discovery of a breach of unsecured protected health information, notify the covered entity of such breach. - (2) Breaches treated as discovered. For purposes of paragraph (a)(1) of this section, a breach shall be treated as\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00131\n\ndiscovered by a business associate as of the first day on which such breach is known to the business associate or, by exercising reasonable diligence, would have been known to the business associate. A business associate shall be deemed to have knowledge of a breach if the breach is known, or by exercising reasonable diligence would have been known, to any person, other than the person committing the breach, who is an employee, officer, or other agent of the business associate (determined in accordance with the Federal common law of agency). *\n\n*\n\n*\n\n*\n\n*\n\n- ■ 43. The authority citation for subpart E of part 164 is revised to read as follows:\n\nAuthority: 42 U.S.C. 1320d-2, 1320d-4, and 1320d-9; sec. 264 of Pub. L. 104-191, 110 Stat. 2033-2034 (42 U.S.C. 1320d-2 (note)); and secs. 13400-13424, Pub. L. 1115, 123 Stat. 258-279."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 199}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 49)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n| Key Activities | Description | Sample Questions | |------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 2."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 48}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the required HIPAA security measures?"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\n## Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on June 27, 2025.\n\nA draft select update to this document was issued on March 13, 2024.\n\nThis document supersedes 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,' issued September 27, 2023.\n\nFor questions about this document regarding CDRH-regulated devices, contact CyberMed@fda.hhs.gov. For questions about this document regarding CBER-regulated devices, contact the Office of Communication, Outreach, and Development (OCOD) at 1-800-835-4709 or 240-402-8010, or by email at industry.biologics@fda.hhs.gov.\n\n<!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Center for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to https://www.regulations.gov. Submit written comments to the Dockets Management Staff, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2021-D-1158. Comments may not be acted upon by the Agency until the document is next revised or updated.\n\n## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an email request to CDRH-Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number GUI00001825 and complete title of the guidance in the request.\n\n## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), WO71, Room 3103, Silver Spring, MD 20903, or by calling 1-800-835-4709 or 240-402-8010,\n\nOffice of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., by email, industry.biologics@fda.hhs.gov, or from the Internet at http"}], "metadata": {"source": "fda_premarket_2023", "implementation_spec": "required", "safeguard_types": ["physical", "technical", "administrative"], "type": "implementation"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What's the difference between required and addressable implementation specifications?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160, 162, and 164 [CMS-0049-F] RIN 0938-AI57\n\n## Health Insurance Reform: Security Standards\n\nAGENCY: Centers for Medicare &amp; Medicaid Services (CMS), HHS. ACTION: Final rule.\n\nSUMMARY: This final rule adopts standards for the security of electronic protected health information to be implemented by health plans, health care clearinghouses, and certain health care providers. The use of the security standards will improve the Medicare and Medicaid programs, and otherFederal health programs and private health programs, and the effectiveness and efficiency of the health care industry in general by establishing a level of protection for certain electronic health information. This final rule implements some of the requirements of the Administrative Simplification subtitle of the Health Insurance Portability andAccountability Act of 1996 (HIPAA).\n\nDATES: Effective Date: These regulations are effective on April 21, 2003.\n\nCompliance Date: Covered entities, with the exception of small health plans, must comply with the requirements of this final rule by April 21, 2005. Small health plans must comply with the requirements of this final rule by April 21, 2006.\n\nFOR FURTHER INFORMATION CONTACT: William Schooler, (410) 786-0089.\n\nSUPPLEMENTARY INFORMATION:\n\n## Availability of Copies and Electronic Access\n\nTo order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 or by faxing to (202) 5122250. The cost for each copy is $10. As an alternative, you can view and photocopy the Federal Register document at most "}], "metadata": {"source": "security_rule_2003", "implementation_spec": "both", "safeguard_types": ["physical", "technical", "administrative"], "type": "implementation"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 14)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nper person for violations of a single standard for a calendar year. The procedural provisions of section 1128A of the Act apply to actions taken to obtain civil monetary penalties under this section.\nSection 1177 establishes penalties for any person that knowingly uses a unique health identifier, or obtains or discloses individually identifiable health information in violation of the part. The penalties include: (1) A fine of not more than $50,000 and/or imprisonment of not more than 1 year; (2) if the offense is ''under false pretenses,'' a fine of not more than $100,000 and/or imprisonment of not more than 5 years; and (3) if the offense is with intent to sell, transfer, or use individually identifiable health information for commercial advantage, personal gain, or malicious harm, a fine of not more than $250,000 and/or imprisonment of not more than 10 years. Under section 1178 of the Act, the requirements of part C, as well as any standards or implementation specifications adopted thereunder, preempt contrary state law. There are three exceptions to this general rule of preemption: State laws that the Secretary determines are necessary for certain purposes set forth in the statute; state laws that the Secretary determines address controlled substances; and state laws relating to the privacy of\n\nFrm 00010\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nindividually identifiable health information that are contrary to and more stringent than the federal requirements. There also are certain areas of state law (generally relating to public health and oversight of health plans) that are explicitly carved out of the general rule of preemption and addressed separately."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 13}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.414(a) require?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n§164.414(a), to make clear that these provisions apply to this subpart as well as subpart E, we have made conforming modifications in each of the above sections of the Privacy Rule to include a reference to this subpart D.\n\nConsistent with section 13402(d)(2) of the Act, "}], "metadata": {"source": "breach_notification_2009", "cfr_section": "§164.414(a)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 179)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nin the electronic form and format requested by the individual, if it is readily producible, or, if not, in a readable electronic form and format as agreed to by the covered entity and the individual.\nAlso, as in the proposed rule, the final rule provides that a covered entity may charge a fee for costs associated with labor and supplies for creating an electronic copy, including electronic portable media if agreed to by the individual, and clarifies that a covered entity may charge for postage if an individual requests that the covered entity transmit portable media containing an electronic copy through mail or courier. However, covered entities may not include fees associated with maintaining systems, retrieval costs, or infrastructure costs in the fee they charge to provide an electronic copy. We continue to believe that this requirement will not result in significant new burdens on covered entities. Individuals already had a right to access protected health information maintained in electronic designated record sets under the prior Rule, and already had a right to receive an electronic copy of such information to the extent the electronic copy was readily producible by the covered entity. The Rule provides significant flexibility to covered entities in honoring individuals' request for electronic access. While a covered entity must provide some type of electronic copy to an individual who requests one, a covered entity is not required to provide the exact form of the copy or access requested by the individual if it is not readily producible in such form. Thus, covered entities may provide readily producible electronic copies of protected health information that are currently available on their various\n\nVerDate Mar&lt;15&gt;2010\n\nsystems."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 178}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 318)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nention Fund has noted in its Health Privacy Principles for Protecting Victims of Domestic Violence (October 2000), victims of domestic violence and abuse sometimes are subject to retaliatory violence.\nBy informing a victim of abuse or domestic violence of a disclosure to law enforcement or other authorities, covered entities give victims the opportunity to take appropriate safety precautions. See the above preamble discussion of § 164.512(c) for more detail about the requirements for disclosing protected health information about victims of domestic violence. Comment: Some commenters argued that a consent requirement should apply at a minimum to disclosures involving victims of crime or victims of domestic violence. Response: We agree, and we modify the proposed rule to require covered entities to obtain an individual's agreement prior to disclosing protected health information in most instances involving victims of a crime or of abuse, neglect, or domestic violence. See the above preamble discussions of\n\n§164.512(c), on disclosures about victims of abuse, neglect, or domestic violence, and § 164.512(f)(3), on disclosures to law enforcement about crime victims. ## Section 164.512(d)-Uses and Disclosures for Health Oversight Activities\n\nComment: A couple of commenters supported the NPRM's approach to health oversight. Several other commenters generally supported the NPRM's approach to disclosure of protected health information for national priority purposes, and they recommended some clarification regarding disclosure for health oversight. Two commenters recommended clarifying in the final rule that disclosure is allowed to all federal, state, and local agencies that use protected health information to carry out legally mandated responsibilities. Response: The final rule permits disclosures to public agencies that meet the definition of a health oversight agency and for oversight of the particular areas described in the statute."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 317}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 358)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nbreach of privacy, such as stigmatization, and discrimination in employment or insurance, may not be tied directly to an individuals' ''rights,'' but would have a significant impact on their welfare.\nTherefore, in the final rule, we have retained the term ''welfare'' in this criterion for the alteration or waiver of authorization but modified the criterion as follows to focus more specifically on privacy concerns and to clarify that it pertains to alterations of authorization: ''the alteration or waiver will not adversely affect the privacy rights and the welfare of the individual.''\n\nComment: A few commenters recommended that the proposed waiver criteria that stated, ''the research could not practicably be conducted without\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nthe waiver,'' be modified to eliminate the term ''practicably.'' These commenters believed that determining ''practicably'' was subjective and that its elimination would facilitate IRBs' and privacy boards' implementation of this criterion. In addition, one commenter was concerned that this term could be construed to require authorization if enough weight is given to a privacy interest, and little weight is given to cost or administrative burden. This commenter recommended that the criterion be changed to allow a waiver if the ''disclosure is necessary to accomplish the research or statistical purpose for which the disclosure is to be made.''\n\nResponse: We disagree with the comments recommending that the term ''practicability'' be deleted from this waiver criterion. We believe that an assessment of practicability is necessary to account for research that may be possible to conduct with authorization but that would be impracticable if authorization were required. For example, in research study that involves thousands of records, it may be possible to track down all potential subjects, but doing so may entail costs that would make the research impracticable."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 357}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 209)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nation for underwriting purposes, a statement that the covered entity is prohibited from using or disclosing protected health information that is genetic information of an individual for such purposes.\n(iv) *\n\n*\n\n*\n\nVerDate Mar&lt;15&gt;2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\n- (A) The right to request restrictions on certain uses and disclosures of protected health information as provided by §164.522(a), including a statement that the covered entity is not required to agree to a requested restriction, except in case of a disclosure restricted under §164.522(a)(1)(vi);\n\n*\n\n*\n\n*\n\n(v) * *\n\n*\n\n*\n\n- (A) A statement that the covered entity is required by law to maintain the privacy of protected health information, to provide individuals with notice of its legal duties and privacy practices with respect to protected health information, and to notify affected individuals following a breach of unsecured protected health information;\n\n*\n\n*\n\n*\n\n*\n\n- (c) * * *\n\n(1) * *\n\n*\n\n- (i) A health plan must provide the notice:\n\n*\n\n*\n\n*\n\n*\n\n*\n\n- (B) Thereafter, at the time of enrollment, to individuals who are new enrollees. *\n\n*\n\n*\n\n*\n\n*\n\n- (v) If there is a material change to the notice:\n- (A) A health plan that posts its notice on its web site in accordance with paragraph (c)(3)(i) of this section must prominently post the change or its revised notice on its web site by the effective date of the material change to the notice, and provide the revised notice, or information about the material change and how to obtain the revised notice, in its next annual mailing to individuals then covered by the plan. - (B) A health plan that does not post its notice on a web site pursuant to paragraph (c)(3)(i) of this section must provide the revised notice, or information about the material change and how to obtain the revised notice, to individuals then covered by the plan within 60 days of the material revision to the notice. *\n\n*\n\n*\n\n*\n\n*\n\n- ■ 54. Amend §164.522 as follows:\n- ■ a."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 208}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 155)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne sanctions. These sanctions do not apply to whistleblower activities that meet the provisions of § 164.502(j) or complaints, investigations, or opposition that meet the provisions of § 164.530(g)(2).\nWe eliminate language regarding business associates from this section. Requirements with respect to business associates are stated in § 164.504. ## Duty To Mitigate\n\nIn proposed § 164.518(f), we would have required covered entities to have policies and procedures for mitigating, to the extent practicable, any deleterious effect of a use or disclosure of protected health information in violation of the requirements of this subpart. The NPRM preamble also included specific language applying this requirement to harm caused by members of the covered entity's workforce and business associates. With respect to business associates, the NPRM preamble but not the NPRM rule text, stated that covered entities would have a duty to take reasonable steps in response to breaches of contract terms. Covered entities generally would not be required to monitor the activities of their business associates, but would be required to take steps to address problems of which they become aware, and, where the breach was serious or repeated, would also be required to monitor the business associate's performance to ensure that the wrongful behavior had been remedied. Termination of the arrangement would be required only if it became clear that a business associate could not be relied upon to maintain the privacy of protected health information provided to it. In the final rule, we clarify this requirement by imposing a duty for covered entities to mitigate any harmful effect of a use or disclosure of protected health information that is known to the covered entity. We apply the duty to mitigate to a violation of the covered entity's policies and procedures, not just a violation of the requirements of the subpart."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 154}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 50)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\n). Comment: One commenter asserted that, without a consent requirement, nothing will stop a health plan from demanding a patient's mental health records as a condition of payment for physical therapy.\nResponse: The Department does not agree that the former consent requirement is the relevant standard with respect to the activities of the health plan that concern the commenter. Rather, the Transactions Rule and the\n\nVerDate Aug&lt;2,&gt;2002\n\nminimum necessary standard of the Privacy Rule prescribe and limit the health information that may be disclosed as part of payment transactions between health plans and health care providers. Although a health plan may request additional information to process a specific claim, in addition to the required and situational elements under the Transactions Rule, the request must comply with the Privacy Rule's minimum necessary requirements. In this example, the health plan can only request mental health records if they are reasonably necessary for the plan to process the physical therapy claim. 2. Disclosures for Treatment, Payment, or Health Care Operations of Another Entity\n\nDecember 2000 Privacy Rule. The Privacy Rule permits a covered entity to use and disclose protected health information for treatment, payment, or health care operations. For treatment purposes, the Rule generally allows protected health information to be shared without restriction. The definition of ''treatment'' incorporates the necessary interaction of more than one entity. In particular, the definition of ''treatment'' includes the coordination and management of health care among health care providers or by a health care provider with a third party, consultations between health care providers, and referrals of a patient for health care from one health care provider to another."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 49}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 185)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nues could be higher. 45 Source: 2010 Medical Expenditure SurveyInsurance Component. Fmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with compliance activities.\nWe have no information on how many of these plans self-administer, and we did not receive any information from commenters in this area and so do not include a separate estimate for plans that selfadminister. We estimate that the breach notification requirements will result in $14.5 million in annual costs to covered entities. Dividing that amount by the approximately 19,000 entities that will actually experience a breach of protected health information each year, we estimate that the costs of complying with the breach notification requirements will amount to, on average, $763 per covered entity that must respond to a breach. Smaller covered entities likely will face much lower costs, as these entities generally have protected health information for far fewer individuals than do larger covered entities and breach notification costs are closely linked to the number of individuals affected by a given breach incident. The other source of costs for covered entities arises from the requirement to provide revised NPPs to the individuals they serve. We estimate that the approximately 700,000 covered entities will experience total costs of approximately $55.9 million for compliance with the NPP requirements, or about $80 per covered entity. We estimate the costs for 200,000400,000 business associates to come into full compliance with the Security Rule to be approximately $22.6-$113 million. The average cost per affected business associate would be approximately $198. Finally, we estimate that 250,000 to 500,000 business associates will incur costs totaling between $21 million and $42 million, respectively, to establish or significantly modify contracts with subcontractors to be in compliance with the rule's requirements for business associate agreements."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 184}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 232)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nly about privacy and thus are not appropriately addressed in this regulation. Comment: A few commenters asked that patient assistance programs (PAPS) should be excluded from the definition of payment.\nSuch programs are run by or on behalf of manufacturers and provide free or discounted medications to individuals who could not afford to purchase them. Commenters were concerned that including such activities in the definition of payment could harm these programs. For example, a university school of pharmacy may operate an outreach program and serve as a clearinghouse for information on various pharmaceutical manufacturer PAPS. Under the program state residents can submit a simple application to the program (including medication regimen and financial information), which is reviewed by program pharmacists who study the eligibility criteria and/or directly call the manufacturer's program personnel to help evaluate eligibility for particular PAPS. The program provides written guidance to the prescribing physicians that includes a suggested approach for helping their indigent patients obtain the medications that they need and enrollment information for particular PAPS. Response: We note that the concerns presented are not affected by definition of ''payment.'' The application of this rule to patient assistance programs activities will depend on how the individual programs operate and are affected primarily by the definition of treatment. Each of these programs function differently, so it is not possible to state a blanket rule for whether and how the rule affects such programs. Under the example provided, the physician who contacts the program on behalf of a patient is managing the patient's care. If the provider is also a covered entity, he or she would be permitted to make such a ''treatment'' disclosure of protected health information if a general consent had been obtained from the patient."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 231}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 12)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\negulation, 28 be established or incorporated into those that already exist, and should address the manufacturer's design, manufacturing, and distribution processes, as well as updates across the TPLC.\nThe processes in the QS regulation which may be relevant in this context include, but are not limited to design controls (21 CFR 820.30), validation of production processes (21 CFR 820.70), and corrective and preventive actions (21 CFR 820.100) to ensure both safety and security risks are adequately addressed. For completeness in performing risk analyses under 21 CFR 820.30(g), FDA recommends that device manufacturers conduct both a safety risk assessment and a separate, accompanying security risk assessment to ensure a more comprehensive identification and management of patient safety risks. A device should be designed to eliminate or mitigate known vulnerabilities. For marketed devices, if comprehensive design mitigations are not possible, compensating controls should be considered. For all devices, when any known vulnerabilities are only partially mitigated or unmitigated by the device design, they should be assessed as reasonably foreseeable risks in the risk assessment and be assessed for additional control measures or risk transfer 29 to the user/operator, or, if necessary, the patient. Risk transfer, if appropriate, should only occur when all relevant risk information is known, assessed, and appropriately communicated to users and includes risks inherited from the supply chain as well as how risk transfer will be handled when the device or manufacturer-controlled assets of the medical device system reach end of support and end of life and whether or how the user is able to take on that role (e.g., if the user may be a patient). 27  AAMI TIR57 Principles for medical device security-Risk management describes the security risk management process and how the security risk management process should have links into the safety risk management process and vice versa."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 11}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 132)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ndividual is not present, such as when a friend is picking up a prescription, we allow the covered entity to use professional judgment and experience with common practice to make reasonable inferences.\nUnder §164.524, a covered entity is required to give individuals access to protected health information about them (under most circumstances). Under the general verification requirements of §164.514(h), the covered entity is required to take reasonable steps to verify the identity of the individual making the request. We do not mandate particular identification requirements ( e.g., drivers licence, photo ID), but rather leave this to the discretion of the covered entity. The covered entity must also establish and document procedures for verification of identity and authority of personal representatives, if not known to the entity. For example, a health care provider can require a copy of a power of attorney, or can ask questions to determine that an adult acting for a young child has the requisite relationship to the child. In Subpart C of Part 160, we require disclosure to the Secretary for purposes of enforcing this regulation. When a covered entity is asked by the Secretary to disclose protected health information for compliance purposes, the covered entity must verify the same information that it is required to verify for any other law enforcement or oversight request for disclosure. VerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00087\n\n## Use of Protected Health Information\n\nThe proposed rule's verification requirements applied to any person requesting protected health information, whether for a use or a disclosure. In the final regulation, the verification provisions apply only to disclosures of protected health information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 131}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the technical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\n## Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on June 27, 2025. A draft select update to this document was issued on March 13, 2024. This document supersedes 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,' issued September 27, 2023. For questions about this document regarding CDRH-regulated devices, contact CyberMed@fda.hhs.gov. For questions about this document regarding CBER-regulated devices, contact the Office of Communication, Outreach, and Development (OCOD) at 1-800-835-4709 or 240-402-8010, or by email at industry.biologics@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Center for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to https://www.regulations.gov. Submit written comments to the Dockets Management Staff, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2021-D-1158. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an email request to CDRH-Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number GUI00001825 and complete title of the guidance in the request."}], "metadata": {"source": "fda_premarket_2023", "safeguard_type": "technical", "implementation_spec": "required", "entity_type": "covered_entity", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 78)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nml . As such, we proposed to amend §164.512(b)(1) by adding a new paragraph that permits covered entities to disclose proof of immunization to schools in States that have school entry or similar laws.\n10 While written authorization that complies with §164.508 would no longer have been required for disclosure of such information under the proposal, the covered entity would still have been required to obtain agreement, which may have been oral, from a parent, guardian or other person acting in loco parentis for the individual, or from the individual him- or herself, if the individual is an adult or emancipated minor. Because the proposed provision would have permitted a provider to\n\n10 We note that once a student's immunization records are obtained and maintained by an educational institution or agency to which the Family Educational Rights and Privacy Act (FERPA) applies, the records are protected by FERPA, rather than the HIPAA Privacy Rule. See paragraphs (2)(i) and (2)(ii) of the definition of ''protected health information'' at § 160.103, which exclude from coverage under the Privacy Rule student records protected by FERPA. In addition, for more information on the intersection of FERPA and HIPAA, readers are encouraged to consult the Joint HHS/ED Guidance on the Application of FERPA and HIPAA to Student Health Records, available at http://www.hhs.gov/ocr/privacy/hipaa/ understanding/coveredentities/ hipaaferpajointguide.pdf . 18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00052\n\naccept a parent's oral agreement to disclose immunization results to a school-as opposed to a written agreement-the NPRM acknowledged a potential for a miscommunication and later objection by the parent. We, therefore, requested comment on whether the Privacy Rule should require that a provider document any oral agreement under this provision to help avoid such problems, or whether a requirement for written documentation would be overly cumbersome, on balance."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 77}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 244)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ndelete the exception for jails and prisons and substitute specific language about what information could be disclosed and the limited circumstances or purposes for which such disclosures could occur.\nOthers recommended omission of the proposed exclusion entirely, arguing that excluding this information from protection sends the message that, with respect to this population, abuses do not matter. Commenters argued that inmates and detainees have a right to privacy of medical records and that individually identifiable health information obtained in these settings can be misused, e.g., when communicated indiscriminately, health information can trigger assaults on individuals with stigmatized conditions by fellow inmates or detainees. It can also lead to the denial of privileges, or inappropriately influence the deliberations of bodies such as parole boards. A number of commenters explicitly took issue with the exclusion relative to individuals, and in particular youths, with serious mental illness, seizure disorders, and emotional or substance abuse disorders. They argued that these individuals come in contact with criminal justice authorities as a result of behaviors stemming directly from their illness and assert that these provisions will cause serious problems. They argue that disclosing the fact that an individual was treated for mental illness while incarcerated could seriously impair the individual's reintegration into the community. Commenters stated that such disclosures could put the individual or family members at risk of discrimination by employers and in the community at large. Some commenters asserted that the rule should be amended to prohibit jails and prisons from disclosing private medical information of individuals who have been discharged from these facilities. They argued that such disclosures may seriously impair individuals' rehabilitation into society and subject them to discrimination as they attempt to re-establish acceptance in the community."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 243}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 67)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ney receive complaints or other information that contain substantial and credible evidence of violations by a business associate, and it must act upon any knowledge of such violation that it possesses.\nWe note that a whistleblowing disclosure by a business associate of a covered entity that meets the requirements of § 164.502(j)(1) does not put the covered entity in violation of this rule, and the covered entity has no duty to correct or cure, or to terminate the relationship. We also qualify the requirement for terminating contracts with noncompliant business associates. The final rule still requires that the business associate contract authorize the covered entity to terminate the contract, if the covered entity determines that the business associate has violated a material term of the contract, and it requires the covered entity to terminate the contract if steps to cure such a material breach fail. The rule now stipulates, however, that if the covered entity is unable to cure a material breach of the business associate's obligation under the contract, it is expected to terminate the contract, when feasible. This qualification has been added to accommodate circumstances where terminating the contract would be unreasonably burdensome on the covered entity, such as when there are no viable alternatives to continuing a contract with that particular business associate. It does not mean, for instance, that the covered entity can choose to continue the contract with a non-compliant business associate merely because it is more convenient or less costly than contracts with other potential business associates. We also require that if a covered entity determines that it is not feasible to terminate a non-compliant business associate, the covered entity must notify the Secretary. We retain all of the requirements for a business associate contract that were listed in proposed § 164.506(e)(2), with some modifications. See § 164.504(e)(2)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 66}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 12)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nocument provides a mapping of the HIPAA Security Rule standards and implementation specifications to Cybersecurity Framework [NIST CSF] Subcategories and the security controls detailed in [SP 800-53].\nIt also provides a crosswalk to other relevant NIST publications that regulated entities may find useful when implementing the Security Rule. For general HIPAA Security Rule information, visit the HHS Security Rule website. 15\n\nTable 1."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 11}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the physical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron Applied Cybersecurity Division Information Technology Laboratory\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\nFebruary 2024\n\n<!-- image -->\n\nU.S. Department of Commerce Gina M. Raimondo, Secretary\n\nNational Institute of Standards and Technology\n\nCertain commercial equipment, instruments, software, or materials, commercial or non-commercial, are identified in this paper in order to specify the experimental procedure adequately. Such identification does not imply recommendation or endorsement of any product or service by NIST, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose. There may be references in this publication to other publications currently under development by NIST in accordance with its assigned statutory responsibilities. The information in this publication, including concepts and methodologies, may be used by federal agencies even before the completion of such companion publications. Thus, until each publication is completed, current requirements, guidelines, and procedures, where they exist, remain operative. For planning and transition purposes, federal agencies may wish to closely follow the development of these new publications by NIST. Organizations are encouraged to review all draft publications during public comment periods and provide feedback to NIST."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_type": "physical", "implementation_spec": "both", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 149)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nde examples within the regulatory text of the definition and another comment stated that it is not\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00098\n\nclear what constitutes a genetic test under the definition.\n## Final Rule\n\nThe final rule adopts without modification the definition of ''genetic test'' as proposed in the NPRM. This definition is consistent with the definition found in the implementing regulations for sections 101-103 of GINA and with which compliance is already required by most health plans. Under this definition, a test to determine whether an individual has a gene variant associated with breast cancer (such as the BRCA1 or BRCA2 variant) is a genetic test. Similarly, a test to determine whether an individual has a genetic variant associated with hereditary nonpolyposis colorectal cancer is a genetic test. Such tests are genetic in nature because they detect genotypes, mutations, or chromosomal changes. In contrast, medical tests that do not detect genotypes, mutations, or chromosomal changes, are not genetic tests. For example, HIV tests, complete blood counts, cholesterol tests, liver function tests, or tests for the presence of alcohol or drugs are not genetic tests. Consistent with the approach taken generally with the HIPAA Privacy Rule, the Department declines to include these examples in the regulatory text. The Department intends to issue future guidance on its web site about this issue. ## d. Definition of ''Genetic Services'' Proposed Rule\n\nGINA provides that the term ''genetic information'' includes, with respect to any individual, any request for, or receipt of, genetic services, or participation in clinical research which includes genetic services, by such individual or any family member of such individual. Section 102(a)(4) of GINA defines ''genetic services'' to mean: (1) A genetic test; (2) genetic counseling (including obtaining, interpreting, or assessing genetic information); or (3) genetic education."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 148}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What is considered a breach under HIPAA?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nlease do not submit duplicate comments):\n\n- Regular, Express, or Overnight Mail: U.S. Department of Health and Human Services, Office for Civil Rights, Attention: HITECH Breach Notification, Hubert H.\nHumphrey Building, Room\n- Federal eRulemaking Portal: http:// www.regulations.gov. Follow the instructions for submitting comments. Attachments should be in Microsoft Word, WordPerfect, or Excel; however, we prefer Microsoft Word. VerDate Nov&lt;24&gt;2008\n\n509F, 200 Independence Avenue, SW., Washington, DC 20201. Please submit one original and two copies. - Hand Delivery or Courier: Office for Civil Rights, Attention: HITECH Breach Notification, Hubert H. Humphrey Building, Room 509F, 200\n\nIndependence Avenue, SW., Washington, DC 20201. Please submit one original and two copies. (Because access to the interior of the Hubert H. Humphrey Building is not readily available to persons without federal government identification, commenters are encouraged to leave their comments in the mail drop slots located in the main lobby of the building.)\n\nInspection of Public Comments: All comments received before the close of the comment period will be available for public inspection, including any personally identifiable or confidential business information t"}], "metadata": {"source": "breach_notification_2009", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 192)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthe privacy of individually identifiable health information, since interpretations as to the scope and extent of ERISA's preemption provisions are outside of the Department's jurisdictional authority.\nOne commenter asked whether a state could enforce a state law which the Secretary had indicated through an advisory opinion is preempted by federal law. This commenter also asked whether the state would be subject to penalties if it chose to continue to enforce its own laws. Response: As discussed above, in part for reasons raised by these comments, the Department has decided not to have a formal process for issuing advisory opinions, as proposed. Several of these concerns, however, raise issues of broader concern that need to be addressed. First, we disagree that the Secretary lacks legal authority to opine on whether or not state privacy laws are preempted. The Secretary is charged by law with determining compliance, and where state law and the federal requirements conflict, a determination of which law controls will have to be made in order to determine whether the federal standard, requirement, or implementation specification at issue has been violated. Thus, the Secretary cannot carry out her enforcement functions without making such determinations. It is further reasonable that, if the Secretary makes such determinations, she can make those determinations known, for whatever persuasive effect they may have. The questions as to whether a state could enforce, or would be subject to penalties if it chose to continue to enforce, its own laws following a denial by the Secretary of an exception request under §160.203 or a holding by a court of competent jurisdiction that a state privacy law had been preempted by a contrary federal privacy standard raise several issues."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 191}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 38)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nssociate contract and documents the attempt and the reasons that these assurances cannot be obtained. We have added a standard for group health plans that parallels the provisions of the Privacy Rule.\nIt became apparent during the course of the security and privacy rulemaking that our original chain of trust approach was both overly broad in scope and failed to address appropriately the circumstances of certain covered entities, particularly the ERISA group health plans. These latter considerations and the solutions arrived at in the Privacy Rule are described in detail in the Privacy Rule at 65 FR 82507 through 82509. Because the purpose of the security standards is in part to reinforce privacy protections, it makes sense to align the organizational policies of the two rules. This decision should also make compliance less burdensome for covered entities than would a decision to have different organizational requirements for the two sets of rules. Thus, we have added at § 164.314(b) a standard for group health plan that tracks the standard at § 164.504(f) very closely. The purpose of these provisions is to ensure that, except when the electronic protected health information disclosed to a plan sponsor is summary health information or enrollment or disenrollment information as provided for by § 164.504(f), group health plan documents provide that the plan sponsor will reasonably and appropriately safeguard electronic protected health information created, received, maintained or transmitted to or by the plan sponsor on behalf of the group health plan."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 37}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the required HIPAA security measures?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\n## RIN 0945-AA03\n\nModifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services.\n\nACTION: Final rule.\n\nSUMMARY: The Department of Health and Human Services (HHS or ''the Department'') is issuing this final rule to: Modify the Health Insurance Portability and Accountability Act (HIPAA) Privacy, Security, and Enforcement Rules to implement statutory amendments under the Health Information Technology for Economic and Clinical Health Act (''the HITECH Act'' or ''the Act'') to strengthen the privacy and security protection for individuals' health information; modify the rule for Breach Notification for Unsecured Protected Health Information (Breach Notification Rule) under the HITECH Act to address public comment received on the interim final rule; modify the HIPAA Privacy Rule to strengthen the privacy protections for genetic information by implementing section 105 of Title I of the Genetic Information Nondiscrimination Act of 2008 (GINA); and make certain other modifications to the HIPAA Privacy, Security, Breach Notification, and Enforcement Rules (the HIPAA Rules) to improve their workability and effectiveness and to increase flexibility for and decrease burden on the regulated entities.\n\nDATES: Effective date: This final rule is effective on March 26, 2013.\n\nCompliance date: Covered entities and business associates must comply with the applicable requirements of this final rule by September 23, 2013.\n\nFOR FURTHER INFORMATION CONTACT: Andra Wicks 202-205-2292.\n\nSUPPLEMENTARY INFORMATION:\n\nVerDate Mar&lt;15&gt;2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n## I. Executive"}], "metadata": {"source": "hitech_omnibus_2013", "implementation_spec": "required", "safeguard_types": ["physical", "technical", "administrative"], "type": "implementation"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 218)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nnt to share information regarding findings of other bodies that conducted similar reviews. We would welcome such\n\nFrm 00144\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ninformation.\nIn developing its enforcement program, we may explore ways it can coordinate with other regulatory or oversight bodies so that we can efficiently and effectively pursue our joint interests in protecting privacy. We do not accept the suggestion that individuals be required to exhaust their remedies under state law before filing a complaint with the Secretary. Our rationale is similar to that discussed above in regard to the suggestion that covered entities be required to exhaust a covered entity's internal complaint process before filing a complaint with the Secretary. Congress provided for federal privacy protection and we want to allow individuals the right to this protection without barriers or delay. Covered entities may in their privacy notice inform individuals of any rights they have under state law including any right to file privacy complaints. We do not have the authority to interfere with state processes and HIPAA explicitly provides that we cannot preempt state laws that provide greater privacy protection. We have not yet addressed the issue as to whether this regulation might be used as a basis for violation findings or penalties under other Department authorities. We note that Medicare conditions of participation require participating providers to have procedures for ensuring the confidentiality of patient records, as well as afford patients with the right to the confidentiality of their clinical records. ## Penalties\n\nComment: Many commenters considered the statutory penalties insufficient to protect privacy, stating that the civil penalties are too weak to have the impact needed to reduce the risk of inappropriate disclosure."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 217}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\n## RIN 0945-AA03\n\nModifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (HHS or ''the Department'') is issuing this final rule to: Modify the Health Insurance Portability and Accountability Act (HIPAA) Privacy, Security, and Enforcement Rules to implement statutory amendments under the Health Information Technology for Economic and Clinical Health Act (''the HITECH Act'' or ''the Act'') to strengthen the privacy and security protection for individuals' health information; modify the rule for Breach Notification for Unsecured Protected Health Information (Breach Notification Rule) under the HITECH Act to address public comment received on the interim final rule; modify the HIPAA Privacy Rule to strengthen the privacy protections for genetic information by implementing section 105 of Title I of the Genetic Information Nondiscrimination Act of 2008 (GINA); and make certain other modifications to the HIPAA Privacy, Security, Breach Notification, and Enforcement Rules (the HIPAA Rules) to improve their workability and effectiveness and to increase flexibility for and decrease burden on the regulated entities. DATES: Effective date: This final rule is effective on March 26, 2013. Compliance date: Covered entities and business associates must comply with the applicable requirements of this final rule by September 23, 2013. FOR FURTHER INFORMATION CONTACT: Andra Wicks 202-205-2292. SUPPLEMENTARY INFORMATION:\n\nVerDate Mar&lt;15&gt;2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n## I."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 0}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 207)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ntion of the individual that is relevant to such person's involvement, unless doing so is inconsistent with any prior expressed preference of the individual that is known to the covered entity. - ■ 51.\nAmend §164.512 as follows: ■ a. Revise the paragraph heading for paragraph (b), the introductory text of\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\n*\n\n*\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with paragraph (b)(1) and the introductory text of paragraph (b)(1)(v)(A);\n\n- ■ b. Add new paragraph (b)(1)(vi);\n- ■ c. Revise the introductory text of paragraph (e)(1)(iii) and paragraph (e)(1)(vi);\n- ■ d. Revise paragraph (i)(2)(iii); and\n- ■ e. Revise paragraphs (k)(1)(ii), (k)(3), and (k)(5)(i)(E). The revisions and additions read as follows:\n\n§164.512 Uses and disclosures for which an authorization or opportunity to agree or object is not required. *\n\n*\n\n*\n\n*\n\n*\n\n- (b) Standard: Uses and disclosures for public health activities. (1) Permitted uses and disclosures. A covered entity may use or disclose protected health information for the public health activities and purposes described in this paragraph to:\n\n*\n\n*\n\n*\n\n(v) *\n\n*\n\n*\n\n*\n\n- (A) The covered entity is a covered health care provider who provides health care to the individual at the request of the employer:\n\n*\n\n*\n\n*\n\n*\n\n*\n\n- (vi) A school, about an individual who is a student or prospective student of the school, if:\n- (A) The protected health information that is disclosed is limited to proof of immunization;\n- (B) The school is required by State or other law to have such proof of immunization prior to admitting the individual; and\n- (C) The covered entity obtains and documents the agreement to the disclosure from either:\n- (1) A parent, guardian, or other person acting in loco parentis of the individual, if the individual is an unemancipated minor; or\n- (2) The individual, if the individual is an adult or emancipated minor."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 206}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 470)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nnic). The initial cost of the consent requirement is estimated to be $166 million. Using our standard assumptions for patient growth, the total costs for the ten years is estimated to be $227 million.\n## Authorizations\n\nPatient authorizations are required for uses or disclosures of protected health information that are not otherwise explicitly permitted under the final rule with or without consent. In addition to uses and disclosures of protected health information for treatment, payment, and health care operations with or without consent, the rule also permits certain uses of protected health information, such as fund-raising for the covered entity and certain types of marketing activity, without prior consent or authorization. Authorizations are generally required if a covered entity wants to provide protected health information to third party for use by the third party for marketing or for research that is not approved by an IRB or privacy board. The requirement for obtaining authorizations for use or disclosure of protected health information for most marketing activity will make direct third-party marketing more difficult because covered entities may not want to obtain and track such authorizations, or they may obtain too few to make the effort economically worthwhile. However, the final rule permits an alternative arrangement: the covered entity can engage in health-related marketing on behalf of a third party, presumably for a fee. Moreover, the covered entity could retain another party, through a business associate relationship, to conduct the actual health-related marketing, such as mailings or telemarketing, under the covered entity's name. The Department is unable to estimate the cost of these changes because there is no credible data on the extent of current third party marketing practices or the price that third party marketers currently pay for information from covered entities."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 469}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 88)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ninformation is to be used or disclosed. The required statement of purpose(s) must provide individuals with the facts they need to make an informed decision whether to allow release of the information.\nWe prohibit the use of broad or blanket authorizations requesting the use or disclosure of protected health information for a wide range of unspecified purposes. Both the information that is to be used or disclosed and the specific purpose(s) for such uses or disclosures must be stated in the authorization. Fmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nAuthorizations requested by covered entities for their own uses and disclosures must also advise individuals of certain rights available to them under this rule. The authorization must state that the individual may inspect or copy the information to be used or disclosed as provided in § 164.524 regarding access for inspection and copying and that the individual may refuse to sign the authorization. We alter the proposed requirements with respect to authorizations for which the covered entity will receive financial gain. When the covered entity initiates the authorization and the covered entity will receive direct or indirect remuneration from a third party (rather than financial gain, as proposed) in exchange for using or disclosing the protected health information, the authorization must include a statement that such remuneration will result. For example, a health plan may wish to sell or rent its enrollee mailing list or a pharmaceutical company may offer a covered provider a discount on its products if the provider obtains authorization to disclose the demographic information of patients with certain diagnoses so that the company can market new drugs to them directly. In each case, the covered entity must obtain the individual's authorization, and the authorization must include a statement that the covered entity will receive remuneration."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 87}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 416)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntrieval, labor costs for copying, expense costs for copying, capital cost for copying, expense costs for mailing, postal costs for mailing, billing and bad-debt expenses, and labor costs for refiling.\nSeveral commenters recommended specific fee structures. Response: We agree that covered entities should be able to recoup their reasonable costs for copying of protected health information, and include such provision in the regulation. We are not specifying a set fee because copying costs could vary significantly depending on the size of the covered entity and the form of such copy ( e.g., paper, electronic, film). Rather, covered entities are permitted to charge a reasonable, cost-based fee for copying (including the costs of supplies and labor), postage, and summary or explanation (if requested and agreed to by the individual) of information supplied. The rule limits the types of costs that may be imposed for providing access to protected health information, but does not preempt applicable state laws regarding specific allowable fees for such costs. The inclusion of a copying fee is not intended to impede the ability of individuals to copy their records. Comment: Many commenters stated that if a covered entity denies a request for access because the entity does not hold the protected health information requested, the covered entity should provide, if known, the name and address of the entity that holds the information. Some of these commenters additionally noted that the Uniform Insurance Information and Patient Protection Act, adopted by 16 states, already imposes this notification requirement on insurance entities. Some commenters also suggested requiring providers who leave practice or move offices to inform individuals of that fact and of how to obtain their records."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 415}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 375)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncation of protected health information should be generally accepted standards in the scientific and statistical community, rather than focusing on a specified list of identifiers that must be removed.\nA few commenters believed that no record of information about an individual can be truly de-identified and that all such information should be treated and protected as identifiable because more and more information about individuals is being made available to the public, such as voter registration lists and motor vehicle and\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ndriver's license lists, that would enable someone to match (and identify) records that otherwise appear to be not identifiable. Response: In the final rule, we reformulate the method for deidentification to more explicitly use the statutory standard of ''a reasonable basis to believe that the information can be used to identify the individual''-just as information is ''individually identifiable'' if there is a reasonable basis to believe that it can be used to identify the individual, it is ''deidentified'' if there is no reasonable basis to believe it can be so used. We also define more precisely how the standard should be applied. We did not accept comments that suggested that we allow only one method of de-identifying information. We find support for both methods in the comments but find no compelling logic for how the competing interests could be met cost-effectively with only one method. We also disagree with the comments that advocated using a standard which required removing only the direct identifiers. Although such an approach may be more convenient for covered entities, we judged that the resulting information would often remain identifiable, and its dissemination could result in significant violations of privacy."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 374}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 516)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nnoncompliance by persons described in paragraph (f)(2)(iii)(A) of this section with the plan document provisions required by this paragraph. - (3) Implementation specifications: Uses and disclosures.\nA group health plan may:\n- (i) Disclose protected health information to a plan sponsor to carry out plan administration functions that the plan sponsor performs only consistent with the provisions of paragraph (f)(2) of this section;\n- (ii) Not permit a health insurance issuer or HMO with respect to the group health plan to disclose protected health information to the plan sponsor except as permitted by this paragraph;\n- (iii) Not disclose and may not permit a health insurance issuer or HMO to disclose protected health information to a plan sponsor as otherwise permitted by this paragraph unless a statement required by § 164.520(b)(1)(iii)(C) is included in the appropriate notice; and (iv) Not disclose protected health information to the plan sponsor for the purpose of employment-related actions or decisions or in connection with any other benefit or employee benefit plan of the plan sponsor. - (g) Standard: Requirements for a covered entity with multiple covered functions. - (1) A covered entity that performs multiple covered functions that would make the entity any combination of a health plan, a covered health care provider, and a health care clearinghouse, must comply with the standards, requirements, and implementation specifications of this subpart, as applicable to the health plan, health care provider, or health care clearinghouse covered functions performed. Frm 00349\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\n- (2) A covered entity that performs multiple covered functions may use or disclose the protected health information of individuals who receive the covered entity's health plan or health care provider services, but not both, only for purposes related to the appropriate function being performed."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 515}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 18)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\narchitecture itself as it relates to safety and effectiveness. Manufacturers should analyze the entire system to understand the full environment and context in which the device is expected to operate.\nThe security architecture should include a consideration of system-level risks, including but not limited to risks related to the supply chain (e.g., to ensure the device remains free of malware, or vulnerabilities inherited from upstream dependencies such as third-party software, among others), design, production, and deployment (i.e., into a connected/networked environment). FDA recommends that this architecture information take the form of 'views,' and that these views be provided during premarket submissions to demonstrate safety and effectiveness. 41 If the documentation identified in this section already exists in other risk management documentation, FDA does not expect manufacturers to separate out this information into new document(s); such documentation can be provided and the submission can reference the relevant sections. Below, FDA outlines the recommended security controls and ways to document the resultant security architecture in premarket submissions through specific Security Architecture Views. 41 Views are discussed in more detail in the following subsections and Appendix 2. ## 1. Implementation of Security Controls\n\nFDA considers the way in which a device addresses cybersecurity risks and the way in which the device responds when exposed to cybersecurity threats as functions of the device design. Effective cybersecurity relies upon security being 'built in' to a device, and not 'bolted on' after the device is designed. FDA recommends that device manufacturers' design processes include design inputs for cybersecurity controls."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 17}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 13)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhave been, and continue to be, an integral part of the suite of Administrative Simplification standards intended to simplify and improve the efficiency of the administration of our health care system.\n## The Administrative Simplification Provisions, and Regulatory Actions to Date\n\nPart C of title XI consists of sections 1171 through 1179 of the Act. These sections define various terms and impose several requirements on HHS, health plans, health care clearinghouses, and health care providers who conduct the identified transactions electronically. The first section, section 1171 of the Act, establishes definitions for purposes of part C of title XI for the following terms: code set, health care clearinghouse, health care provider, health information, health plan, individually identifiable health information, standard, and standard setting organization. Section 1172 of the Act makes the standard adopted under part C applicable to: (1) Health plans, (2) health care clearinghouses, and (3) health care providers who transmit health information in electronic form in connection with transactions referred to in section 1173(a)(1) of the Act (hereinafter referred to as the ''covered entities''). Section 1172 also contains procedural requirements concerning the adoption of standards, including the role of standard setting organizations and required consultations, summarized in subsection F and section VI, below. Section 1173 of the Act requires the Secretary to adopt standards for transactions, and data elements for such transactions, to enable health information to be exchanged electronically. Section 1173(a)(1) describes the transactions to be promulgated, which include the nine transactions listed in section 1173(a)(2) and other transactions determined appropriate by the Secretary."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 12}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 18)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ny principles to their comments, health care entities did not. One study we found indicates that these policies are not adequate to provide appropriate privacy protections and alleviate public concern.\nThe Committee on Maintaining Privacy and Security in Health Care Applications of the National Information Infrastructure made multiple findings highlighting the need for heightened privacy and security, including:\n\nFinding 5: The greatest concerns regarding the privacy of health information derives from widespread sharing of patient information throughout the health care industry and the inadequate federal and state regulatory framework for systematic protection of health information. For the Record: Protecting Electronic Health Information , National Academy Press, Washington DC, 1997. ## Consent Under This Rule\n\nIn the NPRM, we expressed concern about the coercive nature of consents currently obtained by providers and plans relating to the use and disclosure of health information. We also expressed concern about the lack of information available to the patient during the process, and the fact that patients often were not even presented with a copy of the consent that they\n\nJkt 194001\n\nPO 00000\n\nhave signed. These and other concerns led us to propose that covered entities be permitted to use and disclose protected health information for treatment, payment and health care operations without the express consent of the subject individual. In the final rule, we alter our proposed approach and require, in most instances, that health care providers who have a direct treatment relationship with their patients obtain the consent of their patients to use and disclose protected health information for treatment, payment and health care operations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 17}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 9)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n162.103 in paragraph (1)(ii) of the definition of ''protected health information,'' since both definitions, ''electronic media'' and ''protected health information,'' have been moved to this section.\nAlso, it is unnecessary, because the definitions of §160.103 apply to all of the rule in parts 160, 162, and 164. We have also clarified that the physical movement of electronic media from place to place is not limited to magnetic tape, disk, or compact disk. This clarification removes a restriction as to what is considered to be physical electronic media, thereby allowing for future technological innovation. We further clarified that transmission of information not in electronic form before the transmission, for example, paper or voice, is not covered by this definition. §164.103: The following term ''plan sponsor'' now appears in the new §164.103, which consists of definitions of terms common to both subpart C and subpart E (the privacy standards). This definition was moved, without substantive change, from § 164.501 and has the meaning given to it in that section, and comments relating to this definition are discussed in connection with that section in the Privacy Rule at 65 FR 82607, 82611 through 82613, 82618 through 82622, and 82629. §164.304: Definitions specifically applicable to the Security Rule appear in § 164.304, and these are discussed below. These definitions are from, or derived from, currently accepted definitions in industry publications, such as, the International Organization for Standards (ISO) 7498-2 and the American Society for Testing and Materials (ASTM) E1762-95."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 8}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 423)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nwe understand that it could be virtually impossible to get authorization for archival research involving large numbers of individuals or where the location of the individuals is not easy to ascertain.\nWhile providing an accounting of disclosures for research may entail some burden, it is feasible, and we do not believe that IRBs or privacy boards would have a basis for waiving such a requirement. We also note that the majority of comments that we received from individuals supported including more information in the accounting, not less. We understand that requiring covered entities to include disclosures for research in the accounting of disclosures entails some burden, but we believe that the benefits described above outweigh the burden. We do not agree with commenters that we should exempt disclosures where only a few data elements are released or in the case of data released without individuals' names. We recognize that information other than names can identify an individual. We also recognize that even a few data elements could be clues to an individual's identity. The actual volume of information released is not an appropriate indicator of whether an individual could have a concern about privacy. We disagree with comments that suggested that it would be sufficient to provide individuals with a general list of research projects to which information has been disclosed by the covered entity. We believe that individuals are entitled to a level of specificity about disclosures of protected health information about them and should know to which research projects their protected health\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00280\n\ninformation has been disclosed, rather than to which projects protected health information may have been disclosed. However, we have added a provision allowing for a summary accounting of recurrent disclosures."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 422}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 350)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrequest, with an accounting of disclosures made of protected health information about the individual. Comment: One commenter recommended that IRB and privacy boards also be required to be accredited.\nResponse: While we agree that the issue of accrediting IRBs and privacy boards deserves further consideration, we believe it is premature to require covered entities to ensure that the IRB or privacy board that approves an alteration or waiver of authorization is accredited. Currently, there are no accepted accreditation standards for IRBs or privacy boards, nor a designated accreditation body. Recognizing the\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00232\n\nneed for and value of greater uniformity and public accountability in the review and approval process, HHS, with support from the Office of Human Research Protection, National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention, and Agency for Health Care Research and Quality, has engaged the Institute of Medicine to recommend uniform performance resource-based standards for private, voluntary accreditation of IRBs. This effort will draw upon work already undertaken by major national organizations to develop and test these standards by the spring of 2001, followed by initiation of a formal accreditation process before the end of next year. Once the Department has received the Institute of Medicine's recommended accreditation standards and process for IRBs, we plan to consider whether this accreditation model would also be applicable to privacy boards. Comment: A few commenters also noted that if both an IRB and a privacy board reviewed a research study and came to conflicting decisions, proposed §164.510(j) was unclear about which board's decision would prevail. Response: The final rule does not stipulate which board's decision would prevail if an IRB and a privacy board came to conflicting decisions."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 349}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 5)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nv/ocr/privacy/. Any further comments regarding this guidance received in response to the interim final rule will be addressed in the first annual update to the guidance, to be issued in April 2010. B.\nGuidance Specifying the Technologies and Methodologies that Render Protected Health Information Unusable, Unreadable, or Indecipherable to Unauthorized Individuals\n\nProtected health information (PHI) is rendered unusable, unreadable, or indecipherable to unauthorized individuals if one or more of the following applies:\n\n(a) Electronic PHI has been encrypted as specified in the HIPAA Security Rule by ''the use of an algorithmic process to transform data into a form in which there is a low probability of assigning meaning without use of a confidential process or key'' 2 and such confidential process or key that might enable decryption has not been breached. To avoid a breach of the confidential process or key, these decryption tools should be stored on a device or at a location separate from the data they are used to encrypt or decrypt. The encryption processes identified below have been tested by the National Institute of Standards and Technology (NIST) and judged to meet this standard. (i) Valid encryption processes for data at rest are consistent with NIST Special Publication 800-111, Guide to Storage Encryption Technologies for End User Devices . 3 4\n\n(ii) Valid encryption processes for data in motion are those which comply, as appropriate, with NIST Special Publications 800-52, Guidelines for the Selection and Use of Transport Layer Security (TLS) Implementations; 80077, Guide to IPsec VPNs; or 800-113, Guide to SSL VPNs, or others which are Federal Information Processing Standards (FIPS) 140-2 validated. 5\n\n2 45 CFR 164.304, definition of ''encryption.''\n\n3 NIST Roadmap plans include the development of security guidelines for enterprise-level storage devices, and such guidelines will be considered in updates to this guidance, when available."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 4}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 15)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\neach individual whose unsecured protected health information has been, or is reasonably believed by the covered entity to have been, accessed, acquired, used, or disclosed as a result of such breach.\nThis regulatory provision implements section 13402(a) of the Act, but does not include the phrase ''that accesses, maintains, retains, modifies, records, stores, destroys, or otherwise holds, uses, or discloses'' used in the statute to describe a covered entity's actions with respect to unsecured protected health information because inclusion of such terms was deemed unnecessary. In addition, the statute refers to protected health information that has been ''accessed, acquired, or disclosed''; it does not include ''used.'' In contrast, the statutory definition of ''breach'' refers to the ''acquisition, access, use, or disclosure'' of protected health information. For consistency with the definition, therefore, we have added ''used'' to the list of actions for which notification is required in §164.404(a)(1). ## Breaches Treated as Discovered\n\nSection 164.404(a)(2) states that a breach shall be treated as discovered by a covered entity as of the first day the breach is known to the covered entity, or by exercising reasonable diligence would have been known to the covered entity. Thus, a covered entity is not liable for failing to provide notification in cases in which it is not aware of a breach unless the covered entity would have been aware of the breach had it exercised reasonable diligence. Section 164.404(a)(2) further provides that a covered entity is deemed to have knowledge of a breach if such breach is known, or by exercising reasonable diligence would have been known, to any person, other than the person committing the breach, who is a workforce member or agent of the covered entity (determined in accordance with the federal common law of agency)."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 14}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 312)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nance in ensuring that important public policies are achieved, we do not believe that Congress intended to preempt each such law unless HHS specifically recognized the law or purpose in the regulation.\nComment: A number of commenters urged that the provision permitting uses and disclosures required by other law be amended by deleting the last sentence which stated: ''This paragraph does not apply to uses or disclosures that are covered by paragraphs (b) through (m) of this section.'' Some commenters sought deletion of this sentence to avoid any inadvertent preemption of mandatory reporting laws, and requested clarification of the effect on specific statutes. The majority of the commenters focused their concerns on the potential conflict between mandatory reporting laws to law enforcement and the limitations imposed by proposed §164.510(f), on uses and disclosures to law enforcement. For example, the comments raised concerns that mandatory reporting to law enforcement of injuries resulting from violent acts and abuse require the health care provider to initiate such reports to local law enforcement or other state agencies, while the NPRM would have allowed such reporting on victims of crimes only in response to specific law enforcement requests for information. Similarly, mandatory reports of violence-related injuries may implicate suspected perpetrators, as well as victims, and compliance with such laws could be blocked by the proposed requirement that disclosures about suspects was similarly limited to a response to law enforcement inquiries for the specific purpose of identifying the suspect. The NPRM also would have limited the type of protected health information that could have been disclosed about a suspect or fugitive. In general, commenters sought to resolve this overlap by removing the condition that the required-by-other-law provision applied only when no other national priority purpose addressed the particular use or disclosure."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 311}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 482)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrejected. Small entities constitute the vast majority of all entities that are covered; to exempt them would essentially nullify the purpose of the rule. Extensions were also considered but rejected.\nThe rule does not take effect for two years, which is ample time for small entities to learn about the rule and make the necessary changes to come into compliance. ## D. Economic Effects on Small Entities\n\n## 1. Number and Types of Small Entities Affected\n\nThe Small Business Administration defines small businesses in the health care sector as those organizations with less than $5 million in annual revenues. Nonprofit organizations are also considered small entities; 75 however, individuals and states are not included in the definition of a small entity. Similarly, small government jurisdictions with a population of less than 50,000 are considered small entities. 76\n\nSmall business in the health care sector affected by this rule may include such businesses as: Nonprofit health plans, hospitals, and skilled nursing facilities (SNFs); small businesses providing health coverage; small physician practices; pharmacies; laboratories; durable medical equipment (DME) suppliers; health care clearinghouses; billing companies; and vendors that supply software applications to health care entities. The U.S. Small Business Administration reports that as of 1997, there were 562,916 small health care entities 77 classified within the SIC\n\n75 ''Entities'' and ''establishments'' are used synonymously in this RFA. 76 ''Small governments'' were not included in this analysis directly; rather we have included the kinds of institutions within those governments that are likely to incur costs, such as government hospitals and clinics. 77 Entities are the physical location where an enterprise conducts business. An enterprise may conduct business in more than one establishment. E:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\ncodes we have identified as being covered establishments (Table A)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 481}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 184)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nreated as ''state law'' for preemption purposes. We do not have sufficient information to assess the situation raised by this comment with respect to this principle, and so express no opinion thereon.\n## More Stringent\n\nComment: Many commenters supported the policy in the proposed definition of ''individual'' at proposed §164.502, which would have permitted unemancipated minors to exercise, on\n\nFrm 00121\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ntheir own behalf, rights granted to individuals in cases where they consented to the underlying health care. Commenters stated, however, that the proposed preemption provision would leave in place state laws authorizing or prohibiting disclosure to parents of the protected health information of their minor children and would negate the proposed policy for the treatment of minors under the rule. The comments stated that such state laws should be treated like other state laws, and preempted to the extent that they are less protective of the privacy of minors. Other commenters supported the proposed preemption provision-not to preempt a state law to the extent it authorizes or prohibits disclosure of protected health information regarding a minor to a parent. Response: Laws regarding access to health care for minors and confidentiality of their medical records vary widely; this regulation recognizes and respects the current diversity of state law in this area. Where states have considered the balance involved in protecting the confidentiality of minors' health information and have explicitly acted, for example, to authorize disclosure, defer the decision to disclose to the discretion of the health care provider, or prohibit disclosure of minor's protected health information to a parent, the rule defers to these decisions to the extent that they regulate such disclosures."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 183}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 27)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nhat, through the exercise of reasonable diligence, would have been known to the entity. This means that a covered entity or business associate must have reasonable systems in place to detect breaches.\nPutting such systems in place may take some time. On the other hand, the majority of states already have breach notification laws in place. While this interim final rule differs from any such State laws, we believe that most covered entities or business associates should already have some form of breach notification procedures in place. Those covered entities and business associates should be able to build upon such existing procedures in order to come into compliance with this interim final rule. We have decided that, consistent with section 13402(j) of the Act, the provisions of this subpart are effective, and compliance is required, for breaches occurring on or after 30 calendar days from the publication of this rule. However, based on the concerns described above, and based on some ambiguity within the statute, 13 we will\n\n13 While section 13402(j) of the HITECH Act provides that section 13402 becomes effective 30 calendar days after publication of this interim final rule, it is section 13410(a)(2) that provides the Department with authority to impose civil money penalties, pursuant to § 1176 of the Social Security Act (42 U.S.C. 1320d-5), on violations by covered entities of the requirements imposed by the HITECH Act, including those of section 13402. Moreover, authority to impose civil money penalties on business associates for violations of the HITECH Act is provided by sections 13401(b) and 13404(c). Sections 13410(a)(2), 13401(b), and 13404(c) do not become effective until February 18, 2010 (see section 13423 of the Act)."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 26}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 61)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nuding the designation of health care components of a covered entity. 4. A new § 164.105 is added to read as follows:\n\n## §164.105 Organizational requirements. - (a)(1) Standard: Health care component.\nIf a covered entity is a hybrid entity, the requirements of subparts C and E of this part, other than the requirements of this section, §164.314, and § 164.504, apply only to the health care component(s) of the entity, as specified in this section. - (2) Implementation specifications:\n- (i) Application of other provisions. In applying a provision of subparts C and E of this part, other than the requirements of this section, § 164.314, and §164.504, to a hybrid entity:\n- (A) A reference in such provision to a ''covered entity'' refers to a health care component of the covered entity;\n- (B) A reference in such provision to a ''health plan,'' ''covered health care provider,'' or ''health care clearinghouse,'' refers to a health care component of the covered entity if such health care component performs the functions of a health plan, health care provider, or health care clearinghouse, as applicable;\n- (C) A reference in such provision to ''protected health information'' refers to protected health information that is created or received by or on behalf of the health care component of the covered entity; and\n- (D) A reference in such provision to ''electronic protected health information'' refers to electronic protected health information that is created, received, maintained, or transmitted by or on behalf of the health care component of the covered entity. - (ii) Safeguard requirements. The covered entity that is a hybrid entity must ensure that a health care component of the entity complies with the applicable requirements of this section and subparts C and E of this part."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 60}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the technical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\nRIN 0991-AB56\n\n## Breach Notification for Unsecured Protected Health Information\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Interim final rule with request for comments. SUMMARY: The Department of Health and Human Services (HHS) is issuing this interim final rule with a request for comments to require notification of breaches of unsecured protected health information. Section 13402 of the Health Information Technology for Economic and Clinical Health (HITECH) Act, part of the American Recovery and Reinvestment Act of 2009 (ARRA) that was enacted on February 17, 2009, requires HHS to issue interim final regulations within 180 days to require covered entities under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and their business associates to provide notification in the case of breaches of unsecured protected health information. For purposes of determining what information is ''unsecured protected health information,'' in this document HHS is also issuing an update to its guidance specifying the technologies and methodologies that render protected health information unusable, unreadable, or indecipherable to unauthorized individuals. DATES: Effective Date: This interim final rule is effective September 23, 2009. Comment Date: Comments on the provisions of this interim final rule are due on or before October 23, 2009. Comments on the information collection requirements associated with this rule are due on or before September 8, 2009. ADDRESSES: You may submit comments, identified by RIN 0991-AB56, by any of the following methods (please do not submit duplicate comments):\n\n- Regular, Express, or Overnight Mail: U.S. Department of Health and Human Services, Office for Civil Rights, Attention: HITECH Breach Notification, Hubert H."}], "metadata": {"source": "breach_notification_2009", "safeguard_type": "technical", "implementation_spec": "required", "entity_type": "covered_entity", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 189)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nmade the exception so massive that it would swallow the rule. These comments generally expressed concern that laws that were less protective of privacy would be granted exceptions under this language.\nOther commenters criticized the criteria generally as creating a large loophole that would let state laws that do not protect privacy trump the federal privacy standards. Response: We agree with these comments. The scope of the statutory criteria is ambiguous, but they could be read so broadly as to largely swallow the federal protections. We do not think that this was Congress's intent. Accordingly, we have added language to most of the statutory criteria clarifying their scope. With respect to the criteria at 1178(a)(2)(A)(i), this clarifying language generally ties the criteria more specifically to the concern with protecting and making more efficient the health care delivery and payment system that underlies the Administrative Simplification provisions of HIPAA, but, with respect to the catch-all provision at section 1178(a)(2)(A)(i)(IV), also requires that privacy interests be balanced with such concerns, to the extent relevant. We require that exceptions for rules to ensure appropriate state regulation of insurance and health plans be stated in a statute or regulation, so that such exceptions will be clearly tied to statements of priorities made by publicly accountable bodies (e.g., through the public comment process for regulations, and by elected officials through statutes). With respect to the criterion at section 1178(a)(2)(A)(ii), we have further delineated what ''addresses controlled substances'' means. The language provided, which builds on concepts at 21 U.S.C. 821 and the Medicare regulations at 42 CFR 1001.2, delineates the area within which the government traditionally regulates controlled substances, both civilly and criminally; it is our view that HIPAA was not intended to displace such regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 188}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 352)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhes. Response: This recommendation is beyond HHS' legal authority, since HIPAA did not give us the authority to regulate researchers. Therefore, this recommendation was not included in the final rule.\nComment: A number of commenters were concerned that HIPAA did not give the Secretary the authority to protect information once it was disclosed to researchers who were not covered entities. Response: The Secretary shares these commenters' concerns about the Department's limited authority under HIPAA. We strongly support the enactment of additional federal legislation to fill these crucial gaps in the Secretary's authority. Comment: One commenter recommended that covered entities should be required to retain the IRB's or privacy board's documentation of approval of the waiver of individuals' authorization for at least six years from when the waiver was obtained. Response: We agree with this comment and have included such a requirement in the final rule. See §164.530(j). Comment: One commenter recommended that whenever health information is used for research or administrative purposes, a plan is in place to evaluate whether to and how to feed patient-specific information back into the health system to benefit an individual or group of patients from whom the health information was derived. Response: While we agree that this recommendation is consistent with the\n\nFrm 00233\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nresponsible conduct of research, HIPAA did not give us the authority to regulate research. Therefore, this recommendation was not included in the final rule. Comment: A few commenters recommended that contracts between covered entities and researcher be pursued. Comments received in favor of requiring contractual agreements argued that such a contract would be enforceable under law, and should prohibit secondary disclosures by researchers."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 351}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 88)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ns and the sale of protected health information require an authorization), and provide that other uses and disclosures not described in the notice will be made only with the individual's authorization.\nSection 164.520(b)(1)(iii) requires a covered entity to include in its NPP separate statements about certain activities if the covered entity intends to engage in any of the activities. In particular, § 164.520(b)(1)(iii) requires a separate statement in the notice if the covered entity intends to contact the individual to provide appointment reminders or information about treatment alternatives or other healthrelated benefits or services; to contact the individual to fundraise for the covered entity; or, with respect to a group health plan, to disclose protected health information to the plan sponsor. First, with respect to this provision, the NPRM proposed to modify §164.520(b)(1)(iii)(A) to align the required statement with the proposed modifications related to marketing and subsidized treatment communications. The provision would have required a covered health care provider that intends to send treatment communications to individuals and has received financial remuneration in exchange for making the communication to, in its NPP, notify individuals of this intention and to inform them that they can opt out of receiving such communications. Second, at § 164.520(b)(1)(iii)(B) we proposed to require that if a covered entity intends to contact the individual to raise funds for the entity as permitted under §164.514(f)(1), the covered entity must not only inform the individual in the NPP of this intention but also must inform the individual that he or she has the right to opt out of receiving such communications. Section 164.520(b)(1)(iv) requires that the NPP contain statements regarding the rights of individuals with respect to their protected health information and a brief description of how individuals may exercise such rights."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 87}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 37)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nIf not, who will deliver the training? • What is the security training budget? |\n| 5. Implement the Training                                                  | • Schedule and conduct the training outlined in the strategy and plan. • Implement any reasonable technique to disseminate the security messages in an organization, including newsletters, screensavers, video recordings, email messages, teleconferencing sessions, staff meetings, and computer-based training. | • Have all workforce members received adequate training to fulfill their security responsibilities? • Are there sanctions if workforce members do not complete the required training? |\n| 6. Implement Security Reminders Implementation Specification (Addressable) | • Implement periodic security updates. • Provide periodic security updates to staff, business associates, and contractors. • Consider the benefits of ongoing communication with staff (e.g., emails, newsletters) on training topics to achieve HIPAA compliance and protect ePHI. | • What methods are available or already in use to make or keep workforce members aware of security (e.g., posters, booklets, anti-phishing training)? • Is the organization making use of existing resources (e.g., from the 405(d) program or other resources listed in Appendix F) to remind staff of important security topics? • Is security refresher training performed on a periodic basis (e.g., annually)? • Is security awareness discussed with all new hires? • Are security topics reinforced during routine staff meetings? |\n| 7. Monitor and Evaluate the Training Plan 66                               | • Keep the security awareness and training program current. • Solicit trainee feedback to determine whether the training and awareness are successfully reaching the intended audience. • Conduct training whenever changes occur in the technology and practices, as appropriate. • Monitor the training program implementation to ensure that all workforce members participate."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 36}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 114)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nindividual (i.e., harm standard) after considering public comment received in response to the Department's request for information on the HITECH Act's breach notification provisions. See 74 FR 19006.\nThe inclusion of the harm standard was intended to align the Department's rule with many State\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with breach notification laws, as well as existing obligations on Federal agencies pursuant to OMB Memorandum M-0716, that have similar standards for triggering breach notification. In addition, the standard was intended to ensure that consumers were not flooded with breach notifications for inconsequential events, which could cause unnecessary anxiety and eventual apathy among consumers. To determine whether an impermissible use or disclosure of protected health information constitutes a breach under this standard, covered entities and business associates were required to perform a risk assessment to determine if there is a significant risk of harm to the individual as a result of the impermissible use or disclosure. In conducting the risk assessment, covered entities and business associates were to consider a number or combination of factors, including who impermissibly used the information or to whom the information was impermissibly disclosed; whether the covered entity or business associate had taken steps to mitigate or eliminate the risk of harm; whether the protected health information was actually accessed; and what type or amount of protected health information was impermissibly used or disclosed. The rule provided further that an impermissible use or disclosure of protected health information that qualifies as a limited data set but also excludes dates of birth and zip codes (both identifiers that may otherwise be included in a limited data set) does not compromise the security or privacy of the protected health information."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 113}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 29)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\ns final rule. ## F. Physical Safeguards (§ 164.310)\n\nWe proposed requirements and implementation features for documented physical safeguards to guard data integrity, confidentiality, and availability.\nWe proposed to require safeguards in the following areas: Assigned security responsibility; media controls; physical access controls; policies and guidelines on workstation use; a secure workstation location; and security awareness training. A number of specific implementation features were proposed under the media controls and physical access controls requirements. In § 164.310 of this final rule, most of the proposed implementation features are adopted as addressable implementation specifications. The proposed requirements for the assigned security responsibility and security awareness training requirements are relocated in § 164.308. ## 1. General Comments\n\na. Comment: Several commenters made suggestions to modify the language to more clearly describe ''Physical safeguards.''\n\nResponse: In response to comments, we have revised the definition of ''Physical safeguards'' to read as follows: ''Physical safeguards are security measures to protect a covered entity's electronic information systems and related buildings and equipment, from natural and environmental hazards, and unauthorized intrusion.''\n\nb. Comment: One commenter was concerned that electronic security systems could not be used in lieu of physical security systems. Response: This final rule does not preclude the use of electronic security systems in lieu of, or in combination with, physical security systems to meet a ''Physical safeguard'' standard. VerDate Jan&lt;31&gt;2003\n\n## 2. Facility Access Controls (§ 164.310(a)(1))\n\nWe proposed, under the ''Physical access controls'' requirement, formal, documented policies and procedures for limiting physical access to an entity while ensuring that properly authorized access is allowed."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 28}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 175)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nparticularly smaller business associates that may have access to electronic protected health information for limited purposes, may not have engaged in certain of the formal administrative safeguards.\nFor example, these entities may not have performed a risk analysis, established a risk management program, or designated a security official, and may not have written policies and procedures, conducted employee training, or documented compliance as required under §§ 164.308 and 164.316 of the Security Rule. We do not have information on what percentage of business associates may have to engage in efforts to comply with some of the administrative safeguard standards, including documenting their\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00114\n\npolicies and procedures and training their employees on the policies and procedures, nor did the comments on the impact statement offer any specific information to provide an estimate. We assume that up to 80 percent of the 12 million business associates, or between 800,000 and 1.6 million business associates, may handle electronic protected health information and thus may have to document their existing security protocols. Further, of these business associates, we assume that no more than 25 percent are likely to incur some cost to document their administrative safeguards and their policies and procedures as now required by statute and these regulations. We believe that our original assumption of compliance with all Security Rule requirements remains sound for the rest of the business associates, and we received no substantive comments to the contrary."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 174}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 114)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrom an outside researcher's own university IRB or privacy board. In addition, a covered entity could have engaged the services of an outside IRB or privacy board to obtain the necessary documentation.\nAbsent documentation that the requirements described above had been\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nmet, the NPRM would have required individuals' authorization for the use or disclosure of protected health information for research, pursuant to the authorization requirements in proposed §164.508. For research conducted with patient authorization, documentation of IRB or privacy board approval would not have been required. The final rule retains the NPRM's proposed framework for permitting uses and disclosures of protected health information for research purposes, although we are making several important changes for the final rule. These changes are discussed below:\n\n## Documentation Requirements of IRB or Privacy Board Approval of Waiver\n\nThe final rule retains these documentation requirements, but modifies some of them and includes two additional documentation requirements. The final rule's modifications to the NPRM's proposed documentation requirements are described first, followed by a description of the three documentation requirements added in the final rule. The final rule makes the following modifications to the NPRM's proposed documentation requirements for the waiver of individual authorization:\n\n1. IRB and privacy board membership."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 113}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 71)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\ns made available and are workforce members appropriately trained? 148 |\n\n148 See Sec. 5.5.2, HIPAA Standard: Documentation , and Sec. 5.1.5, HIPAA Standard: Security Awareness and Training . ## 5.5.2.\nDocumentation (§ 164.316(b))\n\nHIPAA Standard: (i) Maintain the policies and procedures implemented to comply with this subpart in written (which may be electronic) form; and (ii) if an action, activity or assessment is required by this subpart to be documented, maintain a written (which may be electronic) record of the action, activity, or assessment . Table 29."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 70}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 46)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nd entity may contact the individual to provide appointment reminders or information about treatment alternatives or other healthrelated benefits and services that may be of interest to the individual.\nWhere the sending of such communications involves financial remuneration, the individual will be notified of such communications through the authorization process. Other communications for such purposes that do not involve financial remuneration are adequately captured in a covered entity's description in its notice of privacy practices of treatment and health care operations. However, covered entities that wish to continue to include such a specific statement in their notices of privacy practices may do so. For further discussion about the Notice of Privacy Practices, please see the discussion addressing the provisions at § 164.520 below. We adopt the term ''financial remuneration'' and its definition as proposed without modification in the final rule. Most commenters were generally satisfied with the proposed use of the term and its definition. There was, however, some confusion among commenters as to what constitutes direct or indirect payment from or on behalf of a third party. We clarify that under this provision direct payment means financial remuneration that flows from the third party whose product or service is being described directly to the covered entity. In contrast, indirect payment means financial remuneration that flows from an entity on behalf of the third party whose product or service is being described to a covered entity. We also clarify that where a business associate (including a subcontractor), as opposed to the covered entity itself, receives financial remuneration from a third party in exchange for making a communication about a product or service, such communication also requires prior authorization from the individual."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 45}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 165)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nd by $22.53 to reach $755,882 in labor costs to prepare the mailing. Adding to that the costs of postage and supplies ($1,711,050) and the costs of composing and drafting ($311,125) equals $2,778,057.\nSumming the cost of email and postal mail notices equals\n\n25JAR2\n\nsroberts on DSK5SPTVN1PROD with\n\n$3,467,122. Table 3 presents the results of our analysis in the order they are discussed above."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 164}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 133)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nand provide the notice in accordance with §164.520(c)(1). In addition, some fullyinsured group health plans are required to maintain and provide a notice of the group health plan's privacy practices.\nIf a group health plan provides health benefits solely through an insurance contract with a health insurance issuer or HMO, and the group health plan creates or receives protected health information in addition to summary information (as defined in § 164.504(a)) and information about individuals' enrollment in or disenrollment from a health insurance issuer or HMO offered by the group health plan, the group health plan must maintain a notice that meets the requirements of this section and must provide the notice upon request of any person. The group health plan is not required to meet the other distribution requirements of §164.520(c)(1). Individuals enrolled in such group health plans have the right to notice of the health insurance issuer or HMO's privacy practices and, on request, to notice of the group health plan's privacy practices. If the group health plan, however, provides health benefits solely through an insurance contract with a health insurance issuer or HMO, and the only protected health information the group health plan creates or receives is summary information (as defined in § 164.504(a)) and information about individuals' enrollment in or disenrollment from a health insurance issuer or HMO offered by the group health plan, the group health plan is not required to maintain or provide a notice under this section. In this case, the individuals enrolled in the group health plan would receive notice of the health insurance issuer or HMO's privacy practices, but would not be entitled to notice of the group health plan's privacy practices. Third, in § 164.520(a)(3), we clarify that inmates do not have a right to notice under this section and a correctional institution that is a covered entity is not required to produce a notice."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 132}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 96)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nr a provider could require payment in full at the time of the request for a restriction to avoid payment issues altogether. Finally, many commenters responded to the NPRM's approach to follow-up care.\nThe majority of commenters supported the idea that if an individual does not request a restriction and pay out of pocket for follow up care, then the covered entity may disclose the protected health information necessary to obtain payment from the health plan for such follow up care, recognizing that some of the protected health information may relate to and/or indicate that the individual received the underlying health care item or service to which a restriction applied. A few commenters asked whether individual authorization would be required to disclose previously restricted protected health information to a health plan if the individual does not want to restrict the follow up care. A number of commenters expressed support for providers counseling patients on the consequences of not restricting followup care. A few commenters were\n\nVerDate Mar&lt;15&gt;2010\n\nconcerned as to how a provider would know when such counseling was needed and what it should include, and asked whether giving the individual a written statement explaining the consequences would suffice. ## Final Rule\n\nWe adopt the modifications to §164.522 as proposed in the NPRM to implement section 13405(a) of the HITECH Act. In response to questions and comments regarding how to operationalize these requirements, we provide the following clarifications. We clarify that these provisions do not require that covered health care providers create separate medical records or otherwise segregate protected health information subject to a restricted health care item or service."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 95}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 166)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\noviders (such as doctors or nurses) who work for a larger organization and do not conduct transactions on their own behalf are workforce members of the covered entity, not covered entities themselves.\nComment: A few commenters asked the Department to clarify the definition to provide that a multi-line insurer that sells insurance coverages, some of which do and others which do not meet the definition of ''health plan,'' is not a covered entity with respect to actions taken in connection with coverages that are not ''health plans.''\n\nResponse: The final rule clarifies that the requirements below apply only to the organizational unit or units of the organization that are the ''health care component'' of a covered entity, where the ''covered functions'' are not the primary functions of the entity. Therefore, for a multi-line insurer, the ''health care component'' is the insurance line(s) that conduct, or support the conduct of, the health care function of the covered entity. Also, it should be noted that excepted benefits, such as life insurance, are not included in the definition of ''health plan.'' (See preamble discussion of § 164.504). Comment: A commenter questioned whether the Health Care Financing Administration (HCFA) is a covered entity and how HCFA will share data with Medicare managed care organizations. The commenter also questioned why the regulation must apply to Medicaid since the existing Medicaid statute requires that states have privacy standards in place. It was also requested that the Department provide a definition of ''health plan'' to clarify that state Medicaid Programs are considered as such. Response: HCFA is a covered entity because it administers Medicare and\n\nMedicaid, which are both listed in the statute as health plans. Medicare managed care organizations are also covered entities under this regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 165}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 523)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntrack products if the disclosure is made to a person required or directed by the Food and Drug Administration to track the product; - (C) To enable product recalls, repairs, or replacement (including locating and Frm 00353 Fmt 4701 E:\\FR\\FM\\28DER2.SGM pfrm08 PsN: 28DER2 Sfmt 4700 notifying individuals who have received products of product recalls, withdrawals, or other problems); or (D) To conduct post marketing surveillance to comply with requirements or at the direction of the Food and Drug Administration; (iv) A person who may have been exposed to a communicable disease or may otherwise be at risk of contracting or spreading a disease or condition, if the covered entity or public health authority is authorized by law to notify such person as necessary in the conduct of a public health intervention or investigation; or (v) An employer, about an individual who is a member of the workforce of the employer, if: (A) The covered entity is a covered health care provider who is a member of the workforce of such employer or who provides a health care to the individual at the request of the employer: (1) To conduct an evaluation relating to medical surveillance of the workplace; or (2)"}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 522}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 78)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\ns may not be easy for regulated entities. The tables in this appendix appear in [SP 800-30] and could be helpful in identifying threat sources and threat events as part of a risk assessment. Table 30.\nTaxonomy of threat sources\n\n| Type of Threat Source                                                                                                                                                                                                                                                                                      | Description                                                                                                                                                                                                                                                                                           | Characteristics               |\n|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------|\n| ADVERSARIAL • Individual o Outsider o Insider o Trusted Insider o Privileged Insider • Group o Ad hoc o Established • Organization o Competitor o Supplier o Partner o Customer                                                                                                                            | Individuals, groups, organizations, or states that seek to exploit the organization's dependence on cyber resources (i.e., information in electronic form, information and communications technologies, and the communications and information-handling capabilities provided by those technologies)."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 77}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 443)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nted cost for plans of $0.75 per insured person is so low that it may cover postage, but it\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ncannot include labor and capital usage costs.\nResponse: Based on comments and additional fact finding, the Department was able to gain a better understanding of how covered entities would develop policies and disseminate information. The cost analysis below explains more fully how we derived the final cost estimates for these areas. Comment: A commenter noted that privacy policy costs assume that national associations will develop privacy policies for members but HHS analysis does not account for the cost to the national associations. A provider cost range of $300-$3,000 is without justification and seems low. Response: The cost to the national associations was included in the proposal estimates, and it is included in the final analysis (see below). Comment: A commenter states that the notice costs discussion mixes the terms ''patients'', ''encounters'' and ''episodes'' and 397 million encounter estimate is unclear. Response: A clearer explanation of the concepts employed in this analysis is provided below. ## Systems Compliance Costs\n\nComment: Numerous commenters questioned the methodology used to estimate the systems compliance cost and stated that the ensuing cost estimates were grossly understated. Some stated that the regulation will impose significant information technology costs to comply with requirement to account for disclosures, additional costs for hiring new personnel to develop privacy policies, and higher costs for training personnel. Response: Significant comments were received regarding the cost of systems compliance. In response, the Department retained the assistance of consultants with extensive expertise in health care information technology. We have relied on their work to revise our estimates, as described below. The analysis does not include ''systems compliance'' as a cost item, per se."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 442}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 435)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ny type of organization, association or group such as other covered entities, health oversight agencies and advocacy groups. Comment: A few commenters suggested deleting this provision in its entirety.\nOne commenter indicated that the whistleblower and retaliation provisions could be inappropriately used against a hospital and that the whistleblower's ability to report numerous violations will result in a dangerous expansion of liability. Another commenter stated that covered entities could not take action against an employee who had violated the employer's privacy provisions if this\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nemployee files a complaint with the Secretary. Several commenters suggested deleting ''in any manner'' and ''or opposing any act or practice made unlawful by this subpart'' in §164.522(d)(4). The commenters indicated that, as proposed, the rule would make it difficult to enforce compliance within the workforce. One commenter stated that the proposed 164.522(d)(4) ''is extremely broad and may allow an employee to reveal protected health information to fellow employees, the media and others (e.g., an employee may show a medical record to a friend or relative before filing a complaint with the Department). This commenter further stated that covered entities will ''absolutely be prevented from prohibiting such conduct.'' One commenter suggested adding that a covered entity may take disciplinary action against any member of its work force or any business partner who uses or discloses individually identifiable health information in violation of this subpart in any manner other than through the processes set forth in the regulation. Response: To respond to these comments, we make several changes to the proposed provision."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 434}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 2)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n|     |\n| A. | PREMARKET CONSIDERATIONS.........................................................................................................................12              |     |\n| B.\n| POSTMARKET CONSIDERATIONS .......................................................................................................................13              |     |\n| C. | MAINTAINING SAFETY AND ESSENTIAL PERFORMANCE .........................................................................................14                         |     |\n| VI. | MEDICAL DEVICE CYBERSECURITY RISK MANAGEMENT...................................................................15                                                |     |\n| A. | ASSESSING EXPLOITABILITY OF THE CYBERSECURITY VULNERABILITY ........................................................................15                           |     |\n| B. | ASSESSING SEVERITY OF PATIENT HARM............................................................................................................17                 |     |\n| C. | EVALUATION OF RISK OF PATIENT HARM ...........................................................................................................17                 |     |\n| VII. | REMEDIATING AND REPORTING CYBERSECURITY VULNERABILITIES.................................................18                                                       |     |\n| A. | CONTROLLED RISK OF PATIENT HARM...............................................................................................................19                 |     |\n| B. | UNCONTROLLED RISK TO SAFETY AND ESSENTIAL PERFORMANCE ...........................................................................21                              |     |\n| VIII. | RECOMMENDED CONTENT TO INCLUDE IN PMA PERIODIC REPORTS...............................................25                                                          |     |\n| IX."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 1}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 117)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nment estimates that the net effect of these modifications is to reduce the time necessary to assemble the waivers and for an IRB or Privacy Board to consider and act on waiver requests by one quarter.\nThe Department estimates these simplifications would reduce the expected costs first year costs by $10 million and the ten year costs by $146 million, relative to the December 2000 Privacy Rule. Although the Department requested information to better assess this cost savings, the public comment period failed to produce any sound data. Therefore, the Department's estimates have not changed. The Department adopts three other modifications to simplify the Privacy Rule requirements to relieve the potential administrative burden on research. First, the modifications permit a covered entity to use and disclose protected health information in the form of a limited data set for research, public health, and health care operations. A limited data set does not contain any direct identifiers of individuals, but may contain any other demographic or health information needed for research, public health or health care operations purposes. The covered entity must obtain a data use agreement from the recipient of a limited data set pursuant to which the recipient agrees to restrict use and disclosure of the limited data set and not to identify or contact any individual. With a data use agreement, a researcher may access a limited data set without obtaining individual authorization or having to go through an IRB or a Privacy Board for a waiver of\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00078\n\nthe authorization. ( See discussion at III.G.2.) Second, the modifications simplify the accounting procedures for research disclosures by the covered entity by eliminating the need to account for disclosures which the individual has authorized or which are part of a limited data set, and by providing a simplified basis to account for a research disclosure involving 50 or more records."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 116}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 82)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nhe public comments for the concept of a limited data set, the Department determines that adoption of standards for the use and disclosure of protected health information for this purpose is warranted.\nTherefore, the Department adds at § 164.514(e) a new standard and implementation specifications for a limited data set for research, public health, or health care operations purposes if the covered entity (1) uses or discloses only a ''limited data set'' as defined at §164.514(e)(2), and (2) obtains from the recipient of the limited data set a ''data use agreement'' as defined at §164.514(e)(4). In addition, the Department adds to the permissible uses and disclosures in § 164.502(a) express reference to the limited data set standards. The implementation specifications do not delineate the data that can be released through a limited data set. Rather, the Rule specifies the direct identifiers that must be removed for a data set to qualify as a limited data set. As with the de-identification safe harbor provisions, the direct identifiers listed apply to protected health information about the individual or about relatives, employers, or household members of the individual. The direct identifiers include all of the facial identifiers proposed in the preamble to the NPRM: (1) Name; (2) street address (renamed postal address information, other than city, State and zip code); (3) telephone and fax numbers; (4) e-mail address; (5) social security number; (6) certificate/ license numbers; (7) vehicle identifiers and serial numbers; (8) URLs and IP addresses; and (9) full face photos and any other comparable images. The public comment generally supported the removal of this facially identifying information."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 81}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 111)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\no the commenter, many hospitals and other covered entities currently outsource their records reproduction function for fees that often include administrative costs over and above the costs of copying.\nIn some cases, the fees may be set in accordance with State law. The Privacy Rule, at § 164.524(c)(4), however, permits only reasonable, costbased copying fees to be charged to individuals seeking to obtain a copy of\n\nVerDate Aug&lt;2,&gt;2002\n\ntheir medical record under their right of access. The commenter was concerned that others seeking copies of all or part of the medical record, such as payers, attorneys, or entities that have the individual's authorization, would try to claim the limited copying fees provided in § 164.524(c)(4). The commenter asserted that such a result would drastically alter the economics of the outsourcing industry, driving outsourcing companies out of business, and raising costs for the health industry as a whole. A clarification that the fee structure in § 164.524(c)(4) applies only to individuals exercising their right of access was sought. Response: The Department clarifies that the Rule, at § 164.524(c)(4), limits only the fees that may be charged to individuals, or to their personal representatives in accordance with §164.502(g), when the request is to obtain a copy of protected health information about the individual in accordance with the right of access. The fee limitations in § 164.524(c)(4) do not apply to any other permissible disclosures by the covered entity, including disclosures that are permitted for treatment, payment or health care operations, disclosures that are based on an individual's authorization that is valid under § 164.508, or other disclosures permitted without the individual's authorization as specified in § 164.512. The fee limitation in § 164.524(c)(4) is intended to assure that the right of access provided by the Privacy Rule is available to all individuals, and not just to those who can afford to do so."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 110}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 9)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nle Resources provides an annotated, topical list of additional resources that regulated entities may find useful when implementing the standards and implementation specifications of the Security Rule.\n- Appendix G - Change Log provides a list of the changes made in Revision 2. ## 1.4. How to Use This Document\n\nReaders are reminded that the Security Rule is flexible, scalable, and technology-neutral. For that reason, there is no one single compliance approach that will work for all regulated entities. This publication presents guidance that entities can utilize in whole or in part to help improve their cybersecurity posture and assist with achieving compliance with the Security Rule. Readers are encouraged to use this document as a resource for concepts and tools to assist regulated entities in complying with the HIPAA Security Rule. Risk assessment and risk management processes are foundational to a regulated entity's compliance with the Security Rule and the safeguarding of ePHI. For that reason, regulated entities may benefit from initially focusing on Sec. 3 and Sec. 4 to build fundamental risk management processes. Section 5 may be useful to regulated entities seeking activities to implement for each of the Security Rule standards or for regulated entities that want sample questions to self-evaluate their protection of ePHI. Regulated entities may also find value in the appendices that provide an annotated list of relevant resources, discussions of relevant topics, and a crosswalk to controls and practices that may help in implementing the Security Rule. Small, regulated entities may benefit from the resources listed in Appendix F, especially the Health Industry Cybersecurity Practices (HICP) Technical Volume 1: Cybersecurity Practices for Small Health Care Organizations. Additionally, smaller entities may find the HHS Security Risk Assessment (SRA) Tool [SRA Tool] helpful in the essential task of assessing risk to ePHI."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 8}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\nRIN 0991-AB56\n\n## Breach Notification for Unsecured Protected Health Information\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Interim final rule with request for comments. SUMMARY: The Department of Health and Human Services (HHS) is issuing this interim final rule with a request for comments to require notification of breaches of unsecured protected health information. Section 13402 of the Health Information Technology for Economic and Clinical Health (HITECH) Act, part of the American Recovery and Reinvestment Act of 2009 (ARRA) that was enacted on February 17, 2009, requires HHS to issue interim final regulations within 180 days to require covered entities under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and their business associates to provide notification in the case of breaches of unsecured protected health information. For purposes of determining what information is ''unsecured protected health information,'' in this document HHS is also issuing an update to its guidance specifying the technologies and methodologies that render protected health information unusable, unreadable, or indecipherable to unauthorized individuals. DATES: Effective Date: This interim final rule is effective September 23, 2009. Comment Date: Comments on the provisions of this interim final rule are due on or before October 23, 2009. Comments on the information collection requirements associated with this rule are due on or before September 8, 2009. ADDRESSES: You may submit comments, identified by RIN 0991-AB56, by any of the following methods (please do not submit duplicate comments):\n\n- Regular, Express, or Overnight Mail: U.S. Department of Health and Human Services, Office for Civil Rights, Attention: HITECH Breach Notification, Hubert H."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 0}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 543)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nentity with a written statement that such an accounting to the individual would be reasonably likely to impede the agency's activities and specifying the time for which such a suspension is required.\n(ii) If the agency or official statement in paragraph (a)(2)(i) of this section is made orally, the covered entity must:\n\n- (A) Document the statement, including the identity of the agency or official making the statement;\n- (B) Temporarily suspend the individual's right to an accounting of disclosures subject to the statement; and\n- (C) Limit the temporary suspension to no longer than 30 days from the date of the oral statement, unless a written statement pursuant to paragraph (a)(2)(i) of this section is submitted during that time. - (3) An individual may request an accounting of disclosures for a period of time less than six years from the date of the request. (b) Implementation specifications: Content of the accounting. The covered entity must provide the individual with a written accounting that meets the following requirements. - (1) Except as otherwise provided by paragraph (a) of this section, the accounting must include disclosures of protected health information that occurred during the six years (or such shorter time period at the request of the individual as provided in paragraph (a)(3) of this section) prior to the date of the request for an accounting, including disclosures to or by business associates of the covered entity. - (2) The accounting must include for each disclosure:\n3. (i) The date of the disclosure;\n4. (ii) The name of the entity or person who received the protected health information and, if known, the address of such entity or person;\n5. (iii) A brief description of the protected health information disclosed; and\n6. (iv) A brief statement of the purpose of the disclosure that reasonably informs the individual of the basis for the disclosure; or, in lieu of such statement:\n7."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 542}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 109)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ndetermines that the disclosure is in the individual's best interests. We intend that assessing the individual's best interests includes taking into account any further risk of harm to the individual.\nThis provision does not allow covered entities to initiate disclosures of protected health information to law enforcement; the disclosure must be in response to a request from law enforcement. We do not intend to create a new legal duty on the part of covered entities with respect to the safety of their patients. Rather, we intend to ensure that covered entities can continue to exercise their professional judgment in these circumstances, on a case-by-case basis, as they do today. In some cases, a victim may also be a fugitive or suspect. For example, an individual may receive a gunshot wound during a robbery and seek treatment in a hospital emergency room. In such cases, when law enforcement officials are requesting protected health information because the individual is a suspect (and thus the information may be used against the individual), covered entities may disclose the protected health information pursuant to §164.512(f)(2) regarding suspects and not pursuant to § 164.512(f)(3) regarding victims. Thus, in these situations, covered entities may disclose only the limited identifying information listed in §164.512(f)(2)-not all of the protected health information that may be disclosed under § 164.512(f)(3). The proposed rule did not address whether a covered entity could disclose protected health information to a law enforcement official to alert the official of the individual's death. ## Disclosures About Decedents\n\nIn the final rule, we add a new provision § 164.512(f)(4) in which we permit covered entities to disclose protected health information about an individual who has died to a law enforcement official for the purpose of alerting law enforcement of the death if the covered entity has a suspicion that such death may have resulted from criminal conduct."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 108}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 84)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\no that individuals within organizations reveal critical or sensitive information (e.g., mission information). |\n| Conduct attacks that target and compromise the personal devices of critical employees.\n| Adversary targets key organizational employees by placing malware on their personally owned information systems and devices (e.g., laptop/notebook computers, personal digital assistants, smart phones). The intent is to take advantage of any instances where employees use personal information systems or devices to handle critical or sensitive information. |\n| Conduct supply chain attacks that target and exploit critical hardware, software, or firmware. | Adversary targets and compromises the operation of software (e.g., through malware injections), firmware, and hardware that performs critical functions for organizations. This is largely accomplished as supply chain attacks on both commercial off- the-shelf and custom information systems and components. |\n| Achieve results (i.e., cause adverse impacts, obtain information). | Achieve results (i.e., cause adverse impacts, obtain information). |\n| Obtain sensitive information by network sniffing external networks. | Adversary with access to exposed wired or wireless data channels that organizations (or organizational personnel) use to transmit information (e.g., kiosks, public wireless networks) intercepts communications. |\n| Obtain sensitive information via exfiltration. | Adversary directs malware on organizational systems to locate and surreptitiously transmit sensitive information. |\n| Cause the degradation or denial of attacker-selected services or capabilities. | Adversary directs malware on organizational systems to impair the correct and timely support of organizational mission and business functions. |\n| Cause the deterioration or destruction of critical information system components and functions."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 83}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "When must a HIPAA breach be reported to HHS?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\n## RIN 0945-AA03\n\nModifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (HHS or ''the Department'') is issuing this final rule to: Modify the Health Insurance Portability and Accountability Act (HIPAA) Privacy, Security, and Enforcement Rules to implement statutory amendments under the Health Information Technology for Economic and Clinical Health Act (''the HITECH Act'' or ''the Act'') to strengthen the privacy and security protection for individuals' health information; modify the rule for Breach Notification for Unsecured Protected Health Information (Breach Notification Rule) under the HITECH Act to address public comment received on the interim final rule; modify the HIPAA Privacy Rule to strengthen the privacy protections for genetic information by implementing section 105 of Title I of the Genetic Information Nondiscrimination Act of 2008 (GINA); and make certain other modifications to the HIPAA Privacy, Security, Breach Notification, and Enforcement Rules (the HIPAA Rules) to improve their workability and effectiveness and to increase flexibility for and decrease burden on the regulated entities. DATES: Effective date: This final rule is effective on March 26, 2013. Compliance date: Covered entities and business associates must comply with the applicable requirements of this final rule by September 23, 2013. FOR FURTHER INFORMATION CONTACT: Andra Wicks 202-205-2292. SUPPLEMENTARY INFORMATION:\n\nVerDate Mar&lt;15&gt;2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n## I."}], "metadata": {"source": "hitech_omnibus_2013", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 20)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n| High              |\n| Moderate            | Low               | Moderate          | Moderate          |\n| Low                 | Low               | Low               | Low               |\n\nTable 7.\nDetailed risk-level matrix\n\n| Threat Likelihood   | Level of Impact   | Level of Impact   | Level of Impact   | Level of Impact   | Level of Impact   |\n|---------------------|-------------------|-------------------|-------------------|-------------------|-------------------|\n| Threat Likelihood   | Very Low          | Low               | Moderate          | High              | Very High         |\n| Very High           | Very Low          | Low               | Moderate          | High              | Very High         |\n| High                | Very Low          | Low               | Moderate          | High              | Very High         |\n| Moderate            | Very Low          | Low               | Moderate          | Moderate          | High              |\n| Low                 | Very Low          | Low               | Low               | Low               | Moderate          |\n| Very Low            | Very Low          | Very Low          | Very Low          | Low               | Low               |\n\nTo clarify the use of the risk matrix, consider the examples presented in Step 4. For the tornado threat event, the overall likelihood was assigned a rating of 'Low.' However, the impact of this threat event could easily be assigned a rating of 'High.' Using the matrix in Table 6 , the intersection of ' Low ' likelihood and ' High ' impact results in an overall risk rating of ' Low .' For the phishing threat example, the overall likelihood was rated ' High .' If the regulated entity determined that the impact of a phishing threat was likely to be ' Moderate ,' this would result in an overall risk rating of ' Moderate .' The regulated entity should determine the level of risk for each identified threat/vulnerability pair. 7. Document the risk assessment results."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 19}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 174)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nrements of the HIPAA Rules, as covered entities have been subject to direct liability under the Rules since their inception and have had more than half a dozen years to make their contracts compliant.\nHowever, to the extent that some contracts between covered entities and business associates\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with are not currently in full compliance with the business associate agreement provisions, these entities may experience limited costs to revise their contracts. Although we are less certain about the current state of business associatesubcontractor relationships, we believe that most business associates have made a good faith attempt to include the appropriate contractual requirements. Still, we anticipate that some small business associates, now that they are subject to direct liability under the rules, might establish or significantly modify their subcontracts to come into compliance for the first time. Such business associates would not be eligible for the extended transition period and, as a result, would incur the costs of creating new contracts or renegotiating contracts out of cycle. In the Final Privacy Rule published in 2002, we estimated that entities would need between one and two hours to develop and tailor a business associate agreement to their particular needs. See 67 FR 53182, 53257. Taking the average of the lower and upper estimates provided in the earlier rulemaking, we estimate that developing and tailoring contract language normally would take approximately 90 minutes of professional legal services at $84.32 per hour. 39 However, as in the 2002 Final Privacy Rule (67 FR 53257), we estimate that providing model language will reduce the time required to develop contract language by at least one third."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 173}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.512(g)(2) require?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n§164.512(g)(2) permits covered entities to disclose protected health information to funeral directors, consistent with applicable law, as necessary to carry out their duties with respect to the decedent. Such disclosures are also permitted prior to, and in reasonable anticipation of, the individual's death.\n\nComment: Several commenters urged that the proposed standard for deceased individuals be clarified to allow access by a family member who has demonstrated a legitimate health-related reason for seeking the information when there is no executor, administrator, or other person authorized und"}], "metadata": {"source": "privacy_rule_2000", "cfr_section": "§164.512(g)(2)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 3)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nFTC breach notification rules must also use the Secretary's guidance to determine whether the information subject to a breach was ''unsecured'' and, therefore, whether breach notification is required.\nWhen HHS issued the guidance, HHS also published in the same document a request for information (RFI), inviting public comment both on the guidance itself, as well as on the breach provisions of section 13402 of the Act generally. After considering the public comment, we are issuing an updated version of the guidance in Section II below. In addition, we discuss public comment received on the Act's breach notification provisions where relevant below in the section-by-section description of the interim final rule. We have concluded that we have good cause, under 5 U.S.C. 553(b)(B), to waive the notice-and-comment requirements of the Administrative Procedure Act and to proceed with this interim final rule. Section 13402(j) explicitly required us to issue these regulations as ''interim final regulations'' and to do so within 180 days. Based on this statutory directive and limited time frame, we concluded that notice-and-comment rulemaking was impracticable and contrary to public policy. Nevertheless, we sought comments in the RFI referenced above and considered those comments when drafting this rule. In addition, we provide the public with a 60-day period following publication of this document to submit comments on the interim final rule. ## II. Guidance Specifying the Technologies and Methodologies That Render Protected Health Information Unusable, Unreadable, or Indecipherable to Unauthorized Individuals\n\n## A. Background\n\nAs discussed above, section 13402 of the Act requires breach notification following the discovery of a breach of unsecured protected health information. Section 13402(h) of the Act defines\n\n1 The FTC issued a notice of proposed rulemaking to implement section 13407 of the Act on April 20, 2009 (74 FR 17914)."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 2}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 487)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntify an individual. Small entities without the resources to conduct such an analysis can create deidentified information by removing the full list of possible identifiers set forth in this regulation.\nUnless the covered entity knows that the information could still identify an individual, the requirement of this rule would be fulfilled. However, larger, more sophisticated covered entities may close to determine independently what information needs to be removed based on sophisticated statistical and scientific analysis. Efforts to remove identifiers from information are optional. If a covered entity can not use or disclose protected health information for a particular purpose but believes that removing identifiers is excessively burdensome, it can choose not to release the protected health information, or it can seek an authorization from individuals for the use or disclosure of protected health\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ninformation including some or all of the identifiers. Finally, as discussed in the Regulatory Impact Analysis, the Department believes that very few small entities engage in de-identification currently. Fewer small entities are expected to engage in such activity in the future because the increasing trend toward computerization of large record sets will result in de-identification being performed by relatively few firms or associations over time. We expect that a small covered entity will find it more efficient to contract with specialists in large firms to de-identify protected health information. Larger entities are more likely to have both the electronic systems and the volume of records that will make them attractive for this business. ## Monitoring Business Associates\n\nThe final rule requires a covered entity with a business associate to have a written contract or other arrangement that documents satisfactory assurance that the business associate will appropriately safeguard protected health information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 486}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 139)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nunder §164.504(d), covered entities that are under common ownership or control may designate themselves as a single affiliated covered entity. Joint notice requirements do not apply to such entities.\nSingle affiliated covered entities must produce a single notice, consistent with the requirements described above for any other covered entity. Covered entities under common ownership or control that elect not to designate themselves as a single affiliated covered entity, however, may elect to produce a joint notice if they meet the definition of an organized health care arrangement.)\n\nThe joint notice must meet all of the requirements described above. The covered entities must agree to abide by the terms of the notice with respect to protected health information created or received by the covered entities as part of their participation in the organized health care arrangement. In addition, the joint notice must reasonably identify the covered entities, or class of covered entities, to which the joint notice applies and the service delivery sites, or classes of service delivery sites, to which the joint notice applies. If the covered entities participating in the organized health care arrangement will share protected health information with each other as necessary to carry out treatment, payment, or health care operations relating to the arrangement, that fact must be stated in the notice. Typical examples where this policy may be useful are health care facilities where physicians and other providers who have offices elsewhere also provide services at the facility (e.g. hospital staff privileges, physicians visiting their patients at a residential facility). In these cases, a single notice may cover both the physician and the facility, if the above conditions are met. The physician is required to have a separate notice covering the privacy practices at the physician's office if those practices are different than the practices described in the joint notice."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 138}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 109)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ntation and capacity to provide individuals with almost instantaneous electronic access to the protected health information in those records through personal health records or similar electronic means.\nOn the other hand, we did not propose to limit the right to electronic access of protected health information to certified EHRs, and the variety of electronic systems that are subject to this proposed requirement would not all be able to comply with a timeliness standard based on personal health record capabilities. It was our assumption that a single timeliness standard that would address a variety of electronic systems, rather than having a multitude of standards based on system capacity, would be the preferred approach to avoid workability issues for covered entities. Even under a single standard, nothing would prevent users of EHR systems from exceeding the Privacy Rule's timeliness requirements for providing access to individuals. Additionally, the Medicare and Medicaid EHR Incentive Programs (the ''meaningful use'' programs) require users of Certified EHR Technology to provide individuals with expedited access to information. Based on the assumption that a single standard would be the preferred approach under the Privacy Rule, we requested public comment on an appropriate, common timeliness standard for the provision of access by covered entities with electronic designated record sets generally. We specifically requested comment on aspects of existing systems\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with that would create efficiencies in processing of requests for electronic information, as well as those aspects of electronic systems that would provide little change from the time required for processing a paper record."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 108}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 45)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nion about an individual for purposes of preenrollment underwriting; the underwriting is not an ''operation'' of the provider and that disclosure is not otherwise permitted by a provision of this rule.\n(4) We delete reference to the ''compiling and analyzing information in anticipation of or for use in a civil or criminal legal proceeding'' and replace it with a broader reference to\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nconducting or arranging for ''legal services.''\n\nWe add two new categories of activities:\n\n(5) Business planning and development, such as conducting costmanagement and planning-related analyses related to managing and operating the entity, including formulary development and administration, development or improvement of methods of payment or coverage policies. (6) Business management activities and general administrative functions, such as management activities relating to implementation of and compliance with the requirements of this subchapter, fundraising for the benefit of the covered entity to the extent permitted without authorization under §164.514(f), and marketing of certain services to individuals served by the covered entity, to the extent permitted without authorization under §164.514(e) (see discussion in the preamble to that section, below). For example, under this category we permit uses or disclosures of protected health information to determine from whom an authorization should be obtained, for example to generate a mailing list of individuals who would receive an authorization request. We add to the definition of health care operations disclosure of protected health information for due diligence to a covered entity that is a potential successor in interest."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 44}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 4)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nations. However, these communications qualified for the exception to the definition of ''marketing'' only if they were made orally or, if in writing, were made without remuneration from a third party.\nFor example, it would not have been marketing for a pharmacy to call a patient about the need to refill a prescription, even if that refill reminder was subsidized by a third party; but it would have been marketing for that same, subsidized refill reminder to be sent to the patient in the mail. Generally, if a communication was marketing, the Privacy Rule required the covered entity to obtain the individual's authorization to use or disclose protected health information to make the communication. However, the Privacy Rule, at § 164.514(e), permitted the covered entity to make healthrelated marketing communications without such authorization, provided it complied with certain conditions on the manner in which the communications were made. Specifically, the Privacy Rule permitted a covered entity to use or disclose protected health information to communicate to individuals about the health-related products or services of the covered entity or of a third party, without first obtaining an authorization for that use or disclosure of protected health information, if the communication: (1) Identified the covered entity as the party making the communication; (2) identified, if applicable, that the covered entity received direct or indirect remuneration from a third party for making the communication; (3) with the exception of general circulation materials, contained instructions describing how the individual could opt-out of receiving future marketing communications; and (4) where protected health information was used to target the communication about a product or service to individuals based on their health status or health condition, explained why the individual had been targeted and how the product or service related to the health of the individual."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 3}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 55)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\npermissible if done by the covered entity, but is not permitted by the contractor or any subcontractors if it is not permitted by the covered entity's business associate agreement with the contractor.\nIn short, each agreement in the business associate chain must be as\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00037\n\nstringent or more stringent as the agreement above with respect to the permissible uses and disclosures. Finally, in response to the comments requesting a model business associate agreement, we note that the Department has published sample business associate provisions on its web site. The sample language is designed to help covered entities comply with the business associate agreement requirements of the Privacy and Security Rules. However, use of these sample provisions is not required for compliance with the Rules, and the language should be amended as appropriate to reflect actual business arrangements between the covered entity and the business associate (or a business associate and a subcontractor). ## Response to Other Public Comments\n\nComment: Commenters requested guidance on whether a contract that complies with the requirements of the Graham Leach Bliley Act (GLBA) and incorporates the required elements of the HIPAA Rules may satisfy both sets of regulatory requirements. The commenters urged the Department to permit a single agreement rather than requiring business associates and business associate subcontractors to enter into separate GLBA agreements and business associate agreements. Response: While meeting the requirements of the GLBA does not satisfy the requirements of the HIPAA Rules, covered entities may use one agreement to satisfy the requirements of both the GLBA and the HIPAA Rules. Comment: A few commenters recommended adding an exception to having a business associate agreement for a person that receives a limited dataset and executes a data use agreement for research, health care operations, or public health purposes."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 54}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 122)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nbtain an individual's acknowledgment of receipt of the provider's notice, and to document such acknowledgment or, in the absence of such acknowledgment, the provider's good faith efforts to obtain it.\nThe estimated burden for the acknowledgment of receipt of the notice is 10 seconds for each notice. This is based on the fact that the provider does not need to take elaborate steps to receive acknowledgment. Initialing a box on an existing form or some other simple means will suffice. With the annual estimate of 613,000,000 acknowledgment forms it is estimated that the acknowledgment burden is 1,000,000 hours. A covered entity is also required to document compliance with the notice requirements by retaining copies of the versions of the notice issued by the\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00081\n\ncovered entity, and a direct treatment provider is required to retain a copy of each individual's acknowledgment or documentation of the good faith effort as required by § 164.530(j). 3. Appendix to Preamble-Sample Business Associate Contract Provisions\n\nThe Department also solicits public comments on the collection of information requirements associated with the model business associate contract language displayed in the Appendix to this preamble Rule. The language displayed has been changed in response to comments on the language that was published with the Notice of Proposed Rulemaking on March 27, 2002. The Department provided the model business associate contract provisions in response to numerous requests for guidance. These provisions were designed to help covered entities more easily comply with the business associate contract requirements of the Privacy Rule. However, use of these model provisions is not required for compliance with the Privacy Rule. Nor is the model language a complete contract."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 121}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 64)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nn with other documents, such as the notice acknowledgment, would be less confusing for individuals. To the contrary, the Department believes that combining unrelated documents would be more confusing.\nHowever, the Rule does permit an authorization to be combined with other authorizations so long as the provision of treatment, payment, enrollment in a health plan or eligibility for benefits is not conditioned on obtaining any of the authorizations, and the authorization is not for the use or disclosure of psychotherapy notes. Also, authorizations must contain the same information, whether it is a separate document or combined with another document; and the individual must be given the opportunity to read and discuss that information. Combining an authorization with routine paperwork diminishes individuals' ability to make a considered and informed judgment to permit the use or disclosure of their medical information for some other purpose. Comment: One commenter stated that the requirement for covered entities to use only authorizations that are valid under the Rule must be an unintended result of the Rule, because covered entities would have to use only valid authorizations when requesting information from non-covered entities. The commenter did not believe the Department intended this requirement to apply with respect to non-covered entities, and gave the example of dental health plans obtaining protected health information in connection with paper claims submitted by dental offices. The commenter requested clarification that health plans may continue to use authorization forms currently in use for all claims submitted by non-covered entities. Response: The commenter misapprehends the Rule's requirements. The requirements apply to uses and disclosure of protected health information by covered entities."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 63}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 136)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne required by law to maintain the privacy of protected health information, to provide a notice of their legal duties and privacy practices, and to abide by the terms of the notice currently in effect.\nIn the final rule, we additionally require the covered entity, if it wishes to reserve the right to change its privacy practices and apply the revised practices to protected health information previously created or received, to make a statement to that effect and describe how it will provide individuals with a revised notice. (See below for a more detailed discussion of a covered entity's responsibilities when it changes its privacy practices.)\n\n## Complaints\n\nAs in the proposed rule, a covered entity's notice must inform individuals about how they can lodge complaints with the covered entity if they believe their privacy rights have been violated. See § 164.530(d) and the corresponding preamble discussion for the requirements on covered entities for receiving complaints. The notice must also state that individuals may file complaints with the Secretary. In the final rule, we additionally require the notice to include a statement that the individual will not suffer retaliation for filing a complaint. ## Contact\n\nAs in the proposed rule, the notice must identify a point of contact where the individual can obtain additional information about any of the matters identified in the notice. ## Effective Date\n\nThe notice must include the date the notice went into effect, rather than the proposed requirement to include the date the notice was produced. The effective date cannot be earlier than the date on which the notice was first printed or otherwise published. Covered entities may wish to highlight or otherwise emphasize any material modifications that it has made, in order to help the individual recognize such changes."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 135}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 351)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ninformation is to be used or disclosed for research without an individual's authorization, the additional privacy protections in §164.512(i) are essential to reduce the risk of harm to the individual.\nComment: One commenter believed that it was paradoxical that, under the proposed rule, the disclosure of protected health information for research conducted with an authorization would have been more heavily burdened than research that was conducted without authorization, which they reasoned was far less likely to bring personal benefit to the research subjects. Response: It was not our intent to impose more requirements on covered entities using or disclosing protected health information for research conducted with authorization than for research conducted without authorization. In fact, the proposed rule would have required only authorization as stipulated in proposed § 164.508 for research disclosures made with authorization, and would have been exempt from the documentation requirements in proposed § 164.510(j). We retain this treatment in the final rule. We disagree with the commenter who asserted that the requirements for research conducted with authorization are more burdensome for covered health care providers and plans than the documentation provisions of this paragraph. Comment: A number of comments, mostly from the pharmaceutical industry, recommended that the final rule state that privacy boards be permitted to waive authorization only with respect to research uses of medical information collected in the course of treatment or health care operations, and not with respect to clinical research. Similarly, one commenter recommended that IRBs and privacy boards be authorized to review privacy issues only, not the entire research project."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 350}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 5)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nvaluation standard...................51                                                                                                                                                    |\n| Table 16.\nKey activities, descriptions, and sample questions for the Business Associate Contracts and Other Arrangements standard..........................................................................................................54                    |\n| Table 17. Key activities, descriptions, and sample questions for the Facility Access Controls standard56                                                                                                                                                         |\n| Table 18. Key activities, descriptions, and sample questions for the Workstation Use standard..........59                                                                                                                                                        |\n| Table 19. Key activities, descriptions, and sample questions for the Workstation Security standard...61                                                                                                                                                          |\n| Table 20. Key activities, descriptions, and sample questions for the Device and Media Controls standard..........................................................................................................................................63              |\n| Table 21. Key activities, descriptions, and sample questions for the Access Control standard.............65                                                                                                                                                      |\n| Table 22."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 4}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 135)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nith the definition of the same term used in the HITECH Act, the Department has modified the definition of ''State'' at §160.103 to include reference to American Samoa and the Northern Mariana Islands.\nGiven this change, it is not necessary to include specific reference to American Samoa and the Northern Mariana Islands at § 164.406 and we remove it in this final rule. In response to public comments, we clarify that § 164.406 does not require a covered entity to incur any cost to print or run media notice about a breach of unsecured protected health information\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00089\n\n(unlike the obligations for providing substitute notice to individuals in §164.404(d)(2) if there is insufficient or out-of-date contact information for 10 or more affected individuals) nor does it obligate prominent media outlets who receive notification of a breach from a covered entity to print or run information about the breach. We also emphasize that posting a press release regarding a breach of unsecured protected health information on the home page of the covered entity's Web site will not fulfill the obligation to provide notice to the media (although covered entities are free to post a press release regarding a breach on their Web site). To fulfill the obligation, notification, which may be in the form of a press release, must be provided directly to prominent media outlets serving the State or jurisdiction where the affected individuals reside. ## 4. Section 164.408-Notification to the Secretary\n\nSection 13402(e)(3) of the HITECH Act requires covered entities to notify the Secretary of breaches of unsecured protected health information. The Act requires covered entities to report breaches affecting 500 or more individuals to the Secretary immediately. For breaches affecting fewer than 500 individuals, covered entities may maintain a log of all such breaches occurring during the year and annually submit such log to the Secretary."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 134}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 190)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nized health care arrangement, or that provides a service as described in paragraph (1)(ii) of this definition to or for such organized health care arrangement by virtue of such activities or services.\nCivil money penalty or penalty means the amount determined under § 160.404 of this part and includes the plural of these terms. *\n\n*\n\n*\n\n*\n\n*\n\nCompliance date means the date by which a covered entity or business associate must comply with a standard, implementation specification, requirement, or modification adopted under this subchapter. *\n\n*\n\n*\n\n*\n\n*\n\nDisclosure means the release, transfer, provision of access to, or divulging in\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00124\n\n- any manner of information outside the entity holding the information. *\n\n*\n\n*\n\n*\n\n*\n\nElectronic media means:\n\n- (1) Electronic storage material on which data is or may be recorded electronically, including, for example, devices in computers (hard drives) and any removable/transportable digital memory medium, such as magnetic tape or disk, optical disk, or digital memory card;\n- (2) Transmission media used to exchange information already in electronic storage media. Transmission media include, for example, the Internet, extranet or intranet, leased lines, dial-up lines, private networks, and the physical movement of removable/transportable electronic storage media. Certain transmissions, including of paper, via facsimile, and of voice, via telephone, are not considered to be transmissions via electronic media if the information being exchanged did not exist in electronic form immediately before the transmission. *\n\n*\n\n*\n\n*\n\n*\n\nFamily member means, with respect to an individual:\n\n- (1) A dependent (as such term is defined in 45 CFR 144.103), of the individual; or\n- (2) Any other person who is a firstdegree, second-degree, third-degree, or fourth-degree relative of the individual or of a dependent of the individual."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 189}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 500)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncomponents. 3. (ii) Specification of materials, performance, or operations; or\n4. (iii) Delineation of procedures; or\n- (2) With respect to the privacy of individually identifiable health information.\nStandard setting organization (SSO) means an organization accredited by the American National Standards Institute that develops and maintains standards for information transactions or data elements, or any other standard that is necessary for, or will facilitate the implementation of, this part. State refers to one of the following: (1) For a health plan established or regulated by Federal law, State has the meaning set forth in the applicable section of the United States Code for such health plan. - (2) For all other purposes, State means any of the several States, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, and Guam. Trading partner agreement means an agreement related to the exchange of information in electronic transactions, whether the agreement is distinct or part of a larger agreement, between each party to the agreement. (For example, a trading partner agreement may specify, among other things, the duties and responsibilities of each party to the agreement in conducting a standard transaction.)\n\nTransaction means the transmission of information between two parties to carry out financial or administrative activities related to health care. It includes the following types of information transmissions:\n\n- (1) Health care claims or equivalent encounter information. VerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\n- (2) Health care payment and remittance advice. - (3) Coordination of benefits. - (4) Health care claim status. - (5) Enrollment and disenrollment in a health plan. - (6) Eligibility for a health plan. - (7) Health plan premium payments. - (8) Referral certification and authorization. - (9) First report of injury. - (10) Health claims attachments. - (11) Other transactions that the Secretary may prescribe by regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 499}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the technical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRIN 0991-AB14\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY: Office for Civil Rights, HHS. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (''HHS'' or ''Department'') modifies certain standards in the Rule entitled ''Standards for Privacy of Individually Identifiable Health Information'' (''Privacy Rule''). The Privacy Rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996. The purpose of these modifications is to maintain strong protections for the privacy of individually identifiable health information while clarifying certain of the Privacy Rule's provisions, addressing the unintended negative effects of the Privacy Rule on health care quality or access to health care, and relieving unintended administrative burdens created by the Privacy Rule. DATES: This final rule is effective on October 15, 2002. FOR FURTHER INFORMATION CONTACT: Felicia Farmer, 1-866-OCR-PRIV (1866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION:\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 (or toll-free at 1-866-5121800) or by fax to (202) 512-2250. The cost for each copy is $10.00."}], "metadata": {"source": "privacy_mod_2002", "safeguard_type": "technical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 413)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrepresentative could result in substantial harm to the individual or another person. Access can be denied even if the potential harm may be inflicted by someone other than the personal representative.\nThis provision is designed to strike a balance between the competing interests of ensuring access to protected health information and protecting the individual or others from harm. The ''substantial harm'' standard will ensure that a covered entity cannot deny access in cases where the harm is de minimus. The amount of discretion that a covered entity has to deny access to a personal representative is generally greater than the amount of discretion that a covered entity has to deny access to an individual. Under the final rule, a covered entity may deny access to an individual if a licensed health care professional determines that the access requested is reasonably likely to endanger the life or physical safety of the individual or another person. In this case, concerns about psychological or emotional harm would not be sufficient to justify denial of access. We establish a relatively high threshold because we want to assure that individuals have broad access to health information about them, and due to the potential harm that comes from denial of access, we believe denials should be permitted only in limited circumstances. The final rule grants covered entities greater discretion to deny access to a personal representative than to an individual in order to provide protection to those vulnerable people who depend on others to exercise their rights under the rule and who may be subjected to abuse or neglect. This provision applies to personal representatives of minors as well as other individuals. The same standard for denial of access on the basis of potential harm that applies to personal representatives also applies when an individual is seeking access to his or her protected health information, and the information makes reference to another person."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 412}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 56)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\na health plan and a health care provider, a single activity could be considered to be both treatment and health care operations; for compliance purposes we would consider the purpose of the activity.\nGiven the integration of the health care system we believe that further classification of activities into either treatment or health care operations would not be helpful. See the definition of health care operations for additional discussion. ## Use\n\nWe proposed to define ''use'' to mean the employment, application, utilization, examination, or analysis of information within an entity that holds the information. In the final rule, we clarify that use refers to the use of individually identifiable health information. We replace the term ''holds'' with the term ''maintains.'' These changes are for clarity only, and are not intended to effect any substantive change. ## Section 164.502-General Rules for Uses and Disclosures of Protected Health Information\n\nSection 164.502(a)-Use and Disclosure for Treatment, Payment and Health Care Operations\n\nAs a general rule, we proposed in the NPRM to prohibit covered entities from using or disclosing protected health information except as authorized by the individual who is the subject of such information or as explicitly permitted by the rule. The proposed rule explicitly would have permitted covered entities to use or disclose an individual's protected health information without authorization for treatment, payment, and health care operations. The proposal would not have restricted to whom disclosures could be made for the purposes of treatment, payment, or operations. The proposal would have allowed disclosure of the protected health information of one individual for the treatment or payment of another, as appropriate. We also proposed to prohibit covered entities from seeking individual authorization for uses and disclosures for treatment, payment, and health care operations unless required by state or other applicable law."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 55}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement technical controls?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\nRIN 0991-AB56\n\n## Breach Notification for Unsecured Protected Health Information\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Interim final rule with request for comments. SUMMARY: The Department of Health and Human Services (HHS) is issuing this interim final rule with a request for comments to require notification of breaches of unsecured protected health information. Section 13402 of the Health Information Technology for Economic and Clinical Health (HITECH) Act, part of the American Recovery and Reinvestment Act of 2009 (ARRA) that was enacted on February 17, 2009, requires HHS to issue interim final regulations within 180 days to require covered entities under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and their business associates to provide notification in the case of breaches of unsecured protected health information. For purposes of determining what information is ''unsecured protected health information,'' in this document HHS is also issuing an update to its guidance specifying the technologies and methodologies that render protected health information unusable, unreadable, or indecipherable to unauthorized individuals. DATES: Effective Date: This interim final rule is effective September 23, 2009. Comment Date: Comments on the provisions of this interim final rule are due on or before October 23, 2009. Comments on the information collection requirements associated with this rule are due on or before September 8, 2009. ADDRESSES: You may submit comments, identified by RIN 0991-AB56, by any of the following methods (please do not submit duplicate comments):\n\n- Regular, Express, or Overnight Mail: U.S. Department of Health and Human Services, Office for Civil Rights, Attention: HITECH Breach Notification, Hubert H."}], "metadata": {"source": "breach_notification_2009", "safeguard_type": "technical", "implementation_spec": "required", "entity_type": "covered_entity", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 103)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nexisting contracts until such contracts come up for renewal instead of requiring that all contracts be in compliance with the business associate provisions by the compliance date of the Privacy Rule.\nIn response to these concerns, the Department proposed to relieve some of the burden on covered entities in complying with the business associate provisions by both adding a transition provision to grandfather certain existing contracts for a specified period of time, as well as publishing sample contract language in the proposed Rule. The following discussion addresses the issue of the business associate transition provisions. A discussion of the business associate sample contract language is included in Part X of the preamble. The Department proposed new transition provisions at § 164.532(d) and (e) to allow covered entities, other than small health plans, to continue to operate under certain existing contracts with business associates for up to one year beyond the April 14, 2003, compliance date of the Privacy Rule. The additional transition period would be available to a covered entity, other than a small health plan, if, prior to the effective date of the transition provision, the covered entity had an existing contract or other written arrangement with a business associate, and such contract or arrangement was not renewed or modified between the effective date of this provision and the Privacy Rule's compliance date of April 14, 2003. The proposed provisions were intended to allow those covered entities with contracts that qualified as described above to continue to disclose protected health information to the business associate, or allow the business associate to create or receive protected health information on its behalf, for up to one year beyond the Privacy Rule's compliance date, regardless of whether the contract meets the applicable contract requirements in the Privacy Rule."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 102}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 4)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nions Crosswalk........................105                                                                                                                                                |\n| Appendix E.\nNational Online Informative References (OLIR) Program..............................................106                                                                                                                                        |\n| Appendix F. HIPAA Security Rule Resources (Informative)...............................................................109                                                                                                                                 |\n| Appendix G. Change Log.................................................................................................................110                                                                                                                |\n| List of Tables                                                                                                                                                                                                                                            |\n| Table 1. Security Rule standards and implementation specifications .................................................12                                                                                                                                    |\n| Table 2. Common threat sources ......................................................................................................17                                                                                                                   |\n| Table 3. Assessment scale for overall likelihood................................................................................19                                                                                                                        |\n| Table 4."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 3}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 107)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nproposed §164.510. For example, mandatory reporting to law enforcement officials would not have been allowed unless such disclosures conformed to the requirements of proposed § 164.510(f) of the NPRM.\nProposed §164.510(f) did not explicitly recognize disclosures required by other laws, and it would not have permitted covered entities to comply with some state and other mandatory reporting laws that require covered entities to disclose protected health information to law enforcement officials, such as the reporting of gun shot wounds, stab wounds, and/or burn injuries. We did not intend to preempt generally state and other mandatory reporting laws, and in § 164.512(f)(1)(i) of the final rule, we explicitly permit covered entities to disclose protected health information for law enforcement purposes as required by other law. This provision permits covered entities to comply with these state and other laws. Under this provision, to the extent that a mandatory reporting law falls under the provisions of § 164.512(c)(1)(i) regarding reporting of abuse, neglect, or domestic violence, the requirements of those provisions supersede. In the final rule, we specify that covered entities may disclose protected health information pursuant to this provision in compliance with and as limited by the relevant requirements of legal process or other law. In the NPRM, for the purposes of this portion of the law enforcement paragraph, we proposed to define ''law enforcement inquiry or proceeding'' as an investigation or official proceeding inquiring into a violation of or failure to comply with law; or a criminal, civil or administrative proceeding arising from a violation of or failure to comply with law. In the final rule, we do not include this definition in § 164.512(f), because it is redundant with the definition of ''law enforcement official'' in § 164.501."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 106}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 41)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nom an individual to send communications to the individual about non-health related products or services or to give or sell the individual's protected health information to a third party for marketing.\nStill, concerns have remained about the ability under these provisions for a third party to pay a covered entity to send health-related communications to an individual about the third party's products or services. Section 13406(a) of the HITECH Act limits the health-related communications that may be considered health care operations and thus, that are excepted from the definition of ''marketing'' under the Privacy Rule, to the extent a covered entity receives or has received direct or indirect payment in exchange for making the communication. In cases where the covered entity would receive such\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00028\n\npayment, the HITECH Act at section 13406(a)(2)(B) and (C) requires that the covered entity obtain the individual's valid authorization prior to making the communication, or, if applicable, prior to its business associate making the communication on its behalf in accordance with its written contract. Section 13406(a)(2)(A) of the HITECH Act includes an exception to the payment limitation for communications that describe only a drug or biologic that is currently being prescribed to the individual as long as any payment received by the covered entity in exchange for making the communication is reasonable in amount. Section 13406(a)(3) of the Act provides that the term ''reasonable in amount'' shall have the meaning given to such term by the Secretary in regulation. Finally, section 13406(a)(4) of the Act clarifies that the term ''direct or indirect payment'' does not include any payment for treatment of the individual."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 40}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 37)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nh and/or do not have access to e-mail. We, therefore, assume that only 50 percent of individuals affected as a result of a breach of unsecured protected health information will receive e-mail notices.\nThere will be certain costs that both e-mail and first-class mail communication will share. The cost of preparing the notice and preparing a draft will apply to both forms. The median hourly wage for a healthcare practitioner and technical worker in 2008 was $27. 15 Doubling the amount to account for fringe benefits equals $54. If we assume 30 minutes per breach for composing the letter, the cost equals $27. We assume that it will take 30 minutes per breach for an administrative assistant to draft the letter in either e-mail or printed formats and to document the letter to comply with §§ 164.414(a) and 164.530(j). The median hourly wage for office and administrative support staff is $14.32 per hour. Accounting for benefits, the hourly costs is $29. For the 30 minutes, we estimate $15 per breach. The combined cost for composing and preparing the document is approximately $42 per breach. Half of the cost will be allocated to the mailing of the first-class letter and the other half to the sending of e-mails. Although computer costs for sending e-mail will be insignificant, it will take staff time to select the e-mail address from the entity's mailing list. We assume that a staff person could process and send 200 e-mails per hour at a cost of $30 per hour. For each mailed notice we assume $0.06 for paper and envelope and $0.44 for a first class stamp, totaling $0.50 per letter. We estimate another $30 per hour to prepare the mailing by hand at a rate of 100 letters per hour. notice (106 × $42) equals $4,346. Allocating half the costs to e-mailing and the same amount to regular mail yields $2,173 to each category. For 2008, there were 2,888,804 reported affected individuals."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 36}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 31)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n| Key Activities | Description | Sample Questions | |-----------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 4."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 30}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 83)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nle resource unavailable to intended users or prevent the resource from functioning efficiently or at all, whether temporarily or indefinitely. |\n| Conduct distributed denial-of-service (DDoS) attacks.\n| Adversary uses multiple compromised information systems to attack a single target, thereby causing a denial of service for users of the targeted information systems. |\n| Conduct targeted denial-of-service (DoS) attacks. | Adversary conducts DoS attacks to target critical information systems, components, or supporting infrastructures based on adversary knowledge of dependencies. |\n| Conduct physical attacks on organizational facilities. | Adversary conducts a physical attack on organizational facilities (e.g., sets a fire). |\n| Conduct physical attacks on infrastructures that support organizational facilities. | Adversary conducts a physical attack on one or more infrastructures that support organizational facilities (e.g., breaks a water main, cuts a power line). |\n| Conduct cyber-physical attacks on organizational facilities. | Adversary conducts a cyber-physical attack on organizational facilities (e.g., remotely changes heating and/or energy settings). |\n| Conduct data scavenging attacks in a cloud environment. | Adversary obtains data used and then deleted by organizational processes running in a cloud environment. |\n| Conduct brute force login attempts or password guessing attacks. | Adversary attempts to gain access to organizational information systems by random or systematic guessing of passwords, possibly supported by password-cracking utilities. |\n| Conduct non-targeted zero-day attacks. | Adversary employs attacks that exploit as yet unpublicized vulnerabilities. Attacks are not based on any adversary insights into specific vulnerabilities of organizations. |\n| Conduct externally-based session hijacking."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 82}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 60)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\neding brought by the individual. Section 164.508(a)(3) requires covered entities to obtain an authorization to use or disclose protected health information for marketing purposes, with two exceptions.\nThe authorization requirements for marketing and the comments received on these provisions are discussed in detail in section III.A.1. of the preamble. If the marketing involves any direct or indirect remuneration to the covered entity from a third party, the authorization must state that fact. The comments on this requirement also are discussed in section III.A.1. of the preamble. However, a statement concerning remuneration is not a required notification for other authorizations. Such a statement was never required for all authorizations and the Department believes it would be most meaningful for consumers on authorizations for uses and disclosures of protected health information for marketing purposes. Some commenters urged the Department to require remuneration statements on research authorizations. The Department has not done so because the complexity of such arrangements would make it difficult to define what constitutes remuneration in the research context. Moreover, to require covered entities to disclose remuneration by a third party on authorizations for research would go beyond the requirements imposed in the December 2000 Rule, which did not require such a disclosure on authorizations obtained for the research of a third party. The Department believes that concerns regarding financial conflicts of interest that arise in research are not limited to privacy concerns, but also are important to the objectivity of research and to protecting human subjects from harm. Therefore, in the near future, the Department plans to issue guidance for the research community on this important topic."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 59}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 125)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne NPRM proposed two alternative methods for determining when sufficient identifying information has been removed from a record to render the information de-identified and thus not subject to the rule.\nFirst, the NPRM proposed the establishment of a ''safe harbor'': if all of a list of 19 specified items of information had been removed, and the covered entity had no reason to believe that the remaining information could be used to identify the subject of the information (alone or in combination with other information), the covered entity would have been presumed to have created de-identified information. Second, the NPRM proposed an alternative method so that covered entities with sufficient statistical experience and expertise could remove or encrypt a combination of information different from the enumerated list, using commonly accepted scientific and statistical standards for disclosure avoidance. Such covered entities would have been able to include information from the enumerated list of 19 items if they (1) believed that the probability of reidentification was very low, and (2) removed additional information if they had a reasonable basis to believe that the resulting information could be used to re-identify someone. We proposed that covered entities and their business partners be permitted to use protected health information to create de-identified health information using either of these two methods. Covered entities would have been permitted to further use and disclose such de-identified information in any way, provided that they did not disclose the key or other mechanism that would have enabled the information to be reidentified, and provided that they reasonably believed that such use or disclosure of de-identified information would not have resulted in the use or\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\ndisclosure of protected health information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 124}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 23)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n4.4. 29  A cost-benefit analysis should be conducted for proposed recommended controls to demonstrate that the costs of implementing the controls can be justified by a reduction in the level of risk.\nIn addition to cost, organizations should consider the operational impact and feasibility of introducing the recommended security controls into the operating environment. discussions present an opportunity for leadership to determine the best course of action to refine risk acceptance and tolerance in light of mission objectives (e.g., through a risk exception process, an adjustment to the risk tolerance statement, or increased security requirements). However, if an unacceptable level of risk to ePHI cannot be adequately treated in a costeffective manner, that risk should be avoided. Such a condition may require significantly redesigning relevant systems or processes that handle ePHI. ## 4.4. Documenting Risk Management Activities\n\nAs with the risk assessment, risk management activities should be documented. The regulated entity may build on the documentation developed during the risk assessment by indicating how threat/vulnerability pairs with risk levels above established risk tolerance are mitigated or avoided. Some regulated entities may choose to document their risk management activities through a risk register that records assessment findings, remediation plans, timelines, responsible parties, and other relevant information. Other regulated entities may choose to utilize free or commercially available tools to document their risk management activities. The documentation and retention of risk assessment and risk management activities may be important for future risk management efforts. ## 5. Considerations When Implementing the HIPAA Security Rule\n\nThis section presents security measures that are relevant to each standard of the Security Rule. Each standard is presented in a consistent tabular format. The following tables, organized by HIPAA Security Rule [Sec."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 22}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 58)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nof the final rule, we permit a covered entity to use protected health information to create deidentified information, whether or not the de-identified information is to be used by the covered entity.\nWe clarify that de-identified information created in accordance with our procedures (which have been moved to § 164.514(a)) is not subject to the requirements of these privacy rules unless it is re-identified. Disclosure of a key or mechanism that could be used to re-identify such information is also defined to be disclosure of protected health information. See the preamble to §164.514(a) for further discussion. ## Section 164.502(e)-Business Associates\n\nIn the proposed rule, other than for purposes of consultation or referral for treatment, we would have allowed a covered entity to disclose protected health information to a business partner only pursuant to a written contract that would, among other specified provisions, limit the business partner's uses and disclosures of protected health information to those permitted by the\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ncontract, and would impose certain security, inspection and reporting requirements on the business partner. We proposed to define the term\n\n''business partner'' to mean, with respect to a covered entity, a person to whom the covered entity discloses protected health information so that the person can carry out, assist with the performance of, or perform on behalf of, a function or activity for the covered entity. In the final rule, we change the term ''business partner'' to ''business associate'' and in the definition clarify the full range of circumstances in which a person is acting as a business associate of a covered entity."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 57}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.312 require?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n§164.312(a)(1). With respect to PRBAC, the access control standard does not exclude this control, and entities should adopt it if appropriate to their circumstances.\n\nVerDate Jan&lt;31&gt;2003\n\n## D. General Rules ("}], "metadata": {"source": "security_rule_2003", "cfr_section": "§164.312", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 49)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nther arrangement under the Privacy Rule. Additionally, section 13404(a) applies the other privacy requirements of the HITECH Act directly to business associates just as they apply to covered entities.\nSection 13404(b) applies the provision of § 164.504(e)(1)(ii) regarding knowledge of a pattern of activity or practice that constitutes a material breach or violation of a contract to business associates. Finally, section 13404(c) applies the HIPAA civil and criminal penalties to business associates. We discuss the modifications to the Privacy Rule pursuant to paragraphs (a) and (b) of section 13404 of the HITECH Act below. We address the modifications made to the Enforcement Rule by section 13404(c) regarding the application of penalties to violations by business associates above in the discussion of the changes to the Enforcement Rule. We note that we have not added references to ''business associate'' to all provisions of the Privacy Rule that address uses and disclosures by covered entities. Such additions to the Privacy Rule are unnecessary, as a business associate generally may only use or disclose protected health information in the same manner as a covered entity. Therefore, any Privacy Rule limitation on how a covered entity may use or disclose protected health information automatically extends to a business associate. ## i. Permitted and Required Uses and Disclosures\n\n## Proposed Rule\n\nWe proposed to modify § 164.502(a) of the Privacy Rule containing the general rules for uses and disclosures of protected health information to address the permitted and required uses and disclosures of protected health information by business associates. First, we proposed to modify\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n§164.502(a) to provide that a business associate, like a covered entity, may not use or disclose protected health information except as permitted or required by the Privacy Rule or the Enforcement Rule."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 48}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.414 require?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n§164.414(b) (discussed below), for showing why breach notification was not required. Accordingly, the covered entity or business associate must document why the impermissible use or disclosure falls under one of the above exceptions.\n\n## Overview of Public Comments\n\nOf the approximately 85 public comments received on the interim final rule addressing the definition of breach, approximately 70 of those comments addressed the harm standard and risk assessment approach in the interim final rule. We received approximately 60 comments in support of the harm standard and the risk assessment approach"}], "metadata": {"source": "hitech_omnibus_2013", "cfr_section": "§164.414", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 414)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nes access based on harm to self or others, the individual has the right to have the denial reviewed by another health care professional who did not participate in the original decision to deny access.\nComment: A few commenters objected to the proposal to allow covered entities to deny a request for access to health information if the information was obtained from a confidential source that may be revealed upon the individual's access. They argued that this could be subject to abuse and the information could be inherently less reliable, making the patient's access to it even more important. Response: While we acknowledge that information provided by confidential sources could be inaccurate, we are concerned that allowing unfettered access to such information could undermine the trust between a health care provider and patients other than the individual. We retain the proposed policy because we do not want to interfere with a covered entity's ability to obtain important information that can assist in the provision of health care or to maintain implicit or explicit promises of confidence, which may be necessary to obtain such information. We believe the concerns raised about abuse are mitigated by the fact that the provision does not apply to promises of confidentiality made to a health care provider. We note that a covered entity may provide access to such information. Comment: Some commenters were concerned that the NPRM did not allow access to information unrelated to treatment, and thus did not permit access to research information. Response: In the final rule, we eliminate the proposed special provision for ''research information unrelated to treatment.'' The only restriction on access to research information in this rule applies where the individual agrees in advance to denial of access when consenting to participate in research that includes treatment."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 413}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 66)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n502(a)(5)(ii)(B)( 2 )( iii ). Comment: A few commenters asked that the final rule clarify that transfers of value among entities under common control does not implicate the authorization requirements.\nSimilarly, some commenters sought clarification on whether business transfers on the books for internal reorganization would also be excluded under the transfer, merger, and consolidation exception to the final rule. Response: First, we clarify that uses of protected health information within a covered entity that is a single legal entity are not implicated by the remuneration prohibition as the prohibition applies only to disclosures outside of a covered entity. Second, the use of protected health information among legally separate covered entities under common ownership or control that have designated themselves as an affiliated covered entity (i.e., a single covered entity for purposes of compliance with the HIPAA Rules) is not implicated. See the requirements for affiliated covered entities at §164.105(b). Thus, to the extent that what the commenters contemplate is an otherwise permissible use of protected health information within a single legal entity that is a covered entity or an affiliated covered entity, such use of data is not impacted by these provisions. Third, disclosures of protected health information for the sale, transfer, merger, or consolidation of all or part of a covered entity with another covered entity, or with an entity that following such activity will become a covered entity and due diligence related to such activity are excepted from the definition of sale of protected health information at §164.502(a)(5)(ii)(B)( 2 )( iv )."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 65}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 457)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nine, the costs of firewalls for electronic systems should not be counted as a cost of the regulation except where firewalls create greater security than existed under the previous, paper-based system.\nFinally, the third baseline would require an estimate of the typical level of firewall protections that covered entities would adopt in the absence of regulation, and include in the Regulatory Impact Analysis only the costs that exceed what would otherwise have been adopted. For this analysis, the Department has generally assumed that the status quo would otherwise exist throughout the ten-year period (in a few areas we explicitly discuss likely changes). We made this decision for two reasons. First, predicting the level of change that would otherwise occur is highly problematic. Second, it is a ''conservative'' assumption-that is, any error will likely be an overstatement of the true costs of the regulation. Privacy practices are most often shaped by professional organizations that publish ethical codes of conduct and by state law. On occasion, state laws defer to professional conduct codes. At present, where professional organizations and states have developed only limited guidelines for privacy practices, an entity may implement privacy practices independently. However, it is worth noting that changes in privacy protection continue to increase in various areas. For example, European Union countries may only send individually identifiable information to companies, including U.S. firms, that comply with their privacy standards, and the growing use of health data in other areas of commerce, such as finance and general commercial marketing, have also increased the demand for privacy in ways that were not of concern in the past. ## 1. Professional Codes of Ethics\n\nThe Department examined statements issued by five major professional groups, one national electronic network association and a leading managed care association."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 456}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 473)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nly 10 percent of all requests are made directly from patients, and of those, the majority are for purposes of continuing care (transfer to another provider), not for purposes of individual inspection.\nThe Department assumed that 25 percent of direct patient requests to copy medical records are for purposes of inspecting their accuracy (i.e., 2.5 percent of all copy requests) or 850,000 in 2003 if the current practice remained unchanged. To estimate the marginal increase in copying that might result from the regulation, the Department assumed that as patients gained more awareness of their right to inspect and copy their records, more requests will occur. As a result, the Department assumed a ten percent increase in the number of requests to inspect and copy medical records over the current baseline, which would amount to a little over 85,000 additional requests in 2003 at a cost of $1.3 million. Allowing for a 5.3 percent increase in records based on the increase in ambulatory care visits, the highest growth rate among health service sectors (the National Ambulatory Medical Care Survey, 1998), the total cost for the ten-year period would be $16.8 million. The final rule allows a provider to deny an individual the right to inspect or obtain a copy of protected health information in a designated record set under certain circumstances, and it provides, in certain circumstances, that the patient can request the denial to be reviewed by another licensed health care professional. The initial provider can choose a licensed health care professional to render the second review. The Department assumes denials and subsequent requests for reviews will be extremely rare. The Department estimates there are about 932,000 annual requests for inspections ( i.e., base plus new requests resulting from the regulation), or approximately 11 million over the ten-year period."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 472}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "When must a HIPAA breach be reported to HHS?"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n## Postmarket Management of Cybersecurity in Medical Devices\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on December 28, 2016. The draft of this document was issued on January 22, 2016. For questions regarding this document, contact Suzanne Schwartz, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5434, Silver Spring, MD 20993-0002, 301-796-6937. For questions regarding this document as applied to devices regulated by CBER, contact the Office of Communication, Outreach and Development in CBER at 1-800-835-4709 or 240-402-8010 or ocod@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of the Center Director\n\nCenter for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to http://www.regulations.gov . Submit written comments to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2015-D-5105. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an e-mail request to CDRH-Guidance@fda.hhs.gov to receive an electronic copy of the guidance. Please use the document number 1400044 to identify the guidance you are requesting. ## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), by written request, Office of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., Bldg."}], "metadata": {"source": "fda_postmarket_2016", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 58)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nre elements that must be included in any authorization. These elements are intended to provide individuals with the information they need to make an informed decision about giving their authorization.\nThis information includes specific details about the use or disclosure, and provides the individual fair notice about his or her rights with respect to the authorization and the potential for the information to be redisclosed. Additionally, the authorization must be written in plain language so individuals can read and understand its contents. The Privacy Rule required that authorizations provide individuals with additional information for specific circumstances under the following three sets of implementation specifications: In §164.508(d), for authorizations requested by a covered entity for its own uses and disclosures; in § 164.508(e), for authorizations requested by a covered entity for another entity to disclose protected health information to the covered entity requesting the authorization to carry out treatment, payment, or health care operations; and in § 164.508(f), for authorizations requested by a covered entity for research that includes treatment of the individual. March 2002 NPRM. Various issues were raised regarding the authorization requirements. Commenters claimed the authorization provisions were too complex and confusing. They alleged that the different sets of implementation specifications were not discrete, creating the potential for the\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00039\n\nimplementation specifications for specific circumstances to conflict with the required core elements. Some covered entities were confused about which authorization requirements they should implement in any given circumstance."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 57}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 519)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nty has conditioned the provision of treatment, payment, enrollment in the health plan, or eligibility for benefits under paragraph (b)(4) of this section on the provision of one of the authorizations.\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\n- (4) Prohibition on conditioning of authorizations. A covered entity may not condition the provision to an individual of treatment, payment, enrollment in the health plan, or eligibility for benefits on the provision of an authorization, except:\n2. (i) A covered health care provider may condition the provision of researchrelated treatment on provision of an authorization under paragraph (f) of this section;\n3. (ii) A health plan may condition enrollment in the health plan or eligibility for benefits on provision of an authorization requested by the health plan prior to an individual's enrollment in the health plan, if:\n4. (A) The authorization sought is for the health plan's eligibility or enrollment determinations relating to the individual or for its underwriting or risk rating determinations; and\n5. (B) The authorization is not for a use or disclosure of psychotherapy notes under paragraph (a)(2) of this section;\n6. (iii) A health plan may condition payment of a claim for specified benefits on provision of an authorization under paragraph (e) of this section, if:\n7. (A) The disclosure is necessary to determine payment of such claim; and\n8. (B) The authorization is not for a use or disclosure of psychotherapy notes under paragraph (a)(2) of this section; and\n9. (iv) A covered entity may condition the provision of health care that is solely for the purpose of creating protected health information for disclosure to a third party on provision of an authorization for the disclosure of the protected health information to such third party. - (5) Revocation of authorizations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 518}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 3)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n3\n\nresponse portion of this final rule, for purposes of continuity, however, we use ''requirement'' and ''implementation feature'' when we are referring specifically to matters from the proposed rule.\nIn all other instances, we use ''standard'' and ''implementation specification.''\n\nThe proposed rule would require that each covered entity (as now described in § 160.102) engaged in the electronic maintenance or transmission of health information pertaining to individuals assess potential risks and vulnerabilities to such information in its possession in electronic form, and develop, implement, and maintain appropriate security measures to protect that information. Importantly, these measures would be required to be documented and kept current. The proposed security standard was based on three basic concepts that were derived from the Administrative Simplification provisions of HIPAA. First, the standard should be comprehensive and coordinated to address all aspects of security. Second, it should be scalable, so that it can be effectively implemented by covered entities of all types and sizes. Third, it should not be linked to specific technologies, allowing covered entities to make use of future technology advancements. The proposed standard consisted of four categories of requirements that a covered entity would have to address in order to safeguard the integrity, confidentiality, and availability of its electronic health information pertaining to individuals: administrative procedures, physical safeguards, technical security services, and technical mechanisms. The implementation features described the requirements in greater detail when that detail was needed. Within the four categories, the requirements and implementation features were presented in alphabetical order to convey that no one item was considered to be more important than another."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 2}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 281)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrsons and what activities and functional areas may be included. The commenter alleged that identification of persons needing access to protected health information will be administratively burdensome.\nAnother commenter requested clarification on distinguishing the component entity from non-component entities within an organization and how to administer such relationships. The commenter stated that individuals included in the covered entity could change on a daily basis and advocated for a simpler set of rules governing intra-organizational relationships as opposed to interorganizational relationships. Response: While we have not adopted the component approach for plan sponsors in the final rule, plan sponsors who want protected health information must still identify who in the organization will have access to the information. Several of the changes we make to the NPRM will make this designation easier. First, we move from ''component'' to a more familiar functional approach. We limit the employees of the plan sponsor who may receive protected health information to those employees performing plan administration functions, as that term is understood with respect to ERISA compliance, and as limited by this rule's definitions of payment and health care operation. We also allow designation of a class of employees (e.g., all employees assigned to a particular department) or individual employees. Although some commenters have asked for guidance, we have intentionally left the process flexible to accommodate different organizational structures. Plan sponsors may identify who will have access to protected health information in whatever way best reflects their business needs as long as participants can reasonably identify who will have access. For example, persons may be identified by naming individuals, job titles (e.g. Director of Human Resources), functions (e.g."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 280}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 140)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nequest that a covered entity agree not to disclose protected health information to persons assisting with the individual's care, even if such disclosure is permissible in accordance with § 164.510(b).\nFor example, if an individual requests that a covered entity never disclose protected health information to a particular family member, and the covered entity agrees to that restriction, the covered entity is prohibited from disclosing protected health information to that family member, even if the disclosure would otherwise be permissible under §164.510(b). We note that individuals additionally have the opportunity to agree or object to disclosures to persons assisting in the individual's care under §164.510(b)(2). The individual retains the right to agree or object to such disclosures under § 164.510(b)(2), in accordance with the standards of that provision, regardless of whether the individual has requested a restriction under §164.522(a). See § 164.510(b) and the corresponding preamble discussion regarding the individual's right to agree or object to disclosures to persons assisting in the individual's care. In §§ 164.522(a)(1)(iii) and (iv) we clarify the requirements with respect to emergency treatment situations. In emergency treatment situations, a covered entity that has agreed to a restriction may use, or disclose to a health care provider, restricted protected health information that is\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nnecessary to provide the emergency treatment. If the covered entity discloses restricted protected health information to a health care provider for emergency treatment purposes, it must request that the provider not further use or disclose the information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 139}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 537)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\novision of electronic notice by the covered entity will satisfy the provision requirements of paragraph (c) of this section when timely made in accordance with paragraph (c)(1) or (2) of this section.\n(iii) For purposes of paragraph (c)(2)(i) of this section, if the first service delivery to an individual is delivered electronically, the covered health care provider must provide electronic notice automatically and contemporaneously in response to the individual's first request for service. (iv) The individual who is the recipient of electronic notice retains the right to obtain a paper copy of the notice from a covered entity upon request. (d) Implementation specifications: Joint notice by separate covered entities. Covered entities that participate in organized health care arrangements may comply with this section by a joint notice, provided that:\n\n(1) The covered entities participating in the organized health care arrangement agree to abide by the terms of the notice with respect to protected health information created or received by the covered entity as part of its participation in the organized health care arrangement;\n\n(2) The joint notice meets the implementation specifications in paragraph (b) of this section, except that the statements required by this section may be altered to reflect the fact that the notice covers more than one covered entity; and\n\n(i) Describes with reasonable specificity the covered entities, or class of entities, to which the joint notice applies;\n\n(ii) Describes with reasonable specificity the service delivery sites, or classes of service delivery sites, to which the joint notice applies; and\n\n(iii) If applicable, states that the covered entities participating in the organized health care arrangement will share protected health information with each other, as necessary to carry out treatment, payment, or health care operations relating to the organized health care arrangement."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 536}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement administrative controls?"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n## Postmarket Management of Cybersecurity in Medical Devices\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on December 28, 2016. The draft of this document was issued on January 22, 2016. For questions regarding this document, contact Suzanne Schwartz, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5434, Silver Spring, MD 20993-0002, 301-796-6937. For questions regarding this document as applied to devices regulated by CBER, contact the Office of Communication, Outreach and Development in CBER at 1-800-835-4709 or 240-402-8010 or ocod@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of the Center Director\n\nCenter for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to http://www.regulations.gov . Submit written comments to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2015-D-5105. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an e-mail request to CDRH-Guidance@fda.hhs.gov to receive an electronic copy of the guidance. Please use the document number 1400044 to identify the guidance you are requesting. ## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), by written request, Office of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., Bldg."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_type": "administrative", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 56)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nKey activities, descriptions, and sample questions for the Access Control standard | Key Activities | Description | Sample Questions | |-----------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 1."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 55}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 111)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n---------------------------------------------------|--------------------------------------------------------|\n| 164.510(b)(2)(iii) .................. | ''based the exercise of professional Judgment''.\n| Insert ''on'' after ''based'' ................. | Correct typographical error. |\n| 164.512(b)(1) ...................... | ''Permitted disclosures'' and ''may disclose''. | Insert ''uses and'' and ''use or'' be- fore ''disclosures'' and ''disclose,'' respectively. | Correct inadvertent omission. |\n| 164.512(e)(1)(iii) .................. | ''seeking protecting health informa- tion''. | Change ''protecting'' to ''protected''                                                                             | Correct typographical error. |\n| 164.512(e)(1)(vi) .................. 164.512(k)(3) ....................... | ''paragraph (e)(1)(iv) of this section'' ''authorized by 18 U.S.C. 3056, or to foreign heads of state, or to for the conduct of investigations''. | Change ''(e)(1)(iv)'' to ''(e)(1)(v)'' ..... Remove the comma after ''U.S.C. 3056'' and the ''to'' before ''for''. | Correct cross-reference. Correct typographical errors. |\n\nIn addition to the above technical changes, we proposed to make a few clarifications to existing text in various provisions of the regulation not otherwise addressed in the above preamble. These are as follows. 1. Section 164.506(c)(5) permits a covered entity to disclose protected health information ''to another covered entity that participates in the organized health care arrangement.'' We proposed to change the words ''another covered entity that participates'' to ''other participants'' because not all participants in an organized health care arrangement may be covered entities; for example, some physicians with staff privileges at a hospital may not be covered entities. 2. Section 164.510(a)(1)(ii) permits the disclosure of directory information to members of the clergy and other persons who ask for the individual by name."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 110}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 339)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nmay have stemmed from the inclusion of the phrase ''other distinguishing characteristic''-which could be construed broadly-in the list of items that could have been disclosed pursuant to this section.\nIn the final rule, we delete the phrase ''other distinguishing characteristic'' from the list of items that can be disclosed pursuant to §164.512(f)(2). In its place, we allow disclosure of a description of distinguishing physical characteristics, such as scars, tattoos, height, weight, gender, race, hair and eye color, and the presence or absence of facial hair such as a beard or moustache. We believe that such a change, in addition to the changes described in the paragraph above, responds to commenters' concern that the NPRM would have allowed creation of a government data base of personal identifying information. Further, this modification provides additional guidance to covered entities regarding the type of information that may be disclosed under this provision. Comment: At least one commenter recommended removing social security numbers (SSNs) from the list of items that may be disclosed pursuant to proposed §164.510(f)(2). The commenter was concerned that including SSNs in the (f)(2) list would cause law enforcement agencies to demand that providers collect SSNs. In addition, the commenter was concerned that allowing disclosure of SSNs could lead to theft of identity by unscrupulous persons in policy departments and health care organizations. Response: We disagree. We believe that on balance, the potential benefits from use of SSNs for this purpose outweigh the potential privacy intrusion\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00225\n\nfrom such use of SSNs. For example, SSNs can help law enforcement officials identify suspects are using aliases."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 338}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.502(e)(2) require?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n§164.502(e)(2) must meet the requirements of paragraph (e)(2) or (e)(3) of this section, as applicable.\n\n(ii) A covered entity is not in compliance with the standards in "}], "metadata": {"source": "privacy_rule_2000", "cfr_section": "§164.502(e)(2)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance?"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRIN 0991-AB14\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY: Office for Civil Rights, HHS. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (''HHS'' or ''Department'') modifies certain standards in the Rule entitled ''Standards for Privacy of Individually Identifiable Health Information'' (''Privacy Rule''). The Privacy Rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996. The purpose of these modifications is to maintain strong protections for the privacy of individually identifiable health information while clarifying certain of the Privacy Rule's provisions, addressing the unintended negative effects of the Privacy Rule on health care quality or access to health care, and relieving unintended administrative burdens created by the Privacy Rule. DATES: This final rule is effective on October 15, 2002. FOR FURTHER INFORMATION CONTACT: Felicia Farmer, 1-866-OCR-PRIV (1866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION:\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 (or toll-free at 1-866-5121800) or by fax to (202) 512-2250. The cost for each copy is $10.00."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 0}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 38)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ners to designate themselves as either a hybrid or affiliated entity, since the components of each must belong to a single legal entity or share common ownership or\n\nVerDate Aug&lt;2,&gt;2002\n\ncontrol.\nThese commenters also explained that a typical medical school would not appear to qualify as an organized health care arrangement (OHCA) because it does not engage in any of the requisite joint activities, for example, quality assessment and improvement activities, on behalf of the covered entity. It was stated that it is essential that there not be impediments to the flow of information within an academic medical center. These commenters, therefore, urged that the Department add a definition of ''academic medical center'' to the Privacy Rule and modify the definition of ''common control'' to explicitly apply to the components of an academic medical center, so as to ensure that academic medical centers qualify as affiliated entities for purposes of the Rule. Response: The Department does not believe that a modification to include a special rule for academic medical centers is warranted. The Privacy Rule's organizational requirements at § 164.504 for hybrid entities and affiliated entities, as well as the definition of ''organized health care arrangement'' in § 164.501, provide covered entities with much flexibility to apply the Rule's requirements as best suited to the structure of their businesses. However, in order to maintain privacy protections, the Privacy Rule places appropriate conditions on who may qualify for such organizational options, as well as how information may flow within such constructs."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 37}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 261)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nirectors need to be aware of the presence of a contagious or infectious disease in order to properly advise family members of funeral and disposition options and how they may be affected by state law.\nFor example, certain states may prohibit cremation of remains for a certain period unless the death was caused by a contagious or infectious disease, or prohibit family members from assisting in preparing the body for disposition if there is a risk of transmitting a communicable disease from the corpse. Response: We agree that disclosures to funeral directors for the above purposes should be allowed. Accordingly, the final rule at §164.512(g)(2) permits covered entities to disclose protected health information to funeral directors, consistent with applicable law, as necessary to carry out their duties with respect to the decedent. Such disclosures are also permitted prior to, and in reasonable anticipation of, the individual's death. Comment: Several commenters urged that the proposed standard for deceased individuals be clarified to allow access by a family member who has demonstrated a legitimate health-related reason for seeking the information when there is no executor, administrator, or other person authorized under applicable law to exercise the right of access of the individual. Another commenter asked that the rule differentiate between blood relatives and family members and address their different access concerns, such as with genetic information versus information about transmittable diseases. They also recommended that the regulation allow access to protected health information by blood-related\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nrelatives prior to the end of the two-year period and provide them with the authority to extend the proposed twoyear period of protection if they see fit."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 260}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 255)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncommenter pointed to the legislative history to argue that ''use'' is related to an information exchange outside of the entity. Response: We disagree with the commenter regarding the Congress' intent.\nSection 264 of HIPAA requires that the Secretary develop and send to Congress recommendations on standards with respect to the privacy of individually identifiable health information (which she did on September 11, 1997) and prescribes that the recommendations address among other items ''the uses and disclosures of such information that should be authorized or required.'' Section 264 explicitly requires the Secretary to promulgate standards that address at least the subjects described in these recommendations. It is therefore our interpretation that Congress intended to cover ''uses'' as well as disclosures of individually identifiable health information. We find nothing in the legislative history to indicate that Congress intended to deviate from the common meaning of the term ''use.''\n\nComment: One commenter observed that the definition could encompass the processing of data by computers to execute queries. It was argued that this would be highly problematic because computers are routinely used to identify subsets of data sets. It was explained that in performing this function, computers examine each record in the data set and return only those records in the data set that meet specific criteria. Consequently, a human being will see only the subset of data that the computer returns. Thus, the commenter stated that it is only this subset that could be used or disclosed. Response: We interpret ''use'' to mean only the uses of the product of the computer processing, not the internal computer processing that generates the product. Comments: Some commenters asked that the Department clarify that individualized medical information obtained through a fitness for duty examination is not subject to the privacy protections under the regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 254}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 83)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nessary standard to appropriately limit the amount of protected health information that may be used or disclosed for fundraising purposes; or (3) whether the current limitation should remain unchanged.\nWe also solicited comment on whether, if additional information is permitted to be used or disclosed for fundraising absent an authorization, covered entities should be required to provide individuals with an opportunity to opt out of receiving any fundraising communications before making the first fundraising solicitation, in addition to the opportunity to opt out with every subsequent communication. We invited public comment on whether such a presolicitation opt out would be workable for covered entities and individuals and what mechanisms could be put into place to implement the requirement. ## Overview of Public Comments\n\nIn general, the public comments received in response to the NPRM were supportive of the proposed modifications but many asked that the final rule give covered entities flexibility with respect to operationalizing these requirements. Several commenters provided examples of routine communications and expressed the need for guidance and clarification about what constitutes a fundraising communication. Generally, most commenters supported the NPRM's proposed requirement that the method through which the covered entity permits individuals to opt out of receiving future fundraising communications not cause individuals to incur an undue burden or more than a nominal cost. Many commenters stated that the final rule should give covered entities the flexibility to determine which opt out\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with methods will work best given their circumstances, instead of requiring all covered entities to employ specific opt out methods."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 82}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 95)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nanced electronic and automated systems may allow providers to notify other providers downstream of a restriction, but these commenters stressed that such systems are not widely available at this time.\nWith respect to the requirement's application to health care providers providing care within an HMO context, many commenters expressed support for the suggestion that HMO patients would have to use an out-of-network provider for treatment to ensure that the restricted information would not be\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00063\n\ndisclosed to the HMO. Some commenters indicated that State laws and/or provider contracts with an HMO may prohibit the provider from receiving a cash payment from an HMO patient above the patient's cost-sharing amount for the health care item or service. Conversely, some commenters stated that individuals should not have to go out-of-network when requesting a restriction and instead, providers could and should treat the services as noncovered services and accept payment directly from the patient. Several commenters also suggested that managed care contracts would have to be revised or renegotiated in order to comply with this provision and as such, ample time for renegotiation should be provided. Commenters generally supported the language in the proposed rule making clear that a restriction would apply where an individual requests a restriction, but someone other than the individual (other than the health plan), such as a family member, pays for the individual's care on behalf of the individual. One commenter asked for clarification that payment by any health plan would not constitute payment out of pocket by the individual."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 94}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 453)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhealth plan; and remittance advice and payment claim status), except privacy. At the time the Transactions Rule was developed, the industry provided estimates for the systems changes in the aggregate.\nThe industry argued that affected parties would seek to make all electronic changes in one effort because that approach would be the most cost-efficient. The Department agreed, and therefore, it ''bundled'' all the system change cost in the Transactions Rule estimate. Privacy was not included because at the time the Department had not made a decision to develop a privacy rule. As the Department develops other HIPAA administrative simplification standards, there may be additional costs and savings due to the nonelectronic components of those regulations, and they will be identified in regulatory impact analyses that accompany those regulations. The Department anticipates that such costs and savings will be relatively small compared to the privacy and Transactions rules. The Department anticipates that the net economic impact of the rules will be a net savings to the health care system. 37 Health spending projections from National Health Expenditure Projections 1998-2008 (January 2000), Health Care Financing Administration, Office of the Actuary, &lt;http://hcfa.hhs.gov/stats/ nhe-proj/&gt;."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 452}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 62)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncovered entity for whistleblower disclosures. ## Disclosures by Workforce Members Who Are Crime Victims\n\nThe proposed rule did not address disclosures by workforce members who are victims of a crime.\nIn the final rule, we clarify that a covered entity is not in violation of the rule when a workforce member of a covered entity who is the victim of a crime discloses protected health information to law enforcement officials about the suspected perpetrator of the crime. We limit the amount of protected health information that may be disclosed to the limited information for identification and location described in § 164.512(f)(2). We note that this provision is similar to the provision in § 164.512(f)(5), which permits a covered entity to disclose protected health information to law enforcement that the covered entity believes in good faith constitutes evidence of criminal conduct that occurred on the premises of the covered entity. This provision differs in that it permits the disclosure even if the crime occurred somewhere other than on the premises of the covered entity. For example, if a hospital employee is the victim of an attack outside of the hospital, but spots the perpetrator sometime later when the perpetrator seeks medical care at the hospital, the workforce member who was attacked may notify law enforcement of the perpetrator's location and other identifying information. We do not permit, however, the disclosure of protected health information other than that described in § 164.512(f)(2). ## Section 164.504-Uses and Disclosures-Organizational Requirements-Component Entities, Affiliated Entities, Business Associates and Group Health Plans\n\n## Section 164.504(a)-(c)-Health Care Component (Component Entities)\n\nIn the preamble to the proposed rule we introduced the concept of a ''component entity'' to differentiate the health care unit of a larger organization from the larger organization."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 61}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement physical controls?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\n## RIN 0945-AA03\n\nModifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (HHS or ''the Department'') is issuing this final rule to: Modify the Health Insurance Portability and Accountability Act (HIPAA) Privacy, Security, and Enforcement Rules to implement statutory amendments under the Health Information Technology for Economic and Clinical Health Act (''the HITECH Act'' or ''the Act'') to strengthen the privacy and security protection for individuals' health information; modify the rule for Breach Notification for Unsecured Protected Health Information (Breach Notification Rule) under the HITECH Act to address public comment received on the interim final rule; modify the HIPAA Privacy Rule to strengthen the privacy protections for genetic information by implementing section 105 of Title I of the Genetic Information Nondiscrimination Act of 2008 (GINA); and make certain other modifications to the HIPAA Privacy, Security, Breach Notification, and Enforcement Rules (the HIPAA Rules) to improve their workability and effectiveness and to increase flexibility for and decrease burden on the regulated entities. DATES: Effective date: This final rule is effective on March 26, 2013. Compliance date: Covered entities and business associates must comply with the applicable requirements of this final rule by September 23, 2013. FOR FURTHER INFORMATION CONTACT: Andra Wicks 202-205-2292. SUPPLEMENTARY INFORMATION:\n\nVerDate Mar&lt;15&gt;2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n## I."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_type": "physical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 62)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nirements                                                          | • Establish a formal written set of integrity requirements based on the results of the analysis completed in Key Activities 1 and 2.\n| • Have the requirements been discussed and agreed to by identified key personnel involved in the processes that are affected? • Have the requirements been documented? • Has a written policy been developed and communicated to personnel? |\n\n127 See Sec. 5.1.3, HIPAA Standard: Workforce Security ; Sec. 5.3.1, HIPAA Standard: Access Control ; and Sec. 5.5.1, HIPAA Standard: Policies and Procedures. 128 See Sec. 5.1.3, HIPAA Standard: Workforce Security , and Sec. 5.3.1, HIPAA Standard: Access Control. 129 See Sec. 5.1.3, HIPAA Standard: Workforce Security. 130  See Sec. 5.1.5, HIPAA Standard: Security Awareness and Training. 131 See Sec. 5.3.2, HIPAA Standard: Audit Controls. 132 See Sec. 5.1.1, HIPAA Standard: Security Management Process. 133 See Sec. 5.1.1, HIPAA Standard: Security Management Process. 134 See Sec. 5.1.1, HIPAA Standard: Security Management Process. 135 See Sec. 5.1.1, HIPAA Standard: Security Management Process , and Sec. 5.3.5, HIPAA Standard: Transmission Security."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 61}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 305)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ncomplying with the law based on their interpretation, family members and clergy had difficulty locating patients in the hospital.\nResponse: We share commenters' concern about the need to ensure that family members and clergy who have a legitimate need to locate patients are not prevented from doing so by excessively stringent restrictions on disclosure of protected health information to health care facilities' directories. Accordingly, the final rule takes an opt-out approach, stating that health care institutions may include the name, general condition, religious affiliation, and location of a patient within the facility in the facility's directory unless the patient explicitly objects to the use or disclosure of protected health information for directory purposes. To ensure that this opt-out can be exercised, the final rule requires facilities to notify individuals of their right not to be included in the directory and to give them the opportunity to opt out. The final rule indicates that the notice and opt-out may be oral. The final rule that allows health care facilities to disclose to clergy the four types of protected health information specified above without requiring the clergy to ask for the individual by name will allow the clergy to identify the members of his or her faith who are in the facility, thus ensuring that this rule will not significantly interfere with the exercise of religion, including the clergy's traditional religious mission to provide services to individuals. Comment: A small number of commenters recommended requiring written authorization for all disclosures of protected health information for directory purposes."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 304}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 42)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n| Key Activities | Description | Sample Questions | |---------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | • Is the frequency of backups appropriate for the environment?"}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 41}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 21)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\negard to the commenters' specific example, disclosure of protected health information in a group therapy setting would be a treatment disclosure, and thus permissible without individual authorization.\nFurther, § 164.510(b) generally permits a covered entity to disclose protected health information to a family member or other person involved in the individual's care. In fact, this section specifically provides that, where the individual is present during a disclosure, the covered entity may disclose protected health information if it is reasonable to infer from the circumstances that the individual does not object to the disclosure. Absent countervailing circumstances, the individual's agreement to participate in group therapy or family discussions is a good basis for such a reasonable inference. As such disclosures are permissible disclosures in and of themselves, they would not be incidental disclosures. Comment: Some commenters, while in support of permitting incidental uses and disclosures, requested that the Department provide additional guidance in this area by providing additional examples of permitted incidental uses and disclosures and/or clarifying what would constitute ''reasonable safeguards.''\n\nResponse: The reasonable safeguards and minimum necessary standards are flexible and adaptable to the specific business needs and circumstances of the covered entity. Given the discretion covered entities have in implementing these standards, it is difficult for the Department to provide specific guidance in this area that is generally applicable to many covered entities. However, the Department intends to provide future guidance through frequently asked questions or other materials in response to specific scenarios that are raised by industry. ## 2. Minimum Necessary Standard\n\nDecember 2000 Privacy Rule."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 20}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 132)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nan. *\n\n*\n\n*\n\n*\n\n*\n\n7. Revise § 164.506 to read as follows:\n\n## §164.506 Uses and disclosures to carry out treatment, payment, or health care operations. - (a) Standard: Permitted uses and disclosures.\nExcept with respect to uses or disclosures that require an authorization under § 164.508(a)(2) and (3), a covered entity may use or disclose protected health information for treatment, payment, or health care operations as set forth in paragraph (c) of this section, provided that such use or disclosure is consistent with other applicable requirements of this subpart. - (b) Standard: Consent for uses and disclosures permitted. (1) A covered entity may obtain consent of the individual to use or disclose protected health information to carry out treatment, payment, or health care operations. - (2) Consent, under paragraph (b) of this section, shall not be effective to permit a use or disclosure of protected health information when an authorization, under § 164.508, is required or when another condition must be met for such use or disclosure to be permissible under this subpart. - (c) Implementation specifications: Treatment, payment, or health care operations. - (1) A covered entity may use or disclose protected health information for its own treatment, payment, or health care operations. - (2) A covered entity may disclose protected health information for treatment activities of a health care provider. - (3) A covered entity may disclose protected health information to another covered entity or a health care provider for the payment activities of the entity that receives the information."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 131}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 59)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n| Key Activities | Description | Sample Questions | |-----------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Implementation Specifications (Both Addressable) | o Implement electronic procedures that terminate an electronic session after a predetermined period of inactivity."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 58}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 154)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nit. For example, a dental plan may provide information to all of its enrollees about how to take advantage of\n\n20 See 74 FR 51669, footnote 12. 21 See Q14 at http://www.dol.gov/ebsa/faqs/faqGINA.html.\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with such a benefit, and when an enrollee contacts the plan about obtaining the benefit, may require the individual to take and provide the results of a genetic test to determine the medical appropriateness of providing the supplemental benefit to the individual. ## b. Definition of ''Health Care Operations''\n\n## Proposed Rule\n\nThe definition of ''health care operations'' at § 164.501 includes at paragraph (3) ''underwriting, premium rating, and other activities relating to the creation, renewal or replacement of a contract of health insurance or benefits * * *.'' To avoid confusion with the use of both ''underwriting'' and ''underwriting purposes'' in the Privacy Rule, and in recognition of the fact that the proposed definition of ''underwriting purposes'' includes activities that fall within both the definitions of ''payment'' and ''health care operations'' in the Rule, the Department proposed to remove the term ''underwriting'' from the definition of ''health care operations.'' We also proposed to add the term ''enrollment'' to the express list of health care operations activities to make clear that the removal of the term ''underwriting'' would not impact the use or disclosure of protected health information that is not genetic information for enrollment purposes. These proposed revisions were not intended to be substantive changes to the definition and thus, health plans would be permitted to continue to use or disclose protected health information, except genetic information, for underwriting purposes."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 153}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 367)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nDec 27, 2000\n\nproposed provision would apply in rare circumstances. We clarify, however, that we did not intend for the proposed provision to apply to emergency treatment scenarios as discussed below.\nIn the final rule, to avoid confusion over the circumstances in which we intend this section to apply, we retitle it ''Uses and Disclosures to Avert a Serious Threat to Health or Safety.''\n\nWe do not believe it would be appropriate to narrow further the scope of permissible disclosures under this section to respond to specifically identified ''imminent threats,'' a ''public health emergency,'' or a ''national emergency.'' We believe it would be impossible to enumerate all of the scenarios that may warrant disclosure of protected health information pursuant to this section. Such cases may involve a small number of people and may not necessarily involve a public health emergency or a national emergency. Furthermore, in response to comments arguing that the proposed provision was too broad, we note that under both the NPRM and the final rule, we allow but do not require disclosures in situations involving serious and imminent threats to health or safety. Health plans and covered health care providers may make the disclosures allowed under § 164.512(j) consistent with applicable law and standards of ethical conduct. As indicated in the preamble to the NPRM, the proposed approach is consistent with statutory and case law addressing this issue. The most wellknown case on the topic is Tarasoff v. Regents of the University of California, 17 Cal. 3d 425 (1976), which established a duty to warn those at risk of harm when a therapist's patient made credible threats against the physical safety of a specific person. The Supreme Court of California found that the therapist involved in the case had an obligation to use reasonable care to protect the intended victim of his patient against danger, including warning the victim of the peril."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 366}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 77)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nted that the Department modify the Rule's definition of ''research'' or the provision for preparatory research to explicitly permit the building and maintenance of research databases and repositories.\nThe commenter further asserted that, under the Common Rule, ''research'' signifies an actual research protocol, and would not include a data or tissue compilation that is undertaken to facilitate future protocols. Therefore, since the Privacy Rule and the Common Rule have the same definition of ''research,'' this commenter was concerned that the Privacy Rule would not permit a preresearch practice in which a covered entity compiles protected health information in a systematic way to either assist researchers in their reviews that are preparatory to research, or to conduct future research. Response: The Department does not believe such a modification is necessary. Under the Common Rule, the Office for Human Research Protections (OHRP) has interpreted the definition of ''research'' to include the development of a repository or database for future research purposes. In fact, OHRP has issued guidance on this issue, which can be found at the following URL: http://ohrp.osophs.dhhs.gov/ humansubjects/guidance/reposit.htm. The Department interprets the definition of ''research'' in the Privacy Rule to be consistent with what is considered research under the Common Rule. Thus, the development of research repositories and databases for future research are considered research for the purposes of the Privacy Rule. Comment: A commenter suggested eliminating the minimum necessary requirement for uses and disclosures made pursuant to a waiver of authorization by an IRB or Privacy\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\nBoard."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 76}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 387)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nf identifiable health information will provide an incentive to encourage its use where appropriate. Comment: Several commenters argued that standard transactions should not be subject to the standard.\nResponse: We agree that data elements that are required or situationally required in the standard transactions should not be, and are not, subject to this standard. However, in many cases, covered entities have significant discretion as to the information included in these transactions. Therefore, this standard does apply to those optional data elements. Comment: Some commenters asked for clarification to understand how the minimum necessary standard is intended to interact with the security NPRM. Response: The proposed Security Rule included requirements for electronic health information systems to include access management controls. Under this regulation, the covered entity's privacy policies will determine who has access to what protected health information. We will make every effort to ensure consistency prior to publishing the final Security Rule. Comment: Many commenters, representing health care providers, argued that if the request was being made by a health plan, the health plan should be required to request only the minimum protected health information necessary. Some of these commenters stated that the requestor is in a better position to know the minimum amount of information needed for their purposes. Some of these commenters argued that the minimum necessary standard should be imposed only on the requesting entity. A few of these commenters argued that both the disclosing and the requesting entity should be subject to the minimum necessary standard, to create ''internal tension'' to assure the standard is honored. Response: We agree, and in the final rule we require that a request for protected health information made by one covered entity to another covered entity must be limited to the minimum amount necessary for the purpose."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 386}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 296)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nPO 00000\n\nFrm 00196\n\ncommenters argued that the research records held by researchers who are performing clinical trials and who keep separate research records should not be subject to the final rule.\nThese commenters strongly disagreed that a health provider-researcher cannot carry out two distinct functions while performing research and providing clinical care to research subjects and, thus, asserted that research information unrelated to treatment that is kept separate from the medical record, would not be covered by the privacy rule. Response: We do not agree the Secretary lacks the authority to adopt standards relating to research information, including research information unrelated to treatment. HIPAA provides authority for the Secretary to set standards for the use and disclosure of individually identifiable health information created or received by covered entities. For the reasons commenters identified for why it was not practical or feasible to divide research information into two categories-research information related to treatment and research information unrelated to treatment-we also determined that for a single research study that includes the treatment of research subjects, it is not practical or feasible to divide a researcher into two categories-a researcher who provides treatment and a researcher who does not provide treatment to research subjects. When a researcher is interacting with research subjects for a research study that involves the delivery of health care to subjects, it is not always clear to either the researcher or the research subject whether a particular research activity will generate research information that will be pertinent to the health care of the research subject."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 295}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 506)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n(i) Management activities relating to implementation of and compliance with the requirements of this subchapter;\n7. (ii) Customer service, including the provision of data analyses for policy holders, plan sponsors, or other customers, provided that protected health information is not disclosed to such policy holder, plan sponsor, or customer. (iii) Resolution of internal grievances;\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\n- (iv) Due diligence in connection with the sale or transfer of assets to a potential successor in interest, if the potential successor in interest is a covered entity or, following completion of the sale or transfer, will become a covered entity; and\n- (v) Consistent with the applicable requirements of § 164.514, creating deidentified health information, fundraising for the benefit of the covered entity, and marketing for which an individual authorization is not required as described in § 164.514(e)(2). Health oversight agency means an agency or authority of the United States, a State, a territory, a political subdivision of a State or territory, or an Indian tribe, or a person or entity acting under a grant of authority from or contract with such public agency, including the employees or agents of such public agency or its contractors or persons or entities to whom it has granted authority, that is authorized by law to oversee the health care system (whether public or private) or government programs in which health information is necessary to determine eligibility or compliance, or to enforce civil rights laws for which health information is relevant."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 505}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 25)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nfore a combination of two components: (1) the hardware controller, and (2) the 'user-programmable memory,' or programmable logic, that instructs the hardware controller to execute specified functions.\nNIST defines software as, among other things, 'computer programs and data stored in hardware - typically in read only memory or programmable read-only memory.' Programmable logic is therefore a specific type of computer program and/or data stored on hardware, and is thus a type of software. See the NIST Computer Security Resource Center Glossary for more information on NIST's definitions of these terms. 57 For the purposes of this guidance, 'threat surface' means the set of points on the boundary of a system, a system element, or an environment where a cyber threat can try to enter, cause an effect on, or extract data from, that system, system element, or environment (definition is adapted from the NIST Computer Security Resource Center Glossary). For the purposes of this guidance 'threat surface' is synonymous with the term 'attack surface,' however, FDA uses the term 'threat surface' rather than 'attack surface,' because cyber threats need not necessarily be an 'attack' to pose a risk to a medical device and its related system. ## Contains Nonbinding Recommendations\n\nconnect to the Internet, it is possible that it can be connected to the Internet, regardless of whether such connectivity was intended by the device sponsor. 58\n\nFDA considers devices that include any of the following features to have the ability to connect to the internet. The list below is illustrative, not exhaustive:\n\n- Network, server, or Cloud Service Provider connections;\n- Radio-frequency communications (e.g., Wi-Fi, cellular, Bluetooth, Bluetooth Low Energy);\n- Magnetic inductive communications; 59 and\n- Hardware connectors capable of connecting to the internet (e.g., USB, ethernet, serial port). 60\n\n## C."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 24}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 73)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nEM, Perlner RA, Regenscheid AR, Fenton JL, Burr WE, Richer JP, Lefkovitz NB, Danker JM, Choong Y-Y, Greene KK, Theofanos MF (2017) Digital Identity Guidelines: Authentication and Lifecycle Management.\n(National Institute of Standards and Technology, Gaithersburg, MD), NIST Special Publication (SP) 800-63B, Includes updates as of March 02, 2020. ## https://doi.org/10.6028/NIST.SP.800-63B\n\n- [SP\\_800-88] Kissel RL, Regenscheid AR, Scholl MA, Stine KM (2014) Guidelines for Media Sanitization. (National Institute of Standards and Technology, Gaithersburg, MD), NIST Special Publication (SP) 800-88, Rev. 1. ## https://doi.org/10.6028/NIST.SP.800-88r1\n\n- [SP\\_800-171]  Ross RS, Pillitteri VY, Dempsey KL, Riddle M, Guissanie G (2020) Protecting Controlled Unclassified Information in Nonfederal Systems and Organizations. (National Institute of Standards and Technology, Gaithersburg, MD), NIST Special Publication (SP) 800-171, Rev. 2, Includes updates as of January 28, 2021. https://doi.org/10.6028/NIST.SP.800-171r2\n\n## NIST Interagency or Internal Reports (NIST IRs)\n\n| [IR_8286]   | Stine KM, Quinn SD, Witte GA, Gardner RK (2020) Integrating Cybersecurity and Enterprise Risk Management (ERM). (National Institute of Standards and Technology, Gaithersburg, MD), NIST Interagency or Internal Report (IR) 8286. https://doi.org/10.6028/NIST.IR.8286   |\n|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|\n| [IR_8286A]  | Quinn SD, Ivy N, Barrett MP, Feldman L, Witte GA, Gardner RK (2021) Identifying and Estimating Cybersecurity Risk for Enterprise Risk Management."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 72}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 377)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrisk of disclosure increases as the number of variables common to both types of records increases, as the accuracy or resolution of the data increases, and as the number of external sources increases.\nAs outlined in Statistical Policy Working Paper 22, an expert disclosure analysis would also consider the probability that an individual who is the target of an attempt at reidentification is represented on both\n\n16 Confidentiality and Data Access Committee, Federal Committee on Statistical Methodology, Office of Management and Budget. Fmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nfiles, the probability that the matching variables are recorded identically on the two types of records, the probability that the target individual is unique in the population for the matching variables, and the degree of confidence that a match would correctly identify a unique person. Statistical Policy Working Paper 22 also describes many techniques that can be used to reduce the risk of disclosure that should be considered by an expert when de-identifying health information. In addition to removing all direct identifiers, these include the obvious choices based on the above causes of the risk; namely, reducing the number of variables on which a match might be made and limiting the distribution of the records through a ''data use agreement'' or ''restricted access agreement'' in which the recipient agrees to limits on who can use/receive the data."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 376}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 530)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nosures are permitted for Armed Forces personnel under the notice published in the Federal Register pursuant to paragraph (k)(1)(i) of this section. - (2) National security and intelligence activities.\nA covered entity may disclose protected health information to authorized federal officials for the conduct of lawful intelligence, counterintelligence, and other national security activities authorized by the National Security Act (50 U.S.C. 401, et seq. ) and implementing authority ( e.g., Executive Order 12333). - (3) Protective services for the President and others. A covered entity may disclose protected health\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ninformation to authorized federal officials for the provision of protective services to the President or other persons authorized by 18 U.S.C. 3056, or to foreign heads of state or other persons authorized by 22 U.S.C. 2709(a)(3), or to for the conduct of investigations authorized by 18 U.S.C. 871 and 879. (4) Medical suitability determinations. A covered entity that is a component of the Department of State may use protected health information to make medical suitability determinations and may disclose whether or not the individual was determined to be medically suitable to the officials in the Department of State who need access to such information for the following purposes:\n\n(i) For the purpose of a required security clearance conducted pursuant to Executive Orders 10450 and 12698;\n\n(ii) As necessary to determine worldwide availability or availability for mandatory service abroad under sections 101(a)(4) and 504 of the Foreign Service Act; or\n\n(iii) For a family to accompany a Foreign Service member abroad, consistent with section 101(b)(5) and 904 of the Foreign Service Act. (5) Correctional institutions and other law enforcement custodial situations. (i) Permitted disclosures."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 529}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 408)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ned to abuse. We also include a new § 164.512(c) which recognizes the unique circumstances surrounding disclosure of protected health information about victims of abuse, neglect, and domestic violence.\n## Section 164.522(b)-Confidential Communications Requirements\n\nComment: Several commenters requested that we add a new section to prevent disclosure of sensitive health care services to members of the patient's family through communications to the individual's home, such as appointment notices, confirmation or scheduling of appointments, or mailing a bill or explanation of benefits, by requiring covered entities to agree to correspond with the patient in another way. Some commenters stated that this is necessary in order to protect inadvertent disclosure of sensitive information and to protect victims of domestic violence from disclosure to an abuser. A few commenters suggested that a covered entity should be required to obtain an individual's authorization prior to communicating with the individual at the individual's home with respect to health care relating to sensitive subjects such as reproductive health, sexually transmissible diseases, substance abuse or mental health. Response: We agree with commenters' concerns regarding covered entities' communications with individuals. We created a new provision, § 164.522(b), to address confidential communications by covered entities. This provision gives individuals the right to request that they receive communications from covered entities at an alternative address or by an alternative means, regardless of the nature of the protected health information involved. Covered providers are required to accommodate reasonable requests by individuals and may not require the individual to explain the basis for the request as a condition of accommodation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 407}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 69)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nn control, Common ownership, Health care component, and Hybrid entity. - b. Paragraphs (b) through (d) are removed and reserved. Authority: Sections 1173 and 1175 of the Social Security Act (42 U.S.C.\n1329d-2 and 1320-4). Dated: January 13, 2003. ## Tommy G. Thompson,\n\nSecretary. [FR Doc. 03-3877 Filed 2-13-03; 8:45 am]\n\nBILLING CODE 4120-01-P\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Part 162 [CMS-0003-F and CMS-0005-F] RINs 0938-AK64 and 0938-AK76\n\n## Health Insurance Reform: Modifications to Electronic Data Transaction Standards and Code Sets\n\nAGENCY: Office of the Secretary, HHS. ACTION: Final rule. SUMMARY: In this final rule, we respond to public comments received and finalize provisions applicable to electronic data transaction standards from two related proposed rules published in the May 31, 2002, Federal Register. We are also adopting proposed modifications to implementation specifications for health care entities and others. In addition, we are adopting modifications to implementation specifications for several electronic transaction standards that were omitted from the May 31, 2002, proposed rules. EFFECTIVE DATES: These regulations are effective on March 24, 2003. The incorporation by reference of certain publications listed in this final rule is\n\nVerDate Jan&lt;31&gt;2003\n\napproved by the Director of the Federal Register as of March 24, 2003. FOR FURTHER INFORMATION CONTACT: Gladys Wheeler, (410) 786-0273. ## SUPPLEMENTARY INFORMATION:\n\nAvailability of Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 152507954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 68}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 81)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\niff) network traffic over a continuous period of time within internal organizational information systems or networks. |\n| Insert malicious scanning devices (e.g., wireless sniffers) inside facilities.\n| Adversary uses the postal service or other commercial delivery services to deliver a device to organizational mailrooms that is able to scan wireless communications accessible from within the mailrooms and then wirelessly transmit information back to adversary. |\n| Insert subverted individuals into organizations. | Adversary places individuals within organizations who are willing and able to carry out actions to cause harm to organizational mission or business functions. |\n| Insert subverted individuals into privileged positions in organizations. | Adversary places individuals in privileged positions within organizations who are willing and able to carry out actions to cause harm to organizational mission or business functions. Adversary may target privileged functions to gain access to sensitive information (e.g., user accounts, system files) and may leverage access to one privileged capability to get to another capability. |\n| Exploit and compromise . | Exploit and compromise . |\n| Exploit physical access of authorized staff to gain access to organizational facilities. | Adversary follows ('tailgates') authorized individuals into secure or controlled locations to circumvent physical security checks with the goal of gaining access to facilities. |\n| Exploit poorly configured or unauthorized information systems exposed to the internet. | Adversary gains access through the internet to information systems that are not authorized for internet connectivity or that do not meet organizational configuration requirements. |\n| Exploit split tunneling."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 80}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 35)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nke clear at §164.504(c)(3)(iii) that a hybrid entity must designate as a health care component(s) any component that would meet the definition of ''covered entity'' if it were a separate legal entity.\nThere was some ambiguity in the December 2000 Privacy Rule as to whether a health care provider that does not conduct electronic transactions for which the Secretary has adopted standards ( i.e., a non-covered health care provider) and which is part of a larger covered entity was required to be included in the health care component. To clarify this issue, the proposal also would allow a hybrid entity the discretion to include in its health care component a non-covered health care provider component. Including a noncovered health care provider in the health care component would subject the non-covered provider to the Privacy Rule. Accordingly, the Department proposed a conforming change in §164.504(c)(1)(ii) to make clear that a reference to a ''covered health care provider'' in the Privacy Rule could include the functions of a health care provider who does not engage in electronic transactions, if the covered entity chooses to include such functions in the health care component. The proposal also would permit a hybrid entity to designate otherwise non-covered portions of its operations that provide services to the covered functions, such as parts of the legal or accounting divisions of the entity, as part of the health care component, so that protected health information could be shared with such functions of the entity without business associate agreements or individual authorizations. The proposal would not require that the covered entity designate entire divisions as in or out of the covered component. Rather, it would permit the covered entity to designate functions within such divisions, such as the functions of the accounting division that support health insurance activities, without including those functions that support life insurance activities."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 34}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 10)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ng mere courier services, such as the U.S. Postal Service or United Parcel Service and their electronic equivalents, such as internet service providers (ISPs) providing mere data transmission services.\nAs we have stated in prior guidance, a conduit transports information but does not access it other than on a random or infrequent basis as necessary to perform the transportation service or as required by other law. For example, a telecommunications company may have occasional, random access to protected health information when it reviews whether the data transmitted over its network is arriving\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with at its intended destination. Such occasional, random access to protected health information would not qualify the company as a business associate. In contrast, an entity that requires access to protected health information in order to perform a service for a covered entity, such as a Health Information Organization that manages the exchange of protected health information through a network on behalf of covered entities through the use of record locator services for its participants (and other services), is not considered a conduit and, thus, is not excluded from the definition of business associate. We intend to issue further guidance in this area as electronic health information exchange continues to evolve. We note that the conduit exception is limited to transmission services (whether digital or hard copy), including any temporary storage of transmitted data incident to such transmission. In contrast, an entity that maintains protected health information on behalf of a covered entity is a business associate and not a conduit, even if the entity does not actually view the protected health information. We recognize that in both situations, the entity providing the service to the covered entity has the opportunity to access the protected health information."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 9}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 521)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nnd obtain the individual's oral agreement or objection to a use or disclosure permitted by this section. - (a) Standard: use and disclosure for facility directories. (1) Permitted uses and disclosure.\nExcept when an objection is expressed in accordance with paragraphs (a)(2) or (3) of this section, a covered health care provider may:\n- (i) Use the following protected health information to maintain a directory of individuals in its facility:\n- (A) The individual's name;\n- (B) The individual's location in the covered health care provider's facility;\n- (C) The individual's condition described in general terms that does not communicate specific medical information about the individual; and\n- (D) The individual's religious affiliation; and\n- (ii) Disclose for directory purposes such information:\n- (A) To members of the clergy; or\n\nFrm 00352\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\n- (B) Except for religious affiliation, to other persons who ask for the individual by name. - (2) Opportunity to object. A covered health care provider must inform an individual of the protected health information that it may include in a directory and the persons to whom it may disclose such information (including disclosures to clergy of information regarding religious affiliation) and provide the individual with the opportunity to restrict or prohibit some or all of the uses or disclosures permitted by paragraph (a)(1) of this section. - (3) Emergency circumstances."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 520}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 541)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd health information or a record about the individual in a designated record set for as long as the protected health information is maintained in the designated record set. - (2) Denial of amendment .\nA covered entity may deny an individual's request for amendment, if it determines that the protected health information or record that is the subject of the request:\n- (i) Was not created by the covered entity, unless the individual provides a reasonable basis to believe that the\n\nFrm 00364\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\noriginator of protected health information is no longer available to act on the requested amendment;\n\n- (ii) Is not part of the designated record set;\n\n(iii) Would not be available for inspection under § 164.524; or\n\n(iv) Is accurate and complete. - (b) Implementation specifications: requests for amendment and timely action . (1) Individual's request for amendment . The covered entity must permit an individual to request that the covered entity amend the protected health information maintained in the designated record set. The covered entity may require individuals to make requests for amendment in writing and to provide a reason to support a requested amendment, provided that it informs individuals in advance of such requirements. (2) Timely action by the covered entity . (i) The covered entity must act on the individual's request for an amendment no later than 60 days after receipt of such a request, as follows. (A) If the covered entity grants the requested amendment, in whole or in part, it must take the actions required by paragraphs (c)(1) and (2) of this section. (B) If the covered entity denies the requested amendment, in whole or in part, it must provide the individual with a written denial, in accordance with paragraph (d)(1) of this section."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 540}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 538)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nnd must accommodate reasonable requests by individuals to receive communications of protected health information from the covered health care provider by alternative means or at alternative locations.\n(ii) A health plan must permit individuals to request and must accommodate reasonable requests by individuals to receive communications of protected health information from the health plan by alternative means or at alternative locations, if the individual clearly states that the disclosure of all or part of that information could endanger the individual. (2) Implementation specifications: Conditions on providing confidential communications. (i) A covered entity may require the individual to make a request for a confidential communication described in paragraph (b)(1) of this section in writing. (ii) A covered entity may condition the provision of a reasonable accommodation on:\n\n(A) When appropriate, information as to how payment, if any, will be handled; and\n\n(B) Specification of an alternative address or other method of contact. (iii) A covered health care provider may not require an explanation from the individual as to the basis for the request as a condition of providing communications on a confidential basis. (iv) A health plan may require that a request contain a statement that disclosure of all or part of the information to which the request pertains could endanger the individual. ## § 164.524 Access of individuals to protected health information. (a) Standard: Access to protected health information. (1) Right of access."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 537}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does 45cfr162 say about HIPAA compliance?"}, {"role": "assistant", "content": "According to 45cfr162:\n\n[Skip to main content](#main-content)\n\nMenu\n\n[![GovInfo logo](/media/GovInfo_logo_gray.png)](/)\n[Search](#searchHolder)\n\n* Browse\n  + [A to Z](/browse-a-z)\n  + [Category](/app/browse/category)\n  + [Date](/app/browse/date)\n  + [Committee](/browse/committee)\n  + [Author](/app/browse/author)\n* About\n  + [About](/about)\n  + [Policies](/about/policies)\n  + [Authentication](/about/authentication)\n  + [Digital Preservation](/about/digital-preservation)\n  + [History](/about/history)\n  + [Agency Submission](/about/agency-submission)\n  + [U.S. Government Information](/about/us-gov-info)\n  + [FDsys Retirement](/about#fdsys-transition)\n* Developers\n  + [Developer Hub](/developers)\n  + [API](https://api.govinfo.gov/docs)\n  + [Bulk Data Repository](%20/bulkdata)\n  + [Link Service](/link-docs)\n  + [Feeds](/feeds)\n  + [Sitemaps](/sitemaps)\n  + [System Design](/developers/system-design)\n* Features\n  + [All Features](/features)\n  + [Featured Content](/features/featured-content)\n  + [News](/features/news)\n  + [Release Notes](/features/release-notes)\n  + [Finding Publications](/features/finding-publications)\n* Help\n  + [Help](/help)\n  + [Finding Information](%20/help/finding-info)\n  + [What's Available](/help/whats-available)\n  + [Tutorials and Handouts](/help/tutorials-handouts)\n  + [Other Resources](%20/help/other-resources)\n* Feedback\n  + [Submit Feedback](https://www.surveymonkey.com/r/govinfo-feedback-survey)\n  + [Contact Us](/contact)\n\n* [Toggle the Search Widget\n  Search](#searchHolder)\n\n# Page Not Found\n\n![Icon: Share using Facebook](/sites/default/files/fb-icon-white.png)\n![Icon: Share using Email](/sites/default/files/email-icon-white.png)\n![Icon: Copy Link URL](/sites/default/files/link-icon-white.png)\n\n[Help](/help/other)\n\n---\n\n**Error occurred."}], "metadata": {"source": "45cfr162", "safeguard_types": ["unknown"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 0}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 17)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nparty's need to know should be resolved in favor of the patient, except where that would result in serious health hazard or harm to the patient or others.'' AMA Policy No 140.989. See also, Mass. Med.\nSociety, Patient Privacy and Confidentiality (1996), at 14:\n\nPatients enter treatment with the expectation that the information they share will be used exclusively for their clinical care. Protection of our patients' confidences is an integral part of our ethical training. These codes, however, do not apply to many who obtain information from providers. For example, the National Association of Insurance Commissioners model code, ''Health Information Privacy Model Act'' (1998), applies to insurers but has not been widely adopted. Codes of ethics are also often written in general terms that do not provide guidance to providers and plans confronted with specific questions about protecting health information. State laws are a crucial means of protecting health information, and today state laws vary dramatically. Some states defer to the professional codes of conduct, others provide general guidelines for privacy protection, and\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nothers provide detailed requirements relating to the protection of information relating to specific diseases or to entire classes of information. Cf., D.C. Code Ann. §2-3305.14(16) and Haw. Rev. Stat. 323C, et seq. In general, state statutes and case law addressing consent to use of health information do not support the public's strong expectations regarding consent for use and disclosure of health information. Only about half of the states have a general law that prohibits disclosure of health information without patient authorization and some of these are limited to hospital medical records. Even when a state has a law limiting disclosure of health information, the law typically exempts many types of disclosure from the authorization requirement."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 16}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 235)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nramm-Leach-Bliley (GLB) Act (Pub. L. 106-102) allows financial holding companies to engage in a variety of business activities, such as insurance and securities, beyond traditional banking activities.\nBecause the term ''banking'' may take on broader meaning in light of these changes, the commenter recommended modifying the proposed rule to state that disclosure of diagnostic and treatment information to banks along with payment information would constitute a violation of the rule. Specifically, the organization recommended clarifying in the final rule that the provisions included in the proposed section on banking and payment processes (proposed § 164.510(i)) govern payment processes only and that all activities of financial institutions that did not relate directly to payment processes must be conducted through business partner contracts. Furthermore, this group recommended clarifying that if financial institutions act as payors, they will be covered entities under the rule. Response: We recognize that implementation of the GLB Act will expand significantly the scope of activities in which financial holding companies engage. However, unless a financial institution also meets the definition of a ''covered entity,'' it cannot be a covered entity under this rule. We agree with the commenters that disclosure of diagnostic and specific treatment information to financial institutions for many banking and funds processing purposes may not be consistent with the minimum necessary requirements of this final rule. We also agree with the commenters that financial institutions are business associates if they receive protected health information when they engage in activities other than funds processing for covered entities. For example, if a health care provider contracts with a financial institution to conduct ''back office'' billing and accounts receivable activities, we require the provider to enter into a business associate contract with the institution."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 234}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 79)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\noduced by permitting oral agreements. Some commenters also requested flexibility for covered entities to determine whether or not written documentation is appropriate and necessary for their purposes.\nThe majority of commenters requested that a designated recipient of the student immunization records not be defined, and that schools be allowed flexibility to identify the appropriate individual(s) that can act as the school official permitted to receive the records. Commenters indicated that while the disclosures would ideally be made to a nurse or licensed health professional at the school, such a health professional may not always be present. In such instances, it should be permissible that the immunization records be disclosed to another official designated by the school as a suitable representative. One commenter recommended that the school nurse be designated as the recipient and custodian of the records. Most commenters recommended that the definition of ''school'' be interpreted broadly in order to best support public health efforts. Commenters provided suggestions on the types of schools that should be included, for example, K-12 schools, public and private schools, and post-secondary schools. Many commenters also suggested that daycare, preschool and nursery school facilities be encompassed in the definition of school. One commenter expressly recommended that child care facilities or day care programs not be included in the definition of school, despite acknowledging the need to protect the health of these children, due to the fact that many States have different laws for these settings and are separate from school systems. Two commenters\n\nVerDate Mar&lt;15&gt;2010\n\nsuggested defining schools as being open to children up to age 18, since students become adults at age 18 and can authorize the disclosure of their own information."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 78}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 201)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthe privacy regulation should not impede the DEA's ability to enforce the CSA. First, to the extent the CSA requires disclosures to the DEA, these disclosures would be permissible under § 164.512(a).\nSecond, some of the DEA's CSA activities come within the exception for health oversight agencies which permits disclosures to health oversight agencies for:\n\nActivities authorized by law, including audits; civil, administrative, or criminal investigations; inspections * * * civil, administrative, or criminal proceedings or actions; and other activity necessary for appropriate oversight of the health care system. Therefore, to the extent the DEA is enforcing the CSA, disclosures to it in its capacity as a health oversight agency are permissible under § 164.512(d). Alternatively, CSA required disclosures to the DEA for law enforcement purposes are permitted under §164.512(f). When acting as a law enforcement agency under the CSA, the DEA may obtain the information pursuant to § 164.512(f). Thus, we do not agree that the privacy regulation will impede the DEA's enforcement of the CSA. See the preamble discussion of §164.512 for further explanation. Comment: One commenter suggested clarifying the provisions allowing disclosures that are ''required by law'' to ensure that the mandatory reporting requirements the CSA imposes on covered entities, including making available reports, inventories, and records of transactions, are not preempted by the regulation. Response: We agree that the privacy regulation does not alter covered entities' obligations under the CSA. Because the CSA requires covered entities manufacturing, distributing, and/or dispensing controlled substances to maintain and provide to the DEA specific records and reports, the privacy regulation permits these disclosures under §164.512(a). In addition, when the DEA seeks documents to determine an entity's compliance with the CSA, such disclosures are permitted under §164.512(d)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 200}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 11)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nited exceptions. The Department believes that the authorization process itself will put the individual sufficiently on notice that the covered entity is the source of the protected health information.\nTo the extent that the commenter suggests that these disclosures are necessary for communications that are not ''marketing'as defined by the Rule, the Department disagrees because such a requirement would place an undue burden on necessary health-related communications. Comment: Many commenters opposed the proposed elimination of the provision that would have transformed a communication exempted from\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00008\n\nmarketing into a marketing communication if it was in writing and paid for by a third party. They argued that marketing should include any activity in which a covered entity receives compensation, directly or indirectly, through such things as discounts from another provider, manufacturer, or service provider in exchange for providing information about the manufacturer or service provider's products to consumers, and that consumers should be advised whenever such remuneration is involved and allowed to opt-out of future communications. Response: The Department considered whether remuneration should determine whether a given activity is marketing, but ultimately concluded that remuneration should not define whether a given activity is marketing or falls under an exception to marketing. In fact, the Department believes that the provision in the December 2000 Rule that transformed a treatment communication into a marketing communication if it was in writing and paid for by a third party blurred the line between treatment and marketing in ways that would have made the Privacy Rule difficult to implement."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 10}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 17)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nbe viewed as most critical and perhaps what forms the foundation for all other security actions. Response: The majority of comments received on this subject requested that we prioritize the standards.\nIn response, we have regrouped the standards and implementation specifications in what we believe is a logical order within each of three categories: ''Administrative safeguards,'' ''Physical safeguards,'' and ''Technical safeguards.'' In this final rule, we order the standards in such a way that the ''Security management process'' is listed first under the ''Administrative safeguards'' section, as we believe this forms the foundation on which all of the other standards depend. The determination of the specific security measures to be implemented to comply with the standards will, in large part, be dependent upon completion of the implementation specifications within the security management process standard (see § 164.308(a)(1)). We emphasize, however, that an entity implementing these standards may choose to implement them in any order, as long as the standards are met. g. Comment: One commenter stated that there is a need for requirements concerning organizational practices (for example, education, training, and security and confidentiality policies), as\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\nJkt 200001\n\nwell as technical practices and procedures. Response: We agree. Section 164.308 of this final rule describes administrative safeguards that address these topics. Section 164.308 requires covered entities to implement standards and required implementation specifications, as well as consider and implement, when appropriate and reasonable, addressable implementation specifications. For example, the security management process standard requires implementation of a risk analysis, risk management, a sanction policy, and an information system activity review."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 16}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 29)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nalty. We refer readers to prior Enforcement Rule preambles for additional discussion on the counting methodology. See 70 FR 20224, 2023355 (April 18, 2005) and 71 FR 8390, 8404-07 (February 16, 2006).\nVerDate Mar&lt;15&gt;2010\n\nWith respect to whether the aggregate CMP limit of $1.5 million would apply to all violations in a given calendar year, across an entire enterprise, regardless of violations occurring in different business units of the enterprise, we note that the Enforcement Rule's penalty scheme, and thus the limit for identical violations in a calendar year applies to the legal entity that is a covered entity or business associate. However, as we indicated above, a covered entity or business associate may be liable for multiple violations of multiple requirements, and a violation of each requirement may be counted separately. As such, one covered entity or business associate may be subject to multiple violations of up to a $1.5 million cap for each violation, which would result in a total penalty above $1.5 million. d. Section 160.408-Factors Considered in Determining the Amount of a Civil Money Penalty\n\n## Proposed Rule\n\nSection 160.408 implements section 1176(a)(2) of the Social Security Act, which requires the Secretary, when imposing a civil money penalty, to apply the provisions of section 1128A of the Social Security Act ''in the same manner as such provisions apply to the imposition of a civil money penalty under section 1128A.'' In determining a penalty amount, section 1128A requires the Secretary to take into account the nature of the claims and the circumstances under which they were presented; the degree of culpability, history of prior offenses and financial condition of the person presenting the claims; and such other matters as justice may require. Section 160.408 adopted these factors and provided a more specific list of circumstances within each."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 28}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 94)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nor her rights. However, the Department agrees that such information must be provided in a clear, concise, and easy to\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nunderstand manner.\nTherefore, the Department clarifies that covered entities may utilize a ''layered notice'' to implement the Rule's provisions, so long as the elements required by §164.520(b) are included in the document that is provided to the individual. For example, a covered entity may satisfy the notice provisions by providing the individual with both a short notice that briefly summarizes the individual's rights, as well as other information; and a longer notice, layered beneath the short notice, that contains all the elements required by the Privacy Rule. Covered entities, however, while encouraged to use a layered notice, are not required to do so. Nothing in the final modifications relieve a covered entity of its duty to provide the entire notice in plain language so the average reader can understand it. See §164.520(b)(1). In response to comments regarding a model notice, it would be difficult for the Department to develop a document that would be generally useful to many different types of covered entities. A covered entity's notice must reflect in sufficient detail the particular uses and disclosures that entity may make. Such uses and disclosures likely will be very different for each type of covered entity. Thus, a uniform, model notice could not capture the wide variation in information practices across covered entities. The Department intends, however, to issue further general guidance to help covered entities implement the notice provisions of the Rule. Comment: A number of commenters also requested that the Department lessen the burden associated with distributing the notice."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 93}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 542)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne Secretary pursuant to the procedures established in § 160.306. The description must include the name, or title, and telephone number of the contact person or office designated in §164.530(a)(1)(ii).\n- (2) Statement of disagreement . The covered entity must permit the individual to submit to the covered entity a written statement disagreeing\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\n- with the denial of all or part of a requested amendment and the basis of such disagreement. The covered entity may reasonably limit the length of a statement of disagreement. (3) Rebuttal statement . The covered entity may prepare a written rebuttal to the individual's statement of disagreement. Whenever such a rebuttal is prepared, the covered entity must provide a copy to the individual who submitted the statement of disagreement. - (4) Recordkeeping . The covered entity must, as appropriate, identify the record or protected health information in the designated record set that is the subject of the disputed amendment and append or otherwise link the individual's request for an amendment, the covered entity's denial of the request, the individual's statement of disagreement, if any, and the covered entity's rebuttal, if any, to the designated record set. - (5) Future disclosures . (i) If a statement of disagreement has been submitted by the individual, the covered entity must include the material appended in accordance with paragraph (d)(4) of this section, or, at the election of the covered entity, an accurate summary of any such information, with any subsequent disclosure of the protected health information to which the disagreement relates. 3."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 541}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 30)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n(a)(4) of this section, and to prevent those workforce members who do not have access under paragraph (a)(4) of this section from obtaining access to electronic protected health information. Table 10.\nKey activities, descriptions, and sample questions for the Workforce Security standard\n\n| Key Activities                                                                                                       | Description                                                                                                                                                                                                                                                                                                                             | Sample Questions                                                                                                                                                                                                                                                                                                                                          |\n|----------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|\n| 1."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 29}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 14)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\ncessed therein. It should be noted that employment of telephone voice response and/or faxback systems will generally require security protection by only one of the parties involved, and not the other.\nInformation being transmitted via a telephone (either by voice or a DTMP tone pad) is not in electronic form (as defined in the first paragraph of the definition of ''electronic media'') before transmission and therefore is not subject to the Security Rule. Information being returned via a telephone voice response system in response to a telephone request is data that is already in electronic form and stored in a computer. This latter transmission does require protection under the Security Rule. Although most recently made electronic devices contain microprocessors (a form of computer) controlled by firmware (an unchangeable form of computer program), we intend the term ''computer'' to include only software programmable computers, for example, personal computers, minicomputers, and mainframes. Copy machines, fax machines, and telephones, even those that contain memory and can produce multiple copies for multiple people are not intended to be included in the term ''computer.'' Therefore, because ''paperto-paper'' faxes, person-to-person telephone calls, video teleconferencing, or messages left on voice-mail were not in electronic form before the transmission, those activities are not covered by this rule. See also the definition of ''electronic media'' at §160.103. Fmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\nJkt 200001\n\nWe note that this guidance differs from the guidance regarding the applicability of the Transactions Rule to faxback and voice response systems. HHS has stated that faxback and voice response systems are not required to follow the standards mandated in the Transactions Rule. This new guidance refers only to this rule. e."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 13}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 327)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nscussion of the root causes of such events so they may be identified and addressed. According to the commenter, this is consistent with peer review protections afforded this information by the states.\nResponse: The question of whether or not such information should be protected is currently the subject of debate in Congress and in the states. It would be premature for us to adopt a position on this issue until a clear consensus emerges. Under the final rule, no special protection against disclosure is provided for peer review information of the type the commenter describes. However, unless the request for disclosure fits within one of the categories of permitted or required disclosures under the regulation, it may not be disclosed. For instance, if disclosure of peer review information is required by another law (such as Medicare or a state law), covered entities subject to that law may disclose protected health information consistent with the law. Comment: One commenter stated that the requirements of this section are in conflict with Medicare contractor current practices, as defined by the HCFA Office of General Counsel and suggested that the final rule include more specific guidelines. Response: Because the commenter failed to indicate the nature of these conflicts, we are unable to respond. Comment: One commenter stated that the rule should require rather than permit disclosure pursuant to court orders. Response: Under the statutory framework adopted by Congress in HIPAA, a presumption is established that the data contained in an individual's medical record belongs to the individual and must be protected from disclosure to third parties. The only instance in which covered entities holding that information must disclose it is if the individual requests access to the information himself or herself."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 326}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 130)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nof ''protected health information''. - f. Remove the words ''a covered'' and replace them with ''an'' in the definition of ''required by law''. The revisions read as follows:\n\n## §164.501 Definitions.\n*\n\n*\n\n*\n\n*\n\n*\n\nHealth care operations means * * * (6) * * *\n\n- (iv) The sale, transfer, merger, or consolidation of all or part of the covered entity with another covered entity, or an entity that following such activity will become a covered entity and due diligence related to such activity; and\n- (v) Consistent with the applicable requirements of § 164.514, creating deidentified health information or a limited data set, and fundraising for the benefit of the covered entity. *\n\n*\n\n*\n\n*\n\n*\n\nMarketing means:\n\n- (1) To make a communication about a product or service that encourages recipients of the communication to purchase or use the product or service, unless the communication is made:\n2. (i) To describe a health-related product or service (or payment for such product or service) that is provided by, or included in a plan of benefits of, the covered entity making the communication, including communications about: the entities participating in a health care provider network or health plan network; replacement of, or enhancements to, a health plan; and health-related products or services available only to a health plan enrollee that add value to, but are not part of, a plan of benefits. 3. (ii) For treatment of the individual; or\n4. (iii) For case management or care coordination for the individual, or to direct or recommend alternative treatments, therapies, health care providers, or settings of care to the individual."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 129}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the physical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRIN 0991-AB14\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY: Office for Civil Rights, HHS. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (''HHS'' or ''Department'') modifies certain standards in the Rule entitled ''Standards for Privacy of Individually Identifiable Health Information'' (''Privacy Rule''). The Privacy Rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996. The purpose of these modifications is to maintain strong protections for the privacy of individually identifiable health information while clarifying certain of the Privacy Rule's provisions, addressing the unintended negative effects of the Privacy Rule on health care quality or access to health care, and relieving unintended administrative burdens created by the Privacy Rule. DATES: This final rule is effective on October 15, 2002. FOR FURTHER INFORMATION CONTACT: Felicia Farmer, 1-866-OCR-PRIV (1866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION:\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 (or toll-free at 1-866-5121800) or by fax to (202) 512-2250. The cost for each copy is $10.00."}], "metadata": {"source": "privacy_mod_2002", "safeguard_type": "physical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 360)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nat it would provide no useful knowledge, any risk to patient privacy that might result from the use or disclosure of protected health information without individuals' authorization would be too great.\nComment: A few commenters asserted that the proposed criterion requiring ''an adequate plan to destroy the identifiers at the earliest opportunity consistent with the conduct of the research, unless there is a health or research justification for retaining identifiers,'' conflicted with the regulations of the FDA on clinical record keeping (21 CFR 812.140(d)) and the International Standard Organization on control of quality records (ISO 13483, 4.16), which require that relevant data be kept for the life of a device. In addition, one commenter asserted that this criterion could prevent follow up care. Similarly, other commenters argued that the new waiver criteria would be likely to confuse IRBs and may impair researchers' ability to go back to IRBs to request extensions of time for which samples or data can be stored if researchers are unable to anticipate future uses of the data. Response: We do not agree with the comment that there is a conflict between either the FDA or the ISO regulations and the proposed waiver criteria in the rule. We believe that compliance with such recordkeeping requirements would be ''consistent with the conduct of research'' which is subject to such requirements. Nonetheless, to avoid any confusion, in the final rule we have added the phrase ''or such retention is\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\notherwise required by law'' to this waiver criterion. We also disagree with the comments that this criterion would prevent follow up care to individuals or unduly impair researchers from retaining identifiers on data for future research."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 359}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 21)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nhich entity's protected health information was involved, the covered entities may consider having the business associate provide the notification to the media on behalf of all of the covered entities.\nSection 164.406(c) sets forth the content requirement for covered entities notifying the media. In this section, we require that the notice to the media include the same content as that required for notification to the individual under § 164.404(c). We emphasize that this provision does not replace either direct written or\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\24AUR2.SGM\n\n24AUR2\n\nJkt 217001\n\nerowe on DSK5CLS3C1PROD with RULES\\_2\n\nsubstitute notice to the individual under §164.404. If a covered entity is required to provide substitute notice under §164.404(d)(2)(ii)(A) and chooses to do so through major print or broadcast media, notification to the media under this section would only satisfy such substitute notice if the prominent media outlet ran a notification reasonably calculated to reach the individuals for which substitute notice was required and included all the information required be provided in the individual notice, including the toll-free number required by § 164.404(d)(2)(ii)(B). ## E. Notification to the Secretary164.408\n\nSection 164.408 of the interim final rule implements section 13402(e)(3) of the Act, which requires covered entities to notify the Secretary of breaches of unsecured protected health information. For breaches involving 500 or more individuals, the Act requires covered entities to notify the Secretary immediately. For breaches involving less than 500 individuals, the Act provides that a covered entity may maintain a log of such breaches and annually submit such log to the Secretary documenting the breaches occurring during the year involved. Section 164.408(a) of the interim final rule contains the general rule that requires a covered entity to notify the Secretary following the discovery of a breach of unsecured protected health information."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 20}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 207)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthe privacy interests of the subject of the protected health information in the record requested, but also, when appropriate, those of a deceased individual's family consistent with judicial rulings.\nIf an agency receives a FOIA request for the disclosure of protected health information of a deceased individual, it will need to determine whether or not the disclosure comes within Exemption 6. This evaluation must be consistent with the court's rulings in this area. If the exemption applies, the federal agency will not have to release the information. If the federal agency determines that the exemption does not apply, may release it under § 164.512(a) of this regulation. Comment: One commenter expressed concern that our proposal to protect the individually identifiable health information about the deceased for two years following death would impede public interest reporting and would be at odds with many state Freedom of Information laws that make death records and autopsy reports public information. The commenter suggested permitting medical information to be available upon the death of an individual or, at the very least, that an appeals process be permitted so that health information trustees would be allowed to balance the interests in privacy and in public disclosure and release or not release the information accordingly. Response: These rules permit covered entities to make disclosures that are required by state Freedom of Information Act (FOIA) laws under §164.512(a). Thus, if a state FOIA law designates death records and autopsy reports as public information that must be disclosed, a covered entity may\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ndisclose it without an authorization under the rule. To the extent that such information is required to be disclosed by FOIA or other law, such disclosures are permitted under the final rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 206}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 39)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\ndisposition process that includes proper identification, authorization for disposition, and sanitization of the equipment, as well as removal of Patient Health Information (PHI) or software, or both.\n101\n\nDisposal - a process to end the existence of a system asset or system for a specified intended use, appropriately handle replaced or retired assets, and to properly attend to identified critical\n\n95  Definition is adapted from NIST SP 800-53A Rev. 5 Assessing Security and Privacy Controls in Federal Information Systems and Organizations . https://doi.org/10.6028/NIST.SP.800-53Ar5\n\n96 Definition is adapted from ISO IEC 27000-2018, Clause 3.10: Property that information is not made available or disclosed to unauthorized individuals, entities, or processes. 97  Definition is adapted from NIST SP 800-128 Guide for Security-Focused Configuration Management of Information Systems . https://doi.org/10.6028/NIST.SP.800-128\n\n98 Definition is adapted from NIST SP 800-53 Rev. 5. 99  Definition is adapted from CNSSI 4009-2015 CNSS Glossary . 100\n\n101\n\nDefinition is adapted from ISO IEC 27032: 2012, Clause 4.20. Definition is adapted from Medical Device and Health IT Joint Security Plan version 2 (JSP2). ## Contains Nonbinding Recommendations\n\ndisposal needs (e.g., per an agreement, per organizational policy, or for environmental, legal, safety, or security aspects). 102\n\nEncryption - is the cryptographic transformation of data (called 'plaintext') into a form (called 'ciphertext') that conceals the data's original meaning to prevent it from being known or used. 103\n\nEnd of support - a point beyond which the product manufacturer ceases to provide support, which may include cybersecurity support, for a product or service. Exploitability - the feasibility or ease and technical means by which the vulnerability can be exploited by a threat. 104\n\nFirmware - software program or set of instructions programmed on the flash read-only memory (ROM) of a hardware device."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 38}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 33)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n8 (October 30, 2009), 70 FR 20224, 20237-8 (April 18, 2005) and 71 FR 8390, 8410 (February 16, 2006) for prior, more detailed discussions about the Department's determination of when knowledge exists.\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\nBecause the Department recognized that the minimum penalty amount under the HITECH Act of a violation due to willful neglect that is corrected during the 30-day cure period is significantly less than that for a violation due to willful neglect that is not timely corrected (equating to a $40,000 minimum penalty amount difference), the IFR specifically requested comment on whether there are alternative approaches to calculating the beginning of the 30-day cure period for this purpose. ## Overview of Public Comments\n\nWhile a few commenters expressed support for utilizing the current scheme in determining which tier should apply to a violation due to willful neglect, other commenters expressed concerns with this approach due to the uncertainty with determining exactly when the cure period begins and that a business associate's knowledge of a violation could be imputed to the covered entity prior to the business associate notifying the covered entity, as well as concerns if the Secretary does not notify an entity of a potential violation in a timely manner. A few commenters suggested that the 30-day cure period begin once the Department notifies the covered entity of a complaint. ## Final Rule\n\nThe final rule retains the policy that the 30-day cure period for violations due to willful neglect, like those not due to willful neglect, begins on the date that an entity first acquires actual or constructive knowledge of the violation and will be determined based on evidence gathered by the Department during its investigation, on a case-bycase basis."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 32}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 60)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nrty on behalf of the covered entity as long as any remuneration received by the business associate was for the activities performed by the business associate pursuant to a business associate contract.\nWe proposed to except from the authorization requirement disclosures of protected health information by a covered entity to an individual when requested under §§ 164.524 (providing a right to access protected health information) or 164.528 (providing a right to receive an accounting of\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with disclosures). While section 13405(d)(2)(F) of the HITECH Act explicitly refers only to disclosures under §164.524, we exercised our authority under section 13405(d)(2)(G) of the HITECH Act to likewise include in the exception disclosures to the individual under § 164.528. Section 164.524 permits a covered entity to impose a reasonable, cost-based fee for the provision of access to an individual's protected health information upon request. Section 164.528 requires a covered entity to provide a requesting individual with an accounting of disclosures without charge in any 12-month period but permits a covered entity to impose a reasonable, cost-based fee for each subsequent request for an accounting of disclosures during that 12-month period. Therefore, a disclosure of protected health information under §164.528 is similar to a disclosure under §164.524 in that a covered entity may be paid a fee for making the disclosure. Pursuant to the authority granted to the Secretary in section 13405(d)(2)(G) of the HITECH Act, we proposed an additional exception for disclosures that are required by law as permitted under §164.512(a) of the Privacy Rule."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 59}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 382)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\negivers need to be able to give and receive a\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ncomplete picture of the patient's health to make a diagnosis and develop a treatment plan.\nOther commenters noted that the complexity of medicine is such that it is unreasonable to think that anyone will know the exact parameters of the information another caregiver will need for proper diagnosis and treatment or that a plan will need to support quality assurance and improvement activities. They therefore suggested that the minimum necessary standard be applied instead as an administrative requirement. Providers also emphasized that they already have an ethical duty to limit the sharing of unnecessary medical information, and most already have well-developed guidelines and practice standards in place. Concerns were also voiced that attempts to provide the minimum necessary information in the treatment setting would lead to multiple editions of a record or creation of summaries that turn out to omit crucial information resulting in confusion and error. Response: In response to these concerns, we substantially revise the minimum necessary requirements. As suggested by certain commenters, we provide, in § 164.502(b), that disclosures of protected health information to or requests by health care providers for treatment are not subject to the minimum necessary standard. We also modify the requirements for uses of protected health information. This final rule requires covered entities to make determinations of minimum necessary use, including use for treatment purposes, based on the role of the person or class of workforce members rather than at the level of specific uses. A covered entity must establish policies and procedures that identify the types of persons who are to have access to designated categories of information and the conditions, if any, of that access. We establish no requirements specific to a particular use of information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 381}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 34)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ngency or institution as defined by FERPA. Therefore, its records that contain individually identifiable health information are not education records. These records may be protected health information.\nThe educational institution or agency that employs a school nurse is subject to our regulation as a health care provider if the school nurse or the school engages in a HIPAA transaction. While we strongly believe every individual should have the same level of privacy protection for his/her individually identifiable health information, Congress did not provide us with authority to disturb the scheme it had devised for records maintained by educational institutions and agencies under FERPA. We do not believe Congress intended to amend or preempt FERPA when it enacted HIPAA. With regard to the records described at 20 U.S.C. 1232g(a)(4)(b)(iv), we considered requiring health care providers engaged in HIPAA transactions to comply with the privacy regulation up to the point these records were used or disclosed for purposes other than treatment. At that point, the records would be converted from protected health information into education records. This conversion would occur any time a student sought to exercise his/her access rights. The provider, then, would need to treat the record in accordance with FERPA's requirements and be relieved from its obligations under the privacy regulation. We chose not to adopt this approach because it would be unduly burdensome to require providers to comply with two different, yet similar, sets of regulations and inconsistent with the policy in FERPA that these records be exempt from regulation to the extent the records were used only to treat the student. ## Gramm-Leach-Bliley\n\nIn 1999, Congress passed GrammLeach-Bliley (GLB), Pub. L. 106-102, which included provisions, section 501 et seq."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 33}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 363)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nquired under the rule, unless it agreed otherwise, to destroy protected health information that was collected, nor retrieve protected health information that was disclosed under such an authorization.\nHowever, once an individual has revoked an authorization, no additional protected health information may be used or disclosed unless otherwise permitted by this rule. Comment: Some commenters were concerned that the authorization requirement to disclose ''financial gain'' would be problematic as it would pertain to research. These commenters asserted that this requirement could mislead patients and would make it more difficult to attract volunteers to participate in research. One commenter recommended that the statement be revised to state ''that the clinical investigator will be compensated for the value of his/her services in administrating this clinical trial.'' Another commenter recommended that the authorization requirement for disclosure of financial gain be defined in accordance with FDA's financial disclosure rules. Response: We strongly believe that a requirement for the disclosure of financial gain is imperative to ensure that individuals are informed about how and why protected health information about themselves will be used or disclosed. We agree, however, that the language of the proposed requirement could cause confusion, because most activities involve some type of financial gain. Therefore, in the final rule, we have modified the language to provide that when the covered entity initiates\n\nFrm 00240\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nthe authorization and the covered entity will receive direct or indirect remuneration (rather than financial gain) from a third party in exchange for using or disclosing the health information, the authorization must include a statement that such remuneration will result."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 362}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 12)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\nIdentify and implement compensating controls to adequately mitigate the cybersecurity vulnerability risk, especially when new device design controls 33 may not be feasible or immediately practicable.\nIn addition, manufacturers should consider the level of knowledge and expertise needed to properly implement the recommended control;\n- Provide users with relevant information on recommended device and compensating controls and residual cybersecurity risks so that they can take appropriate steps to mitigate the risk and make informed decisions regarding device use; and\n- Recognize that some changes made to strengthen device security might also significantly affect other device functionality (e.g., use of a different operating system) and assess the scope of change to determine if additional premarket or postmarket regulatory actions are appropriate. In addition to the general recommendations described above, Sections VII.A and VII.B. below clarify specific recommendations for managing controlled and uncontrolled risks of patient harm. 34 While FDA recognizes that multi-stakeholder engagement is necessary to fully address cybersecurity risks, the examples provided in the controlled risk and uncontrolled risk sections below clarify FDA's regulatory expectations for medical device manufacturers. ## A. Controlled Risk of Patient Harm\n\nControlled risk is present when there is sufficiently low (acceptable) residual risk of patient harm due to the vulnerability. Manufacturers are encouraged to proactively promote good cyber hygiene and reduce cybersecurity risks even when residual risk is acceptable. The following are recommendations for changes or compensating control actions taken to address vulnerabilities associated with controlled risk:\n\n32 ISO/IEC 30111:2013: Information Technology - Security Techniques - Vulnerability Handling Processes ."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 11}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 173)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nsiness associates did so already, the risk of criminal and/or civil monetary penalties may spur some business associates to increase their efforts to comply with the\n\nVerDate Mar&lt;15&gt;2010\n\nRules.\nWe explained that we have no information on the degree of contract enforcement and compliance among business associates, and lack information regarding the size or type of business associates that contract with covered entities. We have only rough estimates as to the overall number of business associates, which range from approximately one million to two million depending on the number of business associates that serve multiple covered entities. While we did not have specific information in this regard, we assumed that some business associates and subcontractors already comply with existing privacy and security standards in accordance with their indirect and contractual obligations. For them, the proposed rule would impose only a limited burden. For other business associates, depending on the current level of compliance, the proposed rule could impose significant burdens. We requested comments regarding the amount of burden and the number of affected business associates. Several commenters stated that requiring business associates to undertake compliance with the rule in the same way as covered entities is excessive and burdensome, especially because in some cases business associates do not have the same type of relationship with individuals. Several commenters pointed to the burden on covered entities and business associates to renegotiate business associate agreements and train staff, and many specifically mentioned that compliance with the Security Rule is particularly costly. One commenter stated that it was a business associate party to ''tens of thousands'' of business associate contracts, with a significant cost to bring all into compliance."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 172}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 353)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nse: We agree that it is of foremost importance that individuals' privacy rights and welfare be safeguarded when protected health information about themselves is used or disclosed for research studies.\nWe also strongly believe that continued improvements in the nation's health requires that researchers be permitted access to protected health information without authorization in certain circumstances. Additional privacy protections are needed, however, and we have included several in the final rule. If covered entities plan to disclose protected health without individuals' authorization for research purposes, individuals must be informed of this through the covered entity's notice to patients of their information practices. In addition, before covered health care providers or health plans may use or disclose protected health information for research without authorization, they must obtain documentation that an IRB or privacy board has found that specified waiver criteria have been met, unless the research will include protected health information about deceased individuals only, or is solely for reviews that are preparatory to research. While it is true that the first provision of the Nuremberg Code states that ''the voluntary consent of the human subject is absolutely essential,'' it is important to understand the context of this important document in the history of protecting human subjects research from harm. The Nuremberg Code was developed for the Nuremberg Military Tribunal as standards by which to judge\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00234\n\nthe human experimentation conducted by the Nazis, and was one of the first documents setting forth principles for the ethical conduct of human subjects research."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 352}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement technical controls?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\n## Office of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRin: 0991-AB08\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY : Office of the Assistant Secretary for Planning and Evaluation, DHHS. ACTION\n\n: Final rule. SUMMARY : This rule includes standards to protect the privacy of individually identifiable health information. The rules below, which apply to health plans, health care clearinghouses, and certain health care providers, present standards with respect to the rights of individuals who are the subjects of this information, procedures for the exercise of those rights, and the authorized and required uses and disclosures of this information. The use of these standards will improve the efficiency and effectiveness of public and private health programs and health care services by providing enhanced protections for individually identifiable health information. These protections will begin to address growing public concerns that advances in electronic technology and evolution in the health care industry are resulting, or may result, in a substantial erosion of the privacy surrounding individually identifiable health information maintained by health care providers, health plans and their administrative contractors. This rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and\n\nAccountability Act of 1996. DATES : The final rule is effective on February 26, 2001. ## FOR FURTHER INFORMATION CONTACT :\n\nKimberly Coleman, 1-866-OCR-PRIV (1-866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION :\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954."}], "metadata": {"source": "privacy_rule_2000", "safeguard_type": "technical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 390)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nion so people can avoid solicitations. Response: We agree with commenters that our proposal could have adversely effected charitable giving, and accordingly make several modifications to the proposal.\nFirst, the final rule allows a covered entity to use or disclose to a business associate protected health information without authorization to identify individuals for fundraising for its own benefit. Permissible fundraising activities include appeals for money, sponsorship of events, etc. They do not include royalties or remittances for the sale of products of third parties (except auctions, rummage sales, etc). Second, the final rule allows a covered entity to disclose protected health information without authorization to an institutionally related foundation that has as its mission to benefit the covered entity. This special provision is necessary to accommodate tax code provisions which may not allow such foundations to be business associates of their associated covered entity. We also agree that broad access to protected health information is unnecessary for fundraising and unnecessarily intrudes on individual privacy. The final rule limits protected health information to be used or disclosed for fundraising to demographic information and the date that treatment occurred. Demographic information is not defined in the rule, but will generally include in this context name, address and other contact information, age, gender, and insurance status. The term does not include any information about the illness or treatment. We also agree that a voluntary opt-out is an appropriate protection, and require in § 164.520 that covered entities provide information on their fundraising activities in their ''Notice of Information Practices.'' As part of the notice and in any fundraising materials, covered entities must provide information explaining how individuals may opt out of fundraising communications."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 389}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 32)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\narent access to their minor child's medical records when the minor consents to the treatment without the parent. In this case, the covered entity would be precluded from granting access to the parent.\nIf the State or other law clearly provides a covered entity with discretion to grant a parent access, then the covered entity may exercise such discretion, to the extent permitted under such other law. If State law is silent or unclear on its face, then a covered entity would have to go through the same analysis as it would today to determine if such law permitted, required, or prohibited providing a parent with access to a minor's records. That analysis may involve review of case law, attorney general opinions, legislative history, etc. If such analysis showed that the State would permit an entity to provide a parent access to health information about a minor child, and under the Privacy Rule, the parent would not be the personal representative of the minor because of one of the limited exceptions in § 164.502(g)(3)(i), then the covered entity may exercise such discretion, based on the professional judgment of a licensed health care provider, to choose whether or not to provide the parent access to the medical records of his or her minor child. If, as the commenters suggest, a State consent law were interpreted to prohibit such access, then such access is prohibited under the Privacy Rule as well. Comment: One commenter asserted that the Privacy Rule inappropriately erects barriers between parents and children. Specifically, the commenter stated that § 164.502(g)(5) delegates to private entities government power to decide whether a child may be subjected to abuse or could be endangered. The commenter also stated that the access provisions in §164.502(g)(3) would erect barriers where State law is silent or unclear."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 31}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 120)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ntion has been compromised by considering all the factors in combination, and we expect these risk assessments to be thorough, completed in good faith, and for the conclusions reached to be reasonable.\nIf an evaluation of the factors discussed above fails to demonstrate that there is a low probability that the protected health information has been compromised, breach notification is required. We do note, however, that a covered entity or business associate has the discretion to provide the required notifications following an impermissible use or disclosure of protected health information without performing a risk assessment. Because the final rule clarifies the presumption that a breach has occurred following every impermissible use or disclosure of protected health information, entities may decide to notify without evaluation of the probability that the protected health information has been compromised. In the future, we will issue additional guidance to aid covered entities and business associates in performing risk assessments with respect to frequently occurring scenarios. Fmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\nIn addition to the removal of the harm standard and the creation of more objective factors to evaluate the probability that protected health information has been compromised, we have removed the exception for limited data sets that do not contain any dates of birth and zip codes. In the final rule, following the impermissible use or disclosure of any limited data set, a covered entity or business associate must perform a risk assessment that evaluates the factors discussed above to determine if breach notification is not required."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 119}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 3)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\nation of vulnerabilities may represent a risk to health and typically requires continual maintenance throughout the product life cycle to assure an adequate degree of protection against such exploits.\nProactively addressing cybersecurity risks in medical devices reduces the overall risk to health. This guidance clarifies FDA's postmarket recommendations and emphasizes that manufacturers should monitor, identify, and address cybersecurity vulnerabilities and exploits as part of their postmarket management of medical devices. This guidance establishes a risk-based framework for assessing when changes to medical devices for cybersecurity vulnerabilities require reporting to the Agency and outlines circumstances in which FDA does not intend to enforce reporting requirements under 21 CFR part 806. 21 CFR part 806 requires device manufacturers or importers to report promptly to FDA certain actions concerning device corrections and removals. However, the majority of actions taken by manufacturers to address cybersecurity vulnerabilities and exploits, referred to as 'cybersecurity routine updates and patches,' are generally considered\n\n1 See FDA Guidance titled 'Content of Premarket Submissions for Management of Cybersecurity in Medical Devices' (http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM356190)\n\n## Contains Nonbinding Recommendations\n\nto be a type of device enhancement 2 for which the FDA does not require advance notification or reporting under 21 CFR part 806. For a small subset of actions taken by manufacturers to correct device cybersecurity vulnerabilities and exploits that may pose a risk to health, the FDA would require medical device manufacturers to notify the Agency. 3 Risks to health posed by the device may result in patient harm. This guidance recommends how to assess whether the risk 4 of patient harm is sufficiently controlled or uncontrolled."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 2}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 20)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ns of its public meeting on privacy and related topics. We consulted with representatives of the National Congress of American Indians, the National Indian Health Board, and the self governance tribes.\nWe also met with representatives of the National Governors' Association, the National Conference of State Legislatures, the National Association of Public Health Statistics and Information Systems, and a number of other state organizations to discuss the framework for the proposed rule, issues of special interests to the states, and the process for providing comments on the proposed rule. Many of these groups submitted comments to the proposed rule, and those were taken into account in developing the final regulation. In addition to the required consultations, we met with numerous individuals, entities, and agencies regarding the regulation, with the goal of making these standards as compatible as possible with current business practices, while still enhancing privacy protection. During the open comment period, we met with dozens of groups. Relevant federal agencies participated in the interagency working groups that developed the NPRM and the final regulation, with additional representatives from all operating divisions and many staff offices of HHS. The following federal agencies and offices were represented on the interagency working groups: the Department of Justice, the Department of Commerce, the Social Security Administration, the Department of Defense, the Department of Veterans Affairs, the Department of Labor, the Office of Personnel Management, and the Office of Management and Budget. Fmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\n## II. Section-by-Section Description of Rule Provisions\n\n## Part 160-Subpart A-General Provisions\n\nPart 160 applies to all the administrative simplification regulations. We include the entire regulation text in this rule, not just those provisions relevant to this Privacy regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 19}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 3)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n................. 250,000-500,000 business associates of covered entities ................... 200,000-400,000 business associates of covered entities ................... | $55.9 million. 14.5 million.\n1 21 million-42 million. 22.6 million-113 million. |\n| Total ......................................... | ................................................................................................................ | 114 million-225.4 million. |\n\nB. Statutory and Regulatory Background i. HIPAA and the Privacy, Security, and Enforcement Rules\n\nThe HIPAA Privacy, Security, and Enforcement Rules implement certain of the Administrative Simplification provisions of title II, subtitle F, of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) (Pub. L. 104-191), which added a new part C to title XI of the Social Security Act (sections 1171-1179 of the Social Security Act, 42 U.S.C. 1320d-1320d8). The HIPAA Administrative Simplification provisions provided for the establishment of national standards for the electronic transmission of certain health information, such as standards for certain health care transactions conducted electronically and code sets and unique identifiers for health care providers and employers. The HIPAA Administrative Simplification provisions also required the establishment of national standards to protect the privacy and security of personal health information and established civil money penalties for violations of the Administrative Simplification provisions. The Administrative Simplification provisions of HIPAA apply to three types of entities, which are known as\n\n1 The costs associated with breach notification will be incurred on an annual basis. All other costs are expected in the first year of implementation. VerDate Mar&lt;15&gt;2010\n\n''covered entities'': health care providers who conduct covered health care transactions electronically, health plans, and health care clearinghouses."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 2}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 399)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrst service delivery after the compliance date. After giving the individual a copy of the notice as of that first visit, the covered provider has no other obligation to actively distribute the notice.\nWe believe it is unnecessarily burdensome to require covered providers to mail the notice to all current and former patients each time the notice is revised, because unlike health plans, providers may have a difficult time identifying active patients. All individuals, including those who no longer see the covered provider, have the right to receive a copy of the notice on request. If the covered provider maintains a physical delivery site, it must also post the notice (including revisions to the notice) in a clear and prominent location where it is reasonable to expect individuals seeking service from the covered provider to be able to read the notice. The covered provider must also have the notice available on site for individuals to be able to request and take with them. Comment: Some comments requested clarification about the distribution requirements for a covered entity that is a health plan and a covered health care provider. Response: Under §164.504(g), discussed above, covered entities that conduct multiple types of covered functions, such as the kind of entities described in the above comments, are required to comply with the provisions applicable to a particular type of health care function when acting in that capacity. Thus, in the example described above, the covered entity is required by § 164.504(g) to follow the requirements for health plans with respect to its actions as a health plan and to follow the requirements for health care providers with respect to its actions as a health care provider. Comment: We received many comments about the ability of covered entities to distribute their notices electronically."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 398}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 203)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nUnion to understand how the privacy regulation intersects with the Data Protection Directive. We have provided guidance as to this interaction in the ''Other Federal Laws'' provisions of the preamble.\nComment: A few comments expressed concern that the proposed definition of ''individual'' excluded foreign military and diplomatic personnel and their dependents, as well as overseas foreign\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00134\n\nnational beneficiaries. They noted that the distinctions are based on nationality and are inconsistent with the stance of the E.U. Directive on Data Protection and the Department of Commerce's assurances to the European Commission. Response: We agree with the general principle that privacy protections should protect every person, regardless of nationality. As noted in the discussion of the definition of ''individual,'' the final regulation's definition does not exclude foreign military and diplomatic personnel, their dependents, or overseas foreign national beneficiaries from the definition of individual. As described in the discussion of § 164.512 below, the final rule applies to foreign diplomatic personnel and their dependents like all other individuals. Foreign military personnel receive the same treatment under the final rule as U.S. military personnel do, as discussed with regard to § 164.512 below. Overseas foreign national beneficiaries to the extent they receive care for the Department of Defense or a source acting on behalf of the Department of Defense remain generally excluded from the final rules protections. For a more detailed explanation, see § 164.500. ## Fair Credit Reporting Act\n\nComment: A few commenters requested that we exclude information maintained, used, or disclosed pursuant to the Fair Credit Reporting Act (''FCRA'') from the requirements of the privacy regulation. These commenters noted that the protection in the privacy regulation duplicate those in the FCRA."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 202}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 469)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhe requirement to obtain authorization for use or disclosure of protected health information for research, thereby creating the need for additional IRBs and privacy boards that do not currently exist.\nTo estimate the additional requirements placed on existing IRBs, the Department relied on a survey of IRBs conducted by James Bell Associates on behalf of NIH and on estimates of the total number of existing IRBs provided by NIH staff. Based on this information, the Department concluded that of the estimated 4,000 IRBs in existence, the median number of initial current research project reviews is 133 per IRB, of which only ten percent do not receive direct consent for the use of protected health information. (Obtaining consent nullifies the need for IRB privacy scrutiny.) Therefore, in the first year of implementation, there will be 76,609 initial reviews affected by the regulation, and the Department assumes that the requirement to consider the privacy protections in the research protocols under review will add an average of 1 hour to each review. The cost to researchers for having to develop protocols which protect protected health information is difficult to estimate, but the Department assumes that each of the affected 76,609 studies will require an average of an additional 8 hours of time for protocol development and implementation. At the average medical scientist hourly wage of $46.61, the initial cost is $32.1 million; the total ten-year cost of these requirements is $468 million over ten years. As stated above, some privately funded research not subject to any IRB review currently may need to obtain IRB or privacy board approval under the final rule. Estimating how much research exists which does not currently go through any IRB review is highly speculative, because the experts consulted by the Department all agree that there is no data on the volume of privately funded research. Likewise, public comments on this subject provided no useful data."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 468}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 365)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nes of protected health information for tissue, fluid, or organ donation, the regulation should not present an obstacle to the transfer of donations unsuitable for transplant to the research community.\nHowever, they believed that consent can be obtained for such purposes since the donor or donor's family must generally consent to any transplant purposes, it would seem to be a minimal additional obligation to seek consent for research purposes at the same time, should the material be unsuitable for transplant. Response: Protected health information about a deceased individual, including information related to eyes and eye tissue, can be used or disclosed further for research purposes by a covered entity in accordance with § 164.512(i)(1)(iii) without authorization or IRB or privacy board approval. This rule does not address whether organs unsuitable for transplant may be transferred to researchers with or without consent. ## Modification of the Common Rule\n\nComment: We received a number of comments that interpreted the proposed rule as having unnecessarily and inappropriately amended the Common Rule. Assuming that the Common Rule was being modified, these comments argued that the rule was legally deficient under the Administrative Procedures Act, the Regulatory Flexibility Act, and other controlling Executive orders or laws. In addition, one research organization expressed concern that, by involving IRBs in the process of approving a waiver of authorization for disclosure purposes and establishing new criteria for such waiver approvals, the proposed rule would have subjected covered entities whose IRBs failed to comply with the requirements for reviewing and approving research to potential sanctions under HIPAA. The comment recommended that the rule be changed to eliminate such a punitive result."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 364}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 18)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\ns will have to reassess and revise actions already taken in the spirit of compliance with the security regulations. Response: We cannot predict if or how future legislation may affect the rules below.\nAt present, the privacy standards at subpart E of 42 CFR part 164 have been adopted, and this final rule is compatible with them. m. Comment: One commenter stated that a data classification policy, that is a method of assigning sensitivity ratings to specific pieces of data, should be part of the final regulations. Response: We did not adopt such a policy because this final rule requires a floor of protection of all electronic protected health information. A covered entity has the option to exceed this floor. The sensitivity of information, the risks to and vulnerabilities of electronic protected health information and the means that should be employed to protect it are business determinations and decisions to be made by each covered entity. n. Comment: One commenter stated that this proposed rule conflicts with previously stated rules that acceptable\n\n17:54 Feb 19, 2003\n\nPO 00000\n\nFrm 00013\n\n''standards'' must have been developed by ANSI-recognized Standards Development Organizations (SDOs). Response: In general, HHS is required to adopt standards developed by ANSIaccredited SDOs when such standards exist. The currently existing security standards developed by ANSIrecognized SDOs are targeted to specific technologies and/or activities. No existing security standard, or group of standards, is technology-neutral, scaleable to the extent required by HIPAA, and broad enough to be adopted in this final rule. Therefore, this final rule adopts standards under section 1172(c)(2)(B) of the Act, which permits us to develop standards when no industry standards exist. o. Comment: One commenter stated that this regulation goes beyond the scope of the law, unjustifiably extending into business practices, employee policies, and facility security."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 17}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 251)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nies for dispensing drugs; they also note that virtually every state Board of Pharmacy adopted regulations imposing OBRA'90 requirements on pharmacies for all patients and not just Medicaid recipients.\nResponse: We agree that reducing medical errors is critical, and do not believe that this regulation impairs efforts to reduce medical errors. We define treatment broadly and include quality assessment and improvement activities in the definition of health care operations. Covered pharmacies may conduct such activities, as well as treatment activities appropriate to improve quality and reduce errors. We believe that respect for the privacy rights of individuals and appropriate protection of the confidentiality of their health information are compatible with the goal of reducing medical errors. Comment: Some commenters urged us to clarify that health plans do not perform ''treatment'' activities; some of these were concerned that a different approach in this regulation could cause conflict with state corporate practice of medicine restrictions. Some commenters believed that the proposed definition of treatment crossed into the area of cost containment, which would seem to pertain more directly to payment. They supported a narrower definition that would eliminate any references to third party payors. One commenter argued that the permissible disclosure of protected health information to carry out treatment is too broad for health plans and that health plans that have no responsibility for treatment or care coordination should have no authority to release health information without authorization for treatment purposes. Response: We do not consider the activities of third party payors, including health plans, to be\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\n''treatment.'' Only health care providers, not health plans, conduct ''treatment'' for purposes of this rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 250}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 11)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\ndefines ''system,'' in the context of an information system, in § 164.304 as ''an interconnected set of information resources under the same direct management control that shares common functionality.\nA system normally includes hardware, software, information, data, applications, communications, and people.''\n\n## 9. Workstation (§ 164.304)\n\nComment: One commenter expressed concern that the use of the term ''workstation'' implied limited applicability to fixed devices (such as terminals), excluding laptops and other portable devices. Response: We have added a definition of the term ''workstation'' to clarify that portable devices are also included. This final rule defines workstation as ''an electronic computing device, for example, a laptop or desktop computer, or any other device that performs similar functions, and electronic media stored in its immediate environment.''\n\n## 10. Definitions Not Adopted\n\nSeveral definitions in the proposed regulations text and glossary are not adopted as definitions in the final rule: ''participant,'' ''contingency plan,'' ''risk,'' ''role-based access control,'' and ''user-based access control.'' The terms ''participant,'' ''role-based access control,'' and ''user-based access control'' are not used in this final rule and thus are not defined. ''Risk'' is not defined as its meaning is generally understood. While we do not define the term, we address ''contingency plan'' as a standard in § 164.308(a)(7) below. a. Comment: We received comments requesting that we define the following terms: ''token'' and ''documentation.''\n\nResponse: These terms were defined in Addendum 2 of the proposed rule. In this final rule, we do not adopt a definition for ''token'' because it is not used in the final rule. ''Documentation'' is discussed in § 164.316 below. b. Comment: We received several comments that ''small'' and ''rural'' should be defined as those terms apply\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\20FER2.SGM\n\n20FER2\n\nJkt 200001\n\nto providers."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 10}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 159)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nfects, distributive impacts, and equity). Executive Order 13563 emphasizes the importance of quantifying both costs and benefits, of reducing costs, of harmonizing rules, and of promoting flexibility.\nA regulatory impact analysis must be prepared for major rules that have economically significant effects ($100 million or more in any one year) or adversely affect in a material way the economy, a sector of the economy, productivity, competition, jobs, the environment, public health or safety, or State, local, or Tribal government or communities (58 FR 51741). Based on the following analysis, this rule has been designated as an economically significant regulatory action within the meaning of section 3(f)(4) of Executive Order 12866. Accordingly, the rule has been reviewed by the Office of Management and Budget. To summarize, we estimate that the rule will result in new first-year costs of\n\nVerDate Mar&lt;15&gt;2010\n\nbetween $114 million and $225.4 million. Annualizing the midpoints of our cost estimates at three and seven percent over ten years produces costs of $35.2 million and $42.8 million, respectively. 22\n\nWe estimate that the effects of the requirement for covered entities (including indirect costs incurred by third party administrators, which frequently send out notices on behalf of health plans) to issue new notices of privacy practices, as a result of the final changes to the HIPAA Privacy Rule under both the HITECH Act and GINA, will result in new costs of $55.9 million within 12 months of the effective date of the final rule. Annualizing the costs over 10 years at 3 percent and 7 percent results in annual NPP costs of approximately $6.6 million and $8 million, respectively. We have revised our cost estimate for NPP revisions since the proposed rule to reflect the increased flexibility provided in the final rule, which allows health plans to include their new NPPs in their usual, annual mailing rather than send them to individuals in a separate mailing."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 158}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 16)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntion. The discussion above is rich with evidence about the importance of protecting privacy and the potential adverse consequences to individuals and their health if such protections are not extended.\nThe need to balance these competing interests-the necessity of protecting privacy and the public interest in using identifiable health information for vital public and private purposes-in a way that is also workable for the varied stakeholders causes much of the complexity in the rule. Achieving workability without sacrificing protection means some level of complexity, because the rule must track current practices and current practices are complex. We believe that the complexity entailed in reflecting those practices is better public policy than a perhaps simpler rule that disturbed important information flows. Although the rule taken as a whole is complicated, we believe that the standards are much less complex as they apply to particular actors. What a health plan or covered health care provider must do to comply with the rule is clear, and the two-year delayed implementation provides a substantial period for trade and professional associations, working with their members, to assess the effects of the standards and develop policies and procedures to come into compliance with them. For individuals, the system may look substantially more complicated because, for the first time, we are ensuring that individuals will receive detailed information about how their individually identifiable health information may be used and disclosed. We also provide individuals with additional tools to exercise some control over those uses and disclosures. The additional complexity for individuals is the price of expanding their understanding and their rights. The Department will work actively with members of the health care industry, representatives of individuals and others during the implementation of this rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 15}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 126)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nare meant as guidance. The sample language shall be available on the Office for Civil Rights\n\nVerDate Aug&lt;2,&gt;2002\n\nweb site at www.hhs.gov/ocr/hipaa; and may be updated or revised as necessary.\n## Appendix to the Preamble-Sample Business Associate Contract Provisions\n\n## Statement of Intent\n\nThe Department provides these sample business associate contract provisions in response to numerous requests for guidance. This is only sample language. These provisions are designed to help covered entities more easily comply with the business associate contract requirements of the Privacy Rule. However, use of these sample provisions is not required for compliance with the Privacy Rule. The language may be amended to more accurately reflect business arrangements between the covered entity and the business associate. These or similar provisions may be incorporated into an agreement for the provision of services between the entities or they may be incorporated into a separate business associate agreement. These provisions only address concepts and requirements set forth in the Privacy Rule and alone are not sufficient to result in a binding contract under State law. They do not include many formalities and substantive provisions that are required or typically included in a valid contract. Reliance on this sample is not sufficient for compliance with State law and does not replace consultation with a lawyer or negotiations between the parties to the contract. Furthermore, a covered entity may want to include other provisions that are related to the Privacy Rule but that are not required by the Privacy Rule. For example, a covered entity may want to add provisions in a business associate contract in order for the covered entity to be able to rely on the business associate to help the covered entity meet its obligations under the Privacy Rule."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 125}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 98)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nrequested by the individual, the covered entity must provide assistance in contacting those researchers to whom it is likely that the individual's protected health information was actually disclosed.\nSupport for streamlining accounting for research disclosures came in comments and from NCVHS. The Department wants to encourage research and believes protections afforded information in hands of researcher, particularly research overseen by IRB or Privacy Board, provides assurance of continued confidentiality of information. The Department does not agree that the individual has no need to know that his or her information has been disclosed for a research purpose. Covered entities, of course, may account for research disclosures in the same manner as all other disclosures. Even when the covered entity elects to use the alternative of a protocol listing, the Department encourages covered entities to provide individuals with disclosure of the specific research study or protocol for which their protected health information was disclosed, and other specific information relating to such actual disclosures if they so choose. If the covered entity lists all protocols for which the individual's information may have been disclosed, the Department would further encourage that the covered entity list under separate headings, or on separate lists, all protocols relating to particular health issues or conditions, so that individuals may more readily identify the specific studies for which their protected health information is more likely to have been disclosed. The Department intends to monitor the simplified accounting procedures for certain research disclosures to determine if they are effective in providing meaningful information to individuals about how their protected health information is disclosed for research purposes, while still reducing the administrative burden on covered entities participating in such research efforts."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 97}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 234)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne proposed rule to allow covered entities to provide banks or financial institutions with the data specified in any transaction set mandated under the Transactions Rule for health care claims payment.\nSimilarly, a private company and a state health data organization recommended broadening the scope of permissible disclosures pursuant to the banking section to include integrated claims processing information, as contained in the ASC X12N 835 and proposed for adoption in the proposed Transactions Rule; this transaction standard includes diagnostic and treatment information. The company argued that inclusion of diagnostic and treatment information in the data transmitted in claims processing was necessary for comprehensive and efficient integration in the provider's patient accounting system of data corresponding with payment that financial institutions credit to the provider's account. A state health data organization recommended applying these rules to financial institutions that process electronic remittance advice pursuant to the Transactions Rule. Response: The Transactions Rule was published August 17, 2000, after the issuance of the privacy proposed rule. As noted by the commenters, the ASC X12N 835 we adopted as the ''Health Care Payment and Remittance Advice'' standard in the Transactions Rule has two parts. They are the electronic funds transfer (EFT) and the electronic remittance advice (ERA). The EFT part is optional and is the mechanism that payors use to electronically instruct one financial institution to move money from one account to another at the same or at another financial institution. The EFT includes information about the payor, the payee, the amount, the payment method, and a reassociation trace number."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 233}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 225)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ning health care operations to the underwriting and rating of existing members places a health plan in the position of not being able to evaluate prudently and underwrite a consumer's health care risk.\nResponse: We agree that covered entities should be able to use the\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00149\n\nFmt 4701\n\nSfmt 4700\n\nprotected health information of prospective enrollees to underwrite and rate new business and change the definition of health care operations accordingly. The definition of health care operations below includes underwriting, premium rating, and other activities related to the creation of a contract of health insurance. Comment: Several commenters stated that group health plans needed to be able to use and disclose protected health information for purposes of soliciting a contract with a new carrier and rate setting. Response: We agree and add ''activities relating to the * * * replacement of a contract of insurance'' to cover such disclosures. See § 164.504 for the rules for plan sponsors of group health plans to obtain such information. Comment: Commenters from the business community supported our recognition of the importance of financial risk transfer mechanisms in the health care marketplace by including ''reinsurance'' in the definition of health care operations. However, they stated that the term ''reinsurance'' alone was not adequate to capture ''stop-loss insurance'' (also referred to as excess of loss insurance), another type of risk transfer insurance. Response: We agree with the commenters that stop-loss and excess of loss insurance are functionally equivalent to reinsurance and add these to the definition of health care operations. Comment: Commenters from the employer community explained that there is a trend among employers to contract with a single insurer for all their insurance needs (health, disability, workers' compensation)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 224}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 123)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nties. Other commenters asked that the rule exempt from the breach notification obligations situations in which a covered entity discloses information to a business associate or another covered entity.\nCommenters noted that because covered entities and business associates are required to protect the privacy of protected health information, there is little risk that even an impermissible disclosure between such entities would compromise the security or privacy of the information. Response: We do not agree that such situations warrant a blanket exception from the breach notification rules. In appropriate cases, some of these impermissible disclosures among covered entities and covered entities and business associates may fall within the existing exceptions to breach at paragraphs (1)(i) and (ii) of the definition. Otherwise, such disclosures must be evaluated as to the probability that the protected health information has been compromised based on a risk assessment of a number of factors. While the fact that the recipient of an impermissible disclosure is a covered entity or business associate with obligations to protect the privacy and security of protected health information is a consideration with respect to assessing the risk that the protected health information has been compromised, it is not the only factor. For example, a covered entity or business associate must also evaluate the extent to which the risk to the protected health information has been mitigated. Comment: Several commenters suggested that the exceptions to breach should not apply to situations where\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with workforce members or employees further use or disclose information they unintentionally or inadvertently acquired, accessed, or used, even if such further use or disclosure is permitted under the Privacy Rule."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 122}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 141)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nocedures, permit individuals to file complaints regarding these policies and procedures or a failure to comply with them, and require covered entities to refrain from intimidating or retaliatory acts.\nThus, a covered entity is required to consider and incorporate the breach notification requirements with respect to its administrative compliance and other obligations. Section 164.414(b) provides that, following an impermissible use or disclosure under the Privacy Rule, covered entities and business associates have the burden of demonstrating that all notifications were made as required by this subpart. Additionally, as part of demonstrating that all required notifications were made, a covered entity or business associate, as applicable, also must be able to demonstrate that an impermissible use or disclosure did not constitute a breach, as such term is defined at\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00093\n\n§164.402, in cases where the covered entity or business associate determined that notifications were not required. To conform to these provisions, § 160.534 of the HIPAA Enforcement Rule makes clear that, during any administrative hearing, the covered entity has the burden of going forward and the burden of persuasion with respect to these issues."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 140}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What's the difference between required and addressable implementation specifications?"}, {"role": "assistant", "content": "According to 45cfr160:\n\n[Skip to main content](#main-content)\n\nMenu\n\n[![GovInfo logo](/media/GovInfo_logo_gray.png)](/)\n[Search](#searchHolder)\n\n* Browse\n  + [A to Z](/browse-a-z)\n  + [Category](/app/browse/category)\n  + [Date](/app/browse/date)\n  + [Committee](/browse/committee)\n  + [Author](/app/browse/author)\n* About\n  + [About](/about)\n  + [Policies](/about/policies)\n  + [Authentication](/about/authentication)\n  + [Digital Preservation](/about/digital-preservation)\n  + [History](/about/history)\n  + [Agency Submission](/about/agency-submission)\n  + [U.S. Government Information](/about/us-gov-info)\n  + [FDsys Retirement](/about#fdsys-transition)\n* Developers\n  + [Developer Hub](/developers)\n  + [API](https://api.govinfo.gov/docs)\n  + [Bulk Data Repository](%20/bulkdata)\n  + [Link Service](/link-docs)\n  + [Feeds](/feeds)\n  + [Sitemaps](/sitemaps)\n  + [System Design](/developers/system-design)\n* Features\n  + [All Features](/features)\n  + [Featured Content](/features/featured-content)\n  + [News](/features/news)\n  + [Release Notes](/features/release-notes)\n  + [Finding Publications](/features/finding-publications)\n* Help\n  + [Help](/help)\n  + [Finding Information](%20/help/finding-info)\n  + [What's Available](/help/whats-available)\n  + [Tutorials and Handouts](/help/tutorials-handouts)\n  + [Other Resources](%20/help/other-resources)\n* Feedback\n  + [Submit Feedback](https://www.surveymonkey.com/r/govinfo-feedback-survey)\n  + [Contact Us](/contact)\n\n* [Toggle the Search Widget\n  Search](#searchHolder)\n\n# Page Not Found\n\n![Icon: Share using Facebook](/sites/default/files/fb-icon-white.png)\n![Icon: Share using Email](/sites/default/files/email-icon-white.png)\n![Icon: Copy Link URL](/sites/default/files/link-icon-white.png)\n\n[Help](/help/other)\n\n---\n\n**Error occurred. The page you requested cannot be found.**\n\nPlease report this error to [askGPO.](https://www.gpo.gov/error-pages/askgpo)\n\nProvide the following information to help us resolve this problem: the URL of the page you were trying to acce"}], "metadata": {"source": "45cfr160", "implementation_spec": "both", "safeguard_types": ["unknown"], "type": "implementation"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 66)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nmmenters responded to the Department's request for comments on how to appropriately limit uses and disclosures following revocation of an authorization, while preserving the integrity of the research.\nThe NPRM attempted to clarify that ''even though a revocation will prevent a covered entity from further disclosing protected health information for research purposes, the exception to this requirement is intended to allow for certain continued uses of information as appropriate to preserve the integrity of the research study.'' However, the NPRM further stated that ''if covered entities were permitted to continue using or disclosing protected health information for the research project even after an individual had revoked his or her authorization, this would undermine the primary objective of the authorization requirements to be a voluntary, informed choice of the individual.'' Several commenters were concerned and confused by the NPRM's statements. In particular, the Department received comments urging that the regulation permit covered entities to use and disclose research data already obtained, even after an individual has withdrawn his or her authorization. These commenters suggested that once a subject has authorized the use and disclosure of protected health information for research and the covered entity has relied on the authorization, the covered entity must retain the ability to use or disclose the subject's pre-withdrawal information for purposes consistent with the overall research. One commenter argued that it would be inadequate for the reliance exception at §164.508(b)(5) to be interpreted to permit continued uses of the individual's information as appropriate only to account for an individual's withdrawal from the study."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 65}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 21)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\ngement tool does not necessarily equate to compliance with the HIPAA Security Rule. Regulated entities may find additional resources in Appendix F that can assist in the risk assessment process. ## 4.\nRisk Management Guidance\n\nThe assessment and management of risk to ePHI provide the foundation for a regulated entity's Security Rule [Sec. Rule] compliance efforts. Readers are reminded of the Security Rule's flexibility of approach. HHS OCR does not prescribe any particular risk assessment or risk management methodology. This section provides background information about risk management as well as an approach from [IR 8286] that regulated entities may choose to use when managing risk to ePHI. However, regulated entities are free to use another risk management methodology 25 that effectively safeguards the confidentiality, integrity, and availability of ePHI. All ePHI created, received, maintained, or transmitted by a regulated entity is subject to the Security Rule. Regulated entities are required to implement reasonable and appropriate security measures to protect against reasonably anticipated threats or vulnerabilities to the confidentiality, integrity, and availability of ePHI. Risk management should be performed with regular frequency to examine past decisions, reevaluate risk likelihood and impact levels, and assess the effectiveness of past remediation efforts. ## 4.1. HIPAA Risk Management Requirements\n\nStandard 164.308(a)(1)(i), Security Management Process , requires regulated entities to:\n\nImplement policies and procedures to prevent, detect, contain, and correct security violations. The Security Management Process standard includes four required implementation specifications. Two of these specifications deal directly with risk analysis and risk management. 1."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 20}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 138)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ndiscovered by a business associate as of the first day on which such breach is known to the business associate or, by exercising reasonable diligence, would have been known to the business associate.\nAs with a covered entity, a business associate shall be deemed to have knowledge of a breach if the breach is known, or by exercising reasonable diligence would have been known, to any person, other than the person committing the breach, who is an employee, officer, or other agent of the business associate (determined in accordance with the Federal common law of agency). Similarly, as with knowledge imputed to covered entities, the Federal common law of agency controls in determining who is an agent of the business associate. 18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00091\n\nSection 164.410(b) requires that a business associate provide notice of a breach of unsecured protected health information to a covered entity without unreasonable delay and in no case later than 60 days following the discovery of a breach. With respect to timing, if a business associate is acting as an agent of a covered entity, then, pursuant to §164.404(a)(2), the business associate's discovery of the breach will be imputed to the covered entity. In such circumstances, the covered entity must provide notifications under § 164.404(a) based on the time the business associate discovers the breach, not from the time the business associate notifies the covered entity. In contrast, if the business associate is not an agent of the covered entity, then the covered entity is required to provide notification based on the time the business associate notifies the covered entity of the breach. We encouraged covered entities and business associates to address the timing of this notification in their business associate contracts."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 137}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 87)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nl is necessary. Comment: One commenter said that HHS should not create a list of excluded direct identifiers; rather it should enunciate principles and leave it to researchers to apply the principles.\nResponse: The statistical method of de-identification is based on scientific principles and methods and leaves the application to the researcher and the covered entity. Unfortunately, many have viewed this approach as too complex or imprecise for broad use. To allow broad discretion in selection of variables in the creation of a limited data set would trigger the same concerns as the statistical method, because some\n\nVerDate Aug&lt;2,&gt;2002\n\nmeasure of reasonableness would have to be established. Commenters have consistently asked for precision so that they would not have to worry as to whether they were in compliance with the requirements of the Privacy Rule. The commenter's proposal runs counter to this desire for precision. Comment: One commenter wanted prescription numbers allowed in a limited data set because they do not include any ''facially identifiable information.''\n\nResponse: Prescription numbers are medical record numbers in that they are used to track an individual's encounter with a health care provider and are uniquely associated with that individual. The fact that an individual receives a new prescription number for each prescription, even if it is randomly generated, is analogous to an individual receiving a separate medical record number for different hospital visits. Thus, a prescription number is an excluded direct identifier under the medical record number exclusion for the limited data set (and also must be excluded in the creation of de-identified data). Comment: One commenter wanted clarification that a sponsor of a multiemployer group health plan could utilize the limited data set approach for the purpose of resolving claim appeals."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 86}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 135)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nbed in § 164.508, or the opportunity for the individual to agree or object as described in § 164.510, in the situations covered by this section, subject to the applicable requirements of this section.\n* * *\n\n*\n\n*\n\n*\n\n*\n\nVerDate Aug&lt;2,&gt;2002\n\n*\n\n19:04 Aug 13, 2002\n\nJkt 197001\n\n- (b) Standard: uses and disclosures for public health activities. - (1) Permitted disclosures. * * *\n- (iii) A person subject to the jurisdiction of the Food and Drug Administration (FDA) with respect to an FDA-regulated product or activity for which that person has responsibility, for the purpose of activities related to the quality, safety or effectiveness of such FDA-regulated product or activity. Such purposes include:\n- (A) To collect or report adverse events (or similar activities with respect to food or dietary supplements), product defects or problems (including problems with the use or labeling of a product), or biological product deviations;\n- (B) To track FDA-regulated products;\n- (C) To enable product recalls, repairs, or replacement, or lookback (including locating and notifying individuals who have received products that have been recalled, withdrawn, or are the subject of lookback); or\n- (D) To conduct post marketing surveillance;\n\n*\n\n*\n\n*\n\n*\n\n*\n\n- (i) Standard: Uses and disclosures for research purposes. * * *\n- (2) Documentation of waiver approval. * * *\n- (ii) Waiver criteria."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 134}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 62)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nignate themselves as a single covered entity for purposes of subparts C and E of this part. - (1) Implementation specifications:\n2. (i) Requirements for designation of an affiliated covered entity. 3.\n(A) Legally separate covered entities may designate themselves (including any health care component of such covered entity) as a single affiliated covered entity, for purposes of subparts C and E of this part, if all of the covered entities designated are under common ownership or control. 4. (B) The designation of an affiliated covered entity must be documented and the documentation maintained as required by paragraph (c) of this section. 5. (ii) Safeguard requirements . An affiliated covered entity must ensure that:\n6. (A) The affiliated covered entity's creation, receipt, maintenance, or transmission of electronic protected health information complies with the applicable requirements of subpart C of this part;\n7. (B) The affiliated covered entity's use and disclosure of protected health information comply with the applicable requirements of subpart E of this part; and\n8. (C) If the affiliated covered entity combines the functions of a health plan, health care provider, or health care clearinghouse, the affiliated covered entity complies with\n9. §164.308(a)(4)(ii)(A) and § 164.504(g), as applicable. 10. (c)(1) Standard: Documentation. A covered entity must maintain a written or electronic record of a designation as required by paragraphs (a) or (b) of this section. (2) Implementation specification: Retention period . A covered entity must retain the documentation as required by paragraph (c)(1) of this section for 6 years from the date of its creation or the date when it last was in effect, whichever is later. 5. A new subpart C is added to part 164 to read as follows:\n\n## Subpart C-Security Standards for the Protection of Electronic Protected Health Information\n\nSec. 164.302\n\nApplicability. 164.304 Definitions. 164.306 Security standards: General rules."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 61}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 39)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nizations and Mergers and Takeovers in U.S. Law 5 (July 17, 2000); Department of Commerce, Safe Harbor Privacy Principles Issued by the U.S. Department of Commerce on July 21, 2000, 65 FR 45666 (2000).\nThe Principles and our privacy regulation are based on common principles of fair information practices. We believe they are essentially consistent and that an organization complying with our privacy regulation can fairly and correctly self-certify that it complies with the Principles. If a true conflict arises between the privacy regulation and the Principles, the Department of Commerce's guidance provides that an entity must comply with the U.S. law. ## Part 160-Subpart C-Compliance and Enforcement\n\nProposed §164.522 included five paragraphs addressing activities related to the Secretary's enforcement of the rule. These provisions were based on procedures and requirements in various civil rights regulations. Proposed §164.522(a) provided that the Secretary would, to the extent practicable, seek the cooperation of covered entities in obtaining compliance, and could provide technical assistance to covered entities to help them comply voluntarily. Proposed § 164.522(b) provided that individuals could file complaints with the Secretary. However, where the complaint related to the alleged failure of a covered entity to amend or correct protected health information as proposed in the rule, the Secretary would not make certain determinations such as whether protected health information was accurate or complete. This paragraph also listed the requirements for filing complaints and indicated that the Secretary may investigate such complaints and what might be reviewed as part of such investigation. Under proposed §164.522(c), the Secretary would be able to conduct compliance reviews."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 38}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 381)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ners asserted that this requirement creates a disincentive for covered entities to deidentify data and would compromise the Secretary's desire to see deidentified data used for a multitude of purposes.\nOthers stated that the ''no reason to believe'' test creates an unreasonable burden on covered entities, and would actually chill the release of de-identified information, and set an impossible standard. Response: We recognize that the proposed standards might have imposed a burden that could have prevented the widespread use of de-identified information. We believe that our modifications to the final rule discussed above will make the process less burdensome and remove some of the disincentive. However, we could not loosen the standards as far as many commenters wanted without seriously jeopardizing the privacy of the subjects of the information. As discussed above, we modify the ''no reason to know'' standard that was part of the safe harbor provision and replace it in the final rule with an ''actual knowledge'' standard. We believe that this change provides additional certainty to covered entities using the safe harbor and should eliminate any chilling effect. Comments: Although most commenters wanted to see data elements taken off the list, there were a small number of commenters that wanted to see data items added to the list. They believed that it is also necessary to remove clinical trial record numbers, device model serial numbers, and all proper nouns from the records. Response: In response to these requests, we have slightly revised the list of identifiers that must be removed under the safe harbor provision."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 380}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 126)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ners that must be removed. The intent of the safe harbor is to provide a means to produce some deidentified information that could be used for many purposes with a very small risk of privacy violation.\nThe safe harbor is intended to involve a minimum of burden and convey a maximum of certainty that the rules have been met by interpreting the statutory ''reasonable basis to believe that the information can be used to identify the individual'' to produce an easily followed, cook book approach. Covered entities may use codes and similar means of marking records so that they may be linked or later re-identified, if the code does not contain information about the subject of the information (for example, the code may not be a derivative of the individual's social security number), and if the covered entity does not use or disclose the code for any other purpose. The covered entity is also prohibited from disclosing the mechanism for re-identification, such as tables, algorithms, or other tools that could be used to link the code with the subject of the information. Language to clarify that covered entities may contract with business associates to perform the deidentification has been added to the section on business associates. ## Section 164.514(d)-Minimum Necessary\n\nThe proposed rule required a covered entity to make all reasonable efforts not to use or disclose more than the minimum amount of protected health information necessary to accomplish the intended purpose of the use or disclosure (proposed § 164.506(b)). The proposed minimum necessary standard did not apply to uses or disclosures that were made by covered entities at the request of the individual,\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\neither to allow the individual access to protected health information about him or her or pursuant to an authorization initiated by the individual."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 125}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 36)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nProtection from Malicious Software, Login Monitoring, and Password Management Implementation Specifications (All Addressable) | • As reasonable and appropriate, train workforce members regarding procedures for: o Guarding against, detecting, and reporting malicious software; o Monitoring login attempts and reporting discrepancies; and o Creating, changing, and safeguarding passwords. • Incorporate information concerning workforce members' roles and responsibilities in implementing these implementation specifications into training and awareness efforts. | • Do workforce members know the importance of the timely application of system patches to protect against malicious software and the exploitation of vulnerabilities? • Are workforce members aware that login attempts may be monitored? • Do workforce members who monitor login attempts know to whom to report discrepancies? • Do workforce members understand their roles and responsibilities in selecting a password of appropriate strength, safeguarding their password, and changing a password when it has been compromised or is suspected of being compromised? • Are there policies in place that prohibit workforce members from sharing passwords with others? |\n| 4. Develop Appropriate Awareness and Training Content, Materials, and Methods                                                    | • Select topics to be included in the training materials, and consider current and relevant topics (e.g., phishing, email security) for the protection of ePHI. • Incorporate new information from email advisories, online IT security, daily news, websites, and periodicals, as reasonable and appropriate. • Consider using a variety of media and avenues according to what is appropriate for the organization based on workforce size, location, level of education, and other factors. • Training should be an ongoing, evolving process in response to environmental and operational changes that affect the security of ePHI."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 35}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 26)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nut not to a business associate agent. However, the covered entity is required to enter into a business associate agreement with a business associate agent that it does not treat as a workforce member.\nThe proposed change to § 160.402(c) simply makes the covered entity or business associate liable for the acts of its agents acting within the scope of agency, whether the agents are workforce members or business associates. See the definitions of ''business associate'' and ''workforce member'' at § 160.103. 18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00018\n\nc. Section 160.404-Amount of a Civil Monetary Penalty Interim Final Rule\n\nThe IFR amended §160.404 to revise the range of potential civil money penalty amounts a covered entity (or business associate) will be subject to for violations occurring on or after February 18, 2009, as a result of section 13410(d) of the HITECH Act. Prior to the HITECH Act, section 1176(a) of the Social Security Act authorized the Secretary to impose a civil money penalty of not more than $100 for each violation, with the total amount imposed on a covered entity for all violations of an identical requirement or prohibition during a calendar year not to exceed $25,000. As described above, section 13410(d) of the HITECH Act modified section 1176(a) to establish tiers of increasing penalty amounts for violations based on increasing levels of culpability associated with each tier. Accordingly, the IFR adopted at §160.404(b) the new penalty scheme provided for at section 13410(d) of the HITECH Act for violations occurring on or after February 18, 2009. The IFR retained the pre-HITECH maximum penalty amounts of not more than $100 per violation and $25,000 for identical violations during a calendar year, for violations occurring before February 18, 2009."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 25}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 233)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nithin that definition can be accomplished without authorization. We believe that these changes will clarify the distinction between marketing and payment and address the concerns raised by commenters.\nComment: Commenters asserted that HHS should not include long-term care insurance within the definition of ''health plan.'' If they are included, the commenters argued that the definition of payment must be modified to reflect the activities necessary to support the payment of long-term care insurance claims. As proposed, commenters argued that the definition of payment would not permit long term care insurers to use and disclose protected health information without authorization to perform functions that are ''compatible with and directly relate to * * * payment'' of claims submitted under long term care policies. Response: Long-term care policies, except for nursing home fixedindemnity policies, are defined as health plans by the statute (see definition of ''health plan,'' above). We disagree with the assertion that the definition of payment does not permit long term care insurers to undertake these necessary activities. Processing of premium payments, claims administration, and other activities suggested for inclusion by the commenters are covered by the definition. The rule permits protected health information to be used or disclosed by a health plan to determine or fulfill its responsibility for provision of benefits under the health plan. Comment: Some commenters argued that the definition needs to be expanded to include the functions of obtaining stop-loss and ceding reinsurance. Response: We agree that use and disclosure of protected health information for these activities should be permitted without authorization, but have included them under health care operation rather than payment. Comment: Commenters asked that the definition be modified to include collection of accounts receivable or outstanding accounts."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 232}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 294)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nwithout authorization, and prospective research subjects will be informed about how research information about them would be used and disclosed should they agree to participate in the research study.\nWe believe this provision in the final rule provides covered entities that participate in research necessary flexibility to enhance privacy protections for research information and provides prospective research subjects with needed information to determine whether their privacy interests would be adequately protected before agreeing to participate in a research study that involves the delivery of health care. The intent of this provision is to permit covered entities that participate in research to bind themselves to a more limited scope of uses and disclosures for all or identified subsets of research information generated from research that involves the delivery of treatment than it may apply to other protected health information. In designing their authorizations, we expect covered entities to be mindful of the often highly sensitive nature of research information and the impact of individuals' privacy concerns on their willingness to participate in research. For example, a covered entity conducting a study which involves the evaluation of a new drug, as well as an assessment of a new un-validated genetic marker of a particular disease, could choose to stipulate in the research authorization that the genetic information generated from this study will not be disclosed without authorization for some of the public policy purposes that would otherwise be permitted by the rule under §§164.510 and 164.512 and by the covered entity's notice. A covered entity may not, however, include a limitation affecting its right to make a use or disclosure that is either required by law or is necessary to avert a serious and imminent threat to health or safety."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 293}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 132)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\niduals provide substitute notification to such individuals via posting on their Web site or notification in major print or broadcast media in the areas in which the affected individuals likely reside.\nAdditionally, the statute requires such ''notice in media or web posting will include a toll-free phone number where an individual can learn whether or not the individual's unsecured protected health information is possibly included in the breach.'' Thus, we retain these requirements in this final rule. Response to Other Public Comments\n\nComment: One commenter expressed concern about providing breach notification to individuals by first-class mail because it could require some\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00087\n\nentities, such as those that have Webbased relationships with individuals, to collect more information about individuals (e.g., physical addresses) than they currently do. Response: The Rule allows a covered entity to provide written breach notice to an affected individual by email if the individual agrees to electronic notice and such agreement has not been withdrawn. We would expect that covered entities that have primarily or solely an online relationship with individuals would ask and encourage individuals to receive breach notices by email and that generally individuals would agree. However, an individual that does not affirmatively agree to receive breach notices by email, or that withdraws a prior agreement, has a right to notice by first-class mail. Comment: One commenter suggested that we excuse a covered entity from providing notification of a breach to an individual where a licensed health care professional has determined in the exercise of professional judgment that the provision of such notice is likely to cause substantial harm to the individual. The commenter appeared to be concerned due to the nature of the services it provides-mental health services-and the distress breach notification could cause for certain of its patients."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 131}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 59)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nal Representatives\n\nIn the proposed rule we defined ''individual'' to include certain persons who were authorized to act on behalf of the person who is the subject of the protected health information.\nFor adults and emancipated minors, the NPRM provided that ''individual'' includes a legal representative to the extent to which applicable law permits such legal representative to exercise the individual's rights in such contexts. With respect to unemancipated minors, we proposed that the definition of ''individual'' include a parent, guardian, or person acting in loco parentis , (hereinafter referred to as ''parent'') except when an unemancipated minor obtained health care services without the consent of, or notification to, a parent. Under the proposed rule, if a minor obtained health care services under these conditions, the minor would have had the exclusive rights of an individual with respect to the protected health information related to such health care services. In the final rule, the definition of ''individual'' is limited to the subject of the protected health information, which includes unemancipated minors and other individuals who may lack capacity to act on their own behalf. We remove from the definition of ''individual'' the provisions regarding legal representatives. The circumstances in which a representative must be treated as an individual for purposes of this rule are addressed in a separate standard titled ''personal representatives.'' (§ 164.502(g)). The standard regarding personal representatives incorporates some changes to the proposed provisions regarding legal representatives. In general, under the final regulation, the ''personal representatives'' provisions are directed at the more formal representatives, while § 164.510(b) addresses situations in which persons are informally acting on behalf of an individual."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 58}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 18)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nvailable or disclosed to unauthorized persons or processes). The impact of an unauthorized disclosure of ePHI can range from jeopardizing national security to disclosing data about individual persons.\nThe unauthorized, unanticipated, or unintentional disclosure of ePHI could result in the loss of public confidence, embarrassment, legal action against the organization, and/or federal, state, and local regulatory actions. |\n| Loss of Integrity       | System and data integrity refers to the requirement that information be protected from improper modification (i.e., data or information have not been altered or destroyed in an unauthorized manner). Integrity is lost if unauthorized changes are made to the data or system by either intentional or accidental acts."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 17}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement administrative controls?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160, 162, and 164 [CMS-0049-F] RIN 0938-AI57\n\n## Health Insurance Reform: Security Standards\n\nAGENCY: Centers for Medicare &amp; Medicaid Services (CMS), HHS. ACTION: Final rule. SUMMARY: This final rule adopts standards for the security of electronic protected health information to be implemented by health plans, health care clearinghouses, and certain health care providers. The use of the security standards will improve the Medicare and Medicaid programs, and otherFederal health programs and private health programs, and the effectiveness and efficiency of the health care industry in general by establishing a level of protection for certain electronic health information. This final rule implements some of the requirements of the Administrative Simplification subtitle of the Health Insurance Portability andAccountability Act of 1996 (HIPAA). DATES: Effective Date: These regulations are effective on April 21, 2003. Compliance Date: Covered entities, with the exception of small health plans, must comply with the requirements of this final rule by April 21, 2005. Small health plans must comply with the requirements of this final rule by April 21, 2006. FOR FURTHER INFORMATION CONTACT: William Schooler, (410) 786-0089. SUPPLEMENTARY INFORMATION:\n\n## Availability of Copies and Electronic Access\n\nTo order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 or by faxing to (202) 5122250. The cost for each copy is $10."}], "metadata": {"source": "security_rule_2003", "safeguard_type": "administrative", "implementation_spec": "both", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 24)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nanations are designed to help get an entity started in addressing the HIPAA Security Rule. The first description bullet of each key activity that is also an implementation specification is in italics.\nWhen a relationship exists between description bullets and other Security Rule standards or implementation specifications, it is indicated in an accompanying footnote. - Sample Questions - This column includes questions that a regulated entity may ask itself to determine whether the standard has been adequately implemented. These sample questions are not exhaustive but are representative of the questions that a regulated entity may find helpful when implementing the Security Rule standards and implementation specifications. Affirmative answers to these questions do not necessarily imply that an entity is meeting all of the requirements of the HIPAA Security Rule standards. Negative answers to these questions should prompt the regulated entity to consider whether it needs to take further action to comply with the standards. Organizations with existing information security programs may have already considered many of the sample questions. The questions that an organization asks in implementing the Security Rule should be tailored to fit the unique circumstances of each entity. This document does not discuss Section 164.105 of the HIPAA Security Rule, Organizational Requirements , in detail as it does not set out general security principles. HIPAA-regulated entities are encouraged to review this section of the HIPAA Security Rule in full and seek further guidance if needed. Readers are reminded of the Security Rule's flexibility of approach. The following key activities, descriptions, and sample questions are meant to be informative, not prescriptive. This flexibility allows regulated entities to customize how they implement HIPAA's Security Rule requirements."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 23}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 222)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nstances under which related organizations may be treated as a single covered entity for purposes of protecting the privacy of health information, and modify the rule to accommodate such circumstances.\nIn § 164.504 of the final rule, we specify the conditions under\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00147\n\nwhich affiliated companies may combine into a single covered entity and similarly describe which components of a larger organization must comply with the requirements of this rule. For example, transfers of information within the designated component or affiliated entity are uses while transfers of information outside the designated component or affiliated entity are disclosures. See the discussion of §164.504 for further information and rationale. It is not clear from these comments whether the particular organizational arrangements described could constitute a single covered entity. Comment: A commenter noted that the definition of ''disclosure'' should reflect that health plan correspondence containing protected health information, such as Explanation of Benefits (EOBs), is frequently sent to the policyholder. Therefore, it was suggested that the words ''provision of access to'' be deleted from the definition and that a ''disclosure'' be clarified to include the conveyance of protected health information to a third party. Response: The definition is, on its face, broad enough to cover the transfers of information described and so is not changed. We agree that health plans must be able to send EOBs to policyholders. Sending EOB correspondence to a policyholder by a covered entity is a disclosure for purposes of this rule, but it is a disclosure for purposes of payment. Therefore, subject to the provisions of §164.522(b) regarding Confidential Communications, it is permitted even if it discloses to the policyholder protected health information about another individual (see below)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 221}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 146)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nobability of needing long-term care in the future and diagnosis of a particular condition is not the only way this may be determined and in some cases may not even be relevant to such a determination.\nThe Department also heard similar concerns about the potential negative impact of an underwriting prohibition on the economic viability of the long-term market, from certain members of Congress who wrote to the Secretary on this issue, as well as from certain outside parties during fact finding meetings held by the Department. 18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00096\n\nFinal Rule\n\nThe final rule adopts the approach of the proposed rule to apply the prohibition on using or disclosing protected health information that is genetic information for underwriting purposes to all health plans that are covered entities under the HIPAA Privacy Rule, including those to which GINA does not expressly apply, except with regard to issuers of long term care policies. We continue to disagree with the commenters that stated such an extension would conflict with GINA and is outside the scope of our authority. As explained more fully in the proposed rule, the Department has broad authority under HIPAA to regulate a health plan's uses and disclosures of protected health information, including genetic information, to protect an individual's privacy interests. See 74 FR 51698, 51699-51700. It does not follow that by exempting ''excepted benefits'' from the prohibitions under GINA that Congress intended to restrict the Department's broad authority under HIPAA. Further, there is no conflict with GINA in extending the same privacy protections outlined in GINA to those health plans that are not covered by GINA but are otherwise covered by the HIPAA Privacy Rule. GINA and section 264 of HIPAA are not irreconcilably inconsistent but rather operate concurrently without conflict."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 145}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 24)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nere intended to address those problems or issues that presented workability problems for covered entities or otherwise had the potential to impede an individual's timely access to quality health care.\nMoreover, the proposed modifications to the minimum necessary standard were either minor clarifications of the Department's intent with respect to the standard or would conform the standard to other proposed modifications. The Department has, in previous guidance as well as in the preamble to the December 2000 Privacy Rule, explained its position with respect to the above concerns. The minimum necessary standard is derived from confidentiality codes and practices in common use today. We continue to believe that it is sound practice not to use or disclose private medical information that is not necessary to satisfy a request or effectively carry out a function. The privacy benefits of retaining the minimum necessary standard outweigh the burden involved with implementing the standard. The Department reiterates that position here. Further, the Department designed the minimum necessary standard to be sufficiently flexible to accommodate the various circumstances of any covered entity. Covered entities will develop their own policies and procedures to meet this standard. A covered entity's policies and procedures may and should allow the appropriate individuals within an entity to have access to protected health information as necessary to perform their jobs with respect to the entity's covered functions. The Department is not aware of any workability issues with this standard. With respect to disclosures to another covered entity, the Privacy Rule permits a covered entity reasonably to rely on another covered entity's request for protected health information as the minimum necessary for the intended disclosure. See § 164.514(d)(3)(iii). The Department does not believe, therefore, that a blanket exception for such disclosures is justified."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 23}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 333)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nects may be used in court and thereby become public knowledge. These commenters urged us to take steps to minimize or prevent such protected health information from becoming part of the public record.\nResponse: We agree that individuals should be protected from unnecessary public disclosure of health information about them. However, we do not have the statutory authority in this regulation to require courts to impose protective orders. To the extent possible within the HIPAA statutory authority, we address this problem in § 164.512(e), Judicial and Administrative Proceedings. Comment: Some commenters argued that evidence obtained in violation of the regulation should be inadmissible at trial. Response: In this regulation, we do not have the authority to regulate the courts. We can neither require nor prohibit courts from excluding evidence obtain in violation of this regulation. Comments Regarding Proposed §164.510(f)(1), Disclosures to Law Enforcement Pursuant to Process\n\nComments Supporting or Opposing a Requirement of Consent or Court Order\n\nComment: Some commenters argued that a rule that required a court order for every instance that law enforcement sought protected health information would impose substantial financial and administrative burdens on federal and state law enforcement and courts. Other commenters argued that imposing a new requirement of prior judicial process would compromise the time-sensitive nature of many investigations. Response: We do not impose such a requirement in this regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 332}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 83)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nify that certain compound authorizations, as described below, are defective. We also clarify that authorizations that are not completely filled out with respect to the required elements are defective.\nFinally, we clarify that an authorization with information that the covered entity knows to be false is defective only if the information is material. As under the proposed regulation, an authorization that the covered entity knows has been revoked is not a valid authorization. We note that, although an authorization must be revoked in writing, the covered entity may not always ''know'' that an authorization has been revoked. The writing required for an individual to revoke an authorization may not always trigger the ''knowledge'' required for a covered entity to consider an authorization defective. Conversely, a copy of the written revocation is not required before a provider ''knows'' that an authorization has been revoked. Many authorizations will be obtained by persons other than the covered entity. If the individual revokes an authorization by writing to that other person, and neither the individual nor the other person informs the covered entity of the revocation, the covered entity will not ''know'' that the authorization has been revoked. For example, a government agency may obtain an individual's authorization for ''all providers who have seen the individual in the past year'' to disclose protected health information to the agency for purposes of determining eligibility for benefits. The individual may revoke the authorization by writing to the government agency requesting such revocation. We cannot require the agency to inform all covered entities to whom it has presented the authorization that the authorization has been revoked. If a covered entity does not know of the revocation, the covered entity will not violate this rule by acting pursuant to the authorization."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 82}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 16)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\novided, manufacturers may choose to provide these additional elements as part of the SBOM, or they may provide it separately, such as in an addendum. Industry-accepted formats of SBOMs are encouraged.\nIf a manufacturer is unable to provide the SBOM information to FDA, the manufacturer should provide a justification for why the information cannot be included in the premarket submission. As part of the premarket submission, manufacturers should also identify all known vulnerabilities associated with the device and the software components, including those identified in CISA's Known Exploited Vulnerabilities Catalog. For each known vulnerability, manufacturers should describe how the vulnerabilities were discovered to demonstrate whether the assessment methods were sufficiently robust. For components with known vulnerabilities, device manufacturers should provide in premarket submissions:\n\n- A safety and security risk assessment of each known vulnerability (including device and system impacts); and\n- Details of applicable safety and security risk controls to address the vulnerability. If risk controls include compensating controls, those should be described in an appropriate level of detail. For additional information and discussion regarding proprietary and third-party components, see Section V.B.2, Security Architecture Views, below. ## Contains Nonbinding Recommendations\n\n## 5. Security Assessment of Unresolved Anomalies\n\nFDA's Premarket Software Guidance recommends that device manufacturers provide a list of software anomalies that exist in a product at the time of submission. For each anomaly, FDA recommends that device manufacturers conduct an evaluation of the anomaly's impact on the device's safety and effectiveness, and consult the Premarket Software Guidance to assess the associated documentation recommended for inclusion in such device's premarket submission."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 15}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the administrative safeguards under HIPAA?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160, 162, and 164 [CMS-0049-F] RIN 0938-AI57\n\n## Health Insurance Reform: Security Standards\n\nAGENCY: Centers for Medicare &amp; Medicaid Services (CMS), HHS. ACTION: Final rule. SUMMARY: This final rule adopts standards for the security of electronic protected health information to be implemented by health plans, health care clearinghouses, and certain health care providers. The use of the security standards will improve the Medicare and Medicaid programs, and otherFederal health programs and private health programs, and the effectiveness and efficiency of the health care industry in general by establishing a level of protection for certain electronic health information. This final rule implements some of the requirements of the Administrative Simplification subtitle of the Health Insurance Portability andAccountability Act of 1996 (HIPAA). DATES: Effective Date: These regulations are effective on April 21, 2003. Compliance Date: Covered entities, with the exception of small health plans, must comply with the requirements of this final rule by April 21, 2005. Small health plans must comply with the requirements of this final rule by April 21, 2006. FOR FURTHER INFORMATION CONTACT: William Schooler, (410) 786-0089. SUPPLEMENTARY INFORMATION:\n\n## Availability of Copies and Electronic Access\n\nTo order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 or by faxing to (202) 5122250. The cost for each copy is $10."}], "metadata": {"source": "security_rule_2003", "safeguard_type": "administrative", "implementation_spec": "both", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 150)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nre of the disputed information. Covered entities would have been permitted to establish a limit to the length of the individual's statement of disagreement and to summarize the statement if necessary.\nWe also proposed to permit covered entities to provide a rebuttal to the individual's statement with future disclosures. As in the proposed rule, if a covered entity denies a request for amendment, it must provide the individual with a statement of denial written in plain language. The written denial must include the basis for the denial, how the individual may file a written statement disagreeing with the denial, and how the individual may make a complaint to the covered entity and the Secretary. In the final rule, we additionally require the covered entity to inform individuals of their options with respect to future disclosures of the disputed information in order to ensure that an individual is aware of his or her rights. The written denial must state that if the individual chooses not to file a statement of disagreement, the individual may request that the covered entity include the individual's request for amendment and the covered entity's denial of the request with any future disclosures of the protected health information that is the subject of the requested amendment. As in the proposed rule, the covered entity must permit the individual to submit a written statement disagreeing with the denial and the basis of such disagreement. The covered entity may reasonably limit the length of a statement of disagreement and may prepare a written rebuttal to the individual's statement of disagreement. If the covered entity prepares a rebuttal, it must provide a copy to the individual."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 149}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 461)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntions. That rule adopted standards for eight electronic code sets to be used for those transactions. The proposed rule for security and electronic signature standards was published on August 12, 1998.\nThat proposal specified the security requirements for covered entities that transmit and store information specified in Part C, Title II of the Act. In general, that proposed rule proposed administrative and technical standards for protecting ''* * * any health information pertaining to an individual that is electronically\n\n45 ''Health plans,'' for purposes of the regulatory impact and regulatory flexibility analyses, include licensed insurance carriers who sell health products; third party administrators that will have to comply with the regulation for the benefit of the plan sponsor; and self-insured health plans that are at least partially administered by the plan sponsor. Frm 00305\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nmaintained or transmitted.'' (63 FR 43243). The final Security Rule will detail the system and administrative requirements that a covered entity must meet in order to assure itself and the Secretary that health information is safe from destruction and tampering from people without authorization for its access. By contrast, the Privacy Rule describes the requirements that govern the circumstances under which protected health information must be used or disclosed with and without patient involvement and when a patient may have access to his or her protected health information. While the vast majority of health care entities are privately owned and operated, we note that federal, state, and local government providers are reflected in the total costs as well. Federal, state, and locally funded hospitals represent approximately 26 percent of hospitals in the United States. This is a significant portion of hospitals, but it represents a relatively small proportion of all provider entities."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 460}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 468)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nThis section describes only the cost associated with the production and provision of a notice. The cost of developing the policy stated in the notice is covered under policies and procedures, above.\nCovered health care providers with direct treatment relationships are required to provide a notice of privacy practices no later than the date of the first service delivery to individuals after the compliance date for the covered health care provider. The Department assumed that for most types of health care providers (such as physicians, dentists, and pharmacists) one notice would be distributed to each patient during his or her first visit following the compliance date for the covered provider, but not for subsequent visits. For hospitals, however, the Department assumed that a notice would be provided at each admission, regardless of how many visits an individual has in a given year. In subsequent years, the Department assumed that non-hospital providers would only provide notices to their new patients, because it is assumed that providers can distinguish between new and old patients, although hospitals will continue to provide a notice for each admission. The total number of notices provided in the initial year is estimated to be 816 million. Under the final rule, only providers that have direct treatment relationships with individuals are required to provide notices to them. To estimate the number of visits that trigger a notice in the initial year and in subsequent years, the Department relied on the Medical Expenditure Panel Survey (MEPS, 1996 data) conducted by the Department's Agency for Healthcare Quality and Research. This data set provides estimates for the number of total visits to a variety of health care providers in a given year and estimates of the number of patients with at least one visit to each type of each care provider."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 467}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 26)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nplace of residence used as the patient's home * * * ; - (4) X-ray, radium, and radioactive isotope therapy, including materials and services of technicians; - (5) surgical dressings, and splints, casts, and other devices used for reduction of fractures and dislocations; - (6) durable medical equipment; - (7) ambulance service where the use of other methods of transportation is contraindicated by the individual's condition * * * ; - (8) prosthetic devices (other than dental) which replace all or part of an internal body organ (including colostomy bags and supplies directly related to colostomy care), * * * and including one pair of conventional eyeglasses or contact lenses furnished subsequent to each cataract surgery * * * [;] - (9) leg, arm, back, and neck braces, and artificial legs, arms, and eyes, including replacements if required * * * ; - (10) (A) pneumococcal vaccine and its administration * * *; and - (B) hepatitis B vaccine and its administration * * *, and - (11) services of a certified registered nurse anesthetist * * *; - (12) * * * extra-depth shoes with inserts or custom molded shoes with inserts for an individual with diabetes, if *"}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 25}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 173)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nl be a prerequisite to meeting the definition of health care provider. Many providers included in the statutory definition of provider, such as clinical labs, do not have direct contact with patients.\nFurther, the use and disclosure of protected health information by indirect treatment providers can have a significant effect on individuals' privacy. We acknowledge, however, that providers who treat patients only indirectly need not have the full array of responsibilities as direct treatment providers, and modify the NPRM to make this distinction with respect to several provisions (see, for example §164.506 regarding consent). We also clarify that manufacturers and health care suppliers who are considered providers by Medicare are providers under this rule. Comment: Some commenters suggested that blood centers and plasma donor centers that collect and distribute source plasma not be considered covered health care providers because the centers do not provide ''health care services'' and the blood donors are not ''patients'' seeking health care. Similarly, commenters expressed concern that organ procurement organizations might be considered health care providers. Response: We agree and have deleted from the definition of ''health care'' the term ''procurement or banking of blood, sperm, organs, or any other tissue for administration to patients.'' See prior discussion under ''health care.''\n\nComment: Several commenters proposed to restrict coverage to only those providers who furnished and were paid for services and supplies. It was argued that a salaried employee of a covered entity, such as a hospital-based provider, should not be covered by the rule because that provider would be subject both directly to the rule as a covered entity and indirectly as an employee of a covered entity."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 172}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 47)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nIdentify Entities That Are Business Associates Under the HIPAA Security Rule | • Identify the individual or department who will be responsible for coordinating the execution of business associate agreements or other arrangements. • Reevaluate the list of business associates to determine who has access to ePHI in order to assess whether the list is complete and current. • Identify systems covered by the contract/agreement. • Business associates must have a BAA in place with each of their subcontractor business associates. Subcontractor business associates are also directly liable for their own Security Rule violations. | • Does each written and executed BAA contain sufficient language to ensure that ePHI and any other required information types will be protected? • Have all organizations or vendors that provide a service or function on behalf of the organization been identified? Such services may include: o Cloud service providers o Claims processing or billing o Data analysis o Utilization review o Quality assurance o Benefit management o Practice management o Re-pricing o Hardware/software maintenance o All other HIPAA-regulated functions |\n\n82  See Sec. 5.4.1, HIPAA Standard: Business Associate Contracts or Other Arrangements."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 46}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 202)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ncovered entity's obligations under §164.524(c)(2)(ii) and (3)(ii) with respect to an individual's request for an electronic copy of protected health information. - (5) Prohibited uses and disclosures.\n- (i) Use and disclosure of genetic information for underwriting purposes: Notwithstanding any other provision of this subpart, a health plan, excluding an issuer of a long-term care policy falling within paragraph (1)(viii) of the definition of health plan, shall not use or disclose protected health information that is genetic information for underwriting purposes. For purposes of paragraph (a)(5)(i) of this section, underwriting purposes means, with respect to a health plan:\n- (A) Except as provided in paragraph (a)(5)(i)(B) of this section:\n- ( 1 ) Rules for, or determination of, eligibility (including enrollment and continued eligibility) for, or determination of, benefits under the plan, coverage, or policy (including changes in deductibles or other costsharing mechanisms in return for activities such as completing a health risk assessment or participating in a wellness program);\n- ( 2 ) The computation of premium or contribution amounts under the plan, coverage, or policy (including discounts, rebates, payments in kind, or other premium differential mechanisms in return for activities such as completing a health risk assessment or participating in a wellness program);\n- ( 3 ) The application of any pre-existing condition exclusion under the plan, coverage, or policy; and\n- ( 4 ) Other activities related to the creation, renewal, or replacement of a contract of health insurance or health benefits. - (B) Underwriting purposes does not include determinations of medical appropriateness where an individual seeks a benefit under the plan, coverage, or policy."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 201}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 420)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nr persons that the covered entity knows have the erroneous or incomplete information and may take some action in reliance on the erroneous or incomplete information to the detriment of the individual.\nWe have added language to clarify that the covered entity must obtain the individual's agreement to have the amendment shared with the persons the individual and covered entity identifies. We believe these notification requirements appropriately balance covered entities' burden and individuals' interest in protecting the accuracy of medical information used to make decisions about them. We therefore retain the notification provisions substantially as proposed. Comment: Some commenters argued against the proposed provision requiring a covered entity that receives a notice of amendment to notify its business associates, ''as appropriate,'' of necessary amendments. Some argued that covered entities should only be required to inform business associates of these changes if the amendment could affect the individual's further treatment, citing the administrative and financial burden of notifying all business associates of changes that may not have a detrimental effect on the patient. Other commenters suggested that covered entities should only be required to inform business associates whom they reasonably know to be in possession of the information. Response: We agree with commenters that clarification is warranted. Our intent is that covered entities must meet the requirements of this rule with respect to protected health information they maintain, including protected health information maintained on their behalf by their business associates. We clarify this intent by revising the definition of designated record set (see §164.501) to include records maintained ''by or for'' a covered entity."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 419}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 32)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n5 U.S.C. 552, provides for public disclosure, upon the request of any person, of many types of information in the possession of the federal government, subject to nine exemptions and three exclusions.\nFor example, Exemption 6 permits federal agencies to withhold ''personnel and medical files and similar files the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.'' 5 U.S.C. 552(b)(6). Uses and disclosures required by FOIA come within §164.512(a) of the privacy regulation that permits uses or disclosures required by law if the uses or disclosures meet the relevant requirements of the law. Thus, a federal agency must determine whether it may apply an exemption or exclusion to redact the protected health information when responding to a FOIA request. When a FOIA request asks for documents that include protected health information, we believe the agency, when appropriate, must apply Exemption 6 to preclude the release of medical files or otherwise redact identifying details before disclosing the remaining information. We offer the following analysis for federal agencies and federal contractors who operate Privacy Act systems of records on behalf of federal agencies and must comply with FOIA and the privacy regulation. If presented with a FOIA request that would result in the disclosure of protected health information, a federal agency must first determine if FOIA requires the disclosure or if an exemption or exclusion would be appropriate. We believe that generally a disclosure of protected health information, when requested under FOIA, would come within FOIA Exemption 6. We recognize, however, that the application of this exemption to information about deceased individuals requires a different analysis than that applicable to living individuals because, as a general rule, under the Privacy Act, privacy rights are extinguished at death."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 31}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 48)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nddressable. - Removed ''Formal mechanism for processing records'' (proposed §142.308(a)(4)) since this requirement was determined to be in part intrusive into business functions and in part redundant.\n- Moved proposed §142.308(a)(6), ''Internal audit,'' to § 164.308(a)(1)(ii)(D) as an implementation specification under the ''Security management process'' standard since this was determined to be a more logical placement of this item. Retitled, for clarity, ''Information system activity review.''\n\n•\n\n- Moved proposed §142.308(a)(7), ''Personnel security,'' to §164.308(a)(3)(i) and retitled ''Workforce security.'' Modified language to state that implementation specifications are addressable. Combined proposed\n\n- §142.308(a)(7)(i), and § 142.308(a)(7)(iii) (''Assuring supervision of maintenance personnel by an authorized, knowledgeable person'' and ''Assuring that operations and maintenance personnel have proper access authorization,'') under\n- §164.308(a)(3)(ii)(A) and renamed to ''Authorization and/or supervision.'' Modified description for clarity. - Removed proposed §142.308(a)(7)(v), ''Personnel security policies and procedures,'' as this feature was determined to require redundant effort. - Moved proposed §142.308(a)(7)(iv), ''Personnel clearance procedure,'' to §164.308(a)(3)(ii)(B), renamed to ''Workforce clearance procedure,'' and modified description for clarity. - Removed proposed §142.308(a)(7)(vi), ''Security awareness training.'' Information concerning this subject has been incorporated under §164.308(a)(5)(i), ''Security awareness and training.''\n- Moved proposed §142.308(a)(9), ''Security incident procedures,'' to §164.308(a)(6)(i) and reworded for clarity. Combined ''Report procedures'' and ''Response procedures'' features into a single required implementation specification, named ''Response and Reporting'' at § 164.308(a)(6)(ii). - since this requirement was determined to be redundant. ''Documentation'' has been made a discrete standard at §164.316."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 47}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 252)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nsease Management, October 1999 (from web site of Disease Management Association of America (www.dmaa.org/definition.html) accessed May 21, 2000. Other references used for our analysis include: Mary C.\nGurnee, et al, Constructing Disease Management Programs, Managed Care, June 1997, accessed at http:// managedcaremag.com, 5/19/2000; Peter Wehrwein, Disease Management Gains a Degree of Respectability, Managed Care, August 1997, accessed at www.managedcaremag.com, 5/18/00; John M. Harris, Jr., disease management: New Wine in Old Bottles, 124 Annals of Internal Medicine 838 (1996); Robert S. Epstein and Louis M. Sherwood, From Outcomes research to disease management: A Guide for the Perplexed, 124 Annals of Internal Medicine 832 (1996); Anne Mason et al, disease management, the Pharmaceutical Industry and the NHS, Office of Health Economics (United Kingdom), accessed at www.ohe.org, 5/19/2000; Thomas Bodenheimer, Disease ManagementPromises and Pitfalls, 340 New Eng. J. Med, April 15, 1999, accessed at www.nejm.org, 4/20/99; Bernard Lo and Ann Alpers, Uses and Abuses of Prescription Drug information in pharmacy benefits Management Programs, 283 JAMA 801 (2000); Robert F. DeBusk, Correspondence, Disease Management, and Regina E. Herzlinger, Correspondence, Disease Management, 341 New Eng. J. Med, Sept 2, 1999, accessed 9/2/99; Letter, John A. Gans, American Pharmaceutical Association, to Health Care Financing Administration, Reference HCFA-3002-P, April 12, 1999, accessed at www.aphanet.org, 1/18/2000; Ronald M. Davis, et al, Editorial, Advances in Managing Chronic Disease, 320 BMJ 525 (2000), accessed at www.bmj.com, 2/25/00; Thomas Bodenheimer, Education and Debate, disease management in the American Market, 320 BMJ 563 (2000), accessed at www.bmj.com, 2/25/2000; David J."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 251}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 82)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nmental health learn under supervision to\n\nFrm 00054\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\npractice or improve their skills in group, joint, family, or individual counseling.\nA covered entity may also use psychotherapy notes to defend a legal action or other proceeding brought by the individual pursuant to a consent, without a specific authorization. We note that, while this provision allows disclosure of these records to the covered entity's attorney to defend against the action or proceeding, disclosure to others in the course of a judicial or administrative proceeding is governed by § 164.512(e). This special provision is necessary because disclosure of protected health information for purposes of legal representatives may be made under the general consent as part of ''health care operations.'' Because we require an authorization for disclosure of psychotherapy notes for ''health care operations,'' an exception is needed to allow covered entities to use protected health information about an individual to defend themselves against an action threatened or brought by that individual without asking that individual for authorization to do so. Otherwise, a consent under § 164.506 is not sufficient for the use or disclosure of psychotherapy notes to carry out treatment, payment, or health care operations. Authorization is required. We anticipate these authorizations will rarely be necessary, since psychotherapy notes do not include information that covered entities typically need for treatment, payment, or other types of health care operations. In the NPRM, we proposed to permit covered entities to use and disclose psychotherapy notes for all other purposes permitted or required under the rule without authorization. In the final rule, we specify a more limited set of uses and disclosures of psychotherapy notes that covered entities are permitted to make without authorization."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 81}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 7)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nsome requirements because they already protect health information. Response: The statute does not cover all health care entities that transmit or maintain individually identifiable health information.\nSection 1172(a) of the Act provides that only health plans, health care clearinghouses, and certain health care providers (as discussed above) are covered. With respect to the comments regarding the difference between providers and plans/ clearinghouses, we have structured the Security Rule to be scalable and flexible enough to allow different entities to implement the standards in a manner that is appropriate for their circumstances. Regarding the coverage of entities not within the jurisdiction of HIPAA, see the Privacy Rule at 82567 through 82571. 3. Comment: One commenter asked whether the standards would apply to research organizations, both to those affiliated with health care providers and those that are not. Response: Only health plans, health care clearinghouses, and certain health care providers are required to comply with the security standards. Researchers who are members of a covered entity's work force may be covered by the security standards as part of the covered entity. See the definition of ''workforce'' at 45 CFR 160.103. Note, however, that a covered entity could, under appropriate circumstances, exclude a researcher or research division from its health care component or components ( see §164.105(a)). Researchers who are not part of the covered entity's workforce and are not themselves covered entities are not subject to the standards. 4. Comment: Several commenters stated that internal networks and external networks should be treated differently. One commenter asked for further clarification of the difference\n\nVerDate Jan&lt;31&gt;2003\n\nbetween what needs to be secured external to a corporation versus the security of data movement within an organization."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 6}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 56)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nhe information. The Department was not convinced by the commenters who urged that this condition needed to be eliminated to allow for disclosures to non-covered health care providers or third parties.\nThe Department believes that permitting disclosures of protected health information to a non-covered provider for that provider's treatment and payment purposes is warranted and appropriate so as not to impede such core activities. However, given that an individual's health information will no longer be protected when it is disclosed to a non-covered provider, the Department does not consider disclosures for a non-covered provider's health care operations to warrant similar consideration under the Rule. Moreover, this final Rule at § 164.514(e) permits a covered entity to disclose a limited data set, with direct identifiers removed, to a non-covered provider for any of the provider's health care operations purposes, without individual authorization. Also, the Department believes that expanding the provision to allow disclosures to a third party for any of the third party's business operations would severely weaken the Privacy Rule and essentially negate the need for individual authorization. With respect to those commenters who urged the Department to permit disclosures to non-health care components of a hybrid\n\nVerDate Aug&lt;2,&gt;2002\n\nentity or to an affiliated entity for the purposes of investigating fraud and abuse, the Department's position is that disclosures to a non-health care component within a hybrid entity or to a non-covered affiliated entity present the same privacy risks as do disclosures to a non-covered entity. The Privacy Rule, therefore, permits such disclosures only to the same extent the disclosures are permitted to a separate entity. This policy is further explained in section III.C.1. regarding hybrid entities."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 55}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 37)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\na disclosure of protected health information from the health care component to such other division that is not part of the health care component is the same as a disclosure outside the covered entity.\nBecause an entity cannot have a business associate contract with itself, such a disclosure likely will require individual authorization. The Department clarifies, in response to comments, that a health care provider cannot avoid being a covered entity and, therefore, part of a health care component of a hybrid entity just by relying on a billing department to conduct standard transactions on its behalf. A health care provider is a covered entity if standard transactions are conducted on his behalf, regardless of whether the provider or a business associate (or billing department within a hybrid entity) actually conducts the transactions. In such a situation, however, designating relevant parts of the business associate division as part of the health care component would facilitate the conduct of health care operations and payment. Also in response to comments, the Department clarifies that even if a covered entity does not choose to be a hybrid entity, and therefore is not required to erect firewalls around its health care functions, the entity still only is allowed to use protected health information as permitted by the Privacy Rule, for example, for treatment, payment, and health care operations. Additionally, the covered entity is still subject to minimum necessary restrictions under §§ 164.502 and 164.514(d), and, thus, must have policies and procedures that describe who within the entity may have access to the protected health information. Under these provisions, workforce members may be permitted access to protected health information only as necessary to carry out their duties with respect to the entity's covered functions."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 36}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement physical controls?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160, 162, and 164 [CMS-0049-F] RIN 0938-AI57\n\n## Health Insurance Reform: Security Standards\n\nAGENCY: Centers for Medicare &amp; Medicaid Services (CMS), HHS. ACTION: Final rule. SUMMARY: This final rule adopts standards for the security of electronic protected health information to be implemented by health plans, health care clearinghouses, and certain health care providers. The use of the security standards will improve the Medicare and Medicaid programs, and otherFederal health programs and private health programs, and the effectiveness and efficiency of the health care industry in general by establishing a level of protection for certain electronic health information. This final rule implements some of the requirements of the Administrative Simplification subtitle of the Health Insurance Portability andAccountability Act of 1996 (HIPAA). DATES: Effective Date: These regulations are effective on April 21, 2003. Compliance Date: Covered entities, with the exception of small health plans, must comply with the requirements of this final rule by April 21, 2005. Small health plans must comply with the requirements of this final rule by April 21, 2006. FOR FURTHER INFORMATION CONTACT: William Schooler, (410) 786-0089. SUPPLEMENTARY INFORMATION:\n\n## Availability of Copies and Electronic Access\n\nTo order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 or by faxing to (202) 5122250. The cost for each copy is $10."}], "metadata": {"source": "security_rule_2003", "safeguard_type": "physical", "implementation_spec": "both", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 149)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\novered entities must permit individuals to request that the covered entity amend protected health information about them. We also permit certain specifications for the form and content of the request.\nIf a covered entity informs individuals of such requirements in advance, a covered entity may require individuals to make requests for amendment in writing and to provide a reason to support a requested amendment. If the covered entity imposes such a requirement and informs individuals of the requirement in advance, the covered entity is not required to act on an individual's request that does not meet the requirements. We retain the requirement for covered entities to act on a request for amendment within 60 days of receipt of the request. In the final rule, we specify the nature of the action the covered entity must take within the time frame. The covered entity must inform the individual, as described below, that the request has been either accepted or denied, in whole or in part. It must also take certain actions pursuant to its decision to accept or deny the request, as described below. If the covered entity is unable to meet the deadline, the covered entity may extend the deadline by no more than 30 days. The covered entity must inform the individual in writing, within the initial 60-day period, of the reason for the delay and the date by which the covered entity will complete its action on the request. A covered entity may only extend the deadline one time per request for amendment. ## Section 164.526(c)-Accepting the Amendment\n\nIf a covered health care provider or health plan accepted a request for amendment, in whole or in part, we proposed to require the covered entity to make the appropriate change. The covered entity would have had to identify the challenged entries as amended or corrected and indicate the location of the amended or corrected information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 148}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 425)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ned period of time if the law enforcement official to whom the report is made requests such exclusion. Comment: A few comments noted the lack of exception for disclosures made to intelligence agencies.\nResponse: We agree with the comments and have added an exemption for disclosures made for national security or intelligence purposes under § 164.512(k)(2). Individuals do not have a right to an accounting of disclosures for these purposes. Comment: Commenters noted that the burden associated with this provision would, in part, be determined by other provisions of the rule, including the definitions of ''individually identifiable,'' ''treatment,'' and ''health care operations.'' They expressed concern that the covered entity would have to be able to organize on a patient by patient basis thousands of disclosures of information, which they described as ''routine.'' These commenters point to disclosures for patient directory information, routine banking and payment processes, uses and disclosures in emergency circumstances, disclosures to next of kin, and release of admissions statistics to a health oversight agency. Response: We disagree with the commenters that ambiguity in other areas of the rule increase the burden associated with maintaining an accounting. The definitions of treatment, payment, and health operations are necessarily broad and there is no accounting required for disclosures for these purposes. These terms cover the vast majority of routine disclosures for health care purposes. (See § 164.501 and the associated preamble for a discussion of changes made to these definitions.)\n\nThe disclosures permitted under §164.512 are for national priority purposes, and determining whether a disclosure fits within the section is necessary before the disclosure can be\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nmade. There is no additional burden, once such a determination is made, in determining whether it must be included in the accounting."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 424}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 260)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nperiod would raise many of the same concerns voiced by the commenters regarding our proposed two year period and would not reduce the administrative burden of having to track or learn dates of death.\nWe believe that the policy in this final rule extending protections for as long as the covered entity maintains the information addresses commenter concerns regarding the need for increased protections on the protected health information about the deceased. Comment: Some commenters asserted that information on the decedent from the death certificate is important for assessment and research purposes and requested that the Department clarify accordingly that death certificate data be allowed for use in traditional public health assessment activities. Response: Nothing in the final rule impedes reporting of death by covered entities as required or authorized by other laws, or access to death certificate data to the extent that such data is available publicly from non-covered entities. Death certificate data maintained by a covered entity is protected health information and must only be used or disclosed by a covered entity in accordance with the requirements of this regulation. However, the final rule permits a covered entity to disclose protected health information about a deceased individual for research purposes without authorization and absent IRB or privacy board approval. Comment: A few commenters asked that we include in the regulation a mechanism to provide for notification of date of death. These commenters questioned how a covered entity or business partner would be notified of a death and subsequently be able to determine whether the two-year period of protection had expired and if they\n\nFrm 00172\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nwere permitted to use or disclose the protected health information about the deceased."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 259}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 90)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nwsletter, annual mailing, after 18 months of transition, or in a triennial mailing. In addition, many commenters supported electronic distribution of an NPP or a notice of material changes to the NPP.\nWhile not proposed, some commenters suggested eliminating or alternatives to the current requirements for health care providers with direct treatment relationships to hand the NPP to every individual patient and make a good faith attempt to obtain acknowledgement of receipt. A few commenters also expressed concern regarding the cost burden associated with revising and distributing a new NPP. One commenter argued that considerations of cost do not justify a delay in distributing a revised NPP. ## Final Rule\n\nFirst, the final rule adopts the modification to § 164.520(b)(1)(ii)(E), which requires certain statements in the NPP regarding uses and disclosures that require authorization. We note that, contrary to some commenter concerns, the final rule does not require the NPP to include a list of all situations requiring authorization. Instead, the NPP must contain a statement indicating that most uses and disclosures of psychotherapy notes (where appropriate), uses and disclosures of protected health information for marketing purposes, and disclosures that constitute a sale of protected health information require authorization, as well as a statement that other uses and disclosures not described in the NPP will be made only with authorization from the individual. The final rule does not require the NPP to include a description of a covered entity's recordkeeping practices with respect to psychotherapy notes; however, covered entities are free to include such additional information in their NPP if they choose."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 89}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 24)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ntunity to provide additional guidance. While section 1128A(l) is silent as to how to define ''principal,'' ''agent,'' and ''scope of agency,'' § 160.402(c) references the Federal common law of agency.\nAs we explained in the Enforcement Rule preamble, 71 FR 8390, 8403-04, adopting the Federal common law to determine the definitions and application of these terms achieves nationwide uniformity in the implementation of the HIPAA Rules. We believe that relying on the Federal common law is particularly\n\nVerDate Mar&lt;15&gt;2010\n\nimportant because of HIPAA's express objective of furthering the efficiency and effectiveness of the health care system as a whole. Further, adopting the Federal common law here is consistent with the precept that Federal statutes are meant to have uniform nationwide application. Therefore, we disagree with the comment that argued that Federal common law should not be applied with respect to relationships between covered entities and business associates. An analysis of whether a business associate is an agent will be fact specific, taking into account the terms of a business associate agreement as well as the totality of the circumstances involved in the ongoing relationship between the parties. The essential factor in determining whether an agency relationship exists between a covered entity and its business associate (or business associate and its subcontractor) is the right or authority of a covered entity to control the business associate's conduct in the course of performing a service on behalf of the covered entity. The right or authority to control the business associate's conduct also is the essential factor in determining whether an agency relationship exists between a business associate and its business associate subcontractor. Accordingly, this guidance applies in the same manner to both covered entities (with regard to their business associates) and business associates (with regard to their subcontractors)."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 23}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 95)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ned that the Department eliminate the\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00063\n\nrequirement that a covered entity must provide the notice to every dependent, rather than just the head of the household.\nThis commenter argued that while it makes sense to provide the notice to an emancipated minor or to a minor who pursuant to State law has consented to treatment, it does not make sense to send the notice to a 2-year old child. Response: The Privacy Rule provides that a health plan may satisfy the notice provision requirements by distributing the notice to the named insured of a policy under which coverage is provided to the named insured and one or more dependents. A health plan is not required to distribute the notice to each dependent. See §164.520(c)(1)(iii). Further, a covered health care provider with a direct treatment relationship with the individual is required only to provide the notice to the individual receiving treatment at first service delivery. Where a parent brings a 2-year old child in for treatment, the provider satisfies the notice distribution requirements by providing the notice only to the child's parent. ## I. Section 164.528-Accounting of Disclosures of Protected Health Information\n\nDecember 2000 Privacy Rule. Under the Privacy Rule at § 164.528, individuals have the right to receive an accounting of disclosures of protected health information made by the covered entity, with certain exceptions. These exceptions, or instances where a covered entity is not required to account for disclosures, include disclosures made by the covered entity to carry out treatment, payment, or health care operations, as well as disclosures to individuals of protected health information about them. The individual must request an accounting of disclosures."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 94}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How does NIST SP 800-66 recommend implementing control FR-2003 for HIPAA?"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nFR-2003-02-20/03-3877.                                                                                                                                                             |\n\n## "}], "metadata": {"source": "nist_sp800-66r2", "nist_control": "FR-2003", "safeguard_types": ["physical", "technical", "administrative"], "type": "nist_implementation"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 162)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\non is necessary to provide full privacy protection and have called for members of Congress to pass such legislation to prevent unauthorized and potentially harmful uses and disclosures of information.\n## Part 160-Subpart A-General Provisions Section 160.103-Definitions\n\n## Business Associate\n\nThe response to comments on the definition of ''business partner,'' renamed in this rule as ''business associate,'' is included in the response to comments on the requirements for business associates in the preamble discussion of § 164.504. ## Covered Entity\n\nComment: A number of commenters urged the Department to expand or clarify the definition of ''covered entity'' to include certain entities other than health care clearinghouses, health plans, and health care providers who conduct standard transactions. For example, several commenters asked that the Department generally expand the scope of the rule to cover all entities that receive or maintain individually identifiable health information; others specifically urged the Department to cover employers, marketing firms, and legal entities that have access to individually identifiable health information. Some commenters asked that life insurance and casualty insurance carriers be considered\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00107\n\ncovered entities for purposes of this rule. One commenter recommended that Pharmacy Benefit Management (PBM) companies be considered covered entities so that they may use and disclose protected health information without authorization. In addition, a few commenters asked the Department to clarify that the definition includes providers who do not directly conduct electronic transactions if another entity, such as a billing service or hospital, does so on their behalf. Response: We understand that many entities may use and disclose individually identifiable health information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 161}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 28)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nPersonal Representatives of Unemancipated Minors 1\n\nDecember 2000 Privacy Rule. The Privacy Rule is intended to assure that parents have appropriate access to health information about their children.\nBy creating new Federal protections and individual rights with respect to individually identifiable health information, parents will generally have new rights with respect to the health information about their minor children. In addition, the Department intended that the disclosure of health information about a minor child to a parent should be governed by State or other applicable law. Under the Privacy Rule, parents are granted new rights as the personal representatives of their minor children. ( See §164.502(g).) Generally, parents will be able to access and control the health information about their minor children. ( See §164.502(g)(3).)\n\nThe Privacy Rule recognizes a limited number of exceptions to this general rule. These exceptions generally track the ability under State or other applicable laws of certain minors to obtain specified health care without parental consent. For example, every State has a law that permits adolescents to be tested for HIV without the consent of a parent. These laws are created to assure that adolescents will seek health care that is essential to their own health, as well as the public health. In these exceptional cases, where a minor can obtain a particular health care service without the consent of a parent under State or other applicable law, it is the minor, and not the parent, who may exercise the privacy rights afforded to individuals under the December 2000 Privacy Rule. ( See §164.502(g)(3)(i) and (ii), redesignated as § 164.502(g)(3)(i)(A) and (B)). The December 2000 Privacy Rule also allows the minor to exercise control of\n\n1 Throughout this section of the preamble, ''minor'' refers to an unemancipated minor and ''parent'' refers to a parent, guardian, or other person acting in loco parentis."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 27}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 125)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nagreement. Use of the sample provisions or similar provisions, where appropriate, would be considered strong evidence of compliance with the business associate contract provisions of the Privacy Rule.\nHowever, contracts will necessarily vary based on State law and the relationship between the\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00083\n\ncovered entity and the business associate. Comment: Some commenters were concerned that the sample provision permitting a covered entity to have access to the practices, books, and records of the business associate would impose an audit requirement on the covered entity. Response: The sample business associate contract provisions do not impose any additional requirements on covered entities. Only the regulation imposes requirements. Therefore, the inclusion of the provision that the business associate shall allow the covered entity access to the business associate practices, books, and records does not indicate that the Privacy Rule imposes an audit requirement on the covered entity. We have stated numerous times that the Privacy Rule does not require covered entities to monitor the activities of their business associates. Comment: One commenter noted that the business associate should not be required, under the contract, to mitigate damages resulting from a violation. Response: We disagree. In order for a covered entity to be able to act as it is required to under the Privacy Rule when a business associate is holding protected health information, the covered entity must require the same activities of the business associate through the contract. Comment: One commenter noted that the Privacy Rule does not explicitly direct that a covered entity provide its notice of privacy practices to its business associates. Response: We agree and have modified the language in the sample provision accordingly."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 124}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 52)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n| | Key Activities | Description | Sample Questions | |-------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 3."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 51}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 396)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntheir practices and apply the revised practices to information previously created or obtained. If a covered entity wishes to reserve this right, it must make a statement to that effect in its notice.\nIf it does not make such a statement, the covered entity may still revise its privacy practices, but it may apply the revised practices only to protected health information created or obtained after the effective date of the notice in which the revised practices are reflected. See § 164.530(i) and the corresponding preamble discussion of requirements regarding changes to information policies and procedures. Comment: Some commenters requested clarification of the term ''material changes'' so that entities will be comfortable that they act properly after making changes to their information practices. Some comments stated that entities should notify individuals whenever a new category of disclosures to be made without authorization is created. Response: The concept of ''material change'' appears in other notice laws, such as the ERISA requirements for summary plan descriptions. We therefore retain the ''materiality'' condition for revision of notices, and encourage covered entities to draw on the concept as it has developed through those other laws. We agree that the addition of a new category of use or disclosure of health information that may be made without authorization would likely qualify as a material change. Comment: We proposed to permit covered entities to implement revised policies and procedures without first revising the notice if a compelling reason existed to do so. Some commenters objected to this proposal because they were concerned that the ''compelling reason'' exception would give covered entities broad discretion to engage in post hoc violations of its own information practices. Response: We agree and eliminate this provision."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 395}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 151)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd a written request for exclusion for a specified time period and the request stated that access by the individual during that time period would be reasonably likely to impede the agency's activities.\nWe generally retain the proposed approach in the final rule. As in the proposed rule, individuals have a right to receive an accounting of disclosures made by a covered entity, including disclosures by or to a business associate of the covered entity, for purposes other than treatment, payment, and health care operations, subject to certain exceptions as discussed below. We revise the duration of this right under the final rule. Individuals have a right to an accounting of the applicable disclosures that have been made in the 6 year period prior to the date of a request for an accounting. We additionally clarify in § 164.528(b)(1) that an individual may request, and a covered entity may then provide, an accounting of disclosures for a period of time less than 6 years from the date of the request. For example, an individual could request an accounting only of disclosures that occurred during the year prior to the request. In the final rule, we exclude several additional types of disclosures from the accounting requirement. Covered entities are not required to include in the accounting disclosures to the individual as provided in § 164.502; disclosures for facility directories, disclosures to persons involved in the individual's care, or other disclosures for notification purposes as provided in §164.510; disclosures for national security or intelligence purposes as provided in § 164.512(k)(2); disclosures to correctional institutions or law enforcement officials as provided in §164.512(k)(5); or any disclosures that were made by the covered entity prior to the compliance date of the rule for that covered entity."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 150}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 92)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nprotected health information for these purposes, covered entities must inform individuals in advance and must provide a meaningful opportunity for the individual to prevent or restrict the disclosure.\nIn exceptional circumstances, where even this informal discussion cannot practicably take place, covered entities are permitted to make decisions regarding disclosure or use based on the exercise of professional judgment of what is in the individual's best interest. ## Section 164.510(a)-Use and Disclosure for Facility Directories\n\nThe NPRM proposed to allow covered health care providers to disclose through an inpatient facility's directory a patient's name, location in the facility, and general health condition, provided that the individual had agreed to the disclosure. The NPRM would have allowed this agreement to be oral. Pursuant to the NPRM, when making decisions about incapacitated individuals, a covered health care provider could have disclosed such information at the entity's discretion and consistent with good medical practice and any prior expressions of patient preference of which the covered entity was aware. The preamble to the NPRM listed several factors that we encouraged covered entities to take into account when making decisions about whether to include an incapacitated patient's information in the directory."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 91}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 183)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nt asserting that covered entities may keep decedent information, particularly the information of famous individuals, for longer than 50 years past the date of death in order to monetize those records.\nThe commenter cited an example of an x-ray of a deceased celebrity being sold at an auction for $45,000. However, we do not anticipate that this is or will be a typical scenario. ## 6. Disclosures About a Decedent\n\nWe proposed to permit covered entities to disclose a decedent's protected health information to family members and others who were involved in the care or payment for care prior to the decedent's death, unless doing so is inconsistent with any prior expressed preference of the individual that is known to the covered entity. In the preamble to the proposed rule, we stated our belief that the proposed change would reduce burden by permitting covered entities to disclose protected health information about a decedent to family members and other persons who were involved in an individual's care while the individual was alive, without having to obtain written permission in the form of an authorization from the decedent's personal representative, who may not be known or even exist, and may be more difficult to locate as time passes. However, we had no data to permit us to estimate the reduction in burden and requested public comment on this issue. The final rule adopts the modification as proposed. However, as with the proposed rule, we are unable to quantify any cost-savings with respect this change. While commenters confirmed that permitting such disclosures would help facilitate communications with family members and other persons who were involved in an individual's care or payment for care prior to death, we did not receive any information that could inform estimating a savings. ## 7."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 182}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 50)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nrspective of their own facilities. A covered entity requires written satisfactory assurances that ePHI will be protected by the business associate. 96 See Sec. 5.1.7, HIPAA Standard: Contingency Plan.\n| Key Activities                                                                            | Description                                                                                                                                                                                                              | Sample Questions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |\n|-------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|\n|                                                                                           | • Implement procedures to provide facility access to authorized personnel and visitors and exclude unauthorized persons."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 49}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 115)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nnefit/cost data in support of their proposal. Comment: The Department received comments expressing opposition to obtaining written acknowledgment of the receipt of the notice because it is too costly.\nOthers commented that the acknowledgment increases the administrative burden as it would not replace a signed consent for uses and disclosures of health information when State law requires providers to obtain consent. Response: The Department received no public comment containing empirical, direct evidence on the estimates of financial impact that either supported or contradicted the Department's calculations. Therefore, our estimates remain unchanged. Comment: A number of commenters expressed concern over the perceived increase in liability that would arise from the discretionary standard of ''good faith'' efforts (i.e., risk of tortbased litigation for private right of action under State laws). Response: The Department received no estimate of the impact of this perceived risk of liability. As no empirical, direct evidence on the estimates of financial impact that either supported or contradicted the Department's calculations was supplied, our estimates remain unchanged. ## 3. Business Associates\n\nThe Privacy Rule requires a covered entity to have a written contract, or other arrangement, that documents satisfactory assurances that a business associates will appropriately safeguard protected health information in order to disclose protected health information to the business associate. The regulatory impact analysis for the Privacy Rule provided cost estimates for two aspects of this requirement. In the Privacy Rule, $103 million in first-year costs was estimated for development of a standard business associate contract language."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 114}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What is considered a breach under HIPAA?"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\net. You may also send an email request to CDRH-Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number GUI00001825 and complete title of the guidance in the request.\n## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), WO71, Room 3103, Silver Spring, MD 20903, or by calling 1-800-835-4709 or 240-402-8010,\n\nOffice of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., by email, industry.biologics@fda.hhs.gov, or from the Internet at https://www.fda.gov/vaccines-blood-biologics/guidance-compliance-regulatory-informationbiologics/biologics-guidances\n\n## Preface\n\n## Contains Nonbinding Recommendations\n\n## Table of Contents\n\n| I. | Introduction............................................................................................................................. 1                                                                               | Introduction............................................................................................................................. 1                                                                               | Introduction............................................................................................................................. 1"}], "metadata": {"source": "fda_premarket_2023", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 190)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncare transaction that would implicate more than one state's law would automatically preclude the Secretary's evaluation as to whether the laws were more or less stringent than the federal requirement.\nOther commenters expressed confusion about this proposed requirement, noting that providers and plans operate now in a multi-state environment. Response: We agree with the commenters and have dropped the proposed requirement. As noted by the commenters, health care entities now typically operate in a multi-state environment, so already make the choice of law judgements that are necessary in multi-state transactions. It is the result of that calculus that will have to be weighed against the federal standards, requirements, and implementation specifications in the preemption analysis. Comment: One comment received in the Transactions rulemaking suggested that the Department should allow exceptions to the standard transactions to accommodate abbreviated transactions between state agencies, such as claims between a public health department and the state Medicaid\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nagency. Another comment requested an exception for Home and Community Based Waiver Services from the transactions standards. Response: The concerns raised by these comments would seem to be more properly addressed through the process established for maintaining and modifying the transactions standards. If the concerns underlying these comments cannot be addressed in this manner, however, there is nothing in the rules below to preclude states from requesting exceptions in such cases. They will then have to make the case that one or more grounds for exception applies."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 189}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 317)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nyers may also request employees to provide authorization for the employer to obtain protected health information from covered entities to conduct analyses of work-related health issues. See § 164.508.\nWe also permit covered health care providers who provide health care as a workforce member of an employer or at the request of an employer to disclose protected health information to the employer concerning work-related injuries or illnesses or workplace medical surveillance in situations where the employer has a duty to keep records on or act on such information under the OSHA or similar laws. We added this provision to ensure that employers are able to obtain the information that they need to meet federal and state laws designed to promote safer and healthier workplaces. These laws are vital to protecting the health and safety of workers and we permit specified covered health care providers to disclose protected health information as necessary to carry out these purposes. Comment: A few comments suggested that the final regulation clarify how it would interact with existing and pending OSHA requirements. One of\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00210\n\nthese comments requested that the Secretary delay the effective date of the regulation until reviews of existing requirements are complete. Response: As noted in the ''Relationship to Other Federal Laws'' section of the preamble, we are not undertaking a complete review of all existing laws with which covered entities might have to comply. Instead we have described a general framework under which such laws may be evaluated. We believe that adopting national standards to protect the privacy of individually identifiable health information is an urgent national priority. We do not believe that it is appropriate to delay the effective date of this regulation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 316}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 99)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nght, not the happenstance of discovery by an individual through the accounting requirement, is the best means to detect and prevent serious misdeeds such as those alleged in fraudulent authorizations.\nComment: A number of commenters recommended other types of disclosures for exemption from the accounting requirement. Many recommended elimination of the accounting requirement for public health disclosures arguing that the burden of the requirement may deter entities from making such disclosures and that because many are made directly to public health authorities by doctors and nurses, rather than from a central records component of the entity, public health disclosures are particularly difficult to track and document. Others suggested exempting from an accounting requirement any disclosure required by another law on the grounds that neither the individual nor the entity has any choice about such required disclosures. Still others wanted all disclosures to a governmental entity exempted as many such disclosures are required and often reports are routine or require lots of data. Some wanted disclosures to law enforcement or to insurers for claims investigations exempted from the accounting requirement to prevent interference with such investigatory efforts. Finally, a few commenters suggested that all of the disclosures permitted or required by the Privacy Rule should be excluded from the accounting requirement. Response: Elimination of an accounting requirement for authorized disclosures is justified in large part by the individual's knowledge of and voluntary agreement to such disclosures. None of the above suggestions for exemption of other permitted disclosures can be similarly justified. The right to an accounting of disclosures serves an important function in informing the individual as to which information was sent to which recipients."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 98}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 12)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nsal of electronic media) and the Privacy Rule (e.g., with respect to limiting its uses and disclosures of the protected health information in accordance with its contract with the business associate).\n## Overview of Public Comments\n\nWhile some commenters generally supported extending the business associate provisions of the Rules to subcontractors, many opposed such an extension arguing, among other things, that doing so was not the intent of Congress and beyond the statutory authority of the Department, that confusion may ensue with covered entities seeking to establish direct business associate contracts with subcontractors or prohibiting business associates from establishing subcontractor relationships altogether, and/or that creating direct liability for subcontractors will discourage such entities from operating and participating in the health care industry. Some\n\nVerDate Mar&lt;15&gt;2010\n\ncommenters asked how far down the ''chain'' of subcontractors do the HIPAA Rules apply-i.e., do the Rules apply only to the first tier subcontractor or to all subcontractors down the chain. In response to our request for comment on this issue, several commenters were concerned that use of the term subcontractor was confusing and instead suggested a different term be used, such as business associate contractor or downstream business associate, to avoid confusion between primary business associates of a covered entity and subcontractors. Other commenters suggested changes to the definition of subcontractor itself to better clarify the scope of the definition. Several commenters requested specific guidance on who is and is not a subcontractor under the definitions of ''business associate'' and\n\n''subcontractor.'' For example, one commenter asked whether an entity that shreds documents for a business associate for the business associate's activities and not for the covered entity, would qualify as a subcontractor."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 11}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 344)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nata systems do not identify individuals\n\nWe also received a large volume of comments opposed to the exception for use and disclosure of protected health information for government health data systems.\nMany commenters expressed general concern that the provision threatened their privacy, and many believed that their health information would be subject to abuse by government employees. Commenters expressed concern that the provision would facilitate collection of protected health information in one large, centralized government health database that could threaten privacy. Others argued that the proposed rule would facilitate law enforcement access to protected health information and could, in fact, become a database for law enforcement use. Many commenters asserted that this provision would make individuals concerned about confiding in their health care providers. Some commenters argued that the government should not be allowed to collect individually identifiable health information without patient consent, and that the government could use deidentified data to perform the public policy analyses. Many individual commenters said that HHS lacked statutory and Constitutional authority to give the government access and control of their medical records without consent. Many commenters believed that the NPRM language on government health data systems was too broad and would allow virtually any government collection of data to be covered. They argued that the government health data system exception was unnecessary because there were other provisions in the proposed rules providing sufficient authority for government agencies to obtain the information they need. Some commenters were concerned that the NPRM's government health data system provisions would allow disclosure of protected health information for purposes unrelated to health care."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 343}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 287)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nte laws that are more stringent than the rule, that is, state laws that provide a patient with greater access to protected health information, remain in effect. See discussion of ''Preemption'' above.\n## Electronically Stored Data\n\nComment: Some commenters stated that privacy concerns would be\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nsignificantly reduced if patient information is not stored electronically. One commenter suggested that consent should be given for patient information to be stored electronically. One commenter believed that information stored in data systems should not be individually identifiable. Response: We agree that storing and transmitting health information electronically creates concerns about the privacy of health information. We do not agree, however, that covered entities should be expected to maintain health information outside of an electronic system, particularly as health care providers and health plans extend their reliance on electronic transactions. We do not believe that it would be feasible to permit individuals to opt out of electronic transactions by withholding their consent. We note that individuals can ask providers and health plans whether or not they store information electronically, and can choose only providers who do not do so or who agree not to do so. We also do not believe that it is practical or efficient to require that electronic data bases contain only de-identified information. Electronic transactions have achieved tremendous savings in the health care system and electronic records have enabled significant improvements in the quality and coordination of health care. These improvements would not be possible with de-identified information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 286}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 2)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nealth care clearinghouse, or health care provider that transmits any health information electronically in connection with a covered transaction, such as submitting health care claims to a health plan.\nBusiness associate, as defined in the HIPAA Rules, means a person who performs functions or activities on behalf of, or certain services for, a covered entity that involve the use or disclosure of individually identifiable health information. Examples of business associates include third party administrators or pharmacy benefit managers for health plans, claims processing or billing companies, transcription companies, and persons who perform legal, actuarial, accounting, management, or administrative services for covered entities and who require access to protected health information. The HIPAA Rules define ''protected health information'' as the individually identifiable health information held or transmitted in any form or medium by these HIPAA covered entities and business associates, subject to certain limited exceptions. The Act requires HIPAA covered entities to provide notification to affected individuals and to the Secretary of HHS following the discovery of a breach of unsecured protected health information. In addition, in some cases, the Act requires covered entities to provide notification to the media of breaches. In the case of a breach of unsecured protected health information at or by a business associate of a covered entity, the Act requires the business associate to notify the covered entity of the breach. Finally, the Act requires the Secretary to post on an HHS Web site a list of covered entities that experience breaches of unsecured protected health information involving more than 500 individuals."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 1}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 169)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nim final rule, for breaches involving 500 or more individuals, the breach investigation may take up to 100 hours to complete; however, we assume that the average investigation will take only 50 hours.\nAt an office manager's time of $67 per hour multiplied by 50 hours, this cost equals $3,350 per breach. Multiplying this by the number of breaches (250) yields $837,500. ## Cost of Submitting the Annual Breach Summary to HHS\n\nUnder §164.408, covered entities must notify the Secretary of all breaches; however, covered entities reporting breaches affecting fewer than 500 individuals may report these breaches to the Secretary annually. Since the material for the submission has already been gathered and organized for the issuance of the notices to the affected individuals, we expect that notifying the Department will require at\n\n35 See www.bls.gov/oes/current/oes \\_ nat.htm for All Management Occupations. Fmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nsroberts on DSK5SPTVN1PROD with most an hour of office staff time once per year. At $22.53 per hour multiplied by the total number of breaches (18,750) affecting fewer than 500 individuals, this cost equals $422,438. ## 2. Notifying Individuals of Their New Privacy Rights\n\nCovered entities must provide individuals with NPPs that detail how the covered entity may use and disclose protected health information and explain individuals' rights with respect to their own health information."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 168}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 54)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\n)(2), in response to a comment, the Department deletes the word ''another'' before ''health care provider'' to eliminate any implication that the disclosing entity must also be a health care provider.\nWith respect to payment, the majority of commenters were supportive of the Department's proposal. In response to those commenters who expressed support for the proposal because it would facilitate coordination of benefits, the Department clarifies that the definition of ''payment'' in the\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\nPrivacy Rule allows for uses and disclosures necessary for coordination of benefits. The new language may, however, reinforce that uses and disclosures for such purposes are permitted under the Rule. The Department does not believe, as suggested by one commenter, that a targeted approach, one that would address only the problems raised by the ambulance providers and collection agencies, is a practical solution to these problems. The Department believes that these problems may apply in other situations. For example, an indirect treatment provider, such as a pathologist, may need to obtain health coverage information about an individual for billing purposes from the hospital to which the pathologist provided services. If the Department addressed only these discrete scenarios in this final modification, each additional similar problem that arises would require another rulemaking, which would, in and of itself, create a problem because the Department can change a standard only once per year. In addition, by creating special rules to address multiple, distinct circumstances, the Department would have created a substantially more complicated policy for covered entities to follow and implement."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 53}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 41)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhealth information of an individual. The revised language provides that clearinghouses are not subject to certain requirements in the rule when acting as business associates of other covered entities.\nAs revised, a clearinghouse acting as a business associate is subject only to the provisions of this section, to the definitions, to the general rules for uses and disclosures of protected health information (subject to limitations), to the provision relating to health care components, to the provisions relating to uses and disclosures for which consent, individual authorization or an opportunity to agree or object is not required (subject to limitations), to the transition requirements and to the compliance date. With respect to the uses and disclosures authorized under §164.502 or § 164.512, a clearinghouse acting as a business associate is not authorized by the rule to make any use or disclosure not permitted by its business associate contract. Clearinghouses acting as business associates are not subject to the other requirements of this rule, which include the provisions relating to procedural requirements, requirements for obtaining consent, individual authorization or agreement, provision of a notice, individual rights to request privacy protection, access and amend information and receive an accounting of disclosures and the administrative requirements. We note that, even as business associates, clearinghouses remain covered entities. Clearinghouses, like other covered entities, are responsible under this regulation for abiding by the terms of business associate contracts. For example, while the provisions regarding individuals' access to and right to request corrections to protected health information about them apply only to health plans and covered health care providers, clearinghouses may have some responsibility for providing such access under their business associate contracts."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 40}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 15)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\ntransmitted, regardless of its location. Ensure that the risk assessment scope considers teleworkers and any remote workforce, including external service providers who may have remote access to ePHI.\nThe scope should include all removable media and portable computing devices (e.g., laptops, mobile devices) as well as the myriad of medical devices (e.g., Internet of Things [IoT] used in healthcare) that can store, process, or transmit ePHI. Modern mobile devices and installed apps may not only contain ePHI but may also pose a greater risk to ePHI due to theft or loss. In many ways, the risk assessment process will consider risks to ePHI as it enters the organization, flows within the organization, and leaves the organization. 20 Additionally, the regulated entity should consider identifying the security controls currently being used to protect ePHI. This preparation step is essential to ensuring that vulnerabilities and threats are correctly identified in the risk assessment process. For example, if the regulated entity does not fully identify all parties or systems to which ePHI is transmitted, it may not be possible to completely identify all relevant threats and vulnerabilities. The level of effort needed to gather the necessary information depends heavily on the scope of the assessment and the size and complexity of the regulated entity. Regulated entities may benefit from completing a business impact analysis (BIA) to evaluate, record, and monitor the criticality of organizational assets, including ePHI. The BIA can help inform\n\n19  Appendix F includes useful  resources related to cloud services, including the OCR Guidance on HIPAA &amp; Cloud Computing. 20  An example consideration for regulated entities is online tracking technologies that collect and analyze information about how internet users are interacting with a regulated entity's website or mobile application. HHS provides guidance for the secure use of online tracking technologies."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 14}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 26)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nommenter requested that the minimum necessary standard be made an administrative requirement rather than a standard for uses and disclosures, to ease liability concerns with implementing the standard.\nThe commenter stated that this change would mean that covered entities would be required to implement reasonable minimum necessary policies and procedures and would be liable if: (1) They fail to implement minimum necessary policies and procedures; (2) their policies and procedures are not reasonable; or (3) they fail to enforce their policies and procedures. The commenter further explained that health plans would be liable if their policies and procedures for requesting health information were unreasonable, but the burden of liability for the request shifts largely to the entity best suited to determine whether the amount of information requested is the minimum necessary. Response: The Privacy Rule already requires covered entities to implement reasonable minimum necessary policies and procedures and to limit any use, disclosure, or request for protected health information in a manner consistent with its policies and procedures. The minimum necessary standard is an appropriate standard for uses and disclosures, and is not merely an administrative requirement. The Privacy Rule provides adequate flexibility to adopt minimum necessary policies and procedures that are workable for the covered entity, thereby minimizing a covered entity's liability concerns. Comment: A number of commenters expressed concerns about application of the minimum necessary standard to disclosures for workers' compensation purposes. Commenters argued that the standard will prevent workers' compensation insurers and State administrators, as well as employers, from obtaining the information needed to pay injured workers the benefits guaranteed under the State workers' compensation system."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 25}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 2)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nentation specifications: content requirements. - (d) Implementation specifications: defective consents. - (e) Standard: resolving conflicting consents and authorizations. (f) Standard: joint consents.\n- 164.508 Uses and disclosures for which an authorization is required. - (a) Standard: authorizations for uses and disclosures. - (b) Implementation specifications: general requirements. - (c) Implementation specifications: core elements and requirements. - (d) Implementation specifications: authorizations requested by a covered entity for its own uses and disclosures. - (e) Implementation specifications: authorizations requested by a covered entity for disclosures by others. - (f) Implementation specifications: authorizations for uses and disclosures of protected health information created for research that includes treatment of the individual. - 164.510 Uses and disclosures requiring an opportunity for the individual to agree or to object. - (a) Standard: use and disclosure for facility directories. - (b) Standard: uses and disclosures for involvement in the individual's care and notification purposes. 164.512\n\nUses and disclosures for which consent, an authorization, or opportunity\n\nto agree or object is not required. - (a) Standard: uses and disclosures required by law. - (b) Standard: uses and disclosures for public health activities. - (c) Standard: disclosures about victims of abuse, neglect or domestic violence. - (d) Standard: uses and disclosures for health oversight activities. - (e) Standard: disclosures for judicial and administrative proceedings. - (f) Standard: disclosures for law enforcement purposes. - (g) Standard: uses and disclosures about decedents. - (h) Standard: uses and disclosures for cadaveric organ, eye or tissue donation purposes. E:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\n- (i) Standard: uses and disclosures for research purposes. - (j) Standard: uses and disclosures to avert a serious threat to health or safety."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 1}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 189)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nrevised to read as follows:\n\nAuthority: 42 U.S.C. 1302(a); 42 U.S.C. 1320d-1320d-9; sec. 264, Pub. L. 104-191, 110 Stat. 2033-2034 (42 U.S.C. 1320d-2 (note)); 5 U.S.C. 552; secs. 13400-13424, Pub. L.\n111-5, 123 Stat. 258-279; and sec. 1104 of Pub. L. 111-148, 124 Stat. 146-154. - ■ 2. Revise § 160.101 to read as follows:\n\n## §160.101 Statutory basis and purpose. The requirements of this subchapter implement sections 1171-1180 of the Social Security Act (the Act), sections 262 and 264 of Public Law 104-191, section 105 of Public Law 110-233, sections 13400-13424 of Public Law 111-5, and section 1104 of Public Law 111-148. - ■ 3. Amend §160.102 as follows:\n- ■ a. Redesignate paragraph (b) as paragraph (c); and\n- ■ b. Add new paragraph (b) to read as follows:\n\n## §160.102 Applicability. *\n\n*\n\n*\n\n*\n\n*\n\n(b) Where provided, the standards, requirements, and implementation specifications adopted under this subchapter apply to a business associate. *\n\n*\n\n*\n\n- ■\n- ■ associate'', ''Compliance date'',\n\n*\n\n*\n\n4. Amend §160.103 as follows: a. Revise the definitions of ''Business\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n''Disclosure'', ''Electronic media'', the introductory text of the definition of ''Health information'', paragraphs (1)(vi) through (xi), and (xv) of the definition of ''Health plan'', paragraph (2) of the definition of ''Protected health information,'' and the definitions of ''Standard'', ''State'', and ''Workforce''; and\n\n- ■ b. Add, in alphabetical order, new definitions of ''Administrative simplification provision'', ''ALJ'', ''Civil money penalty or penalty'', ''Family member'', ''Genetic information'', ''Genetic services'', ''Genetic test'', ''Manifestation or manifested'', ''Respondent'', ''Subcontractor'', and\n- ''Violation or violate''. The revisions and additions read as follows:\n\n## §160.103 Definitions."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 188}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 174)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntions are conducted on behalf of the home institution, then the home institution is the covered entity for purposes of the rule and the researcher/provider is a workforce member, not a covered entity.\nComment: One commenter expressed confusion about those instances when a health care provider was a covered entity one day, and one who ''works under a contract'' for a manufacturer the next day. Response: If persons are covered under the rule in one role, they are not necessarily covered entities when they participate in other activities in another role. For example, that person could be a covered health care provider in a hospital one day but the next day read research records for a different employer. In its role as researcher, the person is not covered, and protections do not apply to those research records. Comment: One commenter suggested that the Secretary modify proposed §160.102, to add the following clause at the end (after (c)) (regarding health care provider), ''With respect to any entity whose primary business is not that of a health plan or health care provider licensed under the applicable laws of any state, the standards, requirements, and implementation specifications of this subchapter shall apply solely to the component of the entity that engages in the transactions specified in [§] 160.103.'' (Emphasis added.) Another commenter also suggested that the definition of ''covered entity'' be revised to mean entities that are ''primarily or exclusively engaged in health carerelated activities as a health plan, health care provider, or health care clearinghouse.''\n\nResponse: The Secretary rejects these suggestions because they will impermissibly limit the entities covered by the rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 173}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 137)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nses or disclosures, the individual's rights, the covered entity's legal duties, or other privacy practices described in its notice, it must promptly revise its notice accordingly. See § 164.520(b)(3).\n(Pursuant to § 164.530(i), it must also revise its policies and procedures.) Except when required by law, a material change to any term in the notice may not be implemented prior to the effective date of the notice in which such material change is reflected. In the final rule, however, we revise the circumstances under and extent to which the covered entity may revise the practices stated in the notice and apply the new practices to protected health information it created or received under prior notice. Under §164.530(i), a covered entity that wishes to change its practices over time without segregating its records according to the notice in effect at the time the records were created must reserve the right to do so in its notice. For example, a covered hospital that states in its notice that it will only make public health disclosures required by law, and that does not reserve the right to change this practice, is prohibited from making any discretionary public health disclosures of protected health information created or received during the effective period of that notice. If the covered hospital wishes at some point in the future to make discretionary disclosures for public health purposes, it must revise its notice to so state, and\n\nFrm 00090\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nmust segregate its records so that protected health information created or received under the prior notice is not disclosed for discretionary public health purposes. This hospital may then make discretionary public health disclosures of protected health information created or received after the effective date of the revised notice."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 136}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 45)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nragraph (a) of this section without unreasonable delay and in no case later than 60 calendar days after discovery of a breach. (c) Implementation specifications: Content of notification -(1) Elements.\nThe notification required by paragraph\n\nVerDate Nov&lt;24&gt;2008\n\n(a) of this section shall include, to the extent possible:\n\n- (A) A brief description of what happened, including the date of the breach and the date of the discovery of the breach, if known;\n- (B) A description of the types of unsecured protected health information that were involved in the breach (such as whether full name, social security number, date of birth, home address, account number, diagnosis, disability code, or other types of information were involved);\n\n(C) Any steps individuals should take to protect themselves from potential harm resulting from the breach;\n\n- (D) A brief description of what the covered entity involved is doing to investigate the breach, to mitigate harm to individuals, and to protect against any further breaches; and\n- (E) Contact procedures for individuals to ask questions or learn additional information, which shall include a tollfree telephone number, an e-mail address, Web site, or postal address. - (2) Plain language requirement. The notification required by paragraph (a) of this section shall be written in plain language. - (d) Implementation specifications: Methods of individual notification. The notification required by paragraph (a) of this section shall be provided in the following form:\n- (1) Written notice. (i) Written notification by first-class mail to the individual at the last known address of the individual or, if the individual agrees to electronic notice and such agreement has not been withdrawn, by electronic mail. The notification may be provided in one or more mailings as information is available."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 44}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 535)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n) of this section, the description must include sufficient detail to place the individual on notice of the uses and disclosures that are permitted or required by this subpart and other applicable law.\n- (E) A statement that other uses and disclosures will be made only with the individual's written authorization and\n- that the individual may revoke such authorization as provided by §164.508(b)(5). - (iii) Separate statements for certain uses or disclosures. If the covered entity intends to engage in any of the following activities, the description required by paragraph (b)(1)(ii)(A) of this section must include a separate statement, as applicable, that:\n- (A) The covered entity may contact the individual to provide appointment reminders or information about treatment alternatives or other healthrelated benefits and services that may be of interest to the individual;\n- (B) The covered entity may contact the individual to raise funds for the covered entity; or\n- (C) A group health plan, or a health insurance issuer or HMO with respect to a group health plan, may disclose protected health information to the sponsor of the plan. (iv) Individual rights."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 534}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 166)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n........................ 3,355,000 .................. 9,500 (1 hr per breach). $311,125 ................... 16,775 ....................... $377,940 ................... N/A ............................\n| 19,000 19,000 50,325 |\n|                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                            |                                                                                                                                                                                                                 | 6,710,000            |\n|                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                            |                                                                                                                                                                                                                 | $622,250             |\n| Hours to prepare mailing ................................................................................."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 165}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 14)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nents can be:\n- o Intentional (e.g., malicious intent)\n- o Unintentional (e.g., misconfigured server, data entry error)\n- Threat sources refer to the intent and method targeted at causing harm to ePHI.\nThreat sources can be:\n- o Natural (e.g., floods, earthquakes, storms, tornados)\n- o Human (e.g., intentional, such as identity thieves, hackers, spyware authors; unintentional, such as data entry error, accidental deletions)\n- o Environmental (e.g., power surges and spikes, hazardous material contamination, environmental pollution)\n\n16  Regulated entities may benefit from the NIST IR 8286 series of publications for more comprehensive risk assessment methodologies, including how to integrate ePHI risk assessment with Enterprise Risk Management (ERM). - Vulnerabilities are flaws or weaknesses in a system, system security procedures, internal controls, or implementation that could be exploited or triggered by a threat event. - Likelihood refers to the probability that a given threat event is capable of exploiting a given vulnerability to cause harm . - Impact refers to the magnitude of harm that can be expected to result from the loss of confidentiality, integrity, and/or the availability of ePHI. - Risk refers to the extent to which an entity is threatened by a potential circumstance or event. Risk is typically a function of the likelihood and impact calculations. It can be easy to confuse some of these terms. For example, an organization may determine that it is vulnerable to damage from power surges. The threat sources that could exploit this vulnerability may include overloaded circuits or too much load on the local grid. Other threat sources (e.g., a data entry error) may be unable to exploit this vulnerability. In this example scenario, recommended security controls could range from installing uninterruptible power supply (UPS) systems, additional fuse boxes, and standby generators to rewiring the office."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 13}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 27)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nn $50,000 for each violation; except that a penalty for violations of the same requirement or prohibition under any of these categories may not exceed $1,500,000 in a calendar year. See Table 2 below.\n## TABLE 2-CATEGORIES OF VIOLATIONS AND RESPECTIVE PENALTY AMOUNTS AVAILABLE\n\n| Violation category-Section 1176(a)(1)                                                                                                          | Each violation   | All such violations of an identical provision in a calendar year   |\n|------------------------------------------------------------------------------------------------------------------------------------------------|------------------|--------------------------------------------------------------------|\n| (A) Did Not Know ............................................................................................................................. | $100-$50,000     | $1,500,000                                                         |\n| (B) Reasonable Cause .................................................................................................................... | 1,000-50,000     | 1,500,000                                                          |\n| (C)(i) Willful Neglect-Corrected ........................................................................................................ | 10,000-50,000    | 1,500,000                                                          |\n| (C)(ii) Willful Neglect-Not Corrected ................................................................................................"}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 26}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 21)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nviding specified services to a covered entity creates a business associate relationship if the provision of the service involves the disclosure of protected health information to the service provider.\nIn the proposed rule, we had included a list of persons that were considered to be business partners of the covered entity. However, it is not always clear whether the provision of certain services to a covered entity is ''for'' the covered entity or whether the service provider is acting ''on behalf of'' the covered entity. For example, a person providing management consulting services may need protected health information to perform those services, but may not be acting ''on behalf of'' the covered entity. This we believe led to some general confusion among the commenters as to whether certain arrangements fell within the definition of a business partner under the proposed rule. The construction of the final rule clarifies that the provision of the specified services gives rise to a business associate relationship if the performance of the service involves disclosure of protected health information by the covered entity to the business associate. The specified services are legal, actuarial, accounting, consulting, management, administrative\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00015\n\naccreditation, data aggregation, and financial services. The list is intended to include the types of services commonly provided to covered entities where the disclosure of protected health information is routine to the performance of the service, but when the person providing the service may not always be acting ''on behalf of'' the covered entity. In the final rule, we reorganize the list of examples of the functions or activities that may be conducted by business associates. We place a part of the proposed list in the portion of the definition that addresses when a person is providing functions or activities for or on behalf of a covered entity."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 20}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are covered entity obligations under HIPAA?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\nRIN 0991-AB56\n\n## Breach Notification for Unsecured Protected Health Information\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Interim final rule with request for comments. SUMMARY: The Department of Health and Human Services (HHS) is issuing this interim final rule with a request for comments to require notification of breaches of unsecured protected health information. Section 13402 of the Health Information Technology for Economic and Clinical Health (HITECH) Act, part of the American Recovery and Reinvestment Act of 2009 (ARRA) that was enacted on February 17, 2009, requires HHS to issue interim final regulations within 180 days to require covered entities under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and their business associates to provide notification in the case of breaches of unsecured protected health information. For purposes of determining what information is ''unsecured protected health information,'' in this document HHS is also issuing an update to its guidance specifying the technologies and methodologies that render protected health information unusable, unreadable, or indecipherable to unauthorized individuals. DATES: Effective Date: This interim final rule is effective September 23, 2009. Comment Date: Comments on the provisions of this interim final rule are due on or before October 23, 2009. Comments on the information collection requirements associated with this rule are due on or before September 8, 2009. ADDRESSES: You may submit comments, identified by RIN 0991-AB56, by any of the following methods (please do not submit duplicate comments):\n\n- Regular, Express, or Overnight Mail: U.S. Department of Health and Human Services, Office for Civil Rights, Attention: HITECH Breach Notification, Hubert H."}], "metadata": {"source": "breach_notification_2009", "entity_type": "covered_entity", "safeguard_types": ["physical", "technical", "administrative"], "type": "entity_obligations"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 505)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nmeans:\n\n- (1) A group of records maintained by or for a covered entity that is:\n2. (i) The medical records and billing records about individuals maintained by or for a covered health care provider;\n3.\n(ii) The enrollment, payment, claims adjudication, and case or medical management record systems maintained by or for a health plan; or\n4. (iii) Used, in whole or in part, by or for the covered entity to make decisions about individuals. - (2) For purposes of this paragraph, the term record means any item, collection, or grouping of information that includes protected health information and is maintained, collected, used, or disseminated by or for a covered entity. Direct treatment relationship means a treatment relationship between an individual and a health care provider that is not an indirect treatment relationship. Disclosure means the release, transfer, provision of access to, or divulging in any other manner of information outside the entity holding the information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 504}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 63)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nected health information, even if, as a condition of receiving the funding, the covered entity is required to report protected health information to the agency for program oversight or other purposes.\n(Certain of these disclosures would also be exempt from the sale requirements, depending on whether the requirement to report data was included in regulation or other law.) Similarly, we clarify that the exchange of protected health information through a health information exchange (HIE) that is paid for through fees assessed on HIE participants is not a sale of protected health information; rather the remuneration is for the services provided by the HIE and not for the data itself. (Such disclosures may also be exempt from these provisions under the exception for disclosures to or by a business associate that is being compensated by a covered entity for its services.) In contrast, a sale of protected health information occurs when the covered entity primarily is being compensated to supply data it maintains in its role as a covered entity (or business associate). Thus, such disclosures require the individual's authorization unless they otherwise fall within an exception at §164.502(a)(5)(ii)(B)( 2 ). For example, a disclosure of protected health information by a covered entity to a third party researcher that is conducting the research in exchange for remuneration would fall within these provisions, unless the only\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with remuneration received is a reasonable, cost-based fee to cover the cost to prepare and transmit the data for such purposes (see below). In response to questions by commenters, we also clarify the scope of the term ''remuneration.'' The statute uses the term ''remuneration,'' and not ''payment,'' as it does in the marketing provisions at section 13406(a)."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 62}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 160)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nld be able to sue for breach of privacy. Response: We agree, but do not have the legislative authority to grant a private right of action to sue under this statute. Only Congress can grant that right.\n## Objections to Government Access to Protected Health Information\n\nComment: Many commenters urged the Department not to create a government database of health information, or a tracking system that would enable the government to track individuals health information. Response: This regulation does not create such a database or tracking system, nor does it enable future creation of such a database. This regulation describes the ways in which health plans, health care clearinghouses, and certain health care providers may use and disclose identifiable health information with and without the individual's consent. Comment: Many commenters objected to government access to or control over their health information, which they believe the proposed regulation would provide. Response: This regulation does not increase current government access to health information. This rule sets minimum privacy standards. It does not require disclosure of health information, other than to the subject of the records or for enforcement of this rule. Health plans and health care providers are free to use their own professional ethics and judgement to adopt stricter policies for disclosing health information. Comment: Some commenters viewed the NPRM as creating fewer hurdles for government access to protected health information than for access to protected health information by private organizations. Some health care providers commented that the NPRM\n\nwould impose substantial new restrictions on private sector use and disclosure of protected health information, but would make government access to protected health information easy. One consumer advocacy group made the same observation."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 159}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 142)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nfinal rule made several technical changes to align the HIPAA Rules in light of the new breach notification requirements of subpart D. See 74 FR 42755-56. We did not receive comments on these changes.\nWe retain the technical corrections made in the interim final rule and also make an additional technical correction by adding ''and'' to the end of §160.534(b)(1)(iii) to make clear the relationship between § 160.534(b)(1)(iii) and the new § 160.534(b)(1)(iv). ## 9. Preemption\n\n## Interim Final Rule\n\nThe interim final rule clarified that contrary State law will be preempted by these breach notification regulations. Section 1178 of the Social Security Act, 42 U.S.C. 1320d-7, which was added by HIPAA, provides that HIPAA administrative simplification provisions generally preempt conflicting State law. Section 160.203 states that a standard, requirement, or implementation specification that is adopted as regulation at 45 CFR parts 160, 162, or 164 and that is ''contrary to a provision of State law preempts the provision of State law.'' Thus, whether a State law is contrary to these breach notification regulations is to be determined based on the definition of ''contrary'' at § 160.202, which states that a State law is contrary if ''[a] covered entity would find it impossible to comply with both the State and Federal requirements'' or if the State law ''stands as an obstacle to the accomplishment and execution of the full purposes and objectives'' of the breach notification provisions in the Act. Covered entities must analyze\n\nVerDate Mar&lt;15&gt;2010\n\nrelevant State laws with respect to the breach requirements to understand the interaction and apply this preemption standard appropriately. In the interim final rule, we stated our belief that, in general, covered entities can comply with both the applicable State laws and this regulation and that in most cases, a single notification can satisfy the notification requirements under State laws and this regulation."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 141}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 188)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nng and streamlining requirements and increasing flexibility. Such savings arise from:\n\n1. Eliminating the need for multiple forms for certain research studies by permitting compound authorizations;\n2.\nObviating the need to find past research participants and obtain new authorizations for new research by allowing individuals to authorize future research uses and disclosures at the time of initial enrollment;\n3. Limiting the period of protection for decedent information to permit family members and historians to obtain information about a decedent without needing to find a personal representative of the deceased individual to authorize the disclosure;\n4. Permitting disclosures to a decedent's family members or others involved in the care or payment for care prior to the decedent's death; and\n5. Permitting covered entities to document a parent's informal agreement to disclose immunization information to a child's school rather than requiring a signed authorization form. ## VIII. Collection of Information Requirements\n\nThis final rule contains the following information collections (i.e., reporting, recordkeeping, and third-party disclosures) under the Paperwork Reduction Act. Some of those provisions involve changes from the information collections set out in the proposed and interim final rules. These changes are noted below. ## A. Reporting\n\n- Notification to the Secretary of breaches of unsecured protected health information (§ 164.408). In the final rule, we revise our estimated number of respondents and responses to reflect our experience administering the interim final rule. ## B. Recordkeeping\n\n- Documentation of safeguards and policies and procedures under the Security Rule (§ 164.316). In the proposed rule, we assumed that all business associates were in compliance with the Security Rule's documentation standard because of their contractual obligations to covered entities under the HIPAA Rules."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 187}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 532)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nt implement policies and procedures (which may be standard protocols) that limit the protected health information disclosed to the amount reasonably necessary to achieve the purpose of the disclosure.\n- (ii) For all other disclosures, a covered entity must:\n\n(A) Develop criteria designed to limit the protected health information disclosed to the information reasonably necessary to accomplish the purpose for which disclosure is sought; and\n\n(B) Review requests for disclosure on an individual basis in accordance with such criteria. (iii) A covered entity may rely, if such reliance is reasonable under the circumstances, on a requested disclosure as the minimum necessary for the stated purpose when:\n\n- (A) Making disclosures to public officials that are permitted under §164.512, if the public official represents that the information requested is the minimum necessary for the stated purpose(s);\n- (B) The information is requested by another covered entity;\n- (C) The information is requested by a professional who is a member of its workforce or is a business associate of the covered entity for the purpose of providing professional services to the covered entity, if the professional represents that the information requested is the minimum necessary for the stated purpose(s); or\n- (D) Documentation or representations that comply with the applicable requirements of § 164.512(i) have been provided by a person requesting the information for research purposes. - (4) Implementation specifications: Minimum necessary requests for protected health information. (i) A covered entity must limit any request for protected health information to that which is reasonably necessary to accomplish the purpose for which the request is made, when requesting such information from other covered entities."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 531}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 295)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nearch information. We are aware that some researchers currently retain separate research records and medical records as a means of providing more stringent privacy protections for the research record.\nThe final rule permits\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ncovered entities that participate in research to continue to provide more stringent privacy protections for the research record, and the Secretary strongly encourages this practice to protect research participants from being harmed by the misuse of their research information. As discussed above, in the final rule, we eliminate the special rules for this proposed definition of research information unrelated to treatment and its related provisions, so the comments regarding its application are moot. Comment: Some commenters recommended that the final rule prohibit a covered entity from conditioning treatment, enrollment in a health plan, or payment on a requirement that the individual authorize the use or disclosure of information we proposed to constitute research information unrelated to treatment. Response: Our decision to eliminate the definition of research information unrelated to treatment and its related provisions in the final rule renders this comment moot. Comment: A few commenters opposed distinguishing between research information related to treatment and research information unrelated to treatment, arguing that such a distinction could actually weaken the protection afforded to clinically-related health information that is collected in clinical trials. These commenters asserted that Certificates of Confidentiality shield researchers from being compelled to disclose individually identifiable health information relating to biomedical or behavioral research information that an investigator considers sensitive."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 294}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 34)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nnt clarify whether the\n\nPO 00000\n\nFrm 00023\n\nnew enforcement provisions will apply to violations of all HIPAA Administrative Simplification provisions or just to the privacy and security requirements.\nResponse: The enforcement regulations at 45 CFR Part 160, Subparts C, D, and E, relate to compliance with, and the enforcement of, all of the Administrative Simplification regulations adopted under subtitle F of Title II of HIPAA, including the Standards for Electronic Transactions and Code Sets (Transactions and Code Sets Rule(s) (referred to in both a singular and plural sense); Standards for Privacy of Individually Identifiable Health Information (HIPAA Privacy Rule); Standard Unique Employer Identifier (EIN Rule); Security Standards (HIPAA Security Rule); and Standard Unique Health Identifier for Health Care Providers (NPI Rule). In addition, the Enforcement Rule applies to the Breach Notification Rule for HIPAA covered entities and business associates. ## C. Subparts A and C of Part 164: General Provisions and Modifications to the Security Rule\n\nWe proposed implementing modifications to the Security Rule as a result of the HITECH Act and to make certain other changes. Below we respond to comments received on the proposed changes as well as describe the final rule provisions. We also discuss the final technical and conforming changes to the general provisions in Subpart A of Part 164, which applies to the Security, Privacy, and Breach Notification Rules, and respond to comments where substantive comments were received on these changes. 1. Technical Changes to Subpart AGeneral Provisions\n- a. Section 164.102-Statutory Basis\n\nThis section sets out the statutory basis of Part 164. We proposed and include in this final rule a technical change to include a reference to the provisions of sections 13400 through 13424 of the HITECH Act upon which the regulatory changes discussed below are based. ## b."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 33}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 57)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nsition period would prevent rushed and hasty changes to thousands of on-going existing business associate agreements. We addressed the issue of the business associate transition provisions as follows.\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\nWe proposed new transition provisions at § 164.532(d) and (e) to allow covered entities and business associates (and business associates and business associate subcontractors) to continue to operate under certain existing contracts for up to one year beyond the compliance date of the revisions to the Rules. The additional transition period would be available to a covered entity or business associate if, prior to the publication date of the modified Rules, the covered entity or business associate had an existing contract or other written arrangement with a business associate or subcontractor, respectively, that complied with the prior provisions of the HIPAA Rules and such contract or arrangement was not renewed or modified between the effective date and the compliance date of the modifications to the Rules. The proposed provisions were intended to allow those covered entities and business associates with valid contracts with business associates and subcontractors, respectively, to continue to disclose protected health information to the business associate or subcontractor, or to allow the business associate or subcontractor to continue to create or receive protected health information on behalf of the covered entity or business associate, for up to one year beyond the compliance date of the modifications, regardless of whether the contract meets the applicable contract requirements in the modifications to the Rules."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 56}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 87)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\ntandards and implementation specifications. The mappings to SP 800-53 can provide information about security controls that can be implemented for a particular standard or implementation specification.\nSo that the information in this appendix can be more easily kept up to date, the mapping table has been removed from the document and placed online in the NIST Cybersecurity and Privacy Reference Tool (CPRT). Regulated entities should note that the information in the mapping table is informative and should not be considered a complete checklist of requirements that guarantee compliance with the Security Rule. 151  Note that the mapping to Cybersecurity Framework v1.1 Subcategories was intentionally broad and includes mappings to Subcategories that both directly and indirectly align with standards and implementation specifications of the Security Rule. Once Cybersecurity Framework v2.0 is finalized, this mapping will be updated and may include only those Subcategories that directly align with the standards and implementation specification. ## Appendix E. National Online Informative References (OLIR) Program\n\nThe mapping in Appendix D lists relevant [NIST CSF] Subcategories and [SP 800-53] security controls for each of the Security Rule's standards and implementation specifications. But what if the regulated entity uses a different framework or controls catalog? Can the regulated entity know which Security Rule standards and implementation specifications align with their chosen framework or controls catalog? The NIST National Online Informative References (OLIR) Program can help regulated entities understand how the Security Rule standards and implementation specifications align with other frameworks and controls catalogs (e.g., the Center for Internet Security [CIS] Critical Security Controls, [HITRUST] CSF), thereby assisting regulated entities in achieving compliance with the Security Rule and improving their cybersecurity posture."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 86}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 483)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthat would reduce the burden to small entities. In developing this rule, the Department considered a variety of alternatives for minimizing the economic burden that it will create for small entities.\nWe did not exempt small businesses from the rule because they represent such a large and critical proportion of the health care industry (82.6 percent); a significant portion of individually identifiable health\n\n80 Office of Advocacy, U.S. Small Business Administration, from data provided by the Bureau of the Census, Statistics of U.S. Businesses, 1997. 81 Op.cit., 1997. 82 Health Care Financing Administration, OSCAR. information is generated or held by these small businesses. The guiding principle in our considerations of how to address the burden on small entities has been to make provisions performance rather than specification oriented-that is, the rule states the standard to be achieved but allows institutions flexibility to determine how to achieve the standard within certain parameters. Moreover, to the extent possible, we have allowed entities to determine the extent to which they will address certain issues. This ability to adapt provisions to minimize burden has been addressed in the regulatory impact analysis above, but it will be briefly discussed again in the following section. Before discussing specific provisions, it is important to note some of the broader questions that were addressed in formulating this rule. The Department considered extending the compliance period for small entities but concluded that it did not have the legal authority to do so (see discussion above). The rule, pursuant to HIPAA, creates an extended compliance time of 36 months (rather than 24 months) only for small health plans and not for other small entities."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 482}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the differences between covered entity and business associate obligations under HIPAA?"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\n<!-- image -->\n\n## NIST Special Publication 800 NIST SP 800-66r2\n\n## Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule\n\nA Cybersecurity Resource Guide\n\nJeffrey A. Marron Applied Cybersecurity Division Information Technology Laboratory\n\nThis publication is available free of charge from: https://doi.org/10.6028/NIST.SP.800-66r2\n\nFebruary 2024\n\n<!-- image -->\n\nU.S. Department of Commerce Gina M. Raimondo, Secretary\n\nNational Institute of Standards and Technology\n\nCertain commercial equipment, instruments, software, or materials, commercial or non-commercial, are identified in this paper in order to specify the experimental procedure adequately. Such identification does not imply recommendation or endorsement of any product or service by NIST, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose. There may be references in this publication to other publications currently under development by NIST in accordance with its assigned statutory responsibilities. The information in this publication, including concepts and methodologies, may be used by federal agencies even before the completion of such companion publications. Thus, until each publication is completed, current requirements, guidelines, and procedures, where they exist, remain operative. For planning and transition purposes, federal agencies may wish to closely follow the development of these new publications by NIST. Organizations are encouraged to review all draft publications during public comment periods and provide feedback to NIST."}], "metadata": {"source": "nist_sp800-66r2", "entity_type": "both", "safeguard_types": ["physical", "technical", "administrative"], "type": "entity_obligations"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 421)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nof providing the right to an accounting. One commenter stated that such a provision would be meaningless because those who deliberately perpetrate an abuse are unlikely to note their breach in a log.\nResponse: The final rule retains the right of an individual to receive an accounting of disclosures of protected health information. The provision serves multiple purposes. It provides a means of informing the individual as to which information has been sent to which recipients. This information, in turn, enables individuals to exercise certain other rights under the rule, such as the rights to inspection and amendment, with greater precision and ease. The accounting also allows individuals to monitor how covered entities are complying with the rule. Though covered entities who deliberately make disclosures in violation of the rule may be unlikely to note such a breach in the accounting, other covered entities may document inappropriate disclosures that they make out of ignorance and not malfeasance. The accounting will enable the individual to address such concerns with the covered entity. We believe this approach is consistent with well-established privacy principles, with other law, and with industry standards and ethical guidelines. The July 1977 Report of the Privacy Protection Study Commission recommended that a health care provider should not disclose individually-identifiable information for certain purposes without the individual's authorization unless ''an accounting of such disclosures is kept and the individual who is the subject of the information being disclosed can find out that the disclosure has been made and to whom.'' 32 With certain exceptions, the Privacy Act (5 U.S.C. 552a) requires government agencies to ''keep an accurate accounting of * * *\n\n32 Privacy Protection Study Commission, ''Personal Privacy in an Information Society,'' July 1977, pp. 306-307."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 420}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 64)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nr and to avoid confusion on this point. Also, in the hybrid entity situation the covered entity/legal entity has control over the entire workforce, not just the workforce of the health care component.\nThus, the covered entity is in a position to implement policies and procedures to ensure that the part of its workforce that is doing mixed or non-covered functions does not impermissibly use or disclose protected health information. Its responsibility to do so is clarified in §164.504(c)(3)(ii). ## Section 164.504(d)-Affiliated Entities\n\nSome legally distinct covered entities may share common administration of organizationally differentiated but similar activities (for example, a hospital chain). In § 164.504(d) we permit legally distinct covered entities that share common ownership or control to designate themselves, or their health care components, together to be a single covered entity. Common control exists if an entity has the power, directly or indirectly, significantly to influence or direct the actions or policies of another entity. Common ownership exists if an entity or entities possess an ownership or equity interest of 5 percent or more in another entity. Such organizations may promulgate a single shared notice of information practices and a consent form. For example, a corporation with hospitals in twenty states may designate itself as a covered entity and, therefore, able to merge information for joint marketplace analyses. The requirements that apply to a covered entity also apply to an affiliated covered entity. For example, under the minimum necessary provisions, a hospital in one state could not share protected health information about a particular patient with another hospital if such a use is not necessary for treatment, payment or health care operations. The covered entities that together make up the affiliated covered entity are separately subject to liability under this rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 63}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 152)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\npose under §§ 164.502(a)(2)(ii) or 164.512, the covered entity may provide a summary accounting addressing the series of disclosures rather than a detailed accounting of each disclosure in the series.\nIn this circumstance, a covered entity may limit the accounting of the series of disclosures to the following information: the information otherwise required above for the first disclosure in the series during the accounting period; the frequency, periodicity, or number of disclosures made during the accounting period; and the date of the most recent disclosure in the series. For example, if under §164.512(b), a covered entity discloses the same protected health information to a public health authority for the same purpose every month, it can account for those disclosures by including in the accounting the date of the first disclosure, the public health authority to whom the disclosures were made and the public health authority's address, a brief description of the information disclosed, a brief description of the purpose of the disclosures, the fact that the disclosures were made every month during the accounting period, and the date of the most recent disclosure. ## Provision of the Accounting\n\nWe proposed in the NPRM to require covered entities to provide individuals with an accounting of disclosures as soon as possible, but not later than 30 days following receipt of the request for the accounting. In the final rule, we eliminate the requirement for the covered entity to act as soon as possible. We recognize that circumstances may arise in which an individual will request an accounting on an expedited basis. We encourage covered entities to implement procedures for handling such requests. The time limitation is intended to be an outside deadline, rather than an expectation. We expect covered entities always to be attentive to the circumstances surrounding each request and to respond in an appropriate time frame."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 151}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 12)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nity). Since no comprehensive, scalable, and technology-neutral set of standards currently exists, we proposed to designate a new standard, which would define the security requirements to be fulfilled.\nThe proposed rule proposed to define the security standard as a set of scalable, technology-neutral requirements with implementation features that providers, plans, and clearinghouses would have to include in their operations to ensure that health information pertaining to an individual that is electronically maintained or electronically transmitted remains safeguarded. The proposed rule would have required that each affected entity assess its own security needs and risks and devise, implement, and maintain appropriate security to address its own unique security needs. How individual security requirements would be satisfied and which technology to use would be business decisions that each entity would have to make. In the final rule we adopt this basic framework. In § 164.306, we set forth general rules pertaining to the security standards. In paragraph (a), we describe the general requirements. Paragraph (a) generally reflects section 1173(d)(2) of the Act, but makes explicit the connection between the security standards and the privacy standards (see §164.306(a)(3)). In § 164.306(a)(1), we provide that the security standards apply to all electronic protected health information the covered entity creates, receives, maintains, or transmits. In paragraph (b)(1), we provide explicitly for the scalability of this rule by discussing the flexibility of the standards, and paragraph (b)(2) of §164.306 discusses various factors covered entities must consider in complying with the standards. The provisions of § 164.306(c) provide the framework for the security standards, and establish the requirement that covered entities must comply with the standards."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 11}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 103)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nts and requests for clarification and guidance regarding the permitted methods for offering protected health information on electronic media, and the acceptable form and format of the electronic copy.\nSeveral commenters suggested that covered entities be permitted flexibility in determining available electronic formats and requested clarification on what is considered ''readily producible.'' These commenters expressed concerns that a limited number of permissible electronic formats may result in a situation where protected health information could not be converted from a particular electronic system. Other commenters indicated that there should be minimum standards and clearly defined media that are permissible to meet this requirement. One commenter felt that this requirement is important but should be deferred until covered entities have improved their technological capabilities. Many commenters requested guidance on how to proceed if a covered entity and an individual are unable to come to an agreement on the medium of choice and what is expected in terms of accommodating the individual's medium of choice. Some commenters suggested various alternate solutions if\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with an agreement cannot be reached, including any readily producible format, PDF, or hard copy protected health information. Some covered entities felt that individuals should not have an unlimited choice in terms of the electronic media they are willing to accept, and should only be permitted to confine their choices of electronic media to a couple of options that the covered entity has available."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 102}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 84)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ne involved. For those individuals who have opted out of receiving fundraising communications, commenters generally supported allowing those individuals to opt back in to receiving such communications.\nSome suggested that individuals be able to opt back in using the same methods they used to opt out, while others suggested that any communication indicating a willingness to resume receiving fundraising communications, such as making a donation to the covered entity, should function as an opt in. Other commenters suggested that the final rule limit the amount of time that an individual can opt out, such that after this period of time the individual automatically begins receiving fundraising communications again. A few commenters were opposed to permitting individuals to opt back in to receive fundraising communications, stating that this would be too costly and burdensome for covered entities to track. With respect to the requests for public comments regarding the potential use or disclosure of additional protected health information to provide more targeted fundraising communications, the vast majority of commenters supported allowing the use or disclosure of additional protected health information for fundraising. These commenters stated that the use of additional protected health information would streamline their fundraising efforts and ensure that individuals were sent communications about campaigns that would be meaningful to their experiences. These commenters also stated that it would eliminate the concern of sending a communication to an individual or family that suffered a negative outcome."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 83}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 410)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrs may, in some circumstances and consistent with any known prior preferences of the individual, exercise professional judgment in the individual's best interest to not disclose directory information.\n(See § 164.510(a) regarding directory information.)\n- Covered entities may deny access to protected health information when there are concerns that the access may result in varying levels of harm. (See §164.524(a)(3) regarding denial of access.)\n- Covered entities may, in some circumstances, exercise professional judgment in the individual's best interest to limit disclosure to persons assisting in the individual's care. (See §164.510(b) regarding persons assisting in the individual's care.)\n\nThis approach allows for state law and personal variation in this area. The only type of protected health information that we treat with heightened protection is psychotherapy notes. We provide a different level of protection because they are unique types of protected health information that typically are not used or required for treatment, payment, or health care operations other than by the mental health professional that created the notes. (See § 164.508(a)(2) regarding psychotherapy notes.)\n\n## Section 164.524-Access of Individuals to Protected Health Information\n\nComment: Some commenters recommended that there be no access to disease registries. Response: Most entities that maintain disease registries are not covered entities under this regulation; examples of such non-covered entities are public health agencies and pharmaceutical companies. If, however, a disease registry is maintained by a covered entity and is used to make decisions about individuals, this rule requires the covered entity to provide access to information about a requesting individual unless one of the rule's conditions for denial of access is met."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 409}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 98)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nies to verify the identity and authority of persons to whom they make disclosures. We note that the minimum necessary requirements of §164.514(d) do not apply to disclosures made under this paragraph.\nWe note that this rule does not affect what is required by other law, nor does it compel a covered entity to make a use or disclosure of protected health information required by the legal demands or reporting requirements listed in the definition of ''required by law.'' Covered entities will not be sanctioned under this rule for responding in good faith to such legal process and reporting requirements. However, nothing in this rule affects, either by expanding or contracting, a covered entity's right to challenge such process or reporting requirements under other laws. The only disclosures of protected health information compelled by this rule are disclosures to an individual (or the personal representative of an individual) or to the Secretary for the purposes of enforcing this rule. Uses and disclosures permitted under this paragraph must be limited to the protected health information necessary to meet the requirements of the law that compels the use or disclosure. For example, disclosures pursuant to an administrative subpoena are limited to the protected health information authorized to be disclosed on the face of the subpoena."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 97}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 383)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nPO 00000\n\nFrm 00253\n\nargued that the standard with regard to ''uses'' would be impossible to implement and prohibitively expensive, requiring both medical and legal input to each disclosure decision.\nSome commenters recommended deletion of the minimum necessary standard with regard to ''uses.'' Other commenters specifically recommended deletion of the requirement that the standard be applied on an individual, case-by-case basis. Rather, they suggested that the covered entity be allowed to establish general policies to meet the requirement. Another commenter similarly urged that the standard not apply to internal disclosures or for internal health care operations such as quality improvement/assurance activities. The commenter recommended that medical groups be allowed to develop their own standards to ensure that these activities are carried out in a manner that best helps the group and its patients. Other commenters expressed confusion and requested clarification as to how the standard as proposed would actually work in day-to-day operations within an entity. Response: Commenters' arguments regarding the workability of this standard as proposed were persuasive, and we therefore make significant modification to address these comments and improve the workability of the standard. For all uses and many disclosures, we require covered entities to include in their policies and procedures (see § 164.530), which may be standard protocols, for ''minimum necessary'' uses and disclosures. We require implementation of such policies in lieu of making the ''minimum necessary'' determination for each separate use and disclosure. For uses, covered entities must implement policies and procedures that restrict access to and use of protected health information based on the specific professional roles of members of the covered entity's workforce."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 382}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 393)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nn individuals and covered entities. A few comments, however, argued that the notice requirement would be administratively burdensome and expensive without providing significant benefit to individuals.\nResponse: We retain the requirement for covered health care providers and health plans to produce a notice of information practices. We additionally require health care clearinghouses that create or receive protected health information other than as a business associate of another covered entity to produce a notice. We believe the notice will provide individuals with a clearer understanding of how their information may be used and disclosed and is essential to inform individuals of their privacy rights. The notice will focus individuals on privacy issues, and prompt individuals to have discussions about privacy issues with their health plans, health care providers, and other persons. The importance of providing individuals with notice of the uses and disclosures of their information and of their rights with respect to that information is well supported by industry groups, and is recognized in current state and federal law. The July 1977 Report of the Privacy Protection Study Commission recommended that ''each medical-care provider be required to notify an individual on whom it maintains a medical record of the disclosures that may be made of information in the record without the individual's express authorization.'' 23 The Commission also recommended that ''an insurance institution * * * notify (an applicant or principal insured) as to: * * * the types of parties to whom and circumstances under which information about the individual\n\n23 Privacy Protection Study Commission,\n\n''Personal Privacy in an Information Society,'' July 1977, p. 313."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 392}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 27)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n• Has the regulated entity assured compliance with all policies and procedures by its workforce? |\n| 4. Acquire Information Technology (IT) Systems and Services 35 36 | • Regulated entities should consider how cloud services and other third-party IT system and service offerings can both assist regulated entities in protecting ePHI while also potentially introducing new risks to ePHI. • Although the HIPAA Security Rule does not require purchasing any particular technology, adequately protecting information may require additional hardware, software, or services. Considerations for their selection should include the following: o Applicability of the IT solution to the intended environment; o The sensitivity of the data; o The organization's security policies, procedures, and standards; and o Other requirements, such as resources available for operation, maintenance, and training. | • Will new security controls work with the existing IT architecture? • Have the security requirements of the organization been compared to the security features of existing or proposed hardware and software? • Has a cost-benefit analysis been conducted to determine the reasonableness of the investment given the security risks identified? • Has a training strategy been developed? 37 |\n| 5. Create and Deploy Policies and Procedures 38 39                | • Implement the decisions concerning the management, operational, and technical controls selected to mitigate identified risks. • Create policies that clearly establish roles and responsibilities and assign ultimate responsibility for the implementation of each control to particular individuals or offices."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 26}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 147)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncopies are made to a computer disk, this would include the cost of the computer disk. Covered entities may not charge any fees for retrieving or handling the information or for processing the request.\nIf the individual requests the information to be mailed, the fee may include the cost of postage. Fees for copying and postage provided under state law, but not for other costs excluded under this rule, are presumed reasonable. If such per page costs include the cost of retrieving or handling the information, such costs are not acceptable under this rule. If the individual requests an explanation or summary of the information provided, and agrees in advance to any associated fees, the covered entity may charge for preparing the explanation or summary as well. The inclusion of a fee for copying is not intended to impede the ability of individuals to copy their records. Rather, it is intended to reduce the burden on covered entities. If the cost is excessively high, some individuals will not be able to obtain a copy. We encourage covered entities to limit the fee for copying so that it is within reach of all individuals. We do not intend to affect the fees that covered entities charge for providing protected health information to anyone other than the individual. For example, we do not intend to affect current practices with respect to the fees one health care provider charges for forwarding records to another health care provider for treatment purposes. ## Section 164.524(d)-Denial of Access\n\nWe proposed in the NPRM to require a covered health care provider or health plan that elects to deny a request for inspection or copying to make any other protected health information requested available to the individual to the extent possible, consistent with the denial. In the final rule, we clarify the proposed approach."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 146}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the differences between covered entity and business associate obligations under HIPAA?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160, 162, and 164 [CMS-0049-F] RIN 0938-AI57\n\n## Health Insurance Reform: Security Standards\n\nAGENCY: Centers for Medicare &amp; Medicaid Services (CMS), HHS. ACTION: Final rule. SUMMARY: This final rule adopts standards for the security of electronic protected health information to be implemented by health plans, health care clearinghouses, and certain health care providers. The use of the security standards will improve the Medicare and Medicaid programs, and otherFederal health programs and private health programs, and the effectiveness and efficiency of the health care industry in general by establishing a level of protection for certain electronic health information. This final rule implements some of the requirements of the Administrative Simplification subtitle of the Health Insurance Portability andAccountability Act of 1996 (HIPAA). DATES: Effective Date: These regulations are effective on April 21, 2003. Compliance Date: Covered entities, with the exception of small health plans, must comply with the requirements of this final rule by April 21, 2005. Small health plans must comply with the requirements of this final rule by April 21, 2006. FOR FURTHER INFORMATION CONTACT: William Schooler, (410) 786-0089. SUPPLEMENTARY INFORMATION:\n\n## Availability of Copies and Electronic Access\n\nTo order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 or by faxing to (202) 5122250. The cost for each copy is $10."}], "metadata": {"source": "security_rule_2003", "entity_type": "both", "safeguard_types": ["physical", "technical", "administrative"], "type": "entity_obligations"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 100)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nat the direction of a public health authority. As discussed above, in the final rule we narrow the scope of this paragraph as it applies to disclosures to persons other than public health authorities.\nTo ensure that covered health care providers may make disclosures of protected health information without individual authorization to employers when appropriate under federal and state laws addressing work-related injuries and illnesses or workplace medical surveillance, we include a new provision in the final rule. The provision permits covered health care providers who provide health care as a workforce member of or at the request of an employer to disclose to that employer protected health information concerning work-related injuries or illnesses or workplace medical surveillance in situations where the employer has a duty under the Occupational Safety and Health Act, the Federal Mine Safety and Health Act, or under a similar state law, to keep records on or act on such information. For example, OSHA regulations in 29 CFR part 1904 require employers to record work-related injuries and illnesses if medical treatment is necessary; MSHA regulations at 30 CFR\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00066\n\npart 50 require mine operators to report injuries and illnesses experienced by miners. Similarly, OSHA rules require employers to monitor employees' exposure to certain substances and to remove employees from exposure when toxic thresholds have been met. To obtain the relevant health information necessary to determine whether an injury or illness should be recorded, or whether an employee must be medically removed from exposure at work, employers must refer employees to health care providers for examination and testing. OSHA and MSHA rules do not impose duties directly upon health care providers to disclose health information pertaining to recordkeeping and medical monitoring requirements to employers."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 99}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 13)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nms in the HIPAA Rules to which the Act refers. Rather, the statute expressly contemplates that modifications to the terms may be necessary to carry out the provisions of the Act or for other purposes.\nFurther, we do not agree that covered entities will be confused and seek to establish direct business associate contracts with subcontractors or will prohibit business associates from engaging subcontractors to perform functions or services that require access to protected health information. The final rule makes clear that a covered entity is not required to enter into a contract or other arrangement with a business associate that is a subcontractor. See §§ 164.308(b)(1) and 164.502(e)(1)(i). In addition, as commenters did not present direct evidence to the contrary, we do not believe that covered entities will begin\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with prohibiting business associates from engaging subcontractors as a result of the final rule, in cases where they were not doing so before. Rather, we believe that making subcontractors directly liable for violations of the applicable provisions of the HIPAA Rules will help to alleviate concern on the part of covered entities that protected health information is not adequately protected when provided to subcontractors. The Department also believes that the privacy and security protections for an individual's personal health information and associated liability for noncompliance with the Rules should not lapse beyond any particular business associate that is a subcontractor. Thus, under the final rule, covered entities must ensure that they obtain satisfactory assurances required by the Rules from their business associates, and business associates must do the same with regard to subcontractors, and so on, no matter how far ''down the chain'' the information flows."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 12}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "When must a HIPAA breach be reported to HHS?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\nRIN 0991-AB56\n\n## Breach Notification for Unsecured Protected Health Information\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Interim final rule with request for comments. SUMMARY: The Department of Health and Human Services (HHS) is issuing this interim final rule with a request for comments to require notification of breaches of unsecured protected health information. Section 13402 of the Health Information Technology for Economic and Clinical Health (HITECH) Act, part of the American Recovery and Reinvestment Act of 2009 (ARRA) that was enacted on February 17, 2009, requires HHS to issue interim final regulations within 180 days to require covered entities under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and their business associates to provide notification in the case of breaches of unsecured protected health information. For purposes of determining what information is ''unsecured protected health information,'' in this document HHS is also issuing an update to its guidance specifying the technologies and methodologies that render protected health information unusable, unreadable, or indecipherable to unauthorized individuals. DATES: Effective Date: This interim final rule is effective September 23, 2009. Comment Date: Comments on the provisions of this interim final rule are due on or before October 23, 2009. Comments on the information collection requirements associated with this rule are due on or before September 8, 2009. ADDRESSES: You may submit comments, identified by RIN 0991-AB56, by any of the following methods (please do not submit duplicate comments):\n\n- Regular, Express, or Overnight Mail: U.S. Department of Health and Human Services, Office for Civil Rights, Attention: HITECH Breach Notification, Hubert H."}], "metadata": {"source": "breach_notification_2009", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 28)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n• Establish a frequency for reviewing policy and procedures. | • Is there a process for communicating policies and procedures to the affected employees? • Are policies and procedures reviewed and updated as needed? |\n| 6. Develop and Implement a Sanction Policy 42 Implementation Specification (Required)                        | • Apply appropriate sanctions against workforce members who fail to comply with the security policies and procedures of the covered entity or business associate. • Develop policies and procedures for imposing appropriate sanctions (e.g., reprimand, termination) for noncompliance with the organization's security policies. • Implement sanction policy as cases arise. | • Does the regulated entity have existing sanction policies and procedures to meet the requirements of this implementation specification? If not, can existing sanction policies be modified to include language related to violations of these policies and procedures? • Is there a formal process in place to address system misuse, abuse, and fraudulent activity? • Have workforce members been made aware of policies concerning sanctions for inappropriate access, use, and disclosure of ePHI? • Has the need and appropriateness of a tiered structure of sanctions that accounts for the magnitude of harm and possible types of inappropriate disclosures been considered? • How will managers and workforce members be notified regarding suspect activity? |\n| 7. Develop and Deploy the Information System Activity Review Process Implementation Specification (Required) | • Implement procedures to regularly review records of information system activity, such as audit logs, access reports, and security incident tracking reports. • Implement regular reviews of information system activity and consider ways to automate the review for the protection of ePHI. | • Is there a policy that establishes what reviews will be conducted? • Are there corresponding procedures that describe the specifics of the reviews?"}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 27}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 11)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nered entity does not act merely as a conduit. Rather, the personal health record vendor is maintaining protected health information on behalf of the covered entity (for the benefit of the individual).\nFurther, a personal health record vendor that operates a personal health record on behalf of a covered entity is a business associate if it has access to protected health information, regardless of whether the personal health record vendor actually exercises this access. We believe the revisions to the definition of ''business associate'' discussed above clarify these points. As with other aspects of the definition of ''business associate,'' we intend to provide future guidance on when a personal health record vendor is a business associate for purposes of the HIPAA Rules. 18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00008\n\n## Response to Other Public Comments\n\nComment: One commenter recommended that the term ''person'' used in describing who provides transmission services to a covered entity be clarified to apply also to entities and organizations. Response: The term ''person'' as defined at § 160.103 includes entities as well as natural persons. Comment: One commenter asked whether subcontractors that support business associates with personal health record related functions are subject to the breach notification requirements under the HIPAA Breach Notification Rule or that of the FTC. Response: As discussed below, a subcontractor that creates, receives, maintains, or transmits protected health information on behalf of a business associate, including with respect to personal health record functions, is a HIPAA business associate and thus, is subject to the HIPAA Breach Notification Rule and not that of the FTC. The analysis of whether a subcontractor is acting on behalf of a business associate is the same analysis as discussed above with respect to whether a business associate is acting on behalf of a covered entity. ## iii."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 10}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 176)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\npt the policy implied in the footnote. Response: We agree with the commenter's observation that footnote 18 (64 FR 60014) was inconsistent with the proposed definition. We erred in drafting that note.\nThe definition of ''group health plan'' is adopted from the statutory definition at section 1171(5)(A), and excludes from the rule as ''health plans'' only the few insured or self-insured ERISA plans that have less than 50 participants and are self administered. We reject the commenter's proposed change to the definition as inconsistent with the statute. Comment: A number of insurance companies asked that long term care insurance policies be excluded from the definition of ''health plan.'' It was argued that such policies do not provide sufficiently comprehensive coverage of the cost of medical care, and are limited benefit plans that provide or pay for the cost of custodial and other related services in connection with a long term, chronic illness or disability. These commenters asserted that HIPAA recognizes this nature of long term care insurance, observing that, with respect to HIPAA's portability requirements, Congress enacted a series of exclusions for certain defined types of health plan arrangements that do not typically provide comprehensive coverage. They maintained that Congress recognized that long term care insurance is excluded, so long as it is not a part of a group health plan. Where a long term care policy is offered separately from a group health plan it is considered an excepted benefit and is not subject to the portability and guarantee issue requirements of HIPAA."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 175}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 165)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntion with respect to the unique organizational models and relationships of academic medical centers and their parent universities and the rules that govern information exchange within the institution.\nOne commenter asked whether faculty physicians who are paid by a medical school or faculty practice plan and who are on the medical staff of, but not paid directly by, a hospital are included within the covered entity. Another commenter stated that it appears that only the health center at an academic institution is the covered entity. Uncertainty was also expressed as to whether other components of the institution that might create protected health information only incidentally through the conduct of research would also be covered. Response: The Department understands that in today's health care industry, the relationships among health care entities and non-health care organizations are highly complex and varied. Accordingly, the final rule gives covered entities some flexibility to segregate or aggregate its operations for purposes of the application of this rule. The new component entity provision can be found at §§ 164.504(b)-(c). In response to the request for clarification on whether the rule would apply to a research component of the covered\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00109\n\nentity, we point out that if the research activities fall outside of the health care component they would not be subject to the rule. One organization may have one or several ''health care component(s)'' that each perform one or more of the health care functions of a covered entity, i.e., health care provider, health plan, health care clearinghouse. In addition, the final rule permits covered entities that are affiliated, i.e., share common ownership or control, to designate themselves, or their health care components, together to be a single covered entity for purposes of the rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 164}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement administrative controls?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\n## RIN 0945-AA03\n\nModifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (HHS or ''the Department'') is issuing this final rule to: Modify the Health Insurance Portability and Accountability Act (HIPAA) Privacy, Security, and Enforcement Rules to implement statutory amendments under the Health Information Technology for Economic and Clinical Health Act (''the HITECH Act'' or ''the Act'') to strengthen the privacy and security protection for individuals' health information; modify the rule for Breach Notification for Unsecured Protected Health Information (Breach Notification Rule) under the HITECH Act to address public comment received on the interim final rule; modify the HIPAA Privacy Rule to strengthen the privacy protections for genetic information by implementing section 105 of Title I of the Genetic Information Nondiscrimination Act of 2008 (GINA); and make certain other modifications to the HIPAA Privacy, Security, Breach Notification, and Enforcement Rules (the HIPAA Rules) to improve their workability and effectiveness and to increase flexibility for and decrease burden on the regulated entities. DATES: Effective date: This final rule is effective on March 26, 2013. Compliance date: Covered entities and business associates must comply with the applicable requirements of this final rule by September 23, 2013. FOR FURTHER INFORMATION CONTACT: Andra Wicks 202-205-2292. SUPPLEMENTARY INFORMATION:\n\nVerDate Mar&lt;15&gt;2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n## I."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_type": "administrative", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 72)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nesearch altogether. Some of these commenters felt strongly that studyspecific authorizations are critical to protect patients, and are the only way that individuals can make a truly informed decision.\nThese commenters suggested that outreach to patients and potential research participants to solicit feedback, as well as a study on the potential burdens that enhanced authorizations may have on stakeholders, were necessary before any changes were made. In its comment letter on the NPRM, the Secretary's Advisory Committee on Human Research Protections supported the proposal to harmonize HIPAA authorizations with the Common Rule informed consent requirements, and also requested consultation with the FDA to ensure that authorizations for future research align not only with the\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00048\n\nCommon Rule standards but also FDA standards for informed consent. They indicated that the authorization should be reasonably specific such that individuals are aware of the types of research that may be conducted. However, the Secretary's Advisory Committee on Human Research Protections emphasized the need for flexibility to rely on Institutional Review Board judgment and recommended against requiring prescribed statements about certain types of ''sensitive'' research, since these concepts change over time and requiring prescribed authorization statements may conflict with Institutional Review Boards' judgments about how to appropriately describe the research in the informed consent. ## Modified Interpretation\n\nWe modify the prior Departmental interpretation that research authorizations must be study specific. This modification does not make any changes to the authorization requirements at § 164.508. A HIPAA authorization for future research must still address each of the core elements and statements required at § 164.508(c)."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 71}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.105 require?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n§164.105 now also applies to Subpart D of Part 164 regarding breach notification for unsecured protected health information, we proposed to remove several specific references to Subparts C and E throughout this section to make clear that the provisions of this section also apply to Subpart D of Part 164. The final rule adopts these modifications.\n\nIn addition, we proposed the following modifications to this section.\n\n## i. Section 164.105(a)(2)(ii)(C)-(E)\n\n## Proposed Rule\n\nAs a covered entity's obligation to ensure that a health care component complies with the Privacy and Security Rules is a"}], "metadata": {"source": "hitech_omnibus_2013", "cfr_section": "§164.105", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 113)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n8\n\nPsN: 28DER2\n\nSfmt 4700\n\ninformation to financial institutions. The preamble to the proposed rule said that diagnostic and treatment information never was necessary to process a payment transaction.\nThe preamble said we believed that in most cases, the permitted disclosure would include only: (1) The name and address of the account holder; (2) the name and address of the payor or provider; (3) the amount of the charge for health services; (4) the date on which health services were rendered; (5) the expiration date for the payment mechanism, if applicable; and (6) the individual's signature. The preamble noted that the proposed regulation text did not include an exclusive list of information that could lawfully be disclosed to process payments, and it solicited comments on whether more elements would be needed for banking and payment transactions and on whether including a specific list of protected health information that could be disclosed was an appropriate approach. The preamble also noted that under section 1179 of HIPAA, certain activities of financial institutions were exempt from this rule, to the extent that these activities constituted authorizing, processing, clearing, settling, billing, transferring, reconciling, or collecting payments for health care or health plan premiums. In the final rule, we eliminate the NPRM's provision on ''banking and payment processes.'' All disclosures that would have been allowed pursuant to proposed § 164.510(i) are allowed under §164.502(a) of the final rule, regarding disclosure for payment purposes."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 112}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.508(f) require?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n§164.508(f) which describes how it will use and disclose the protected health information it creates for the research for purposes of treatment, payment, and health care operations. Section 164.506(b)(4) permits the covered entity to satisfy these two requirements with a single document. See "}], "metadata": {"source": "privacy_rule_2000", "cfr_section": "§164.508(f)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 22)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nwill need to be addressed. If using a scale of 'low,' 'moderate,' and 'high,' the regulated entity may determine that any moderate or high level of risk to ePHI is unacceptable and must be remediated.\nOnce a regulated entity implements the standards, required implementation specifications, and addressable 26 implementation specifications in accordance with the Security Rule, the regulated entity should determine whether the risks to ePHI have been sufficiently addressed. That is, do the implemented standards and implementation specifications reduce the risk of the threat/vulnerability pairs that were deemed unacceptably high to levels that are within the organizational risk tolerance? For example, a regulated entity's risk assessment may have identified that their ability to recover from ransomware attacks poses a high level of risk to ePHI (i.e., high likelihood rating and high impact rating). After implementing three required implementation specifications Response and Reporting [164.308(a)(6)((ii)], Data Backup Plan [(164.308(a)(7)(ii)(A)], and Disaster Recovery Plan [164.308(a)(7)(ii)(B)] - the regulated entity reassesses that the level of risk due to ransomware attacks has been reduced to 'Low.' The likelihood of a ransomware attack may still be rated 'High,' but the three required implementation specifications have\n\n26  Regulated entities should consult Section 2.2 and/or the [Sec. Rule] § 164.306(d) for additional information about addressable implementation specifications and how to adequately implement them in the regulated entity's environment. helped reduce the impact rating to 'Low,' resulting in an overall risk rating that is within organizational risk tolerance."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 21}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 78)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ning these principles and methods, including describing types of techniques intended to reduce the risk of disclosure that should be considered by a professional when de-identifying health information.\nThese techniques include removing all direct identifiers, reducing the number of variables on which a match might be made, and limiting the distribution of records through a ''data use agreement'' or ''restricted access agreement'' in which the recipient agrees to limits on who can use or receive the data. Alternatively, covered entities may choose to use the Privacy Rule's safe harbor method for de-identification. Under the safe harbor method, covered entities must remove all of a list of 18 enumerated identifiers and have no actual knowledge that the information remaining could be used, alone or in combination, to identify a subject of the information. The identifiers that must be removed include direct identifiers, such as name, street address, social security number, as well as other identifiers, such as birth date, admission and discharge dates, and five-digit zip code. The safe harbor requires removal of geographic subdivisions smaller than a State, except for the initial three digits of a zip code if the geographic unit formed by combining all zip codes with the same initial three digits contains more than 20,000 people. In addition, age, if less than 90, gender, ethnicity, and other demographic information not listed may remain in the information. The safe harbor is intended to provide covered entities with a simple, definitive method that does not require much judgment by the covered entity to determine if the information is adequately de-identified."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 77}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 144)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd in records that are subject to the Privacy Act if such denial is permitted under the Privacy Act. This ground for denial exists in addition to the other grounds for denial available under this rule.\nIf an individual requests access to protected health information that is also subject to the Privacy Act, a covered entity may deny access to that information for any of the reasons permitted under the Privacy Act and for any of the reasons permitted under this rule. Fifth, as in the proposed rule, a covered entity may deny an individual access to protected health information if the covered entity obtained the requested information from someone other than a health care provider under a promise of confidentiality and such access would be reasonably likely to reveal the source of the information. This provision is intended to preserve a covered entity's ability to maintain an implicit or explicit promise of confidentiality. A covered entity may not, however, deny access to protected health information when the information has been obtained from a health care provider. An individual is entitled to have access to all information about him or her generated by the health care system (apart from the other exceptions we provide here). Confidentiality promises to health care providers should not interfere with that access. As in the proposed rule, a covered entity may deny access to protected health information under certain circumstances in which the access may\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nharm the individual or others. In the final rule, we specify that a covered entity may only deny access for these reasons if the covered entity provides the individual with a right to have the denial reviewed. (See below for a discussion of the right to review.)\n\nThere are three types of denials for which covered entities must provide the individual with a right to review."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 143}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 192)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nAct,\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\n*\n\nmeans *\n\n*\n\n*\n\nsroberts on DSK5SPTVN1PROD with section 264 of Public Law 104-191, or sections 13400-13424 of Public Law 111-5, as applicable.\nMore stringent * * *\n\n(1) * * *\n\n- (i) Required by the Secretary in connection with determining whether a covered entity or business associate is in compliance with this subchapter; or\n\n*\n\n*\n\n*\n\n*\n\n*\n\n- ■ 8. Revise § 160.300 to read as follows:\n\n## §160.300 Applicability. This subpart applies to actions by the Secretary, covered entities, business associates, and others with respect to ascertaining the compliance by covered entities and business associates with, and the enforcement of, the applicable provisions of this part 160 and parts 162 and 164 of this subchapter. ## §160.302 [Removed and Reserved]\n\n- ■ 9. Remove and reserve § 160.302. - ■ 10. Revise § 160.304 to read as follows:\n\n## §160.304 Principles for achieving compliance. - (a) Cooperation. The Secretary will, to the extent practicable and consistent with the provisions of this subpart, seek the cooperation of covered entities and business associates in obtaining compliance with the applicable administrative simplification provisions. - (b) Assistance. The Secretary may provide technical assistance to covered entities and business associates to help them comply voluntarily with the applicable administrative simplification provisions. - ■ 11. In § 160.306, revise paragraphs (a) and (c) to read as follows:\n\n## §160.306 Complaints to the Secretary. - (a) Right to file a complaint. A person who believes a covered entity or business associate is not complying with the administrative simplification provisions may file a complaint with the Secretary. *\n\n*\n\n*\n\n*\n\n*\n\n- (c) Investigation. (1) The Secretary will investigate any complaint filed under this section when a preliminary review of the facts indicates a possible violation due to willful neglect."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 191}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement technical controls?"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\n## Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on June 27, 2025. A draft select update to this document was issued on March 13, 2024. This document supersedes 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,' issued September 27, 2023. For questions about this document regarding CDRH-regulated devices, contact CyberMed@fda.hhs.gov. For questions about this document regarding CBER-regulated devices, contact the Office of Communication, Outreach, and Development (OCOD) at 1-800-835-4709 or 240-402-8010, or by email at industry.biologics@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Center for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to https://www.regulations.gov. Submit written comments to the Dockets Management Staff, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2021-D-1158. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an email request to CDRH-Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number GUI00001825 and complete title of the guidance in the request."}], "metadata": {"source": "fda_premarket_2023", "safeguard_type": "technical", "implementation_spec": "required", "entity_type": "covered_entity", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 28)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nment information as authorized by law. We also do not consider the agency to be a business associate when conducting these functions, as we describe further in the business associate discussion above.\nThe definition in the final rule also reflects the following changes promulgated in the Transactions Rule:\n\n- (1) Exclusion of nursing home fixedindemnity policies;\n- (2) Addition of the word ''issuer'' to Medicare supplemental policy, and long-term care policy;\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\n- (3) Addition or revision of the relevant statutory cites where appropriate;\n- (4) Deletion of the term ''or assisted'' when referring to government programs;\n- (5) Replacement of the word ''organization'' with ''program'' when referring to Medicare + Choice;\n- (6) Deletion of the term ''health'' when referring to a group plan in subparagraph (xvi);\n- (7) Extraction of the definitions of ''group health plan,'' ''health insurance issuer,'' and ''health maintenance organization'' into Part 160 as distinct definitions;\n- (8) In the definition of ''group health plan,'' deletion of the term ''currently'' from the reference to the statutory cite of ERISA, addition of the relevant statutory cite for the term ''participant,'' and addition of the term ''reimbursement;''\n- (9) In the definition of ''health insurance issuer,'' addition of the relevant statutory cite, deletion of the term ''or other law'' after ''state law,'' addition of health maintenance organizations for consistency with the statute, and clarification that the term does not include a group health plan; and\n- (10) In the definition of ''health maintenance organization,'' addition of the relevant statutory cite. Finally, we add to this definition a high risk pool that is a mechanism established under state law to provide health insurance coverage or comparable coverage to eligible individuals."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 27}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 24)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\npt a formal policy for access authorization, while a small provider may decide that a desktop standard operating procedure will meet the specifications. The final rule has been revised accordingly. c.\nComment: Clarification was requested concerning the meaning of ''formal.''\n\n18:40 Feb 19, 2003\n\nPO 00000\n\nFrm 00017\n\nResponse: The word ''formal'' has caused considerable concern among commenters, as it was thought ''formal'' carried the connotation of a rigidly defined structure similar to what might be found in the Department of Defense instructions. As used in the proposed rule, this word was not intended to convey such a strict structure. Rather, it was meant to convey that documentation should be an official organizational statement as opposed to word-of-mouth or cryptic notes scratched on a notepad. While documentation is still required (see §164.316), to alleviate confusion, the word ''formal'' has been deleted. d. Comment: One commenter asked that we clarify that this requirement relates to both the establishment of policies for the access control function and to access control (the implementation of those policies). Response: ''Information access management'' does address both the establishment of access control policies and their implementation. We use the term ''implement'' to clarify that the procedures must be in use, and we believe that the requirement to implement policies and procedures requires, as an antecedent condition, the establishment or adaptation of those policies and procedures. ## 5. Security Awareness and Training (§ 164.308(a)(5)(i))\n\nWe proposed, under the requirement ''Training,'' that security training be required for all staff, including management. Training would include awareness training for all personnel, periodic security reminders, user education concerning virus protection, user education in the importance of monitoring login success/failure, and how to report discrepancies, and user education in password management."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 23}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 44)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nwe expand the proposed list to reflect many changes requested by commenters. We modify the proposal that health care operations represent activities ''in support of'' treatment and payment functions.\nInstead, in the final rule, health care operations are the enumerated activities to the extent that the activities are related to the covered entity's functions as a health care provider, health plan or health care clearinghouse, i.e., the entity's ''covered functions.'' We make this change to clarify that health care operations includes general administrative and business functions necessary for the covered entity to remain a viable business. While it is possible to draw a connection between all the enumerated activities and ''treatment and payment,'' for some general business activities ( e.g., audits for financial disclosure statements) that connection may be tenuous. The proposed concept also did not include the operations of those health care clearinghouses that may be covered by this rule outside their status as business associate to a covered entity. We expand the definition to include disclosures for the enumerated activities of organized health care arrangements in which the covered entity participates. See also the definition of organized health care arrangements, below. In addition, we make the following changes and additions to the enumerated subparagraphs:\n\n(1) We add language to clarify that the primary purpose of the studies encompassed by ''quality assessment and improvement activities'' must not be to obtain generalizable knowledge. A study with such a purpose would meet the rule's definition of research, and use or disclosure of protected health information would have to meet the requirements of §§ 164.508 or 164.512(i). Thus, studies may be conducted as a health care operation if development of generalizable knowledge is not the primary goal."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 43}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 278)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nacts specify that the employer and employees jointly conduct patient quality of care reviews. The commenter requested clarification as to whether this arrangement made the employee a business partner.\nResponse: An employee organization that agrees to perform quality assurance for a group health plan meets the definition of a business associate. We note that the employee representatives acting on behalf of the employee organization would be performing the functions of the organization, and the employee organization would be responsible under the business associate contract to ensure that the representatives abided by the restrictions and conditions of the contract. If the employee organization is a plan sponsor of the group health plan, the similar provisions of § 164.504(f) would apply instead of the business associate requirements. See §164.502(e)(1). Comment: Some commenters supported regulating employers as business partners of the health plan. These commenters believed that this approach provided flexibility by giving employers access to information when necessary while still holding employers accountable for improper use of the information. Many commenters, however, stressed that this approach would turn the relationship between employers, employees and other agents ''on its head'' by making the employer subordinate to its agents. In addition, several commenters objected to the business partner approach because they alleged it would place employers at risk for greater liability. Response: We do not require a business associate contract for disclosure of protected health information from group health plans to employers. We do, however, put other conditions on the disclosure of protected health information from group health plans to employers who sponsor the plan. See further discussion in §164.504 on disclosure of protected health information to employers."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 277}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 196)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nd add new paragraph (a)(2)(iii)(C);\n- ■ c. Revise newly redesignated paragraph (a)(2)(iii)(D); and\n- ■ d. Revise paragraph (b). The revisions read as follows:\n\n## §164.105 Organizational requirements.\n(a)(1) Standard: Health care component. If a covered entity is a hybrid entity, the requirements of this part, other than the requirements of this section, § 164.314, and § 164.504, apply only to the health care component(s) of the entity, as specified in this section. (2) *\n\n*\n\n*\n\n- (i) Application of other provisions. In applying a provision of this part, other than the requirements of this section, §164.314, and § 164.504, to a hybrid entity:\n\n*\n\n*\n\n*\n\n*\n\n*\n\n- (ii) Safeguard requirements. The covered entity that is a hybrid entity must ensure that a health care component of the entity complies with the applicable requirements of this part."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 195}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 354)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nwho recommended that an ''opt out'' provision be included in the final rule. In the final rule, we do require covered entities to include research disclosures in their notice of information practices.\nTherefore, individuals who do not wish for protected health information about themselves to be disclosed for research purposes without their authorization could select a health care provider or health plan on this basis. In addition, the final rule also permits covered health care providers or health plans to agree not to disclose protected health information for research purposes, even if research disclosures would otherwise be permitted under their notice of information practices. Such an agreement between a covered health care provider or health plan and an individual would not be enforceable under the final rule, but might be enforceable under applicable state law. Comment: Some commenters explicitly recommended that there should be no provision permitting individuals to opt out of having their information used for research purposes. Response: We agree with these commenters for the reasons discussed above. ## IRB and Privacy Board Review\n\nComments: The NPRM imposed no requirements for the location or sponsorship of the IRB or privacy board. One commenter supported the proposed approach to permit covered entities to rely on documentation of a waiver by a IRB or privacy board that was convened by the covered entity, the researcher, or another entity. In contrast, a few commenters recommended that the NPRM require that the IRB or privacy board be outside of the entity conducting the research, although the rationale for these recommendations was not provided. Several industry and consumer groups alternatively recommended that the regulation require that privacy boards be based at the covered entity."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 353}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 227)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nentities. Thus, disclosures to private accrediting organizations are\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ndisclosures for health care operations, not for oversight purposes.\nWhen they are performing accreditation activities for a covered entity, private accrediting organizations will meet the definition of business associate, and the covered entity must enter into a business associate contract with the accrediting organization in order to disclose protected health information. This is consistent with current practice; today, accrediting organizations perform their work pursuant to contracts with the accredited entity. This approach is also consistent with the recommendation by the Joint Commission on Accreditation of Healthcare Organizations and the National Committee for Quality Assurance, which stated in their report titled Protecting Personal Health Information: A Framework for Meeting the Challenges in a Managed Care Environment (1998) that ''Oversight organizations, including accrediting bodies, states, and federal agencies, should include in their contracts terms that describe their responsibility to maintain the confidentiality of any personally identifiable health information that they review.''\n\nWe agree with the commenter who believed that private companies providing information to insurers and employers are not performing an oversight function; the definition of health oversight agency does not include such companies. In developing and clarifying the definition of health oversight in the final rule, we seek to achieve a balance in accounting for the full range of activities that public agencies may undertake to perform their health oversight functions while establishing clear and appropriate boundaries on the definition so that it does not become a catch-all category that public and private agencies could use to justify any request for information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 226}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 161)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nedical information are clearly in the public interest. In this regulation, we must balance individuals' privacy interests against the legitimate public interests in certain uses of health information.\nWhere there is an important public interest, this regulation imposes procedural safeguards that must be met prior to release of health information, in lieu of a requirement for consent. In some instances the procedural safeguards consist of limits on the circumstances in which information may be disclosed, in others the safeguards consist of limits on what information may be disclosed, and in other cases we require some form of legal process ( e.g., a warrant or subpoena) prior to release of health information. We also allow disclosure of health information without consent where other law mandates the disclosures. Where such other law exists, another public entity has made the determination that the public interests outweigh the individual's privacy interests, and we do not upset that determination in this regulation. In short, we tailor the safeguards to match the specific nature of the public purpose. The specific safeguards are explained in each section of this regulation below. Comment: Many comments address matters not relevant to this regulation, such as alternative fuels, hospital reimbursement, and gulf war syndrome. Response: These and similar matters are not relevant to this regulation and will not be addressed further. Frm 00106\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nComment: A few commenters questioned why this level of detail is needed in response to the HIPAA Congressional mandate."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 160}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 203)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nbased fee to cover the cost to prepare and transmit the protected health information for such purpose or a fee otherwise expressly permitted by other law. (b) *\n\n*\n\n*\n\n- (1) Minimum necessary applies.\nWhen using or disclosing protected health information or when requesting\n\nVerDate Mar&lt;15&gt;2010\n\n- protected health information from another covered entity or business associate, a covered entity or business associate must make reasonable efforts to limit protected health information to the minimum necessary to accomplish the intended purpose of the use, disclosure, or request. *\n\n*\n\n*\n\n*\n\n*\n\n(e)(1) Standard: Disclosures to business associates. (i) A covered entity may disclose protected health information to a business associate and may allow a business associate to create, receive, maintain, or transmit protected health information on its behalf, if the covered entity obtains satisfactory assurance that the business associate will appropriately safeguard the information. A covered entity is not required to obtain such satisfactory assurances from a business associate that is a subcontractor. - (ii) A business associate may disclose protected health information to a business associate that is a subcontractor and may allow the subcontractor to create, receive, maintain, or transmit protected health information on its behalf, if the business associate obtains satisfactory assurances, in accordance with §164.504(e)(1)(i), that the subcontractor will appropriately safeguard the information. - (2) Implementation specification: Documentation. The satisfactory assurances required by paragraph (e)(1) of this section must be documented through a written contract or other written agreement or arrangement with the business associate that meets the applicable requirements of § 164.504(e). - (f) Standard: Deceased individuals."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 202}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 145)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nformation that is genetic information for underwriting to all health plans that are subject to the Privacy Rule, rather than solely to the plans GINA explicitly requires be subject to the prohibition.\nAs explained in the proposed rule, the HIPAA Administrative Simplification provisions provide the Secretary with\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with broad authority to craft privacy standards that uniformly apply to all health plans, regardless of whether such health plans are governed by other portions of the HIPAA statute. In addition, the Department indicated in the proposed rule that nothing in GINA explicitly or implicitly curtails this broad authority of the Secretary to promulgate privacy standards for any and all health plans that are governed by the HIPAA Administrative Simplification provisions. Under the Privacy Rule, and consistent with HIPAA, an individual's privacy interests and rights with respect to the use and disclosure of protected health information are protected uniformly without regard to the type of health plan that holds the information. Thus, under the Privacy Rule, individuals can expect and benefit from privacy protections that do not diminish based on the type of health plan from which they obtain health coverage. In developing the proposed rule, the Department believed that individuals' interests in uniform protection under the Privacy Rule against the use or disclosure of their genetic information for underwriting purposes would outweigh any adverse impact on health plans that are not covered by GINA, particularly since it was not expected that all of the health plans subject to the Privacy Rule use or disclose protected health information that is genetic information for underwriting (or even perform underwriting generally, in the case of some of the public benefit plans)."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 144}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 16)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nl all the facts of the breach could be confirmed. Others suggested that 60 days was an insufficient amount of time to conduct a complete investigation and send the required notifications. We disagree.\nWaiting longer than 60 days to notify individuals of breaches of their unsecured protected health information could substantially increase the risk of harm to individuals as a result of the breach and decrease the ability of the individuals to effectively protect themselves from such harm. The statute and interim final rule provide that the notification must be provided without unreasonable delay and in no case later than 60 calendar days. The purpose of this period is to give covered entities and business associates time to conduct a prompt investigation into the incident to identify and collect the information needed to provide meaningful notice to the individual about what happened. Thus, the time period for breach notification begins when the incident is first known, not when the investigation of the incident is complete, even if it is initially unclear whether the incident constitutes a breach as defined in this rule. Further, the duration of an investigation is limited by the statute and interim final rule's requirement that any delay be reasonable-the investigation cannot take an unreasonable amount of time. Thus, if a covered entity learns of an impermissible use or disclosure but unreasonably allows the investigation to lag for 30 days, this would constitute an unreasonable delay. Further, the 60 days is an outer limit and therefore, in some cases, it may be an ''unreasonable delay'' to wait until the 60th day to provide notification. For example, if a covered entity has compiled the information necessary to provide notification to individuals on day 10 but waits until day 60 to send the notifications, it would constitute an unreasonable delay despite the fact that the covered entity has provided notification within 60 days."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 15}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 517)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\novided in paragraph (f)(1) of this section, a consent obtained by a covered entity under this section is not effective to permit another covered entity to use or disclose protected health information.\n- (b) Implementation specifications: General requirements. (1) A covered health care provider may condition treatment on the provision by the individual of a consent under this section. - (2) A health plan may condition enrollment in the health plan on the provision by the individual of a consent under this section sought in conjunction with such enrollment. - (3) A consent under this section may not be combined in a single document with the notice required by § 164.520. - (4)(i) A consent for use or disclosure may be combined with other types of written legal permission from the individual ( e.g., an informed consent for treatment or a consent to assignment of benefits), if the consent under this section:\n- (A) Is visually and organizationally separate from such other written legal permission; and\n- (B) Is separately signed by the individual and dated. - (ii) A consent for use or disclosure may be combined with a research authorization under § 164.508(f). - (5) An individual may revoke a consent under this section at any time, except to the extent that the covered entity has taken action in reliance thereon. Such revocation must be in writing. - (6) A covered entity must document and retain any signed consent under this section as required by § 164.530(j). - (c) Implementation specifications: Content requirements."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 516}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 37)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nwhich the health care clearinghouse is\n\n17:54 Feb 19, 2003\n\nPO 00000\n\nFrm 00026\n\none. External communication must be protected as sent by the clearinghouse, but need not be protected once received. b.\nComment: One commenter asked that the first sentence in § 142.306(b) of the proposed rule, ''If a health care clearinghouse is part of a larger organization, it must assure all health information is protected from unauthorized access by the larger organization'' be expanded to read, ''If a health care clearinghouse or any other health care entity is part of a larger organization . . .''\n\nResponse: The Act specifically provides, at section 1173(d)(1)(B), that the Secretary must adopt standards to ensure that a health care clearinghouse, if part of a larger organization, has policies and security procedures to protect information from unauthorized access by the larger organization. Health care providers and health plans are often part of larger organizations that are not themselves health care providers or health plans. The security measures implemented by health plans and covered health care providers should protect electronic protected health information in circumstances such as the one identified by the commenter. Therefore, we agree with the comment that the requirement should be expanded as suggested by the commenter. In this final rule, those components of a hybrid entity that are designated as health care components must comply with the security standards and protect against unauthorized access with respect to the other components of the larger entity in the same way as they must deal with separate entities. ## 2. Business Associate Contracts and Other Arrangements\n\nWe proposed that parties processing data through a third party would be required to enter into a chain of trust partner agreement, a contract in which the parties agree to electronically exchange data and to protect the transmitted data. This final rule narrows the scope of agreements required."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 36}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 40)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nrocesses that reduce the number and severity of vulnerabilities in products. Additional information about an SPDF and its implementation is discussed in Sections IV and V, and throughout the guidance.\n115\n\nSecurity Architecture -a set of physical and logical security-relevant representations (i.e., views) of system architecture that conveys information about how the system is partitioned into security domains and makes use of security-relevant elements to enforce security policies within and between security domains based on how data and information must be protected. The security architecture reflects security domains, the placement of security-relevant elements within the security domains, the interconnections and trust relationships between the securityrelevant elements, and the behavior and interactions between the security-relevant elements. 116\n\nSecurity Strength - a measure of the computational complexity associated with recovering certain secret and/or security-critical information concerning a given cryptographic algorithm\n\n111 Definition is adapted from NIST SP 800-45 Version 2. 112 Patient harm from cybersecurity risks is discussed at length throughout this guidance and the Postmarket Cybersecurity Guidance. 113  Definition is adapted from ISO 14971:2019 Medical Devices - Application of Risk Management to Medical Devices . 114 Definition is cited from NISTSP 800-53 Rev. 4 Security and Privacy Controls for Federal Information Systems and Organizations , definition of Information System Resilience. https://doi.org/10.6028/NIST.SP.800-53r4\n\n115  The term 'Secure Product Development Framework' was developed for the purposes of this guidance to help reflect and encompass the concepts related to secure development lifecycles and frameworks. While the term SPDF is new, the concepts around secure product development and risk management are not new, and align with expectations in the Quality System and Labeling Regulations."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 39}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 70)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nnts or at the direction of the Food and Drug Administration.'' In lieu of this language, the Department proposed to describe at the outset the public health purposes for which disclosures may be made.\nThe proposed language read: ''A person subject to the jurisdiction of the Food and Drug Administration (FDA) with respect to an FDA-regulated product or activity for which that person has responsibility, for the purpose of activities related to the quality, safety or effectiveness of such FDA-regulated product or activity.''\n\nThe proposal retained the specific activities identified in paragraphs (A), (B), (C), and (D) as examples of common FDA purposes for which disclosures would be permitted, but eliminated the language that would have made this listing the only activities for which such disclosures would be allowed. These activities include reporting of adverse events and other product defects, the tracking of FDA-regulated products, enabling product recalls, repairs, or replacement, and conducting postmarketing surveillance. Additionally, the Department proposed to include ''lookback'' activities in paragraph (C), which are necessary for tracking blood and plasma products, as well as quarantining tainted blood or plasma and notifying recipients of such tainted products. In addition to these specific changes, the Department solicited comments on whether a limited data set should be required or permitted for some or all public health purposes, or if a special rule should be developed for public health reporting. The Department also requested comments as to whether the proposed modifications would be sufficient, or if additional measures, such as a good-faith safe harbor, would be needed for covered entities to continue to report vital information concerning FDA-regulated products or activities on a voluntary basis. Overview of Public Comments. The following discussion provides an overview of the public comment received on this proposal."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 69}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 101)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nh that does not, and no distinction between the requirements for research conducted with a patient's legal permission and research conducted with an IRBapproved waiver of a patient's informed consent.\nIn sum, the NPRM proposed that covered entities be permitted to use or disclose protected health information created or received for a specific research study before the compliance date (if there was no agreed-to restriction in accordance with §164.522(a)), if the covered entity has obtained, prior to the compliance date, any one of the following: (1) An authorization or other express legal permission from an individual to use or disclose protected health information for the research study; (2) the informed consent of the individual to participate in the research study; or (3) a waiver, by an IRB of informed consent for the research study in accordance with the Common Rule or FDA's human subject protection regulations. However, even if the researcher obtained, from an IRB, a waiver of informed consent, an authorization would be required if informed consent is later obtained. This may occur if there is a temporary waiver of informed consent for emergency research under the Food and Drug Administration human subject protection regulations. Overview of Public Comments. The following discussion provides an overview of the public comment received on this proposal. Additional comments received on this issue are discussed below in the section entitled, ''Response to Other Public Comments.''\n\nMost commenters supported the proposed revisions to the Privacy Rule's transition provisions for research. However, a few commenters requested that the transition provisions be broadened to permit covered entities to rely on an express legal permission or informed consent approved by an IRB before the compliance date, even if the permission or consent had not been signed by the individual prior to the compliance date."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 100}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 309)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nrelates to the person's involvement in the individual's current health care. It is not intended to allow disclosure of past medical history that is not relevant to the individual's current condition.\nIn addition, as discussed above, we do not intend to disrupt covered entities' current practices with respect to disclosing specific information about a patient's condition to family members or others when the individual is incapacitated due to a medical emergency and the family member or other individual comes to the covered entity seeking specific information about the patient's condition. For example, this section allows a hospital to disclose to a family member the fact that a patient had a heart attack, and to provide updated information to the family member about the patient's progress and prognosis during his or her period of incapacity. We agree with the recommendation to require written authorization for a disclosure of psychotherapy notes to family, close personal friends, or others involved in the individual's care. As discussed below, the final rule allows disclosure of psychotherapy notes without authorization in a few limited circumstances; disclosure to individuals involved in a person's care is not among those circumstances. See § 164.508 for a further discussion of the final rule's provisions regarding disclosure of psychotherapy notes. We do not agree, however, with the suggestion to treat some medical information as more sensitive than others. In most cases, individuals will have the opportunity to prohibit or limit such disclosures. For situations in which an individual is unable to do so, covered entities may, in the exercise of professional judgement, determine whether the disclosure is in the individual's best interests and, if so, disclose only the protected health information that is directly relevant to the person's involvement with the individual's health care."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 308}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 200)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne of this equipment because while it is Y2K compliant, it may be HIPAA non-compliant. Response: This comment raises two distinct issues-(1) the investment in new equipment and (2) the compliance date.\nWith regard to the first issue, we reject the comment's assertion that the regulation requires covered entities to purchase new information systems or\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\ninformation technology equipment, but realize that some covered entities may need to update their equipment. We have tried to minimize the costs, while responding appropriately to Congress' mandate for privacy rules. We have dealt with the cost issues in detail in the ''Regulatory Impact Analysis'' section of this Preamble. With regard to the second issue, Congress, not the Secretary, established the compliance data at section 1175(b) of the Act. ## Civil Rights of Institutionalized Persons Act\n\nComment: A few comments expressed concern that the privacy regulation would inadvertently hinder the Department of Justice Civil Rights Divisions' investigations under the Civil Rights of Institutionalized Persons Act (''CRIPA''). These comments suggested clearly including civil rights enforcement activities as health care oversight. Response: We agree with this comment. We do not intend for the privacy rules to hinder CRIPA investigations. Thus, the final rule includes agencies that are authorized by law to ''enforce civil rights laws for which health information is relevant'' in the definition of ''health oversight agency'' at § 164.501. Covered entities are permitted to disclose protected health information to health oversight agencies under § 164.512(d) without an authorization. Therefore, we do not believe the final rule should hinder the Department of Justice's ability to conduct investigations pursuant to its authority in CRIPA."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 199}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 10)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\neach notification laws, which, as a general matter, only require notification when certain identifiers are exposed and when there is a likelihood that the breach will result in harm to the individual.\nWe also asked commenters if they believed that the removal of an individual's date of birth or zip code, in addition to the 16 direct identifiers in 45 CFR 164.514(e)(2), would reduce the risk of re-identification of the information such that it could be included in the guidance. Several commenters responded to this question. While some stated that the removal of these data elements would render the\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\24AUR2.SGM\n\n24AUR2\n\nJkt 217001\n\nerowe on DSK5CLS3C1PROD with RULES\\_2\n\ninformation useless to the research and public health communities, which may, for example, require zip codes for many population based studies, many commenters did acknowledge that the removal of these additional identifiers would reduce the risk of reidentification of the information. After considering these comments, we decided against including the limited data set in the guidance as a method for rendering protected health information unusable, unreadable, or indecipherable to unauthorized individuals due to the potential risk of re-identification of this information. However, we address breaches of limited data sets in the definition of ''breach'' as follows. Under the definition of ''breach'' at §164.402, in order to determine whether a covered entity's or business associate's impermissible use or disclosure of protected health information constitutes a breach, the covered entity or business associate will need to perform the risk assessment discussed above. This applies to impermissible uses or disclosures of protected health information that constitute a limited data set, unless, as discussed below, the protected health information also does not include zip codes or dates of birth."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 9}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 63)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nhis or her privacy, and cited the disclosure of remuneration by a third party as an example of unnecessary content, alleging that the disclosure of remuneration is not relevant to protecting privacy.\nOne commenter suggested that covered entities should be given the flexibility to decide which contents are applicable in a given situation. Response: The Department believes the core elements are all essential information. Individuals need to know this information to make an informed decision about giving the authorization to use or disclose their protected health information. Therefore, the Department believes all of the core elements are necessary content in all situations. The Department does not agree that the remuneration statement required on an authorization for uses and disclosures of an individual's protected health information for marketing purposes is not relevant to protecting privacy. Individuals exercise control over the privacy of their protected health information by either giving or denying an authorization, and remuneration from a third party to the covered entity for obtaining an authorization for marketing is an important factor in making that choice. Comment: One commenter suggested that covered entities should not be required to state on an authorization a person's authority to act on an individual's behalf, and they should be trusted to require such identification or proof of legal authority when the authorization is signed. The commenter stated that this requirement only increases administrative burden for covered entities. Response: The Department does not agree. The authorization requirement is intended to give individuals some control over uses and disclosures of protected health information that are not otherwise permitted or required by the Rule."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 62}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 41)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nstill resides in the software because a sponsor deemed it appropriate not to correct or fix the anomaly, according to a risk-based rationale about its impact to the device's safety and effectiveness.\n123\n\nUpdatability and Patchability -the ease and timeliness with which a device and related assets can be changed for any reason (e.g., feature update, security patch, hardware replacement). Update -corrective, preventative, adaptive, or perfective modifications made to software of a medical device. 124\n\nVulnerability - a weakness in an information system, system security procedure(s), internal control(s), human behavior, or implementation that could be exploited. Vulnerability Chaining - the sequential exploit of multiple vulnerabilities in order to attack to attack a system, where one or more exploits at the end of the chain require the successful completion of prior exploits in order to be exploited. 125\n\n123 Definition is consistent with the Premarket Software Guidance even though we use the terms differently. 124 Definition is cited from IMDRF Guidance 'Principles and Practices for Medical Device Cybersecurity.'\n\n125  Definition is adapted from the Common Vulnerability Scoring System (CVSS) specification document (v3.1)."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 40}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 53)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\non contained in the electronic remittance advice or the premium payment enrollee data portions of the transactions is not necessary either to conduct the funds transfer or to forward the transactions.\nTherefore, a covered entity may not disclose the protected health information to a financial institution for these purposes. A covered entity may transmit the portions of the transactions containing protected health information through a financial institution if the protected health information is encrypted so it can be read only by the intended recipient. In such cases no protected health information is disclosed and the financial institution is acting solely as a conduit for the individually identifiable data. ## Plan Sponsor\n\nIn the final rule we add a definition of ''plan sponsor.'' We define plan sponsor by referencing the definition of the term provided in (3)(16)(B) of the Employee Retirement Income Security Act (ERISA). The plan sponsor is the employer or employee organization, or both, that establishes and maintains an employee benefit plan. In the case of a plan established by two or more employers, it is the association, committee, joint board of trustees, or other similar group or representative of the parties that establish and maintain the employee benefit plan. This term includes church health plans and government health plans. Group health plans may disclose protected health information to plan sponsors who conduct payment and health care operations activities on behalf of the group health plan if the requirements for group health plans in § 164.504 are met. The preamble to the Transactions Rule noted that plan sponsors of group health plans are not covered entities and, therefore, are not required to use the standards established in that regulation to perform electronic transactions, including enrollment and disenrollment transactions. We do not change that policy through this rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 52}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement technical controls?"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n## Postmarket Management of Cybersecurity in Medical Devices\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on December 28, 2016. The draft of this document was issued on January 22, 2016. For questions regarding this document, contact Suzanne Schwartz, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5434, Silver Spring, MD 20993-0002, 301-796-6937. For questions regarding this document as applied to devices regulated by CBER, contact the Office of Communication, Outreach and Development in CBER at 1-800-835-4709 or 240-402-8010 or ocod@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of the Center Director\n\nCenter for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to http://www.regulations.gov . Submit written comments to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2015-D-5105. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an e-mail request to CDRH-Guidance@fda.hhs.gov to receive an electronic copy of the guidance. Please use the document number 1400044 to identify the guidance you are requesting. ## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), by written request, Office of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., Bldg."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_type": "technical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.306(a) require?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n§164.306(a).\n- (C) Sanction policy (Required). Apply appropriate sanctions against workforce members who fail to comply with the security policies and procedures of the covered entity.\n- (D) Information system activity review (Required). Implement procedures to regularly review records of information system activity, such as audit logs, access reports, and security incident tracking reports.\n- (2) Standard: Assigned security responsibility. Identify the security official who is responsible for the development and implementation of the policies and procedures required by this subpart for the en"}], "metadata": {"source": "security_rule_2003", "cfr_section": "§164.306(a)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 326)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ns not required to make a determination whether or not the\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00216\n\norder might otherwise meet the minimum necessary requirement.\nIf the disclosure is pursuant to a satisfactory assurance from the party seeking the disclosure, at least a good faith attempt has been made to notify the individual in writing of the disclosure before it is made or the parties have sought a qualified protective order that prohibits them from using or disclosing the protected health information for any purpose other than the litigation or proceeding for which the information was requested and that the information will be returned to the covered entity or destroyed at the end of the litigation or the proceeding. Alternatively, the covered entity may seek such notice or qualified protective order itself. This approach provides the individual with protections and places the burden on the parties to resolve their differences about the appropriateness and scope of disclosure as part of the judicial or administrative procedure itself before the order is issued, rather than requiring the covered entity to get involved in evaluating the merits of the dispute in order to determine whether or not the particular request is appropriate or too broad. In these cases, the covered entity must disclose only the protected health information that is the minimum amount necessary to achieve the purpose for which the information is sought. We share the concern of the commenters that covered entities should redact any information about third parties before disclosing an individual's protected health information. During the fact-finding stage of our consideration of revisions to the proposed rule, we discussed this issue with representatives of covered entities. Currently, information about third parties is sometimes redacted by medical records personnel responding to requests for information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 325}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 79)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nisions explicitly to except the reidentification code or other means of record identification permitted by §164.514(c) from the listed identifiers (§ 164.514(b)(2)(i)(R)). Overview of Public Comments.\nThe following provides an overview of the public comment received on this proposal. Additional comments received on this issue are discussed below in the section entitled, ''Response to Other Public Comments.''\n\nAll commenters on our clarification of the safe harbor re-identification code not being an enumerated identifier supported our proposed regulatory clarification. Final Modifications. Based on the Department's intent that the reidentification code not be considered one of the enumerated identifiers that must be excluded under the safe harbor for de-identification, and the public comment supporting this clarification, the Department adopts the provision as proposed. The re-identification code or other means of record identification permitted by § 164.514(c) is expressly excepted from the listed safe harbor identifiers at § 164.514(b)(2)(i)(R). ## Response to Other Public Comments\n\nComment: One commenter asked if data can be linked inside the covered entity and a dummy identifier substituted for the actual identifier when the data is disclosed to the external researcher, with control of the dummy identifier remaining with the covered entity. Response: The Privacy Rule does not restrict linkage of protected health information inside a covered entity. The model that the commenter describes for the dummy identifier is consistent with the re-identification code allowed under the Rule's safe harbor so long as the covered entity does not generate the dummy identifier using any individually identifiable information. For example, the dummy identifier cannot be derived from the individual's social security number, birth date, or hospital record number."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 78}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 394)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nd many comments on the model notice provided in the proposed rule. Some commenters argued that patients seeing similar documents would be less likely to become disoriented when examining a new notice.\nOther commenters, however, opposed the inclusion of a model notice or expressed concern about particular language included in the model. They maintained that a uniform model notice would never capture the varying practices of covered entities. Many commenters opposed requirements for a particular format or specific language in the notice. They stated that covered entities should be afforded maximum flexibility in fashioning their notices. Other commenters requested inclusion of specific language as a header to indicate the importance of the notice. A few commenters recommended specific formatting requirements, such as font size or type. Response: On the whole, we found commenters' arguments for flexibility in the regulation more persuasive than those arguing for more standardization. We agree that a uniform notice would not capture the wide variation in information practices across covered entities. We therefore do not include a model notice in the final rule, and do not require inclusion of specific language in the notice (except for a standard header). We also do not require particular formatting. We do, however, require the notice to be written in plain language. (See above for guidance on writing documents in plain language.) We also agree with commenters that the notice should contain a standard header to draw the individual's attention to the notice and facilitate the individual's ability to recognize the notice across covered entities. We believe that post-publication guidance will be a more effective\n\n27 ASTM, ''Standard Guide for Confidentiality, Privacy, Access and Data Security, Principles for Health Information Including Computer-Based Patient Records,'' E 1869-97, § 9.2. mechanism for helping covered entities design their notices than the regulation itself."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 393}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 68)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncovered entities to contract with business associates to undertake quality assurance and comparative analyses that involve the protected health information of more than one contracting covered entity.\nWe except data aggregation from the general requirement that a business associate contract may not authorize a business associate to use or further disclose protected health information in a manner that would violate the requirements of this subpart if done by the covered entity in order to permit the combining or aggregation of protected health information received in its capacity as a business associate of different covered entities when it is performing this service. In many cases, the combining of this information for the respective health care operations of the covered entities is not something that the covered entities could do-a covered entity cannot generally disclose protected health information to another covered entity for the disclosing covered entity's health care operations. However, we permit covered entities that enter into business associate contracts with a business associate for data aggregation to permit the business associate to combine or aggregate the protected health information they\n\nFrm 00045\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ndisclose to the business associate for their respective health care operations. We note that there may be other instances in which a business associate may combine or aggregate protected health information received in its capacity as a business associate of different covered entities, such as when it is performing health care operations on behalf of covered entities that participate in an organized health care arrangement. A business associate that is performing payment functions on behalf of different covered entities also may combine protected health information when it is necessary, such as when the covered entities share financial risk or otherwise jointly bill for services."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 67}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 69)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nf the commenters seeking to supplement the requirement, but points out that, although the final Rule will not require this addition, it is permissible to include such a statement in the authorization.\nIn addition, since the Privacy Rule does not require IRB or Privacy Board review of research uses and disclosures made with patient authorization, the Department determined that adding the commenters' suggestion to the final Rule would be inappropriate. Section III.E.1. above provides further discussion of this provision. ## F. Section 164.512-Uses and Disclosures for Which Authorization or Opportunity To Agree or Object Is Not Required\n\n1. Uses and Disclosures Regarding FDARegulated Products and Activities\n\nDecember 2000 Privacy Rule. The Privacy Rule permits covered entities to disclose protected health information without consent or authorization for public health purposes. Generally, these disclosures may be made to public health authorities, as well as to contractors and agents of public health authorities. However, in recognition of the essential role of drug and medical device manufacturers and other private persons in carrying out the Food and Drug Administration's (FDA) public health mission, the December 2000 Privacy Rule permitted covered entities to make such disclosures to a person who is subject to the jurisdiction of the FDA, but only for the following specified purposes: (1) To report adverse events, defects or problems, or biological product deviations with respect to products regulated by the FDA (if the disclosure is made to the person required or directed to report such information to the FDA); (2) to track products (if the disclosure is made to the person required or directed to report such information to the FDA); (3) for product recalls, repairs, or replacement; and (4) for conducting post-marketing surveillance to comply with FDA requirements or at the direction of the FDA. March 2002 NPRM."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 68}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 58)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\n| Key Activities | Description | Sample Questions | |------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 6."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 57}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 105)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nnal; or (2) where an individual was a party to the proceeding and his or her medical condition or history was at issue and the disclosure was pursuant to lawful process or otherwise authorized by law.\nUnder the NPRM, if the request for disclosure of protected health information was accompanied by a court order, a covered entity could have disclosed that protected health information which the court order authorized to be disclosed. If the request for disclosure of protected health information were not accompanied by a court order, covered entities could not have disclosed the information requested unless a request authorized by law had been made by the agency requesting the information or by legal counsel representing a party to litigation, with a written statement certifying that the protected health information requested concerned a litigant to the proceeding and that the health condition of the litigant was at issue at the proceeding. In § 164.512(e) of the final rule, we permit covered entities to disclose protected health information in a judicial or administrative proceeding if the request for such protected health information is made through or pursuant to an order from a court or administrative tribunal or in response to a subpoena or discovery request from, or other lawful process by a party to the proceeding. When a request is made pursuant to an order from a court or administrative tribunal, a covered entity may disclose the information requested without additional process. For example, a subpoena issued by a court constitutes a disclosure which is required by law as defined in this rule, and nothing in this rule is intended to interfere with the ability of the covered entity to comply with such subpoena."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 104}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the administrative safeguards under HIPAA?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\n## RIN 0945-AA03\n\nModifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (HHS or ''the Department'') is issuing this final rule to: Modify the Health Insurance Portability and Accountability Act (HIPAA) Privacy, Security, and Enforcement Rules to implement statutory amendments under the Health Information Technology for Economic and Clinical Health Act (''the HITECH Act'' or ''the Act'') to strengthen the privacy and security protection for individuals' health information; modify the rule for Breach Notification for Unsecured Protected Health Information (Breach Notification Rule) under the HITECH Act to address public comment received on the interim final rule; modify the HIPAA Privacy Rule to strengthen the privacy protections for genetic information by implementing section 105 of Title I of the Genetic Information Nondiscrimination Act of 2008 (GINA); and make certain other modifications to the HIPAA Privacy, Security, Breach Notification, and Enforcement Rules (the HIPAA Rules) to improve their workability and effectiveness and to increase flexibility for and decrease burden on the regulated entities. DATES: Effective date: This final rule is effective on March 26, 2013. Compliance date: Covered entities and business associates must comply with the applicable requirements of this final rule by September 23, 2013. FOR FURTHER INFORMATION CONTACT: Andra Wicks 202-205-2292. SUPPLEMENTARY INFORMATION:\n\nVerDate Mar&lt;15&gt;2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n## I."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_type": "administrative", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 98)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ntem or service. For example, consider an individual who is meeting with her primary physician and requests a restriction on tests that are being administered to determine if she has a heart condition.\nIf, after conducting the tests, the patient's primary physician refers the patient to a cardiologist, it is the patient's obligation to request a restriction from the subsequent provider, the cardiologist, if she wishes to pay out of pocket rather than have her health plan billed for the visit. Although the primary physician in this example would not be required to alert the cardiologist of the patient's potential desire to request a restriction, we encourage providers to do so if feasible or in the very least, to engage in a dialogue with the patient to ensure that he or she is aware that it is the patient's obligation to request restrictions from subsequent providers. In response to commenters who were confused about whether the individual or the provider would have the obligation of notifying subsequent providers when a Health Information Exchange is involved, we clarify that the responsibility to notify downstream providers of a restriction request in this situation also remains with the individual, and not the provider. With respect to HMOs, we clarify that a provider providing care in such a setting should abide by an individual's requested restriction unless doing so would be inconsistent with State or other law. Thus, if a provider within an HMO is prohibited by law from accepting payment from an individual\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00065\n\nabove the individual's cost-sharing amount (i.e., the provider cannot accept an out of pocket payment from the individual for the service), then the provider may counsel the individual that he or she will have to use an outof-network provider for the health care item or service in order to restrict the disclosure of protected health information to the HMO for the health care."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 97}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the differences between covered entity and business associate obligations under HIPAA?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\n## Office of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRin: 0991-AB08\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY : Office of the Assistant Secretary for Planning and Evaluation, DHHS. ACTION\n\n: Final rule. SUMMARY : This rule includes standards to protect the privacy of individually identifiable health information. The rules below, which apply to health plans, health care clearinghouses, and certain health care providers, present standards with respect to the rights of individuals who are the subjects of this information, procedures for the exercise of those rights, and the authorized and required uses and disclosures of this information. The use of these standards will improve the efficiency and effectiveness of public and private health programs and health care services by providing enhanced protections for individually identifiable health information. These protections will begin to address growing public concerns that advances in electronic technology and evolution in the health care industry are resulting, or may result, in a substantial erosion of the privacy surrounding individually identifiable health information maintained by health care providers, health plans and their administrative contractors. This rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and\n\nAccountability Act of 1996. DATES : The final rule is effective on February 26, 2001. ## FOR FURTHER INFORMATION CONTACT :\n\nKimberly Coleman, 1-866-OCR-PRIV (1-866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION :\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954."}], "metadata": {"source": "privacy_rule_2000", "entity_type": "both", "safeguard_types": ["physical", "technical", "administrative"], "type": "entity_obligations"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 22)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nrformed at regular intervals commensurate with the risk (e.g., annually) to ensure that potential vulnerabilities are identified and able to be addressed prior to their ability to be exploited. ## VI.\nCybersecurity Transparency\n\nCybersecurity transparency is critical to ensure safe and effective use and integration of devices and systems. 48 This transparency can be conveyed through both device labeling and the establishment of manufacturer vulnerability management plans. However, different types of users (e.g., manufacturers, servicers, patients) will have different abilities to take on a mitigation role, and the need for actions to ensure continued cybersecurity should be appropriate for the type of user. Manufacturers of cyber devices should consider the recommendations in this section as they 'design, develop, and maintain processes and procedures to provide a reasonable assurance that the device and related systems are cybersecure . . .' (section 524B(b)(2) of the FD&amp;C Act; see Section VII.C.2). ## A. Labeling Recommendations for Devices with Cybersecurity Risks\n\nFDA regulates device labeling in several ways. For example, section 502(f) of the FD&amp;C Act requires that labeling include adequate directions for use. Under section 502(a)(1) of the FD&amp;C Act, a medical device is deemed misbranded if its labeling is false or misleading in any particular. 47  The following standards may partially meet the security testing recommendations: ANSI/UL 2900 Software Cybersecurity for Network-Connectable Products , ANSI/ISA 62443-4-1 Security for industrial automation and control systems Part 4-1: Product security development life-cycle requirements , in addition to IEC 81001-5-1. Additional standards may also meet or partially meet the testing recommendations outlined in this section. 48 Users often manage security risks in medical device systems by an end user or within a larger risk management framework like the NIST CSF."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 21}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 135)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nlth information, and the covered entity's policies and procedures with respect to such uses and disclosures, that the health plan or covered provider expected to make without individual authorization.\nThe covered provider or health plan would have had to distinguish between those uses and disclosures required by law and those permitted but not required by law. We also proposed to require covered health care providers and health plans to state in the notice that all other uses and disclosures would be made only with the individual's authorization and that such authorization could be revoked. The notice would also have been required to state that the individual could request restrictions on certain uses and disclosures and that the covered entity would not be required to agree to such a request. We significantly modify these requirements in the final rule. Covered entities must describe all uses and disclosures of protected health information that they are permitted or required to make under this rule without authorization, including those uses and disclosures subject to the consent requirements under § 164.506. If other applicable law prohibits or materially limits the covered entity's ability to make any uses or disclosures that would otherwise be permitted under the rule, the covered entity must describe only the uses and disclosures permitted under the more stringent law. Covered entities must separately describe each purpose for which they are permitted to use or disclose protected health information under this rule without authorization, and must do so in sufficient detail to place the individual on notice of those uses and disclosures. With respect to uses and disclosures to carry out treatment,\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00089\n\npayment, and health care operations, the description must include at least one example of the types of uses and disclosures that the covered entity is permitted to make."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 134}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 171)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nstent with the practices of public programs, such as Medicare, which has a policy of mailing one notice or a set of program materials to a household of four or fewer beneficiaries at the same address.\nAs a result, although there are 50.7 million individual Medicare beneficiaries, the program only sends out approximately 36 million pieces of mail per mailing. Actuarial Research Corporation (ARC), our consultant, estimated the number of policy holders for all classes of insurance products to be approximately 183.6 million, including all public programs. The data comes from the Medical Expenditure Panel Survey from 2004-2006 projected to 2010. ARC estimated 112.6 million private sector policy holders and 71.0 million public ''policy holders.'' The total, including more recent Medicare data, is 188.3 million persons (which results in roughly a split of 60 percent private policy holders and 40 percent public ''policy holders''), whom we expect to receive NPPs from their plans. The estimates do not capture policy holders who are in hospitals or nursing homes at the time of the survey, or individuals who may have been insured under more than one plan in a year, for example, because their job status changed, they have supplemental policies, or they have more than one employer, creating duplicate coverage. Therefore, ARC recommended we use 200 million for the number of NPPs that will actually be sent. We estimate the costs of drafting, printing, and distributing the NPP to all potential recipients to be the following. First, drafting the NPP is estimated to require one-third hour of legal services at a cost of $28 × 1,500 insurance plans and insurance administrative entities, which equals $42,000. Second, we need to calculate printing and distribution costs for all potential recipients assuming the revised notice would be sent in a separate mailing."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 170}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What's the difference between required and addressable implementation specifications?"}, {"role": "assistant", "content": "According to 45cfr162:\n\n[Skip to main content](#main-content)\n\nMenu\n\n[![GovInfo logo](/media/GovInfo_logo_gray.png)](/)\n[Search](#searchHolder)\n\n* Browse\n  + [A to Z](/browse-a-z)\n  + [Category](/app/browse/category)\n  + [Date](/app/browse/date)\n  + [Committee](/browse/committee)\n  + [Author](/app/browse/author)\n* About\n  + [About](/about)\n  + [Policies](/about/policies)\n  + [Authentication](/about/authentication)\n  + [Digital Preservation](/about/digital-preservation)\n  + [History](/about/history)\n  + [Agency Submission](/about/agency-submission)\n  + [U.S. Government Information](/about/us-gov-info)\n  + [FDsys Retirement](/about#fdsys-transition)\n* Developers\n  + [Developer Hub](/developers)\n  + [API](https://api.govinfo.gov/docs)\n  + [Bulk Data Repository](%20/bulkdata)\n  + [Link Service](/link-docs)\n  + [Feeds](/feeds)\n  + [Sitemaps](/sitemaps)\n  + [System Design](/developers/system-design)\n* Features\n  + [All Features](/features)\n  + [Featured Content](/features/featured-content)\n  + [News](/features/news)\n  + [Release Notes](/features/release-notes)\n  + [Finding Publications](/features/finding-publications)\n* Help\n  + [Help](/help)\n  + [Finding Information](%20/help/finding-info)\n  + [What's Available](/help/whats-available)\n  + [Tutorials and Handouts](/help/tutorials-handouts)\n  + [Other Resources](%20/help/other-resources)\n* Feedback\n  + [Submit Feedback](https://www.surveymonkey.com/r/govinfo-feedback-survey)\n  + [Contact Us](/contact)\n\n* [Toggle the Search Widget\n  Search](#searchHolder)\n\n# Page Not Found\n\n![Icon: Share using Facebook](/sites/default/files/fb-icon-white.png)\n![Icon: Share using Email](/sites/default/files/email-icon-white.png)\n![Icon: Copy Link URL](/sites/default/files/link-icon-white.png)\n\n[Help](/help/other)\n\n---\n\n**Error occurred. The page you requested cannot be found.**\n\nPlease report this error to [askGPO.](https://www.gpo.gov/error-pages/askgpo)\n\nProvide the following information to help us resolve this problem: the URL of the page you were trying to acce"}], "metadata": {"source": "45cfr162", "implementation_spec": "both", "safeguard_types": ["unknown"], "type": "implementation"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 19)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nthe substitute notice, the covered entity may provide substitute notice of the breach in major print or broadcast media in geographic areas where the individuals affected by the breach likely reside.\nWhat constitutes major print or broadcast media for a particular area will depend on the geographic area where the affected individuals are likely to reside and what is reasonably calculated to reach the affected individuals. We emphasize that what is considered major print or broadcast media for a metropolitan area\n\n15:01 Aug 21, 2009\n\nPO 00000\n\nFrm 00013\n\nmay be very different from what is considered major print or broadcast media in a rural area. For example, if the affected individuals are reasonably likely to reside in a rural area, then a local newspaper could be the major newspaper serving that area and most likely to reach the individuals affected. For affected individuals in a metropolitan area, then a newspaper serving the entire metropolitan area or the entire State would be more likely to reach the individuals affected. If the affected individuals likely reside in different regions or States, then the covered entity may need to utilize multiple media outlets to reasonably reach these individuals. Also, we clarify in this interim final rule that any notice in print or broadcast media under this section must be conspicuous, similar to the posting on the Web site. Thus, for example, for notice in print media, thought should be given to what location and duration of the notice is reasonably calculated to reach the affected individuals. Some commenters were concerned that providing substitute notice in major media would be costly and onerous. Covered entities that are concerned with the cost of providing substitute notice in this manner have the option of instead posting the substitute notice on their Web sites."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 18}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 526)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\npose for which the information is sought; and\n- ( 3 ) De-identified information could not reasonably be used. - (2) Permitted disclosures: Limited information for identification and location purposes.\nExcept for disclosures required by law as permitted by paragraph (f)(1) of this section, a covered entity may disclose protected health information in response to a law enforcement official's request for such information for the purpose of identifying or locating a suspect, fugitive, material witness, or missing person, provided that:\n- (i) The covered entity may disclose only the following information:\n- (A) Name and address;\n- (B) Date and place of birth;\n- (C) Social security number;\n- (D) ABO blood type and rh factor;\n- (E) Type of injury;\n- (F) Date and time of treatment;\n- (G) Date and time of death, if applicable; and\n- (H) A description of distinguishing physical characteristics, including height, weight, gender, race, hair and eye color, presence or absence of facial hair (beard or moustache), scars, and tattoos. - (ii) Except as permitted by paragraph (f)(2)(i) of this section, the covered entity may not disclose for the purposes of identification or location under paragraph (f)(2) of this section any protected health information related to the individual's DNA or DNA analysis, dental records, or typing, samples or analysis of body fluids or tissue. - (3) Permitted disclosure: Victims of a crime."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 525}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 195)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n'' and not to preempt state laws that are more stringent. Congress also determined over whom the Secretary would have authority, the type of information protected, and the minimum level of regulation.\n## Separation of Powers\n\nComment: Some commenters asserted that the federal government may not preempt state laws that are not as strict as the privacy regulation because to do so would violate the separation of powers in the U.S. Constitution. One comment suggested that the rules raised a substantial constitutional issue because, as proposed, they permitted the Secretary to make determinations on preemption, which is a role reserved for the judiciary. Response: We disagree. We note that this comment only pertains to determinations under section 1178(a)(2)(A); as discussed above, the rules below provide for no Secretarial determinations with respect to state privacy laws coming within section 1178(a)(2)(B). With respect to determinations under section 1178(a)(2)(A), however, the final rules, like the proposed rules, provide that at a state's request the Secretary may make certain determinations regarding the preemptive effect of the rules on a particular state law. As usually the case with any administrative decisions, these are subject to judicial review pursuant to the Administrative Procedure Act. ## First Amendment\n\nComment: Some comments suggested that the rules violated the First Amendment. They asserted that if the rule included Christian Science practitioners as covered entities it would violate the separation of church and state doctrine. Response: We disagree. The First Amendment does not always prohibit the federal government from regulating secular activities of religious organizations. However, we address concerns relating to Christian Science practitioners more fully in the response to comments discussion of the definition of ''covered entity'' in §160.103."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 194}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 464)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntrict internal uses of protected health information to the minimum necessary. Initially, this will require 560 hours for hospitals, 160 hours for health plans, and 12 hours for non-hospital providers.\n47 The wage for health care providers and hospitals is estimated at $47.28, a weighted average of various health care professionals based on CPS data; the wage for health plans is estimated to be $33.82, based on average wages in the insurance industry (note that all wage assumptions in this impact analysis assume a 39 percent load for benefits, the standard Bureau of Labor Statistics assumption). In addition, there will be time required on an annual basis to ensure that the implemented practices continue to meet the requirements of the rule. Therefore, the Department estimates that on an annual ongoing basis (after the first year), hospitals will require 320 hours, health plans 100 hours, and nonhospital providers 8 hours to comply with this provision. The initial cost attributable to the minimum necessary provision is $926 million. The total cost of the provision is $5.757 billion. (These estimates are for the cost of complying with the minimum necessary provisions that restrict internal uses to the minimum necessary. The Department has estimated in the business associates section below the requirement limiting disclosures outside the covered entity to the minimum amount necessary.)\n\n## Privacy Official\n\nThe final rule requires entities to designate a privacy official who will be responsible for the development and implementation of privacy policies and procedures."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 463}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 273)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nmay be unenforceable in some states. These commenters suggested that the complexity and variation of state third party beneficiary law would increase cost and confusion with limited privacy benefits.\nCommenters predicted that the provision would result in a dramatic increase in frivolous litigation, increased costs throughout the health care system, and a chilling effect on the willingness of entities to make authorized disclosures of protected information. Many commenters predicted that fear of lawsuits by individuals would impede the flow of communications necessary for the smooth operation of the health care system, ultimately affecting quality of care. For example, some predicted that the provision would inhibit providers from making authorized disclosures that would improve care and reduce medical errors. Others predicted that it would limit vendors' willingness to support information systems requirements. One large employer stated that the provision would create a substantial disincentive for employers to sponsor group health plans. Another commenter noted that the provision creates an anomaly in that individuals may have greater recourse against business partners and covered entities that contract with them than against covered entities acting alone. However, some commenters strongly supported the concept of providing individuals with a mechanism to enforce the provisions of the rule, and considered the provision among the\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nmost important privacy protections in the proposed rule. Response: We eliminate the requirement that business associate contracts contain a provision stating that individuals whose protected health information is disclosed under the contract are intended third-party beneficiaries of the contract. We do not intend this change to affect existing laws regarding when individuals may be third party beneficiaries of contracts."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 272}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_postmarket_2016 say about HIPAA compliance? (Part 11)"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\nration 29 (CPE). ## B. Assessing Severity of Patient Harm\n\nManufacturers should also have a process for assessing the severity of patient harm, if the cybersecurity vulnerability were to be exploited.\nWhile there are many potentially acceptable approaches for conducting this type of analysis, one such approach may be based on qualitative severity levels as described in ANSI/AAMI/ISO 14971: 2007/(R)2010: Medical Devices Application of Risk Management to Medical Devices:\n\nCommon Term\n\nPossible Description\n\nNegligible:\n\nInconvenience or temporary discomfort\n\nMinor:\n\nResults in temporary injury or impairment not requiring professional medical intervention\n\nSerious:\n\nResults in injury or impairment requiring professional medical intervention\n\nCritical:\n\nResults in permanent impairment or life-threatening injury\n\nCatastrophic:\n\nResults in patient death\n\n## C. Evaluation of Risk of Patient Harm\n\nA key purpose of conducting the cyber-vulnerability risk assessment is to evaluate whether the risk of patient harm is controlled (acceptable) or uncontrolled (unacceptable). One method of assessing the acceptability of risk involves using a matrix with combinations of 'exploitability' and 'severity of patient harm' to determine whether the risk of patient harm is controlled or uncontrolled. A manufacturer can then conduct assessments of the exploitability and severity of patient harm and then use such a matrix to assess the risk of patient harm for the identified cybersecurity vulnerabilities. For risks that remain uncontrolled, additional remediation should be implemented. The following figure is an example matrix that shows a possible approach to evaluate the relationship between exploitability and patient harm. It can be used to assess the risk of patient harm from a cybersecurity vulnerability as controlled or uncontrolled."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 10}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 26)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nication regulations. We solicit comment in this area. Whether a State law is contrary to these breach notification regulations is to be determined based on the definition of ''contrary'' at § 160.202.\nA State law is contrary if ''a covered entity could find it impossible to comply with both the State and federal requirements'' or if the State law ''stands as an obstacle to the accomplishment and execution of the full purposes and objectives'' of the breach notification provisions in the Act. As discussed above, we make a conforming change to paragraph (2) of the definition of ''contrary'' in this section to incorporate reference to the breach notification provisions at section 13402 of the Act. Therefore, covered entities will need to analyze relevant State laws with respect to this regulation to understand the interaction\n\n12 We do not interpret the preemption exception at § 160.203(b), which addresses more stringent State law related to privacy, as applying to these breach notification provisions because that paragraph only applies to the provisions of the Privacy Rule promulgated under section 264(c) of the HIPAA statute. See section 264(c)(2) of HIPAA. VerDate Nov&lt;24&gt;2008\n\nand apply this preemption standard appropriately. Although we received many comments concerning perceived conflicts between the interaction of State laws and these breach notification provisions, based on the ''contrary'' standard for preemption, in general we believe that covered entities can comply with both the applicable State laws and this regulation. In addition, based on the comments received, we believe that, in most cases, a single notification can satisfy the notification requirements under State laws and this regulation."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 25}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 384)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\napplied to uses and disclosures for payment or health care operations. Response: Commenter's arguments for exempting these uses and disclosures from the minimum necessary standard were not compelling.\nWe believe that our modifications to application of the minimum necessary standard to internal uses of protected health information, and to routine disclosures, address many of the concerns raised, particularly the concerns about administrative burdens and the concerns about having the information necessary for day-to-day operations. We do not eliminate this standard in part because we also remain concerned that covered entities may be tempted to disclose an entire medical record when only a few items of information are necessary, to avoid the administrative step of extracting the necessary information (or redacting the unnecessary information). We also believe this standard will cause covered entities to assess their privacy practices, give the privacy interests of their patients and enrollees greater attention, and make improvements that might otherwise not have been made. For this reason, the privacy benefits of retaining the minimum necessary standard for these purposes outweigh the burdens involved. We note that the minimum necessary standard is tied to the purpose of the disclosure; thus, providers may disclose protected health information as necessary to obtain payment. Comment: Other commenters urged us to apply a ''good faith'' provision to all disclosures subject to the minimum necessary standard. Commenters presented a range of options to modify the proposed provisions which, in their view, would have mitigated their liability if they failed to comply with minimum necessary standard. Response: We believe that the modifications to this standard, described above, substantially address these commenters' concerns."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 383}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 471)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nehalf of the group health plan, to disclose protected health information to a plan sponsor who performs administrative functions on its behalf for certain purposes and if certain requirements are met.\nThe plan documents must be amended to: describe the permitted uses and disclosures of protected health information by the plan sponsor; specify that disclosure is permitted only upon receipt of a certification by the plan sponsor that the plan documents have been amended and the plan sponsor agrees to certain restrictions on the use of protected health information; and provide for adequate firewalls to assure unauthorized personnel do not have access to individually identifiable health information. Some plan sponsors may need information, not to administer the group health plan, but to amend, modify, or terminate the plan. ERISA case law describes such activities as settlor functions. For example, a plan sponsor may want to change its contract from a preferred provider organization to a health maintenance organization (HMO). In order to obtain premium information, the plan sponsor may need to provide the HMO with aggregate claims information. Under the rule, the plan sponsor can obtain summary information with certain identifiers removed, in order to provide it to the HMO and receive a premium rate. The Department assumes that most plan sponsors who are small employers (those with 50 or fewer employees) will elect not to receive protected health information because they will have little, if any, need for such data. Any needs that plan sponsors of small group health plans may have for information can be accomplished by receiving the information in summary form. The Department has assumed that only 5 percent of plan sponsors of small group health plans that provide coverage through a contract with an issuer will actually take the steps necessary to receive protected health information. This is approximately 96,900 firms."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 470}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 5)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ncommunications, as compared to the disclosure and opt-out conditions of §164.514(e). Second, the Department proposed minor clarifications to the Privacy Rule's definition of ''marketing'' at §164.501.\nSpecifically, the Department proposed to define ''marketing'' as ''to make a communication about a product or service to encourage recipients of the communication to purchase or use the product or service.'' The proposed modification retained the substance of the ''marketing'' definition, but changed the language slightly to avoid the implication that in order for a communication to be marketing, the purpose or intent of the covered entity in making such a communication would have to be determined. The simplified language permits the Department to make the determination based on the communication itself. Third, with respect to the exclusions from the definition of ''marketing'' in §164.501, the Department proposed to simplify the language to avoid confusion and better conform to other sections of the regulation, particularly in the area of treatment communications. The proposal retained the exclusions for communications about a covered entity's own products and services and about the treatment of the individual. With respect to the exclusion for a communication made ''in the course of managing the treatment of that individual,'' the Department proposed to modify the language to use the terms ''case management'' and ''care coordination'' for that individual. These terms are more consistent with the terms used in the definition of ''health care operations,'' and were intended to clarify the Department's intent. One substantive change to the definition proposed by the Department was to eliminate the condition on the above exclusions from the definition of ''marketing'' that the covered entity could not receive remuneration from a third party for any written communication. This limitation was not well understood and treated similar communications differently."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 4}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 22)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nPRM. The Department proposed a number of minor modifications to the minimum necessary standard to clarify the Department's intent or otherwise conform these provisions to other proposed modifications.\nFirst, the Department proposed to separate §164.502(b)(2)(ii) into two subparagraphs (§ 164.502(b)(2)(ii) and (iii)) to eliminate confusion regarding the exception to the minimum necessary standard for uses or disclosures made pursuant to an authorization under §164.508, and the separate exception for disclosures made to the individual. Second, to conform to the proposal to eliminate the special authorizations required by the Privacy Rule at §164.508(d), (e), and (f), the Department proposed to exempt from the minimum necessary standard any uses or disclosures for which the covered entity had received an authorization that meets the requirements of § 164.508, rather than just those authorizations initiated by the individual. Third, the Department proposed to modify §164.514(d)(1) to delete the term ''reasonably ensure'' in response to concerns that the term connotes an absolute, strict standard and, therefore, is inconsistent with the Department's intent that the minimum necessary requirements be reasonable and flexible to the unique circumstances of the covered entity. In addition, the Department proposed to generally revise the language in § 164.514(d)(1) to be more consistent with the description of standards elsewhere in the Privacy Rule. Fourth, so that the minimum necessary standard would be applied consistently to requests for, and disclosures of, protected health information, the Department proposed to add a provision to § 164.514(d)(4) to make the implementation specifications for applying the minimum necessary standard to requests for protected health information by a covered entity more consistent with the corresponding implementation specifications for disclosures."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 21}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 288)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nion Study Commission, ''Personal Privacy in an Information Society,'' July 1977, p. 306. 10 Privacy Protection Study Commission, ''Personal Privacy in an Information Society,'' July 1977, pp. 215-217.\n11 Health Privacy Working Group, ''Best Principles for Health Privacy,'' Health Privacy Project, Institute for Health Care Research and Policy, Georgetown University, July 1999, p. 19. social considerations.'' 12 We build on these standards in this final rule. Comment: Some comments suggested that, under the proposed rule, a covered entity could not use protected health information to solicit authorizations from individuals. For example, a covered entity could not use protected health information to generate a mailing list for sending an authorization for marketing purposes. Response: We agree with this concern and clarify that covered entities are permitted to use protected health information in this manner without authorization as part of the management activities relating to implementation of and compliance with the requirements of this rule. See § 164.501 and the corresponding preamble regarding the definition of health care operations. Comment: We received several comments suggesting that we not require written authorizations for disclosures to the individual or for disclosures initiated by the individual or the individual's legal representative. Response: We agree with this concern and in the final rule we clarify that disclosures of protected health information to the individual who is the subject of the information do not require the individual's authorization. See §164.502(a)(1). We do not intend to impose barriers between individuals and disclosures of protected health information to them."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 287}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 219)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nf multiple parties would constitute a single or multiple infractions, for the purpose of calculating the penalty amount. Response: The enforcement regulation will address the calculation of penalties.\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00145\n\nHowever, we note that section 1176 subjects persons to civil monetary penalties of not more than $100 for each violation of a requirement or prohibition and not more than $25,000 in a calendar year for all violations of an identical requirement or prohibition. For example, if a covered entity fails to permit amendment of protected health information for 10 patients in one calendar year, the entity may be fined up to $1000 ($100 times 10 violations equals $1000). ## Part 164-Subpart A-General Requirements Part 164-Subpart B-D-Reserved Part 164-Subpart E-Privacy Section 164.500-Applicability\n\n## Covered Entities\n\nThe response to comments on covered entities is included in the response to comments on the definition of ''covered entity'' in the preamble discussion of §160.103. ## Covered Information\n\nThe response to comments on covered information is included in the response to comments on the definition of ''protected health information'' in the preamble discussion of § 164.501. ## Section 164.501-Definitions\n\n## Designated record set\n\nComment: Many commenters generally supported our proposed definition of designated record set. Commenters suggested different methods for narrowing the information accessible to individuals, such as excluding information obtained without face-to-face interaction (e.g., phone consultations). Other commenters recommended broadening the information accessible to individuals, such as allowing access to ''the entire medical record,'' not just a designated record set. Some commenters advocated for access to all information about individuals."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 218}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the administrative safeguards under HIPAA?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\n## Office of the Secretary\n\n## 45 CFR Parts 160 and 164\n\nRin: 0991-AB08\n\n## Standards for Privacy of Individually Identifiable Health Information\n\nAGENCY : Office of the Assistant Secretary for Planning and Evaluation, DHHS. ACTION\n\n: Final rule. SUMMARY : This rule includes standards to protect the privacy of individually identifiable health information. The rules below, which apply to health plans, health care clearinghouses, and certain health care providers, present standards with respect to the rights of individuals who are the subjects of this information, procedures for the exercise of those rights, and the authorized and required uses and disclosures of this information. The use of these standards will improve the efficiency and effectiveness of public and private health programs and health care services by providing enhanced protections for individually identifiable health information. These protections will begin to address growing public concerns that advances in electronic technology and evolution in the health care industry are resulting, or may result, in a substantial erosion of the privacy surrounding individually identifiable health information maintained by health care providers, health plans and their administrative contractors. This rule implements the privacy requirements of the Administrative Simplification subtitle of the Health Insurance Portability and\n\nAccountability Act of 1996. DATES : The final rule is effective on February 26, 2001. ## FOR FURTHER INFORMATION CONTACT :\n\nKimberly Coleman, 1-866-OCR-PRIV (1-866-627-7748) or TTY 1-866-7884989. ## SUPPLEMENTARY INFORMATION :\n\nAvailability of copies, and electronic access. Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954."}], "metadata": {"source": "privacy_rule_2000", "safeguard_type": "administrative", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 49)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nl proceedings as inquiring into a potential violation of law. In addition, it describes law enforcement-related civil, criminal, or administrative proceedings as arising from alleged violation of law.\n## Marketing\n\nThe proposed rule did not include a definition of ''marketing.'' The proposed rule generally required that a covered entity would need an authorization from an individual to use or disclose protected health information for marketing. In the final rule we define marketing as a communication about a product or service a purpose of which is to encourage recipients of the communication to purchase or use the product or service. The definition does not limit the type or means of communication that are considered marketing. The definition of marketing contains three exceptions. If a covered entity\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nreceives direct or indirect remuneration from a third party for making a written communication otherwise described in an exception, then the communication is not excluded from the definition of marketing. The activities we except from the definition of marketing are encompassed by the definitions of treatment, payment, and health care operations. Covered entities may therefore use and disclose protected health information for these excepted activities without authorization under §164.508 and pursuant to any applicable consent obtained under §164.506. The first exception applies to communications made by a covered entity for the purpose of describing the entities participating in a provider network or health plan network. It also applies to communications made by a covered entity for the purpose of describing if and the extent to which a product or service, or payment for a product or service, is provided by the covered entity or included in a benefit plan."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 48}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 38)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nactor; rather, this is the obligation of the business associate that has engaged the subcontractor to perform a function or service that involves the use or disclosure of protected health information.\n## d. Section 164.314-Organizational Requirements\n\n## Proposed Rule\n\nWhile Section 13401 of the HITECH Act does not expressly include §164.314 among the provisions for which business associates are directly liable, it states that § 164.308 of the Security Rule applies to business associates ''in the same manner'' that the provision applies to covered entities. Section 164.308(b) requires a covered entity's business associate agreements to conform to the requirements of § 164.314. Accordingly, in order for § 164.308(b) to apply to business associates in the same manner as it applies to covered entities, we proposed to revise § 164.314 to reflect that it is also applicable to agreements between business associates and subcontractors that create, receive, maintain, or transmit electronic protected health information. We also proposed a number of modifications to streamline the requirements of § 164.314. First, since a business associate for purposes of the Security Rule is also always a business associate for purposes of the Privacy Rule, we proposed to remove contract provisions that were merely duplicative\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00026\n\nof parallel provisions in the Privacy Rule's business associate contract provisions at § 164.504. We also proposed to remove the specific requirements under § 164.314(a)(2)(ii) for other arrangements, such as a memorandum of understanding when both a covered entity and business associate are governmental entities, and instead simply refer to the parallel Privacy Rule requirements at §164.504(e)(3)."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 37}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 181)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nof the underwriting prohibition on the long-term care market, the final rule exempts such plans from the prohibition. Thus, there are no costs to be attributed to long term care plans with this rule.\nFurther, given we did not receive other comments that would lead us to question the underlying assumptions in the proposed rule, we do not expect this provision of the final rule to result in substantial new costs on health plans, particularly those that have been required to comply with the regulations implementing GINA's nondiscrimination provisions for several years now. ## f. Enforcement Provisions\n\nThe amendments contained within this final rule to the HIPAA Enforcement Rule conform the regulatory language of the Rule to the enhanced enforcement provisions of the HITECH Act. Consistent with its reasoning in prior HIPAA Enforcement rulemakings, 41 the Department expects the costs covered entities, and now business associates, may incur with respect to their compliance with the Enforcement Rule, itself, should be low in most cases. That is, covered entities and business associates that comply with the HIPAA rules voluntarily, as is expected, should not incur any additional, significant costs as a result of the Enforcement Rule. Further, we believe the increased penalties and other enhancements provided by the HITECH Act and which are reflected in this final rule provide even more incentive to covered entities and business associates to take steps necessary to comply and thus not be liable for violations. ## D. Qualitative Analysis of Unquantified Benefits\n\nWhile we are certain that the regulatory changes in this final rule represent significant benefits, we cannot monetize their value. Many commenters agreed with our assumptions regarding the benefits to individuals, but we did not receive any comments that included specific information about quantifying those benefits. The following sections describe in greater detail the qualitative benefits of the final rule."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 180}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 80)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nf protected health information, other than psychotherapy notes and research information unrelated to treatment, for purposes of treatment, payment, and health care operations (see proposed § 164.506).\nWe also proposed to require covered entities to disclose protected health information to the individual for inspection and copying (see proposed § 164.514) and to the Secretary as required for\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00053\n\nenforcement of the rule (see proposed §164.522). Individual authorization would not have been required for these uses and disclosures. We proposed to require covered entities to obtain the individual's authorization for all other uses and disclosures of protected health information. Under proposed §164.508(a), uses and disclosures that would have required individual authorization included, but were not limited to, the following:\n\n- Disclosure by sale, rental, or barter;\n- Use for marketing of health and non-health items and services by the covered entity;\n- Use and disclosure to non-health related divisions of the covered entity, e.g., for use in marketing life or casualty insurance or banking services;\n- Disclosure to an employer for use in employment determinations; and\n- Disclosure, prior to an individual's enrollment in a health plan, to the health plan or health care provider for making eligibility or enrollment determinations relating to the individual or for underwriting or risk rating determinations;\n- Use or disclosure for fundraising. In the preamble to the proposed rule, we stated that covered entities would be bound by the terms of authorizations. Uses or disclosures by the covered entity for purposes inconsistent with the statements made in the authorization would have constituted a violation of the rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 79}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 45)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nese commenters generally suggested that the final rule give covered entities the flexibility to determine whether the financial remuneration received is truly in exchange for making the communication.\nWe received a great deal of public comment on the exception to the definition of ''marketing'' for providing refill reminders or to otherwise communicate about a drug or biologic currently being prescribed for the individual where the only financial remuneration received by the covered entity in exchange for making the communication is reasonably related to the covered entity's cost of making the communication. In general, most commenters supported this exception; however, a few commenters disagreed with the exception and felt that refill reminders should be treated as treatment communications requiring a statement in the notice and an opportunity to opt out if the communication is subsidized. Many commenters expressed the need for guidance on the scope of this exception and stated that certain communications should fall into the exception, such as communications about generic alternatives and drug adherence, and communications related to every component of a drug or biologic delivery system (especially where patients must self-administer medication). Some commenters specifically asked that the final rule exclude certain types of communications from this exception. With respect to the proposed cost limitation on the refill reminder exception, while some commenters suggested that the cost be limited to either the actual cost or the fair market value of providing the communication, generally, most commenters supported the position that reasonably related costs should not be limited to actual costs."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 44}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 124)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ns purpose. The modifications also clarify that parties can negotiate the time and manner of providing the covered entity with access to the business associate's internal practices, books, and records.\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\nFinally, the Department has modified the sample language to clarify that business associates are only required to notify the covered entity of uses and disclosures of protected health information not provided for by the agreement of which it becomes aware in order to more closely align the sample contract provisions with the regulation text. The Department did not intend to imply a different standard than that included in the regulation. The Department has modified the General Use and Disclosure sample language to clarify that there are two possible approaches, and that in each approach the use or disclosure of protected health information by a business associate shall be consistent with the minimum necessary policies and procedures of the covered entity. The Department has adopted one change to the sample language under Specific Use and Disclosure that clarifies that a permitted specific use of protected health information by the business associate includes reporting violations of law to appropriate Federal and State authorities. This would permit a business associate to use or disclose protected health information in accordance with the standards in §164.502(j)(1). We indicate that this is optional text, not required by the Privacy Rule. Because we have included this language as sample language, we have deleted discussion of this issue in the statement preceding the sample business associate contract provisions."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 123}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 118)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nry text, covered entities and business associates should examine their policies to ensure that when evaluating the risk of an impermissible use or disclosure they consider all of the required factors.\nIn addition, given the circumstances of the impermissible use or disclosure, additional factors may need to be considered to appropriately assess the risk that the protected health information has been compromised. We note that, although we have included this risk assessment in the final rule, this type of assessment of risk should not be a new or different exercise for covered entities and business associates. Similar assessments of risk that data have been compromised must be performed routinely following security\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00078\n\nbreaches and to comply with certain State breach notification laws. The first factor requires covered entities and business associates to evaluate the nature and the extent of the protected health information involved, including the types of identifiers and the likelihood of re-identification of the information. To assess this factor, entities should consider the type of protected health information involved in the impermissible use or disclosure, such as whether the disclosure involved information that is of a more sensitive nature. For example, with respect to financial information, this includes credit card numbers, social security numbers, or other information that increases the risk of identity theft or financial fraud. With respect to clinical information, this may involve considering not only the nature of the services or other information 11 but also the amount of detailed clinical information involved (e.g., treatment plan, diagnosis, medication, medical history information, test results)."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 117}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 108)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nopy or electronic media (i.e., physical media such as a compact disc (CD) or universal serial bus (USB) flash drive), if the individual requests that the electronic copy be provided on portable media.\nWe do not require that covered entities obtain new types of technology needed to comply with specific individual requests, and therefore the cost of obtaining such new technologies is not a permissible fee to include in the supply costs. With respect to § 164.524(c)(4)(iii), we clarify that a covered entity is permitted to charge for postage if an individual requests that the covered entity transmit portable media containing an electronic copy through mail or courier (e.g., if the individual requests that the covered entity save protected health information to a CD and then mail the CD to a designee). Fees associated with maintaining systems and recouping capital for data access, storage and infrastructure are not considered reasonable, cost-based fees, and are not permissible to include under this provision. Covered entities are not required to adopt or purchase new systems under this provision, and thus any costs associated with maintaining them are present regardless of the new electronic access right. Additionally, although the proposed rule indicated that a covered entity could charge for the actual labor costs associated with the retrieval of electronic information, in this final rule we clarify that a covered entity may not charge a retrieval fee (whether it be a standard retrieval fee or one based on actual retrieval costs). This\n\nVerDate Mar&lt;15&gt;2010\n\ninterpretation will ensure that the fee requirements for electronic access are consistent with the requirements for hard copies, which do not allow retrieval fees for locating the data. Response to Other Public Comments\n\nComment: Commenters requested clarification on how to proceed when State laws designate fees."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 107}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.504(e)(2)(ii) require?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n§164.504(e)(2)(ii)(H) (and to renumber the current paragraphs (H) and (I) accordingly) to requires that, to the extent the business associate is to carry out a covered entity's obligation under this subpart, the business associate must comply with the requirements of the Privacy Rule that apply to the covered entity in the performance of such obligation. This provision would clarify that when a covered entity delegates a responsibility under the Privacy Rule to the business associate, the business associate would be contractually required to comply with the requirements of the Privacy Rule in "}], "metadata": {"source": "hitech_omnibus_2013", "cfr_section": "§164.504(e)(2)(ii)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 71)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\nreceived products that have been withdrawn, recalled, or are the subject of lookback), and (4) to conduct postmarketing surveillance.\nThe Department believes these modifications are necessary to remove barriers that could prevent or chill the continued flow of vital information between health care providers and manufacturers of food, drugs, medical and other devices, and biological products. Health care providers have been making these disclosures to manufacturers for many years, and commenters opposed to the proposal did not cite any examples of abuses of information disclosed for such purposes. Furthermore, both the individuals who are the subjects of the information and the general public benefit from these disclosures, which are an important means of identifying and dealing with FDA-regulated products on the market that potentially pose a health or safety threat. For example, FDA learns a great deal about the safety of a drug after it is marketed as a result of voluntary adverse event reports made by covered entities to the product's manufacturer. The manufacturer is required to submit these safety reports to FDA, which uses the information to help make the product safer by, among other things, adding warnings or changing the product's directions for use. The modifications provide the necessary assurances to covered entities that such voluntary reporting may continue. Although the list of permissible disclosures is no longer exclusive, the Department disagrees with commenters that asserted the modifications permit virtually unlimited disclosures for FDA purposes. As modified, such disclosures must still be made to a person subject to the jurisdiction of the FDA."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 70}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 106)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nsubmitted to the court or administrative tribunal with jurisdiction, or that the party seeking the protected health information has requested a qualified protective order from such court or tribunal.\nWe encourage the development of ''model'' protective orders that will facilitate adherence with this subpart. In the final rule we also permit the covered entity itself to satisfy the requirement to make reasonable efforts to notify the individual whose information has been requested or to seek a qualified protective order. We intend this to be a permissible activity for covered entities: we do not require covered entities to undertake these efforts in response to a subpoena, discovery request, or similar process (other than an order from a court or administrative tribunal). If a covered entity receives such a request without receiving the satisfactory assurances described above from the party requesting the information, the covered entity is free to object to the disclosure and is not required to undertake the reasonable efforts itself. We clarify that the provisions of this paragraph do not supersede or otherwise invalidate other provisions of this rule that permit uses and disclosures of protected health information. For example, the fact that protected health information is the subject of a matter before a court or tribunal does not prevent its disclosure under another provision of the rule, such as §§ 164.512(b), 164.512(d), or 164.512(f), even if a public agency's method of requesting the information is pursuant to an administrative proceeding. For example, where a public agency commences a disciplinary action against a health professional, and requests protected health information as part of its investigation, the disclosure made be made to the agency under paragraph (d) of this section (relating to health oversight) even if the method of making the request is through the proceeding."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 105}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are covered entity obligations under HIPAA?"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\n## Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on June 27, 2025. A draft select update to this document was issued on March 13, 2024. This document supersedes 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,' issued September 27, 2023. For questions about this document regarding CDRH-regulated devices, contact CyberMed@fda.hhs.gov. For questions about this document regarding CBER-regulated devices, contact the Office of Communication, Outreach, and Development (OCOD) at 1-800-835-4709 or 240-402-8010, or by email at industry.biologics@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Center for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to https://www.regulations.gov. Submit written comments to the Dockets Management Staff, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2021-D-1158. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an email request to CDRH-Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number GUI00001825 and complete title of the guidance in the request."}], "metadata": {"source": "fda_premarket_2023", "entity_type": "covered_entity", "safeguard_types": ["physical", "technical", "administrative"], "type": "entity_obligations"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 359)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\na researcher could practicably use de-identified health information for a research study, protected health information should not be used or disclosed for the study without individuals' authorization.\nTherefore, we retain this criterion in the final rule. In considering this criterion, we expect IRBs and privacy boards to consider the amount of information that is needed for the study. To ensure the covered health care provider or health plan is informed of what information the IRB or privacy board has determined may be used or disclosed without authorization, the final rule also requires that the documentation of IRB or privacy board approval of the alteration or waiver describe the protected health information for which use or access has been determined to be necessary. Comment: A large number of comments objected to the proposed waiver criterion, which stated that, ''the research is of sufficient importance so as to outweigh the intrusion of the privacy of the individual whose information is subject to the disclosure.'' The majority of these commenters argued that the criterion was overly subjective, and that due to its subjectivity, IRBs and privacy boards would inevitably apply it inconsistently. Several commenters asserted that this criterion was unsound in that it would impose on reviewing bodies the explicit requirement to form and debate conflicting value judgments about the relative weights of the research proposal versus an individual's right to privacy. Furthermore these commenters argued that this criterion was also unnecessary because the Common Rule already has a requirement that deals with this issue more appropriately. In addition, one commenter argued that the rule eliminate this criterion because common purposes should not override individual rights in a democratic society. Based on these arguments, these commenters recommended that this criterion be deleted."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 358}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 478)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ne areas where reliable and relatively complete data are available for this kind of analysis. The logic of the analysis, however, applies to any health condition, including relatively minor conditions.\nWe expect that some individuals might be concerned with maintaining privacy even if they have no significant health problems because it is likely that they will develop a medical condition in the future that they will want to keep private. ## Cancer\n\nThe societal burden of disease imposed by cancer is indisputable. Cancer is the second leading cause of death in the US, 56 exceeded only by heart disease. In 2000, it is estimated that 1.22 million new cancer cases will be diagnosed. 57 The estimated prevalence of cancer cases (both new and existing cases) in 1999 was 8.37 million. 58 In addition to mortality, incidence, and prevalence rates, the other primary methods of assessing the burden of disease are cost-of-illness and quality of life measures. 59 Cost of illness measures the economic costs associated with treating the disease (direct costs) and lost income associated with morbidity and mortality (indirect costs). 56 American Cancer Society. http://4a2z.com/cgi/ rfr.cgi?4CANCER-2-http://www.cancer.org/ frames.html\n\n57 American Cancer Society. http:// www3.cancer.org/cancerinfo/sitecenter.asp?ctid= 8&amp;scp= 0&amp;scs= 0&amp;scss= 0&amp;scdoc = 40000. 58 Polednak, AP. ''Estimating Prevalence of Cancer in the United States,'' Cancer 1997; 8-:13641\n\n59 Martin Brown, ''The Burden of Illness of Cancer: Economic Cost and Quality of Life.'' Annual Review of Public Health, 2001:22:91-113. The National Institutes of Health estimates that the overall annual cost of cancer in 1990 was $96.1 billion; $27.5 billion in direct medical costs and $68.7 billion for lost income due to morbidity and mortality. 60 Health-related quality of life measures integrate the mortality and morbidity effects of disease to produce health status scores for an individual or population."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 477}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 434)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nause any prudent entity would do it. Some practitioner organizations as well as a health plan, expressed concern about the obligation to mitigate in the context of the business associate relationship.\nArguing that it is unnecessary for the regulation to explicitly extend the duty to mitigate to business associates, commenters noted that: Any prudent entity would discipline a vendor or employee that violates a regulation; that the matter is best left to the terms of the contract, and that it is difficult and expensive for a\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nbusiness associate to have a separate set of procedures on mitigation for each client/provider. One commenter suggested that the federal government should fund the monitoring needed to administer the requirement. Response: Eliminating the requirement to mitigate harm would undermine the purposes of this rule by reducing covered entities' accountability to their patients for failure to protect their confidential data. To minimize burden, we do not prescribe what mitigation policies and procedures must be implemented. We require only that the covered entity mitigate harm. We also assume that violations will be rare, and so the duty to mitigate harm will rarely be triggered. To the extent a covered entity already has methods for mitigating harm, this rule will not pose significant burden, since we don't require the covered entity to follow any prescribed method or set of rules. We also modify the NPRM to impose the duty to mitigate only where the covered entity has actual knowledge of harm. Further reducing burden, the rule requires mitigation ''to the extent practicable.'' It does not require the covered entity to eliminate the harm unless that is practicable."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 433}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 26)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nld present controlled risk, as described in FDA's Postmarket Cybersecurity Guidance. Updates and/or patches to address these vulnerabilities may be intended to maintain the supportability of software.\nGenerally, software should be regularly updated to maintain the supportability of the software. For examples of vulnerabilities associated with controlled risk, see the Postmarket Cybersecurity Guidance. Updates and patches to address these types of vulnerabilities are not to reduce uncontrolled risk, and therefore not to reduce a risk to health or to correct a violation of the FD&amp;C Act. See below for more information on section 524B(b)(2)(B) of the FD&amp;C Act. - Section 524B(b)(2)(B) of the FD&amp;C Act requires manufacturers of cyber devices to make available updates and patches to the device and related systems to address as soon as possible out of cycle, 65 critical vulnerabilities that could cause uncontrolled risks. 61 For the purposes of this guidance, manufacturer procedures to carry out disclosures of the vulnerabilities and exploits may include procedures to inform device users, customers, patients, and other relevant healthcare parties. 62 An update is defined by NIST as '[a] patch, upgrade, or other modification to code that corrects security and/or functionality problems in software' (see NIST Computer Security Resource Center Glossary). Patches are defined by CISA as 'software and operating system (OS) updates that address security vulnerabilities within a program or product' (see Understanding Patches and Software Updates). We consider an update or patch that would satisfy the requirements under section 524B(b)(2)(A)-(B) for updates or patches as an action that modifies device code to address a cyber risk. 63 For the purposes of this guidance, we refer to the evaluation of 'related systems' to the extent needed to determine that the device, as it interacts with related systems, remains cybersecure."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 25}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 245)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nan individual to a particular facility, §164.512(k)(5) is applicable. ## Psychotherapy Notes\n\nComment: Some commenters thought the definition of psychotherapy notes was contrary to standard practice.\nThey claimed that reports of psychotherapy are typically part of the medical record and that psychologists are advised, for ethical reasons and liability risk management purposes, not to keep two separate sets of notes. Others acknowledged that therapists may maintain separate notations of therapy sessions for their own purpose. These commenters asked that we make clear that psychotherapy notes, at least in summary form, should be included in the medical record. Many plans and providers expressed concern that the proposed definition would encourage the creation of ''shadow'' records which may be dangerous to the patient and may increase liability for the health care providers. Some commenters claimed that psychotherapy notes contain information that is often essential to treatment. Response: We conducted fact-finding with providers and other knowledgeable parties to determine the standard practice of psychotherapists and determined that only some psychotherapists keep separate files with notes pertaining to psychotherapy sessions. These notes are often referred to as ''process notes,'' distinguishable from ''progress notes,'' ''the medical record,'' or ''official records.'' These process notes capture the therapist's\n\nFrm 00162\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nimpressions about the patient, contain details of the psychotherapy conversation considered to be inappropriate for the medical record, and are used by the provider for future sessions. We were told that process notes are often kept separate to limit access, even in an electronic record system, because they contain sensitive information relevant to no one other than the treating provider."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 244}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the administrative safeguards under HIPAA?"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\n## Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on June 27, 2025. A draft select update to this document was issued on March 13, 2024. This document supersedes 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,' issued September 27, 2023. For questions about this document regarding CDRH-regulated devices, contact CyberMed@fda.hhs.gov. For questions about this document regarding CBER-regulated devices, contact the Office of Communication, Outreach, and Development (OCOD) at 1-800-835-4709 or 240-402-8010, or by email at industry.biologics@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Center for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to https://www.regulations.gov. Submit written comments to the Dockets Management Staff, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2021-D-1158. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an email request to CDRH-Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number GUI00001825 and complete title of the guidance in the request."}], "metadata": {"source": "fda_premarket_2023", "safeguard_type": "administrative", "implementation_spec": "required", "entity_type": "covered_entity", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 25)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nfor the referenced provisions of the Act that were promulgated in the Transactions Rule. To assist the reader, we also provide here excerpts from the relevant sections of the Act. (Refer to the U.S.C.\nsections cited above for complete definitions in sections 1861(u) and 1861(s).) Section 1861(u) of the Act defines a ''provider of services,'' to include, for example, a hospital, critical access hospital, skilled nursing facility, comprehensive outpatient rehabilitation facility, home health agency, hospice program, or, for purposes of section 1814(g) (42 U.S.C. 1395f(g)) and section 1835(e) (42 U.S.C. 1395n(e)), a fund.'' Section 1861(s) of the Act defines the term, ''medical and other health services,'' and includes a list of covered items or services, as illustrated by the following excerpt:\n\n(s) Medical and other health services. The term ''medical and other health services'' means any of the following items or services:\n\n- (1) Physicians' services;\n- (2) (A) services and supplies * * * furnished as an incident to a physician's professional service, or kinds which are commonly furnished in physicians' offices and are commonly either rendered without charge or included in the physicians' bills;\n3. (B) hospital services * * * incident to physicians' services rendered to outpatients and partial hospitalization services incident to such services;\n4. (C) diagnostic services which are-\n5. (i) furnished to an individual as an outpatient by a hospital or by others under arrangements with them made by a hospital, and\n6. (ii) ordinarily furnished by such hospital (or by others under such arrangements) to its outpatients for the purpose of diagnostic study;\n7. (D) outpatient physical therapy services and outpatient occupational therapy services;\n8. (E) rural health clinic services and federally qualified health center services;\n9. (F) home dialysis supplies and equipment, self-care home dialysis support services, and institutional dialysis services and supplies;\n10."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 24}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 136)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nFurther, as with other required documentation, a covered entity must make such information available to the Secretary upon request for compliance and enforcement purposes in accordance with § 160.310.\n## Overview of Public Comments\n\nSome commenters expressed concern regarding the timing of providing notification to the Secretary of breaches affecting fewer than 500 individuals. These commenters asked when notification should be provided if a covered entity discovers, after the reporting deadline, a breach that\n\nVerDate Mar&lt;15&gt;2010\n\noccurred in the previous year. Several others commented on the interim final rule's process for providing the Secretary with breach notification. Some commenters asked that this process be revised to allow covered entities to maintain a log of all breaches affecting fewer than 500 individuals and then submit that log, via attachment (such as an Excel spreadsheet), to the Secretary on an annual basis. These commenters stated that submitting reports of these smaller breaches in this manner would be much less burdensome than submitting the reports individually. Other commenters asked that we provide a template log for entities to use to document smaller breaches for annual submission to the Secretary. Additionally, several commenters suggested that there be access or authentication controls for submitting breach reports because of concerns of false breach reports being submitted to the Secretary without the covered entity's knowledge. ## Final Rule\n\nThe final rule retains § 164.408(c) with one modification."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 135}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 72)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ncan be made without disclosing protected health information. Such may be the case with many adverse drug events where it is important to know what happened but it may not be important to know to whom.\nHowever, in other circumstances, such as device tracking or blood lookback, it is essential for the manufacturer to have identifying patient information in order\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00048\n\nto carry out its responsibilities under the Food, Drug, and Cosmetic Act. Therefore, identifiable health information can be disclosed for these purposes, consistent with the minimum necessary standard. As the Department stated in the preamble of the NPRM, ''a person'' subject to the jurisdiction of the FDA does not mean that the disclosure must be made to a specific individual. The Food, Drug, and Cosmetic Act defines ''person'' to include an individual, partnership, corporation, and association. Therefore, covered entities may continue to disclose protected health information to the companies subject to FDA's jurisdiction that have responsibility for the product or activity. Covered entities may identify responsible companies by using information obtained from product labels or product labeling (written material about the product that accompanies the product) including sources of labeling, such as the Physician's Desk Reference. The Department believes these modifications effectively balance the privacy interests of individuals with the interests of public health and safety. Since the vast majority of commenters were silent on the question of the potential need for a ''good faith'' exception, the Department believes that these modifications will be sufficient to preserve the current public health activities of persons subject to the jurisdiction of the FDA, without such a safe harbor. However, the Department will continue to evaluate the effect of the Rule to determine whether there is need for further modifications or guidance."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 71}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 182)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nposal to have the Department undertake this function. Response: Despite the general support for the advisory opinion proposal, we decided not to provide specifically for the issuance of such opinions.\nThe following considerations led to this\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00120\n\ndecision. First, the assumption by commenters that an advisory opinion would establish what law applied in a given situation and thereby simplify the task of ascertaining what legal requirements apply to a covered entity or entities is incorrect. Any such opinion would be advisory only. Although an advisory opinion issued by the Department would indicate to covered entities how the Department would resolve the legal conflict in question and would apply the law in determining compliance, it would not bind the courts. While we assume that most courts would give such opinions deference, the outcome could not be guaranteed. Second, the thousands of questions raised in the public comment about the interpretation, implications, and consequences of all of the proposed regulatory provisions have led us to conclude that significant advice and technical assistance about all of the regulatory requirements will have to be provided on an ongoing basis. We recognize that the preemption concerns that would have been addressed by the proposed advisory opinions were likely to be substantial. However, there is no reason to assume that they will be the most substantial or urgent of the questions that will most likely need to be addressed. It is our intent to provide as much technical advice and assistance to the regulated community as we can with the resources available. Our concern is that setting up an advisory opinion process for just one of the many types of issues that will have to be addressed will lead to a non-optimal allocation of those resources."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 181}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 29)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ness associate. If there is no business associate contract, we assume the person is a member of the covered entity's workforce. We note that independent contractors may or may not be workforce members.\nHowever, for compliance purposes we will assume that such personnel are members of the workforce if no business associate contract exists. ## Part 160-Subpart B-Preemption of State Laws\n\n## Statutory Background\n\nSection 1178 of the Act establishes a ''general rule'' that state law provisions that are contrary to the provisions or requirements of part C of title XI or the standards or implementation specifications adopted or established thereunder are preempted by the federal requirements. The statute provides three exceptions to this general rule: (1) In section 1178(a)(2)(A)(i), for state laws that the Secretary determines are necessary to prevent fraud and abuse, ensure appropriate state regulation of insurance and health plans, for state reporting on health care delivery, and other purposes; (2) in section 1178(a)(2)(A)(ii), for state laws that address controlled substances; and (3) in section 1178(a)(2)(B), for state laws relating to the privacy of individually identifiable health information that as provided for by the related provision of section 264(c)(2) of HIPAA, are contrary to and more stringent than the federal requirements. Section 1178 also carves out, in sections 1178(b) and 1178(c), certain areas of state authority that are not limited or invalidated by the provisions of part C of title XI: these areas relate to public health and state regulation of health plans. The NPRM proposed a new Subpart B of the proposed part 160. The new Subpart B, which would apply to all standards, implementation specifications, and requirements adopted under HIPAA, would consist of four sections. Proposed § 160.201 provided that the provisions of Subpart B applied to exception determinations and advisory opinions issued by the Secretary under section 1178."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 28}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does 45cfr164 say about HIPAA compliance?"}, {"role": "assistant", "content": "According to 45cfr164:\n\n[Skip to main content](#main-content)\n\nMenu\n\n[![GovInfo logo](/media/GovInfo_logo_gray.png)](/)\n[Search](#searchHolder)\n\n* Browse\n  + [A to Z](/browse-a-z)\n  + [Category](/app/browse/category)\n  + [Date](/app/browse/date)\n  + [Committee](/browse/committee)\n  + [Author](/app/browse/author)\n* About\n  + [About](/about)\n  + [Policies](/about/policies)\n  + [Authentication](/about/authentication)\n  + [Digital Preservation](/about/digital-preservation)\n  + [History](/about/history)\n  + [Agency Submission](/about/agency-submission)\n  + [U.S. Government Information](/about/us-gov-info)\n  + [FDsys Retirement](/about#fdsys-transition)\n* Developers\n  + [Developer Hub](/developers)\n  + [API](https://api.govinfo.gov/docs)\n  + [Bulk Data Repository](%20/bulkdata)\n  + [Link Service](/link-docs)\n  + [Feeds](/feeds)\n  + [Sitemaps](/sitemaps)\n  + [System Design](/developers/system-design)\n* Features\n  + [All Features](/features)\n  + [Featured Content](/features/featured-content)\n  + [News](/features/news)\n  + [Release Notes](/features/release-notes)\n  + [Finding Publications](/features/finding-publications)\n* Help\n  + [Help](/help)\n  + [Finding Information](%20/help/finding-info)\n  + [What's Available](/help/whats-available)\n  + [Tutorials and Handouts](/help/tutorials-handouts)\n  + [Other Resources](%20/help/other-resources)\n* Feedback\n  + [Submit Feedback](https://www.surveymonkey.com/r/govinfo-feedback-survey)\n  + [Contact Us](/contact)\n\n* [Toggle the Search Widget\n  Search](#searchHolder)\n\n# Page Not Found\n\n![Icon: Share using Facebook](/sites/default/files/fb-icon-white.png)\n![Icon: Share using Email](/sites/default/files/email-icon-white.png)\n![Icon: Copy Link URL](/sites/default/files/link-icon-white.png)\n\n[Help](/help/other)\n\n---\n\n**Error occurred."}], "metadata": {"source": "45cfr164", "safeguard_types": ["unknown"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 0}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 28)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nst partner agreement with their business partners, in which the partners would agree to electronically exchange data and protect the integrity, confidentiality, and availability of the data exchanged.\nThis standard has been modified from the proposed requirement to reflect, in § 164.308(b)(1) ''Business associate contracts and other arrangements,'' the business associate structure put in place by the Privacy Rule. In this final rule, covered entities must enter into a contract or other arrangement with persons that meet the definition of business associate in §160.103. The covered entity must obtain satisfactory assurances from the business associate that it will appropriately safeguard the information in accordance with these standards (see §164.314(a)(1)). The comments received on the proposed chain of trust partner agreements are discussed in section 2 ''Business associate contracts and other arrangements'' of the discussion of §164.314 below. 9. Proposed Requirements Not Adopted in This Final Rule a. Security Configuration Management\n\nWe proposed that an organization would be required to implement measures, practices, and procedures regarding security configuration management. They would be coordinated and integrated with other system configuration management practices for the security of information systems. These would include documentation, hardware and/or software installation and maintenance review and testing for security features, inventory procedures, security testing, and virus checking. Comment: Several commenters asked that the entire requirement be deleted. Several others asked that the inventory and virus checking implementation features be removed as they believe those features are not germane to security configuration management."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 27}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 15)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncovered entity. From the comments and our factfinding, however, we learned that these terms do not have consistent meanings today; rather, they encompass diverse activities and information practices.\nFurther, the statutory definitions of key terms such as health care provider and health care clearinghouse describe functions, not specific types of persons or entities. To respect both the Congressional approach and industry evolution, we design the rule to follow activities and functions, not titles and labels. Similarly, many comments asked whether a particular person would be a ''business associate'' under the rule, based on the nature of the person's business. Whether a business associate arrangement must exist under the rule, however, depends on the relationship between the entities and the services being performed, not on the type of persons or companies involved. Our approach is also significantly informed by the limited jurisdiction conferred by HIPAA. In large part, we have the authority to regulate those who create and disclose health information, but not many key stakeholders who receive that health information from a covered entity. Again, this led us to look to the balance between the burden on covered entities and need to protect privacy in determining our approach to such disclosures. In some instances, we\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00011\n\napproach this dilemma by requiring covered entities to obtain a representation or documentation of purpose from the person requesting information. While there would be advantages to legislation regulating such third persons directly, we cannot justify abandoning any effort to enhance privacy. It also became clear from the comments and our fact-finding that we have expectations as a society that conflict with individuals' views about the privacy of health information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 14}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 172)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nth one of the HIPAA transactions are covered, but does not use the term ''receive'' or a similar term. Comment: Some comments related to online companies as health care providers and covered entities.\nOne commenter argued that there was no reason ''why an Internet pharmacy should not also be covered'' by the rule as a health care provider. Another commenter stated that online health care service and content companies, including online medical record companies, should be covered by the definition of health care provider. Another commenter pointed out that the definitions of covered entities cover ''Internet providers who 'bill' or are 'paid' for health care services or supplies, but not those who finance those services in other ways, such as through sale of identifiable health information or advertising.'' It was pointed out that thousands of Internet sites use information provided by individuals who access the sites for marketing or other purposes. Response: We agree that online companies are covered entities under the rule if they otherwise meet the definition of health care provider or health plan and satisfy the other requirements of the rule, i.e., providers must also transmit health information in electronic form in connection with a HIPAA transaction. We restate here the language in the preamble to the proposed rule that ''An individual or organization that bills and/or is paid for health care services or supplies in the normal course of business, such as * * * an ''online'' pharmacy accessible on the Internet, is also a health care provider for purposes of this statute'' (64 FR 59930)."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 171}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 131)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nan authorization under §164.508;\n\n*\n\n*\n\n*\n\nPO 00000\n\n*\n\n*\n\nFrm 00087\n\nFmt 4701\n\nSfmt 4700\n\n- (g)(1) Standard: Personal representatives. * * *\n- (3) Implementation specification: unemancipated minors.\n* * *\n\n(i) *\n\n* *\n\n- (ii) Notwithstanding the provisions of paragraph (g)(3)(i) of this section:\n- (A) If, and to the extent, permitted or required by an applicable provision of State or other law, including applicable case law, a covered entity may disclose, or provide access in accordance with §164.524 to, protected health information about an unemancipated minor to a parent, guardian, or other person acting in loco parentis ;\n- (B) If, and to the extent, prohibited by an applicable provision of State or other law, including applicable case law, a covered entity may not disclose, or provide access in accordance with §164.524 to, protected health information about an unemancipated minor to a parent, guardian, or other person acting in loco parentis ; and\n- (C) Where the parent, guardian, or other person acting in loco parentis , is not the personal representative under paragraphs (g)(3)(i)(A), (B), or (C) of this section and where there is no applicable access provision under State or other law, including case law, a covered entity may provide or deny access under §164.524 to a parent, guardian, or other person acting in loco parentis, if such action is consistent with State or other applicable law, provided that such decision must be made by a licensed health care professional, in the exercise of professional judgment. *\n\n*\n\n*\n\n*\n\n*\n\n6. Amend §164.504 as follows:\n- a. In paragraph (a), revise the definitions of ''health care component'' and ''hybrid entity''. - b. Revise paragraph (c)(1)(ii). - c. Revise paragraph (c)(2)(ii). - d. Revise paragraph (c)(3)(iii). - e. Revise paragraph (f)(1)(i). - f. Add paragraph (f)(1)(iii). The revisions and addition read as follows:\n\n## §164.504 Uses and disclosures: Organizational requirements. (a) Definitions."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 130}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 139)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nentity will be required, following a breach of unsecured protected health information, so long as all required notifications are provided and the other requirements of the interim final rule were met.\nWe encouraged the parties to consider which entity is in the best position to provide notice to the individual, which may depend on circumstances, such as the functions the business associate performs on behalf of the covered entity and which entity has the relationship with the individual. We also encouraged the parties to ensure the individual does not receive notifications from both the covered entity and the business associate about the same breach, which may be confusing to the individual. ## Overview of Public Comments\n\nMany commenters expressed concern over the interim final rule's treatment of a covered entity's knowledge of a breach that occurs at or by a business associate. Some commenters stated that a covered entity's knowledge of a breach should begin when the business associate notifies them of the breach, regardless of whether the business associate is an agent of the covered entity or a non-\n\nVerDate Mar&lt;15&gt;2010\n\nagent independent contractor. If knowledge is imputed when the business associate discovers the breach, one commenter argued that a covered entity would not have sufficient time to provide the required notifications to individuals in a timely manner. Other commenters argued that all business associates should be treated as agents of the covered entity, such that the business associate's knowledge of a breach is imputed to the covered entity. Finally, some commenters asked for more guidance on when a business associate is acting as an agent versus as an independent contractor and how to determine this status under the Federal common law of agency."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 138}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 66)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ned entity that is a business associate of another covered entity constitutes a violation of this rule. In the final rule, we make significant changes to the requirements regarding business associates.\nAs explained below in more detail: we make significant changes to the content of the required contractual satisfactory assurances; we include exceptions for arrangements that would otherwise meet the\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00044\n\ndefinition of business associate; we make special provisions for government agencies that by law cannot enter into contracts with one another or that operate under other legal requirements incompatible with some aspects of the required contractual satisfactory assurances; we provide a new mechanism for covered entities to hire a third party to aggregate data. The final rule provides several exception to the business associate requirements, where a business associate relationship would otherwise exist. We substantially expand the exception for disclosure of protected health information for treatment. Rather than allowing disclosures without business associate assurances only for the purpose of consultation or referral, in the final rule we allow covered entities to make any disclosure of protected health information for treatment purposes to a health care provider without a business associate arrangement. This provision includes all activities that fall under the definition of treatment. We do not require a business associate contract for a group health plan to make disclosures to the plan sponsor, to the extent that the health plan meets the applicable requirements of § 164.504(f). We also include an exception for certain jointly administered government programs providing public benefits."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 65}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 61)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nreliance on the authorization, or if the authorization was obtained as a condition of obtaining insurance coverage and other law gives the insurer the right to contest the claim or the policy itself.\nThe Department adopts the proposed modification to the latter exception so that insurers can exercise the right to contest an insurance policy under other law. Public comment was generally supportive of this proposed modification. Section 164.508(b)(6) requires covered entities to document and retain authorizations as required under §164.530(j). This requirement is not changed. The different sets of implementation criteria are consolidated into one set of criteria under § 164.508(c), thus eliminating the confusion and uncertainty associated with different requirements for specific circumstances. Covered entities may use one authorization form for all purposes. The Department adopts in paragraph (c)(1), the following core elements for a valid authorization: (1) A description of the information to be used or disclosed, (2) the identification of the persons or class of persons authorized to make the use or disclosure of the protected health information, (3) the identification of the persons or class of persons to whom the covered entity is authorized to make the use or disclosure, (4) a description of each purpose of the use or disclosure, (5) an expiration date or event, (6) the individual's signature and date, and (7) if signed by a personal representative, a description of his or her authority to act for the individual. An authorization that does not contain all of the core elements does not meet the requirements for a valid authorization. The Department intends for the authorization process to provide individuals with the opportunity to know and understand the circumstances surrounding a requested authorization."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 60}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 199)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nities Act without an individual's authorization, because this law, in the commenter's view, provides more than adequate protection for the confidentiality of medical records in the employment context.\nThe comment noted that under these laws employers may receive information related to fitness for duty, pre-employment physicals, routine examinations, return to work examinations, examinations following other types of absences, examinations triggered by specific events, changes in\n\nFrm 00131\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ncircumstances, requests for reasonable accommodations, leave requests, employee wellness programs, and medical monitoring. Other commenters suggested that the ADA requires the disclosure of protected health information to employers so that the employee may take advantage of the protections of these laws. They suggested that the final rules clarify that employment may be conditioned on obtaining an authorization for disclosure of protected health information for lawful purposes and provide guidance concerning the interaction of the ADA with the final regulation's requirements. Several commenters wanted clarification that the privacy regulation would not permit employers to request or use protected health information in violation of the ADA. Response: We disagree with the comment that the final rule should allow disclosures of protected health information authorized by the ADA without the individual's authorization. We learned from the comments that access to and use of protected health information by employers is of particular concern to many people. With regard to employers, we do not have statutory authority to regulate them. Therefore, it is beyond the scope of this regulation to prohibit employers from requesting or obtaining protected health information. Covered entities may disclose protected health information about individuals who are members of an employer's workforce with an authorization."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 198}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 54)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nd to mobile and remote computing risks to ePHI | • Are safeguards such as anti-theft devices, physical privacy screens, or other procedures used to help prevent unauthorized audio and video recording?\n• Have workforce members been trained on security? 101 • Are some devices not owned by the organization? Do these ownership considerations preclude the use of any physical security controls on the device? • Do the policies and procedures specify the use of additional security measures to protect devices with ePHI, such as using privacy screens, enabling password- protected screen savers, or logging off the device? |\n\n101  See Sec. 5.1.5, HIPAA Standard: Security Awareness and Training. ## 5.2.4. Device and Media Controls (§ 164.310(d))\n\nHIPAA Standard: Implement policies and procedures that govern the receipt and removal of hardware and electronic media that contain electronic protected health information into and out of a facility, and the movement of these items within the facility. Table 20."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 53}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 21)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\ned we change the title of the requirement to ''logging and violation monitoring.''\n\nA number of commenters stated this requirement could result in an undue burden and would be economically unfeasible.\nResponse: Our intent for this requirement was to promote the periodic review of an entity's internal security controls, for example, logs, access reports, and incident tracking. The extent, frequency, and nature of the reviews would be determined by the covered entity's security environment. The term ''internal audit'' apparently, based on the comments received, has certain rigid formal connotations we did not intend. We agree that the implementation of formal internal audits could prove burdensome or even unfeasible, to some covered entities due to the cost and effort involved. However, we do not want to overlook the value of internal reviews. Based on our review of the comments and the text to which they refer, it is clear that this\n\n17:54 Feb 19, 2003\n\nPO 00000\n\nFrm 00015\n\nrequirement should be renamed for clarity and that it should actually be an implementation specification of the security management process rather than an independent standard. We accordingly remove ''internal audit'' as a separate requirement and add ''information system activity review'' under the security management process standard as a mandatory implementation specification. 2. Assigned Security Responsibility (§ 164.308(a)(2))\n\nWe proposed that the responsibility for security be assigned to a specific individual or organization to provide an organizational focus and importance to security, and that the assignment be documented. Responsibilities would include the management and supervision of (1) the use of security measures to protect data, and (2) the conduct of personnel in relation to the protection of data. In this final rule, we clarify that the final responsibility for a covered entity's security must be assigned to one official."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 20}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 121)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nthe covered entity or business associate's risk assessment to help the individual better assess the level of threat posed by the breach and to better determine the appropriate steps, if any, to take.\nWe decline to require that the covered entity's notice of privacy practices include a description of how a risk assessment will be conducted, although covered entities may include such information in their notice of privacy practices if they choose. While each risk assessment will differ depending on the specific facts and circumstances surrounding the impermissible use or disclosure, we believe that the modifications in this final rule will help ensure that covered entities and business associates perform risk assessments more uniformly and objectively. We also note that the content requirements for the notice to the individual outlined in § 164.404(c) already require that the individual be notified of the circumstances of a breach, as well as what steps individuals should take to protect themselves from potential harm resulting from the breach. One commenter suggested that we require a covered entity to hire an independent organization to assess the risk of an impermissible use or disclosure to determine if breach notification is required. We do not believe such a requirement is necessary, although covered entities are free to engage independent organizations to assist in making such determinations provided that, if access to protected health information is required, business associate agreements are entered into to protect the information. Further, we believe the modifications in this final\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00080\n\nrule are conducive to more uniform risk assessments across covered entities and business associates."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 120}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 208)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n0000\n\nFrm 00136\n\n- apply to the limited data set recipient with respect to such information; and\n\n*\n\n*\n\n*\n\n*\n\n*\n\n- (f) Fundraising communications. - (1) Standard: Uses and disclosures for fundraising.\nSubject to the conditions of paragraph (f)(2) of this section, a covered entity may use, or disclose to a business associate or to an institutionally related foundation, the following protected health information for the purpose of raising funds for its own benefit, without an authorization meeting the requirements of § 164.508:\n- (i) Demographic information relating to an individual, including name, address, other contact information, age, gender, and date of birth;\n- (ii) Dates of health care provided to an individual;\n- (iii) Department of service information;\n- (iv) Treating physician;\n- (v) Outcome information; and\n- (vi) Health insurance status. - (2) Implementation specifications: Fundraising requirements. (i) A covered entity may not use or disclose protected health information for fundraising purposes as otherwise permitted by paragraph (f)(1) of this section unless a statement required by §164.520(b)(1)(iii)(A) is included in the covered entity's notice of privacy practices. - (ii) With each fundraising communication made to an individual under this paragraph, a covered entity must provide the individual with a clear and conspicuous opportunity to elect not to receive any further fundraising communications. The method for an individual to elect not to receive further fundraising communications may not cause the individual to incur an undue burden or more than a nominal cost. - (iii) A covered entity may not condition treatment or payment on the individual's choice with respect to the receipt of fundraising communications. - (iv) A covered entity may not make fundraising communications to an individual under this paragraph where the individual has elected not to receive such communications under paragraph (f)(1)(ii)(B) of this section."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 207}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 80)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nture objections by parents or individuals, and the concerns that covered entities may have regarding liability, penalty or other enforcement actions for disclosures made pursuant to an oral agreement.\nSeveral commenters recommended that in lieu of an oral agreement, disclosure of immunization records to schools are presumed to be permitted, while giving individuals the option to opt out of this presumption or request a restriction to the disclosure. One commenter advocated for this public health exemption for disclosure of immunization records as being particularly critical for children who may be, for example, homeless, living with someone other than a parent or legal guardian, or living with a parent that does not speak English. We remove the written authorization requirement to help facilitate these disclosures with as much flexibility as possible. However, we do not intend this provision to change the current practice of parents, guardians, or other persons acting in loco parentis contacting a child's health care provider to request proof of immunization be sent to the child's school. Therefore, we still require active agreement from the appropriate individual, and a health care provider may not disclose immunization records to a school under this provision without such agreement. The agreement must be an affirmative assent or request by a parent, guardian, or other person acting in loco parentis (or by an adult individual or emancipated minor, if applicable) to the covered entity, which may be oral and over the phone, to allow the disclosure of the immunization records. A mere request by a school to a health care provider for the immunization records of a student would not be sufficient to permit disclosure under this provision (and\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with such a request by a school might also raise implications under other laws, such as FERPA)."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 79}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 246)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n''counseling'' had no commonly agreed upon definition, but seemed to be widely understood in practice. We do not intend to limit the practice of psychotherapy to any specific professional disciplines.\nComment: One commenter noted that the public mental health system is increasingly being called upon to integrate and coordinate services among other providers of mental health services and they have developed an integrated electronic medical record system for state-operated hospitals, part of which includes psychotherapy notes, and which cannot be easily modified to provide different levels of confidentiality. Another commenter recommended allowing use or disclosure of psychotherapy notes by members of an integrated health care facility as well as the originator. Response: The final rule makes it clear that any notes that are routinely shared with others, whether as part of the medical record or otherwise, are, by definition, not psychotherapy notes, as we have defined them. To qualify for the definition and the increased protection, the notes must be created and maintained for the use of the provider who created them i.e., the originator, and must not be the only source of any information that would be critical for the treatment of the patient or for getting payment for the treatment. The types of notes described in the comment would not meet our definition for psychotherapy notes. Comment: Many providers expressed concern that if psychotherapy notes were maintained separately from other protected health information, other health providers involved in the individual's care would be unable to treat the patient properly. Some recommended that if the patient does\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nnot consent to sharing of psychotherapy notes for treatment purposes, the treating provider should be allowed to decline to treat the patient, providing a referral to another provider."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 245}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 540)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nsted by the individual, if it is readily producible in such form or format; or, if not, in a readable hard copy form or such other form or format as agreed to by the covered entity and the individual.\n- (ii) The covered entity may provide the individual with a summary of the protected health information requested, in lieu of providing access to the protected health information or may provide an explanation of the protected\n- health information to which access has been provided, if:\n\n(A) The individual agrees in advance to such a summary or explanation; and\n\n- (B) The individual agrees in advance to the fees imposed, if any, by the covered entity for such summary or explanation. - (3) Time and manner of access . The covered entity must provide the access as requested by the individual in a timely manner as required by paragraph (b)(2) of this section, including arranging with the individual for a convenient time and place to inspect or obtain a copy of the protected health information, or mailing the copy of the protected health information at the individual's request. The covered entity may discuss the scope, format, and other aspects of the request for access with the individual as necessary to facilitate the timely provision of access. - (4) Fees . If the individual requests a copy of the protected health information or agrees to a summary or explanation of such information, the covered entity may impose a reasonable, cost-based fee, provided that the fee includes only the cost of:\n- (i) Copying, including the cost of supplies for and labor of copying, the protected health information requested by the individual;\n- (ii) Postage, when the individual has requested the copy, or the summary or explanation, be mailed; and\n- (iii) Preparing an explanation or summary of the protected health information, if agreed to by the individual as required by paragraph (c)(2)(ii) of this section. - (d) Implementation specifications: Denial of access ."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 539}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 248)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ned that the proposed definition of\n\n''generalizable knowledge'' within the definition of ''research,'' which limited generalizable knowledge to knowledge that is ''related to health,'' was too narrow.\nFor example, one commenter stated that gun shot wound, spousal abuse, and other kinds of information from emergency room statistics are often used to conduct research with ramifications for social policy, but may not be ''related to health.'' Several of these commenters recommended that the definition of research be revised to delete the words ''related to health.'' Additional commenters who argued that the definition was too narrow raised the following concerns: the difference between ''research'' and ''health care operations'' is irrelevant from the patients' perspective, and therefore, the proposed rule should have required documentation of approval by an IRB or privacy board before protected health information could be used or disclosed for either of these purposes, and the proposed definition was too limited because it did not capture research conducted by non-profit entities to ensure public health goals, such as disease-specific registries. Commenters who argued that the definition was too broad recommended that certain activities should be explicitly excluded from the definition. In general, these commenters were concerned that if certain activities were considered to be ''research'' the rule's research requirements would represent a problematic level of regulation on industry initiatives. Some activities that these commenters recommended be explicitly excluded from the definition of ''research'' included: marketing research, health and productivity management, quality assessment and improvement activities, and internal research conducted to improve health. Response: We agree that the final rule's definition of ''research'' should be\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nconsistent with the Common Rule's definition of this term."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 247}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 187)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ny Rule's preemption provisions do not raise Federalism issues. The HITECH Act, at section 13421(a), provides that the HIPAA preemption provisions shall apply to the HITECH provisions and requirements.\nWhile we have made minor technical changes to the preemption provisions in Subpart B of Part 160 to conform to and incorporate the HITECH Act preemption provisions, these changes do not raise new Federalism issues. The changes include: (1) Amending the definitions of ''contrary'' and ''more stringent'' to reference business associates; and (2) further amending the definition of contrary to provide that State law would be contrary to the HIPAA Administrative Simplification provisions if it stands as an obstacle to the accomplishment and execution of the full purposes and objectives of not only HIPAA, but also the HITECH Act. ## ESTIMATED COSTS OF THE FINAL RULE [In 2011 millions]\n\n| Costs (annualized)                                                                                                                   |   Primary estimate ($M) |   Minimum estimate ($M) |   Maximum estimate ($M) |\n|--------------------------------------------------------------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|\n| Discounted @7% ............................................................................................................. |                    42.8 |                    34.8 |                    50.6 |\n| @3% ................................................................................................................................ |                    35.2 |                    28.7 |                    41.7 |\n\nIn the RIA, we acknowledged several potential sources of costs that we were unable to quantify."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 186}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 301)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntion Study Commission, ''Personal Privacy in an Information Society,'' July 1977, p. 196-197. 14 Privacy Protection Study Commission, ''Personal Privacy in an Information Society,'' July 1977, p. 315.\n15 ASTM, ''Standard Guide for Confidentiality, Privacy, Access and Data Security, Principles for Health Information Including Computer-Based Patient Records,'' E 1869-97, § 12.1.4. Fmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nResponse: In the final rule, we do not classify authorizations as those initiated by the individual versus those initiated by a covered entity. Instead, we establish a core set of elements and requirements that apply to all authorizations and require certain additional elements for particular types of authorizations initiated by covered entities. Comment: Some commenters urged us to permit authorizations that designate a class of entities, rather than specifically named entities, that are authorized to use or disclose protected health information. Commenters made similar recommendations with respect to the authorized recipients. Commenters suggested these changes to prevent covered entities from having to seek, and individuals from having to sign, multiple authorizations for the same purpose. Response: We agree. Under §164.508(c)(1), we require authorizations to identify both the person(s) authorized to use or disclose the protected health information and the person(s) authorized to receive protected health information. In both cases, we permit the authorization to identify either a specific person or a class of persons. Comment: Many commenters requested clarification that covered entities may rely on electronic authorizations, including electronic signatures. Response: All authorizations must be in writing and signed. We intend e-mail and electronic documents to qualify as written documents. Electronic signatures are sufficient, provided they meet standards to be adopted under HIPAA."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 300}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 545)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nt to be construed to permit or excuse an action that violates any other standard, implementation specification, or other requirement of this subpart. - (2) Standard: Changes to policies or procedures.\n(i) A covered entity must change its policies and procedures as\n\nJkt 194001\n\nPO 00000\n\n- necessary and appropriate to comply with changes in the law, including the standards, requirements, and implementation specifications of this subpart;\n- (ii) When a covered entity changes a privacy practice that is stated in the notice described in § 164.520, and makes corresponding changes to its policies and procedures, it may make the changes effective for protected health information that it created or received prior to the effective date of the notice revision, if the covered entity has, in accordance with §164.520(b)(1)(v)(C), included in the notice a statement reserving its right to make such a change in its privacy practices; or\n- (iii) A covered entity may make any other changes to policies and procedures at any time, provided that the changes are documented and implemented in accordance with paragraph (i)(5) of this section. - (3) Implementation specification: Changes in law. Whenever there is a change in law that necessitates a change to the covered entity's policies or procedures, the covered entity must promptly document and implement the revised policy or procedure. If the change in law materially affects the content of the notice required by §164.520, the covered entity must promptly make the appropriate revisions to the notice in accordance with § 164.520(b)(3). Nothing in this paragraph may be used by a covered entity to excuse a failure to comply with the law. - (4) Implementation specifications: Changes to privacy practices stated in the notice."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 544}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 338)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nistance in identifying a suspect on the evening news. It includes ''Wanted'' posters, public announcements, and similar requests to the general public for assistance in locating suspects or fugitives.\nComment: A few commenters recommended additional restrictions on disclosure of protected health information for identification purposes. For example, one commenter recommended that the provision should either (1) require that the information to be disclosed for identifying purposes be relevant and material to a legitimate law enforcement inquiry and that the request be as specific and narrowly drawn as possible; or (2) limit disclosures to circumstances in which (a) a crime of violence has occurred and the perpetrator is at large, (b) the perpetrator received an injury during the commission of the crime, (c) the inquiry states with specificity the type of injury received and the time period during which treatment would have been provided, and (d) ''probable cause'' exists to believe the perpetrator received treatment from the provider. Response: We do not agree that these additional restrictions are appropriate for disclosures of limited identifying information for purposes of locating or identifying suspects, fugitives, material witnesses or missing persons. The purpose of this provision is to permit law enforcement to obtain limited timesensitive information without the process requirements applicable to disclosures for other purposes. Only limited information may be disclosed under this provision, and disclosure is permitted only in limited circumstances. We believe that these\n\nFrm 00224\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nsafeguards are sufficient, and that creating additional restrictions would undermine the purpose of the provision and that it would hinder law enforcement's ability to obtain essential, time-sensitive information."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 337}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 23)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nthe minimum necessary provisions that applied to the now-eliminated special authorizations. All uses and disclosures made pursuant to any authorization are exempt from the minimum necessary standard.\nIn response to commenters who opposed this proposal as a potential weakening of privacy protections or who wanted the minimum necessary requirements to apply to authorizations other than disclosures to the individual, the Department notes that nothing in the final Rule eliminates an individual's control over his or her protected health information with respect to an authorization. All authorizations must include a description of the information to be used and disclosed that identifies the information in a specific and meaningful fashion as required by §164.508(c)(1)(i). If the individual does not wish to release the information requested, the individual has the right to not sign the authorization or to negotiate a narrower authorization with the requestor. Additionally, in response to those commenters who raised specific concerns with respect to authorizations which request release of psychotherapy notes, the Department clarifies that the final Rule does not require a covered entity to use and disclose protected health information pursuant to an authorization. Rather, as with most other uses and disclosures under the Privacy Rule, this is only a permissible use or disclosure. If a covered health care provider is concerned that a request for an individual's psychotherapy notes is not warranted or is excessive, the provider may consult with the individual to determine whether or not the authorization is consistent with the individual's wishes. Further, the Privacy Rule does not permit a health plan to condition enrollment, eligibility for benefits, or payment of a claim on obtaining the individual's authorization to use or disclose psychotherapy notes. Nor may a health care provider condition treatment on an authorization for the use or disclosure of psychotherapy notes."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 22}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 48)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\noviding that such remuneration must be reasonably related to the covered entity's cost of making the communication for the exception from marketing to apply. We adopt this provision in the final rule.\nIn response to comments regarding what types of costs fall within permissible remuneration, we clarify that we consider permissible costs for which a covered entity may receive remuneration under this exception are those which cover only the costs of labor, supplies, and postage to make the communication. Where the financial remuneration a covered entity receives in exchange for making the communication generates a profit or includes payment for other costs, such financial remuneration would run afoul of the Act's ''reasonable in amount'' language. Thus, under this final rule, if a pharmacy receives financial remuneration from a drug manufacturer to provide refill reminders to individuals taking a particular drug that covers only the pharmacy's cost of drafting, printing, and mailing the refill reminders, the exception would apply and no authorization would be required. However, where the drug manufacturer also provides the pharmacy with a financial incentive beyond the cost of making the communication to encourage the pharmacy's continued willingness to send such communications on behalf of the drug manufacturer, the exception would not apply and the pharmacy must obtain individual authorization. We note, however, that if a pharmacy provides refill reminders to individuals only when they visit the pharmacy (in face to face encounters), such communications would be permitted under §164.508(a)(3)(i)(A) and thus, authorization would not be required even if the pharmacy receives financial remuneration above and beyond what is reasonably related to the pharmacy's cost of making the communication. Finally, in addition to the communications that fall within the refill reminder exception, two other types of communications continue to be exempt from the marketing provisions."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 47}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 55)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nif the individual no longer was covered by the health plan, provided that the period for which information is needed overlaps with the period for which the individual was enrolled in the health plan.\nIn response to commenters who were concerned that this condition would impede certain health care operations activities where the covered entity may not have a relationship with the individual, the Department notes that the new limited data set provisions in §164.514(e) are intended to provide a mechanism for disclosures of protected health information for quality and other health care operations where the covered entity requesting the information does not have a relationship with the individual. Under those provisions, the final modifications permit a covered entity to disclose protected health information, with direct identifiers removed, for any health care operations activities of the entity requesting the information, subject to a data use agreement. Additionally, as clarified by §164.506(c)(5), covered entities that participate in an OHCA may share\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00037\n\nprotected health information for the health care operations of the OHCA, without the condition that each covered entity have a relationship with the individual who is the subject of the information. The Department believes that such provisions provide adequate avenues for covered entities to obtain the information they need for health care operations activities, without eliminating appropriate privacy protections and conditions on such disclosures. The Department also was not persuaded by the comments that the proposal should be broadened to allow disclosures for other types of health care operations activities, such as resolution of internal grievances, customer service, or medical review or auditing activities."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 54}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement physical controls?"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n## Postmarket Management of Cybersecurity in Medical Devices\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on December 28, 2016. The draft of this document was issued on January 22, 2016. For questions regarding this document, contact Suzanne Schwartz, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5434, Silver Spring, MD 20993-0002, 301-796-6937. For questions regarding this document as applied to devices regulated by CBER, contact the Office of Communication, Outreach and Development in CBER at 1-800-835-4709 or 240-402-8010 or ocod@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of the Center Director\n\nCenter for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to http://www.regulations.gov . Submit written comments to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2015-D-5105. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an e-mail request to CDRH-Guidance@fda.hhs.gov to receive an electronic copy of the guidance. Please use the document number 1400044 to identify the guidance you are requesting. ## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), by written request, Office of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., Bldg."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_type": "physical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 374)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncompensation systems. To assure that workers' compensations systems are not disrupted, we have added a new\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nprovisions to the final rule.\nThe new §164.512(l) permits covered entities to disclose protected health information as authorized by and to the extent necessary to comply with workers' compensation or other similar programs established by law that provide benefits for work-related injuries or illnesses without regard to fault. We also note that where a state or other law requires a use or disclosure of protected health information under a workers' compensation or similar scheme, the disclosure would be permitted under §164.512(a). Comment: Several commenters stated that if workers' compensation carriers are to receive protected health information, they should only receive the minimum necessary as required in §164.514. The commenters argued that employers and workers' compensation carriers should not have access to the entire medical history or portions of the medical history that have nothing to do with the injury in question. Further, the covered provider and not the employer or carrier should determine minimum necessary since the provider is a covered entity and only covered entities are subject to sanctions for violations of the rule. These commenters stated that the rule should clearly indicate the ability of covered entities to refuse to disclose protected health information if it went beyond the scope of the injury. Workers' compensation carriers, on the other hand, argued that permitting providers to determine the minimum necessary was inappropriate because determining eligibility for benefits is an insurance function, not a medical function."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 373}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 81)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nnd fax numbers, e-mail address, social security number, certificate/license number, vehicle identifiers and serial numbers, URLs and IP addresses, and full face photos and any other comparable images.\nThe proposed limited data set could include the following identifiable information: admission, discharge, and service dates; date of death; age (including age 90 or over); and five-digit zip code. The Department solicited comment on whether one or more other geographic units smaller than State, such as city, county, precinct, neighborhood or other unit, would be needed in addition to, or be preferable to, the five-digit zip code. In addition, to address concerns raised by commenters regarding access to birth date for research or other studies relating to young children or infants, the Department clarified that the Privacy Rule de-identification safe harbor allows disclosure of the age of an individual, including age expressed in months, days, or hours. Given that the limited data set could include all ages, including age in months, days, or hours (if preferable), the Department requested comment on whether date of birth would be needed and, if so, whether the entire date would be needed, or just the month and year. In addition, to further protect privacy, the Department proposed to condition the disclosure of the limited data set on covered entities obtaining from the recipients a data use or similar agreement, in which the recipient would agree to limit the use of the limited data set to the purposes specified in the Privacy Rule, to limit who can use or receive the data, and agree not to re-identify the data or contact the individuals. Overview of Public Comments. The following discussion provides an overview of the public comment received on this proposal."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 80}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.506(c)(1) require?"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n§164.506(c)(1), the consent must inform the individual that protected health information may be used and disclosed by the covered entity to carry out treatment, payment, or health care operations. The covered entity must determine which of these elements (use and/or disclosure; treatment, payment, and/or health care operations) to include in the consent\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\ndocument, as appropriate for the covered entity's practices.\n\nFor covered health care providers that are required to obtain consent, the requirement applies only to the extent the "}], "metadata": {"source": "privacy_rule_2000", "cfr_section": "§164.506(c)(1)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.308(a)(4) require?"}, {"role": "assistant", "content": "According to security_rule_2003:\n\n§164.308(a)(4)(ii)(B) and (C) below, the proposed implementation features are made addressable specifications. We have added in "}], "metadata": {"source": "security_rule_2003", "cfr_section": "§164.308(a)(4)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does §164.404(a) require?"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\n§164.404(a)(1).\n\n## Breaches Treated as Discovered\n\nSection 164.404(a)(2) states that a breach shall be treated as discovered by a covered entity as of the first day the breach is known to the covered entity, or by exercising reasonable diligence would have been known to the covered entity. Thus, a covered entity is not liable for failing to provide notification in cases in which it is not aware of a breach unless the covered entity would have been aware of the breach had it exercised reasonable diligence. Section 164.404(a)(2) further provides that a covered entity is deemed to have knowledge"}], "metadata": {"source": "breach_notification_2009", "cfr_section": "§164.404(a)", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "cfr_section"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the physical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\n## Postmarket Management of Cybersecurity in Medical Devices\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on December 28, 2016. The draft of this document was issued on January 22, 2016. For questions regarding this document, contact Suzanne Schwartz, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5434, Silver Spring, MD 20993-0002, 301-796-6937. For questions regarding this document as applied to devices regulated by CBER, contact the Office of Communication, Outreach and Development in CBER at 1-800-835-4709 or 240-402-8010 or ocod@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of the Center Director\n\nCenter for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to http://www.regulations.gov . Submit written comments to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2015-D-5105. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an e-mail request to CDRH-Guidance@fda.hhs.gov to receive an electronic copy of the guidance. Please use the document number 1400044 to identify the guidance you are requesting. ## CBER\n\nAdditional copies are available from the Center for Biologics Evaluation and Research (CBER), by written request, Office of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., Bldg."}], "metadata": {"source": "fda_postmarket_2016", "safeguard_type": "physical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 514)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\n(iii) Authorize termination of the contract by the covered entity, if the covered entity determines that the business associate has violated a material term of the contract. (3) Implementation specifications: Other arrangements. (i) If a covered entity and its business associate are both governmental entities:\n\n(A) The covered entity may comply with paragraph (e) of this section by entering into a memorandum of understanding with the business associate that contains terms that accomplish the objectives of paragraph (e)(2) of this section. (B) The covered entity may comply with paragraph (e) of this section, if other law (including regulations adopted by the covered entity or its business associate) contains requirements applicable to the business associate that accomplish the objectives of paragraph (e)(2) of this section. (ii) If a business associate is required by law to perform a function or activity on behalf of a covered entity or to provide a service described in the definition of business associate in §160.103 of this subchapter to a covered entity, such covered entity may disclose protected health information to the business associate to the extent necessary to comply with the legal mandate without meeting the requirements of this paragraph (e), provided that the covered entity attempts in good faith to obtain satisfactory assurances as required by paragraph (e)(3)(i) of this section, and, if such attempt fails, documents the attempt and the reasons that such assurances cannot be obtained. (iii) The covered entity may omit from its other arrangements the termination authorization required by paragraph (e)(2)(iii) of this section, if such authorization is inconsistent with the statutory obligations of the covered entity or its business associate. (4) Implementation specifications: Other requirements for contracts and other arrangements."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 513}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 115)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ndocumentation of IRB or privacy board approval of a waiver of an authorization as required by § 164.508, to indicate that only some or all of the § 164.508 authorization requirements have been waived.\nIn addition, the final rule clarifies that the documentation of IRB or privacy board approval may indicate that the authorization requirements have been altered. Also, for all of the proposed waiver of authorization criteria that used the term ''subject,'' we replace this term with the term ''individual'' in the final rule. In addition, the final rule (1) eliminates proposed waiver criterion iv, (2) modifies proposed waiver criteria ii, iii, vi, and viii, and (3) adds a waiver criterion. Proposed waiver criterion ii (waiver criterion § 164.512(i)(2)(ii)(B) in the final rule) is revised as follows to focus more narrowly on the privacy interests of individuals, and to clarify that it also pertains to alterations of individual authorization: ''the alteration or waiver will not adversely affect the privacy rights and the welfare of the individuals.'' Under criterion §164.512(i)(2)(ii)(B), the question is whether the alteration or waiver of individual authorization would adversely affect the privacy rights and the welfare of individuals, not whether the research project itself would adversely affect the privacy rights or the welfare of individuals."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 114}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 297)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthat they feel are irrelevant or for which they do not have an answer. They argued that requiring covered entities to follow up with each individual to complete the form will cause unwarranted delays.\nIn addition, commenters were concerned that large covered entities might act in good faith on a completed authorization, only to find out that a component of the entity ''knew'' some of the information on the form to be false or that the authorization had been revoked. These commenters did not feel that covered entities should be held in violation of the rule in such situations. Response: We retain the provision as proposed and include one additional element: the authorization is invalid if it is combined with other documents in violation of the standards for compound authorizations. We also clarify that an authorization is invalid if material information on the form is known to be false. The elements we require to be included in the authorization are intended to ensure that individuals knowingly and willingly authorize the use or disclosure of protected health information about them. If these elements are missing or incomplete, the covered entity cannot know which protected health information to use or disclose to whom and cannot be confident that the individual intends for the use or disclosure to occur. We have attempted to make the standards for defective authorizations as unambiguous as possible. In most cases, the covered entity will know whether the authorization is defective by looking at the form itself. Otherwise, the covered entity must know that the authorization has been revoked, that material information on the form is false, or that the expiration date or event has occurred. If the covered entity does not know these things and the authorization is otherwise satisfactory on its face, the covered entity is permitted to make the use or disclosure in compliance with this rule."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 296}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 484)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\non small entities. The varying needs and capacities of entities should be reflected in the policies and procedures adopted by the organization and the overall approach it takes to achieve compliance.\n## Minimum Necessary\n\nThe ''minimum necessary'' policy in the final rule has essentially three components: first, it does not pertain to certain uses and disclosures including treatment-related exchange of information among health care providers; second, for disclosures that are made on a routine basis, such as insurance claims, a covered entity is required to have policies and procedures governing such exchanges (but the rule does not require a case-bycase determination in such cases); and third, providers must have a process for reviewing non-routine requests on a case-by-case basis to assure that only the minimum necessary information is disclosed. The final rule makes changes to the NPRM that reduce the burden of compliance on small businesses. Based on public comments and subsequent fact-finding, the Department sought to lessen the burden of this\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nprovision. The NPRM proposed applying the minimum necessary standard to disclosures to providers for treatment purposes and would have required individual review of all uses of protected health information. The final rule exempts disclosures of protected health information from a covered entity to a health care provider for treatment from the minimum necessary provision and eliminates the case-by-case determinations that would have been necessary under the NPRM. The Department has concluded that the requirements of the final rule are similar to the current practice of most health care providers. For standard disclosure requests, for example, providers generally have established procedures."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 483}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 25)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nnd procedures, whether through contract language or other means. Covered entities are not required to provide training to business associates or anyone else that is not a member of their workforce. c.\nComment: Several commenters questioned why security awareness training appeared in two places, under ''Physical safeguards'' as well as ''Administrative safeguards.'' Others questioned the appropriateness of\n\nVerDate Jan&lt;31&gt;2003\n\nsecurity awareness training under ''Physical safeguards.''\n\nResponse: We reviewed the definitions of the proposed ''Awareness training for all personnel'' (''Administrative safeguards'') implementation feature and the proposed ''Security awareness training'' (''Physical safeguards'') requirement. We agree that, to avoid confusion and eliminate redundancy, security awareness and training should appear in only one place. We believe the appropriate location for it is under ''Administrative safeguards,'' as such training is essentially an administrative function. d. Comment: Several commenters objected to the blanket requirement for security awareness training of individuals who may be on site for a limited time period (for example, a single day). Response: Each individual who has access to electronic protected health information must be aware of the appropriate security measures to reduce the risk of improper access, uses, and disclosures. This requirement does not mean lengthy training is appropriate in every instance; there are alternative methods to inform individuals of security responsibilities (for example, provisions of pamphlets or copies of security policies, and procedures). e. Comment: One commenter asked that ''training'' be changed to ''orientation.''\n\nResponse: We believe the term ''training,'' as presented within this rule is the more appropriate term."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 24}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 137)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nity does not report information to the Secretary that later turns out to be incorrect because the entity did not have sufficient time to conduct an investigation into the facts surrounding the breach.\nIn addition, this interpretation satisfies the statutory requirement that notifications of larger breaches be provided to the Secretary immediately (as they occur) as compared to the reports of smaller breaches the statute allows be reported annually to the Secretary. Comment: Some commenters asked for further guidance on submitting online breach notifications to the Secretary. Additionally, some commenters asked that HHS provide a confirmation to submitters that an initial breach report or an addendum to a breach report has been successfully submitted. Response: Since the publication of the interim final rule, OCR has posted\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with instructions for filling out and submitting the breach form on its Web site: http://www.hhs.gov/ocr/privacy/ hipaa/administrative/ breachnotificationrule/ brinstruction.html. We will continue to examine the instructions for submitting breach notification to the Secretary and will update this information, as necessary, to ensure that covered entities are able to navigate and submit the form easily. The Department has also made changes to the process to ensure that covered entities receive a confirmation following their submission of breach notification to the Secretary. Additionally, we note that the breach reporting form does include an option for indicating that a submission is an addendum to a previous submission. OCR updates the original breach report, as appropriate, with any additional or modified information submitted in an addendum."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 136}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 6)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\npaper records or a verbal exchange of information. Today, however, more and more health care providers, plans, and others are utilizing electronic means of storing and transmitting health information.\nIn 1996, the health care industry invested an estimated $10 billion to $15 billion on information technology. See National Research Council, Computer Science and Telecommunications Board, ''For the Record: Protecting Electronic Health Information,'' (1997). The electronic information revolution is transforming the recording of health information so that the disclosure of information may require only a push of a button. In a matter of seconds, a person's most profoundly private information can be shared with hundreds, thousands, even millions of individuals and organizations at a time. While the majority of medical records still are in paper form, information from those\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00005\n\nrecords is often copied and transmitted through electronic means. This ease of information collection, organization, retention, and exchange made possible by the advances in computer and other electronic technology affords many benefits to individuals and to the health care industry. Use of electronic information has helped to speed the delivery of effective care and the processing of billions of dollars worth of health care claims. Greater use of electronic data has also increased our ability to identify and treat those who are at risk for disease, conduct vital research, detect fraud and abuse, and measure and improve the quality of care delivered in the U.S."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 5}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 33)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nhat include all the elements required by both regulations. The substance abuse rule provides a sample notice and a sample authorization form and states that the use of these forms would be sufficient.\nWhile these forms do not satisfy all of the requirements of the privacy regulation, there is no conflict because the substance abuse regulation does not mandate the use of these forms. ## Employee Retirement Income Security Act of 1974\n\nERISA was enacted in 1974 to regulate pension and welfare employee benefit plans established by private sector employers, unions, or both, to provide benefits to their workers and dependents. Under ERISA, plans that provide ''through the purchase of insurance or otherwise * * * medical, surgical, or hospital care or benefits, or benefits in the event of sickness, accident, disability, [or] death'' are defined as employee welfare benefit plans. 29 U.S.C. 1002(1). In 1996, HIPAA amended ERISA to require portability, nondiscrimination, and renewability of health benefits provided by group health plans and group health insurance issuers. Numerous, although not all, ERISA plans are covered under the rules proposed below as ''health plans.''\n\nSection 514(a) of ERISA, 29 U.S.C. 1144(a), preempts all state laws that ''relate to'' any employee benefit plan. However, section 514(b) of ERISA, 29 U.S.C. 1144(b)(2)(A), expressly saves from preemption state laws that regulate insurance. Section 514(b)(2)(B) of ERISA, 29 U.S.C. 1144(b)(2)(B), provides that an ERISA plan is deemed not to be an insurer for the purpose of regulating the plan under the state insurance laws. Thus, under the deemer clause, states may not treat ERISA plans as insurers subject to direct regulation by state law. Finally, section 514(d) of ERISA, 29 U.S.C."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 32}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 23)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\npolicy on labeling changes and submission requirements, manufacturers can use the Search for FDA Guidance Documents tool to identify relevant guidance documents for their product and submission type.\n51  See IEC TR 80001-2-2 Application of risk management for IT-networks incorporating medical devices -Part 22: Guidance for the communication of medical device security needs, risks and controls ; IEC TR 80001-2-8 Application of risk management for IT-networks incorporating medical devices-Part 2-8: Application guidance Guidance on standards for establishing the security capabilities identified in IEC 80001-2-2 ; and IEC TR 80001-2-9 Application of risk management for IT-networks incorporating medical devices-Part 2-9: Application guidance Guidance for use of security assurance cases to demonstrate confidence in IEC/TR 80001-2-2 security capabilities for further labeling information for compliance with these standards. ## Contains Nonbinding Recommendations\n\nencryption interfaces). Where appropriate, such guidance should include technical instructions to permit secure network deployment and servicing, and instructions for users on how to respond upon detection of a cybersecurity vulnerability or incident. - An SBOM as specified in Section V.A.4 or in accordance with an industry accepted format to effectively manage their assets, to understand the potential impact of identified vulnerabilities to the medical device system, and to deploy countermeasures to maintain the device's safety and effectiveness. Manufacturers should provide or make available SBOM information to users on a continuous basis. If an online portal is used, manufacturers should ensure that users have up-to-date links that contain accurate information. The SBOM should be in a machine-readable format. - A description of systematic procedures for users to download version-identifiable manufacturer-authorized software and firmware, including a description of how users will know when software is available."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 22}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 11)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nns that a regulated entity must make regarding addressable implementation specifications, and requires the maintenance of security measures to continue reasonable and appropriate protection of ePHI\n2.\nAdministrative Safeguards - Defined in the Security Rule as the 'administrative actions and policies, and procedures to manage the selection, development, implementation, and maintenance of security measures to protect electronic protected health information and to manage the conduct of the covered entity's workforce in relation to the protection of that information'\n3. Physical Safeguards - Defined as the 'physical measures, policies, and procedures to protect a covered entity's electronic information systems and related buildings and equipment, from natural and environmental hazards, and unauthorized intrusion'\n\n12  For more information on the Security Rule's flexibility of approach, see § 164.306(b) of the HIPAA Security Rule (Security standards - General rules: Flexibility of approach). 13  Sections of the HIPAA regulations that are included in the Security Rule and, therefore, addressed in this document but do not have their own modules are Part 160 - General Administrative Requirements § 160.103, Definitions; Part 164 - Security and Privacy §§ 164.103, Definitions; 164.104, Applicability; 164.105, Organizational requirements; 164.302 Applicability; 164.304, Definitions; 164.306, Security standards: General rules; and 164.318, Compliance dates for the initial implementation of the security standards. 4. Technical Safeguards - Defined as 'the technology and the policy and procedures for its use that protect electronic protected health information and control access to it'\n5. Organizational Requirements - Includes standards for business associate contracts and other arrangements between a covered entity and a business associate and between a business associate and a subcontractor, as well as requirements for group health plans\n6."}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 10}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 101)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\narate requirements for different systems would not be confusing, and requiring electronic access to electronic designated record sets that are not EHRs would be highly burdensome for covered entities.\nSpecifically, commenters stated that the proposed requirement for electronic access would include numerous types of legacy systems, many of which are incapable of producing reports in easily readable formats that can be transmitted electronically. These commenters indicated that a significant amount of information technology development and investment would be needed to comply with this requirement if it applies to all electronic designated record sets. A number of consumer advocates supported the expanded scope to include all electronic designated records sets in addition to EHRs. These commenters felt that this would provide complete transparency for consumers, help individuals gain access to their medical records and make betterinformed decisions about their health care, and promote consistent and uniform practices. ## Final Rule\n\nThe final rule adopts the proposal to amend the Privacy Rule at §164.524(c)(2)(ii) to require that if an individual requests an electronic copy of protected health information that is maintained electronically in one or more designated record sets, the covered\n\n18:57 Jan 24, 2013\n\nPO 00000\n\nFrm 00067\n\nentity must provide the individual with access to the electronic information in the electronic form and format requested by the individual, if it is readily producible, or, if not, in a readable electronic form and format as agreed to by the covered entity and the individual. In such cases, to the extent possible, we expect covered entities to provide the individual with a machine readable copy of the individual's protected health information. The Department considers machine readable data to mean digital information stored in a standard format enabling the information to be processed and analyzed by computer."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 100}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 74)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nation, a covered entity may use or disclose a decedent's protected health information in that situation only if the covered entity obtains an authorization from the decedent's personal representative.\nThe personal representative for a decedent is the executor, administrator, or other person who has authority under applicable law to act on behalf of the decedent or the decedent's estate. The Department heard a number of concerns since the publication of the Privacy Rule that it can be difficult to locate a personal representative to authorize the use or disclosure of the decedent's protected health information, particularly after an estate is closed. Furthermore, archivists, biographers, and historians had expressed frustration regarding the lack of access to ancient or old records of historical value held by covered entities, even when there are likely few surviving individuals concerned with the privacy of such information. Archives and libraries may hold medical records, as well as correspondence files, physician diaries and casebooks, and photograph collections containing fragments of\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with identifiable health information, that are centuries old. Currently, to the extent such information is maintained by a covered entity, it is subject to the Privacy Rule. Accordingly, we proposed to amend §164.502(f) to require a covered entity to comply with the requirements of the Privacy Rule with regard to the protected health information of a deceased individual for a period of 50 years following the date of death. We also proposed to modify the definition of ''protected health information'' at §160.103 to make clear that the individually identifiable health information of a person who has been deceased for more than 50 years is not protected health information under the Privacy Rule."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 73}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 151)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\ne and yet never develop the disease. In other cases, the presence of a genetic variant indicates that the individual will eventually develop the disease, such as is the case with Huntington's disease.\nHowever, an individual may obtain a positive test that shows the genetic variant for Huntington's disease decades before any clinical symptoms appear. Under the proposed definition, the presence of a genetic variant alone would not constitute the diagnosis of a disease even in cases where it is certain the individual possessing the genetic variant will eventually develop the disease, such as with Huntington's disease. ## Overview of Public Comments\n\nA few commenters expressed support for adopting the proposed definition of ''manifestation or manifested'' because it would provide clarity to the rule and the scope of the underwriting prohibition. One commenter requested that the Department include the examples provided in the preamble to the proposed rule directly within the regulatory definition. A few commenters raised concerns about the inclusion in the proposed definition of the clarification that ''a disease, disorder, or pathological condition is not manifested if the diagnosis is based principally on genetic information.'' It was argued that the proposed definition was too narrow because, for some diseases, disorders, or pathological conditions, a genetic test is the primary means of diagnosing the condition and further that genetic tests will more frequently be used to diagnose diseases or conditions in the future given the continuing evolution of genetics. It was also argued that the proposed definition went beyond GINA by indicating how a manifested disease or disorder is diagnosed. ## Final Rule\n\nThe final rule adopts without modification the definition of ''manifestation or manifested'' proposed in the NPRM."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 150}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 79)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nwill rarely be necessary, because we expect covered entities that maintain protected health information to obtain consents that permit them to make anticipated uses and disclosures for these purposes.\nNevertheless, covered entities are permitted under § 164.508(e) to obtain\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nauthorization for another covered entity to use or disclose protected health information to carry out treatment, payment, and health care operations. We recognize these authorizations may be useful to demonstrate an individual's intent and relationship to the intended recipient of the information. For example, these authorizations may be useful in situations where a health plan wants to obtain information from one provider in order to determine payment of a claim for services provided by a different provider (e.g., information from a primary care physician that is necessary to determine payment of services provided by a specialist) or where an individual's new physician wants to obtain the individual's medical records from prior physicians. Other persons not covered by this rule may also seek authorizations and state law may require written permission for specific types of information, such as information related to HIV/AIDS or to mental health. Because an individual may sign conflicting documents over time, we clarify that the covered entity maintaining the protected health information to be used or disclosed must adhere to the more restrictive permission the individual has granted, unless the covered entity resolves the conflict with the individual."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 78}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 31)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncation of a regulation-onregulation conflict is unclear, courts agree that administrative rules and regulations that do not conflict with express statutory provisions have the force and effect of law.\nThus, we believe courts would apply the standard rules of interpretation that apply to statutes to address questions of interpretation with regard to regulatory conflicts. When faced with two potentially conflicting statutes, courts attempt to construe them so that both are given effect. If this construction is not possible, courts will look for express language in the later statute, or an intent in its legislative history, indicating that Congress intended the later statute to repeal the earlier one. If there is no expressed intent to repeal the earlier statute, courts will characterize the statutes as either general or specific. Ordinarily, later, general statutes will not repeal the special provisions of an earlier, specific statute. In some cases, when a later, general statute creates an irreconcilable conflict or is manifestly inconsistent with the earlier, specific statute in a manner that indicates a clear and manifest Congressional intent to repeal the earlier statute, courts will find that the later statute repeals the earlier statute by implication. In these cases, the latest legislative action may prevail and repeal the prior law, but only to the extent of the conflict. There should be few instances in which conflicts exist between a statute or regulation and the rules below. For example, if a statute permits a covered entity to disclose protected health information and the rules below permit such a disclosure, no conflict arises; the covered entity could comply with both and choose whether or not to disclose the information. In instances in which a potential conflict appears, we would attempt to resolve it so that both laws applied."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 30}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 35)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nwork management and control functions that are included with the provision of network services. A health care entity would not expect to be responsible for these technical telecommunications features.\n''Access controls'' has also been deleted from the implementation features since the consideration of the use of encryption\n\nVerDate Jan&lt;31&gt;2003\n\nwill satisfy the intent of this feature. We retain as addressable implementation specifications two features: (1) ''Integrity controls'' and ''encryption''. ''Message authentication'' has been deleted as an implementation feature because the use of data authentication codes (called for in the ''integrity controls'' implementation specification) satisfies the intent of ''Message authentication.''\n\nc. Comment: A number of comments were received asking that this final rule establish a specific (or at least a minimum) cryptographic algorithm strength. Others recommended that the rule not specify an encryption strength since technology is changing so rapidly. Several commenters requested guidelines and minimum encryption standards for the Internet. Another stated that, since an example was included (small or rural providers for example), the government should feel free to name a specific encryption package. One commenter stated that the requirement for encryption on the Internet should reference the ''CMS Internet Security Policy.''\n\nResponse: We remain committed to the principle of technology neutrality and agree with the comment that rapidly changing technology makes it impractical and inappropriate to name a specific technology. Consistent with this principle, specification of an algorithm strength or specific products would be inappropriate. Moreover, rapid advances in the success of ''brute force'' cryptanalysis techniques suggest that any minimum specification would soon be outmoded."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 34}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 97)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nthat if a physician or supplier charges or attempts to charge a beneficiary any remuneration for a service that is covered by Medicare, then the physician or supplier must submit a claim to Medicare.\nHowever, there is an exception to this rule where a beneficiary (or the beneficiary's legal representative) refuses, of his/her own free will, to authorize the submission of a bill to Medicare. In such cases, a Medicare provider is not required to submit a claim to Medicare for the covered service and may accept an out of pocket payment for the service from the beneficiary. The limits on what the provider may collect from the beneficiary continue to apply to charges for the covered service, notwithstanding the absence of a claim to Medicare. See the Medicare Benefit Policy Manual, Internet only Manual pub. 100-2, ch. 15, sect. 40, available at http:// www.cms.gov/manuals/Downloads/ bp102c15.pdf . Thus, if a Medicare beneficiary requests a restriction on the disclosure of protected health information to Medicare for a covered service and pays out of pocket for the service (i.e., refuses to authorize the submission of a bill to Medicare for the service), the provider must restrict the disclosure of protected health information regarding the service to Medicare in accordance with §164.522(a)(1)(vi). Fmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\25JAR2.SGM\n\n25JAR2\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\nCertain commenters raised concerns with an individual requesting a restriction with respect to only one of several health care items or services provided in a single patient encounter, and a provider being prohibited from unbundling, or it being more costly to unbundle, the services for purposes of billing a health plan."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 96}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 303)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nn for its own use or disclosure, however, the individual and the covered entity maintaining the protected health information should have a mutual understanding of the purpose of the use or disclosure.\nSimilarly, when a covered entity is requesting authorization for a disclosure by another covered entity that may have already obtained the individual's consent for the disclosure, the individual and covered entity that maintains the protected health information should be aware of this potential conflict. There are two additional requirements for authorizations requested by a covered entity for its own use or disclosure of protected health information it maintains. First, we require the covered entity to describe the individual's right to inspect or copy the protected health information to be used or disclosed. Individuals may want to review the information to be used or disclosed before signing the authorization and should be reminded of their ability to do so. This requirement is not appropriate for authorizations for a covered entity to receive protected health information from another covered entity, however, because the covered entity requesting the authorization is not the covered entity that maintains the protected health information and cannot, therefore, grant or describe the individual's right to access the information. If applicable, we also require a covered entity that requests an authorization for its own use or disclosure to state that the use or disclosure of the protected health information will result in direct or indirect remuneration to the entity. Individuals should be aware of any conflicts of interest or financial incentives on the part of the covered entity requesting the use or disclosure. These statements are not appropriate, however, in relation to uses and disclosures to carry out treatment, payment, and health care operations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 302}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 502)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nexcept a provision of State law from preemption under §160.203(a) may be submitted to the Secretary. A request by a State must be submitted through its chief elected official, or his or her designee.\nThe request must be in writing and include the following information:\n\n- (1) The State law for which the exception is requested;\n- (2) The particular standard, requirement, or implementation specification for which the exception is requested;\n- (3) The part of the standard or other provision that will not be implemented based on the exception or the additional data to be collected based on the exception, as appropriate;\n\n(4) How health care providers, health plans, and other entities would be affected by the exception;\n\n- (5) The reasons why the State law should not be preempted by the federal standard, requirement, or implementation specification, including how the State law meets one or more of the criteria at § 160.203(a); and\n- (6) Any other information the Secretary may request in order to make the determination. 3. (b) Requests for exception under this section must be submitted to the Secretary at an address that will be published in the Federal Register . Until the Secretary's determination is made, the standard, requirement, or implementation specification under this subchapter remains in effect. 4. (c) The Secretary's determination under this section will be made on the basis of the extent to which the information provided and other factors demonstrate that one or more of the criteria at § 160.203(a) has been met. ## §160.205 Duration of effectiveness of exception determinations."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 501}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 40)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ninformation to a plan sponsor provided that, among other requirements, the plan documents are amended appropriately to reflect and restrict the plan sponsor's uses and disclosures of such information.\nThe Department further determined that there were two situations in which protected health information could be shared between the group health plan and the plan\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00027\n\nsponsor without individual authorization or an amendment to the plan documents. First, § 164.504(f) permits the group health plan to share summary health information (as defined in § 164.504(a)) with the plan sponsor. Second, a group health plan is allowed to share enrollment or disenrollment information with the plan sponsor without amending the plan documents as required by § 164.504(f). As explained in the preamble to the December 2000 Privacy Rule, a plan sponsor is permitted to perform enrollment functions on behalf of its employees without meeting the requirements of § 164.504(f), as such functions are considered outside of the plan administration functions. However, the second exception was not stated in the regulation text. March 2002 NPRM. The ability of group health plans to disclose enrollment or disenrollment information without amending the plan documents was addressed only in the preamble to the Privacy Rule. The absence of a specific provision in the regulation text caused many entities to conclude that plan documents would need to be amended for enrollment and disenrollment information to be exchanged between plans and plan sponsors. To remedy this misunderstanding and make its policy clear, the Department proposed to add an explicit exception at §164.504(f)(1)(iii) to clarify that group or HMOs with respect to group health plans, as appropriate) are permitted to disclose enrollment or disenrollment information to a plan sponsor without health plans (or health insurance issuers meeting the plan document amendment and other related requirements."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 39}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 83)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nnecessary requirement to keep the Rule simple while avoiding abuse. Birth date should only be disclosed where the researcher and covered entity agree that it is needed for the purpose of the research.\nFurther, even though birth date may be included with a limited data set, the Department clarifies, as it did in the preamble to the proposed rulemaking, that the Privacy Rule allows the age of an individual to be expressed in years or in months, days, or hours as appropriate. Moreover, the limited data set may include the five-digit zip code or any other geographic subdivision, such as State, county, city, precinct and their equivalent geocodes, except for street address. We substitute for street address the term postal address information, other than city, State and zip code in order to make clear that individual elements of postal address such as street name by itself are also direct identifiers. Commenters identified a variety of needs for various geographical codes (county, city, neighborhood, census tract, precinct) to support a range of essential research, public health and health care operations activities. Some of the examples provided included the need to analyze local geographic variations in disease burdens or in the provision of health services, conducting research looking at pathogens or patterns of health risks which may need to compare areas within a single zip code, or studies to examine data by county or neighborhood when looking for external causes of disease, as would be the case for illnesses and diseases such as bladder cancer that may have environmental links. The Department agrees with these commenters that a variety of geographical designations other than five-digit zip code are needed to permit useful and significant studies and other research to go forward unimpeded."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 82}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 102)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nd impose unnecessary burdens on researchers, IRBs, and Privacy Boards, with respect to the few research studies that would fall in this category. ## 2. Business Associates\n\nDecember 2000 Privacy Rule.\nThe Privacy Rule at § 164.502(e) permits a covered entity to disclose protected health information to a business associate who performs a function or activity on behalf of, or provides a service to, the covered entity that involves the creation, use, or disclosure of, protected health information, provided that the covered entity obtains satisfactory assurances that the business associate will appropriately safeguard the information. The Department recognizes that most covered entities do not perform or carry out all of their health care activities and functions by themselves, but rather use the services of, or receive assistance from, a variety of other persons or entities. Given this framework, the Department intended these provisions to allow such business relationships to continue while ensuring that identifiable health information created or shared in the course of the relationships was protected. The Privacy Rule requires that the satisfactory assurances obtained from the business associate be in the form of a written contract (or other written arrangement, as between governmental entities) between the covered entity and the business associate that contains the elements specified at § 164.504(e). For example, the agreement must identify the uses and disclosures of protected health information the business associate is permitted or required to make, as well as require the business associate to put in place appropriate safeguards to protect against a use or disclosure not permitted by the contract or agreement."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 101}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 19)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ntion, employers today are moving toward simplified enrollment forms, using check-off boxes and similar devices. The opportunity for any meaningful consideration or interaction at that point is slight.\nFor these and other reasons, we decided that, to the extent a consent can accomplish the goal sought by individuals and providers, it must be focused on the direct interaction between an individual and provider. The comments and fact-finding indicate that our approach will not significantly change the administrative aspect of consent as it exists today. Most direct treatment providers today obtain some type of consent for some uses and disclosures of health information. Our regulation will ensure that those consents cover the routine uses and disclosures of health information, and provide an opportunity for individuals to obtain further information and have further discussion, should they so desire. ## Administrative Costs\n\nSection 1172(b) of the Act provides that ''[a]ny standard adopted under this part [part C of title XI of the Act] shall be consistent with the objective of reducing the administrative costs of providing and paying for health care.'' The privacy and security standards are the platform on which the remaining standards rest; indeed, the design of part C of title XI makes clear that the various standards are intended to function together. Thus, the costs of privacy and security are properly attributable to the suite of administrative simplification regulations as a whole, and the cost savings realized should likewise be calculated on an aggregated basis, as is done below."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 18}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 2)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\ne XI consists of sections 1171 through 1179 of the Act. These sections define various terms and impose requirements on HHS, health plans, health care clearinghouses, and certain health care providers.\nThese statutory sections are discussed in the Transactions Rule, at 65 FR 50312, on pages 50312 through 50313, and in the final rules adopting Standards for Privacy of Individually Identifiable Health Information, published on December 28, 2000 at 65 FR 82462 (Privacy Rules), on pages 82470 through 82471, and on August 14, 2002 at 67 FR 53182. The reader is referred to those discussions. Section 1173(d) of the Act requires the Secretary of HHS to adopt security standards that take into account the technical capabilities of record systems used to maintain health information, the costs of security measures, the need to train persons who have access to health information, the value of audit trails in computerized record systems, and the needs and capabilities of small health care providers and rural health care providers. Section 1173(d) of the Act also requires that the standards ensure that a health care clearinghouse, if part of a larger organization, has policies and security procedures that isolate the activities of the clearinghouse with respect to processing information so as to prevent unauthorized access to health information by the larger organization. Section 1173(d) of the Act provides that covered entities that maintain or transmit health information are required to maintain reasonable and appropriate administrative, physical, and technical safeguards to ensure the integrity and confidentiality of the information and to protect against any reasonably anticipated threats or hazards to the security or integrity of the information and unauthorized use or disclosure of the information. These safeguards must also otherwise ensure compliance with the statute by the officers and employees of the covered entities. ## II."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 1}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What is considered a breach under HIPAA?"}, {"role": "assistant", "content": "According to fda_postmarket_2016:\n\ntional copies are available from the Center for Biologics Evaluation and Research (CBER), by written request, Office of Communication, Outreach, and Development (OCOD), 10903 New Hampshire Ave., Bldg.\n71, Room 3128, Silver Spring, MD 209930002, or by calling 1-800-835-4709 or 240-402-8010, by email, ocod@fda.hhs.gov or from the Internet at http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/G uidances/default.htm. ## Preface\n\n## Contains Nonbinding Recommendations\n\n## Table of Contents\n\n| I. | ................................................................ INTRODUCTION ................................ ............................... | 4   |\n|-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----|\n| II. | BACKGROUND................................................................................................................................. | 5   |\n| III. | SCOPE.............................................................................................................................................. | 8   |\n| IV. | DEFINITIONS..............................................................................................................................."}], "metadata": {"source": "fda_postmarket_2016", "type": "breach_notification", "cfr_section": "§164.400-414"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 139)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nd or modified from\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\nOctober 15, 2002, until the compliance date set forth in § 164.534. (2) Limited deemed compliance period.\nA prior contract or other arrangement that meets the qualification requirements in paragraph (e) of this section, shall be deemed compliant until the earlier of:\n\nVerDate Aug&lt;2,&gt;2002\n\n- (i) The date such contract or other arrangement is renewed or modified on or after the compliance date set forth in §164.534; or\n- (ii) April 14, 2004. - (3) Covered entity responsibilities. Nothing in this section shall alter the requirements of a covered entity to\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00093\n\ncomply with part 160, subpart C of this subchapter and §§ 164.524, 164.526, 164.528, and 164.530(f) with respect to protected health information held by a business associate. [FR Doc. 02-20554 Filed 8-9-02; 2:00 pm]\n\nBILLING CODE 4153-01-P\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001"}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 138}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 14)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nprotected health information from the patient. If the nurse can reasonably conclude that the patient could not have read or otherwise retained the information, then this would not constitute a breach.\nWith respect to any of the three exceptions discussed above, a covered entity or business associate has the burden of proof, pursuant to §164.414(b) (discussed below), for showing why breach notification was not required. Accordingly, the covered entity or business associate must document why the impermissible use or disclosure falls under one of the above exceptions. Based on the above, we envision that covered entities and business associates will need to do the following to determine whether a breach occurred. First, the covered entity or business associate must determine whether there has been an impermissible use or disclosure of protected health information under the Privacy Rule. Second, the covered entity or business associate must determine, and document, whether the impermissible use or disclosure compromises the security or privacy of the protected health information. This occurs when there is a significant risk of financial, reputational, or other harm to the individual. Lastly, the covered entity or business associate may need to determine whether the incident falls under one of the exceptions in paragraph (2) of the breach definition. We treat the breach as having occurred at the time of the impermissible use or disclosure (or in the case of the exceptions listed at paragraphs (2)(i) and (ii) of the definition of ''breach,'' at the time of the ''further'' impermissible use or disclosure), but recognize that a covered entity or business associate may require a reasonable amount of time to confirm whether the incident qualifies as a breach. As discussed below, a breach is considered discovered when the incident becomes known, not when the covered entity or business associate concludes the above analysis of whether the facts constitute a breach. ## 2."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 13}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 113)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\nacy Rule focused on the key policy\n\n19:04 Aug 13, 2002\n\nPO 00000\n\nFrm 00075\n\nareas addressed by the privacy standards, some of which are affected by the modifications adopted in this rulemaking. ## B.\nProposed Modifications To Prevent Barriers to Access to or Quality of Health Care\n\nThe modifications adopted in this rulemaking are intended to address the possible adverse effects of the final privacy standards on an individual's access to, or the quality of, health care. The modifications touch on five of the key policy areas addressed by the final regulatory impact analysis, including consent, research, marketing, notice, and business associates. The Department received few comments on this section of the March 2002 proposal. Most of the comments on the cost implications of the modifications indicated a general belief that the costs would be higher than the Department estimated. None of commenters, however, provided sufficient specific information concerning costs to permit the Department to adjust its estimates. The public comment on each of the key policy areas is summarized in the following sections. However, the estimated cost impact of each area has not changed. ## 1. Consent\n\nUnder the December 2000 Privacy Rule, a covered health care provider with a direct treatment relationship with an individual must have obtained the individual's prior written consent for use or disclosure of protected health information for treatment, payment, or health care operations, subject to a limited number of exceptions. Other covered health care providers and health plans may have obtained such a consent if they so chose. The initial cost of the consent requirement was estimated in December 2000 to be $42 million. Based on assumptions for growth in the number of patients, the total costs for ten years was estimated to be $103 million. See 65 FR 82771 (December 28, 2000). 2\n\nThe modifications eliminate the consent requirement."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 112}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does security_rule_2003 say about HIPAA compliance? (Part 13)"}, {"role": "assistant", "content": "According to security_rule_2003:\n\nn records covered by the Family and Educational Rights and Privacy Act (FERPA); (2) records described in 20 U.S.C. 1232g(a)(4)(B)(iv); and (3) employment records. (see the Privacy Rule at 65 FR 82496.\nSee also 67 FR 53191 through 53193). The scope of information covered in the Privacy Rule is referred to as ''protected health information.'' Based upon the comments we received, we align the requirements of the Security and Privacy Rules with regard to the scope of information covered, in order to eliminate confusion and ease implementation. Thus, this final rule requires protection of the same scope of information as that covered by the Privacy Rule, except that it only covers that information if it is in electronic form. We note that standards for the security of all health information or protected health information in nonelectronic form may be proposed at a later date. a. Comment: One commenter stated that the rule should apply to aggregate information that is not identifiable to an individual. In contrast, another commenter asked that health information used for statistical analysis be exempted if the covered entity may reasonably expect that the removed information cannot be used to reidentify an individual. Response: As a general proposition, any electronic protected health information received, created, maintained, or transmitted by a covered entity is covered by this final rule. We agree with the second commenter that certain information, from which identifiers have been stripped, does not come within the purview of this final rule. Information that is de-identified, as defined in the Privacy Rule at §164.502(d) and § 164.514(a), is not\n\nVerDate Jan&lt;31&gt;2003\n\n''individually identifiable'' within the meaning of these rules and, thus, does not come within the definition of ''protected health information.'' It accordingly is not covered by this final rule."}], "metadata": {"source": "security_rule_2003", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 12}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 82)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nn 13406(b) of the HITECH Act that provides that an election by an individual not to receive further fundraising communications shall be treated as a revocation of authorization under the Privacy Rule.\nFurther, we proposed to provide that a covered entity may not send fundraising communications to an individual who has elected not to receive such communications. This would strengthen the current requirement at § 164.514(f)(2)(iii) that a covered entity make ''reasonable efforts'' to ensure that those individuals who have opted out of receiving fundraising communications are not sent such communications. The NPRM proposed stronger language to make clear the expectation that covered entities abide by an individual's decision not to receive fundraising communications, as well as to make the fundraising opt out operate more like a revocation of authorization, consistent with the statutory language and legislative history of section 13406(b) of the HITECH Act discussed above. With respect to the operation of the opt out, we requested comment regarding to what fundraising communications the opt out should apply (i.e., should the opt out apply to all future fundraising communications or should and can the opt out be structured in a way to apply only to the particular fundraising campaign described in the letter). We also requested comment on whether the Rule\n\nVerDate Mar&lt;15&gt;2010\n\nshould allow a similar method, short of the individual signing an authorization, by which an individual who has previously opted out can put his or her name back on an institution's fundraising list. We proposed to retain the requirement that a covered entity that intends to contact the individual to raise funds under these provisions include a statement to that effect in its notice of privacy practices. However, we proposed that the required statement also inform individuals that they have a right to opt out of receiving such communications."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 81}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 88)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\neceipt of the provider's notice of privacy practices. Other covered entities, such as health plans, would not be required to obtain this acknowledgment from individuals, but could do so if they chose.\nThe Department proposed to strengthen the notice requirements in order to preserve a valuable aspect of the consent process. The notice acknowledgment proposal was intended to create the ''initial moment'' between a covered health care provider and an individual, formerly a result of the consent requirement, when individuals may focus on information practices and privacy rights and discuss with the\n\nFmt 4701\n\nSfmt 4700\n\nE:\\FR\\FM\\14AUR4.SGM\n\npfrm17\n\nPsN: 14AUR4\n\nJkt 197001\n\nprovider any concerns related to the privacy of their protected health information. This ''initial moment'' also would provide an opportunity for an individual to make a request for additional restrictions on the use or disclosure of his or her protected health information or for additional confidential treatment of communications, as permitted under §164.522. With one exception for emergency treatment situations, the proposal would require that the good faith effort to obtain the written acknowledgment be made no later than the date of first service delivery, including service delivered electronically. To address potential operational difficulties with implementing these notice requirements in emergency treatment situations, the Department proposed in § 164.520(c)(2) to delay the requirement for provision of notice until reasonably practicable after the emergency treatment situation, and exempt health care providers with a direct treatment relationship with the individual from having to make a good faith effort to obtain the acknowledgment altogether in such situations. Other than requiring that the acknowledgment be in writing, the proposal would not prescribe other details of the form of the acknowledgment or limit the manner in which a covered health care provider could obtain the acknowledgment."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 87}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 257)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nly lack the authority under HIPAA to regulate the practices of this industry, the final rule addresses when covered entities may disclose protected health information to property and casualty insures.\nWe believe that the final rule permits property and casualty insurers to obtain the protected health information that they need to maintain their promises to their policyholders. For example, the rule permits a covered entity to use or disclose protected health information relating to an individual when authorized by the individual. Property and casualty insurers are free to obtain authorizations from individuals for release by covered entities of the health information that the insurers need to administer claims, and this rule does not affect their ability to condition payment on obtaining such an authorization from insured individuals. Property and casualty insurers providing payment on a third-party basis have an opportunity to obtain authorization from the individual and to condition payment on obtaining such authorization. The final rule also permits covered entities to make disclosures to obtain payment, whether from a health plan or from another person such as a property and casualty insurer. For example, where an automobile insurer is paying for medical benefits on a first-party basis, a health care provider may disclose protected health information to the insurer as part of a request for payment. We also include in the final rule a new provision that permits covered entities to use or disclose protected health information as authorized by workers' compensation or similar programs established by law addressing work-related injuries or illness. See § 164.512(l). These statutory programs establish channels of information sharing that are necessary\n\nFrm 00170\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nto permit compensation of injured workers."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 256}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 310)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\ncal treatment. This commenter also proposed stating that mentally retarded individuals who are able to provide agreement have the right to control the disclosure of their protected health information.\nThe commenter expressed concern that the parent, relative, or other person acting in loco parentis may not have the individual's best interest in mind in seeking or authorizing for the individual the disclosure of protected health information. Response: The final rule regulates only uses and disclosures of protected health information, not the delivery of health care. Under the final rule's section on personal representatives (§ 164.502(g)), a person with authority to make decisions about the health care of an individual, under applicable law, may make decisions about the protected health information of that individual, to the extent that the protected health information is relevant to such person's representation. Fmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nIn the final rule, § 164.510(b) may apply to permit disclosures to a person other than a personal representative. Under §164.510(b), when an individual is present and has the capacity to make his or her own decisions, a covered entity may disclose protected health information only if the covered entity: (1) Obtains the individual's agreement to disclose protected health information to the third parties involved in the individual's care; (2) provides the individual with an opportunity to object to such disclosure, and the individual does not express an objection; or (3) reasonably infers from the circumstances, based on the exercise of professional judgment, that the individual does not object to the disclosure. These conditions apply to disclosure of protected health information about individuals with mental retardation as well as to disclosures about all other individuals."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 309}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 11)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nifications [510(k)].'\n\n22 Addressing cybersecurity risks is in addition to addressing other risks, including software, biocompatibility, sterilization, and electromagnetic compatibility, among others.\n## Contains Nonbinding Recommendations\n\nthen be managed (e.g., installed, configured, updated, review of device logs) through the device design and associated labeling by the device manufacturers and/or users (e.g., patients, healthcare facilities). For healthcare facilities, these devices can also be managed within their own cybersecurity risk management frameworks, such as the National Institute of Standards and Technology (NIST) Framework for Improving Critical Infrastructure Cybersecurity, generally referred to as the NIST Cybersecurity Framework or NIST CSF. 23\n\nFDA recommends that manufacturers use device design processes such as those described in the QS regulation to support secure product development and maintenance. To preserve flexibility for manufacturers, manufacturers may use other existing frameworks that satisfy the QS regulation and align with FDA's recommendations for using an SPDF. Possible frameworks to consider include, but are not limited to, the medical device-specific framework that can be found in the Medical Device and Health IT Joint Security Plan (JSP2) 24 and IEC 81001-5-1. Frameworks from other sectors may also comply with the QS regulations, like the framework provided in ANSI/ISA 62443-4-1 Security for industrial automation and control systems Part 41: Product security development life-cycle requirements . 25\n\nThe following subsections provide recommendations for using SPDF processes that FDA believes provide important considerations for the development of devices that are safe and effective, how these processes can complement the QS regulation, and the documentation FDA recommends manufacturers provide for review as part of premarket submissions."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 10}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does nist_sp800-66r2 say about HIPAA compliance? (Part 19)"}, {"role": "assistant", "content": "According to nist_sp800-66r2:\n\nExamples of adverse impacts | Type of Impact | Impact | |--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Harm to Operations | • Inability to perform current mission or business functions o In a sufficiently timely manner o With sufficient confidence and/or correctness o Within planned resource constraints • Inability or limited ability to restore mission or business functions in the future o In a sufficiently timely manner o With sufficient confidence and/or correctness o Within planned resource constraints • Harms (e.g., financial costs, sanctions) due to noncompliance o With applicable laws or regulations o With contractual requirements or other requirements in other binding agreements (e.g., liability) • Direct financial costs • Relational harms | | Type of Impact | Impact | |-----------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | o Damage to trust relationships o Damage to image or reputation (and, hence, future or potential trust relationships) | | Harm to Assets | • Damage to or loss of physical facilities • Damage to or loss of information systems or networks • Damage to or loss of information technology or equipment • Damage to or loss of component parts or supplies • Damage to or loss of information assets • Loss of intellectual property | | Harm to Individuals"}], "metadata": {"source": "nist_sp800-66r2", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 18}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 70)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nthat the brochure or information sheet is incorporated by reference into the authorization/consent form such that it is considered to be part of the form (even if not physically attached to the form).\nIn addition, if the brochure or information sheet includes required elements of the authorization (or informed consent), and authorization/consent has not been altered by an Institutional Review Board, then the brochure or information sheet must be made available to\n\nVerDate Mar&lt;15&gt;2010\n\npotential research participants before they are asked to sign the authorization/ consent document (unless the authorization form itself includes the required elements). Finally, in such cases, a covered entity must keep not only the signed authorization/consent form, but also a copy of the brochure or information sheet, in order to be in compliance with the documentation requirements at § 164.530(j). Comment: The Secretary's Advisory Committee on Human Research Protections requested confirmation that the compound authorization proposal would not affect the waiver provisions currently existing in the Privacy Rule, such that such provisions could be used, if appropriate, for new studies distinct from both the original study and the banking activity. Response: The new compound authorization provision does not affect the waiver of authorization provisions in the Privacy Rule."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 69}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 466)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nion is deidentified (i.e., that it is not individually identifiable health information) if certain conditions are met. Currently, some entities release de-identified information for research purposes.\nDeidentified information may originate from automated systems (such as records maintained by pharmacy benefit managers) and non-automated systems (such as individual medical records maintained by providers). As compared with current practice, the rule requires that an expanded list of identifiers be removed for the data (such as driver's license numbers, and detailed geographic and certain age information). For example, as noted in a number of public comments, currently complete birth dates (day, month, and year) and zip codes are often included in deidentified information. The final rule requires that only the year of birth (except in certain circumstances) and the first three digits of the zip code can be included in de-identified information. These changes will not require extensive change from current practice. Providers generally remove most of the 19 identifiers listed in the final rule. The Department relied on Gartner Group estimates that some additional programmer time will be required by covered entities that produce deidentified information to make revisions in their procedures to eliminate additional identifiers. Entities that deidentify information will have to review existing and future data flows to assure compliance with the final rule. For example, an automated system may need to be re-programmed to remove additional identifiers from otherwise protected health information. (The costs of educating staff about the deidentification requirements are included in the cost estimate for training staff on privacy policies.)\n\nThe Department was not able to obtain any reliable information on the volume of medical data that is currently de-identified."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 465}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 37)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\novisions that require covered entities or others to use or\n\nVerDate 11&lt;MAY&gt;2000\n\n19:16 Dec 27, 2000\n\nJkt 194001\n\nPO 00000\n\nFrm 00025\n\ndisclose protected health information for specific purposes.\nWhen a covered entity is faced with a question as to whether the privacy regulation would prohibit the disclosure of protected health information that it seeks to disclose pursuant to a federal law, the covered entity should determine if the disclosure is required by that law. In other words, it must determine if the disclosure is mandatory rather than merely permissible. If it is mandatory, a covered entity may disclose the protected health information pursuant to § 164.512(a), which permits covered entities to disclose protected health information without an authorization when the disclosure is required by law. If the disclosure is not required (but only permitted) by the federal law, the covered entity must determine if the disclosure comes within one of the other permissible disclosures. If the disclosure does not come within one of the provisions for permissible disclosures, the covered entity must obtain an authorization from the individual who is the subject of the information or de-identify the information before disclosing it. If another federal law prohibits a covered entity from using or disclosing information that is also protected health information, but the privacy regulation permits the use or disclosure, a covered entity will need to comply with the other federal law and not use or disclose the information. ## Federal Disability Nondiscrimination Laws\n\nThe federal laws barring discrimination on the basis of disability protect the confidentiality of certain medical information. The information protected by these laws falls within the larger definition of ''health information'' under this privacy regulation. The two primary disability nondiscrimination laws are the Americans with Disabilities Act (ADA), 42 U.S.C. 12101 et seq."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 36}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 43)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nons within 180 days of enactment to require HIPAA covered entities and their business associates to notify affected individuals and the Secretary of breaches of unsecured protected health information.\nSection 164.404 of this interim final regulation requires HIPAA covered entities to notify affected individuals of a breach of their unsecured protected health information without reasonable delay and in any case within 60 days of discovery of the breach, and, in some cases, to notify the media of such breaches pursuant to § 164.406. Section 164.408 requires covered entities to provide the Secretary with immediate notice of all breaches of unsecured protected health information involving more than 500 individuals. Additionally, the Act requires covered entities to provide the Secretary with an annual log of all breaches of unsecured protected health information that involve less than 500 individuals. Finally, covered entities must maintain appropriate documentation under §164.530(j) to comply with their burden of proof under § 164.414. The estimated annualized burden table below was developed using the same estimates and workload assumptions in the impact statement in section V, above. erowe on DSK5CLS3C1PROD with RULES\\_2\n\n## List of Subjects\n\n## 45 CFR Part 160\n\nAdministrative practice and procedure, Computer technology, Electronic information system, Electronic transactions, Employer benefit plan, Health, Health care, Health facilities, Health insurance, Health records, Hospitals, Investigations, Medicaid, Medical research, Medicare, Penalties, Privacy, Reporting and recordkeeping requirements, Security. ## 45 CFR Part 164\n\nAdministrative practice and procedure, Computer technology, Electronic information system, Electronic transactions, Employer benefit plan, Health, Health care, Health facilities, Health insurance, Health records, Hospitals, Medicaid, Medical research, Medicare, Privacy, Reporting and recordkeeping requirements, Security."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 42}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_mod_2002 say about HIPAA compliance? (Part 114)"}, {"role": "assistant", "content": "According to privacy_mod_2002:\n\ncost savings associated with the elimination of the consent requirement. The comments did not include any reliable estimation that would cause the Department to reevaluate its savings estimate. ## 2.\nNotice\n\nIn eliminating the consent requirement, the Department preserves the opportunity for a covered health care provider with a direct treatment relationship with an individual to engage in a meaningful communication about the provider's privacy practices and the individual's rights by strengthening the notice requirements. Under the Privacy Rule, these health care providers are required to distribute to individuals their notice of privacy practices no later than the date of the first service delivery after the compliance date. The modifications do not change this distribution requirement, but add a new documentation requirement. A covered health care provider with a direct treatment relationship is required to make a good faith effort to obtain the individual's acknowledgment of receipt of the notice provided at the first service delivery. The form of the acknowledgment is not prescribed and can be as unintrusive as retaining a copy of the notice initialed by the individual. If the provider's good faith effort fails, documentation of the attempt is all that is required. Since the modification does not require any change in the form of the notice or its distribution, the tenyear cost estimate of $391 million for these areas in the Privacy Rule's impact analysis remains the same. See 65 FR 82770. However, the additional effort by direct treatment providers in obtaining and documenting the individual's acknowledgment of receipt of the notice adds costs. This new requirement attaches only to the initial provision of notice by a direct treatment provider to an individual after the compliance date. Under the modification, providers have considerable flexibility on how to achieve this."}], "metadata": {"source": "privacy_mod_2002", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 113}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does breach_notification_2009 say about HIPAA compliance? (Part 44)"}, {"role": "assistant", "content": "According to breach_notification_2009:\n\nnal, civil, or administrative proceeding arising from an alleged violation of law. *\n\n*\n\n*\n\n*\n\n*\n\n- ■ 8. In § 164.304, revise the definition of ''Access'' to read as follows:\n\n## §164.304 Definitions.\n*\n\n*\n\n*\n\n*\n\n*\n\nAccess means the ability or the means necessary to read, write, modify, or communicate data/information or otherwise use any system resource. (This definition applies to ''access'' as\n\nPO 00000\n\nFrm 00029\n\n- used in this subpart, not as used in subparts D or E of this part.)\n\n*\n\n*\n\n*\n\n*\n\n*\n\n- ■ 9. Add a new subpart D to part 164 to read as follows:\n\n## Subpart D-Notification in the Case of Breach of Unsecured Protected Health Information\n\nSec. 164.400\n\nApplicability. 164.402\n\nDefinitions. 164.404 Notification to individuals. 164.406 Notification to the media. 164.408 Notification to the Secretary. 164.410\n\nNotification by a business\n\nassociate. 164.412\n\nLaw enforcement delay. 164.414 Administrative requirements and burden of proof. Authority: Secs. 13400 and 13402, Pub. L. 111-5, 123 Stat. 258-263. ## Subpart D-Notification in the Case of Breach of Unsecured Protected Health Information\n\n## §164.400 Applicability. The requirements of this subpart shall apply with respect to breaches of protected health information occurring on or after September 23, 2009. ## §164.402 Definitions. As used in this subpart, the following terms have the following meanings:\n\nBreach means the acquisition, access, use, or disclosure of protected health information in a manner not permitted under subpart E of this part which compromises the security or privacy of the protected health information. - (1)(i) For purposes of this definition, compromises the security or privacy of the protected health information means poses a significant risk of financial, reputational, or other harm to the individual."}], "metadata": {"source": "breach_notification_2009", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 43}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 210)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nby the individual, if it is readily producible in such form and format; or, if not, in a readable hard copy form or such other form and format as agreed to by the covered entity and the individual. 2.\n(ii) Notwithstanding paragraph (c)(2)(i) of this section, if the protected health information that is the subject of a request for access is maintained in one or more designated record sets electronically and if the individual requests an electronic copy of such information, the covered entity must provide the individual with access to the protected health information in the electronic form and format requested by the individual, if it is readily producible in such form and format; or, if not, in a readable electronic form and format as agreed to by the covered entity and the individual. *\n\n*\n\n*\n\n*\n\n*\n\n- (3) Time and manner of access. (i) The covered entity must provide the access as requested by the individual in a timely manner as required by paragraph (b)(2) of this section, including arranging with the individual for a convenient time and place to inspect or obtain a copy of the protected health information, or mailing the copy of the protected health information at the individual's request. The covered entity may discuss the scope, format, and other aspects of the request for access with the individual as necessary to facilitate the timely provision of access. 2. (ii) If an individual's request for access directs the covered entity to transmit the copy of protected health information directly to another person designated by the individual, the covered entity must provide the copy to the person designated by the individual. The individual's request must be in writing, signed by the individual, and clearly identify the designated person and where to send the copy of protected health information."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 209}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "How should organizations implement technical controls?"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\n&lt;unknown&gt;\n\n## DEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nOffice of the Secretary\n\n45 CFR Parts 160 and 164\n\n## RIN 0945-AA03\n\nModifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules\n\nAGENCY: Office for Civil Rights, Department of Health and Human Services. ACTION: Final rule. SUMMARY: The Department of Health and Human Services (HHS or ''the Department'') is issuing this final rule to: Modify the Health Insurance Portability and Accountability Act (HIPAA) Privacy, Security, and Enforcement Rules to implement statutory amendments under the Health Information Technology for Economic and Clinical Health Act (''the HITECH Act'' or ''the Act'') to strengthen the privacy and security protection for individuals' health information; modify the rule for Breach Notification for Unsecured Protected Health Information (Breach Notification Rule) under the HITECH Act to address public comment received on the interim final rule; modify the HIPAA Privacy Rule to strengthen the privacy protections for genetic information by implementing section 105 of Title I of the Genetic Information Nondiscrimination Act of 2008 (GINA); and make certain other modifications to the HIPAA Privacy, Security, Breach Notification, and Enforcement Rules (the HIPAA Rules) to improve their workability and effectiveness and to increase flexibility for and decrease burden on the regulated entities. DATES: Effective date: This final rule is effective on March 26, 2013. Compliance date: Covered entities and business associates must comply with the applicable requirements of this final rule by September 23, 2013. FOR FURTHER INFORMATION CONTACT: Andra Wicks 202-205-2292. SUPPLEMENTARY INFORMATION:\n\nVerDate Mar&lt;15&gt;2010\n\n18:57 Jan 24, 2013\n\nJkt 229001\n\nsroberts on DSK5SPTVN1PROD with\n\n## I."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_type": "technical", "implementation_spec": "required", "entity_type": "both", "type": "safeguard"}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does fda_premarket_2023 say about HIPAA compliance? (Part 5)"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\nitecture View ............................................................... |   47 |\n| Appendix 3. Submission Documentation for Investigational Device Exemptions....................... | Appendix 3.\nSubmission Documentation for Investigational Device Exemptions....................... |   50 |\n| Appendix 4. General Premarket Submission Documentation Elements and Scaling with Risk .. | Appendix 4. General Premarket Submission Documentation Elements and Scaling with Risk .. |   51 |\n\n## Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nThis guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. To discuss an alternative approach, contact the FDA staff or Office responsible for this guidance as listed on the title page. ## I. Introduction\n\nWith the increasing integration of wireless, Internet- and network-connected capabilities, portable media (e.g., USB or CD), and the frequent electronic exchange of medical devicerelated health information and other information, the need for robust cybersecurity controls to ensure medical device safety and effectiveness has become more important. In addition, cybersecurity threats to the healthcare sector have become more frequent and more severe, carrying increased potential for clinical impact. Cyber incidents have rendered medical devices and hospital networks inoperable, disrupting the delivery of patient care across healthcare facilities in the U.S. and globally. Such cyber incidents and exploits may lead to patient harm as a result of clinical hazards, such as delay in diagnoses and/or treatment."}], "metadata": {"source": "fda_premarket_2023", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "covered_entity", "type": "semantic_chunk", "chunk_id": 4}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does hitech_omnibus_2013 say about HIPAA compliance? (Part 152)"}, {"role": "assistant", "content": "According to hitech_omnibus_2013:\n\nssociated with Huntington's disease), and the results of the examination do not support a diagnosis of Huntington's disease, then Huntington's disease is not manifested with respect to the individual.\nIn contrast, if the individual exhibits additional neurological and behavioral symptoms, and the results of the examination support a diagnosis of Huntington's disease by the neurologist, then Huntington's disease is manifested with respect to the individual. Frm 00100\n\nmanifested disease with respect to the individual. In contrast, if the individual undergoes a colonoscopy or other medical tests that indicate the presence of HNPCC, and the individual's physician makes a diagnosis of HNPCC, HNPCC is a manifested disease with respect to the individual. · If a health care professional with appropriate expertise makes a diagnosis based on the symptoms of the patient, and uses genetic tests to confirm the diagnosis, the disease will be considered manifested, despite the use of genetic information. For example, if a neurologist sees a patient with uncontrolled movements, a loss of intellectual faculties, and emotional disturbances, and the neurologist suspects the presence of Huntington's disease, the neurologist may confirm the diagnosis with a genetic test. While genetic information is used as part of the diagnosis, the genetic information is not the sole or principal basis for the diagnosis, and, therefore, the Huntington's disease would be considered a manifested disease of the patient. As with the definition of ''genetic test,'' the Department declines to include these examples in the regulatory text as this is inconsistent with the approach generally taken in the HIPAA Privacy Rule. The Department intends to issue future guidance on its web site with respect to the Rule's protections for genetic information. ## g."}], "metadata": {"source": "hitech_omnibus_2013", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 151}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What does privacy_rule_2000 say about HIPAA compliance? (Part 322)"}, {"role": "assistant", "content": "According to privacy_rule_2000:\n\nthorization. As discussed in greater detail in § 164.514, the final rule's minimum necessary standard applies to disclosures under § 164.512 unless the disclosure is required by law under §164.512(a).\nFrm 00213\n\nFmt 4701\n\nE:\\FR\\FM\\28DER2.SGM\n\npfrm08\n\nPsN: 28DER2\n\nSfmt 4700\n\nComment: A large number of commenters expressed concern about the potential for health oversight agencies to become, in effect, the ''back door'' for law enforcement access to such information. The commenters suggested that health oversight agencies could use their relatively unencumbered access to protected health information to circumvent the more stringent process requirements that otherwise would apply to disclosures for law enforcement purposes. These commenters urged us to prohibit health oversight agencies from re-disclosing protected health information to law enforcement. Response: As indicated above, we do not intend for the rule's permissive approach to health oversight or the absence of specific documentation to permit the government to gather large amounts of protected health information for purposes unrelated to health oversight as defined in the rule, and we do not intend for these oversight provisions to serve as a ''back door'' for law enforcement access to protected health information. While we do not have the statutory authority to regulate law enforcement and oversight agencies' re-use and re-disclosure of protected health information, we strongly support enactment of comprehensive privacy legislation that would govern public agencies' re-use and re-disclosure of this information. Furthermore, in an effort to prevent health oversight provisions from becoming the back door to law enforcement access to protected health information, the President is issuing an Executive Order that places strict limitations on the use of protected health information gathered in the course of an oversight investigation for law enforcement activities."}], "metadata": {"source": "privacy_rule_2000", "safeguard_types": ["physical", "technical", "administrative"], "entity_type": "both", "type": "semantic_chunk", "chunk_id": 321}}
{"messages": [{"role": "system", "content": "You are a HIPAA compliance expert with deep knowledge of the Security Rule, Privacy Rule, and Breach Notification Rule. You provide accurate, practical guidance on HIPAA requirements, implementation specifications, and compliance procedures. You cite specific CFR sections and distinguish between covered entity and business associate obligations."}, {"role": "user", "content": "What are the physical safeguards under HIPAA?"}, {"role": "assistant", "content": "According to fda_premarket_2023:\n\n## Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions\n\n## Guidance for Industry and Food and Drug Administration Staff\n\nDocument issued on June 27, 2025. A draft select update to this document was issued on March 13, 2024. This document supersedes 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,' issued September 27, 2023. For questions about this document regarding CDRH-regulated devices, contact CyberMed@fda.hhs.gov. For questions about this document regarding CBER-regulated devices, contact the Office of Communication, Outreach, and Development (OCOD) at 1-800-835-4709 or 240-402-8010, or by email at industry.biologics@fda.hhs.gov. <!-- image -->\n\nU.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Center for Biologics Evaluation and Research\n\n## Public Comment\n\nYou may submit electronic comments and suggestions at any time for Agency consideration to https://www.regulations.gov. Submit written comments to the Dockets Management Staff, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852. Identify all comments with the docket number FDA-2021-D-1158. Comments may not be acted upon by the Agency until the document is next revised or updated. ## Additional Copies\n\n## CDRH\n\nAdditional copies are available from the Internet. You may also send an email request to CDRH-Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number GUI00001825 and complete title of the guidance in the request."}], "metadata": {"source": "fda_premarket_2023", "safeguard_type": "physical", "implementation_spec": "required", "entity_type": "covered_entity", "type": "safeguard"}}